Citrus Sinensis ID: 006887
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FY48 | 1625 | E3 ubiquitin-protein liga | no | no | 0.416 | 0.160 | 0.295 | 3e-29 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.314 | 0.505 | 0.263 | 6e-15 | |
| P51957 | 841 | Serine/threonine-protein | yes | no | 0.387 | 0.288 | 0.257 | 8e-14 | |
| O14299 | 1401 | MAP kinase kinase kinase | yes | no | 0.416 | 0.186 | 0.259 | 1e-13 | |
| Q9Z1J2 | 792 | Serine/threonine-protein | yes | no | 0.387 | 0.306 | 0.261 | 2e-13 | |
| Q5B4Z3 | 1346 | Cytokinesis protein sepH | yes | no | 0.360 | 0.167 | 0.274 | 4e-13 | |
| Q54XJ4 | 1495 | Probable serine/threonine | yes | no | 0.258 | 0.108 | 0.327 | 4e-13 | |
| Q5BKK4 | 418 | Serine/threonine-protein | yes | no | 0.385 | 0.578 | 0.271 | 8e-13 | |
| Q6GPN6 | 434 | Serine/threonine-protein | N/A | no | 0.385 | 0.557 | 0.274 | 9e-13 | |
| A2QHV0 | 1336 | Cytokinesis protein sepH | yes | no | 0.360 | 0.169 | 0.270 | 1e-12 |
| >sp|Q9FY48|KEG_ARATH E3 ubiquitin-protein ligase KEG OS=Arabidopsis thaliana GN=KEG PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 130 bits (328), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 87/294 (29%), Positives = 143/294 (48%), Gaps = 33/294 (11%)
Query: 43 LKLRHRIGR----GPFG--EVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
+KL +IG G FG E+W AT C H VAVK + ++ + + +L
Sbjct: 137 MKLVRQIGEESSSGGFGGVEMWDATVAGGGGRCK--HRVAVKKMTLTEDMDVEWMQGQLE 194
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
L +C G+ ++G +C++M GSV M Q G+L+L + RY D+
Sbjct: 195 SLRRASMWCRNVCTFHGVVKMDGSLCLLMDRCFGSVQSEM-QRNEGRLTLEQILRYGADV 253
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG---- 212
A+G+ +LH+ G++ +N+KP N +L+ + AV+ D G+ +L P P
Sbjct: 254 ARGVAELHAAGVICMNIKPSNLLLDASGNAVVSDYGLAPILKK-PTCQKTRPEFDSSKVT 312
Query: 213 --------TPNYMAPEQWQP------EVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV 258
+P+Y APE W P E +S E+D+W F C+++EM TG P G S
Sbjct: 313 LYTDCVTLSPHYTAPEAWGPVKKLFWEDASGVSPESDAWSFGCTLVEMCTGSTPWDGLSR 372
Query: 259 DEIYDAVVRRQEIPP-----IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+EI+ AVV+ +++PP + G+P + ++ C ++ RP +L F
Sbjct: 373 EEIFQAVVKARKVPPQYERIVGVGIPRELWKMIGECLQFKPSKRPTFNAMLATF 426
|
Mediates E2-dependent protein ubiquitination. Acts as a negative regulator of abscisic acid signaling. Required for ABI5 degradation. Arabidopsis thaliana (taxid: 3702) EC: 6EC: .EC: 3EC: .EC: 2EC: .EC: - |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 83.2 bits (204), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 8/205 (3%)
Query: 122 CIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180
CII ++ +G++ + + + LS+ V R A+D+++G+ LHS+G++ +LK N +L
Sbjct: 161 CIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLL 220
Query: 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
N+ R + D G L + +GT +MAPE + P + + D + F
Sbjct: 221 NDEMRVKVADFGTSCL----ETQCREAKGNMGTYRWMAPEMIK---EKPYTRKVDVYSFG 273
Query: 241 CSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM 300
+ E+ T + P G + + AV + E PP+P+ PA+ +++ C+ + RP
Sbjct: 274 IVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDF 333
Query: 301 TDILRVFKSSQNSVHSDGGWTGHGS 325
++I+ V + V T H S
Sbjct: 334 SNIVAVLEKYDECVKEGLPLTSHAS 358
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51957|NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 79.3 bits (194), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 17/260 (6%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G+G +GEV L H D +Y V K+ R R E+ L + + +
Sbjct: 12 VGKGSYGEVTLVKH---RRDGKQY--VIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIV 66
Query: 109 CWLQGISVINGKICIIMKFYEGSVGD---RMAQLKGGKLSLSNVFRYAIDLAQGILQLHS 165
+ + +G + I+M F EG GD ++ + KG L + V + + +A + LH
Sbjct: 67 TYKESWEGGDGLLYIVMGFCEG--GDLYRKLKEQKGQLLPENQVVEWFVQIAMALQYLHE 124
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
K IL +LK N L + +GD+GI +L +S L +GTP YM+PE +
Sbjct: 125 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHCDMASTL---IGTPYYMSPELFS-- 179
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285
P ++++D W C + EM T + ++ + ++ + +PP+P P + +
Sbjct: 180 -NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPRDYSPELAEL 237
Query: 286 LLGCFEYDLRSRPLMTDILR 305
+ RP + ILR
Sbjct: 238 IRTMLSKRPEERPSVRSILR 257
|
Seems to act exclusively upon threonine residues. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O14299|WIS4_SCHPO MAP kinase kinase kinase wis4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 78.6 bits (192), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 81/312 (25%), Positives = 126/312 (40%), Gaps = 51/312 (16%)
Query: 17 VFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW----------LATHYLST 66
VF + D ++ A + SN T W + H + G FG+V+ LA +
Sbjct: 1017 VFRNRDFIKLASSFSNITIRW------QQGHFVRSGMFGDVYTGVNMETGDLLAVKEIKL 1070
Query: 67 EDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126
+D + +I + + +LERLN + G+ V K+ I M+
Sbjct: 1071 QDSRTFRSTVDQIHNEM------TVLERLNH--------PNVVTYYGVEVHREKVYIFME 1116
Query: 127 FYEG-SVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184
F +G S+ D +A G++ NV + Y + L +G+ +HS+ IL ++KP N +L+
Sbjct: 1117 FCQGGSLADLLAH---GRIEDENVLKVYVVQLLEGLAYIHSQHILHRDIKPANILLDHRG 1173
Query: 185 RAVLGDVGIPHLLLGIPLPSS----------DLPRRLGTPNYMAPEQWQPEVRGPISFET 234
D G L + P+ +L GTP YMAPE +G
Sbjct: 1174 MIKYSDFGSA---LYVSPPTDPEVRYEDIQPELQHLAGTPMYMAPEIILGTKKGDFG-AM 1229
Query: 235 DSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG--LPPAVENVLLGCFEY 292
D W C I+EM+TG P + V P IP + + + CFE
Sbjct: 1230 DIWSLGCVILEMMTGSTPWSEMDNEWAIMYHVAAMHTPSIPQNEKISSLARDFIEQCFER 1289
Query: 293 DLRSRPLMTDIL 304
D RP D+L
Sbjct: 1290 DPEQRPRAVDLL 1301
|
Involved in a signal transduction pathway that is activated in under conditions of heat shock, oxidative stress or limited nutrition. Unlike win1, it is not activated by changes in the osmolarity of the extracellular environment. Activates the wis1 MAP kinase kinase by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9Z1J2|NEK4_MOUSE Serine/threonine-protein kinase Nek4 OS=Mus musculus GN=Nek4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 78.2 bits (191), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 17/260 (6%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+GRG +GEV L H D +Y V K+ R R E+ L + + +
Sbjct: 12 VGRGSYGEVTLVKH---RRDGKQY--VIKKLNLRNASSRERRAAEQEAQLLSQLKHPNIV 66
Query: 109 CWLQGISVINGKICIIMKFYEGSVGD---RMAQLKGGKLSLSNVFRYAIDLAQGILQLHS 165
+ + +G + I+M F EG GD ++ + KG L S V + + +A + LH
Sbjct: 67 TYKESWEGGDGLLYIVMGFCEG--GDLYRKLKEQKGQLLPESQVVEWFVQIAMALQYLHE 124
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
K IL +LK N L + +GD+GI +L +S L +GTP YM+PE +
Sbjct: 125 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENHGDMASTL---IGTPYYMSPELFS-- 179
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285
P ++++D W C + EM T + ++ + ++ + +PP+P + +
Sbjct: 180 -NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKVYSTELAEL 237
Query: 286 LLGCFEYDLRSRPLMTDILR 305
+ RP + ILR
Sbjct: 238 IRTMLSRRPEERPSVRSILR 257
|
Seems to act exclusively upon threonine residues. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5B4Z3|SEPH_EMENI Cytokinesis protein sepH OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=sepH PE=3 SV=2 | Back alignment and function description |
|---|
Score = 77.0 bits (188), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPVKEDRMRVLLERLNDLFLKCQGVE 106
+GRG FG V+ A ++ + E VAVK L + + +RV++ ++ LK
Sbjct: 66 LGRGAFGSVYRALNWNTGE------TVAVKQIKLADLPKSELRVIMLEID--LLKNLDHP 117
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I QG + II+++ E +A+ G+ + V Y + G+L LH +
Sbjct: 118 NIVKYQGFVKSAETLNIILEYCENGSLHSIAK-NFGRFPETLVGVYMSQVLHGLLYLHDQ 176
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
G++ ++K N + + L D G+ G+ S +GTP +MAPE E+
Sbjct: 177 GVIHRDIKGANILTTKEGLVKLADFGVASRTTGLSESSV-----VGTPYWMAPEVI--EL 229
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285
G + +D W C++IE+L G P + + ++ V + PP+P G PAV++
Sbjct: 230 SGATT-ASDIWSLGCTVIELLEGKPPYYNLQPMPALFRIV--NDDHPPLPQGASPAVKDF 286
Query: 286 LLGCFEYD 293
L+ CF+ D
Sbjct: 287 LMQCFQKD 294
|
Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring. Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (taxid: 227321) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54XJ4|Y8901_DICDI Probable serine/threonine-protein kinase DDB_G0278901 OS=Dictyostelium discoideum GN=DDB_G0278901 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 77.0 bits (188), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/174 (32%), Positives = 92/174 (52%), Gaps = 12/174 (6%)
Query: 123 IIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182
I+M+F E +++ + + G L S V Y + G+ LH +G++ ++K N +++
Sbjct: 99 IVMEFIENGSLEKIIK-RHGLLPESLVTVYIAQVLNGLEYLHRQGVIHRDIKAANLLIST 157
Query: 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRL--GTPNYMAPEQWQPEVRGPISFETDSWGFA 240
L D G+ + + SSD P GTP +MAPE Q ++G IS D W
Sbjct: 158 DGSIKLADFGVATKVSDL---SSDNPDDTFAGTPYWMAPEVIQ--MQG-ISTACDVWSLG 211
Query: 241 CSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYD 293
C+IIE+LTG P G + +Y V +++ PPIP G+ A+++ LL CF+ D
Sbjct: 212 CTIIELLTGTPPYFGLAPAAALYKIV--QEDHPPIPPGISAALKDFLLNCFKKD 263
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5BKK4|SGK1_XENTR Serine/threonine-protein kinase Sgk1 OS=Xenopus tropicalis GN=sgk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 76.3 bits (186), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMR 89
+N KPS + IG+G FG+V LA H + DE AVK+L K++
Sbjct: 76 SNPHAKPSDFQFLKIIGKGSFGKVLLARH-----NADEKF-YAVKVLQKKAILKKKEEKH 129
Query: 90 VLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNV 149
++ ER ++ LK + L ++ I+ + G G+ L+ + L
Sbjct: 130 IMSER--NVLLKNVKHPFLVGLHFSFQTTSRLYFILDYING--GELFYHLQRERCFLEPR 185
Query: 150 FR-YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
R YA ++A + LHS I+ +LKP N +L+ +L D G+ + P+
Sbjct: 186 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIILTDFGLCKENIE---PNGTTS 242
Query: 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
GTP Y+APE + P D W + EML G+ P R+ E+YD ++ +
Sbjct: 243 TFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 299
Query: 269 QEIPPIPSGLPPAV----ENVLLGCFEYDLRSR 297
P L P + N+L G + D R
Sbjct: 300 ------PLQLKPNITNSARNLLEGLLQKDRTKR 326
|
Protein kinase that may play an important role in cellular stress response (By similarity). Plays an important role in activating certain potassium, sodium, and chloride channels, suggesting an involvement in the regulation of processes such as cell survival, neuronal excitability, and renal sodium excretion. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6GPN6|SGK1A_XENLA Serine/threonine-protein kinase Sgk1-A OS=Xenopus laevis GN=sgk1-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 75.9 bits (185), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 75/273 (27%), Positives = 116/273 (42%), Gaps = 31/273 (11%)
Query: 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMR 89
+N KPS + IG+G FG+V LA H DE AVK+L K++
Sbjct: 92 SNPHAKPSDFQFLKIIGKGSFGKVLLARH-----QADEKF-YAVKVLQKKAILKKKEEKH 145
Query: 90 VLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNV 149
++ ER ++ LK + L ++ I+ + G G+ L+ + L
Sbjct: 146 IMSER--NVLLKNVKHPFLVGLHFSFQTTSRLYFILDYING--GELFYHLQRERCFLEPR 201
Query: 150 FR-YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
R YA ++A + LHS I+ +LKP N +L+ VL D G+ + P+
Sbjct: 202 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---PNGTTS 258
Query: 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
GTP Y+APE + P D W + EML G+ P R+ E+YD ++ +
Sbjct: 259 TFCGTPEYLAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 315
Query: 269 QEIPPIPSGLPPAV----ENVLLGCFEYDLRSR 297
P L P + N+L G + D R
Sbjct: 316 ------PLQLKPNITNSARNLLEGLLQKDRTKR 342
|
Protein kinase that may play an important role in cellular stress response (By similarity). Plays an important role in activating certain potassium, sodium, and chloride channels, suggesting an involvement in the regulation of processes such as cell survival, neuronal excitability, and renal sodium excretion. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2QHV0|SEPH_ASPNC Cytokinesis protein sepH OS=Aspergillus niger (strain CBS 513.88 / FGSC A1513) GN=sepH PE=3 SV=1 | Back alignment and function description |
|---|
Score = 75.5 bits (184), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/248 (27%), Positives = 117/248 (47%), Gaps = 22/248 (8%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK--EDRMRVLLERLNDLFLKCQGVE 106
+G+G FG V+ A ++ + E VAVK + V + +RV++ ++ LK
Sbjct: 65 LGKGAFGSVYRALNWNTGE------TVAVKQIKLVDLPKSELRVIMLEID--LLKNLDHP 116
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I QG + II+++ E +A+ G+ + V Y + G+L LH +
Sbjct: 117 NIVKYQGFVKSAETLNIILEYCENGSLHSIAK-NFGRFPENLVGLYMSQVLHGLLYLHEQ 175
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
G++ ++K N + + L D G+ G+ S +GTP +MAPE E+
Sbjct: 176 GVIHRDIKGANILTTKEGLVKLADFGVASRTTGLSESSV-----VGTPYWMAPEVI--EL 228
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285
G + +D W C++IE+L G P + + ++ V + PP+P G PAV++
Sbjct: 229 SGATT-ASDIWSLGCTVIELLEGKPPYYNLQPMPALFRIV--NDDHPPLPQGASPAVKDF 285
Query: 286 LLGCFEYD 293
L+ CF+ D
Sbjct: 286 LMQCFQKD 293
|
Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring. Aspergillus niger (strain CBS 513.88 / FGSC A1513) (taxid: 425011) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | ||||||
| 255548886 | 632 | protein kinase, putative [Ricinus commun | 1.0 | 0.992 | 0.694 | 0.0 | |
| 296082051 | 750 | unnamed protein product [Vitis vinifera] | 0.979 | 0.818 | 0.702 | 0.0 | |
| 225430314 | 638 | PREDICTED: uncharacterized protein LOC10 | 0.979 | 0.962 | 0.702 | 0.0 | |
| 224089274 | 583 | predicted protein [Populus trichocarpa] | 0.921 | 0.991 | 0.743 | 0.0 | |
| 224141907 | 562 | predicted protein [Populus trichocarpa] | 0.894 | 0.998 | 0.733 | 0.0 | |
| 449437150 | 626 | PREDICTED: uncharacterized protein LOC10 | 0.977 | 0.979 | 0.653 | 0.0 | |
| 225442924 | 630 | PREDICTED: uncharacterized protein LOC10 | 0.998 | 0.993 | 0.651 | 0.0 | |
| 297743474 | 946 | unnamed protein product [Vitis vinifera] | 0.923 | 0.612 | 0.671 | 0.0 | |
| 255553227 | 658 | protein kinase, putative [Ricinus commun | 0.993 | 0.946 | 0.633 | 0.0 | |
| 297798736 | 612 | kinase family protein [Arabidopsis lyrat | 0.963 | 0.986 | 0.657 | 0.0 |
| >gi|255548886|ref|XP_002515499.1| protein kinase, putative [Ricinus communis] gi|223545443|gb|EEF46948.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2361), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/632 (69%), Positives = 529/632 (83%), Gaps = 5/632 (0%)
Query: 1 MAGKVAAGQPA-DFEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MAGKV QPA FEYE+F+ D D LRT VA+SN + WI P LKLRHRIGRGPFG+VW
Sbjct: 1 MAGKVVPAQPATSFEYELFEGDYDRLRTVVASSNQSTPWIDPENLKLRHRIGRGPFGDVW 60
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LATH+ STED DEYHEVA+K+LHPVKED +RVLL++ +DLFLKC G+EG+C ++GIS+IN
Sbjct: 61 LATHHHSTEDYDEYHEVALKMLHPVKEDHVRVLLDKFDDLFLKCGGIEGVCLIRGISIIN 120
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GKICIIM+FYEGS+GD+MA+ KGGK+SL++V RY I+LAQG+L+LH+K +LVLNLK NF
Sbjct: 121 GKICIIMRFYEGSIGDKMARRKGGKISLADVLRYGIELAQGVLELHAKDLLVLNLKSSNF 180
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+LNE D+A+LGDVGIP+LLLGIPL SSD+ LGTPNYMAPEQWQPEVRGP+S ETDSWG
Sbjct: 181 LLNENDQAILGDVGIPYLLLGIPLRSSDMSYMLGTPNYMAPEQWQPEVRGPLSAETDSWG 240
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
FAC ++EMLTG+QP GRSV+EIYD VVR+QE P IP GLPP VENVL CFEYD R+RP
Sbjct: 241 FACGVVEMLTGIQPWSGRSVEEIYDLVVRKQEKPRIPEGLPPPVENVLHSCFEYDFRNRP 300
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKS-SSGYTEWFLSKEDLKVDDVVRSRKP 357
LM DILR+FKSSQN+V+ DGGW GSR + DKS +GY++WFL K+ L+V D VRSRKP
Sbjct: 301 LMKDILRIFKSSQNAVYGDGGWRELGSRTILDKSGGTGYSKWFLLKDHLQVGDTVRSRKP 360
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
NS K ENMDVPE VVG+E + + + F+LVRV GIHDPLRV + LERVTFGLAAGDWV
Sbjct: 361 LNSSKSENMDVPEAIVVGLERDADQDGFLLVRVLGIHDPLRVPILTLERVTFGLAAGDWV 420
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RLKEE++RHSPVGILHSI RDGSVAVGF+G+ET WKG+ SELQMA+SY VGQFVRLKA +
Sbjct: 421 RLKEENKRHSPVGILHSINRDGSVAVGFIGVETFWKGNSSELQMAKSYFVGQFVRLKAKI 480
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+SP+FEWPRKR+G WATG+I ++PNGCL+V FPGRLTFGE+ ++FLADP EVE V+FNT
Sbjct: 481 LSPRFEWPRKRQGAWATGKIRHILPNGCLVVNFPGRLTFGEEHNTFLADPGEVEEVSFNT 540
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLRGAKAKKLQSSVIQKDGQH 597
CPGMVKKYQHLED+HWAVRPL IALGLFTAM++G VG+K+ +K +KL+S+V+Q D Q
Sbjct: 541 CPGMVKKYQHLEDIHWAVRPLLIALGLFTAMKVGVFVGKKMGRSKGRKLESNVVQNDDQP 600
Query: 598 VDGQVAGNP--AWLPPSMANMLSKGTSAAAGR 627
+ G +G+ AW PPS+AN+L T+AA R
Sbjct: 601 MAGPSSGHSGQAWFPPSVANILGVTTAAAPPR 632
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082051|emb|CBI21056.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2331), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/619 (70%), Positives = 519/619 (83%), Gaps = 5/619 (0%)
Query: 1 MAGKVAAGQPAD-FEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MAGK AA Q A FE+E+F+ D DHLRT VAT N + WI P+ LKLRHRIGRGPFG+VW
Sbjct: 113 MAGKAAATQSAAAFEFELFEGDPDHLRTVVATPNLISPWIDPATLKLRHRIGRGPFGDVW 172
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LAT +L ED DEYHEVA+K+LHP+KED M+V+L++L +LF KCQG++G+CWL GISVI+
Sbjct: 173 LATQHLFAEDYDEYHEVAIKMLHPIKEDLMKVVLDKLENLFSKCQGLKGVCWLHGISVIS 232
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GKICIIMKFYEGS+GD+MA LKGGKLSL ++ RY IDLAQ IL+LHSK ILVLNLKP+NF
Sbjct: 233 GKICIIMKFYEGSLGDKMAHLKGGKLSLRDILRYGIDLAQAILELHSKEILVLNLKPYNF 292
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+L++ D A+LGD+GIP+LLL IPLPSSD+ RRLGTPNYMAPEQWQPEVRGP+S ETDSWG
Sbjct: 293 LLDQNDEAILGDLGIPYLLLQIPLPSSDIARRLGTPNYMAPEQWQPEVRGPLSLETDSWG 352
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
F CSI+EMLTGVQP CG+SV+E++D+VVR+QE P IPSGLPPAVE V++GCF YD RSRP
Sbjct: 353 FGCSIVEMLTGVQPWCGKSVEEVHDSVVRKQEKPFIPSGLPPAVERVIIGCFAYDFRSRP 412
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKS-SSGYTEWFLSKEDLKVDDVVRSRKP 357
M +IL FKSS+N+V+SDGGWTG GSR + D +GY+EWFLSKE+ V D+VRSRKP
Sbjct: 413 SMKNILEAFKSSENAVYSDGGWTGLGSRTITDNFIVNGYSEWFLSKENFLVGDLVRSRKP 472
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
P+S KPENMDVP G VVG+E +++ + +VLVRV GIHDPLRVH LERVT GLAAGDWV
Sbjct: 473 PHSCKPENMDVPGGTVVGLERDSDQDGYVLVRVLGIHDPLRVHKYTLERVTSGLAAGDWV 532
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RL+ EDRR+S VGILHSI RDGSV VGF+G+ETLWKG + LQMAESYC GQFVRLKANV
Sbjct: 533 RLETEDRRNSRVGILHSISRDGSVDVGFIGMETLWKGSCTNLQMAESYCKGQFVRLKANV 592
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+SP+FEWPRKR G WATGRI V+PNGCL+V FPGRL G++CSSFLADPAEVE+V+FNT
Sbjct: 593 LSPRFEWPRKRGGAWATGRIWQVLPNGCLVVNFPGRLPIGDECSSFLADPAEVELVSFNT 652
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRK--LRGAKAKKLQSSVIQKDG 595
PG+VKKYQHLED HWAVRPL IALGLF+AM+ G VG+K + +K K+ QS++ Q +
Sbjct: 653 SPGLVKKYQHLEDFHWAVRPLLIALGLFSAMKFGIFVGKKIGIGRSKEKRGQSTMTQNES 712
Query: 596 QHVDGQVAGNPAWLPPSMA 614
Q +D Q AGN AWLP ++A
Sbjct: 713 QRLDNQTAGNAAWLPQTVA 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225430314|ref|XP_002282747.1| PREDICTED: uncharacterized protein LOC100268069 [Vitis vinifera] gi|147822641|emb|CAN70648.1| hypothetical protein VITISV_025237 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2324), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/619 (70%), Positives = 519/619 (83%), Gaps = 5/619 (0%)
Query: 1 MAGKVAAGQPAD-FEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MAGK AA Q A FE+E+F+ D DHLRT VAT N + WI P+ LKLRHRIGRGPFG+VW
Sbjct: 1 MAGKAAATQSAAAFEFELFEGDPDHLRTVVATPNLISPWIDPATLKLRHRIGRGPFGDVW 60
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LAT +L ED DEYHEVA+K+LHP+KED M+V+L++L +LF KCQG++G+CWL GISVI+
Sbjct: 61 LATQHLFAEDYDEYHEVAIKMLHPIKEDLMKVVLDKLENLFSKCQGLKGVCWLHGISVIS 120
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GKICIIMKFYEGS+GD+MA LKGGKLSL ++ RY IDLAQ IL+LHSK ILVLNLKP+NF
Sbjct: 121 GKICIIMKFYEGSLGDKMAHLKGGKLSLRDILRYGIDLAQAILELHSKEILVLNLKPYNF 180
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+L++ D A+LGD+GIP+LLL IPLPSSD+ RRLGTPNYMAPEQWQPEVRGP+S ETDSWG
Sbjct: 181 LLDQNDEAILGDLGIPYLLLQIPLPSSDIARRLGTPNYMAPEQWQPEVRGPLSLETDSWG 240
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
F CSI+EMLTGVQP CG+SV+E++D+VVR+QE P IPSGLPPAVE V++GCF YD RSRP
Sbjct: 241 FGCSIVEMLTGVQPWCGKSVEEVHDSVVRKQEKPFIPSGLPPAVERVIIGCFAYDFRSRP 300
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKS-SSGYTEWFLSKEDLKVDDVVRSRKP 357
M +IL FKSS+N+V+SDGGWTG GSR + D +GY+EWFLSKE+ V D+VRSRKP
Sbjct: 301 SMKNILEAFKSSENAVYSDGGWTGLGSRTITDNFIVNGYSEWFLSKENFLVGDLVRSRKP 360
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
P+S KPENMDVP G VVG+E +++ + +VLVRV GIHDPLRVH LERVT GLAAGDWV
Sbjct: 361 PHSCKPENMDVPGGTVVGLERDSDQDGYVLVRVLGIHDPLRVHKYTLERVTSGLAAGDWV 420
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RL+ EDRR+S VGILHSI RDGSV VGF+G+ETLWKG + LQMAESYC GQFVRLKANV
Sbjct: 421 RLETEDRRNSRVGILHSISRDGSVDVGFIGMETLWKGSCTNLQMAESYCKGQFVRLKANV 480
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+SP+FEWPRKR G WATGRI V+PNGCL+V FPGRL G++CSSFLADPAEVE+V+FNT
Sbjct: 481 LSPRFEWPRKRGGAWATGRIWQVLPNGCLVVNFPGRLPIGDECSSFLADPAEVELVSFNT 540
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRK--LRGAKAKKLQSSVIQKDG 595
PG+VKKYQHLED HWAVRPL IALGLF+AM+ G VG+K + +K K+ QS++ Q +
Sbjct: 541 SPGLVKKYQHLEDFHWAVRPLLIALGLFSAMKFGIFVGKKIGIGRSKEKRGQSTMTQNES 600
Query: 596 QHVDGQVAGNPAWLPPSMA 614
Q +D Q AGN AWLP ++A
Sbjct: 601 QRLDNQTAGNAAWLPQTVA 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224089274|ref|XP_002308671.1| predicted protein [Populus trichocarpa] gi|222854647|gb|EEE92194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2317), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/580 (74%), Positives = 503/580 (86%), Gaps = 2/580 (0%)
Query: 1 MAGKVAAGQPAD-FEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWL 59
MA KV QP FE+E+++D DHLRT VA+S+ I P+ LKLRHRIGRGPFG+VWL
Sbjct: 1 MASKVVPAQPVTPFEFELYEDPDHLRTVVASSSQPTPRIDPAKLKLRHRIGRGPFGDVWL 60
Query: 60 ATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119
ATH+ STED DE HEVAVK+LHP+KE+ MRV+L++ ++LF KCQG+E +C+L GISVING
Sbjct: 61 ATHHQSTEDYDECHEVAVKMLHPIKEEHMRVVLDKFDNLFSKCQGIENVCFLHGISVING 120
Query: 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179
KICI+MKFYEGSVGD+MA+LKGGKLSL +V RY I LAQGI QLH+K ILV NLKP +F+
Sbjct: 121 KICIVMKFYEGSVGDKMARLKGGKLSLPDVLRYGIVLAQGIAQLHAKEILVFNLKPCSFL 180
Query: 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGF 239
LNE D+AVLGDVGIP LL GIPLPS+D+ RRLGTPNYMAPEQWQPE+RGP+SFETDSWGF
Sbjct: 181 LNENDQAVLGDVGIPFLLFGIPLPSADMSRRLGTPNYMAPEQWQPEIRGPVSFETDSWGF 240
Query: 240 ACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPL 299
CS++EMLTGVQP G+SV+EIY++VVR+QE P IP GLPP VENVLLGCFEYDLRSRPL
Sbjct: 241 GCSVVEMLTGVQPWRGKSVEEIYESVVRKQEKPRIPEGLPPPVENVLLGCFEYDLRSRPL 300
Query: 300 MTDILRVFKSSQNSVHSDGGWTGHGSRILPDK-SSSGYTEWFLSKEDLKVDDVVRSRKPP 358
MTDI+RVFKSSQN+V DGGWTG GSR +K S +GYTEWFLSK+ L+V D+VRSR+PP
Sbjct: 301 MTDIVRVFKSSQNAVFVDGGWTGFGSRTTLEKFSGTGYTEWFLSKDHLQVGDMVRSRRPP 360
Query: 359 NSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVR 418
NS KPENMDVPEG VVG+E + + + FVLVRVHGIHDPLR+ VS LERVTFGLAAGDWV
Sbjct: 361 NSCKPENMDVPEGTVVGLERDPDRDGFVLVRVHGIHDPLRLPVSTLERVTFGLAAGDWVH 420
Query: 419 LKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANVV 478
LKEEDRRHSPVGILHSI+RDGSVAVGF+G+ETLWKG+ SELQMAE Y VGQFVR +ANV+
Sbjct: 421 LKEEDRRHSPVGILHSIKRDGSVAVGFIGVETLWKGNSSELQMAEPYFVGQFVRPRANVL 480
Query: 479 SPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNTC 538
SP+FEWPRK G WATGRI ++PNGCLIV+FPGRLT G++ SSFLADPAEVEVV+FN+C
Sbjct: 481 SPRFEWPRKTGGAWATGRIWWILPNGCLIVKFPGRLTIGQENSSFLADPAEVEVVSFNSC 540
Query: 539 PGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKL 578
PG+VKKYQH ED HWAVRPL IALG+FTAM++GF VG+K+
Sbjct: 541 PGVVKKYQHFEDFHWAVRPLVIALGIFTAMKVGFFVGKKI 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141907|ref|XP_002324302.1| predicted protein [Populus trichocarpa] gi|222865736|gb|EEF02867.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/562 (73%), Positives = 490/562 (87%), Gaps = 1/562 (0%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
LKLRHRIGRGPFG+VWLATH+ STED DEYHEVAVK+L P+KE+ MR++L++ + LF KC
Sbjct: 1 LKLRHRIGRGPFGDVWLATHHQSTEDYDEYHEVAVKMLQPLKEEHMRLVLDKFDGLFSKC 60
Query: 103 QGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
QGVE +C+L GISV+NGKICI+MKFYEGS+GD+MA LKGGKL+L +V RY I+LAQGI +
Sbjct: 61 QGVENVCFLHGISVMNGKICIVMKFYEGSIGDKMALLKGGKLTLPDVLRYGIELAQGIAE 120
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQW 222
LH+K ILVLNLKP +F+LNE D+AVLGD+GIP+LL GIPL SSD+P RLGTPNYMAPEQW
Sbjct: 121 LHAKEILVLNLKPCSFLLNENDQAVLGDIGIPYLLFGIPLTSSDMPWRLGTPNYMAPEQW 180
Query: 223 QPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
QPE+RGPIS ETDSWGF CSI+EMLTGV P CG+S++EIYD+VVR+QE P IP GLPP V
Sbjct: 181 QPEIRGPISSETDSWGFGCSIVEMLTGVLPWCGKSIEEIYDSVVRKQEKPHIPEGLPPPV 240
Query: 283 ENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSS-SGYTEWFL 341
EN+LLGCFEYDLRSRPLMTDILRVFKSSQN+V DGGWTG GSR + +KSS +GYTEWFL
Sbjct: 241 ENILLGCFEYDLRSRPLMTDILRVFKSSQNAVFVDGGWTGFGSRTILEKSSGAGYTEWFL 300
Query: 342 SKEDLKVDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHV 401
SK+ L+V D+VRSR+PPNS KPENMDVPEG VVG+E N + + FVLV VHGIHDPLR+ V
Sbjct: 301 SKDHLQVGDMVRSRRPPNSCKPENMDVPEGTVVGLERNPDRDGFVLVSVHGIHDPLRLPV 360
Query: 402 SALERVTFGLAAGDWVRLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQM 461
S LE+V+FGLAAGDWV LKEE+ +HSPVGILHSI RDGSVAVGF+G+ETLWKG +SELQM
Sbjct: 361 STLEKVSFGLAAGDWVHLKEENNKHSPVGILHSINRDGSVAVGFIGVETLWKGKYSELQM 420
Query: 462 AESYCVGQFVRLKANVVSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCS 521
AESY VGQFVRLK NV+SP+FEWPRK G WATG+I ++PNGCLIV+FPGR T G++ S
Sbjct: 421 AESYFVGQFVRLKTNVLSPRFEWPRKTGGAWATGKIWWILPNGCLIVKFPGRFTIGQENS 480
Query: 522 SFLADPAEVEVVTFNTCPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLRGA 581
SFLADPAEVEVV+FNTCPG+VKKYQHLED HWAVRPL IALG+FTAM++GF G+K+R +
Sbjct: 481 SFLADPAEVEVVSFNTCPGVVKKYQHLEDFHWAVRPLVIALGIFTAMKVGFFTGKKIRRS 540
Query: 582 KAKKLQSSVIQKDGQHVDGQVA 603
+ + + + +Q +GQ+ DGQ +
Sbjct: 541 RVNRPRGNAVQSNGQYTDGQTS 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437150|ref|XP_004136355.1| PREDICTED: uncharacterized protein LOC101208616 [Cucumis sativus] gi|449525714|ref|XP_004169861.1| PREDICTED: uncharacterized LOC101208616 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2219), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/620 (65%), Positives = 514/620 (82%), Gaps = 7/620 (1%)
Query: 1 MAGKVAAGQPA-DFEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
M+ + AA QP FEYE+ D D+DH+RT VA+SN ++ I+PS +KLRHRIGRG FG+VW
Sbjct: 1 MSTQEAASQPVPSFEYELLDGDTDHVRTVVASSNYSSPRIEPSKVKLRHRIGRGVFGDVW 60
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LATH+ ST+D DEYHEVAVK+L+PVKED MRV+L++L D F KCQ +G+C L G+S+I
Sbjct: 61 LATHHQSTKDYDEYHEVAVKMLNPVKEDHMRVVLDKLEDRFYKCQAAKGVCRLYGVSIIG 120
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GK+CIIMKFYEGS+ D+MA+LK GKLS +V RY I+LAQGI +LHSK ILVLN+KP N
Sbjct: 121 GKLCIIMKFYEGSIADKMARLKDGKLSPPDVLRYGINLAQGIFELHSKEILVLNMKPSNM 180
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+L D+A+LGD+GIP LL +P+P+SD+ +RLGTPNYMAPEQWQPEVRGPIS+ETDSWG
Sbjct: 181 LLTTKDQAILGDIGIPFLLHSVPIPNSDIVQRLGTPNYMAPEQWQPEVRGPISYETDSWG 240
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
FAC IIEMLTGVQP G+SVDEI+ +VVR+QE P IPSGLPP +ENVLLGCFEYDLRSRP
Sbjct: 241 FACCIIEMLTGVQPWRGKSVDEIFHSVVRKQEKPCIPSGLPPLIENVLLGCFEYDLRSRP 300
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHG-SRILPDKSSSGYTEWFLSKEDLKVDDVVRSRKP 357
LMTDIL VF+S Q H +G W G S++L S++G+TEWFLSK+ L+V+D+VRSRKP
Sbjct: 301 LMTDILNVFQSFQ---HVNGDWQAIGSSKVLNKSSATGHTEWFLSKDHLQVNDLVRSRKP 357
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
NS K +NM++PEG++VG+E TE ++FVLVRV GIHDP+RV+ S LERV+FGLAAGDW+
Sbjct: 358 LNSCKSDNMNIPEGKIVGLEGETEKDAFVLVRVRGIHDPVRVYASTLERVSFGLAAGDWI 417
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RLKE D++HSPVGILHSI R G+VAV F+G+ETLWKG+ S+ QMAES+CVGQFVR+KA++
Sbjct: 418 RLKEADKKHSPVGILHSIDRVGNVAVAFIGVETLWKGNSSQFQMAESFCVGQFVRIKASI 477
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+ P+FEW RK+ VWATG+I ++PNGCL+V+FPG L+F E+C+S++ADPAEVEVV F+T
Sbjct: 478 LRPRFEWLRKKGSVWATGKIWWILPNGCLMVKFPGILSFKEECNSYMADPAEVEVVNFST 537
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLRGAKAKKLQSSVIQKDGQH 597
CPGMVKKYQHLED HW+VRP+ IA G+FTAM++G + G+ R +K KK QS+++ + QH
Sbjct: 538 CPGMVKKYQHLEDFHWSVRPILIAFGMFTAMKLGIAFGKVGR-SKVKKGQSNLVYCESQH 596
Query: 598 VDGQVAGNPAWLPPSMANML 617
V+GQ NPAW+PP + N+L
Sbjct: 597 VEGQNTNNPAWIPPPVKNIL 616
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442924|ref|XP_002265172.1| PREDICTED: uncharacterized protein LOC100268161 isoform 1 [Vitis vinifera] gi|359482371|ref|XP_003632763.1| PREDICTED: uncharacterized protein LOC100268161 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/631 (65%), Positives = 506/631 (80%), Gaps = 5/631 (0%)
Query: 1 MAGKV-AAGQPADFEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MA K+ AA PA FEYE+F+ D DHLRT ATS + WI P++LKL+HRIGRG FG+VW
Sbjct: 1 MAEKIGAAPPPASFEYELFEGDPDHLRTVAATSTQLSPWIDPASLKLKHRIGRGLFGDVW 60
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LATH+ S +D DEYHEVAVK+LH ++ED M++ L++ +FLKC+ ++G+CWL GIS+
Sbjct: 61 LATHHQSADDYDEYHEVAVKMLHTIREDHMQMFLDKFAGIFLKCRQLKGVCWLHGISIKT 120
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GK+CI MKFYEGSVGDRMA LKGGKL LS+V RY I+LA+GI++LHS G+LVLNLKP NF
Sbjct: 121 GKVCIAMKFYEGSVGDRMAHLKGGKLPLSDVLRYGIELAKGIMELHSTGVLVLNLKPSNF 180
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+LNE D+ VLGD+GIP+LLLGIPLP+ D+ RLGTPNYMAPEQW+PEVRGPIS ETD+WG
Sbjct: 181 LLNEHDQVVLGDMGIPYLLLGIPLPNPDMVLRLGTPNYMAPEQWEPEVRGPISCETDTWG 240
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
F CSI+EMLTGVQP CGRS++EIY +VV +QE P IPSGLPP VENVL GCFEYDLR+RP
Sbjct: 241 FGCSIVEMLTGVQPWCGRSIEEIYQSVVIKQEKPHIPSGLPPEVENVLNGCFEYDLRNRP 300
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS-GYTEWFLSKEDLKVDDVVRSRKP 357
LM DIL+ F+SSQN+V+SDGGW G SR ++S+S GYT WFLSK+ L V D+VRSRKP
Sbjct: 301 LMVDILQAFESSQNAVYSDGGWIGLESRTCTERSNSRGYTSWFLSKDSLHVGDIVRSRKP 360
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
N+ KP+ MDVPEG VVG + + + + FVLV++ G H+PLRVHVS LERVT GL DWV
Sbjct: 361 LNACKPQIMDVPEGTVVGFDGDNDRDGFVLVKIRGKHNPLRVHVSTLERVTSGLVVTDWV 420
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RLKE +R+HS VGILHS+QRDGSVAVGFLGLETLW+GH SELQMAE+Y VGQFVRLK NV
Sbjct: 421 RLKEPNRKHSTVGILHSVQRDGSVAVGFLGLETLWRGHSSELQMAETYYVGQFVRLKTNV 480
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+P+F+WPRK+ G W TGRI V+PNGCL+VRFPGR FG + +SFLADPAEVE+V+F+
Sbjct: 481 FTPRFDWPRKKGGAWVTGRIAQVLPNGCLVVRFPGRFVFGVESNSFLADPAEVELVSFDK 540
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLRGAKAKKLQSSVIQKDGQH 597
C G+V+KY H+ED HWAVRPL IA G+FT +++G VG + + +K ++ DGQ
Sbjct: 541 CHGVVEKYHHIEDFHWAVRPLVIAFGVFTTLKLGVFVGGNV-CVRMRKSPRNLTPNDGQC 599
Query: 598 VDGQVAGNPAWLPPSMANMLSK-GTSAAAGR 627
DGQ GNPAW+PP++AN+L + G A R
Sbjct: 600 QDGQAGGNPAWIPPTVANILFREGPPTATAR 630
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743474|emb|CBI36341.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/582 (67%), Positives = 478/582 (82%), Gaps = 3/582 (0%)
Query: 1 MAGKV-AAGQPADFEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MA K+ AA PA FEYE+F+ D DHLRT ATS + WI P++LKL+HRIGRG FG+VW
Sbjct: 74 MAEKIGAAPPPASFEYELFEGDPDHLRTVAATSTQLSPWIDPASLKLKHRIGRGLFGDVW 133
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LATH+ S +D DEYHEVAVK+LH ++ED M++ L++ +FLKC+ ++G+CWL GIS+
Sbjct: 134 LATHHQSADDYDEYHEVAVKMLHTIREDHMQMFLDKFAGIFLKCRQLKGVCWLHGISIKT 193
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
GK+CI MKFYEGSVGDRMA LKGGKL LS+V RY I+LA+GI++LHS G+LVLNLKP NF
Sbjct: 194 GKVCIAMKFYEGSVGDRMAHLKGGKLPLSDVLRYGIELAKGIMELHSTGVLVLNLKPSNF 253
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+LNE D+ VLGD+GIP+LLLGIPLP+ D+ RLGTPNYMAPEQW+PEVRGPIS ETD+WG
Sbjct: 254 LLNEHDQVVLGDMGIPYLLLGIPLPNPDMVLRLGTPNYMAPEQWEPEVRGPISCETDTWG 313
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
F CSI+EMLTGVQP CGRS++EIY +VV +QE P IPSGLPP VENVL GCFEYDLR+RP
Sbjct: 314 FGCSIVEMLTGVQPWCGRSIEEIYQSVVIKQEKPHIPSGLPPEVENVLNGCFEYDLRNRP 373
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS-GYTEWFLSKEDLKVDDVVRSRKP 357
LM DIL+ F+SSQN+V+SDGGW G SR ++S+S GYT WFLSK+ L V D+VRSRKP
Sbjct: 374 LMVDILQAFESSQNAVYSDGGWIGLESRTCTERSNSRGYTSWFLSKDSLHVGDIVRSRKP 433
Query: 358 PNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWV 417
N+ KP+ MDVPEG VVG + + + + FVLV++ G H+PLRVHVS LERVT GL DWV
Sbjct: 434 LNACKPQIMDVPEGTVVGFDGDNDRDGFVLVKIRGKHNPLRVHVSTLERVTSGLVVTDWV 493
Query: 418 RLKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
RLKE +R+HS VGILHS+QRDGSVAVGFLGLETLW+GH SELQMAE+Y VGQFVRLK NV
Sbjct: 494 RLKEPNRKHSTVGILHSVQRDGSVAVGFLGLETLWRGHSSELQMAETYYVGQFVRLKTNV 553
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
+P+F+WPRK+ G W TGRI V+PNGCL+VRFPGR FG + +SFLADPAEVE+V+F+
Sbjct: 554 FTPRFDWPRKKGGAWVTGRIAQVLPNGCLVVRFPGRFVFGVESNSFLADPAEVELVSFDK 613
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLR 579
C G+V+KY H+ED HWAVRPL IA G+FT +++G VG ++
Sbjct: 614 CHGVVEKYHHIEDFHWAVRPLVIAFGVFTTLKLGVFVGGNVK 655
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553227|ref|XP_002517656.1| protein kinase, putative [Ricinus communis] gi|223543288|gb|EEF44820.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/630 (63%), Positives = 496/630 (78%), Gaps = 7/630 (1%)
Query: 1 MAGKVAAGQPA-DFEYEVFD-DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVW 58
MA K+ +PA FEY +F+ D DHLRT VAT + WI+P+ LKL+HRIGRG FG+VW
Sbjct: 33 MAEKIRVPEPATSFEYMLFEGDPDHLRTVVATPTQISPWIEPAELKLKHRIGRGIFGDVW 92
Query: 59 LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118
LATH+ S++D DEYHEVAVK+LHP+KED ++ +++ LFLKC+ + G+ WL GIS++N
Sbjct: 93 LATHHQSSDDFDEYHEVAVKMLHPLKEDLTQIFVDKFEKLFLKCREILGVGWLHGISIMN 152
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
G+ICI MKFY+GS+ DR+A +KGGKL LS++ RY IDLA+GI +LHS G+LVLNLKP NF
Sbjct: 153 GQICIAMKFYKGSIADRIALVKGGKLQLSDILRYGIDLAKGIQELHSIGLLVLNLKPSNF 212
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
++NE D AVLGD GI LL GIPL +S++ RLGTPNYMAPEQW+PEVRGPISFETDSWG
Sbjct: 213 LINEHDHAVLGDFGISFLLHGIPLLNSEMALRLGTPNYMAPEQWEPEVRGPISFETDSWG 272
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
F CSI+EMLTGVQP G+S++EIY +VV +QE P IP+GLPPAVENVL GCF+YDLR+RP
Sbjct: 273 FGCSIVEMLTGVQPFFGKSIEEIYQSVVIKQETPQIPNGLPPAVENVLGGCFQYDLRNRP 332
Query: 299 LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKVDDVVRSRKPP 358
LM D+L F SSQN+V+S GW G SR L KSS YT W+LS+++L++ D VRSRKP
Sbjct: 333 LMEDVLHAFHSSQNAVNSGEGWVGLESRALSGKSSGSYTAWYLSRDNLQLGDTVRSRKPL 392
Query: 359 NSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVR 418
N+ KP+ MDVP+G +VG + N + FVLV+V G+H+PLRV S LERVTFG A GDWV
Sbjct: 393 NACKPQTMDVPKGTLVGPDSNDDRNGFVLVKVAGLHNPLRVQESTLERVTFGFAEGDWVY 452
Query: 419 LKEEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANVV 478
LKEE HSPVGILHS+QRDG VAVGF+GLETLW G +S+LQMA++Y VGQFVRLKAN+V
Sbjct: 453 LKEETSMHSPVGILHSVQRDGGVAVGFVGLETLWMGTYSDLQMAKAYYVGQFVRLKANLV 512
Query: 479 SPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNTC 538
+ +F+WPRKR G WATGRI V+ NGCLIV FPGRL FG++ ++FLADPAEVEVV+F+TC
Sbjct: 513 TARFKWPRKRGGGWATGRISQVLSNGCLIVSFPGRLVFGDESNTFLADPAEVEVVSFDTC 572
Query: 539 PGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKLRGAKAKKLQSSVIQKDGQHV 598
PG+++KYQH+ED HW+VRPL IALGLFTAM++ SVGR + + KL+ +G
Sbjct: 573 PGVMEKYQHVEDFHWSVRPLAIALGLFTAMKLTLSVGRSI----STKLRKGRKSGEGHSQ 628
Query: 599 DGQVAGNPAWLPPSMANMLSK-GTSAAAGR 627
DGQ GN AWLPP +AN+L K G AA R
Sbjct: 629 DGQGGGNAAWLPPPVANILFKEGVPAATVR 658
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798736|ref|XP_002867252.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313088|gb|EFH43511.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/613 (65%), Positives = 485/613 (79%), Gaps = 9/613 (1%)
Query: 1 MAGKVAAGQPADFEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLA 60
MA K+ AG+P D EYE+ + A TS W+ S LKLRHRIGRGPFG+VWLA
Sbjct: 1 MASKIIAGKPDDSEYEIIEGESESALAAGTS----PWMNSSTLKLRHRIGRGPFGDVWLA 56
Query: 61 THYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120
TH+ STED DE+HEVA+K+LHP+KED+ RV++++ DLF KCQGVE +C L+G+S I+GK
Sbjct: 57 THHQSTEDYDEHHEVAIKMLHPIKEDQRRVVVDKFEDLFSKCQGVENVCLLRGVSSISGK 116
Query: 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180
ICIIMKFYEGSVGD+MA+LKGGKLSL +V RY +DLA GIL+LHSKG L+LNLKP NF+L
Sbjct: 117 ICIIMKFYEGSVGDKMARLKGGKLSLPDVLRYGVDLATGILELHSKGFLILNLKPSNFLL 176
Query: 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
++ D+AVLGDVGIP+LLL IPLPSSD+ RLGTP+YMAPEQWQPEVRGP+SFETDSWGF
Sbjct: 177 SDNDKAVLGDVGIPYLLLSIPLPSSDMTVRLGTPSYMAPEQWQPEVRGPMSFETDSWGFG 236
Query: 241 CSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM 300
CSI+EMLTGVQP GRS DEIYD VVR+QE IP+ +PP ++N+L GCF YDLRSRP M
Sbjct: 237 CSIVEMLTGVQPWSGRSADEIYDLVVRKQEKLSIPNTIPPPLDNLLRGCFMYDLRSRPSM 296
Query: 301 TDILRVFKSSQNSVHSDGGWTGHGSR-ILPDKSSSGYTEWFLSKEDLKVDDVVRSRKPPN 359
TDIL V KS Q S+ + W G SR I+ + GYTEWFLSK+ L+V D VRSRKP N
Sbjct: 297 TDILLVLKSLQ-SLEEEQVWRGIDSREIMKSSGTLGYTEWFLSKDHLQVGDTVRSRKPAN 355
Query: 360 SFKPENMDVPEGRVVGVEHN-TEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVR 418
S K ENMDVPEG VVG+E + T+ + F+LV+VHG+HDPLRVHVS LERVT GLA+GDWVR
Sbjct: 356 SCKHENMDVPEGIVVGLERDTTDPDGFMLVKVHGVHDPLRVHVSVLERVTSGLASGDWVR 415
Query: 419 LK-EEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
LK +D+RHSPVG+LHSI R+G+VAVGF+GL TLWKG S+LQMA++Y VGQFV+LK NV
Sbjct: 416 LKVRKDKRHSPVGVLHSIDREGNVAVGFIGLPTLWKGTSSQLQMAKAYSVGQFVKLKTNV 475
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
V P+F+W RK G+WATGRI V+PNGCL V FPG L FGE+ S LADPAEVE+V FNT
Sbjct: 476 VIPRFKWMRKSRGIWATGRISQVLPNGCLEVDFPGVLPFGEEHGSCLADPAEVEIVNFNT 535
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKL-RGAKAKKLQSSVIQKDGQ 596
C G+VKKYQHLED+HWAVRPL IA+GL TAM++GF VG+K+ R K+ S Q D +
Sbjct: 536 CQGVVKKYQHLEDIHWAVRPLLIAMGLLTAMKLGFFVGKKIGRSKDGKQRDGSSGQDDCK 595
Query: 597 HVDGQVAGNPAWL 609
DG+ +G WL
Sbjct: 596 IPDGKGSGKSKWL 608
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 627 | ||||||
| TAIR|locus:2116545 | 611 | AT4G32250 [Arabidopsis thalian | 0.963 | 0.988 | 0.632 | 6.5e-209 | |
| TAIR|locus:2185061 | 1625 | KEG "AT5G13530" [Arabidopsis t | 0.400 | 0.154 | 0.273 | 9.5e-21 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.441 | 0.481 | 0.255 | 3.3e-14 | |
| WB|WBGene00003472 | 1420 | mtk-1 [Caenorhabditis elegans | 0.484 | 0.214 | 0.243 | 3.6e-13 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.425 | 0.489 | 0.242 | 8.1e-13 | |
| UNIPROTKB|E1C5S2 | 786 | NEK4 "Uncharacterized protein" | 0.390 | 0.311 | 0.240 | 2.5e-12 | |
| TAIR|locus:2092890 | 1368 | MAPKKK7 "mitogen-activated pro | 0.382 | 0.175 | 0.273 | 2.5e-12 | |
| UNIPROTKB|E1BWZ5 | 838 | NEK4 "Uncharacterized protein" | 0.390 | 0.292 | 0.240 | 2.8e-12 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.457 | 0.503 | 0.233 | 3.1e-12 | |
| TAIR|locus:2077417 | 1367 | MAPKKK6 "mitogen-activated pro | 0.379 | 0.174 | 0.275 | 3.2e-12 |
| TAIR|locus:2116545 AT4G32250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2020 (716.1 bits), Expect = 6.5e-209, P = 6.5e-209
Identities = 388/613 (63%), Positives = 470/613 (76%)
Query: 1 MAGKVAAGQPADFEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLA 60
MA K+ AG+P D EYE+ + A TS W+ S LKLRHRIGRGPFG+VWLA
Sbjct: 1 MASKIIAGKPDDTEYEIIEGESESALAAGTS----PWMNSSTLKLRHRIGRGPFGDVWLA 56
Query: 61 THYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120
TH+ STED DE+HEVA+K+L+P+KED+ RV++++ DLF KCQG+E +C L+G+S INGK
Sbjct: 57 THHQSTEDYDEHHEVAIKMLYPIKEDQRRVVVDKFEDLFSKCQGLENVCLLRGVSSINGK 116
Query: 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180
IC++MKFYEGS+GD+MA+LKGGKLSL +V RY +DLA GIL+LHSKG L+LNLKP NF+L
Sbjct: 117 ICVVMKFYEGSLGDKMARLKGGKLSLPDVLRYGVDLATGILELHSKGFLILNLKPSNFLL 176
Query: 181 NEADRAVLGDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
++ D+A+LGDV SSD+ RLGTPNYMAPEQWQP+VRGP+SFETDSWGF
Sbjct: 177 SDNDKAILGDVGIPYLLLSIPLPSSDMTERLGTPNYMAPEQWQPDVRGPMSFETDSWGFG 236
Query: 241 CSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM 300
CSI+EMLTGVQP GRS DEIYD VVR+QE IPS +PP +EN+L GCF YDLRSRP M
Sbjct: 237 CSIVEMLTGVQPWSGRSADEIYDLVVRKQEKLSIPSSIPPPLENLLRGCFMYDLRSRPSM 296
Query: 301 TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS-GYTEWFLSKEDLKVDDVVRSRKPPN 359
TDIL V KS QNS + G SR + S++ GYTEWFLSK+ L+V D VRSRKP N
Sbjct: 297 TDILLVLKSLQNS-EEEQVRRGIDSREIRKSSATLGYTEWFLSKDHLQVRDTVRSRKPAN 355
Query: 360 SFKPENMDVPEGRVVGVEHN-TEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVR 418
S K ENMDVPEG VVG+E + T+ + FVLV+VHG+HDPLRVHVS LERVT GLA+GDWVR
Sbjct: 356 SCKHENMDVPEGMVVGLERDSTDPDGFVLVKVHGVHDPLRVHVSVLERVTNGLASGDWVR 415
Query: 419 LK-EEDRRHSPVGILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANV 477
LK +D+RHSPVG+LHSI R+G+VAVGF+GL TLWKG S+LQMA+ Y VGQFV+LKANV
Sbjct: 416 LKVRKDKRHSPVGVLHSIDREGNVAVGFIGLPTLWKGTSSQLQMAKVYSVGQFVKLKANV 475
Query: 478 VSPQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFGEQCSSFLADPAEVEVVTFNT 537
V P+F+W RK G+WATGRI V+PNGCL V FPG L FGE+ S+LADPAEVE+V FNT
Sbjct: 476 VIPRFKWMRKGRGIWATGRISQVLPNGCLEVDFPGMLPFGEEHGSYLADPAEVEIVNFNT 535
Query: 538 CPGMVKKYQHLEDLHWAVRPLFIALGLFTAMQMGFSVGRKL-RGAKAKKLQSSVIQKDGQ 596
C G V+KYQHLED HWAVRPL IA+GL TAM++G V +K+ R K+ S Q D +
Sbjct: 536 CQGAVEKYQHLEDFHWAVRPLLIAMGLLTAMKLGICVRKKIGRSKDGKQRDGSTGQGDCK 595
Query: 597 HVDGQVAGNPAWL 609
DG+ + WL
Sbjct: 596 IPDGKGSDKSKWL 608
|
|
| TAIR|locus:2185061 KEG "AT5G13530" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 193 (73.0 bits), Expect = 9.5e-21, Sum P(2) = 9.5e-21
Identities = 77/282 (27%), Positives = 126/282 (44%)
Query: 52 GPFG--EVWLATHYLSTEDCDEYHEVAVK---ILHPVKEDRMRVLLERLNDLFLKCQGVE 106
G FG E+W AT C H VAVK + + + M+ LE L + C+ V
Sbjct: 150 GGFGGVEMWDATVAGGGGRCK--HRVAVKKMTLTEDMDVEWMQGQLESLRRASMWCRNV- 206
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGG-KLSL-----SNVFRYAIDL-AQG 159
C G+ ++G +C++M GSV M + +G L ++V R +L A G
Sbjct: 207 --CTFHGVVKMDGSLCLLMDRCFGSVQSEMQRNEGRLTLEQILRYGADVARGVAELHAAG 264
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRA-VLGDVXXXXXXXXXXXXSSDLPRRLGT--PNY 216
++ ++ K +L N ++++ A +L L T P+Y
Sbjct: 265 VICMNIKPSNLLLDASGNAVVSDYGLAPILKKPTCQKTRPEFDSSKVTLYTDCVTLSPHY 324
Query: 217 MAPEQWQP------EVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
APE W P E +S E+D+W F C+++EM TG P G S +EI+ AVV+ ++
Sbjct: 325 TAPEAWGPVKKLFWEDASGVSPESDAWSFGCTLVEMCTGSTPWDGLSREEIFQAVVKARK 384
Query: 271 IPP-----IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+PP + G+P + ++ C ++ RP +L F
Sbjct: 385 VPPQYERIVGVGIPRELWKMIGECLQFKPSKRPTFNAMLATF 426
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 215 (80.7 bits), Expect = 3.3e-14, P = 3.3e-14
Identities = 76/298 (25%), Positives = 135/298 (45%)
Query: 25 RTAVATSND-TNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP 82
RT V ND T+ W I LK H+I G +G+++ T+ C + EVA+K+L P
Sbjct: 270 RTHVPIPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTY------CSQ--EVAIKVLKP 321
Query: 83 VKEDRMRVLLERLNDLFLKCQ-GVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLK 140
+ D + E ++F+ + + + G +CI+ +F G SV D + + K
Sbjct: 322 ERLDS-DLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQK 380
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVXXXXXXXXX 200
G L +F+ AID+ +G+ LH I+ +LK N +++E + + D
Sbjct: 381 G-VFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQT 439
Query: 201 XXXSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE 260
+++ GT +MAPE + + P + D + + + E+LTG P + +
Sbjct: 440 GVMTAET----GTYRWMAPEVIEHK---PYDHKADVFSYGIVLWELLTGKLPYEYMTPLQ 492
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318
VV++ P IP P + +L +E+D RP ++I+ + V +G
Sbjct: 493 AAVGVVQKGLRPTIPKNTHPKLAELLERLWEHDSTQRPDFSEIIEQLQEIAKEVGEEG 550
|
|
| WB|WBGene00003472 mtk-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 211 (79.3 bits), Expect = 3.6e-13, P = 3.6e-13
Identities = 80/329 (24%), Positives = 136/329 (41%)
Query: 16 EVFDDSDHLRTAVATSNDTNAWIK-PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHE 74
+V D + +AT D K P L I G FG V A D D +
Sbjct: 1099 KVITDDNRRNFVLAT--DKKITTKAPFQWALLDHIASGSFGSVHRAM------DIDSHRV 1150
Query: 75 VAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD 134
+A K++ ++ + + + +N +F + E + G+ V + + I M++ +
Sbjct: 1151 IAAKVMR-IQRENHKAIESEIN-IFRQLIH-ENLVKYYGVQVEDSDVIIFMEYCSQGTLE 1207
Query: 135 RMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVXXX 194
R+ GK+ L V +Y L + + LHS I+ ++KP N L++ LGD
Sbjct: 1208 RICH---GKMDLKMVRQYTNSLLRAVQYLHSHKIIHRDIKPANIFLDKCTVLKLGDFGCS 1264
Query: 195 XXXXXXXXXSSDLPRRLGTPNYMAPEQW----QPEVRGPISF---ETDSWGFACSIIEML 247
+ GTP +MAPE + + E G S D W +++ M+
Sbjct: 1265 SRLVESSTVYGEFQTTAGTPQFMAPEIYSYGEKDETTGSYSGYGRSVDIWALGATVVNMM 1324
Query: 248 TGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
TG P G++ +I A+ R++ P P + P V+ CFE+ RP ++L+
Sbjct: 1325 TGKVPFEGQTRHQIAFALCFRKQKPTYPDIADKRPDVKRFFDNCFEFLPNDRPTAAELLQ 1384
Query: 306 VFKSSQNSVHSDGGWT-GHGSRILPDKSS 333
++ N D + S+ DKSS
Sbjct: 1385 TTFANVNITFQDENHIPDYQSQSSKDKSS 1413
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 202 (76.2 bits), Expect = 8.1e-13, P = 8.1e-13
Identities = 70/289 (24%), Positives = 135/289 (46%)
Query: 31 SNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR 89
++ T+ W I + LK+ ++ G +G++ T+ C + EVA+K L P + +
Sbjct: 273 TDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTY------CSQ--EVAIKFLKPDRVNN-E 323
Query: 90 VLLERLNDLFL--KCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSL 146
+L E ++F+ K + + +L G + +CI+ +F GS+ D + + K L
Sbjct: 324 MLREFSQEVFIMRKVRHKNVVQFL-GACTRSPTLCIVTEFMARGSIYDFLHKQKCA-FKL 381
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVXXXXXXXXXXXXSSD 206
+ + A+D+A+G+ LH I+ +LK N +++E + D +++
Sbjct: 382 QTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAE 441
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
GT +MAPE + + P + + D + +A + E+LTG P + + VV
Sbjct: 442 T----GTYRWMAPEVIEHK---PYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVV 494
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315
++ P IP P V+ +L C+ D RPL +I+ + + V+
Sbjct: 495 QKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVN 543
|
|
| UNIPROTKB|E1C5S2 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 200 (75.5 bits), Expect = 2.5e-12, P = 2.5e-12
Identities = 62/258 (24%), Positives = 113/258 (43%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G+G +GEV L H +D +Y + + H R R E+ L + + +
Sbjct: 12 VGKGSYGEVSLVRH---RQDSKQYVIKKLNLKHA--SSRERKAAEQEAQLLSQLKHPNIV 66
Query: 109 CWLQGISVINGKICIIMKFYEGS-VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG 167
+ + +G + I+M F EG + R+ + KG L + V + + +A + LH K
Sbjct: 67 AYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 126
Query: 168 ILVLNLKPFNFILNEADRAVLGDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQWQPEVR 227
IL +LK N L + +GD+ +S L +GTP YM+PE + +
Sbjct: 127 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELFSNK-- 181
Query: 228 GPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLL 287
P ++++D W C + EM T + ++ + ++ + +PP+P P + ++
Sbjct: 182 -PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPQLVEIIQ 239
Query: 288 GCFEYDLRSRPLMTDILR 305
RP + ILR
Sbjct: 240 TMLSKRPEQRPSVKSILR 257
|
|
| TAIR|locus:2092890 MAPKKK7 "mitogen-activated protein kinase kinase kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 203 (76.5 bits), Expect = 2.5e-12, P = 2.5e-12
Identities = 70/256 (27%), Positives = 120/256 (46%)
Query: 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQG 104
L IG+G +G V+ L E+ D V + + V+ED + +++ + DL LK
Sbjct: 22 LGDEIGKGAYGRVYKG---LDLENGDFVAIKQVSLENIVQED-LNTIMQEI-DL-LKNLN 75
Query: 105 VEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+ I G S + II+++ E GS+ + + K G S V Y + +G++ L
Sbjct: 76 HKNIVKYLGSSKTKTHLHIILEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYL 135
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQWQ 223
H +G++ ++K N + + L D + + +GTP +MAPE
Sbjct: 136 HEQGVIHRDIKGANILTTKEGLVKLADFGVATKLNEADVNTHSV---VGTPYWMAPEVI- 191
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPPAV 282
E+ G + +D W C++IE+LT V P + + ++ V + + PPIP L P +
Sbjct: 192 -EMSG-VCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIV--QDDNPPIPDSLSPDI 247
Query: 283 ENVLLGCFEYDLRSRP 298
+ L CF+ D R RP
Sbjct: 248 TDFLRQCFKKDSRQRP 263
|
|
| UNIPROTKB|E1BWZ5 NEK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 200 (75.5 bits), Expect = 2.8e-12, P = 2.8e-12
Identities = 62/258 (24%), Positives = 113/258 (43%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G+G +GEV L H +D +Y + + H R R E+ L + + +
Sbjct: 12 VGKGSYGEVSLVRH---RQDSKQYVIKKLNLKHA--SSRERKAAEQEAQLLSQLKHPNIV 66
Query: 109 CWLQGISVINGKICIIMKFYEGS-VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG 167
+ + +G + I+M F EG + R+ + KG L + V + + +A + LH K
Sbjct: 67 AYRESWQGEDGLLYIVMGFCEGGDLYHRLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 126
Query: 168 ILVLNLKPFNFILNEADRAVLGDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQWQPEVR 227
IL +LK N L + +GD+ +S L +GTP YM+PE + +
Sbjct: 127 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELFSNK-- 181
Query: 228 GPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLL 287
P ++++D W C + EM T + ++ + ++ + +PP+P P + ++
Sbjct: 182 -PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPQLVEIIQ 239
Query: 288 GCFEYDLRSRPLMTDILR 305
RP + ILR
Sbjct: 240 TMLSKRPEQRPSVKSILR 257
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 197 (74.4 bits), Expect = 3.1e-12, P = 3.1e-12
Identities = 72/309 (23%), Positives = 140/309 (45%)
Query: 13 FEYEVFDDSDHLRTAVATSND-TNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCD 70
FE++ ++ L V D T+ W I LK+ ++ G +GE++ T+ C
Sbjct: 261 FEHDK-STNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGTY------CS 313
Query: 71 EYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ-GVEGICWLQGISVINGKICIIMKFY- 128
+ EVA+KIL P + + +L E ++++ + + + G + +CI+ +F
Sbjct: 314 Q--EVAIKILKPERVNA-EMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 129 EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188
GS+ D + + KG + ++ + A+D+++G+ LH I+ +LK N +++E + +
Sbjct: 371 RGSIYDFLHKHKG-VFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKV 429
Query: 189 GDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT 248
D +++ GT +MAPE + + P D + +A + E+LT
Sbjct: 430 ADFGVARVQTESGVMTAET----GTYRWMAPEVIEHK---PYDHRADVFSYAIVLWELLT 482
Query: 249 GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
G P + + VV++ P IP P + +L C++ D RP +I+ +
Sbjct: 483 GELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIEMLN 542
Query: 309 SSQNSVHSD 317
V D
Sbjct: 543 QLIREVGDD 551
|
|
| TAIR|locus:2077417 MAPKKK6 "mitogen-activated protein kinase kinase kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 202 (76.2 bits), Expect = 3.2e-12, P = 3.2e-12
Identities = 71/258 (27%), Positives = 121/258 (46%)
Query: 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPVKEDRMRVLLERLNDLFLKC 102
L IG+G +G V++ L E+ D VA+K L + ++ + +++ + DL LK
Sbjct: 22 LGDEIGKGAYGRVYIG---LDLENGDF---VAIKQVSLENIGQEDLNTIMQEI-DL-LKN 73
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
+ I G + II+++ E GS+ + + K G S V Y + +G++
Sbjct: 74 LNHKNIVKYLGSLKTKTHLHIILEYVENGSLANIIKPNKFGPFPESLVTVYIAQVLEGLV 133
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVXXXXXXXXXXXXSSDLPRRLGTPNYMAPEQ 221
LH +G++ ++K N + + L D + + +GTP +MAPE
Sbjct: 134 YLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLNEADFNTHSV---VGTPYWMAPEV 190
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPP 280
E+ G + +D W C+IIE+LT V P + + +Y V + + PPIP L P
Sbjct: 191 I--ELSG-VCAASDIWSVGCTIIELLTCVPPYYDLQPMPALYRIV--QDDTPPIPDSLSP 245
Query: 281 AVENVLLGCFEYDLRSRP 298
+ + L CF+ D R RP
Sbjct: 246 DITDFLRLCFKKDSRQRP 263
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00032670001 | SubName- Full=Putative uncharacterized protein (Chromosome chr4 scaffold_6, whole genome shotgun sequence); (638 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 627 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-09 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 0.001 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.001 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.001 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.001 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.003 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.004 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.004 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.004 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 48/261 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G FG V+LA D +VA+KI+ + L R ++ K I
Sbjct: 1 LGEGGFGTVYLA------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNI 53
Query: 109 CWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG 167
L G+ + ++M++ E GS+ D + + GKLS + R + + +G+ LHS G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 168 ILVLNLKPFNFILNEAD-RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
I+ +LKP N +L+ + + L D G+ LL +GTP YMAPE +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT---IVGTPAYMAPEVLLGK- 168
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286
G S ++D W + E+ P +++++
Sbjct: 169 -GYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194
Query: 287 LGCFEYDLRSRPLMTDILRVF 307
+ D RP +IL
Sbjct: 195 RKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 70/269 (26%), Positives = 104/269 (38%), Gaps = 36/269 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPVKEDRMRVL------LERL 95
+GRG FG V+LA T + +AVK L E+ + L L L
Sbjct: 3 TRGELLGRGSFGSVYLAL-DKDTGE-----LMAVKSVELSGDSEEELEALEREIRILSSL 56
Query: 96 NDLFL-KCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYA 153
+ + G E + I +++ GS+ + K GKL + +Y
Sbjct: 57 QHPNIVRYYGSE-------RDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYT 107
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ +G+ LHS GI+ ++K N +++ L D G L I R GT
Sbjct: 108 RQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR-GT 166
Query: 214 PNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYDAVVRRQ 269
P +MA PEV D W C++IEM TG P G + +Y +
Sbjct: 167 PYWMA-----PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSG 220
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
E P IP L ++ L C D + RP
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 23/267 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLK 101
++ ++G G FG+V+LA T VA+K++ +K+DR R+L E LK
Sbjct: 2 EILEKLGEGSFGKVYLARD-KKTG-----KLVAIKVIKKKKIKKDRERILREIK---ILK 52
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGI 160
I L + K+ ++M++ EG GD LK G+LS Y + +
Sbjct: 53 KLKHPNIVRLYDVFEDEDKLYLVMEYCEG--GDLFDLLKKRGRLSEDEARFYLRQILSAL 110
Query: 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPE 220
LHSKGI+ +LKP N +L+E L D G+ L ++ +GTP YMAPE
Sbjct: 111 EYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT----FVGTPEYMAPE 166
Query: 221 QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPIPS-GL 278
D W + E+LTG P G + E++ + + + P P +
Sbjct: 167 VLL---GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305
P ++++ D R + L+
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 67/275 (24%), Positives = 104/275 (37%), Gaps = 28/275 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVE 106
+G G FGEV+LA VA+K+L E + R +
Sbjct: 8 LGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQGILQLH 164
I L G + ++M++ +G + + + G G LS S + + LH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 165 SKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPR---RLGTPNYMAPE 220
SKGI+ ++KP N +L+ R V L D G+ LL SS +GTP YMAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 221 QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-----------RQ 269
S +D W ++ E+LTG+ P G ++
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P P + A ++L D ++R + L
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/264 (26%), Positives = 105/264 (39%), Gaps = 21/264 (7%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVE 106
++G G FG V+ A H VAVKIL E R + +
Sbjct: 6 KLGSGSFGTVYKAKHK------GTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH-P 58
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHS 165
I L + ++M++ EG GD L +GG LS + A+ + +G+ LHS
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEG--GDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
GI+ +LKP N +L+E + D G+ LL SS L +GTP YMAPE
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLK---SSSSLTTFVGTPWYMAPEVLL-- 171
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQP---RCGRSVDEIYDAVVRRQEIPPIP--SGLPP 280
+ D W + E+LTG P ++ ++ P S
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 281 AVENVLLGCFEYDLRSRPLMTDIL 304
++++ C D RP +IL
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 52/278 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVA--VKILHPVKEDRMRVLLE------------- 93
IG+G FG+V+L D Y V + + + +++R L E
Sbjct: 8 IGKGSFGKVYLVRR---KSDGKLY--VLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK-----GGKLSLSN 148
+ + F + GK+CI+M++ +G GD ++K G
Sbjct: 63 KYYESFEE----------------KGKLCIVMEYADG--GDLSQKIKKQKKEGKPFPEEQ 104
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
+ + + L + LHS+ IL ++KP N L LGD GI +L + DL
Sbjct: 105 ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS----TVDLA 160
Query: 209 R-RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267
+ +GTP Y++PE Q P ++++D W C + E+ T P G ++ E+ +++
Sbjct: 161 KTVVGTPYYLSPELCQ---NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
Q PPIPS + N++ + D RP + IL+
Sbjct: 218 GQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
++ +IG+G FGEV+ A H + + EVA+K++ +++ ++ + + KC+
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGK------EVAIKVIKLESKEKKEKIINEIQ-ILKKCK 55
Query: 104 -----GVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
G +L+ ++ I+M+F GS+ D + + L+ S + +L
Sbjct: 56 HPNIVKYYG-SYLK-----KDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELL 108
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+G+ LHS GI+ ++K N +L L D G+ L ++ +GTP +M
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWM 164
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTG 249
APE P ++ D W + IE+ G
Sbjct: 165 APEVIN---GKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 16/190 (8%)
Query: 120 KICIIMKFYEGSVGD-----RMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLK 174
K+CI+M++ GD + K + ++R I L +G+ LH + IL +LK
Sbjct: 73 KLCIVMEYAPF--GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK 130
Query: 175 PFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET 234
N +L D +GD+GI +L + ++GTP+YMAPE W+ P S+++
Sbjct: 131 SANILLVANDLVKIGDLGISKVLKKNMAKT-----QIGTPHYMAPEVWK---GRPYSYKS 182
Query: 235 DSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDL 294
D W C + EM T P RS+ ++ V R + PPIP ++N + +
Sbjct: 183 DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSMLQVKP 241
Query: 295 RSRPLMTDIL 304
+ RP IL
Sbjct: 242 KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177
GK+ I+M++ E G + + +G L V+R+ I + G+ LHSK IL ++K N
Sbjct: 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLN 131
Query: 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR-LGTPNYMAPEQWQPEVRGPISFETDS 236
L+ D +GD+G+ LL +++ +GTP Y++PE + + P + ++D
Sbjct: 132 LFLDAYDNVKIGDLGVAKLL----SDNTNFANTIVGTPYYLSPELCEDK---PYNEKSDV 184
Query: 237 WGFACSIIEMLTGVQPRCGRSVDEIYDAVVR---RQEIPPIPSGLPPAVENVLLGCFEYD 293
W + E TG P + A++ R PP+ + ++ C D
Sbjct: 185 WALGVVLYECCTGKHPFDANN----QGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240
Query: 294 LRSRPLMTDILR 305
R RP +LR
Sbjct: 241 YRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 21/272 (7%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF--L 100
L L ++G G FGEV+ T L + + EVAVK L ++ R + L
Sbjct: 1 LTLGKKLGEGAFGEVYKGT--LKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
+ + L G+ + I+M++ G + D + + + +LSLS++ +A+ +A+G
Sbjct: 59 DHPNI--VK-LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP---NY 216
+ L SK + +L N ++ E + D G L L D + G +
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFG-----LSRDLYDDDYYKVKGGKLPIRW 170
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
MAPE + G + ++D W F + E+ T G +P G S E+ + + + P P
Sbjct: 171 MAPESLK---EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLPKP 226
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
PP + ++L C+ D RP ++++ +
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 22/272 (8%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF--L 100
L L ++G G FGEV+ L + + EVAVK L ++ R + L
Sbjct: 1 LTLGKKLGEGAFGEVYKGK--LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
V + L G+ + I+M++ E G + + + KLSLS++ +A+ +A+G
Sbjct: 59 DHPNV--VK-LLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARG 114
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP---NY 216
+ L SK + +L N ++ E + D G L L D R+ G +
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFG-----LSRDLYDDDYYRKRGGKLPIRW 169
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
MAPE + G + ++D W F + E+ T G QP G S +E+ + + P P
Sbjct: 170 MAPESLK---EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQP 225
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
PP + +++L C+ D RP ++++ +
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 71/274 (25%), Positives = 114/274 (41%), Gaps = 19/274 (6%)
Query: 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL- 98
P+ + +G+G FG V+L D D E+AVK + + + +N L
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCY------DVDTGRELAVKQVPFDPDSPE--TKKEVNALE 52
Query: 99 ----FLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYA 153
LK E I G + + I M++ G SV D++ G L+ + +Y
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYT 110
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ +G+ LHS I+ ++K N + + A LGD G L I + + GT
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
P +M+PE E G + D W C+++EMLT P + + P
Sbjct: 171 PYWMSPEVISGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ 227
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+PS + P N L F + + RP ++LR F
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 39/281 (13%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
L+L ++G G FGEV+ T E + +VAVK L KE E + FL+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTET--KVAVKTL---KEGAS----EEEREEFLE- 50
Query: 103 QGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFR 151
E I L G+ + I+ ++ G + D + + G KL+L ++ +
Sbjct: 51 ---EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQ 106
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG----IPLPSSDL 207
A+ +A+G+ L SK + +L N ++ E + D G+ + L
Sbjct: 107 MALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL 166
Query: 208 PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
P +MAPE + G + ++D W F + E+ T G QP G S +E+ + +
Sbjct: 167 P-----IKWMAPESLK---DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL- 217
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
P P P + ++L C+ YD RP ++++
Sbjct: 218 EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 36/261 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPVKEDRMRV------LLERLNDLFL 100
IGRG FG V+ + + ++ VA+K L +KE+ ++ LL+ L
Sbjct: 8 IGRGAFGVVYKGLN----LETGDF--VAIKQISLEKIKEEALKSIMQEIDLLKNLKH--- 58
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
I G + + II+++ E GS+ + K G S V Y + QG
Sbjct: 59 -----PNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQG 111
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR--LGTPNYM 217
+ LH +G++ ++K N + + L D G + L +GTP +M
Sbjct: 112 LAYLHEQGVIHRDIKAANILTTKDGVVKLADFG-----VATKLNDVSKDDASVVGTPYWM 166
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE + S +D W C++IE+LTG P + +V+ PP+P G
Sbjct: 167 APEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH-PPLPEG 222
Query: 278 LPPAVENVLLGCFEYDLRSRP 298
+ P +++ L+ CF+ D RP
Sbjct: 223 ISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 39/259 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMR-VLLERLNDLFLKCQG 104
IG G F V LA + + E A+KIL +KE +++ V +E+ ++ + G
Sbjct: 9 IGEGSFSTVVLAK------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK--EVLTRLNG 60
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQ 162
GI L + ++++ G+ + Q K G L YA ++ +
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPN--GE-LLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 163 LHSKGILVLNLKPFNFILNEADRA---------VLGDVGIPHLLLGIPLPSSDLPRRL-- 211
LHSKGI+ +LKP N +L++ VL P G +
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 212 ------GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265
GT Y++PE P +D W C I +MLTG P G + + +
Sbjct: 178 RFASFVGTAEYVSPELLN---EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 266 VRRQEIPPIPSGLPPAVEN 284
++ + P PP ++
Sbjct: 235 LKLE--YSFPPNFPPDAKD 251
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 5e-17
Identities = 65/267 (24%), Positives = 104/267 (38%), Gaps = 50/267 (18%)
Query: 49 IGRGPFGEVWLATH----------YLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL 98
+G+G FG+V L L + + EV H + E R +L R+N
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE----HTLTE---RNILSRINHP 53
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
F+ V+ Q K+ +++++ G G+ + L K G+ S YA ++
Sbjct: 54 FI----VKLHYAFQT----EEKLYLVLEYAPG--GELFSHLSKEGRFSEERARFYAAEIV 103
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL------ 211
+ LHS GI+ +LKP N +L+ L D G+ + +L
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL----------AKELSSEGSRTNTF 153
Query: 212 -GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
GTP Y+APE D W + EMLTG P EIY+ +++
Sbjct: 154 CGTPEYLAPEVLL---GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP- 209
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSR 297
P L P +++ G + D R
Sbjct: 210 -LRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 17/260 (6%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G+G +GEV L H D +Y V K+ R R E+ L + + +
Sbjct: 8 VGKGSYGEVSLVRH---RTDGKQY--VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 109 CWLQGISVINGKICIIMKFYEGSVGD---RMAQLKGGKLSLSNVFRYAIDLAQGILQLHS 165
+ + +G + I+M F EG GD ++ + KG L + V + + +A + LH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEG--GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
K IL +LK N L + +GD+GI +L +S L +GTP YM+PE + +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELFSNK 177
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285
P ++++D W C + EM T + ++ + ++ ++PP+P P + +
Sbjct: 178 ---PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGEL 233
Query: 286 LLGCFEYDLRSRPLMTDILR 305
+ RP + ILR
Sbjct: 234 IATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 46/283 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER----LNDLFLKCQG 104
+G G FGEV+ L +D + EVAVK L + R + + L G
Sbjct: 3 LGEGAFGEVYKGK--LKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-----G 54
Query: 105 VEGICWLQGISVINGKICIIMKFYEG--------SVGDRMAQLKGGKLSLSNVFRYAIDL 156
+ L G+ + +++++ EG + LSL ++ +AI +
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD---------L 207
A+G+ L SK + +L N ++ E + D G L + D L
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFG-----LSRDVYDDDYYRKKTGGKL 169
Query: 208 PRRLGTPNYMAPEQWQPEVRGPI-SFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265
P R +MAPE ++ I + ++D W F + E+ T G P G S +E+ + +
Sbjct: 170 PIR-----WMAPES----LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
Query: 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
R+ P P P + ++L C++ D RP ++++ +
Sbjct: 221 -RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 63/251 (25%), Positives = 95/251 (37%), Gaps = 38/251 (15%)
Query: 44 KLRHRIGRGPFGEVW----------LATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE 93
+L IG+G FG+V A Y++ + C E V +L R +L+
Sbjct: 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVL------NERRILQ 55
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD-RMAQLKGGKLSLSNVFRY 152
LN FL L + +++ G GD R + K S V +
Sbjct: 56 ELNHPFL--------VNLWYSFQDEENMYLVVDLLLG--GDLRYHLSQKVKFSEEQVKFW 105
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
++ + LHSKGI+ ++KP N +L+E + D I + P + G
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV----TPDTLTTSTSG 161
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-- 270
TP YMAPE + S D W + E L G +P G S I D + +QE
Sbjct: 162 TPGYMAPEVLCRQGY---SVAVDWWSLGVTAYECLRGKRPYRGHS-RTIRDQIRAKQETA 217
Query: 271 IPPIPSGLPPA 281
P+
Sbjct: 218 DVLYPATWSTE 228
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 78/275 (28%), Positives = 117/275 (42%), Gaps = 24/275 (8%)
Query: 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL- 98
P +L +GRG FGEV+L D D E+AVK + P D E +N L
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCY------DADTGRELAVKQV-PFDPDSQETSKE-VNALE 52
Query: 99 ----FLKCQGVEGICWLQGI--SVINGKICIIMKFYEG-SVGDRMAQLKG-GKLSLSNVF 150
LK + I G K+ I +++ G S+ D QLK G L+ +
Sbjct: 53 CEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD---QLKAYGALTENVTR 109
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
RY + QG+ LHS I+ ++K N + + A LGD G + I + + +
Sbjct: 110 RYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
GTP +M+PE E G + D W AC+++EMLT P + +
Sbjct: 170 TGTPYWMSPEVISGEGYGR---KADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P +P G+ A + L F + + RP +LR
Sbjct: 227 KPMLPDGVSDACRDFLKQIF-VEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 63/242 (26%), Positives = 105/242 (43%), Gaps = 37/242 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-------RVLLERLNDLFLK 101
I +G +G V+LA ST D A+K+ +K+ M +VL ER D+ +
Sbjct: 1 ISKGAYGRVFLAKK-KSTGDI-----YAIKV---IKKADMIRKNQVDQVLTER--DILSQ 49
Query: 102 CQG---VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLA 157
Q V+ QG + ++M++ G GD + L+ G L Y ++
Sbjct: 50 AQSPYVVKLYYSFQGKK----NLYLVMEYLPG--GDLASLLENVGSLDEDVARIYIAEIV 103
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGD-----VGIPHLLLGIPLPSSDLPRRLG 212
+ LHS GI+ +LKP N +++ L D VG+ + + + R +G
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
TP+Y+APE + S D W C + E L G+ P G + +EI+ ++ +I
Sbjct: 164 TPDYIAPEVI---LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-KIE 219
Query: 273 PI 274
Sbjct: 220 WP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 77/287 (26%), Positives = 112/287 (39%), Gaps = 58/287 (20%)
Query: 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKI---------LHPVKEDRMRVLLERL 95
++IG G FG+V+ A + D +AVK D M+VL E L
Sbjct: 4 RGNKIGGGTFGKVYTAV------NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVL-ELL 56
Query: 96 NDLFL-KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAI 154
L K GVE V K+ I M++ G + + + G L + Y +
Sbjct: 57 KHPNLVKYYGVE---------VHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTL 106
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---- 210
L +G+ LHS GI+ ++KP N L+ LGD G L ++
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL----KNNTTTMGEEVQS 162
Query: 211 -LGTPNYMAPEQWQPEVRGPISFET--------DSWGFACSIIEMLTGVQP--RCGRSVD 259
GTP YMAPE I+ D W C ++EM TG +P
Sbjct: 163 LAGTPAYMAPEV--------ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214
Query: 260 EIYDAVVRRQEIPPIPS--GLPPAVENVLLGCFEYDLRSRPLMTDIL 304
++ V PPIP L P ++ L C E D + RP +++L
Sbjct: 215 IMFH--VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL----LERLNDLFL---- 100
+G+G FGEV A +T ++ K L ++M +L LE++N F+
Sbjct: 1 LGKGGFGEV-CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 101 -KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
+ +C + +S++NG +K++ +VG+R L + V Y+ + G
Sbjct: 60 YAFESKTHLCLV--MSLMNGGD---LKYHIYNVGER-------GLEMERVIHYSAQITCG 107
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD-LPRRLGTPNYMA 218
IL LHS I+ ++KP N +L++ L D+G L + L + +R GT YMA
Sbjct: 108 ILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLG-----LAVELKDGKTITQRAGTNGYMA 162
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
PE + E P S+ D + CSI EM+ G P
Sbjct: 163 PEILKEE---PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLFLKCQG 104
I +G FG V+LA + +Y A+K+L K V ER + QG
Sbjct: 4 ISKGAFGSVYLAKKRST----GDY--FAIKVLKKSDMIAKNQVTNVKAERAI---MMIQG 54
Query: 105 ----VEGICWLQGISVINGK-ICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQ 158
V + + S + + ++M++ G GD + +K G L +Y ++
Sbjct: 55 ESPYVAKLYY----SFQSKDYLYLVMEYLNG--GDCASLIKTLGGLPEDWAKQYIAEVVL 108
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYM 217
G+ LH +GI+ ++KP N ++++ L D G+ L ++ GTP+Y+
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL--------ENKKFVGTPDYL 160
Query: 218 APEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
APE + G +D W C I E L G P + D ++D ++ R
Sbjct: 161 APET----ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 36/278 (12%)
Query: 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFL 100
S L+ +G+G G V+ H + + A+K +H ++ R L R
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGK------IYALKKIHVDGDEEFRKQLLRELKTLR 54
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
C+ + G G+I I++++ + GS+ D + K GK+ + A + +G
Sbjct: 55 SCE-SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKG 111
Query: 160 ILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL------- 211
+ LH+K I+ ++KP N ++N + D GI S L L
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI----------SKVLENTLDQCNTFV 161
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGV---QPRCGRSVDEIYDAVVRR 268
GT YM+PE+ Q E S+ D W +++E G P S E+ A+
Sbjct: 162 GTVTYMSPERIQGE---SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-D 217
Query: 269 QEIPPIPSGL-PPAVENVLLGCFEYDLRSRPLMTDILR 305
P +P+ P + + C + D + RP ++L+
Sbjct: 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 69/266 (25%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR----VLLERLNDLFLKCQG 104
IG G FG+++LA +E C E+ + + PVKE +LL ++ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNI---- 61
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL---KGGKLSLSNVFRYAIDLAQGIL 161
V Q NG++ I+M++ +G GD M ++ +G S + + + ++ G+
Sbjct: 62 VTFFASFQE----NGRLFIVMEYCDG--GDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 162 QLHSKGILVLNLKPFNFILNEADR-AVLGDVGIPHLLLGIPLPSSDLPRR-LGTPNYMAP 219
+H + IL ++K N L++ A LGD GI L S +L +GTP Y++P
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----SMELAYTCVGTPYYLSP 171
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
E Q P + +TD W C + E+ T P G ++ ++ + + PI
Sbjct: 172 EICQNR---PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-FAPISPNFS 227
Query: 280 PAVENVLLGCFEYDLRSRPLMTDILR 305
+ +++ F+ R RP +T IL+
Sbjct: 228 RDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 73/254 (28%), Positives = 112/254 (44%), Gaps = 23/254 (9%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IG+G FG+V LA D Y AVK+L K+++ ++ ER ++ LK
Sbjct: 3 IGKGSFGKVLLAKR---KSDGSFY---AVKVLQKKTILKKKEQNHIMAER--NVLLKNLK 54
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQL 163
+ L K+ ++ + G G+ L+ + L R YA ++A I L
Sbjct: 55 HPFLVGLHYSFQTAEKLYFVLDYVNG--GELFFHLQRERCFLEPRARFYAAEVASAIGYL 112
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS I+ +LKP N +L+ VL D G+ G+ P GTP Y+APE +
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVE-PEETTSTFCGTPEYLAPEVLR 169
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283
E P D W + EML G+ P R V ++YD ++ + +P G A
Sbjct: 170 KE---PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--QLPGGKTVAAC 224
Query: 284 NVLLGCFEYDLRSR 297
++L+G D R R
Sbjct: 225 DLLVGLLHKDQRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 72/270 (26%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 45 LRHRIGRGPFGEVWLA--THYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLF 99
L+ R+G+G FG V+L ++ E E+ V L+P V+ ++ LL +L+
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-- 61
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDL 156
I + CII ++ EG + ++ +LK G LS + V + I L
Sbjct: 62 ------PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPN 215
G+ +H + IL +LK N L + +GD G+ LL+G S DL GTP
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG----SCDLATTFTGTPY 170
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275
YM+PE + + G S ++D W C + EM G++ + +V P +P
Sbjct: 171 YMSPEALKHQ--GYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLP 226
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ +++ D RP +ILR
Sbjct: 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 37 WIKPSA-LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W P LKL ++G G FGEVW+AT+ +++ +VAVK + P + L
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATY-------NKHTKVAVKTMKPGSMS-VEAFLAEA 52
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAI 154
N +K + + L + V I II +F GS+ D + +G K L + ++
Sbjct: 53 N--VMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
+A+G+ + + + +L+ N +++ + + D G+ + + ++ R G
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-----IEDNEYTAREGAK 164
Query: 215 NYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270
P +W PE G + ++D W F ++E++T G P G S E+ A+ R
Sbjct: 165 ---FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR 221
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRP 298
+P + P + N+++ C++ RP
Sbjct: 222 MPRPEN-CPEELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 42/274 (15%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV-- 105
++G G FG V + + VAVK L K L + ++D + +
Sbjct: 2 KLGDGSFGVVRRGE---WSTSGGKVIPVAVKCLKSDK------LSDIMDDFLKEAAIMHS 52
Query: 106 ---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
E + L G+ V+ + ++ + GS+ DR+ + G +S + YA+ +A G+
Sbjct: 53 LDHENLIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG--------T 213
L SK + +L N +L D+ +GD G L R L
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFG--------------LMRALPQNEDHYVME 157
Query: 214 PNYMAPEQW-QPEVRGPISFE--TDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269
+ P W PE +F +D W F ++ EM T G +P G S +I + +
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
E P P + NV+L C+ ++ RP +
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 37/261 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG- 107
+G+G FG+V LA + +E+ A+K L K+D V+LE D ++C VE
Sbjct: 3 LGKGSFGKVMLA----ELKGTNEFF--AIKAL---KKD---VVLE---DDDVECTMVERR 47
Query: 108 ----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDL 156
+ L + +M++ G GD M ++ G+ + YA ++
Sbjct: 48 VLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG--GDLMFHIQSSGRFDEARARFYAAEI 105
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
G+ LH KGI+ +LK N +L++ + D G+ + +S GTP+Y
Sbjct: 106 ICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF---CGTPDY 162
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE + + + D W F + EML G P G DE++D++ + P P
Sbjct: 163 IAPEILKGQK---YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPR 217
Query: 277 GLPPAVENVLLGCFEYDLRSR 297
+ ++ L FE D R
Sbjct: 218 WISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 14/137 (10%)
Query: 120 KICIIMKFYEGSVGD---RMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPF 176
+C++M G GD + + + YA + G+ LH + I+ +LKP
Sbjct: 67 DLCLVMTLMNG--GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE 124
Query: 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-RLGTPNYMAPEQWQPEVRGPISFETD 235
N +L++ G+V I L L + L + R GTP YMAPE Q EV F D
Sbjct: 125 NVLLDD-----HGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV---YDFSVD 176
Query: 236 SWGFACSIIEMLTGVQP 252
+ C++ EM+ G P
Sbjct: 177 WFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 29/273 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK------EDRMRVLLERLNDLFLKC 102
IG+G +G V+LA + + E +AVK + + R + +++ L
Sbjct: 9 IGKGTYGRVYLALNVTTGE------MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 103 QGVE--GICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
+ ++ I G + I +++ G S+G + G+ V + + +G
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEG 120
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ LHSKGIL +LK N +++ + D GI I ++ + G+ +MAP
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAP 179
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR---RQEIPPIP- 275
E +G S + D W C ++EM G +P S +E A+ + ++ PPIP
Sbjct: 180 EVIHSYSQG-YSAKVDIWSLGCVVLEMFAGRRP---WSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 276 ---SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
L P + L CF + +RP ++L+
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 69/264 (26%), Positives = 105/264 (39%), Gaps = 22/264 (8%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEG 107
+G+G +G V+ A D +A+K + P ++ R ++ L E +
Sbjct: 16 LGKGTYGIVYAA------RDLSTQVRIAIKEI-PERDSRYVQPLHEEI--ALHSYLKHRN 66
Query: 108 ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSL--SNVFRYAIDLAQGILQLHS 165
I G NG I M+ G + + K G L + Y + +G+ LH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 166 KGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGI-PLPSSDLPRRLGTPNYMAPEQWQ 223
I+ ++K N ++N V + D G L GI P + GT YMAPE
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET----FTGTLQYMAPEVID 182
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
RG D W C+I+EM TG P G ++ + + P IP L
Sbjct: 183 KGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH-PEIPESLSAE 240
Query: 282 VENVLLGCFEYDLRSRPLMTDILR 305
+N +L CFE D R D+L+
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/266 (24%), Positives = 121/266 (45%), Gaps = 24/266 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I ++KL ++G G FGEVW+ + ST +VAVK L P ++ LE N
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNST-------KVAVKTLKPGTMS-VQAFLEEAN- 53
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+K + + L + I II ++ +GS+ D + +GGK+ L + ++ +
Sbjct: 54 -LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 112
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
A+G+ + K + +L+ N +++E+ + D G+ + + ++ R G
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV-----IEDNEYTAREGAK-- 165
Query: 217 MAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272
P +W PE G + ++D W F + E++T G P G S ++ A+ R +P
Sbjct: 166 -FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRP 298
P + +++ C++ RP
Sbjct: 225 R-MENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 15/121 (12%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-R 210
YA ++ G+ LH + + +LKP N +L++ + D+G L + +P + R R
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLG-----LAVKIPEGESIRGR 161
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
+GT YMAPE + D WG C I EM+ G P GR V+R+E
Sbjct: 162 VGTVGYMAPEVLNNQRYT---LSPDYWGLGCLIYEMIEGQSPFRGRK------EKVKREE 212
Query: 271 I 271
+
Sbjct: 213 V 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 124 IMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182
+M+F G GD M ++ G+ L YA ++ G+ LHSKGI+ +LK N +L+
Sbjct: 74 VMEFLNG--GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 183 ADRAVLGDVGI-PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFAC 241
+ D G+ + G S+ GTP+Y+APE Q +F D W F
Sbjct: 132 DGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEILQGL---KYTFSVDWWSFGV 184
Query: 242 SIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+ EML G P G DE+++++ R + P P + +++L FE D R
Sbjct: 185 LLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 22/263 (8%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL-LERLNDLFLKCQGVEG 107
+G G FG V+ L+ +D D + V + + + V LE+ L K Q
Sbjct: 8 LGSGSFGSVYEG---LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PN 63
Query: 108 ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I G + I ++ GS+ + K G + Y + G+ LH +
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 167 GILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
+ ++K N IL + + V L D G+ ++ S G+P +MAPE +
Sbjct: 122 NTVHRDIKGAN-ILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWMAPEVIAQQ 176
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV---VRRQEIPPIPSGLPPAV 282
G D W C+++EM TG P S E AV R +E+PPIP L
Sbjct: 177 --GGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 283 ENVLLGCFEYDLRSRPLMTDILR 305
++ +L C + D RP ++L
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 70/263 (26%), Positives = 110/263 (41%), Gaps = 31/263 (11%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IG+G FG+V LA H +E AVK+L K++ ++ ER ++ LK
Sbjct: 3 IGKGSFGKVLLARH-----KAEEKF-YAVKVLQKKAILKKKEEKHIMSER--NVLLKNVK 54
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQL 163
+ L K+ ++ + G G+ L+ + L R YA ++A + L
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYING--GELFYHLQRERCFLEPRARFYAAEIASALGYL 112
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS I+ +LKP N +L+ VL D G+ + + GTP Y+APE
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---HNGTTSTFCGTPEYLAPEVLH 169
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283
+ P D W + EML G+ P R+ E+YD ++ + P L P +
Sbjct: 170 KQ---PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNIT 220
Query: 284 N----VLLGCFEYDLRSRPLMTD 302
N +L G + D R D
Sbjct: 221 NSARHLLEGLLQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 9/187 (4%)
Query: 121 ICIIMKFYEG-SVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
+ I M++ G SV D QLK G L+ S +Y + +G+ LHS I+ ++K N
Sbjct: 81 LTIFMEYMPGGSVKD---QLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI 137
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+ + A LGD G L I + + + GTP +M+PE E G + D W
Sbjct: 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR---KADVWS 194
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
C+++EMLT P + + P +PS + + LGC + R RP
Sbjct: 195 LGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD-FLGCIFVEARHRP 253
Query: 299 LMTDILR 305
++LR
Sbjct: 254 SAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 69/268 (25%), Positives = 110/268 (41%), Gaps = 30/268 (11%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G FGEV+ T VAVK L D+ + + L I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNI 61
Query: 109 CWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK--------LSLSNVFRYAIDLAQGI 160
L G+ ++N IIM+ EG GD ++ L+ + L+L + +D+A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEG--GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 161 LQLHSKGILVLNLKPFNFILNE----ADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTP- 214
+ L + +L N +++E ADR V +GD G L + SD R+ G
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG-----LARDIYKSDYYRKEGEGL 174
Query: 215 ---NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270
+MAPE + G + ++D W F + E+LT G QP + E+ V
Sbjct: 175 LPVRWMAPESL---LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRP 298
+ P P + ++ C+ D RP
Sbjct: 232 LQK-PENCPDKIYQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 43/234 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG- 107
+G+G FG+V LA + DE + A+KIL K+D + + D ++C VE
Sbjct: 8 LGKGSFGKVMLAER----KGTDELY--AIKIL---KKDVV------IQDDDVECTMVEKR 52
Query: 108 ----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDL 156
+ L ++ +M++ G GD M Q++ G+ + YA ++
Sbjct: 53 VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG--GDLMYQIQQVGRFKEPHAVFYAAEI 110
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI--PHLLLGIPLPSSDLPRRLGTP 214
A G+ LHSKGI+ +LK N +L+ + D G+ ++ G+ + GTP
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF-----CGTP 165
Query: 215 NYMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
+Y+APE +QP + D W F + EML G P G DE++ +++
Sbjct: 166 DYIAPEIIAYQPYGK-----SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 24/264 (9%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEY--HEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV 105
+IG G FG+ L ED +Y E+ + + P + + R + L+++
Sbjct: 7 KIGEGSFGKAILVKS---KEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-----KH 58
Query: 106 EGICWLQGISVINGKICIIMKFYEGSVGD---RMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
I Q NG + I+M + EG GD ++ +G + + + + +
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEG--GDLYKKINAQRGVLFPEDQILDWFVQICLALKH 116
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR-LGTPNYMAPEQ 221
+H + IL ++K N L + LGD GI +L + +L R +GTP Y++PE
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----TVELARTCIGTPYYLSPEI 172
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
+ P + ++D W C + EM T ++ + ++R PP+ S
Sbjct: 173 CENR---PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYD 228
Query: 282 VENVLLGCFEYDLRSRPLMTDILR 305
+ N++ F+ + R RP + IL
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 53/278 (19%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-------RMRVLLERLNDLFLK 101
IGRG +G V+ H + VA+KI++ D R LL +L +
Sbjct: 9 IGRGAYGAVYRGKHVPTG------RVVALKIINLDTPDDDVSDIQREVALLSQL-----R 57
Query: 102 CQGVEGI-----CWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLS---LSNVFRYA 153
I +L+G + IIM++ EG G +K G ++ +S + R
Sbjct: 58 QSQPPNITKYYGSYLKGPRL-----WIIMEYAEG--GSVRTLMKAGPIAEKYISVIIR-- 108
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
++ + +H G++ ++K N ++ L D G+ LL S +GT
Sbjct: 109 -EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF---VGT 164
Query: 214 PNYMAPEQWQPEVRGPISFET--DSWGFACSIIEMLTGVQPRCG----RSVDEIYDAVVR 267
P +MAPE + ++T D W +I EM TG P R++ I +
Sbjct: 165 PYWMAPEV----ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP 220
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
R E +G + + C + + + R ++L+
Sbjct: 221 RLE----DNGYSKLLREFVAACLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLFLKCQG- 104
+G+G FG+V LA E Y AVK+L +++D + + L L
Sbjct: 3 LGKGSFGKVMLAR---LKESGRLY---AVKVLKKDVILQDDDVECTMTEKRILSLARNHP 56
Query: 105 --VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGIL 161
+ C Q ++ +M+F G GD M + K + + YA ++ ++
Sbjct: 57 FLTQLYCCFQTPD----RLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEITSALM 110
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
LH KGI+ +LK N +L+ L D G+ + +S GTP+Y+APE
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF---CGTPDYIAPEI 167
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
Q + GP D W + EML G P + D++++A++ + + P
Sbjct: 168 LQEMLYGP---SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 47/249 (18%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMR-VLLER--------- 94
++G+G +G+V+LA +D E VA+K + K + +R VL ER
Sbjct: 8 QVGQGGYGQVFLA----KKKDTGEI--VALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 95 -LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRY 152
L L Q E + + M++ G GD L G LS + Y
Sbjct: 62 WLVKLLYAFQDDE-------------YLYLAMEYVPG--GDFRTLLNNLGVLSEDHARFY 106
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
++ + + LH G + +LKP NF+++ + L D G+ + +S +G
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG--IVTYANS----VVG 160
Query: 213 TPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271
+P+YMAPE +RG F D W C + E L G P G + +E ++ + +E
Sbjct: 161 SPDYMAPEV----LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 272 PPIPSGLPP 280
P P
Sbjct: 217 LQRPVYDDP 225
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 40/118 (33%), Positives = 58/118 (49%), Gaps = 9/118 (7%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-R 210
YA ++ G+ LH + I+ +LKP N +L++ G + I L L + +P + R R
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDD-----YGHIRISDLGLAVEIPEGETIRGR 161
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
+GT YMAPE + E +F D WG C I EM+ G P R + V RR
Sbjct: 162 VGTVGYMAPEVVKNE---RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 49/280 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRM-------RVLLERLNDL 98
+G+G FG+V LA T++ AVK+L +++D + RVL
Sbjct: 3 LGKGSFGKVLLA-ELKGTDEL-----YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHP 56
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL + Q ++ +M++ G GD M + + G+ YA ++
Sbjct: 57 FL----TQLHSCFQTKD----RLFFVMEYVNG--GDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
G+ LH +GI+ +LK N +L+ + D G+ GI L GTP+Y+
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGI-LGGVTTSTFCGTPDYI 163
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE + P D W + EML G P G DE++ +++ + P
Sbjct: 164 APEILSYQ---PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VRYPRW 218
Query: 278 LPPAVENVL-----------LGCFEY---DLRSRPLMTDI 303
L +++L LGC D++ P +I
Sbjct: 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 28/270 (10%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--VKEDRMRVLLERLNDLFLKCQGV 105
+IG+G FG+V+ +TE VAVK + + + L E LK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-------VAVKTCRSTLPPDLKRKFLQE---AEILKQYDH 51
Query: 106 EGICWLQGISVINGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQL 163
I L G+ V I I+M+ G G + L K +L++ + + ++D A G+ L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPG--GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
SK + +L N ++ E + + D G+ G SD +++ P +W
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-------PIKWT 162
Query: 224 -PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
PE G + E+D W + + E + G P G S + + + +P P P
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCP 221
Query: 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ ++L C+ YD +RP ++I +
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 73/262 (27%), Positives = 111/262 (42%), Gaps = 38/262 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLER-----LNDLFL 100
+G+G FG+V+L D A+K+L DR+R +ER +N F
Sbjct: 4 LGQGSFGKVFLVRKITGP---DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF- 59
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQG 159
I L GK+ +I+ F G GD +L K + +V Y +LA
Sbjct: 60 -------IVKLHYAFQTEGKLYLILDFLRG--GDLFTRLSKEVMFTEEDVKFYLAELALA 110
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR----LGTPN 215
+ LHS GI+ +LKP N +L+E L D G+ S D ++ GT
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVE 163
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275
YMAPE R + D W F + EMLTG P G+ E +++ + +P
Sbjct: 164 YMAPEVVN---RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--GMP 218
Query: 276 SGLPPAVENVLLGCFEYDLRSR 297
L P +++L F+ + +R
Sbjct: 219 QFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLND 97
P+ +L +G+G FG V+L D D E+AVK + P + + +N
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCY------DADTGRELAVKQVQFDPESPETSK----EVNA 50
Query: 98 LFLKCQGVEGICWLQGISV-------INGKICIIMKFY-EGSVGDRMAQLKG-GKLSLSN 148
L + Q ++ + + + + + I M+ GS+ D QLK G L+ +
Sbjct: 51 LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENV 107
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
+Y + +G+ LHS I+ ++K N + + LGD G L I L + +
Sbjct: 108 TRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
GTP +M+PE E G + D W C+++EMLT P + E A+ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGR---KADIWSVGCTVVEMLTEKPP---WAEFEAMAAIFKI 221
Query: 269 QEIPPIPSGLPPAVENV---LLGCFEYDLRSRPLMTDILR 305
P P LPP V + L + + RP ++LR
Sbjct: 222 ATQPTNPV-LPPHVSDHCRDFLKRIFVEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 62/286 (21%), Positives = 119/286 (41%), Gaps = 30/286 (10%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
LK ++G G FG+V L Y D + +VAVK L+ E++ R ER ++ L+
Sbjct: 6 LKFIKQLGEGHFGKVELC-RYDPLGD-NTGEQVAVKSLNHSGEEQHRSDFEREIEI-LRT 62
Query: 103 QGVEGICWLQGISVINGK--ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
E I +G+ G + +IM++ GS+ D + + + +++L + ++ + +G
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKG 121
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ L S+ + +L N ++ D + D G+ + LP + P +P
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV-----LPEDKDYYYVKEPG-ESP 175
Query: 220 EQW-QPEV--RGPISFETDSWGFACSIIEMLTGVQP------------RCGRSVDEIYDA 264
W PE S +D W F ++ E+ T P + +
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 265 VVRRQEIP--PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
+ +E P P P V +++ C+E + + RP D++ +
Sbjct: 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 47/192 (24%), Positives = 73/192 (38%), Gaps = 22/192 (11%)
Query: 127 FYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184
F E G ++ L K G + + Y L +G+ LH I+ ++K N +++
Sbjct: 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG 140
Query: 185 RAV-LGDVGIPHLLLGIPLPSSDLPRR-------LGTPNYMAPEQWQPEVRGPISFETDS 236
+ + + D G L ++ LGT +MAPE + E G D
Sbjct: 141 QRLRIADFGAAARL------AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSC---DV 191
Query: 237 WGFACSIIEMLTGVQPRCGRSVDEIYDAVVR---RQEIPPIPSGLPPAVENVLLGCFEYD 293
W C IIEM T P + + P IP L P + +V L C E
Sbjct: 192 WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQ 251
Query: 294 LRSRPLMTDILR 305
RP ++L+
Sbjct: 252 PEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 27/284 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
++ + L+ +G G FG+V+L Y E ++ VAVK L + R ER +
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECY-HLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEG--------SVGDRMAQLKG-----GKL 144
L L E I G+ ++ ++ E S G A LK G+L
Sbjct: 61 L-LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204
+LS + + A+ +A G++ L S+ + +L N ++ +GD G+ + +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT 174
Query: 205 SDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260
+D R G M P +W P + + E+D W F + E+ T G QP G S +E
Sbjct: 175 TDYYRVGGHT--MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
+ + + + + + P P V +++LGC++ D + R + DI
Sbjct: 233 VIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 27/263 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERL---NDLFLKCQG 104
+G G FG L H S + K V++ R VLL ++ N + K +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK-ES 66
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSL---SNVFRYAIDLAQGIL 161
E +G + I+M++ +G GD M ++K + L + ++ + + G+
Sbjct: 67 FEA----------DGHLYIVMEYCDG--GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
+H K +L ++K N L + + LGD G LL P + +GTP Y+ PE
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS---PGAYACTYVGTPYYVPPEI 171
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
W+ P + ++D W C + E+ T P S + V + P+PS
Sbjct: 172 WE---NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYE 227
Query: 282 VENVLLGCFEYDLRSRPLMTDIL 304
+ +++ F+ + RSRP T IL
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 42/118 (35%), Positives = 57/118 (48%), Gaps = 9/118 (7%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-R 210
YA +L G+ L + I+ +LKP N +L+ DR G + I L L + +P + R R
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLD--DR---GHIRISDLGLAVQIPEGETVRGR 161
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268
+GT YMAPE E +F D WG C I EM+ G P R + V RR
Sbjct: 162 VGTVGYMAPEVINNE---KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 46/273 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDE--YHEVAVKIL-HPVKEDRMR--VLLERLN------- 96
+G+G FGE AT Y TED + EV + L + D + V+L L
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 97 -DLFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAI 154
+ F+ + + I M++ G ++ D++ + KG V Y
Sbjct: 65 YNHFMD----------------DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---L 211
+ + +H GIL ++K N L +A LGD GI +L S+ +
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL------GSEYSMAETVV 162
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271
GTP YM+PE Q +F++D W C + E+LT + + + +V+
Sbjct: 163 GTPYYMSPELCQGV---KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG-NY 218
Query: 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P+ S + +++ + D RP ++L
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 70/267 (26%), Positives = 109/267 (40%), Gaps = 49/267 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMR-------VLLERLNDL 98
IG+G FG+V LA H D Y AVK+L +K+ + VLL+ +
Sbjct: 3 IGKGSFGKVLLAKH---KADGKFY---AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56
Query: 99 FL-----KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-Y 152
FL Q + K+ ++ + G G+ L+ + R Y
Sbjct: 57 FLVGLHYSFQTAD-------------KLYFVLDYVNG--GELFFHLQRERSFPEPRARFY 101
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
A ++A + LHS I+ +LKP N +L+ VL D G+ GI S G
Sbjct: 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIE-HSKTTSTFCG 158
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
TP Y+APE + + P D W + EML G+ P R E+YD ++ +
Sbjct: 159 TPEYLAPEVLRKQ---PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---- 211
Query: 273 P--IPSGLPPAVENVLLGCFEYDLRSR 297
P + + + ++L G + D R
Sbjct: 212 PLRLKPNISVSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------DRMRVL 91
I +L+L ++G G FGEVW+ T +T+ VAVK L P + +++
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTK-------VAVKTLKPGTMSPESFLEEAQIM 55
Query: 92 LERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVF 150
+ +D ++ V V I I+ ++ +GS+ D + +G L L N+
Sbjct: 56 KKLRHDKLVQLYAV----------VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV 105
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
A +A G+ + + +L+ N ++ + + D G+ L+ ++ R
Sbjct: 106 DMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI-----EDNEYTAR 160
Query: 211 LGTP---NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
G + APE + G + ++D W F + E++T G P G + E+ + V
Sbjct: 161 QGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
R +P P P ++ ++L C++ D RP
Sbjct: 218 RGYRMP-CPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 31/263 (11%)
Query: 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFL 100
L L IG G FG V L Y +VAVK +K D +
Sbjct: 6 QKLTLGEIIGEGEFGAV-LQGEYTG-------QKVAVKN---IKCDVTAQAFLEETAVMT 54
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
K + + L G+ + NG + I+M+ +G++ + + +S+ + ++++D+A+G
Sbjct: 55 KLHH-KNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ L SK ++ +L N +++E A + D G+ + +G N P
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV------------GSMGVDNSKLP 160
Query: 220 EQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
+W PE S ++D W + + E+ + G P S+ E+ + V + + P P
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-P 219
Query: 276 SGLPPAVENVLLGCFEYDLRSRP 298
G P V ++ C+E + + RP
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRM-------RVLLERLNDL 98
+G+G FG+V LA + DE + A+KIL +++D + RVL +
Sbjct: 8 LGKGSFGKVMLA----ERKGTDELY--AIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLA 157
FL L ++ +M++ G GD M ++ GK YA +++
Sbjct: 62 FLT--------QLHSCFQTVDRLYFVMEYVNG--GDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI--PHLLLGIPLPSSDLPRRLGTPN 215
G+ LH +GI+ +LK N +L+ + D G+ H++ G+ + GTP+
Sbjct: 112 VGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-----CGTPD 166
Query: 216 YMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
Y+APE +QP + D W + + EML G P G DE++ +++
Sbjct: 167 YIAPEIIAYQPYGK-----SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 27/287 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + L +G+G FG V+ + VA+K ++ MR +E LN+
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGL-AKGVVKGEPETRVAIKTVNE--NASMRERIEFLNE 59
Query: 98 L-FLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLK--------GGKLSLS 147
+K + L G+ ++M+ +G + + + G +L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
+ A ++A G+ L +K + +L N ++ E +GD G+ + +D
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-----ETDY 174
Query: 208 PRRLGT---P-NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262
R+ G P +MAPE + G + ++D W F + EM T QP G S +E+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231
Query: 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
V+ + P P + ++ C++Y+ + RP +I+ K
Sbjct: 232 KFVIDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 65/267 (24%), Positives = 111/267 (41%), Gaps = 34/267 (12%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLKCQGVE 106
RIG+G FGEV+ + E VA+KI+ ED + + + + + +C
Sbjct: 11 RIGKGSFGEVYKGIDNRTKE------VVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDS-P 62
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I G + K+ IIM++ G G + LK G L + + ++ +G+ LHS+
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGG--GSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
+ ++K N +L+E L D G+ L + + +GTP +MAPE +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIK--- 174
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE--- 283
+ F+ D W + IE+ G P + + + IP PP +E
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPP---------NSDLHPMRVLFLIPKNSPPTLEGQY 225
Query: 284 -----NVLLGCFEYDLRSRPLMTDILR 305
+ C D R RP ++L+
Sbjct: 226 SKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+L RIG G +G+V+ A + E VA+K+ + LE +D + Q
Sbjct: 6 ELIQRIGSGTYGDVYKARDIATGE------LVAIKV----------IKLEPGDDFEIIQQ 49
Query: 104 GVE--------GICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKG--GKLSLSNVFRY 152
+ I G + K+ I+M++ G S+ D +G +L ++ V R
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR-- 210
+ +G+ LH G + ++K N +L E L D G+ L ++ + +R
Sbjct: 110 TL---KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKS 160
Query: 211 -LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR 253
+GTP +MAPE E +G + D W + IE+ P
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 74/288 (25%), Positives = 113/288 (39%), Gaps = 45/288 (15%)
Query: 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPV---KEDRMRVL 91
WIK + IG G FG V+L + S E +AVK L V +DR R +
Sbjct: 2 WIKGAL------IGSGSFGSVYLGMNASSGE------LMAVKQVELPSVSASSKDRKRSM 49
Query: 92 LERLND--LFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSN 148
L+ L LK E I G S+ + I +++ G SV + G +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETL 107
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
V + + +G+ LH++GI+ ++K N +++ + D GI L S
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTK 164
Query: 209 RRLGTPNYMAPEQWQ-PEVRGPISF--ETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265
P+ W PEV S+ + D W C ++EMLTG P +
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP---------FPDC 215
Query: 266 VRRQEI--------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ Q I P IPS + + L FE D RP ++L+
Sbjct: 216 TQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 45/234 (19%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG- 107
+G+G FG+V LA + DE + A+KIL K+D V+++ D ++C VE
Sbjct: 8 LGKGSFGKVMLAERKGT----DELY--AIKIL---KKD---VIIQ---DDDVECTMVEKR 52
Query: 108 ----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDL 156
+ L ++ +M++ G GD M ++ GK + YA ++
Sbjct: 53 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG--GDLMYHIQQVGKFKEPHAVFYAAEI 110
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI--PHLLLGIPLPSSDLPRRL-GT 213
A G+ LHSKGI+ +LK N +L+ + D G+ ++ G R GT
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG------KTTRTFCGT 164
Query: 214 PNYMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265
P+Y+APE +QP + D W F + EML G P G DE++ ++
Sbjct: 165 PDYIAPEIIAYQPYGKS-----VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 62/284 (21%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFL 100
SA++ +G FG+++ YL D VA+K L + + ++ L
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLP--GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMA 62
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-----------------GSVGDRMAQLKGGK 143
+ +C L G+ +C++ ++ G D +K
Sbjct: 63 ELHHPNIVCLL-GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS-S 120
Query: 144 LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203
L + AI +A G+ L S + +L N ++ E + D+G L +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG-----LSREIY 175
Query: 204 SSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVD 259
S+D R P + P +W P + G S ++D W F + E+ + G+QP G S
Sbjct: 176 SADYYRV--QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
E+ + +VR++++ P PP + +++ C++ RP DI
Sbjct: 234 EVIE-MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IG+G FG+V LA L D Y AVK+L ++++ ++ ER ++ LK
Sbjct: 3 IGKGSFGKVLLAKRKL---DGKCY---AVKVLQKKIVLNRKEQKHIMAER--NVLLKNVK 54
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQL 163
+ L K+ ++ F G G+ L+ + R YA ++A + L
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNG--GELFFHLQRERSFPEPRARFYAAEIASALGYL 112
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS I+ +LKP N +L+ VL D G+ + ++ GTP Y+APE +
Sbjct: 113 HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF---CGTPEYLAPEVIR 169
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269
+ P D W + EML G+ P R V E+YD ++ +
Sbjct: 170 KQ---PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFL 100
++ +IGRG F EV+ AT L + VA+K + + + + R + DL L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLL------DGVPVALKKVQIFDLMDAKARADCIKEIDL-L 56
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGK--LSLSNVFRYAIDLA 157
K + + + ++ I+++ + G + + K K + V++Y + L
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+ +HS+ ++ ++KP N + LGD+G+ + L +GTP YM
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYM 173
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV--VRRQEIPPIP 275
+PE+ +F++D W C + EM P G ++ +Y + + + PP+P
Sbjct: 174 SPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLP 229
Query: 276 SG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
S + ++ C D RP +T + V K
Sbjct: 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 27/202 (13%)
Query: 118 NGKICIIMKFYEGSVGDRMAQL----KGGKLSLSNVFRYAIDLAQGILQLH--------S 165
N + I+M++ EG GD +AQL K + + F + I L Q +L L+
Sbjct: 73 NQTLYIVMEYCEG--GD-LAQLIQKCKKERKYIEEEFIWRI-LTQLLLALYECHNRSDPG 128
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR--LGTPNYMAPEQWQ 223
+L +LKP N L+ + LGD G L L + +GTP YM+PEQ
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFG-----LAKILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283
++D W C I E+ P R+ ++ + ++ + IP +
Sbjct: 184 ---HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-ASKIKEGKFRRIPYRYSSELN 239
Query: 284 NVLLGCFEYDLRSRPLMTDILR 305
V+ D RP ++L+
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 54/244 (22%), Positives = 105/244 (43%), Gaps = 23/244 (9%)
Query: 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDL 98
+ ++ +IGRG F EV+ AT L + VA+K + + + + R + DL
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDAKARQDCVKEIDL 55
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK-----LSLSNVFRYA 153
+ I +L + + ++ I+++ GD +K K + V++Y
Sbjct: 56 LKQLNHPNVIKYLDSF-IEDNELNIVLEL--ADAGDLSQMIKYFKKQKRLIPERTVWKYF 112
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ L + +HS+ ++ ++KP N + LGD+G+ + L +GT
Sbjct: 113 VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGT 169
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEI-YDAVVRRQEIP 272
P YM+PE+ +F++D W C + EM P G ++ + + + P
Sbjct: 170 PYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP 226
Query: 273 PIPS 276
P+P+
Sbjct: 227 PLPT 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 23/192 (11%)
Query: 124 IMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182
+M++ G GD M ++ K L YA ++ G+ LHSKGI+ +LK N +L+
Sbjct: 74 VMEYLNG--GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 183 ADRAVLGDVGI-PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFAC 241
+ D G+ +LG + GTP+Y+APE + D W F
Sbjct: 132 DGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQKYN---TSVDWWSFGV 184
Query: 242 SIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCF----------E 291
+ EML G P G +E++ ++ R + P P L +++L+ F +
Sbjct: 185 LLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFVREPERRLGVK 242
Query: 292 YDLRSRPLMTDI 303
D+R P +I
Sbjct: 243 GDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 35/268 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-----RMRVLLERLNDLFLKCQ 103
+G+G FGEV+ T T VAVK KED +++ L E LK
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-------VAVKT---CKEDLPQELKIKFLSEAR---ILKQY 49
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK--LSLSNVFRYAIDLAQGIL 161
I L G+ I I+M+ G GD ++ L+ K L + ++A+D A G+
Sbjct: 50 DHPNIVKLIGVCTQRQPIYIVMELVPG--GDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
L SK + +L N ++ E + + D G+ SS L + P +
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ--------IPIK 159
Query: 222 WQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
W PE G S E+D W + + E + GV P G + + + V + + P
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-SCPQK 218
Query: 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305
P V V+ C++Y +RP +++ +
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG G G V +AT S + VAVK + K+ R +L + + ++ E
Sbjct: 27 KIGEGSTGIVCIATVKSSGK------LVAVKKMDLRKQQRRELLFNEV--VIMRDYQHEN 78
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ + ++ ++ ++M+F EG ++ D + + + ++ V + + + + LH++
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQ 135
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQWQ 223
G++ ++K + +L R L D G + S ++PRR +GTP +MAPE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV------SKEVPRRKSLVGTPYWMAPELIS 189
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQP 252
R P E D W +IEM+ G P
Sbjct: 190 ---RLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG G G V +A S +VAVK++ K+ R +L + + ++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGR------QVAVKMMDLRKQQRRELLFNEV--VIMRDYQHQN 79
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ + ++ ++ ++M+F +G ++ D ++Q + + ++ V + Q + LHS+
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL---QALCYLHSQ 136
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQWQ 223
G++ ++K + +L R L D G + S D+P+R +GTP +MAPE
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKDVPKRKSLVGTPYWMAPEVIS 190
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
R P E D W +IEM+ G P D A+ R ++ PP
Sbjct: 191 ---RTPYGTEVDIWSLGIMVIEMVDGEPPYFS---DSPVQAMKRLRDSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 25/266 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I +L+L ++G+G FGEVW+ T +T VA+K L P L E
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTMSPEAFLQEA--- 52
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+K E + L + V I I+ ++ +GS+ D + G L L + A +
Sbjct: 53 QVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 111
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP-- 214
A G+ + + +L+ N ++ E + D G+ L + ++ R G
Sbjct: 112 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-----IEDNEYTARQGAKFP 166
Query: 215 -NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272
+ APE + G + ++D W F + E+ T G P G E+ D V R +
Sbjct: 167 IKWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM- 222
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRP 298
P P P ++ +++ C+ + RP
Sbjct: 223 PCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 43/146 (29%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 123 IIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181
++M++ G G+ + L+ G+ S S YA ++ + LHSK I+ +LKP N +L+
Sbjct: 78 MLMEYVPG--GELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD 135
Query: 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMAPEQWQPEVRGPISFETDSWGFA 240
+ L D G L D L GTP Y+APE Q + D W
Sbjct: 136 KEGHIKLTDFGFAKKL-------RDRTWTLCGTPEYLAPEVIQSKGHNK---AVDWWALG 185
Query: 241 CSIIEMLTGVQPRCGRSVDEIYDAVV 266
I EML G P + IY+ ++
Sbjct: 186 ILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLK 101
L+ +G G G V H + +AVK + + E + +L L D+ K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTG------KIMAVKTIRLEINEAIQKQILREL-DILHK 55
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
C I G NG I I M++ +G D++ + G++ + + A+ + +G+
Sbjct: 56 CNS-PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLT 114
Query: 162 QLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-----GTPN 215
LH K I+ ++KP N ++N + L D G+ S L L GT +
Sbjct: 115 YLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV----------SGQLVNSLAKTFVGTSS 164
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYD---AVVRRQE 270
YMAPE+ Q S D W S+IE+ TG P D I++ +V E
Sbjct: 165 YMAPERIQGNDYSVKS---DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV--NE 219
Query: 271 IPP-IPSG-LPPAVENVLLGCFEYDLRSRP 298
PP +PSG P ++ + C D R RP
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 41/152 (26%), Positives = 63/152 (41%), Gaps = 20/152 (13%)
Query: 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180
+C +M++ G GD M + S YA + G+ LH I+ +LK N +L
Sbjct: 77 VCFVMEYAAG--GDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET------ 234
+ + D G+ +G GTP ++APE + ET
Sbjct: 135 DTEGFVKIADFGLCKEGMG---FGDRTSTFCGTPEFLAPE---------VLTETSYTRAV 182
Query: 235 DSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
D WG I EML G P G +E++D++V
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 37 WIKP-SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLE 93
W P LKL ++G G FGEVW+ + + + +VA+K L K+ M L
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYY-------NGHTKVAIKSL---KQGSMSPEAFLA 50
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRY 152
N +K + L + V I II ++ E GS+ D + +G KL+++ +
Sbjct: 51 EAN--LMKQLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
A +A+G+ + K + +L+ N +++E + D G+ L + ++ R G
Sbjct: 108 AAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-----IEDNEYTAREG 162
Query: 213 TPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268
P +W PE G + ++D W F + E++T G P G + E+ + R
Sbjct: 163 AK---FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219
Query: 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
+ P P P + ++ C++ RP
Sbjct: 220 YRM-PRPDNCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 19/134 (14%)
Query: 164 HSKGILVLNLKPFNFILNEAD---RAVLGDVGIPHLLLGI-PLPSSDLPRR---LGTPNY 216
H++GI+ +LKP N ++++ A + D GI LL G+ + L R LGTP Y
Sbjct: 96 HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY 155
Query: 217 MAPEQWQPEVRGPISFETD--SWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274
APEQ + E P++ +D +WG +E LTG + G SV EI Q++ P+
Sbjct: 156 CAPEQLRGE---PVTPNSDLYAWGLI--FLECLTGQRVVQGASVAEIL-----YQQLSPV 205
Query: 275 PSGLPPAVENVLLG 288
LPP + LG
Sbjct: 206 DVSLPPWIAGHPLG 219
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG G G V +AT + +VAVK + K+ R +L + + ++
Sbjct: 26 KIGEGSTGIVCIATDKSTGR------QVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPN 77
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I + ++ ++ ++M+F EG ++ D + + + ++ V + + + LH++
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQ 134
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQWQ 223
G++ ++K + +L R L D G + S ++PRR +GTP +MAPE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV------SKEVPRRKSLVGTPYWMAPEVIS 188
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQP 252
R P E D W +IEM+ G P
Sbjct: 189 ---RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 62/272 (22%), Positives = 115/272 (42%), Gaps = 37/272 (13%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------DRMRVL 91
I +L+L ++G+G FGEVW+ T +T+ VA+K L P +++
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTK-------VAIKTLKPGTMMPEAFLQEAQIM 55
Query: 92 LERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVF 150
+ +D + V V I I+ +F +GS+ D + + G L L +
Sbjct: 56 KKLRHDKLVPLYAV----------VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV 105
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
A +A G+ + + +L+ N ++ + + D G+ L+ ++ R
Sbjct: 106 DMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI-----EDNEYTAR 160
Query: 211 LGTP---NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
G + APE + G + ++D W F + E++T G P G E+ + V
Sbjct: 161 QGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
R +P P G P ++ ++ C++ D RP
Sbjct: 218 RGYRMP-CPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 34/291 (11%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERL 95
IK + L+ +G G FG+V+LA Y + D+ VAVK L K+ + R +R
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKML-VAVKAL---KDPTLAARKDFQRE 57
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIM---------KFYEGSVGDRMAQLKG----- 141
+L Q E I G+ + ++ KF D M + G
Sbjct: 58 AELLTNLQH-EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 142 -GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
G+L LS + A +A G++ L S+ + +L N ++ +GD G+
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----- 171
Query: 201 PLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256
+ S+D R G + M P +W P + + E+D W F + E+ T G QP
Sbjct: 172 DVYSTDYYRVGG--HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229
Query: 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
S E+ + + + + + P P V +++LGC++ + + R + +I ++
Sbjct: 230 SNTEVIECITQGRVLER-PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 57/284 (20%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--------VKEDR 87
W I +LKL ++G G FGEVW+ T +T +VAVK L P ++E +
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTT-------KVAVKTLKPGTMSPEAFLQEAQ 53
Query: 88 -MRVLL-ERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKL 144
M+ L ++L L+ C E I I+ ++ GS+ D + +G KL
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEE-------------PIYIVTEYMSKGSLLDFLKSGEGKKL 100
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204
L + A +A+G+ L S+ + +L N ++ E + D G
Sbjct: 101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFG------------ 148
Query: 205 SDLPRRLGTPNYMA------PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRC 254
L R + Y A P +W PE G + ++D W F + E++T G P
Sbjct: 149 --LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206
Query: 255 GRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
G + E+ + V R + P P P + +++L C++ D RP
Sbjct: 207 GMTNREVLEQVERGYRM-PRPPNCPEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG G G V +AT + + +VAVK + K+ R +L + + ++ E
Sbjct: 29 KIGEGSTGIVCIATEKHTGK------QVAVKKMDLRKQQRRELLFNEV--VIMRDYHHEN 80
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ + ++ ++ ++M+F EG ++ D + + + ++ V + + + + LH++
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQ 137
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQWQ 223
G++ ++K + +L R L D G + S ++P+R +GTP +MAPE
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV------SKEVPKRKSLVGTPYWMAPEVIS 191
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQP 252
R P E D W +IEM+ G P
Sbjct: 192 ---RLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 45/278 (16%)
Query: 37 WIKP-SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W +P L ++G G FGEVW VA+KIL K D +
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVR-------VAIKIL---KSDDLLKQ---- 46
Query: 96 NDLFLKCQGVEG-----ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNV 149
D + Q ++ + L + + + II + E GS+ + +G L ++++
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL 106
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
A +A+G+ L + + +L N ++ E + D G L R
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG--------------LAR 152
Query: 210 RLGTPNYMA-----PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260
+ Y++ P +W PE G S ++D W F + EM T G P G + E
Sbjct: 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
+YD + +P P+ P + ++L C+ + RP
Sbjct: 213 VYDQITAGYRMPC-PAKCPQEIYKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD-LPRR 210
YA ++ G+ LH + I+ +LKP N +L++ + D+G L + +P + R
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLG-----LAVHVPEGQTIKGR 161
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
+GT YMAPE + E +F D W C + EM+ G P
Sbjct: 162 VGTVGYMAPEVVKNE---RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 31/285 (10%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
IK + L+ +G G FG+V+LA H L E + VAVK L E R +R
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQ--DKMLVAVKALKEASES-ARQDFQREA 58
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG--------------G 142
+L Q + I G+ + ++ ++ +R + G G
Sbjct: 59 ELLTVLQH-QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG 117
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
+L+L + A +A G++ L S + +L N ++ + +GD G+ +
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DI 172
Query: 203 PSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSV 258
S+D R G M P +W P + + E+D W F + E+ T G QP S
Sbjct: 173 YSTDYYRVGG--RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
Query: 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
E + + + +E+ P PP V ++ GC++ + + R ++ DI
Sbjct: 231 TEAIECITQGRELER-PRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
++ L+ +G G G V H + +A K++H + +R + R
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGT------VMAKKVVHIGAKSSVRKQILRELQ 55
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ +C+ I G + IC+ M+F + DR+ + KGG + + + + A+ +
Sbjct: 56 IMHECRS-PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVV 113
Query: 158 QGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
+G+ L++ I+ ++KP N ++N + L D G+ L+ +S +GT Y
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-----NSIADTFVGTSTY 168
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE--------IYDAVVR- 267
M+PE+ Q G + ++D W SIIE+ G P ++D+ I D + +
Sbjct: 169 MSPERIQG---GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 268 RQEIPP-IPSG-LPPAVENVLLGCFEYDLRSRP 298
QE PP +PS P + + + C D RP
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 44/251 (17%)
Query: 30 TSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR 89
T DT++W K S ++ +G G FG V +A H + EY A+K L + +M+
Sbjct: 8 TKPDTSSW-KLSDFEMGETLGTGSFGRVRIAKHKGT----GEY--YAIKCLKKREILKMK 60
Query: 90 ---------VLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL- 139
+L L+ F+ V +C Q ++ +++F G G+ L
Sbjct: 61 QVQHVAQEKSILMELSHPFI----VNMMCSFQD----ENRVYFLLEFVVG--GELFTHLR 110
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199
K G+ Y +L LHSK I+ +LKP N +L+ + D G
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF------ 164
Query: 200 IPLPSSDLPRRL----GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255
+ +P R GTP Y+APE Q + G D W + E + G P
Sbjct: 165 ----AKKVPDRTFTLCGTPEYLAPEVIQSKGHGK---AVDWWTMGVLLYEFIAGYPPFFD 217
Query: 256 RSVDEIYDAVV 266
+ IY+ ++
Sbjct: 218 DTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 52/268 (19%), Positives = 101/268 (37%), Gaps = 36/268 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL--HPVKEDRMRVLLERLNDLFLKCQGVE 106
+GRG FG V L + V +K + + +D +
Sbjct: 8 VGRGAFGIVHLCRRK------ADQKLVIIKQIPVEQMTKDERLAAQNECQ-VLKLLSHPN 60
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK-LSLSNVFRYAIDLAQGILQLHS 165
I + + + + + I+M++ G Q + L + + + + + +H+
Sbjct: 61 IIEYYENF-LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 166 KGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQP 224
K IL +LK N +L++ V +GD GI +L S +GTP Y++PE +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----KSKAYTVVGTPCYISPELCEG 175
Query: 225 EVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV--------VRRQEIPPIPS 276
+ P + ++D W C + E+ S+ ++A + PI
Sbjct: 176 K---PYNQKSDIWALGCVLYELA---------SLKRAFEAANLPALVLKIMSGTFAPISD 223
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P + ++L D RP ++ I+
Sbjct: 224 RYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 66/286 (23%), Positives = 108/286 (37%), Gaps = 51/286 (17%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLAT--------------HYLSTEDCDEYHEVAVKILHPV 83
I PS L L IG G FG VWL +S ED E +V +K+ HP
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHP- 59
Query: 84 KEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK 143
+L L+ G+ IC++ +F E + + GK
Sbjct: 60 ----------KLVQLY-------------GVCTERSPICLVFEFMEHGCLSDYLRAQRGK 96
Query: 144 LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203
S + +D+ +G+ L S ++ +L N ++ E + D G+ +L
Sbjct: 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156
Query: 204 SSDLPRRLGTPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVD 259
SS GT P +W PEV S ++D W F + E+ + G P RS
Sbjct: 157 SST-----GTK---FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
Query: 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
E+ + + + P +V ++ C++ RP + +L
Sbjct: 209 EVVETINAGFRLYK-PRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 41/276 (14%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W I ++++L ++G G FGEVW +T VAVK L P M
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-------VAVKTLKP---GTMDP----- 45
Query: 96 NDLFLKCQGV------EGICWLQGISVINGKICII---MKFYEGSVGDRMAQLKGGKLSL 146
FL + + L + + I I+ MK+ GS+ + + G L L
Sbjct: 46 -KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKL 102
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
+ A +A G+ L ++ + +L N ++ E + + D G+ ++
Sbjct: 103 PQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK-----EDI 157
Query: 207 LPRRLGTPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262
R G P +W PE S ++D W F + E++T G P G + E+
Sbjct: 158 YEAREGAK---FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
Query: 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
V + +P P G P + +++L C++ D RP
Sbjct: 215 QQVDQGYRMPC-PPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 73/274 (26%), Positives = 104/274 (37%), Gaps = 63/274 (22%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IGRG FGEV L + D H A+KIL KE + ER D+ ++ G
Sbjct: 9 IGRGAFGEVRL------VQKKDTGHIYAMKILRKADMLEKEQVAHIRAER--DILVEADG 60
Query: 105 VEGICWLQGI--SVINGK-ICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGI 160
W+ + S + + + +IM+F G GD M L K LS Y + I
Sbjct: 61 A----WVVKMFYSFQDKRNLYLIMEFLPG--GDMMTLLMKKDTLSEEATQFYIAETVLAI 114
Query: 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL-------------PSSDL 207
+H G + ++KP N +L+ L D G L G+ P SD
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG---LCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 208 P----------------RR------LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245
RR +GTP+Y+APE + + D W + E
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL---CDWWSLGVIMYE 228
Query: 246 MLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
ML G P C + E Y V+ +E P +P
Sbjct: 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 13/181 (7%)
Query: 119 GKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177
K+ +++ F G G+ L + G+ LS Y +L + LH ++ +LKP N
Sbjct: 66 EKLYLVLAFING--GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123
Query: 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMAPEQWQPEVRGPISFETDS 236
+L+ L D G L + + D GTP Y+APE D
Sbjct: 124 ILLDYQGHIALCDFG----LCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA---VDW 176
Query: 237 WGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRS 296
W + EMLTG+ P +V+E+Y ++ QE P G +++L+G D
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTR 234
Query: 297 R 297
R
Sbjct: 235 R 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 65/269 (24%), Positives = 108/269 (40%), Gaps = 27/269 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVK--ILHPVKEDRMRVLLERLN---DLFLKCQ 103
+G+G +G V+ ++ +AVK L E+L DL +
Sbjct: 8 LGKGAYGTVYCGL-------TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 104 GVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
V + +L G + + I I M+F G S+ + + G L +Y + G+
Sbjct: 61 HVNIVQYL-GTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAY 117
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL--LGIPLPSSDLPRRL-GTPNYMAP 219
LH+ ++ ++K N +L L D G L +G+ S++ + + GTP +MAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE---IYDAVVRRQEIPPIPS 276
E G S D W C++ EM TG P S+D ++ R +P +P
Sbjct: 178 EVINESGYGRKS---DIWSIGCTVFEMATGKPPLA--SMDRLAAMFYIGAHRGLMPRLPD 232
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305
A + + C D RP +LR
Sbjct: 233 SFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 27/270 (10%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVK----ILHPVKEDRMRVLLERLNDLFLKCQ 103
RIGRG FGEV+ + L ++ VAVK L P + + + L E LK
Sbjct: 2 RIGRGNFGEVF--SGRLRADNT----PVAVKSCRETLPP--DLKAKFLQEAR---ILKQY 50
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
I L G+ I I+M+ +G + +G +L + + + + A G+ L
Sbjct: 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
SK + +L N ++ E + + D G+ S+ +++ P +W
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-------PVKWT 163
Query: 224 -PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
PE G S E+D W F + E + G P S + +A+ + +P P P
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCP 222
Query: 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
AV ++ C+EYD RP + + + +S
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 76/292 (26%), Positives = 112/292 (38%), Gaps = 64/292 (21%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IGRG FGEV L + D H A+KIL KE + ER D+ ++
Sbjct: 9 IGRGAFGEVRL------VQKKDTGHVYAMKILRKADMLEKEQVGHIRAER--DILVEADS 60
Query: 105 VEGICWLQGI-----SVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
+ W+ + +N + +IM+F G GD M L K L+ Y +
Sbjct: 61 L----WVVKMFYSFQDKLN--LYLIMEFLPG--GDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL-----------LGIPLPSS-- 205
I +H G + ++KP N +L+ L D G+ L L LPS
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 206 -------------DLPRR------LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
RR +GTP+Y+APE + + D W + EM
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL---CDWWSLGVIMYEM 229
Query: 247 LTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP---PAVENVLLGCFEYDLR 295
L G P C + E Y V+ +E P +P A + +L C E++ R
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHR 281
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 34/203 (16%)
Query: 118 NGKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLH-SKGILVLNL 173
N ++ I+M EG +G+ LK + + ++ + + + LH K I+ +L
Sbjct: 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL 140
Query: 174 KPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFE 233
P N +L E D+ + D G L P S L +GT Y PE + E P +
Sbjct: 141 TPNNIMLGEDDKVTITDFG----LAKQKQPESKLTSVVGTILYSCPEIVKNE---PYGEK 193
Query: 234 TDSWGFACSIIEMLTGVQP---------RCGRSVDEIYDAVVRRQEIPPIPSGL-PPAVE 283
D W F C + +M T +QP + V+ +Y+ P+P G+ V
Sbjct: 194 ADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVEAVYE---------PLPEGMYSEDVT 243
Query: 284 NVLLGCFEYDLRSRPLMTDILRV 306
+V+ C D +RP DI++V
Sbjct: 244 DVITSCLTPDAEARP---DIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-EDRMRVLLERLNDLF-LKCQGV 105
IG+G FGEV+ A T VA+K++ + ED + + + + L + +
Sbjct: 8 CIGKGSFGEVYKA-IDKRTNQ-----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 106 ---EGICWLQGISVING-KICIIMKFYE-GSVGDRMAQLKGGKL---SLSNVFRYAIDLA 157
G S + G K+ IIM++ GS D LK GKL ++ + R ++
Sbjct: 62 TKYYG-------SFLKGSKLWIIMEYCGGGSCLD---LLKPGKLDETYIAFILR---EVL 108
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTP 214
G+ LH +G + ++K N +L+E L D G+ L +S + +R +GTP
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL------TSTMSKRNTFVGTP 162
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255
+MAPE + + + D W + IE+ G P
Sbjct: 163 FWMAPEVIK---QSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 44/171 (25%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDL 207
+++Y + L + +HSK I+ ++KP N + A V LGD+G LG S
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLG-----LGRFFSSKTT 161
Query: 208 P--RRLGTPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDA 264
+GTP YM+PE+ + +F++D W C + EM P G ++ +Y
Sbjct: 162 AAHSLVGTPYYMSPER----IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSL 216
Query: 265 V--VRRQEIPPIPSGLPPA-VENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312
+ + + PP+P+ + +++ C D RP ++ +L+V K
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 42/297 (14%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERL 95
+ L+ IG G G+V+ + H +AVK + KE+ R+L++
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTG------HVMAVKQMRRTGNKEENKRILMDL- 64
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG-------GKLSLSN 148
D+ LK I G + + + I M+ + + +++G GK++++
Sbjct: 65 -DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123
Query: 149 VFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
V + + L K G++ ++KP N +L+ + L D GI L+ S
Sbjct: 124 V--------KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD----SKAK 171
Query: 208 PRRLGTPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAV 265
R G YMAPE+ P P D W S++E+ TG P + E+ +
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
Query: 266 VRRQEIPPIPS---GLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSV 314
+ QE PP G P + + C D R RP L +R +++++ V
Sbjct: 232 L--QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 27/258 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLFLKCQG 104
IGRG FGEV+ D A+K L +K+ L ER+ +
Sbjct: 2 IGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQL 163
I + K+C I+ G GD L + G S + YA ++ G+ +
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEMRFYATEIILGLEHM 113
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
H++ ++ +LKP N +L+E + D+G L +GT YMAPE Q
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMAPEVLQ 168
Query: 224 PEVRGPISFETDSW-GFACSIIEMLTGVQP-RCGRSVD--EIYDAVVRRQEIPPIPSGLP 279
+G + W C + ++L G P R ++ D EI D + + +P
Sbjct: 169 ---KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTVNV-ELPDSFS 223
Query: 280 PAVENVLLGCFEYDLRSR 297
P ++++L G + D+ R
Sbjct: 224 PELKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 2e-06
Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 56/224 (25%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------R-MRVLLERLNDL 98
++G G +G V+ A + E VA+K + E+ R + +L E
Sbjct: 6 KLGEGTYGVVYKARD----KKTGEI--VALKKIRLDNEEEGIPSTALREISLLKE----- 54
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQ 158
LK I L + K+ ++ ++ + + + + + G LS + + L +
Sbjct: 55 -LKH---PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK-RPGPLSPNLIKSIMYQLLR 109
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL--LLGIPLPSSDLPRRLGTPN- 215
G+ HS IL +LKP N ++N L D G L GIPL + T
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFG---LARAFGIPLRTY-------THEV 159
Query: 216 ----YMAPE------QWQPEVRGPISFETDSWGFACSIIEMLTG 249
Y APE + V D W C EM+TG
Sbjct: 160 VTLWYRAPEILLGSKHYSTAV--------DIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 120 KICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
++ +++++ G GD M + + KL + YA ++ + LH +GI+ +LK N
Sbjct: 70 RLFLVIEYVNG--GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNV 127
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+L+ L D G+ LG P GTPNY+APE + E G F D W
Sbjct: 128 LLDADGHIKLTDYGMCKEGLG---PGDTTSTFCGTPNYIAPEILRGEEYG---FSVDWWA 181
Query: 239 FACSIIEMLTGVQP 252
+ EM+ G P
Sbjct: 182 LGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 63/289 (21%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ----- 103
IG G +G+V+ A H + + VA+KI+ ++++ + E N L
Sbjct: 14 IGEGTYGKVYKARHKKTGQ------LVAIKIMDIIEDEEEEIKEE-YNILRKYSNHPNIA 66
Query: 104 GVEGICWLQGISVINGKICIIMKFYE-GSVGD--RMAQLKGGKLSLSNVFRYAI-DLAQG 159
G + + ++ ++M+ GSV D + + KG +L Y + + +G
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK-EEWIAYILRETLRG 125
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNY 216
+ LH ++ ++K N +L + L D G+ L S L RR +GTP +
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL------DSTLGRRNTFIGTPYW 179
Query: 217 MAPE----QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
MAPE QP+ +D W + IE+ G P C ++
Sbjct: 180 MAPEVIACDEQPDAS--YDARSDVWSLGITAIELADGKPPLC---------------DMH 222
Query: 273 P------IPSGLPPAV----------ENVLLGCFEYDLRSRPLMTDILR 305
P IP PP + + + C + RP M ++L
Sbjct: 223 PMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 27/276 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
IK + L+ +G G FG+V+LA Y + D+ VAVK L D R R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKIL-VAVKTLKDA-SDNARKDFHREAE 59
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIM---------KFYEGSVGDRMAQLKGG---KLS 145
L Q E I G+ V + ++ KF D + +G +L+
Sbjct: 60 LLTNLQH-EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
S + A +A G++ L S+ + +L N ++ E +GD G+ + S+
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYST 173
Query: 206 DLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261
D R G + M P +W P + + E+D W + E+ T G QP S +E+
Sbjct: 174 DYYRVGG--HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+ + + + + P P V +++LGC++ + R
Sbjct: 232 IECITQGRVLQR-PRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 52/237 (21%)
Query: 47 HRIGRGPFGEVW----LATH-------YLSTEDCDEYHEVA---VKILHPVKEDRMRVLL 92
+G G +G V AT + +ED ++ + A VK+L ++ + +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN----I 62
Query: 93 ERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRY 152
L + F + G++ ++ ++ E ++ + + GG L V Y
Sbjct: 63 VNLKEAFRR----------------KGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSY 105
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
L Q I HS I+ ++KP N +++E+ L D G L P+S L +
Sbjct: 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA--RPASPLTDYVA 163
Query: 213 TPNYMAPE------QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIY 262
T Y APE + V D W C + E+L G G S +D++Y
Sbjct: 164 TRWYRAPELLVGDTNYGKPV--------DVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 33/113 (29%), Positives = 48/113 (42%), Gaps = 21/113 (18%)
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR------LGTPNY 216
LH++GI+ +LKP N +L+ L D G + L GTP Y
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYVKLVDFGF----------AKKLKSGQKTWTFCGTPEY 158
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD--EIYDAVVR 267
+APE +G F D W + E+LTG P D EIY+ +++
Sbjct: 159 VAPEIILN--KG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 63/288 (21%), Positives = 119/288 (41%), Gaps = 29/288 (10%)
Query: 22 DHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH 81
+ LRT V+ + + + +IG+G G V+ A D EVA+K ++
Sbjct: 6 EKLRTIVSIGDPKKKYTR------YEKIGQGASGTVFTAI------DVATGQEVAIKQIN 53
Query: 82 PVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLK 140
K+ + +++ + L +K I ++ ++ ++M++ G S+ D + +
Sbjct: 54 LQKQPKKELIINEI--LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC 111
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
+ ++ V R + Q + LH+ ++ ++K N +L L D G I
Sbjct: 112 MDEAQIAAVCRECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFG---FCAQI 165
Query: 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VD 259
S +GTP +MAPE + GP + D W IEM+ G P + +
Sbjct: 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMVEGEPPYLNENPLR 222
Query: 260 EIYDAVVRRQEIPPI--PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+Y ++ P + P L P + L C E D+ R ++L+
Sbjct: 223 ALY--LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G +G V+ A H + + VA+K++ PV+ED + + + +C I
Sbjct: 11 LGEGSYGSVYKAIHKETGQ------VVAIKVV-PVEEDLQE--IIKEISILKQCDS-PYI 60
Query: 109 CWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS---LSNVFRYAIDLAQGILQLH 164
G N + I+M++ GSV D M ++ L+ ++ + + +G+ LH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTL---KGLEYLH 116
Query: 165 SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQP 224
S + ++K N +LNE +A L D G+ L + + +GTP +MA P
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV---IGTPFWMA-----P 168
Query: 225 EVRGPISFE--TDSWGFACSIIEMLTGVQPR 253
EV I + D W + IEM G P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 26 TAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE 85
++ A+ + +A S L+ +RIG G G V+ H + A+K+++ E
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGR------LYALKVIYGNHE 112
Query: 86 DRMRVLLER----LNDL----FLKCQGVEGICWLQGISVINGKICIIMKFYEGSV--GDR 135
D +R + R L D+ +KC + NG+I ++++F +G G
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDH---------NGEIQVLLEFMDGGSLEGTH 163
Query: 136 MAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195
+A + L++V R + GI LH + I+ ++KP N ++N A + D G+
Sbjct: 164 IAD----EQFLADVARQILS---GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216
Query: 196 LLLGI--PLPSSDLPRRLGTPNYMAPEQWQPEVRGPI--SFETDSWGFACSIIEMLTGVQ 251
+L P SS +GT YM+PE+ ++ + D W SI+E G
Sbjct: 217 ILAQTMDPCNSS-----VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271
Query: 252 P 252
P
Sbjct: 272 P 272
|
Length = 353 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 31/282 (10%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I PS + + IG G FGEV+ + + VA+K L P ++ R D
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQR------QD 52
Query: 98 LFLKCQGVEG------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
FL + G I L+G+ II ++ E D+ + G+ S +
Sbjct: 53 -FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG 111
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP-----LPSSD 206
+A G+ L + +L N ++N + D G+ +L P
Sbjct: 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK 171
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265
+P R P +A ++ + +D W F + E+++ G +P S E+ A+
Sbjct: 172 IPIRWTAPEAIAYRKF--------TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
Query: 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+P P P AV ++L C++ D RP DI+ +
Sbjct: 224 NDGFRLPA-PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLFLKCQG 104
IGRG FGEV+ D A+K L +K+ L ER+ +
Sbjct: 2 IGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQL 163
I + K+ I+ G GD L + G S + + YA ++ G+ +
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR-----LGTPNYMA 218
H++ ++ +LKP N +L+E + D+G+ + D ++ +GT YMA
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGL----------ACDFSKKKPHASVGTHGYMA 163
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
PE Q V S D + C + ++L G P
Sbjct: 164 PEVLQKGVAYDSS--ADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 16/146 (10%)
Query: 117 INGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKP 175
++ ++ ++M+F GSV D + KG L + ++ +G+ LH ++ ++K
Sbjct: 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 139
Query: 176 FNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPE----QWQPEVRG 228
N +L E L D G+ L + RR +GTP +MAPE P+
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTPYWMAPEVIACDENPD--A 191
Query: 229 PISFETDSWGFACSIIEMLTGVQPRC 254
F++D W + IEM G P C
Sbjct: 192 TYDFKSDLWSLGITAIEMAEGAPPLC 217
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
+L RIG G +G+V+ A + + E + V L P ED V E + + C
Sbjct: 11 FELIQRIGSGTYGDVYKARNV----NTGELAAIKVIKLEP-GEDFAVVQQEII--MMKDC 63
Query: 103 QGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
+ + + G + K+ I M+F G + + G LS S + + + QG+
Sbjct: 64 KHSNIVAYF-GSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYY 121
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAP 219
LHSKG + ++K N +L + L D G+ + ++ + +R +GTP +MAP
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI------TATIAKRKSFIGTPYWMAP 175
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
E E +G + D W + IE L +QP
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 62/282 (21%), Positives = 108/282 (38%), Gaps = 29/282 (10%)
Query: 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFL 100
SA++ +G G FG+V+ + VA+K L E +++ + +L
Sbjct: 5 SAVRFLEELGEGAFGKVYKG-ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE--------------GSVGDRMAQLKGGK-LS 145
Q +C L G+ C++ ++ VG L
Sbjct: 64 DLQHPNIVCLL-GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
S+ AI +A G+ L S + +L N ++ E + D G+ + S+
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-----SA 177
Query: 206 DLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261
D R + P +W P + G + E+D W F + E+ + G+QP G S E+
Sbjct: 178 DYYRVQS--KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
+ + RQ + P P P V +++ C+ RP DI
Sbjct: 236 IEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 41/293 (13%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL--HPVKEDRMRVLLERL 95
+ ++ L +G G FGEV+ + D E +VAVK L ++D L+E L
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVEL-QVAVKTLPESCSEQDESDFLMEAL 61
Query: 96 -----NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK------- 143
N + I L G+S I+++ G GD + L+ +
Sbjct: 62 IMSKFNH--------QNIVRLIGVSFERLPRFILLELMAG--GDLKSFLRENRPRPERPS 111
Query: 144 -LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA--DRAV-LGDVGIPHLLLG 199
L++ ++ A D+A+G L + ++ N +L R + D G+ +
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
Query: 200 IPLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCG 255
+ R+ G M P +W P + G + +TD W F + E+ + G P G
Sbjct: 172 -----ASYYRKGGRA--MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 256 RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
R+ E+ + V + P P G P V ++ C+++ RP IL +
Sbjct: 225 RTNQEVMEFVTGGGRLDP-PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 65/280 (23%), Positives = 99/280 (35%), Gaps = 84/280 (30%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR------VLLER------- 94
IGRG FGEVWL D A+K+L K D ++ V ER
Sbjct: 8 VIGRGAFGEVWLVRDK------DTGQVYAMKVLR--KSDMIKRNQIAHVRAERDILADAD 59
Query: 95 ---LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
+ L+ Q E + ++M++ G GD M L +VF
Sbjct: 60 SPWIVKLYYSFQDEE-------------HLYLVMEYMPG--GDLM-----NLLIRKDVFP 99
Query: 152 ------YAIDLAQGILQLHSKGILVLNLKPFNFILNE------------------ADRAV 187
Y +L + +H G + ++KP N +++ DR
Sbjct: 100 EETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 188 LGDVGIPHLLLGIPLPSSDLPRRL--------GTPNYMAPEQWQPEVRG-PISFETDSWG 238
+ L L ++ GTP+Y+APE +RG P E D W
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV----LRGTPYGLECDWWS 215
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---IPPIP 275
+ EML G P ++ E Y+ ++ +E PP P
Sbjct: 216 LGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDP 255
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 62/265 (23%), Positives = 107/265 (40%), Gaps = 24/265 (9%)
Query: 37 WIKPSA-LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W S LKL IG+G FG+V L + +VAVK L L E
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDY--------RGQKVAVKCLKDDSTAAQAFLAE-- 50
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAI 154
+ + + L G+ + + I+ ++ GS+ D + ++L+ +A+
Sbjct: 51 ASVMTTLRHPNLVQ-LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL 109
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
D+ +G+ L K + +L N +++E A + D G+ S LP +
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQDSGKLPVK---- 164
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273
+ APE + S ++D W F + E+ + G P + ++ V + +
Sbjct: 165 -WTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRP 298
P G PP V V+ C+E D RP
Sbjct: 221 -PEGCPPEVYKVMKDCWELDPAKRP 244
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPF 176
+G+I I M+ +G D++ + K G++ + + +I + +G+ L K I+ ++KP
Sbjct: 75 DGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133
Query: 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDS 236
N ++N L D G+ L+ S +GT +YM+PE+ Q S ++D
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQGT---HYSVQSDI 185
Query: 237 WGFACSIIEMLTG---VQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYD 293
W S++EM G + P + ++ ++ V P S P Y
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD---PAESETSPRPRPPGRPLSSYG 242
Query: 294 LRSRPLM 300
SRP M
Sbjct: 243 PDSRPPM 249
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 61/279 (21%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
++ + + ++H++G G +GEV+ VAVK L KED M V +
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEG--VWKKYSL----TVAVKTL---KEDTMEV------E 47
Query: 98 LFLKCQGV------EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVF 150
FLK V + L G+ II +F G++ D + + +++ +
Sbjct: 48 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 107
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG---IPLPSSDL 207
A ++ + L K + +L N ++ E + D G+ L+ G +
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 167
Query: 208 PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
P + P +A ++ S ++D W F + E+ T G+ P G + ++Y+ +
Sbjct: 168 PIKWTAPESLAYNKF--------SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
Query: 267 R--RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
+ R E P G PP V ++ C++++ RP +I
Sbjct: 220 KGYRMERPE---GCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLKCQGVE 106
RIG+G FGEV+ D VA+KI+ ED + + + + + +C
Sbjct: 11 RIGKGSFGEVFKGI------DNRTQQVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDS-P 62
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ G + K+ IIM++ G G + L+ G + ++ +G+ LHS+
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGG--GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
+ ++K N +L+E L D G+ L + + +GTP +MAPE Q
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIQ--- 174
Query: 227 RGPISFETDSWGFACSIIEMLTGVQP 252
+ + D W + IE+ G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 9e-06
Identities = 56/239 (23%), Positives = 89/239 (37%), Gaps = 57/239 (23%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM---------RVLLERLNDLF 99
+G G FG V L H + A+KIL K ++ + +L+ + F
Sbjct: 9 LGTGSFGRVMLVRH-KGSGKY-----YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
+ L G + + ++M++ G G+ + L K G+ YA AQ
Sbjct: 63 --------LVNLYGSFQDDSNLYLVMEYVPG--GELFSHLRKSGRFPEPVARFYA---AQ 109
Query: 159 GILQ---LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL---- 211
+L LHS I+ +LKP N +L+ + D G +R+
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG--------------FAKRVKGRT 155
Query: 212 ----GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
GTP Y+APE D W I EML G P + +IY+ ++
Sbjct: 156 YTLCGTPEYLAPEIIL---SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 13/205 (6%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
IGRG + +V L + + + + + V V +D ++ +F + +
Sbjct: 3 IGRGSYAKVLL----VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 58
Query: 109 CWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKG 167
L ++ ++++ G GD M + + KL + Y+ +++ + LH +G
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 168 ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVR 227
I+ +LK N +L+ L D G+ L P GTPNY+APE + E
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 228 GPISFETDSWGFACSIIEMLTGVQP 252
G F D W + EM+ G P
Sbjct: 174 G---FSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 43/242 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP------------VKEDRMRVLLER-- 94
+G+G FG+V LA + DE + A+K+L + E R+ L +
Sbjct: 3 LGKGSFGKVMLA----ELKGTDEVY--AIKVLKKDVILQDDDVDCTMTEKRILALAAKHP 56
Query: 95 -LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRY 152
L L Q + ++ +M++ G GD M Q+ + K Y
Sbjct: 57 FLTALHCCFQTKD-------------RLFFVMEYVNG--GDLMFQIQRSRKFDEPRSRFY 101
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
A ++ ++ LH G++ +LK N +L+ L D G+ GI L G
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE--GI-LNGVTTTTFCG 158
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
TP+Y+APE Q GP D W + EM+ G P + D+++++++ +
Sbjct: 159 TPDYIAPEILQELEYGP---SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY 215
Query: 273 PI 274
P+
Sbjct: 216 PV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 61/274 (22%), Positives = 116/274 (42%), Gaps = 34/274 (12%)
Query: 49 IGRGPFGEVWLATHYLSTEDC-DEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+GRG FGEV+LA + V VK L K++ ++ R D+F K +
Sbjct: 13 LGRGEFGEVFLA--KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KN 69
Query: 108 ICWLQGISVINGKICIIMKFYEGSVGD----------RMAQLKGGKLSLSNVFRYAIDLA 157
+ L G+ +I+++ + +GD + +LK LS +A
Sbjct: 70 VVRLLGLCREAEPHYMILEYTD--LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI------PLPSSDLPRRL 211
G+ L + + +L N +++ + R V V + L + L ++ +P R
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVS-SQREV--KVSLLSLSKDVYNSEYYKLRNALIPLR- 183
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270
++APE Q S ++D W F + E+ T G P G S +E+ + + +
Sbjct: 184 ----WLAPEAVQ---EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P+P G P + ++ C+ + + RP ++++
Sbjct: 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 63/287 (21%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I S ++ +G FG+V+ H T ++ VA+K L E +R +
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKG-HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 98 LFLKCQGVEGICWL------QGISVINGKIC-------IIMKFYEGSVG----DRMAQLK 140
+ + Q +C L Q +S+I ++M+ VG D+ +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK-- 118
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
L ++ +A G+ L S ++ +L N ++ + + D+G L
Sbjct: 119 -STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLG-----LFR 172
Query: 201 PLPSSDLPRRLGTPNYMAPEQW-QPE--VRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256
+ ++D + +G N + P +W PE + G S ++D W + + E+ + G+QP CG
Sbjct: 173 EVYAADYYKLMG--NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
S ++ + ++R +++ P P P V ++L C+ RP DI
Sbjct: 231 SNQDVIE-MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 34/267 (12%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLKCQGVE 106
+IG+G FGEV+ D VA+KI+ ED + + + + + +C
Sbjct: 11 KIGKGSFGEVFKGI------DNRTQKVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDS-P 62
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ G + + K+ IIM++ G G + L+ G L + + ++ +G+ LHS+
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGG--GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
+ ++K N +L+E L D G+ L + + +GTP +MAPE +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIK--- 174
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE--- 283
+ + D W + IE+ G P E++ V + IP PP +E
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPH-----SELHPMKV----LFLIPKNNPPTLEGNY 225
Query: 284 -----NVLLGCFEYDLRSRPLMTDILR 305
+ C + RP ++L+
Sbjct: 226 SKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 44/185 (23%), Positives = 69/185 (37%), Gaps = 16/185 (8%)
Query: 120 KICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
K+ +I+ + G G+ L + + S V Y ++ + LH GI+ ++K N
Sbjct: 79 KLHLILDYVNG--GELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENI 136
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMAPEQWQPEVRGPI---SFET 234
+L+ VL D G+ L + GT YMAPE +RG
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLA---EEEERAYSFCGTIEYMAPEV----IRGGSGGHDKAV 189
Query: 235 DSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR--QEIPPIPSGLPPAVENVLLGCFEY 292
D W E+LTG P + RR + PP P + + + E
Sbjct: 190 DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEK 249
Query: 293 DLRSR 297
D + R
Sbjct: 250 DPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 51/224 (22%), Positives = 81/224 (36%), Gaps = 53/224 (23%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
RIG G G V+ A + E VA+K +V L RL E
Sbjct: 7 RIGEGAHGIVFKAKDRETGE------TVALK----------KVALRRLEGGIPNQALRE- 49
Query: 108 ICWLQGISVIN-----------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
I LQ ++M++ + + + + L + V Y L
Sbjct: 50 IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER-PLPEAQVKSYMRML 108
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR----RLG 212
+G+ +H+ GI+ +LKP N +++ + D G+ L S + PR ++
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF------SEEEPRLYSHQVA 162
Query: 213 TPNYMAPE------QWQPEVRGPISFETDSWGFACSIIEMLTGV 250
T Y APE ++ P V D W C E+L G
Sbjct: 163 TRWYRAPELLYGARKYDPGV--------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR--------YAIDLAQGILQLHSKGILVL 171
K+ +IM++ GS GD Q+K +L F+ Y I LA + ++HS+ ++
Sbjct: 139 KLLLIMEY--GSGGDLNKQIKQ-RLKEHLPFQEYEVGLLFYQIVLA--LDEVHSRKMMHR 193
Query: 172 NLKPFNFILNEADRAVLGDVGIPHLL---LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRG 228
+LK N L LGD G + + + SS GTP Y+APE W+ R
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCGTPYYLAPELWE---RK 246
Query: 229 PISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLG 288
S + D W + E+LT +P G S EI V+ + P P + ++ +L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL-YGKYDPFPCPVSSGMKALLDP 305
Query: 289 CFEYDLRSRPLMTDIL 304
+ RP +L
Sbjct: 306 LLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 67/279 (24%), Positives = 96/279 (34%), Gaps = 70/279 (25%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL------------HPVKEDRMRVLLERLN 96
IGRG FGEV L + H A+K L H V+ +R +L E N
Sbjct: 9 IGRGAFGEVRLVQKKDTG------HIYAMKKLRKSEMLEKEQVAH-VRAER-DILAEADN 60
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAID 155
+K Q + +IM++ G GD M L K + Y +
Sbjct: 61 PWVVKLY-----YSFQD----ENYLYLIMEYLPG--GDMMTLLMKKDTFTEEETRFYIAE 109
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI----------------PHLLLG 199
I +H G + ++KP N +L+ L D G+ H L
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 200 IPLPSSDLP-------------RR------LGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
L P RR +GTP+Y+APE + E D W
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK---ECDWWSLG 226
Query: 241 CSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
+ EML G P C + E Y ++ +E P +P
Sbjct: 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP 265
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMAPEQ 221
+HSK ++ ++K N +L LGD G + S D+ R GTP Y+APE
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV--SDDVGRTFCGTPYYVAPEI 216
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
W+ R P S + D + + E+LT +P G +++E+ + + P+P + P
Sbjct: 217 WR---RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-YDPLPPSISPE 272
Query: 282 VENVLLGCFEYDLRSRP-----LMTDILRVFKSS-QNSVHSDGGWTGHGSRILPDKSSSG 335
++ ++ D + RP L I ++F S V + G++G + +
Sbjct: 273 MQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQ- 331
Query: 336 YTEWFLSKEDLKVDDVVRSRKPPNS 360
+K+ L+V+ R+
Sbjct: 332 ------TKQLLQVE----RRRIVRQ 346
|
Length = 496 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 116 VINGKICIIMKFYE-GSVGDRMAQL--KGG--KLSLSNVFRYAIDLAQGILQLHSKGILV 170
V+ ++ ++M + GS+ D M +GG + ++ V + ++ +G+ LHS G +
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYLHSNGQIH 125
Query: 171 LNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR-----LGTPNYMAPEQWQPE 225
++K N +L E + D G+ L D R+ +GTP +MAPE + +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLA----DGGDRTRKVRKTFVGTPCWMAPEVME-Q 180
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQP 252
V G F+ D W F + IE+ TG P
Sbjct: 181 VHG-YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 16/143 (11%)
Query: 120 KICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
++ ++M+F GSV D + KG L + ++ +G+ LH+ ++ ++K N
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPE----QWQPEVRGPIS 231
+L E L D G+ L + RR +GTP +MAPE P+
Sbjct: 153 LLTENAEVKLVDFGVSAQL------DRTVGRRNTFIGTPYWMAPEVIACDENPD--ATYD 204
Query: 232 FETDSWGFACSIIEMLTGVQPRC 254
+ +D W + IEM G P C
Sbjct: 205 YRSDIWSLGITAIEMAEGAPPLC 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 24/124 (19%)
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN----------------EADRA 186
K S+ + I +HSKG+L +LKP N +L + +
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 187 VLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMAPEQWQPEVRG-PISFETDSWGFACSII 244
L D+ + I S +P ++ GTP+YMAPE+ + G P S TD + +
Sbjct: 169 DLLDIDVD--ERNICYSSMTIPGKIVGTPDYMAPER----LLGVPASESTDIYALGVILY 222
Query: 245 EMLT 248
+MLT
Sbjct: 223 QMLT 226
|
Length = 932 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 60/249 (24%), Positives = 92/249 (36%), Gaps = 47/249 (18%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL--------HPVKEDRMRVLLERLNDLF 99
+IG G +G V+ A L+ E VA+K + P R LL+ LN
Sbjct: 6 KIGEGTYGVVYKARDKLT----GEI--VAIKKIKLRFESEGIPKTALREIKLLKELNH-- 57
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD--RMAQLKGGKLSLSNVFRYAIDLA 157
I L + G + ++ +F + + + Q L S + Y L
Sbjct: 58 ------PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
QG+ HS GIL +LKP N ++N L D G+ P + + T Y
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH---YVVTRWYR 165
Query: 218 APE------QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQE 270
APE + V D W C E+L+ G+S +D+++ + R
Sbjct: 166 APELLLGDKGYSTPV--------DIWSVGCIFAELLSRRPLFPGKSEIDQLFK--IFRTL 215
Query: 271 IPPIPSGLP 279
P P P
Sbjct: 216 GTPDPEVWP 224
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFL--K 101
+L R+G G +G+V+ A + + E AVKI+ D ++ + ++F+ +
Sbjct: 12 ELIQRVGSGTYGDVYKARNLHTGE------LAAVKIIKLEPGDDFSLIQQ---EIFMVKE 62
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQG 159
C+ + + G + K+ I M++ G + + G +L ++ V R + QG
Sbjct: 63 CKHCNIVAYF-GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QG 118
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNY 216
+ LHSKG + ++K N +L + L D G+ + ++ + +R +GTP +
Sbjct: 119 LAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI------TATIAKRKSFIGTPYW 172
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
MAPE E G + D W + IE L +QP
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQLHSKGILVLNLKPFN 177
GK+ +I+++ G G+ L+ + + + Y +++ + LH +GI+ +LKP N
Sbjct: 73 GKLYLILEYLSG--GELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPEN 130
Query: 178 FILNEADRAVLGDVGI--PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETD 235
+L+ L D G+ + G + GT YMAPE G D
Sbjct: 131 ILLDAQGHVKLTDFGLCKESIHEGTVTHTF-----CGTIEYMAPEILMRSGHGK---AVD 182
Query: 236 SWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQEIPP 273
W + +MLTG P + + D +++ + +PP
Sbjct: 183 WWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 15/128 (11%)
Query: 128 YEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH---SKGILVLNLKPFNFILNEAD 184
+E G ++++ LS + AI +A+ + LH S ++V NL P I++ D
Sbjct: 762 HEYIEGKNLSEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820
Query: 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII 244
PHL L +P + + Y+APE + I+ ++D +GF +I
Sbjct: 821 E--------PHLRLSLPGLLCTDTKCFISSAYVAPETRE---TKDITEKSDIYGFGLILI 869
Query: 245 EMLTGVQP 252
E+LTG P
Sbjct: 870 ELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 39/134 (29%), Positives = 55/134 (41%), Gaps = 9/134 (6%)
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
G +S+ NV + L +G+ H + IL +LKP N ++NE L D G L
Sbjct: 97 GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFG---LARAK 153
Query: 201 PLPSSDLPRRLGTPNYMAPEQW--QPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV 258
+P+ + T Y P+ E PI D WG C + EM TG G +V
Sbjct: 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI----DMWGVGCILYEMATGRPMFPGSTV 209
Query: 259 DEIYDAVVRRQEIP 272
E + R P
Sbjct: 210 KEELHLIFRLLGTP 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH----PVKEDRMRVLLERLNDL 98
LK +G G FG+V L + + + E VAVK L + + L L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEM--VAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 99 FLK-CQGVEGICWLQGISVINGKIC-IIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+ + +G C QG GK +IM++ +G L KL+L+ + +A +
Sbjct: 64 YHENIVKYKGCCSEQG-----GKGLQLIMEYV--PLGSLRDYLPKHKLNLAQLLLFAQQI 116
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+G+ LHS+ + +L N +L + DR V +GD G L +P R+ +
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL-DNDRLVKIGDFG-----LAKAVPEGHEYYRV-RED 169
Query: 216 YMAPEQW-QPEV--RGPISFETDSWGFACSIIEMLTG--------------VQPRCGR-S 257
+P W E S+ +D W F ++ E+LT + P+ G+ +
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312
V + + + R + P P P V ++ C+E + + RP ++ + K +
Sbjct: 230 VVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPF 176
+G+I I M+ +G D++ + K G++ + + + +I + +G+ L K I+ ++KP
Sbjct: 71 DGEISICMEHMDGGSLDQVLK-KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDS 236
N ++N L D G+ L+ S +GT +YM+PE+ Q + ++D
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQGT---HYTVQSDI 181
Query: 237 WGFACSIIEMLTGVQP 252
W S++EM G P
Sbjct: 182 WSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/212 (26%), Positives = 83/212 (39%), Gaps = 37/212 (17%)
Query: 47 HRIGRGPFGEVWLATHYLSTE---------DCDEYHEVAVKILHPVKEDRMRVLLERLND 97
H IG G FG V+ AT+ + E + +E I+ VK + L+ N
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ---LKHPNT 83
Query: 98 LFLK-CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+ K C E WL +M++ GS D L+ K L V AI
Sbjct: 84 IEYKGCYLKEHTAWL------------VMEYCLGSASD---LLEVHKKPLQEVEIAAITH 128
Query: 157 A--QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
QG+ LHS ++ ++K N +L E + L D G P++ +GTP
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSF---VGTP 181
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
+MAPE G + D W + IE+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL-- 95
I+ + L IG G FG+V+ Y+S E+ E VAVK K + E+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGV-YMSPEN--EKIAVAVKT---CKNCTSPSVREKFLQ 56
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAI 154
++ I L G+ N + I+M+ G + + K L L+++ Y+
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSY 114
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD-------- 206
L+ + L SK + ++ N +++ D LGD G+ L D
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-------EDESYYKASK 167
Query: 207 --LPRRLGTPNYMAPEQWQPEVRGPISFE-----TDSWGFACSIIEMLT-GVQPRCG-RS 257
LP + +MAPE I+F +D W F + E+L GV+P G ++
Sbjct: 168 GKLPIK-----WMAPES--------INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
D I + E P+P PP + +++ C+ YD RP T++
Sbjct: 215 NDVI--GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 62/239 (25%), Positives = 93/239 (38%), Gaps = 27/239 (11%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLFLKCQGV 105
IGRG FGEV TE A+KIL+ +K E N L V
Sbjct: 9 IGRGAFGEV-AVVKMKHTERI-----YAMKILNKWEMLKRAETACFREERNVL------V 56
Query: 106 EGIC-WLQGISVI---NGKICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQG 159
G C W+ + + ++M +Y G GD + L +L Y ++
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVG--GDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
I +H + ++KP N +L+ L D G + S + +GTP+Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 220 E--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
E Q + G E D W + EML G P S+ E Y ++ +E PS
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 23/137 (16%)
Query: 119 GKICIIMKFYEG----SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLK 174
I I M++ EG S+ ++ + +GG++ + + A + +G+ LHS+ I+ ++K
Sbjct: 74 SSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132
Query: 175 PFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-----GTPNYMAPEQWQPEVRGP 229
P N +L + L D G+ S +L L GT YMAPE+ Q P
Sbjct: 133 PSNILLTRKGQVKLCDFGV----------SGELVNSLAGTFTGTSFYMAPERIQ---GKP 179
Query: 230 ISFETDSWGFACSIIEM 246
S +D W +++E+
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 6/101 (5%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL 211
Y+ +++ + LH +GI+ +LK N +L+ L D G+ + P
Sbjct: 101 YSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---PGDTTSTFC 157
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
GTPNY+APE + E G F D W + EM+ G P
Sbjct: 158 GTPNYIAPEILRGEDYG---FSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 9/122 (7%)
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
G +++ NV + L +G+ H + +L +LKP N ++NE L D G L
Sbjct: 98 GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFG---LARAK 154
Query: 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET--DSWGFACSIIEMLTGVQPRCGRSV 258
+P+ + T Y P+ + G + T D WG C EM TG G +V
Sbjct: 155 SIPTKTYSNEVVTLWYRPPDI----LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210
Query: 259 DE 260
+E
Sbjct: 211 EE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK-ILHPVKEDRMRVLLERLNDLFLK 101
++ + +G G G V+ A H L+ +AVK I + + + ++ L L+ K
Sbjct: 3 IQYQEILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELEILY-K 55
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
C I + V N +I I +F +G D K+ + R A+ + +G+
Sbjct: 56 CDSPYIIGFYGAFFVEN-RISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLT 109
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
L S IL ++KP N ++N + L D G+ L+ +S +GT YMAPE+
Sbjct: 110 YLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKTYVGTNAYMAPER 164
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
E G S D W S +E+ G P
Sbjct: 165 ISGEQYGIHS---DVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 8/166 (4%)
Query: 123 IIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180
++M +Y G GD + L +L Y ++ I +H + ++KP N ++
Sbjct: 78 LVMDYYVG--GDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPE--QWQPEVRGPISFETDSWG 238
+ L D G L+ S + +GTP+Y++PE Q + +G E D W
Sbjct: 136 DMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDGKGKYGPECDWWS 193
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284
+ EML G P S+ E Y ++ +E P+ + E+
Sbjct: 194 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 36/260 (13%)
Query: 49 IGRGPFGEVWL----------ATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL 98
+G+G FG+V L A L E EVA H V E R +L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESR---VLQNTRHP 55
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLA 157
FL L+ + ++C +M++ G G+ L ++ R Y ++
Sbjct: 56 FLTA--------LKYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFYGAEIV 105
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+ LHS+ ++ ++K N +L++ + D G+ GI + + GTP Y+
Sbjct: 106 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GIS-DGATMKTFCGTPEYL 162
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE + G D WG + EM+ G P + + +++ ++ +EI P
Sbjct: 163 APEVLEDNDYGR---AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-MEEI-RFPRT 217
Query: 278 LPPAVENVLLGCFEYDLRSR 297
L P +++L G + D + R
Sbjct: 218 LSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 36/169 (21%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 144 LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP-- 201
L++ ++ Y+ +A+G+ L S+ + +L N +L+E + + D G+ + P
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 202 --LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSV 258
S+ LP + +MAPE +V + ++D W F + E+ + G P G +
Sbjct: 231 VRKGSARLPLK-----WMAPESIFDKV---YTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282
Query: 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+E + ++ P P + ++L C++ D + RP + ++ +
Sbjct: 283 NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 10/103 (9%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR- 210
Y + G+ LH + I+ +LKP N +L+ G+V I L L + L +
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDND-----GNVRISDLGLAVELKDGQSKTKG 156
Query: 211 -LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
GTP +MAPE Q E F D + ++ EM+ P
Sbjct: 157 YAGTPGFMAPELLQGE---EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 31/280 (11%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I S +K+ IG G FGEV L E VA+K L ++ R
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGR--LKLPGKREIF-VAIKTLKSGYTEKQR-------R 50
Query: 98 LFLKCQGVEG------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
FL + G I L+G+ + + II +F E D + G+ ++ +
Sbjct: 51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG 110
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL 211
+A G+ L + +L N ++N + D G+ L +SD P
Sbjct: 111 MLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSD-PTYT 166
Query: 212 GTPNYMAPEQWQ-PEVRGPISFE-----TDSWGFACSIIEMLT-GVQPRCGRSVDEIYDA 264
+ P +W PE I++ +D W + + E+++ G +P S ++ +A
Sbjct: 167 SSLGGKIPIRWTAPEA---IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223
Query: 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
+ + +PP P P A+ ++L C++ D +RP I+
Sbjct: 224 IEQDYRLPP-PMDCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 54/294 (18%)
Query: 43 LKLRHRIGRGPFGEVWLA-----THYL---STEDCDEYHEVAVKILHP-----VKEDRMR 89
L+L+ ++G G FGEV L +L + E + VAVK+L + D ++
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 90 --VLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGK--- 143
++ RL + I L G+ V + +C+I ++ E G + ++Q +
Sbjct: 67 EIKIMSRLKN--------PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118
Query: 144 -------LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196
+S++N+ A+ +A G+ L S + +L N ++ + D G+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 197 LLGIPLPSSDLPRRLGTP----NYMAPEQWQPEVRGPISFETDSWGFACSIIEM--LTGV 250
L S D R G +MA W+ + G + +D W F ++ EM L
Sbjct: 179 LY-----SGDYYRIQGRAVLPIRWMA---WESILLGKFTTASDVWAFGVTLWEMFTLCKE 230
Query: 251 QPRCGRSVDEIYDAVVR------RQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
QP S +++ + RQ P V +++ C+ D++ RP
Sbjct: 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 168 ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ---P 224
I+ ++KP N ++N + L D G+ L+ +S +G +YMAPE+ + P
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-----ASLAKTNIGCQSYMAPERIKSGGP 178
Query: 225 EVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY---DAVVRRQEIPPIPSGLPPA 281
+ ++D W SI+EM G P + I+ A+V + P +PSG
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDPPTLPSGYSDD 237
Query: 282 VENVLLGCFEYDLRSRP 298
++ + C RP
Sbjct: 238 AQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 66/268 (24%), Positives = 114/268 (42%), Gaps = 27/268 (10%)
Query: 43 LKLRHRIGRGPFGEVWLATHY-LSTEDCDEYHEVAVKILHP-VKEDRMRVLLERLNDLFL 100
L +G G FG+V AT Y LS D +VAVK+L P L+ L +
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDA--VMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 101 KCQGVEGICWLQGISVINGKICIIMKF--YEGSVGDRMAQLKGGK---LSLSNVFRYAID 155
E I L G I G I +I ++ Y GD + L+ + L+L ++ ++
Sbjct: 95 LGNH-ENIVNLLGACTIGGPILVITEYCCY----GDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG----IPLPSSDLPRRL 211
+A+G+ L SK + +L N +L + D G+ ++ + ++ LP +
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK- 208
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270
+MAPE +FE+D W + + E+ + G P G VD + +++
Sbjct: 209 ----WMAPESI---FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRP 298
P P + +++ C++ D RP
Sbjct: 262 RMAQPEHAPAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 67/287 (23%), Positives = 109/287 (37%), Gaps = 42/287 (14%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I PS + + IG G FGEV L + +VA+K L D+ R
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKE---IDVAIKTLKAGSSDKQR-------L 50
Query: 98 LFLKCQGVEG------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
FL + G I L+G+ + + II ++ E D+ + GK ++ +
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVG 110
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL 211
+A G+ L + +L N ++N + D G L RRL
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG--------------LSRRL 156
Query: 212 GTPN--YMA-----PEQWQ-PEVRGPISFET--DSWGFACSIIEMLT-GVQPRCGRSVDE 260
Y P +W PE F + D W F + E+++ G +P S +
Sbjct: 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+ AV +PP P P A+ ++L C++ D RP + I+
Sbjct: 217 VIKAVEDGYRLPP-PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 142 GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201
G L NV + L +G+ +H + IL +LKP N ++++ L D G+
Sbjct: 98 GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR---AKS 154
Query: 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET--DSWGFACSIIEMLTGV 250
+PS + T Y P+ + G + T D WG C +EM+ GV
Sbjct: 155 VPSHTYSNEVVTLWYRPPDV----LLGSTEYSTCLDMWGVGCIFVEMIQGV 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 5e-04
Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 20/134 (14%)
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199
K + S + Y L +G+ LHS GIL ++K N ++N L D G+
Sbjct: 93 PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY-- 150
Query: 200 IPLPSSDLPRRLGTPNYMAPE------QWQPEVRGPISFETDSWGFACSIIEMLTGVQPR 253
S+D R+ T Y PE ++ PEV D W C + E+ G
Sbjct: 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEV--------DMWSVGCILAELFLGKPIF 202
Query: 254 CGRS----VDEIYD 263
G + +++I++
Sbjct: 203 QGSTELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 57/271 (21%), Positives = 113/271 (41%), Gaps = 39/271 (14%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------RMRVLLER 94
LKL IG+G FG+V L + ++VAVK +K D V+ +
Sbjct: 8 LKLLQTIGKGEFGDVMLGDY--------RGNKVAVKC---IKNDATAQAFLAEASVMTQL 56
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFY-EGSVGDRMAQLKGGKLSLSNVFRYA 153
+ ++ GV I G + I+ ++ +GS+ D + L + +++
Sbjct: 57 RHSNLVQLLGV--------IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+D+ + + L + + +L N +++E + A + D G+ + LP +
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK--- 164
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272
+ APE + + S ++D W F + E+ + G P + ++ V + ++
Sbjct: 165 --WTAPEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 219
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
P G PP V +V+ C+ D +RP +
Sbjct: 220 A-PDGCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 15/127 (11%)
Query: 125 MKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184
+K Y + G R G L + V + L +GI H +L +LKP N ++N+
Sbjct: 84 LKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG 137
Query: 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET--DSWGFACS 242
L D G+ GIP+ + + T Y AP+ + G ++ T D W C
Sbjct: 138 ELKLADFGLAR-AFGIPV--NTFSNEVVTLWYRAPDV----LLGSRTYSTSIDIWSVGCI 190
Query: 243 IIEMLTG 249
+ EM+TG
Sbjct: 191 MAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 50/278 (17%)
Query: 49 IGRGPFGEVWLATH----------YLSTEDCDEY--HEVAVKILHPVKEDRMRVLLERLN 96
+G G FG+V+ A H + E +E V + IL K + L E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY- 71
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAID 155
K+ I+++F +G ++ M +L+ G L+ +
Sbjct: 72 -------------------FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQ 111
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LG 212
+ + + LHS ++ +LK N +L L D G+ S L +R +G
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK------STLQKRDTFIG 165
Query: 213 TPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
TP +MAPE E P ++ D W ++IE+ P + + +++ +
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE- 224
Query: 271 IPPI---PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
PP PS + + L C D RP ++L+
Sbjct: 225 -PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 60/284 (21%), Positives = 115/284 (40%), Gaps = 25/284 (8%)
Query: 24 LRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV 83
LRT V+ + + + +IG+G G V+ A ++T EVA+K ++
Sbjct: 8 LRTIVSVGDPKKKYTR------FEKIGQGASGTVYTAID-VATG-----QEVAIKQMNLQ 55
Query: 84 KEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGG 142
++ + +++ + L ++ I ++ ++ ++M++ G S+ D + +
Sbjct: 56 QQPKKELIINEI--LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 113
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
+ ++ V R + Q + LHS ++ ++K N +L L D G I
Sbjct: 114 EGQIAAVCR---ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITP 167
Query: 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEI 261
S +GTP +MAPE + GP + D W IEM+ G P + + +
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
Y P L + L C E D+ R ++L+
Sbjct: 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 48/180 (26%), Positives = 70/180 (38%), Gaps = 8/180 (4%)
Query: 73 HEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSV 132
VA+K++ E+ + R L LK I L I + + ++ +
Sbjct: 31 QLVALKVISMKTEEGVPFTAIREASL-LKGLKHANIVLLHDIIHTKETLTFVFEYMHTDL 89
Query: 133 GDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192
M Q GG L NV + L +G+ +H + IL +LKP N +++ L D G
Sbjct: 90 AQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFG 148
Query: 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
L +PS + T Y P+ S D WG C IEML G QP
Sbjct: 149 ---LARAKSIPSQTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAGCIFIEMLQG-QP 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 64/279 (22%), Positives = 106/279 (37%), Gaps = 37/279 (13%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I PS L +G G FG V L + D VA+K++ E M D
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLG-KWRGKID------VAIKMIR---EGAMS------ED 44
Query: 98 LFLKCQGV------EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVF 150
F++ V + L G+ I I+ ++ G + + + + K GKL +
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLL 103
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
D+ + + L S G + +L N ++ E + + D G+ +L SS
Sbjct: 104 DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ---- 159
Query: 211 LGTPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
GT P +W PEV S ++D W F + E+ + G P S E+ ++V
Sbjct: 160 -GTK---FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ P P V ++ C+ RP +L
Sbjct: 216 AGYRLYR-PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLF 99
L +G+G FG V A L +ED + +VAVK+L D L E
Sbjct: 1 FTLGRMLGKGEFGSVREA--QLKSED-GSFQKVAVKMLKADIFSSSDIEEFLREAA---C 54
Query: 100 LKCQGVEGICWLQGISV---INGKICI---IMKFYEGSVGDRMAQLKGGK-------LSL 146
+K + L G+S+ G++ I I+ F + GD L + L L
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKH--GDLHTFLLMSRIGEEPFTLPL 112
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
+ R+ ID+A G+ L SK + +L N +LNE + D G L + S D
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG-----LSKKIYSGD 167
Query: 207 LPRRLGTPNYMAPEQW---QPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262
R+ G + + P +W + + +D W F ++ E++T G P G EIY
Sbjct: 168 YYRQ-GCASKL-PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225
Query: 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
+ +++ + P V ++ C+ + + RP +
Sbjct: 226 NYLIKGNRLKQ-PPDCLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 25/194 (12%)
Query: 121 ICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179
+C++M++ EG GD LK G L + Y + + LH+ GI+ +LKP N +
Sbjct: 76 LCMVMEYVEG--GDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 180 LNEADRAVLGDVGIPHLLLGIPLPSSDL--------------PRRLGTPNYMAPEQWQPE 225
+ L D G+ +G+ +++L + GTP Y+APE +
Sbjct: 134 ITSMGHIKLTDFGLSK--IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191
Query: 226 VRG-PISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGLPPAVE 283
G P+ D W + E L G P G + +E++ V+ E P LP +
Sbjct: 192 GYGKPV----DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQ 247
Query: 284 NVLLGCFEYDLRSR 297
+++ + R
Sbjct: 248 DLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 9/131 (6%)
Query: 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179
K+ ++ +F + M + L + Y L QG+ HS +L +LKP N +
Sbjct: 73 KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 132
Query: 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET--DSW 237
+N L D G+ G+P+ + + T Y APE + G + T D W
Sbjct: 133 INTEGAIKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPEI----LLGCKYYSTAVDIW 185
Query: 238 GFACSIIEMLT 248
C EM+T
Sbjct: 186 SLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G FG+V+ A ++ + A K++ E+ + + + ++ C I
Sbjct: 20 LGDGAFGKVYKA------KNKETGALAAAKVIETKSEEELEDYMVEI-EILATCNH-PYI 71
Query: 109 CWLQGISVINGKICIIMKFYEGSVGDR-MAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG 167
L G +GK+ I+++F G D M +L G L+ + + + + LHS
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMK 130
Query: 168 ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQWQP 224
I+ +LK N +L L D G+ + L RR +GTP +MAPE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV------KTLQRRDSFIGTPYWMAPEVVMC 184
Query: 225 EVR--GPISFETDSWGFACSIIEM 246
E P ++ D W ++IEM
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 58/287 (20%), Positives = 105/287 (36%), Gaps = 39/287 (13%)
Query: 49 IGRGPFGEVWLATH--YLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVE 106
IG+G FG V+ A L E + VAVK+L M+ +R L +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEP---FTMVAVKMLKEEASADMQADFQREAALMAEFDH-P 68
Query: 107 GICWLQGISVINGKICIIMKFYE-------------------GSVGDRMAQLKGGKLSLS 147
I L G+ + +C++ ++ + L LS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 148 NVFRYAI--DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
+ I +A G+ L + + +L N ++ E + D G+ + S+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY-----SA 183
Query: 206 DLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261
D + + N P +W P + E+D W + + E+ + G+QP G + +E+
Sbjct: 184 DYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
VR + P P + N++ C+ RP I R+ +
Sbjct: 242 I-YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 57/262 (21%), Positives = 109/262 (41%), Gaps = 23/262 (8%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG+G G V+ A D EVA+K ++ ++ + +++ + L ++
Sbjct: 26 KIGQGASGTVYTAI------DIATGQEVAIKQMNLQQQPKKELIINEI--LVMRENKNPN 77
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I ++ ++ ++M++ G S+ D + + + ++ V R + Q + LHS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSN 134
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
++ ++K N +L L D G I S +GTP +MAPE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPI--PSGLPPAVE 283
GP + D W IEM+ G P + + +Y ++ P + P L
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LIATNGTPELQNPERLSAVFR 246
Query: 284 NVLLGCFEYDLRSRPLMTDILR 305
+ L C E D+ R ++L+
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 55/262 (20%), Positives = 109/262 (41%), Gaps = 23/262 (8%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107
+IG+G G V+ A D EVA++ ++ ++ + +++ + L ++
Sbjct: 27 KIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEI--LVMRENKNPN 78
Query: 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
I ++ ++ ++M++ G S+ D + + + ++ V R + Q + LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSN 135
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
++ ++K N +L L D G I S +GTP +MAPE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPI--PSGLPPAVE 283
GP + D W IEM+ G P + + +Y ++ P + P L
Sbjct: 193 YGP---KVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIATNGTPELQNPEKLSAIFR 247
Query: 284 NVLLGCFEYDLRSRPLMTDILR 305
+ L C + D+ R ++L+
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 31/282 (10%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I S +K+ IG G FGEV + L E VA+K L ++ R D
Sbjct: 1 IDASCIKIEKVIGAGEFGEV--CSGRLKLPGKREIP-VAIKTLKAGYTEKQR------RD 51
Query: 98 LFLKCQGVEG------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
FL + G I L+G+ + + I+ ++ E D + G+ ++ +
Sbjct: 52 -FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG 110
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS-----SD 206
+A G+ L G + +L N ++N + D G+ +L P +
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265
+P R P +A ++ + +D W + + E+++ G +P S ++ A+
Sbjct: 171 IPIRWTAPEAIAYRKF--------TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
Query: 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+P P P A+ ++L C++ D RP I+ +
Sbjct: 223 EEGYRLPA-PMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 20/224 (8%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV----KEDRMRVLLERLNDLFLKCQG 104
IGRG FGEV L H S + A+K+L + D ER F
Sbjct: 51 IGRGAFGEVQLVRHKSSQK------VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 105 V-EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
V + C Q + + ++M++ G GD + + + Y ++ + +
Sbjct: 105 VVQLFCAFQD----DKYLYMVMEYMPG--GDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS G++ ++KP N +L++ L D G + + D +GTP+Y++PE +
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLK 216
Query: 224 PE-VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
+ G E D W + EML G P S+ Y ++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 34/125 (27%), Positives = 55/125 (44%), Gaps = 10/125 (8%)
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
G +S+ NV + + +G+ H + +L +LKP N ++NE L D G L
Sbjct: 98 GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFG---LARAK 154
Query: 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFET--DSWGFACSIIEMLTGVQPRCGRSV 258
+P+ + T Y P+ + G + T D WG C EM +G G +V
Sbjct: 155 SVPTKTYSNEVVTLWYRPPDV----LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210
Query: 259 -DEIY 262
DE++
Sbjct: 211 EDELH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 41/179 (22%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR-YAIDLAQGILQLHSKGILVLNLKPFNF 178
++C +M++ G G+ L ++ + R Y ++ + LHS I+ +LK N
Sbjct: 69 RLCFVMEYVNG--GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL 126
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG 238
+L++ + D G+ GI ++ + GTP Y+APE + G D WG
Sbjct: 127 MLDKDGHIKITDFGLCKE--GIT-DAATMKTFCGTPEYLAPEVLEDNDYGR---AVDWWG 180
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+ EM+ G P + +++++ ++ E P L +++L G D R
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 111 LQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILV 170
L G+ V + I ++ ++ + D + +SL A LA + L K ++
Sbjct: 66 LYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH 124
Query: 171 LNLKPFNFILNEADRAV-------LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
N+ N ++ L D GIP +L +P ++APE
Sbjct: 125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------WIAPEC-- 175
Query: 224 PEVRGPISFET---DSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
+R + T D W F +++E+ + G +P S E + + Q P+P
Sbjct: 176 --IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQDQHRLPMPDC-- 230
Query: 280 PAVENVLLGCFEYDLRSRPLMTDILR 305
+ N++ C+ YD RP ILR
Sbjct: 231 AELANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 49/293 (16%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W + L L +G G FG+V A + ++ +E VAVK+L K+D +
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAE-AVGLDNPNETSTVAVKML---KDDATE---KD 58
Query: 95 LNDLF-----LKCQGV-EGICWLQGISVINGKICIIMKF------------------YEG 130
L+DL +K G + I L G+ G + +++++ Y
Sbjct: 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 131 SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190
R L+ ++ +A +A+G+ L SK + +L N ++ E + D
Sbjct: 119 PDDPR---PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 191 VGIPHLLLGIPLPSSDLPRRLGT---P-NYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
G L + D R+ P +MAPE V + ++D W F + E+
Sbjct: 176 FG-----LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLLWEI 227
Query: 247 LT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
T G P G V+E++ + + P + +++ C+ RP
Sbjct: 228 FTLGGSPYPGIPVEELFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRP 279
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 41/142 (28%), Positives = 59/142 (41%), Gaps = 16/142 (11%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL 211
Y+ ++ + LH GI+ ++K N +L+ VL D G+ L S + R
Sbjct: 110 YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL-----SEEKERTY 164
Query: 212 ---GTPNYMAPEQWQPEVRGPISF--ETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
GT YMAPE +RG D W I E+LTG P V
Sbjct: 165 SFCGTIEYMAPEI----IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 267 RR--QEIPPIPSGLPPAVENVL 286
RR + PP PS + P +++L
Sbjct: 221 RRILKCDPPFPSFIGPEAQDLL 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 39/161 (24%), Positives = 64/161 (39%), Gaps = 17/161 (10%)
Query: 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178
G + ++ YE + MAQ Y +L I +H G + ++KP N
Sbjct: 86 GDLLSLLNRYEDQFDEDMAQF------------YLAELVLAIHSVHQMGYVHRDIKPENV 133
Query: 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQP---EVRGPISFETD 235
+++ L D G L + +S LP +GTP+Y+APE + +G E D
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 236 SWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
W EM+ G P + + Y+ ++ Q P
Sbjct: 192 WWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE 232
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDC-DEYHEVAVK--ILHPVKEDRMRVLLERLND--- 97
KL + IG G FG V+ A C D +VA+K + P ++R ++++ LN
Sbjct: 69 KLGNIIGNGSFGVVYEAI-------CIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINI 121
Query: 98 LFLKCQGVEGICWLQGISVINGKIC--IIMKFYEGSVGDRMAQLKGGKLSLSN--VFRYA 153
+FLK + + I ++M+F +V M +L V Y+
Sbjct: 122 IFLK-----DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLG 212
L + + +HSK I +LKP N +++ + L D G LL S + R
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 213 TPNYMAPEQWQPEVRGPISFET--DSWGFACSIIEMLTGVQPRCGR-SVDEI 261
Y APE + G ++ T D W C I EM+ G G+ SVD++
Sbjct: 236 ---YRAPEL----MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 38/242 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
IGRG FGEV L H + + A+K+L + +++R + F
Sbjct: 51 IGRGAFGEVQLVRHKSTRK------VYAMKLLSKFE------MIKRSDSAFF-------- 90
Query: 109 CWLQGISVINGKICIIMKFYEGSVGDR-----MAQLKGGKLS--LSN-------VFRYAI 154
W + + +++ + DR M + GG L +SN Y
Sbjct: 91 -WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
++ + +HS G + ++KP N +L+++ L D G + + D +GTP
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTP 207
Query: 215 NYMAPEQWQPE-VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
+Y++PE + + G E D W + EML G P S+ Y ++ +
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 267
Query: 274 IP 275
P
Sbjct: 268 FP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 47/222 (21%), Positives = 91/222 (40%), Gaps = 45/222 (20%)
Query: 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER---LNDL----- 98
+IG G GEV+ AT + + EVA+K + +++ +++ + D
Sbjct: 25 EKIGEGASGEVYKATDRATGK------EVAIKKMR-LRKQNKELIINEILIMKDCKHPNI 77
Query: 99 --FLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAID 155
+ V W+ +M++ + GS+ D + Q +++ + +
Sbjct: 78 VDYYDSYLVGDELWV------------VMEYMDGGSLTDIITQ-NFVRMNEPQIAYVCRE 124
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LG 212
+ QG+ LHS+ ++ ++K N +L++ L D G L + + +R +G
Sbjct: 125 VLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL------TKEKSKRNSVVG 178
Query: 213 TPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPR 253
TP +MAPE ++ + D W IEM G P
Sbjct: 179 TPYWMAPEV----IKRKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 43/213 (20%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH------------PVKEDRMRVLLERLN 96
IG G FG V+ A ++E VA+K + +KE R L N
Sbjct: 23 IGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 97 DLFLK-CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYA 153
+ + C E WL +M++ GS D + K ++ ++ V A
Sbjct: 77 TIQYRGCYLREHTAWL------------VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ QG+ LHS ++ ++K N +L+E LGD G ++ P++ +GT
Sbjct: 125 L---QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXF---VGT 174
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
P +MAPE G + D W + IE+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 36/179 (20%)
Query: 121 ICIIMKFYEGSVGDRMAQLK---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177
+C++M + G G+ L+ G LS YA ++ + LH GI+ +LKP N
Sbjct: 76 LCLVMDYCPG--GELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN 133
Query: 178 FILNEADRAVLGD------------VGIPHLLLGIPLPSSDLPRRL-------------- 211
+L+E+ +L D L G S +
Sbjct: 134 ILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFV 193
Query: 212 GTPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269
GT Y+APE + G D W + EML G P G + DE + +++++
Sbjct: 194 GTEEYIAPEV----ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.8 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.6 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.45 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.35 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.34 | |
| PLN02236 | 344 | choline kinase | 96.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.93 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.98 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.6 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.39 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.24 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.14 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 90.83 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 89.21 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 87.71 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 87.4 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 85.33 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=444.88 Aligned_cols=328 Identities=23% Similarity=0.281 Sum_probs=261.6
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+++|++++.||+|+||.||+++...++ +.||+|++++...... ......+. -++...+||+||.++.
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~------kiYAmKvl~K~~iv~~~e~~~~~~Er-~IL~~v~hPFiv~l~y 92 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTG------KIYAMKVLKKKKIVEKKEVRHTKAER-NILSKIKHPFIVKLIY 92 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEEEEcccC------ceeehhhhhhhHhhhhhhHHHHHHHH-HHHHhCCCCcEeeeEE
Confidence 3678899999999999999999999988665 4899999987543222 22222222 3556699999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.|++.+.+|||+||+.| ++++.++ +++.|+++.++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||
T Consensus 93 sFQt~~kLylVld~~~G--GeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 93 SFQTEEKLYLVLDYLNG--GELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ecccCCeEEEEEeccCC--ccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccc
Confidence 99999999999999997 4444443 46899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
||+..... .....++|||+.|||||++.+ .+|+..+|+||||+++|||++|.+||.+.+..+++++|.... .+
T Consensus 171 L~k~~~~~---~~~t~tfcGT~eYmAPEil~~---~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~ 243 (357)
T KOG0598|consen 171 LCKEDLKD---GDATRTFCGTPEYMAPEILLG---KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LP 243 (357)
T ss_pred cchhcccC---CCccccccCCccccChHHHhc---CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CC
Confidence 99976542 234456899999999999984 479999999999999999999999999999999999998654 34
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCccccCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPL----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKV 348 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 348 (627)
..|..++.+.++++.++|..||++|.. +.+|.+ |+||..++|+.+..+.+.||+.|..... .+...+
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~------HpfF~~inW~~l~~k~l~PpF~P~~~~~---~~~~~F 314 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR------HPFFKGINWEKLLAKKLSPPFKPNVTGL---EDTSNF 314 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc------CcccccCCHHHHHhcCCCCCeecCCCCc---cccccc
Confidence 456669999999999999999999974 444443 9999999999999999999999886554 455556
Q ss_pred CccccCCCCCCCCCCCCCCCCCCceeeeecCCCCcceEEE
Q 006887 349 DDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLV 388 (627)
Q Consensus 349 ~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~~~~~~~~v 388 (627)
+...+..++..++.....+.+.....+......|.+|+++
T Consensus 315 d~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~ 354 (357)
T KOG0598|consen 315 DNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYV 354 (357)
T ss_pred cHHHHhccccCCccccCcccccccccccccccccCCcccc
Confidence 6666666555555432112122333333333445555554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=450.31 Aligned_cols=321 Identities=21% Similarity=0.297 Sum_probs=268.6
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..++.++|.++++||+|+||+|++|..+.+++ .||||++++... +..... ..+.+++....+||.++.|+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e------~yAIK~LKK~~Il~~d~Ve~~-~~EkrI~~la~~HPFL~~L~ 435 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNE------YYAIKVLKKGDILQRDEVESL-MCEKRIFELANRHPFLVNLF 435 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCc------EEEEEEeeccceeccccHHHH-HHHHHHHHHhccCCeEeecc
Confidence 46888999999999999999999999998886 899999998542 222222 22334444445899999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 113 GISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.+|++.+++|+||||+.| +|.+.....+.|++..+.+|+++|+.||+|||++||||||||.+|||||.+|++||+|||
T Consensus 436 ~~fQT~~~l~fvmey~~G--gdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 436 SCFQTKEHLFFVMEYVAG--GDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred cccccCCeEEEEEEecCC--CcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccc
Confidence 999999999999999998 444444455899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
||+.... .....+++||||.|||||++.++ .|+.++|+|||||+|||||.|..||.+.+.+++++.|+.. .+
T Consensus 514 lcKe~m~---~g~~TsTfCGTpey~aPEil~e~---~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~ 585 (694)
T KOG0694|consen 514 LCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQ---SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EV 585 (694)
T ss_pred cccccCC---CCCccccccCChhhcChhhhccC---cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CC
Confidence 9997653 24466789999999999999854 7999999999999999999999999999999999999754 67
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCccccC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLK 347 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~~ 347 (627)
.+|..+|.++.++++++|.++|++|..+ .+|.. |+||..++|+.+..+.+.||+.|..... .|-.+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~------hpFFr~i~w~~L~~r~i~PPf~P~i~~~---~D~sn 656 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK------HPFFRSIDWDDLLNRRIKPPFVPTIKGP---EDVSN 656 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh------CCccccCCHHHHhhccCCCCCCcccCCh---hhhcc
Confidence 7899999999999999999999999976 44554 9999999999999999999999986544 56677
Q ss_pred CCccccCCCCCCCCCCCCCCCCCCceeeeecCCCCcceEEEE
Q 006887 348 VDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLVR 389 (627)
Q Consensus 348 ~~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~~~~~~~~v~ 389 (627)
++..+++..|..++ +. ...+..++++. |.+|.++.
T Consensus 657 Fd~eFt~e~p~Lt~-~~-----~~~l~~~~q~~-F~~Fs~~~ 691 (694)
T KOG0694|consen 657 FDEEFTSEKPALTP-SD-----PRPLTEEEQEA-FRDFSFVA 691 (694)
T ss_pred cchhhhcCCCccCC-CC-----ccccchhhHHH-hcCccccC
Confidence 88888888888775 21 22233334333 55665543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-51 Score=434.11 Aligned_cols=340 Identities=20% Similarity=0.251 Sum_probs=256.5
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHH-HHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL-LERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~-~~~~~~~ll~~~~hpnIv~l~ 112 (627)
....+..++|++++.||+|+||.||+|+.+.|++ .||+|++++......... .-+.++.++.....|.||+|+
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~------iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGE------IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCc------EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 3557889999999999999999999999988876 899999987654322211 112222345558999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..|++..++||||||++| ++..++. +.+.|++.++++|+++++.|++.||+.|||||||||+|+|||..||+||+||
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 999999999999999996 5555554 5678999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC----------------------CC-----CC-----------------CCCccCCCCCcCCcccccCCCC
Q 006887 192 GIPHLLLGIP----------------------LP-----SS-----------------DLPRRLGTPNYMAPEQWQPEVR 227 (627)
Q Consensus 192 Gla~~~~~~~----------------------~~-----~~-----------------~~~~~~GT~~YmAPE~~~~~~~ 227 (627)
|||..+.... .+ .. .....+|||.|||||++.+.
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-- 363 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-- 363 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--
Confidence 9997543210 00 00 01124799999999999864
Q ss_pred CCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHH
Q 006887 228 GPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPL---MTD 302 (627)
Q Consensus 228 ~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs---~~e 302 (627)
.|+..+|+|||||||||||.|.+||.+.++.+++.+|+.......+| ..+++++++||.+||. ||++|.. +.|
T Consensus 364 -gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 364 -GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred -CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 59999999999999999999999999999999999999888666666 4578999999999998 9999986 445
Q ss_pred HHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCccccCCCccc---cCCCCCCCCCCCC-CCCCCCceeeeec
Q 006887 303 ILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKVDDVV---RSRKPPNSFKPEN-MDVPEGRVVGVEH 378 (627)
Q Consensus 303 il~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~---~~~~p~~~~~p~~-~~~~~~~~v~~~~ 378 (627)
|.+ ||||..++|+.+.... +|+.|...+..+. .++++.. ...+......+.. +..+.+.. -...
T Consensus 442 IK~------HPfF~~v~W~~l~~~~--apfvP~v~~~~DT---~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~-~~~~ 509 (550)
T KOG0605|consen 442 IKK------HPFFKGVDWDHLREMP--APFVPQVNSELDT---QYFDDFPEEDSMTPTADKSGPSRKMLSMVDTN-NSSK 509 (550)
T ss_pred Hhc------CCccccCCcchhhcCC--CCCCCCCCCcccc---cccccCcccccCcccccccccchhhhhccccc-CCcc
Confidence 544 9999999999987754 7777765443222 2222221 1111111111111 11111111 1122
Q ss_pred CCCCcceEEEEecccCCCC
Q 006887 379 NTEGESFVLVRVHGIHDPL 397 (627)
Q Consensus 379 ~~~~~~~~~v~~~~~~~~~ 397 (627)
+..|.||+++.+...+...
T Consensus 510 ~~~FvgfTyk~~~~~~~~~ 528 (550)
T KOG0605|consen 510 DINFVGFTYKNFDGLNKAN 528 (550)
T ss_pred cccccceeeeccccccccc
Confidence 3458899999988887554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=404.72 Aligned_cols=272 Identities=24% Similarity=0.324 Sum_probs=239.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHH-HHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN-DLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~-~~ll~~~~hpnIv~l~~~~~ 116 (627)
...++|++++.||.|+||.|.+++++.++. .||+|++++...-.++....... ..+++...||+++++.+.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~------yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGN------YYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCc------eeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 788999999999999999999999987764 89999998766544443333222 23677788999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
+.+.+||||||++| .|..++. +.++|++..+++|++||+.||+|||+++|++|||||+|||||.+|++||+|||+|+
T Consensus 115 d~~~lymvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceE
Confidence 99999999999996 4444433 45789999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.+.+ ...+.||||.|+|||++. ..+|+.++|+|||||++|||+.|.+||.+.++.+++++|... ...+|
T Consensus 193 ~v~~------rT~TlCGTPeYLAPEii~---sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~--~v~fP 261 (355)
T KOG0616|consen 193 RVSG------RTWTLCGTPEYLAPEIIQ---SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG--KVKFP 261 (355)
T ss_pred EecC------cEEEecCCccccChHHhh---cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC--cccCC
Confidence 8753 457889999999999998 457999999999999999999999999999999999999876 46789
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
..+++++++|+.++|+.|-.+|. ...+|.. |+||...+|....++.+.+|..|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~------H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKN------HPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhhhcCcCCCcccccc------CcccccccHHHHhhccccCCCCC
Confidence 99999999999999999999994 3345554 99999999999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-49 Score=416.94 Aligned_cols=270 Identities=21% Similarity=0.327 Sum_probs=236.2
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.-.+.+|...+.||+|+|++|++|++..++ ++||||++.+... +.......++...+..+.+||+|++|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~------keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATG------KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCC------ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 677899999999999999999999988776 4899999987432 22233445555556666699999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
|+++..+|+|+||++ |+|++++. +.+.|++..+.+|++||+.||+|||++|||||||||+|||||++|+++|+|||.
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccc
Confidence 999999999999999 78988887 447899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC----------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 006887 194 PHLLLGIPLP----------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263 (627)
Q Consensus 194 a~~~~~~~~~----------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~ 263 (627)
|+.+...... .....+++||-.|.+||++. ++..++.+|+|+|||+||+|+.|.+||.+.+..-+++
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~---~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN---DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhc---CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 9988643322 11225689999999999998 5578899999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 264 ~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
+|+.. .-.+|+.+++.+++|+.++|..||.+|++..+|.+ |+||..++|..+-+
T Consensus 298 kI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~------HpFF~~Vdw~nlw~ 351 (604)
T KOG0592|consen 298 KIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA------HPFFEGVDWENLWQ 351 (604)
T ss_pred HHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh------CcccccCChhhhhh
Confidence 99865 45689999999999999999999999999999888 99999999988443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=415.48 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=222.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..|...+.||+|||+.||++++..+++ .||+|++.+... ..+......+. .+.+.++|||||.++++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge------~~A~KvVpk~~l~k~~~reKv~~EI-eIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE------VVAVKVVPKKLLKKPKQREKVLNEI-EIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc------EEEEEEeehHHhcCcchHHHHHHHH-HHHHhcCCCcEEeeeeEeecC
Confidence 579999999999999999999987776 899999987432 22222233332 367889999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+++|||+|+|. |+|..++. +.+++++.+++.++.||+.||.|||+++|||||||..||||+++.++||+|||||..+
T Consensus 91 ~nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred CceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999 66666655 6678999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. +.....+.||||+|+|||++.. ..+++.+||||+||+||.||+|++||...+..+++..|... .-.+|..
T Consensus 169 e~---~~Erk~TlCGTPNYIAPEVl~k---~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--~Y~~P~~ 240 (592)
T KOG0575|consen 169 EY---DGERKKTLCGTPNYIAPEVLNK---SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--EYSMPSH 240 (592)
T ss_pred cC---cccccceecCCCcccChhHhcc---CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--Ccccccc
Confidence 64 2345568899999999999983 46899999999999999999999999999999999999765 4567889
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++.++++||.++|+.||.+||++.++++ |+||..
T Consensus 241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~------h~Ff~~ 274 (592)
T KOG0575|consen 241 LSAEAKDLIRKLLRPNPSERPSLDEVLD------HPFFKS 274 (592)
T ss_pred cCHHHHHHHHHHhcCCcccCCCHHHHhc------CHhhhC
Confidence 9999999999999999999999999999 888843
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=403.19 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=221.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH------HHHHHHHHHHHHHHhcCCCCc
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR------MRVLLERLNDLFLKCQGVEGI 108 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~------~~~~~~~~~~~ll~~~~hpnI 108 (627)
.+..-.+.|.+.+.||+|+||.|-+|..+.++. .||||++++..... .....+++. .+++.++||||
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk------~vAiKIi~krk~~~~s~~~~~~~~v~~Ei-eILkkL~HP~I 238 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGK------QVAIKIINKRKSTGCSRAIAKTRDVQNEI-EILKKLSHPNI 238 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCc------EEEeeeeehhhcccccccccchhhhHHHH-HHHHhcCCCCE
Confidence 344456789999999999999999999988875 89999998743322 111222332 36778999999
Q ss_pred eeeEEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC---C
Q 006887 109 CWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA---D 184 (627)
Q Consensus 109 v~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~---g 184 (627)
|+++++++..+..||||||++| +|.+.+. .++.+.+...+.++.||+.|+.|||++||+||||||+|||++.+ -
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcce
Confidence 9999999999999999999995 6666665 45778899999999999999999999999999999999999766 7
Q ss_pred CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH-HHH
Q 006887 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE-IYD 263 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e-~~~ 263 (627)
.+||+|||+|+.... .+.+.++||||.|.|||++.......+..++|+||+||+||-+|+|.+||.+..... +.+
T Consensus 317 llKItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e 392 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE 392 (475)
T ss_pred EEEecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence 899999999998753 456778999999999999986544445568999999999999999999999876665 777
Q ss_pred HHHhccCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 264 AVVRRQEI--PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 264 ~i~~~~~~--~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.|..+... +.....++++..+||.+||..||++||++.|+|+ |||+...
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~------hpW~~~~ 443 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN------HPWFKDA 443 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc------Chhhhcc
Confidence 77655432 2345679999999999999999999999999998 9998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=394.30 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=225.1
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++++.++.||+|..|+||+++|+.++. .+|+|++........+..+.++.+++..+ +||+||.+|+.|
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~------i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF 146 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGK------IYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAF 146 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCe------EEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEE
Confidence 45667799999999999999999999998875 89999997666666555566666565555 999999999999
Q ss_pred EECCE-EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCC
Q 006887 116 VINGK-ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 116 ~~~~~-~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
..++. ++|+||||+| +|.+.+. ..+.+++.....++.++++||.|||. ++||||||||+|||++..|.+||+|||
T Consensus 147 ~~~~~~isI~mEYMDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 147 YSNGEEISICMEYMDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EeCCceEEeehhhcCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 99994 9999999995 5555554 33789999999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHh
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-----SVDEIYDAVVR 267 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-----~~~e~~~~i~~ 267 (627)
.++.+.+ +...++.||..|||||.+.++ .|+.++||||||++++||++|+.||... +..+++..|..
T Consensus 225 VS~~lvn-----S~a~tfvGT~~YMsPERi~g~---~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 225 VSGILVN-----SIANTFVGTSAYMSPERISGE---SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred ccHHhhh-----hhcccccccccccChhhhcCC---cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 9998864 356788999999999999865 6999999999999999999999999874 67888988886
Q ss_pred ccCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 268 RQEIPPIPSG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 268 ~~~~~~~p~~-~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+ ..|..|.. +|+++++|+..||++||.+||++.++++ |+|...
T Consensus 297 ~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~------Hpfi~~ 340 (364)
T KOG0581|consen 297 E-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ------HPFIKK 340 (364)
T ss_pred C-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc------CHHHhh
Confidence 4 46778886 9999999999999999999999999998 887653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=381.90 Aligned_cols=286 Identities=20% Similarity=0.240 Sum_probs=237.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHH-HHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLL-ERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~-~~~~~~ll~~~~hpnIv~l~ 112 (627)
....+.+++|+++++||+|.-|+||+++...++. .+|+|++.+.......... ...++.+++.+.||.+++||
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~------~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNC------LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCc------eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 4567888999999999999999999999988764 8999999876544322222 22334478889999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..++.++..|+|||||+| +|..++..+.++.|++..+++|+++++.||+|||..|||+|||||+||||.++|++.|+||
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeec
Confidence 999999999999999995 7766777667799999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC---------------------------------C--------------------CCCCCCccCCCCCcCC
Q 006887 192 GIPHLLLGIP---------------------------------L--------------------PSSDLPRRLGTPNYMA 218 (627)
Q Consensus 192 Gla~~~~~~~---------------------------------~--------------------~~~~~~~~~GT~~YmA 218 (627)
.|+....... . .......++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9876432100 0 0011235689999999
Q ss_pred cccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 006887 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298 (627)
Q Consensus 219 PE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RP 298 (627)
||++.|+ ..+.++|||+||+++||||.|..||.|.+..+.+..|+.+....+-.+.++..+++||+++|.+||.+|.
T Consensus 304 PEvI~G~---GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 304 PEVIRGE---GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred ceeeecC---CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 9999976 4677999999999999999999999999999999999876544444457889999999999999999999
Q ss_pred C----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 299 L----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 299 s----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
. +.||.+ |+||...+|. .-+...||..|..
T Consensus 381 g~~rGA~eIK~------HpFF~gVnWa--Lir~~~PP~iP~~ 414 (459)
T KOG0610|consen 381 GSKRGAAEIKR------HPFFEGVNWA--LIRCARPPEIPKP 414 (459)
T ss_pred ccccchHHhhc------CccccCCChh--heeccCCCcCCCc
Confidence 8 666655 9999999999 3344566666553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=388.28 Aligned_cols=271 Identities=26% Similarity=0.397 Sum_probs=230.9
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
....|+.+++.+.+.||+|+||+||+|.+..+. .||||++......... ....++. .++..++||||+.++
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-------~vavK~~~~~~~~~~~~~~f~~E~-~il~~l~HpNIV~f~ 105 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTD-------VVAVKIISDPDFDDESRKAFRREA-SLLSRLRHPNIVQFY 105 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCce-------eEEEEEecchhcChHHHHHHHHHH-HHHHhCCCCCeeeEE
Confidence 456788899999999999999999999987653 3999999875533322 2222222 356669999999999
Q ss_pred EEEEECC-EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecccCCCcEEEecCC-Ceee
Q 006887 113 GISVING-KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG-ILVLNLKPFNFILNEAD-RAVL 188 (627)
Q Consensus 113 ~~~~~~~-~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g-IvHrDLKP~NILld~~g-~vkL 188 (627)
|++.... .++|||||++ |+|.+++.......+++..++.++.||+.||.|||+++ ||||||||+|||++.++ ++||
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEE
Confidence 9999877 7999999999 56666665435789999999999999999999999999 99999999999999998 9999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+++...... ...+...||+.|||||++.+. ..+|+.++||||||++||||+||+.||.+....++...+...
T Consensus 186 ~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 186 ADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CCCccceeecccc---ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999998765321 233447899999999999865 457999999999999999999999999999998888888888
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..++.+|..+++.+..++.+||..||..||++.+++..|+........
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 889999999999999999999999999999999999999876654433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.89 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=213.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..+|.+.++||+|+||+||+|+++.++. .||||.+.+... ......+..+. .+++.++|||||.+++++..+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~------~VAIK~i~~~~l~~k~~e~L~~Ei-~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGT------EVAIKCIAKKKLNKKLVELLLSEI-KILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCc------eEEeeeehhhccCHHHHHHHHHHH-HHHHhcCCcceeeEEEEEecC
Confidence 4689999999999999999999988774 899999987753 22233333332 357778899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC------CCeeeccC
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA------DRAVLGDV 191 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~------g~vkL~DF 191 (627)
+.+|||||||. |+|.+.+. ..+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999 57766665 44589999999999999999999999999999999999999764 35899999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+||.+.. .....+.||+|.|||||+++ .+.|+.|+|+||+|+++|+|++|++||...+..|++..+......
T Consensus 160 GfAR~L~~----~~~a~tlcGSplYMAPEV~~---~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~ 232 (429)
T KOG0595|consen 160 GFARFLQP----GSMAETLCGSPLYMAPEVIM---SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI 232 (429)
T ss_pred chhhhCCc----hhHHHHhhCCccccCHHHHH---hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence 99998863 34456789999999999997 457999999999999999999999999999999999888765544
Q ss_pred C-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 P-PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~-~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
. .++..++..+.+++...+..++.+|-+..+.+.
T Consensus 233 ~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 233 VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred cCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 3 455678888999999999999999988877654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.63 Aligned_cols=300 Identities=19% Similarity=0.291 Sum_probs=251.8
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-HHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-LNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-~~~~ll~~~~hpnIv~l~ 112 (627)
....+..++|..++.||+|.||.|.+++.+.++. .||||++++.-.-........ -+...++..+||.+..|.
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k------~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGK------LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCc------eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence 3556788999999999999999999999888774 899999987543222222221 123467788999999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..|+.++++|+||||..| ++++.++ +...|+++.+.+|..+|+.||.|||+++||+||||.+|+|+|++|++||+||
T Consensus 235 YsFQt~drlCFVMeyanG--GeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANG--GELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred hhhccCceEEEEEEEccC--ceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeec
Confidence 999999999999999997 3444333 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+|+.-.. ......++||||.|+|||++. ...|+.++|+|.+||+||||++|++||+..+.+.++..|... .
T Consensus 313 GLCKE~I~---~g~t~kTFCGTPEYLAPEVle---DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--d 384 (516)
T KOG0690|consen 313 GLCKEEIK---YGDTTKTFCGTPEYLAPEVLE---DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--D 384 (516)
T ss_pred ccchhccc---ccceeccccCChhhcCchhhc---cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--h
Confidence 99986432 345567899999999999998 447999999999999999999999999999999999988754 5
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCcccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDL 346 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~ 346 (627)
..+|..++++++.|+..+|.+||.+|.. +.||.+ |.||..++|.......+.||++|..++. .+..
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~------h~FF~~v~W~~~~~Kki~PPfKPqVtSe---tDTr 455 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR------HRFFASVDWEATYRKKIEPPFKPQVTSE---TDTR 455 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh------hhhhccCCHHHHHHhccCCCCCCCcccc---cchh
Confidence 6789999999999999999999999974 344444 9999999999999999999999986543 5566
Q ss_pred CCCccccCCCCC
Q 006887 347 KVDDVVRSRKPP 358 (627)
Q Consensus 347 ~~~~~~~~~~p~ 358 (627)
++++.+++....
T Consensus 456 yFD~EFT~q~v~ 467 (516)
T KOG0690|consen 456 YFDEEFTSQPVT 467 (516)
T ss_pred hhhhhhhcceeE
Confidence 677776665433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=372.21 Aligned_cols=260 Identities=22% Similarity=0.399 Sum_probs=216.6
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHH-HHHHhcCCCCceeeEE-
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND-LFLKCQGVEGICWLQG- 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~-~ll~~~~hpnIv~l~~- 113 (627)
...+..+|+++++||+|+||.||++....++. .||.|.++-...+.... ..-..+ -+++.++||||+.+++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~------l~a~K~i~f~~md~k~r-q~~v~Ei~lLkQL~HpNIVqYy~~ 86 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGK------LVALKKIQFGMMDAKAR-QDCVKEISLLKQLNHPNIVQYYAH 86 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcc------hhhhhhcchhhccHHHH-HHHHHHHHHHHhcCCchHHHHHHH
Confidence 44566789999999999999999999988775 89999997333222221 122222 2788899999999998
Q ss_pred EEEECCE-EEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecccCCCcEEEecCCC
Q 006887 114 ISVINGK-ICIIMKFYE-GSVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHS--KG--ILVLNLKPFNFILNEADR 185 (627)
Q Consensus 114 ~~~~~~~-~~LVmEy~~-GsL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs--~g--IvHrDLKP~NILld~~g~ 185 (627)
.+..++. ++||||||. |+|...+.+.+ .+.+++.++++++.|++.||..+|+ .. |+||||||.||+|+.+|.
T Consensus 87 ~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 87 SFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred hhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 5555554 999999999 78887776654 3679999999999999999999999 45 999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
+||+||||++++... .+...+.+|||.||+||.+.+ .+|+++|||||+||++|||+.-++||.+.+..++..+|
T Consensus 167 vKLGDfGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~---~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSK---TTFAHSLVGTPYYMSPERIHE---SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred eeeccchhHhHhcch---hHHHHhhcCCCcccCHHHHhc---CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 999999999998642 233457899999999999984 47999999999999999999999999999999999999
Q ss_pred HhccCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 266 VRRQEIPPIP-SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 266 ~~~~~~~~~p-~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.+. ..+++| ..+|.++..||..|+..||+.||+...++..+.+
T Consensus 241 ~qg-d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQG-DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HcC-CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 866 456667 7899999999999999999999986665554443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.39 Aligned_cols=329 Identities=22% Similarity=0.294 Sum_probs=263.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHH-HHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLER-LNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~-~~~~ll~~~~hpnIv~l~ 112 (627)
...|...+|..+.+||+|+||.|.+|..+.+.| .||||++++.-.-+.. ..... +.+.+...-+.|.++.++
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdE------LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlH 416 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDE------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLH 416 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcch------hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHH
Confidence 457888999999999999999999999988876 8999999875321111 11111 112222334567899999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~GsL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
.+|+.-+++|+||||+.| +|++.+..+ ++|.+..+.+|+++|+-||-+||++|||+||||.+|||||.+|++||+||
T Consensus 417 ScFQTmDRLyFVMEyvnG--GDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 417 SCFQTMDRLYFVMEYVNG--GDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred HHhhhhhheeeEEEEecC--chhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeec
Confidence 999999999999999998 566655443 88999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++.-.- ...+..++||||.|+|||++. +.+|+.++|+||+||+|||||.|++||.+.+.+++++.|.+. .
T Consensus 495 GmcKEni~---~~~TTkTFCGTPdYiAPEIi~---YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--n 566 (683)
T KOG0696|consen 495 GMCKENIF---DGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--N 566 (683)
T ss_pred cccccccc---CCcceeeecCCCcccccceEE---ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--c
Confidence 99986432 344556899999999999998 668999999999999999999999999999999999999876 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCcccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDL 346 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~ 346 (627)
-.+|..+|.++.++...+|.+.|.+|... ++|.+ |+||..++|+.++.+.+.||+.|....- ++..
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~------H~FFR~iDWek~E~~eiqPPfkPk~k~~---r~~e 637 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIRE------HPFFRRIDWEKLERREIQPPFKPKIKCG---RDAE 637 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhh------CcchhhccHHHHhhccCCCCCCCccccC---Cchh
Confidence 66899999999999999999999999754 24444 9999999999999999999999875332 4444
Q ss_pred CCCccccCCCCCCCCCCCCCCCCCCcee-eeecCCCCcceEEEEecccCCC
Q 006887 347 KVDDVVRSRKPPNSFKPENMDVPEGRVV-GVEHNTEGESFVLVRVHGIHDP 396 (627)
Q Consensus 347 ~~~~~~~~~~p~~~~~p~~~~~~~~~~v-~~~~~~~~~~~~~v~~~~~~~~ 396 (627)
+++..++..++...+ |+..+. .+|+ ++|++|++++..=.++.
T Consensus 638 NFD~~Ft~~~~~lTP-------pD~~v~~nldq-~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 638 NFDKFFTREPTDLTP-------PDKLVMMNLDQ-SEFEGFSFVNPEFVKPI 680 (683)
T ss_pred hhhHHHhcCCCCCCC-------chHHHHhcCch-hhcCceeeeChhhcCCC
Confidence 555555555444332 222222 2333 45999999887665543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=372.98 Aligned_cols=267 Identities=19% Similarity=0.297 Sum_probs=219.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-HHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-LNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
+.||+|+||.||+|++..+++ .||||++++............ .+..+++.++||||+.+++++..++..||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK------YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence 469999999999999876654 899999975432111111111 1123566789999999999999999999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 126 KFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 126 Ey~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
||++| +|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 75 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---~ 149 (323)
T cd05571 75 EYANGGELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---G 149 (323)
T ss_pred eCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC---C
Confidence 99995 5655554 4567899999999999999999999999999999999999999999999999998754321 2
Q ss_pred CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+...++..+... ...+|..+++++.+
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 224 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKS 224 (323)
T ss_pred CcccceecCccccChhhhcC---CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHH
Confidence 22345689999999999974 46889999999999999999999999998888887777543 45678889999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 285 VLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 285 li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+|.+||+.||++|| ++.++++ |+||...+|.........+|..+.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~------h~~f~~~~~~~~~~~~~~~~~~~~ 274 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIME------HRFFASINWQDVVQKKLEPPFKPQ 274 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCC
Confidence 99999999999999 7899887 999999999888777777776554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=373.23 Aligned_cols=274 Identities=21% Similarity=0.290 Sum_probs=226.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
......++|++.+.||+|+||.||+|++..+++ .||+|++......... .....+. .++..++||||++++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGE------YYAIKCLKKREILKMKQVQHVAQEK-SILMELSHPFIVNMM 84 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHH-HHHHhCCCCCCCcEE
Confidence 344566899999999999999999999877664 8999999754321111 1112222 256678999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++..++..|+||||+.| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeec
Confidence 999999999999999985 6666664 3467899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++.... ......||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+.+..+... .
T Consensus 163 g~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~ 231 (329)
T PTZ00263 163 GFAKKVPD------RTFTLCGTPEYLAPEVIQS---KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--R 231 (329)
T ss_pred cCceEcCC------CcceecCChhhcCHHHHcC---CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C
Confidence 99986532 2234589999999999974 35788999999999999999999999999888888877654 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
..+|..++..+++||.+||+.||.+||+ +.++++ |+||...+|.....+...+|..+
T Consensus 232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~------hp~f~~~~~~~~~~~~~~~~~~~ 293 (329)
T PTZ00263 232 LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN------HPYFHGANWDKLYARYYPAPIPV 293 (329)
T ss_pred cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CCccCCCCHHHHHhCCCCCCcCC
Confidence 5677889999999999999999999996 678877 99999999987766665555433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=376.77 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=220.9
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc----hhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK----EDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~----~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...+.|++.+.||+|+||+|++|.+..+++ .||+|++++.. .........++..++.....||||+++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~------~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGE------KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCC------eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence 556799999999999999999999988774 89999887641 11233333444444444444999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDV 191 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DF 191 (627)
++.....+||||||+.| +|++.+.. .+++.+..+.+++.||+.|++|||++||+||||||+|||++.+ +++||+||
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 99999999999999995 77777764 6789999999999999999999999999999999999999999 99999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPI-SFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~-s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|++.... .......+.|||+.|+|||++.+.. .| +.++|+||+||+||.|++|+.||.+.+...++..|...
T Consensus 166 G~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~--~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-- 238 (370)
T KOG0583|consen 166 GLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKG--TYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-- 238 (370)
T ss_pred ccccccC---CCCCcccCCCCCcccCCHHHhCCCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--
Confidence 9998763 1234567889999999999998642 15 48899999999999999999999999999999887543
Q ss_pred CCCCCCCC-CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 IPPIPSGL-PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 ~~~~p~~~-s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+|..+ ++++++|+.+||..||.+|+++.++++ |+|+..
T Consensus 239 ~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~------h~w~~~ 280 (370)
T KOG0583|consen 239 EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE------HPWFQK 280 (370)
T ss_pred CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh------Chhhcc
Confidence 56778888 999999999999999999999999997 888875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.04 Aligned_cols=276 Identities=19% Similarity=0.283 Sum_probs=231.1
Q ss_pred ccCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCc
Q 006887 29 ATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108 (627)
Q Consensus 29 ~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnI 108 (627)
...++..+.+++++|++...||.|.-++||+|+...+++ .||||+++..+-+.....+.++.. .+.+++||||
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e------~VAIK~inLEkc~~~ld~l~kE~~-~msl~~HPNI 86 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNE------VVAIKIINLEKCNNDLDALRKEVQ-TMSLIDHPNI 86 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCC------EEEEEEeehhhhhhhHHHHHHHHH-HhhhcCCCCc
Confidence 444456777999999999999999999999999988886 899999987665544344444432 4677899999
Q ss_pred eeeEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 109 CWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 109 v~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
+.++-.|..+..+|+||.||. |++++.+...-...|++..+..++++++.||.|||.+|.||||||+.||||+.+|.++
T Consensus 87 v~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 87 VTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred ceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence 999999999999999999999 7999999887666799999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCC-CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPLPSS-DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~ 266 (627)
|+|||.+-.+........ .+.++.|||+|||||++..+.+| |+.|+||||||++..||.+|..||....+.+++...+
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~G-YdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHG-YDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccC-ccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999998766655332111 22677999999999997766554 9999999999999999999999999999988876665
Q ss_pred hccCCCC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 267 RRQEIPP--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 267 ~~~~~~~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
++..... ....++..++.++..||.+||++||++.++++ |+||...
T Consensus 246 qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk------h~FFk~~ 299 (516)
T KOG0582|consen 246 QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK------HAFFKKA 299 (516)
T ss_pred cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc------cHHHhhc
Confidence 5432211 11346778999999999999999999999998 7776644
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=410.60 Aligned_cols=323 Identities=21% Similarity=0.277 Sum_probs=254.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC---chhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV---KEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~---~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
-.+..++|.+++.||+|+||.|.+++++.++. .||+|++++- .......+ .++.. ++...+.+=|+.|+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~------VYAMK~lnK~eMlKr~~tA~F-~EERD-imv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEK------VYAMKILNKWEMLKRAETACF-REERD-IMVFGNSEWIVQLH 141 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeecccc------chhHHHhhHHHHhhchhHHHH-HHHhH-HHHcCCcHHHHHHH
Confidence 35678999999999999999999999998875 8999999872 22222222 22333 44445567799999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..|++++++|||||||+| +|+.++.. ..+++++.+.+|+.+|+.||.-||+.|+|||||||+|||||..||+||+||
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk--~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSK--FDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhh--cCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999995 66666653 348999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccC--CCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQP--EVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|.|-.+.... .......+|||.|++||++.. ...+.|+..+|+||+||++|||+.|..||+..+..+.|.+|+...
T Consensus 220 GsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 220 GSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred hhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 9997765322 223356799999999999874 223689999999999999999999999999999999999999988
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCcc
Q 006887 270 EIPPIP--SGLPPAVENVLLGCFEYDLRSRPL---MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKE 344 (627)
Q Consensus 270 ~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs---~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~ 344 (627)
....+| ..+|+++++||.+++. +|+.|.. +.++.. ||||.+++|+.+ +...||..|..+.. .|
T Consensus 298 ~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~------HpFF~g~~W~~i--R~~~pP~vPevssd---~D 365 (1317)
T KOG0612|consen 298 ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN------HPFFEGIDWDNI--RESVPPVVPEVSSD---DD 365 (1317)
T ss_pred hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh------CccccCCChhhh--hhcCCCCCCcCCCC---Cc
Confidence 888888 6699999999999994 7888887 888877 999999999554 44677888775443 44
Q ss_pred ccCCCccccCCCCCCCCCCCCCCCCCCceeeeecCC-CCcceEEEE
Q 006887 345 DLKVDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNT-EGESFVLVR 389 (627)
Q Consensus 345 ~~~~~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~-~~~~~~~v~ 389 (627)
.++++.......+....+|.. ..++.++- .|-||+|..
T Consensus 366 TsnFd~~~dd~~~~e~~p~~~-------~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 366 TSNFDVDEDDLRDAETFPPRI-------PKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred cccccccccccchhhccCCCC-------CCCCcCCcCCeeeeeecc
Confidence 555554444555444443311 12222231 366777765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=370.92 Aligned_cols=259 Identities=31% Similarity=0.456 Sum_probs=211.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
..+|...+.||+|+||.||++.+..+++ ..|||.+....... ...++++.. ++..++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~------~~AvK~v~~~~~~~-~~~l~~Ei~-iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGE------LMAVKSVELEDSPT-SESLEREIR-ILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCc------ceeeeeeecccchh-HHHHHHHHH-HHHhCCCCCEEeeCCcccccc
Confidence 5678999999999999999999887654 79999987654333 222333333 455566999999999754444
Q ss_pred --EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCccc
Q 006887 120 --KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPH 195 (627)
Q Consensus 120 --~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~ 195 (627)
.++|.|||++ |+|.+.+....+ +|++..+.+|.+||++||.|||++|||||||||+|||++. ++.+||+|||+++
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 6999999999 588888876444 8999999999999999999999999999999999999999 7999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCC-CCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~-~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~~~ 273 (627)
................|||.|||||++.. +. ..+++|||||||+++||+||.+||.. ....+.+-.+......|.
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPE 243 (313)
T ss_pred ccccccccccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCC
Confidence 77642222233446789999999999973 22 23599999999999999999999997 455554555555556788
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+|..+|+++++|+.+|+.+||++|||+.++|+ |+|..
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~------hpf~~ 280 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE------HPFLK 280 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh------Chhhh
Confidence 99999999999999999999999999999999 77654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.10 Aligned_cols=274 Identities=18% Similarity=0.286 Sum_probs=221.4
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.|++.+.||+|+||.||+|.+..++. .||+|++.+....... .....+ ..++..++|++|+.+++++..++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E-~~il~~l~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNE-KRILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCc------eEEEEEeeHhhhhhhhhHHHHHHH-HHHHHhcCCCcEEEEEEEEccCC
Confidence 48899999999999999999877664 8999998754322211 111122 23566789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.......+++..++.++.|++.||.|||+.+|+||||||+|||+++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999999995 66556554344578999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR--RQEIPPIPS 276 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~--~~~~~~~p~ 276 (627)
.. .......||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+.......+.. ......++.
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 154 EG----ETVRGRVGTVGYMAPEVINN---EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226 (285)
T ss_pred CC----CeecCCCCCCCccCHhhhcC---CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc
Confidence 21 22234579999999999974 4688999999999999999999999987654322222111 122345677
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
.+++++.+|+.+||+.||.+||+ +.++++ |+||...+|..+..+.+++|..|.
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~------h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ------HPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc------CHhhcCCCHHHHHhCcCCcCCCCC
Confidence 89999999999999999999997 788887 999999999999999888888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.49 Aligned_cols=270 Identities=21% Similarity=0.275 Sum_probs=219.7
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHH--HHHhcCCCCceeeEEEEEEC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDL--FLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~--ll~~~~hpnIv~l~~~~~~~ 118 (627)
|++++.||+|+||.||+|.+..++. .||||++++.... .....+..+..+ .+..++||||+++++++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGE------LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 7889999999999999999877654 8999999754311 111112222222 23467899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|...+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~~~lv~E~~~~~~L~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred CEEEEEEcCCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999996 443333 4467999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+++..+... ...+|..
T Consensus 152 ~~~---~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~ 223 (324)
T cd05589 152 MGF---GDRTSTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRF 223 (324)
T ss_pred CCC---CCcccccccCccccCHhHhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCC
Confidence 321 122345689999999999874 36888999999999999999999999999888888877654 3457788
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++++.++|.+||+.||.+|| ++.++++ |+||...+|.....+...++..+.
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~------~~~f~~~~~~~~~~~~~~~~~~~~ 280 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK------QPFFRDINWDDLLARKIKPPFVPT 280 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh------CCCcCCCCHHHHHhCCCCcCccCC
Confidence 999999999999999999999 4666666 999999988877776666666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.82 Aligned_cols=280 Identities=19% Similarity=0.196 Sum_probs=231.8
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+..++|++.+.||+|+||.||+|.+..++. ..||+|++....... .......+. .++..++||||+++
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDF-----PPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNL 96 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCC-----eEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCCcce
Confidence 3566788899999999999999999998765432 479999986432211 111112222 35677899999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++...+..|+||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEec
Confidence 9999999999999999984 6666664 345799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ......||+.|||||++.+ ..++.++|+|||||++|||++|.+||.+.+...++..+...
T Consensus 175 FG~a~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-- 243 (340)
T PTZ00426 175 FGFAKVVDT------RTYTLCGTPEYIAPEILLN---VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-- 243 (340)
T ss_pred CCCCeecCC------CcceecCChhhcCHHHHhC---CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--
Confidence 999986532 2245689999999999974 35788999999999999999999999999888888877654
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
...+|..+++.+.++|.+||+.||.+|+ ++.++++ |+||...+|.....+....|..|.+..
T Consensus 244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~------hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE------HPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 3456788999999999999999999995 7888887 999999999887777777777776544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.80 Aligned_cols=270 Identities=23% Similarity=0.267 Sum_probs=225.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|.+..+++ .||+|++....... .......+. .+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEH------YYALKVMAIPEVIRLKQEQHVHNEK-RVLKEVSHPFIIRLFWTEHDQ 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC------EEEEEEEEHHHHhhhHHHHHHHHHH-HHHHhCCCCcHhhhHhhhccC
Confidence 479999999999999999999876654 89999997543221 111122222 356778999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 999999999984 6766665 3457899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+... ...+|..
T Consensus 152 ~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~ 220 (291)
T cd05612 152 RD------RTWTLCGTPEYLAPEVIQS---KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRH 220 (291)
T ss_pred cC------CcccccCChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCcc
Confidence 32 2234579999999999874 35788999999999999999999999999988888887654 4567788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+++.++++|.+||+.||.+||+ +.++++ |+|+...+|....++...++..|..
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~p~~ 278 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN------HRWFKSVDWDDVPQRKLKPPIVPKV 278 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc------CccccCCCHHHHhcCCCCCCEeCCC
Confidence 8999999999999999999995 888887 9999999998877777666655543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=370.02 Aligned_cols=272 Identities=21% Similarity=0.266 Sum_probs=217.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..++. .||||++++...... ......+. .++..++|+||+++++.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~~~~~~iv~~~~~~~~~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGH------VYAMKILRKADMLEKEQVGHIRAER-DILVEADSLWVVKMFYSFQDK 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhhHHHHHHHHH-HHHHhCCCCCcceEEEEEecC
Confidence 479999999999999999999877654 899999975432111 11222222 355667999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+||||||++| +|.+.+. ..+.+++..+..++.|++.||.|||++||+||||||+|||++.+++++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 999999999985 6666664 3467999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCC--------------------------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHH
Q 006887 198 LGIPLP--------------------------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245 (627)
Q Consensus 198 ~~~~~~--------------------------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLye 245 (627)
...... .......+||+.|||||++.+ ..++.++|+|||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC---CCCCCchhhhhhHHHHHH
Confidence 321100 001124589999999999974 468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCCHHHHHHHHHhhhcCCC---CCCCHHHHHHHHHhcccccCCCCCC
Q 006887 246 MLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS--GLPPAVENVLLGCFEYDLR---SRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 246 lltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~--~~s~~l~~li~~cL~~dP~---~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
|++|+.||.+.+..+.+..+........+|. .++++++++|.+|+. +|. .||++.++++ |+||...+|
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~------hp~f~~~~~ 301 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT------NPFFEGVDW 301 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC------CCCCCCCCH
Confidence 9999999999998888888876444444453 478999999999764 444 4689999988 999999999
Q ss_pred CCCCcccCCCC
Q 006887 321 TGHGSRILPDK 331 (627)
Q Consensus 321 ~~~~~~~~~~~ 331 (627)
.....+..+.|
T Consensus 302 ~~~~~~~~~~~ 312 (363)
T cd05628 302 EHIRERPAAIP 312 (363)
T ss_pred HHHHhCCCCCC
Confidence 88765544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.82 Aligned_cols=261 Identities=19% Similarity=0.258 Sum_probs=218.7
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
-.++|.++++||.|.||.||+|+...+++ .||||.+++....-.+...-++...+.+...||||++|.+++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~------~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGE------LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCc------eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 34689999999999999999999888876 799999976543322222223333344544599999999999988
Q ss_pred C-EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 G-KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~-~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+ .+|+|||||+.+|.+++.. ++..|++..+..|+.||++||+|+|.+|+.||||||+|||+..+..+||+|||+||.+
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~-R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKD-RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhh-cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 8999999999999999987 5889999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP----- 272 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~----- 272 (627)
.. ....+..+.|.+|.|||++.. .+.|+.+.|+||+|||++|+.+-++.|.|.+..+.+-+|.+--..|
T Consensus 161 ~S----kpPYTeYVSTRWYRAPEvLLr--s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RS----KPPYTEYVSTRWYRAPEVLLR--SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cc----CCCcchhhhcccccchHHhhh--ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 65 334456689999999999985 5679999999999999999999999999988766555555422111
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 -----------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 -----------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.+.+.+++++.++|.+||++||.+|||+.++++ |+||...
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~------~pffq~~ 297 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ------HPFFQVG 297 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc------Ccccccc
Confidence 112458899999999999999999999999998 8888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=357.25 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=216.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|+.+.++|+|+||+||+++++.|++ .||||++.....+.........+-.+++.++|+|+|.|+++|....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq------IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ------IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCccc------EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 568889999999999999999888775 89999997665544444443333347899999999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
++||+|||+-++++.+.+..+ .++...+..|+.|++.|+.|+|++++|||||||+||||+.+|.+||+|||+|+.+..
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred eEEEeeecchHHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 999999999999999987554 478899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--------- 271 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--------- 271 (627)
+....+..+.|.+|.|||.+.|. .+|+..+||||+||++.||++|.+.|.+.+.-+.+-.|...-..
T Consensus 154 --pgd~YTDYVATRWYRaPELLvGD--tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 --PGDNYTDYVATRWYRAPELLVGD--TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred --CcchhhhhhhhhhccChhhhccc--CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 34455667899999999999874 47999999999999999999999999998765544333321100
Q ss_pred ----------CCC----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 272 ----------PPI----------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 272 ----------~~~----------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+. -+.++..+.+|+..||+.||++|++..+++. |++|
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~------H~yF 287 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH------HPYF 287 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc------ChHH
Confidence 010 1356778899999999999999999999998 7777
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.70 Aligned_cols=267 Identities=18% Similarity=0.234 Sum_probs=218.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..+++ .||||++.+.... ........+..++....+||||+.+++++...+..|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv 74 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE------VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV 74 (321)
T ss_pred CccccCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence 369999999999999876654 8999999754221 11111222233344456899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~E~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--- 149 (321)
T cd05591 75 MEYVNGGDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--- 149 (321)
T ss_pred EeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---
Confidence 999995 6655554 3467899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
........||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+... ...+|..+++++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~ 224 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQE---LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAV 224 (321)
T ss_pred CccccccccCccccCHHHHcC---CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 222345679999999999874 46889999999999999999999999999998888887654 3456778899999
Q ss_pred HHHHHhhhcCCCCCC-------CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRP-------LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 284 ~li~~cL~~dP~~RP-------s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++.+||+.||++|| ++.++++ |+|+...+|.........+++.+.
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~------hp~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQ------HPFFKEIDWVLLEQRKIKPPFKPK 277 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhc------CCccCCCCHHHHHhCCCCCCCCCC
Confidence 999999999999999 7788877 999999999888777777666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=370.28 Aligned_cols=276 Identities=20% Similarity=0.191 Sum_probs=214.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+.|++++.||+|+||.||+|++..++. .||||++....... .......+. .++..++|+||+++++++.+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~ 73 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHA------LYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVKLYYSFQDK 73 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhcCCCCeeeeEEEEecC
Confidence 469999999999999999999877664 89999997543211 111222222 256678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+|+||||++| +|.+.+. ....+++..+..++.||+.||.|||+.||+||||||+|||++.+++++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred CEEEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999985 6666664 3457899999999999999999999999999999999999999999999999998643
Q ss_pred cCCCC--------------------------------------------CCCCCCccCCCCCcCCcccccCCCCCCCCcc
Q 006887 198 LGIPL--------------------------------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFE 233 (627)
Q Consensus 198 ~~~~~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~ 233 (627)
..... ........+||+.|||||++.+ ..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~ 228 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR---KGYTQL 228 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---CCCCCc
Confidence 21000 0001124579999999999874 468899
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhh--hcCCCCCCCHHHHHHHHHh
Q 006887 234 TDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCF--EYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 234 sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL--~~dP~~RPs~~eil~~L~~ 309 (627)
+|||||||++|||++|+.||...+..+....+........+| ..+++++.+||.+|+ ..++..||++.++++
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~---- 304 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA---- 304 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc----
Confidence 999999999999999999999888777666665433333344 358999999999955 455556999999998
Q ss_pred cccccCCCCCCCCCCcccCCCCCCCC
Q 006887 310 SQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 310 ~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
|+||...+|..... ..++|..|.
T Consensus 305 --hp~f~~~~~~~~~~-~~~~~~~p~ 327 (381)
T cd05626 305 --HPFFSEVDFSSDIR-TQPAPYVPK 327 (381)
T ss_pred --CcccCCCChhHHhh-cCCCCccCc
Confidence 99999998876432 334444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=362.78 Aligned_cols=272 Identities=21% Similarity=0.284 Sum_probs=224.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||+|++..++. .||||++.+...... ......+..++....+|++|+.+++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 58999999999999999999876654 899999976432111 1112222233444557899999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++ |+|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 75 ~~~lv~E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EEEEEEcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998 56666654 34578999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
.. .......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+++..+... ...+|..+
T Consensus 153 ~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~ 224 (323)
T cd05616 153 WD---GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSM 224 (323)
T ss_pred CC---CCccccCCCChhhcCHHHhcC---CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcC
Confidence 21 122345689999999999974 46899999999999999999999999999988888888654 45577889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+.++.+++.+||+.||.+|++. .++++ |+||...+|.....+...+|..+.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~------h~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRYIDWEKLERKEVQPPYKPK 280 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCCc
Confidence 9999999999999999999975 55554 999999999988888877777665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.27 Aligned_cols=272 Identities=23% Similarity=0.316 Sum_probs=218.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++.+...... ......+...+++.++||||+++++.+...+..|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGK------FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence 469999999999999876654 899999975432111 111122223356778999999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 75 LDYVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred EcCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 999995 6655554 3567999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+... ...++..+++.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSAR 224 (323)
T ss_pred CCccccccCChhhcChhhhcC---CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence 223345679999999999874 46889999999999999999999999999988888877654 3456678899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
++|.+||+.||.+||++.+.+..+. .|+||...+|.........+|+.+..
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~il--~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAKDDFLEIK--NHVFFSSINWDDLVNKKITPPFNPNV 275 (323)
T ss_pred HHHHHHhhcCHHhCCCCCCCHHHHH--cCCCcCCCCHHHHhhccCCCCcCCCC
Confidence 9999999999999998853222221 29999999998887777777766653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=369.63 Aligned_cols=273 Identities=19% Similarity=0.242 Sum_probs=215.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|.+..+++ .||||++.+..... .......+. .++..++||||+++++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGK------IYAMKTLLKSEMFKKDQLAHVKAER-DVLAESDSPWVVSLYYSFQDA 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcC
Confidence 479999999999999999999877664 89999986532211 111222222 245678999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..||||||++ |+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999998 56666664 3467899999999999999999999999999999999999999999999999999643
Q ss_pred cCCCCC------------C--------------------------------CCCCccCCCCCcCCcccccCCCCCCCCcc
Q 006887 198 LGIPLP------------S--------------------------------SDLPRRLGTPNYMAPEQWQPEVRGPISFE 233 (627)
Q Consensus 198 ~~~~~~------------~--------------------------------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~ 233 (627)
...... . ......+||+.|||||++.+ ..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~ 228 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ---QGYGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---CCCCCc
Confidence 211000 0 00012479999999999874 468899
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCC---CCHHHHHHHHH
Q 006887 234 TDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS--GLPPAVENVLLGCFEYDLRSR---PLMTDILRVFK 308 (627)
Q Consensus 234 sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~--~~s~~l~~li~~cL~~dP~~R---Ps~~eil~~L~ 308 (627)
+|||||||++|||++|.+||.+.+..+.+..+........+|. .++.++++||.+||. +|.+| +++.+++.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~--- 304 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS--- 304 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc---
Confidence 9999999999999999999999888888877765444444444 578999999999997 67765 59999988
Q ss_pred hcccccCCCCCCCCCCcccCCCCCCC
Q 006887 309 SSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 309 ~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
|+|+...+|+... ...+|..+
T Consensus 305 ---hp~~~~~~~~~~~--~~~~~~~~ 325 (377)
T cd05629 305 ---HPFFRGVDWDTIR--QIRAPFIP 325 (377)
T ss_pred ---CCCcCCCCHHHHc--cCCCCccc
Confidence 9999998887663 33444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=361.79 Aligned_cols=271 Identities=23% Similarity=0.308 Sum_probs=219.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++++.||+|+||.||+|++..++. .||||++.+... ...... ..+..++....+|++|+.+++++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~-~~e~~~l~~~~~~~~i~~~~~~~~~~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVIIQDDDVECT-MVEKRVLALPGKPPFLTQLHSCFQTM 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHH-HHHHHHHHhcCCCCceeeeEEEEEcC
Confidence 58999999999999999999877654 899999975321 111222 22222333344556789999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999999985 6665554 3457899999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .......+||+.|+|||++.+ .+++.++|+|||||++|||++|+.||.+.+..+.+..+... ...+|..
T Consensus 152 ~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~ 223 (324)
T cd05587 152 IFG---GKTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKS 223 (324)
T ss_pred CCC---CCceeeecCCccccChhhhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCC
Confidence 221 122345679999999999974 46889999999999999999999999999988888887643 4567888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++++.+++.+||+.||.+|++. .++++ |+||...+|.....+...++..+.
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~------hp~~~~~~~~~~~~~~~~~~~~~~ 280 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE------HAFFRRIDWEKLERREIQPPFKPK 280 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCccCc
Confidence 99999999999999999999976 55655 999999999877776666666554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.68 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=218.2
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||||++.+.... ........+..++....+||||+++++++...+.+|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv 74 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV 74 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence 469999999999999876654 8999999753211 11111222233344456899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~Ey~~~g~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--- 149 (320)
T cd05590 75 MEFVNGGDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--- 149 (320)
T ss_pred EcCCCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence 999995 6555554 3467999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
........||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+++..+... ...+|..++.++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQE---MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAV 224 (320)
T ss_pred CCcccccccCccccCHHHHcC---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHH
Confidence 122345689999999999874 36888999999999999999999999999988888887643 3456778999999
Q ss_pred HHHHHhhhcCCCCCCCH------HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLM------TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~------~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+++.+||+.||.+||++ .++++ |+||...+|.....+...+|..+..
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~~~~~------h~~f~~~~~~~~~~~~~~~~~~~~~ 277 (320)
T cd05590 225 DILKAFMTKNPTMRLGSLTLGGEEAILR------HPFFKELDWEKLNRRQIEPPFRPRI 277 (320)
T ss_pred HHHHHHcccCHHHCCCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999999999999998 55555 9999999998877777777766553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=362.08 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=217.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..+++ .||+|+++..... ........+..++....+||||+++++++..++..|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv 74 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNE------FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence 469999999999999877654 8999999754221 11111122223344456899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++......
T Consensus 75 ~e~~~gg~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 75 MEYLNGGDLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred EcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 999985 6655554 34579999999999999999999999999999999999999999999999999997643221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+++..+.. ..+.+|..++.++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~ 224 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKG---QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAK 224 (316)
T ss_pred -CccccccCCccccCHHHHcC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHH
Confidence 22345689999999999974 3688999999999999999999999999998888887754 35667888999999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+++.+||+.||.+||++. ++++ |+|+...+|.....+..++++.+..
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIRQ------HPFFRGIDWERLEKREIPPPFKPKV 272 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc------CcccCCCCHHHHHhCCCCCCcCCCC
Confidence 999999999999999875 5655 9999999998777776666665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=362.58 Aligned_cols=265 Identities=21% Similarity=0.300 Sum_probs=217.4
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
+.||+|+||.||++++..++. .||+|++.+.... ....... + ..+++.++||||+++++++..++..||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~-E-~~~l~~l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGK------YYAMKILKKEVIIAKDEVAHTLT-E-SRVLKNTRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHH-H-HHHHHhCCCCCCcceEEEEEcCCEEEE
Confidence 469999999999999876654 8999999754321 1122222 1 135677899999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||++| +|.+.+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 73 v~Ey~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-- 148 (328)
T cd05593 73 VMEYVNGGELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-- 148 (328)
T ss_pred EEeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--
Confidence 9999985 5655553 3467999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l 282 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|+|++|+.||.+.+..++...+.. ....+|..+++++
T Consensus 149 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~ 222 (328)
T cd05593 149 -AATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADA 222 (328)
T ss_pred -ccccccccCCcCccChhhhcC---CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHH
Confidence 122345689999999999874 4688999999999999999999999998888887776643 3456788999999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 283 ENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 283 ~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
.++|.+||+.||++|| ++.++++ |+||...+|.........++..+.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~------h~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR------HSFFTGVNWQDVYDKKLVPPFKPQ 274 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCCc
Confidence 9999999999999997 8889887 999999999877666666665544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=360.69 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=214.9
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
||+|+||.||+|++..++. .||+|++.+... ....... .+ ..++..++||||+++++++...+..|+||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~-~E-~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR------IYALKTIRKAHIVSRSEVTHTL-AE-RTVLAQVNCPFIVPLKFSFQSPEKLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHH-HH-HHHHHhCCCCcEeceeeEEecCCeEEEEE
Confidence 6999999999999876654 899999975322 1111111 12 23566689999999999999999999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 126 KFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 126 Ey~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++..... .
T Consensus 73 e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~ 147 (312)
T cd05585 73 AFINGGELFHHLQ--REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD---D 147 (312)
T ss_pred cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC---C
Confidence 99995 6666664 3567999999999999999999999999999999999999999999999999998764321 1
Q ss_pred CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+... ...++..+++++.+
T Consensus 148 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 222 (312)
T cd05585 148 DKTNTFCGTPEYLAPELLLG---HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKD 222 (312)
T ss_pred CccccccCCcccCCHHHHcC---CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHH
Confidence 22345689999999999974 46889999999999999999999999999888888877643 45678889999999
Q ss_pred HHHHhhhcCCCCCCC---HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 285 VLLGCFEYDLRSRPL---MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 285 li~~cL~~dP~~RPs---~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+|.+||+.||.+||+ +.++++ |+|+...+|.........++..+.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~------hp~~~~~~~~~~~~~~~~~~~~~~ 270 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN------HPFFSQLSWKKLLMKGIQPPFKPA 270 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCC
Confidence 999999999999985 667776 999998888766655555555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=363.94 Aligned_cols=271 Identities=20% Similarity=0.330 Sum_probs=210.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.+..++|++.+.||+|+||.||+|.+..... ...++.||+|++..............+..++....+||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDK-KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCC-cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45677899999999999999999998643321 12345799999975443332222333334455555899999999988
Q ss_pred EE-CCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006887 116 VI-NGKICIIMKFYE-GSVGDRMAQLK----------------------------------------------------- 140 (627)
Q Consensus 116 ~~-~~~~~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 140 (627)
.. ++.+++||||++ |+|.+.+....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 75 446899999999 57776665321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCC
Q 006887 141 -------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213 (627)
Q Consensus 141 -------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT 213 (627)
..++++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+..... ........+|
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 13478889999999999999999999999999999999999999999999999986543211 1112234567
Q ss_pred CCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhc
Q 006887 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEY 292 (627)
Q Consensus 214 ~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~ 292 (627)
+.|||||++.+ ..++.++|||||||++|||++ |..||.+....+.+............+..+++++.+++.+||+.
T Consensus 240 ~~y~aPE~~~~---~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 240 LKWMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred ccccCcHHhhc---CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999873 468999999999999999997 99999886654444344444445566788999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcc
Q 006887 293 DLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 293 dP~~RPs~~eil~~L~~~~ 311 (627)
||.+||++.++++.|+...
T Consensus 317 dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 317 DPKERPTFSALVEILGDLL 335 (338)
T ss_pred ChhhCcCHHHHHHHHHHHH
Confidence 9999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=361.39 Aligned_cols=268 Identities=18% Similarity=0.292 Sum_probs=217.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-HHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-LNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
+.||+|+||.||++++..++. .||+|+++............. .+..+++.++||||+++++++..++..||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence 469999999999999876654 899999975422111111111 1123566789999999999999999999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 126 KFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 126 Ey~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..... .
T Consensus 75 E~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---~ 149 (323)
T cd05595 75 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---G 149 (323)
T ss_pred eCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC---C
Confidence 99995 5555543 3467899999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
.......||+.|||||++.+ +.++.++|+|||||++|||++|+.||.+.+..+.+..+... ...+|..+++++.+
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 224 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKS 224 (323)
T ss_pred CccccccCCcCcCCcccccC---CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHH
Confidence 22345679999999999973 46889999999999999999999999998888887776543 34577889999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 285 VLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 285 li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+|.+||+.||++|| ++.++++ |+||....|.........++..+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKPQV 275 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999999999998 7888888 9999999998877666666665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=360.35 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=217.3
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
+.||+|+||.||+|++..++. .||||+++.... ..... ...+...+....+||||+++++++...+.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~-~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ------FFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhcchHHH-HHHHHHHHHhccCCCcCcceEEEEEeCCEEEE
Confidence 469999999999999877654 899999976421 11111 12222334445699999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||++| +|.+.+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 74 v~ey~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 149 (316)
T cd05619 74 VMEYLNGGDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-- 149 (316)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--
Confidence 9999985 6666654 3457899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l 282 (627)
........||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..++++.+... .+.+|..++.++
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 223 (316)
T cd05619 150 -DAKTCTFCGTPDYIAPEILLG---QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREA 223 (316)
T ss_pred -CCceeeecCCccccCHHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHH
Confidence 122345679999999999874 36889999999999999999999999999888888777543 355677899999
Q ss_pred HHHHHHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 283 ENVLLGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 283 ~~li~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
.+++.+||+.||++||++. ++++ |+|+...+|.....+...++..+..
T Consensus 224 ~~li~~~l~~~P~~R~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05619 224 KDILVKLFVREPERRLGVKGDIRQ------HPFFREIDWSALEEREIEPPFKPKV 272 (316)
T ss_pred HHHHHHHhccCHhhcCCChHHHHc------CcccCCCCHHHHHhCCCCCCcCCCC
Confidence 9999999999999999997 6665 9999999998777666666665543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=361.51 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=218.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||||++.+....... .....+. .++..++||||+++++++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGE------IVALKRMKKSLLFKLNEVRHVLTER-DILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHH-HHHHhCCCCCCccEEEEEEcC
Confidence 479999999999999999999877664 8999999754322111 1111222 245667899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..||||||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 999999999985 6766664 3457899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP-- 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p-- 275 (627)
.. ......||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+..+.+..+.........|
T Consensus 152 ~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 152 VT------YANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222 (333)
T ss_pred cc------ccCCcccCccccChhHhcCC---CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC
Confidence 32 23456899999999999743 68899999999999999999999999998888877766433222222
Q ss_pred ----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 276 ----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 276 ----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
..+++++.++|.+||..+|.+||++.++++ |+|+...+|.... ...++..|
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~------h~~~~~~~~~~~~--~~~~~~~~ 277 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN------HPFFKEVDWNELR--ELKPPFVP 277 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh------CcccCCCCHHHHh--hCCCCCCC
Confidence 256899999999999999999999999998 9999988886654 33444443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.05 Aligned_cols=269 Identities=20% Similarity=0.270 Sum_probs=217.4
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
+.||+|+||.||++++.... ..++.||+|+++...... .......+ ..++..++||||+++++++..++..|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E-~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGA---DTGKIFAMKVLKKATIVRNQKDTAHTKAE-RNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccC---CCCCEEEEEEEEHHHHHhhhhhHHHHHHH-HHHHHhCCCCchhceeeEEecCCeEEE
Confidence 67999999999999875432 245689999997533211 11111122 235677899999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 153 (323)
T cd05584 78 ILEYLSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-- 153 (323)
T ss_pred EEeCCCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence 9999996 6655554 4567899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l 282 (627)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+... ...+|..+++++
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 227 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMR---SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEA 227 (323)
T ss_pred -CCcccccCCCccccChhhccC---CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHH
Confidence 122334679999999999974 35788999999999999999999999998888877777543 456788899999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 283 ENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 283 ~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
.++|.+||+.||++|| ++.++++ |+|+....|.........++..+.
T Consensus 228 ~~li~~~l~~~p~~R~~~~~~~~~~l~~------h~~~~~~~~~~~~~~~~~~~~~~~ 279 (323)
T cd05584 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQS------HPFFRHVNWDDLLARKVEPPFKPL 279 (323)
T ss_pred HHHHHHHcccCHhHcCCCCCCCHHHHhc------CCCcCCCCHHHHhcCCCCCCcCCC
Confidence 9999999999999999 7888887 999998888877666665554443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.21 Aligned_cols=282 Identities=19% Similarity=0.259 Sum_probs=224.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+..++|++.+.||+|+||.||+|++..++. .||+|++.+.... .......++ ..+++..+||||+++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e-~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK------VYAMKLLSKFEMIKRSDSAFFWEE-RDIMAFANSPWVVQLFC 110 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhhHHHHHHH-HHHHHhCCCCCEeeEEE
Confidence 34566899999999999999999999877664 8999998653211 111122222 23567789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++..++..|+||||++| +|.+.+. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999985 6666653 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCC-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... .......+||+.|||||++.+.. .+.++.++|+|||||++|||++|+.||.+.+..+.+..+......
T Consensus 188 ~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05621 188 TCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred cceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Confidence 998764211 11224568999999999987532 234788999999999999999999999999988888888765544
Q ss_pred CCCCC--CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 272 PPIPS--GLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 272 ~~~p~--~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
..+|. .++..+++++..||..++.+ |+++.++++ |+|+....|.....+...+|..|.
T Consensus 266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~------hp~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05621 266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ------HPFFKNDQWNWDNIRETAAPVVPE 327 (370)
T ss_pred cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc------CcccCCCCcChHhcCCCCCCcCCC
Confidence 55554 56999999999999855543 889999988 999998777655544555555554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=363.80 Aligned_cols=265 Identities=20% Similarity=0.322 Sum_probs=216.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++...... .......+ ..++..++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ------VYAMKVLRKSDMIKRNQIAHVRAE-RDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCC------EEEEEEEEHHHHhhccHHHHHHHH-HHHHHhcCCCCccchhhheecC
Confidence 479999999999999999999877654 89999997543211 11122222 2356677899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 999999999984 77777653 367999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--------------------------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCC
Q 006887 198 LGIPL--------------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ 251 (627)
Q Consensus 198 ~~~~~--------------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~ 251 (627)
..... .........||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCceeeEecchhhhhhccCCC
Confidence 43220 00122345799999999999743 68899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhcccccCCCCCCCCCC
Q 006887 252 PRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPL-MTDILRVFKSSQNSVHSDGGWTGHG 324 (627)
Q Consensus 252 Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs-~~eil~~L~~~~~~~~~~~~w~~~~ 324 (627)
||.+.+..+.+..+........+| ..+++++.++|.+||. ||.+||+ +.++++ |+|+...+|....
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~------hp~~~~~~~~~~~ 297 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS------HPFFKGIDWENLR 297 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc------CCCcCCCCHHHHh
Confidence 999998888887777633333333 3469999999999997 9999999 999998 9999999887655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=361.58 Aligned_cols=271 Identities=23% Similarity=0.310 Sum_probs=217.8
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++.+...... ......+...+++.++|+||+++++++...+..|+|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEK------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence 469999999999999876653 899999975432111 111222223356778999999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--- 149 (325)
T cd05602 75 LDYINGGELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--- 149 (325)
T ss_pred EeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence 999996 5655554 3467889999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+... ...++..+++.+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSAR 224 (325)
T ss_pred CCCcccccCCccccCHHHHcC---CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHH
Confidence 122345689999999999974 46889999999999999999999999999988888877654 3445678999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++.+||+.||.+||++.+.+..+.+ |+|+...+|+........++..+.
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDFMEIKN--HIFFSPINWDDLINKKITPPFNPN 274 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCHHHHhc--CcccCCCCHHHHHhCCCCcCcCCC
Confidence 99999999999999988755443333 889999999887766666555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.08 Aligned_cols=278 Identities=21% Similarity=0.292 Sum_probs=218.4
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++.+.||+|+||.||++++.... ..+..||+|++.+.... ........+..++....+|++|+.+++++..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH---DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence 5899999999999999999875322 24568999999753221 11122223333444444799999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999995 6666664 3457999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR----SVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~----~~~e~~~~i~~~~~~~~ 273 (627)
.... .......+||+.|||||++.+. ..++.++|||||||++|||++|..||... ...++...+.. ..+.
T Consensus 156 ~~~~--~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~ 229 (332)
T cd05614 156 LSEE--KERTYSFCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPP 229 (332)
T ss_pred cccC--CCccccccCCccccCHHHhcCC--CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCC
Confidence 3321 1222356899999999998743 24788999999999999999999999743 23334443432 3456
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
++..+++.+.+++.+||+.||++|| ++.++++ |+|+...+|.........++..+..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE------HPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 7788999999999999999999999 7778887 9999999898877766666665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.76 Aligned_cols=283 Identities=19% Similarity=0.265 Sum_probs=228.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..++. .||+|++.+.... ........+ ..+++.++||||++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e-~~il~~~~h~~iv~~~ 109 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ------VYAMKLLSKFEMIKRSDSAFFWEE-RDIMAHANSEWIVQLH 109 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhhHHHHHHH-HHHHHhCCCCCcceEE
Confidence 445778899999999999999999999877664 8999999653211 111112222 2356778999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++..++..|+||||++| +|.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 110 YAFQDDKYLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EEEecCCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEec
Confidence 999999999999999985 6665553 346899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCC-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++...... .......+||+.|||||++.+.. ...++.++|+|||||++|||++|++||.+.+....+..+.....
T Consensus 187 G~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05596 187 GTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred cceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 9998654321 11223568999999999987532 23578999999999999999999999999998888888876554
Q ss_pred CCCCCC--CCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 271 IPPIPS--GLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 271 ~~~~p~--~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
...+|. .++.++.++|.+||..+|.+ |+++.++++ |+|+...+|.....+...+|..|.
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~------h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS------HPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc------CcccCCCChhhHHhcCCCcCccCc
Confidence 455554 57999999999999999988 999999998 999999888765555555555444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=359.64 Aligned_cols=268 Identities=20% Similarity=0.276 Sum_probs=217.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||||++++..... .......+..++....+||||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE------LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence 469999999999999877654 89999997543211 1111222333344444899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 149 (318)
T cd05570 75 MEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--- 149 (318)
T ss_pred EcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence 999985 6655554 3457999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+++..+... ...+|..+++++.
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSY---QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAK 224 (318)
T ss_pred CCcccceecCccccCHHHhcC---CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHH
Confidence 122334579999999999974 46889999999999999999999999998888888777544 3456788999999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+||.+||+.||.+||++ .++++ |+|+...+|.........+|..+..
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~------~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKG------HPFFREIDWDKLERKEIKPPFKPKI 276 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999999999999999 88877 9999999998776666666665543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=371.29 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=217.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH-HHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-LLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~-~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|-+.+.||+|+||.||+|+.+.+.+ .||+|.+.+........ -+.++. .+++.++||||+.+++.|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~------~vAik~i~K~gr~~k~l~~l~~ev-~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ------VVAIKFIDKSGRNEKELKNLRQEV-RILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeeccccccee------EEEEEEehhcCCchHHHHHHHHHH-HHHHhcCCcchhhHHHhhcccc
Confidence 578888999999999999999888775 89999998765433221 122222 3567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.+|+|+||+.|+|...+. ..+.++++.+..++.+++.||.|||+++|+|||+||.|||++.+|++|++|||+||....
T Consensus 75 ~~~vVte~a~g~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 75 HLWVVTEYAVGDLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred eEEEEehhhhhhHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999999999998887776 567899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
.....+...|||.|||||...+ ++|+..+|+|||||++|||++|++||...+..++.+.|... ....|..++
T Consensus 153 ---~t~vltsikGtPlYmAPElv~e---~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S 224 (808)
T KOG0597|consen 153 ---NTSVLTSIKGTPLYMAPELVEE---QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTAS 224 (808)
T ss_pred ---CceeeeeccCcccccCHHHHcC---CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCccccc
Confidence 3344567899999999999984 48999999999999999999999999999999999998654 455677999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+..|+..+|.+||.+|.+-.+++.
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhc
Confidence 99999999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.57 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=217.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.+-|++.+.||.|+-|.|-+|++..|+ +..|||++.+... +....-++++. ++++++.|||++++++++.+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TG------qlaaiKii~k~~~~s~s~~~~IerEI-viMkLi~HpnVl~LydVwe~ 83 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETG------QLAAIKIIPKRSELSSSQPAGIEREI-VIMKLIEHPNVLRLYDVWEN 83 (786)
T ss_pred ccceeccccccCCCCceehhhhccccc------ceeEEEeeccccccccccccchhhhh-HHHHHhcCCCeeeeeeeecc
Confidence 356999999999999999999987766 4899999987532 12222223322 47888999999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+..+|+|.||++ |.|.+.+. ..+++++.++.+++.||+.|+.|+|..+|+||||||+|+|||.++++||+|||+|.+
T Consensus 84 ~~~lylvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred CceEEEEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 999999999999 57777775 568899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
-. +.....+.||+|.|.|||++.|..+ -+.++||||.|||||.||||++||.+.+...++.++..+ ...+|.
T Consensus 162 e~----~gklLeTSCGSPHYA~PEIV~G~pY--dG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--~f~MPs 233 (786)
T KOG0588|consen 162 EV----PGKLLETSCGSPHYAAPEIVSGRPY--DGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--VFEMPS 233 (786)
T ss_pred cc----CCccccccCCCcccCCchhhcCCCC--CCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--cccCCC
Confidence 43 3556678899999999999997632 358999999999999999999999999999999998654 567889
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+|+++++||.+||..||.+|.++.+|++
T Consensus 234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 234 NISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred cCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 99999999999999999999999999998
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.88 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=216.0
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..+++ .||+|++++... .........+..++....+||||+++++++..++.+|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGE------YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence 469999999999999877664 899999975321 111112222233344556899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||+.| +|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~E~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05620 75 MEFLNGGDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--- 149 (316)
T ss_pred ECCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---
Confidence 999995 6666554 3467899999999999999999999999999999999999999999999999998753211
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..++++.+... .+.+|..++.+++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQG---LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPHYPRWITKESK 224 (316)
T ss_pred CCceeccCCCcCccCHHHHcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence 122345689999999999974 46889999999999999999999999999888888777543 4567778999999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
++|.+||+.||++||++. ++++ |+||...+|.........+|..+.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~~------h~~f~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIRG------HPFFKTINWTALEKRELDPPFKPK 271 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHHc------CCCcCCCCHHHHHhCCCCCCcCCC
Confidence 999999999999999974 6666 999999988776655555555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.97 Aligned_cols=265 Identities=20% Similarity=0.200 Sum_probs=211.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|++..++. .||||++.+..... ......++. .++..++|+||+++++.+..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA------LYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC------EEEEEEEcHHHHHhhhhHHHHHHHH-HHHHhCCCCCcceEEEEEEcC
Confidence 479999999999999999999877654 89999986532211 111122222 356778999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+||||||++ |+|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+|..+
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999998 56777664 3457899999999999999999999999999999999999999999999999998533
Q ss_pred cCCC----------------------------------------CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcch
Q 006887 198 LGIP----------------------------------------LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSW 237 (627)
Q Consensus 198 ~~~~----------------------------------------~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiw 237 (627)
.... .........+||+.|||||++.+ ..++.++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Diw 228 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQLCDWW 228 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC---CCCCcceeee
Confidence 1000 00001124579999999999974 4688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCC---CHHHHHHHHHhccc
Q 006887 238 GFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRP---LMTDILRVFKSSQN 312 (627)
Q Consensus 238 SlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RP---s~~eil~~L~~~~~ 312 (627)
||||++|||++|+.||.+.+..+....+........++ ..+++++.++|.+|+ .+|.+|+ ++.++++ |
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~------h 301 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA------H 301 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC------C
Confidence 99999999999999999988877766665443333333 468999999999977 5999999 8899988 9
Q ss_pred ccCCCCCCCCCC
Q 006887 313 SVHSDGGWTGHG 324 (627)
Q Consensus 313 ~~~~~~~w~~~~ 324 (627)
+|+...+|....
T Consensus 302 ~~~~~~~~~~~~ 313 (376)
T cd05598 302 PFFKGIDFASLI 313 (376)
T ss_pred CCcCCCCHHHHh
Confidence 999988886654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.77 Aligned_cols=276 Identities=20% Similarity=0.271 Sum_probs=221.2
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|+..+.||+|+||.||+|++..++. .||+|++.+.... ........+..++....+|++|+.+++++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 47889999999999999999877664 8999999754221 111112222333444456788999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.+|+||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EEEEEEcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999985 6665554 34679999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
.. ........||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..++++.+... ...+|..+
T Consensus 153 ~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~ 224 (323)
T cd05615 153 VD---GVTTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSL 224 (323)
T ss_pred CC---CccccCccCCccccCHHHHcC---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccC
Confidence 21 122335679999999999974 46889999999999999999999999999988888887654 34577889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHH-HHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTD-ILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~e-il~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+.++.+++.+||+.+|.+|++..+ ..+.+. .|+||...+|.....+...+|..+.
T Consensus 225 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~--~h~~f~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05615 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIR--EHAFFRRIDWDKLENREIQPPFKPK 280 (323)
T ss_pred CHHHHHHHHHHcccCHhhCCCCCCCCHHHHh--cCcccCCCCHHHHhcCCCCcCccCc
Confidence 999999999999999999997431 122222 2999999999888887777777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=364.59 Aligned_cols=262 Identities=19% Similarity=0.314 Sum_probs=220.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
...+.|+.+++||+|.||.||+|++..+++ .||+|++.....+. .-.+..+++ .+++.++||||++|.+...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgk------ivALKKvr~d~~~~~~~~t~~REI-~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGK------IVALKKVRFDNEKEGFPITAIREI-KILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCc------EEEEEEeecccCCCcchHHHHHHH-HHHHhcCCCcccceeeEEE
Confidence 444789999999999999999999988775 89999998765332 223333333 4678899999999999988
Q ss_pred EC--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 117 IN--GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 117 ~~--~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.. +.+|||+|||+-+|.-++.. ..-+|++.+++.|+.||+.||+|||++||+|||||.+|||||.+|.+||+|||||
T Consensus 187 ~~~~~siYlVFeYMdhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred ecCCceEEEEEecccchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 76 78999999999887777653 5668999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP- 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~- 273 (627)
+++.... ....+..+-|.+|.|||.+.|.. .|+.++|+||+||||.||++|++.|.+.+.-+.++.|...-..|.
T Consensus 266 r~y~~~~--~~~~T~rVvTLWYRpPELLLG~t--~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 266 RFYTPSG--SAPYTSRVVTLWYRPPELLLGAT--SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred eeccCCC--CcccccceEEeeccChHHhcCCc--ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 9876532 23467788999999999999863 699999999999999999999999999998888877765332211
Q ss_pred -------CC-------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 274 -------IP-------------------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 274 -------~p-------------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+| ..+++...+|+..||..||++|.|+.++|+ +.||..
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~------seyF~t 405 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ------SEYFTT 405 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc------Cccccc
Confidence 11 246888999999999999999999999988 778743
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.04 Aligned_cols=271 Identities=24% Similarity=0.320 Sum_probs=217.5
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++.+.... ........+...+++.++||||+++++.+..++..|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGK------CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence 469999999999999876654 8999999754221 11112222223456778999999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 149 (325)
T cd05604 75 LDFVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--- 149 (325)
T ss_pred EcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence 999995 5555543 4567999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+... ...+++.++..+.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRK---QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAW 224 (325)
T ss_pred CCCcccccCChhhCCHHHHcC---CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHH
Confidence 122345689999999999974 46889999999999999999999999999888888877653 3445667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++.+||+.+|.+||++.+.++.+.. |+||....|........+++..+.
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~~~~i~~--h~~f~~~~~~~~~~~~~~~~~~~~ 274 (325)
T cd05604 225 SILEELLEKDRQRRLGAKEDFLEIQE--HPFFESLSWTDLEQKKIPPPFNPN 274 (325)
T ss_pred HHHHHHhccCHHhcCCCCCCHHHHhc--CCCcCCCCHHHHHhCCCCCCcCCc
Confidence 99999999999999988643333322 999999988777666666666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.33 Aligned_cols=332 Identities=20% Similarity=0.283 Sum_probs=260.1
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc--hhHHHHHHHHHHHHHHHhcCCCCcee
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK--EDRMRVLLERLNDLFLKCQGVEGICW 110 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~--~~~~~~~~~~~~~~ll~~~~hpnIv~ 110 (627)
..++-+..++|.++..||+|+|+.|.++++..+.. .||+|++++.- .+......+.+...+-+..+||.+|-
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~q------iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQ------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccce------eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 46777889999999999999999999999988874 89999998742 22223344555666777889999999
Q ss_pred eEEEEEECCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 111 LQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
|+.+|+.+.++++|.||++| +|++.+. ++.+++++.+.+|..+|+.||.|||++|||+||||.+|+|||..|++||+
T Consensus 316 lhscfqtesrlffvieyv~g--gdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred hhhhhcccceEEEEEEEecC--cceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec
Confidence 99999999999999999997 4555443 45789999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC-------CCHHH-H
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-------RSVDE-I 261 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~-------~~~~e-~ 261 (627)
|+|+++.-.. +....+++||||+|+|||+++++ .|++.+|+|+|||+|+||+.|+.||.- .+.++ +
T Consensus 394 dygmcke~l~---~gd~tstfcgtpnyiapeilrge---eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 394 DYGMCKEGLG---PGDTTSTFCGTPNYIAPEILRGE---EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred ccchhhcCCC---CCcccccccCCCcccchhhhccc---ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 9999986433 34566789999999999999976 699999999999999999999999962 23333 4
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH--HHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCccc
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTD--ILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEW 339 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~e--il~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~ 339 (627)
++.|+++ ...+|..+|-.+..+++..|.+||.+|....- -+..++. |+||..++|+.+.++...||+.|..+..
T Consensus 468 fqvilek--qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~--h~ffr~idwd~leqk~v~ppf~p~i~~d 543 (593)
T KOG0695|consen 468 FQVILEK--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKS--HAFFRSIDWDLLEQKQVLPPFQPQITDD 543 (593)
T ss_pred HHHHhhh--cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhc--chhhhhCCHHHHhhcccCCCCCCccccc
Confidence 5555544 35688999999999999999999999975321 1222222 8999999999999999999999986543
Q ss_pred ccCccccCCCccccCCCCCCCCCCCCCCCCCCceeeeecCCCCcceEEEEecc
Q 006887 340 FLSKEDLKVDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHG 392 (627)
Q Consensus 340 ~~s~~~~~~~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~~~~~~~~v~~~~ 392 (627)
+.. -.++..+++..+..++.. ++-+..+|++ +|++|.|++...
T Consensus 544 ~~l---~~fd~qft~e~~qltpdd------~d~i~ridqs-efegfeyinpl~ 586 (593)
T KOG0695|consen 544 YGL---DNFDTQFTSEPVQLTPDD------EDAIKRIDQS-EFEGFEYINPLL 586 (593)
T ss_pred cCc---cccccccccCCcccCCCC------HHHHHhcchh-hcCcceecchhh
Confidence 211 122333344444443322 2223444444 499999886544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=361.64 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=214.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..++. .||||++...... ........+. .++..++||||+++++++..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGH------IYAMKKLRKSEMLEKEQVAHVRAER-DILAEADNPWVVKLYYSFQDE 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcC
Confidence 479999999999999999999877654 8999999753211 1111122222 356677899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..||||||++| +|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CeEEEEECCCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999985 5655554 3457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCC-----------------------------------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHH
Q 006887 198 LGIPLPS-----------------------------------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACS 242 (627)
Q Consensus 198 ~~~~~~~-----------------------------------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGvi 242 (627)
....... ......+||+.|||||++.+ ..++.++|+|||||+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~i 228 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ---TGYNKECDWWSLGVI 228 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC---CCCCCeeeeecchhH
Confidence 3211000 01113479999999999873 468899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHhcccccCCC
Q 006887 243 IIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS--GLPPAVENVLLGCFEYDLRSRPL---MTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 243 LyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~--~~s~~l~~li~~cL~~dP~~RPs---~~eil~~L~~~~~~~~~~ 317 (627)
+|||++|.+||.+.+..+.+..+........+|. .+++++.++|.+|+. +|.+|++ +.++++ |+|+..
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~------h~~~~~ 301 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS------HPFFKG 301 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc------CCCcCC
Confidence 9999999999999988888877765544444443 578999999999996 9999998 889888 999999
Q ss_pred CCCCCCC
Q 006887 318 GGWTGHG 324 (627)
Q Consensus 318 ~~w~~~~ 324 (627)
.+|....
T Consensus 302 ~~~~~~~ 308 (364)
T cd05599 302 VDWEHIR 308 (364)
T ss_pred CCHHHHh
Confidence 9887543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.08 Aligned_cols=268 Identities=20% Similarity=0.286 Sum_probs=212.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++++.... ........+..++....+||||+.+++++...+..|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTER------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence 469999999999999877654 8999999764321 11222233333455566899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~E~~~~~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--- 149 (329)
T cd05618 75 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--- 149 (329)
T ss_pred EeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence 999995 5555443 3467999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccCCCCC
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---------SVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---------~~~e~~~~i~~~~~~~~~ 274 (627)
........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||... ....+.+.+.. ....+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~ 224 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRI 224 (329)
T ss_pred CCccccccCCccccCHHHHcC---CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--CCCCC
Confidence 122345689999999999974 46888999999999999999999999521 11223333432 34567
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPL------MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs------~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
|..++..+.++|.+||+.||++||+ +.++++ |+||...+|.....+...++..+..
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~------hp~f~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDLMEQKQVVPPFKPNI 286 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc------CCCCCCCCHHHHHcCCCCcCccCCC
Confidence 8899999999999999999999998 467666 9999999998877777777666553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=357.42 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=211.6
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++++.... ........+..++....+||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR------IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence 469999999999999877664 8999999764321 11222333333444555899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 149 (329)
T cd05588 75 IEFVSGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--- 149 (329)
T ss_pred EeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence 999995 6655554 3467999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhccCCCCC
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---------VDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---------~~e~~~~i~~~~~~~~~ 274 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|+|++|+.||.... ...+.+.+.. ....+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 224 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--KQIRI 224 (329)
T ss_pred CCccccccCCccccCHHHHcC---CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--CCCCC
Confidence 223345689999999999974 468889999999999999999999996321 1223444433 24567
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPL------MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs------~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
|..++.++.++|.+||+.||.+||+ +.++++ |+||...+|.........++..+.
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~------hp~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS------HPFFRNIDWDLLEQKQVLPPYKPN 285 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc------CCCCCCCCHHHHHhCCCCCCcccc
Confidence 8889999999999999999999997 567766 999999999877766666555544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=362.62 Aligned_cols=275 Identities=19% Similarity=0.190 Sum_probs=215.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|++..++. .||+|++.+.... ........+. .+++.++|+||+++++.+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKA------LYAMKTLRKKDVLLRNQVAHVKAER-DILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCC------EEEEEEEeHHHhhhHHHHHHHHHHH-HHHHhCCCCcCCeEEEEEEeC
Confidence 369999999999999999999877664 8999999753321 1111222222 356678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+||||||++| +|.+.+. +.+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 999999999985 6766664 3457899999999999999999999999999999999999999999999999997543
Q ss_pred cCCCC--------------------------------------------CCCCCCccCCCCCcCCcccccCCCCCCCCcc
Q 006887 198 LGIPL--------------------------------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFE 233 (627)
Q Consensus 198 ~~~~~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~ 233 (627)
..... ........+||+.|||||++.+ ..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~ 228 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQL 228 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC---CCCCCe
Confidence 11000 0001123579999999999974 368899
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHHH
Q 006887 234 TDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPL---MTDILRVFK 308 (627)
Q Consensus 234 sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs---~~eil~~L~ 308 (627)
+|||||||++|||++|++||.+.+..+....+.........| ..+++++.++|.+|+ .+|.+|++ +.++++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~--- 304 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA--- 304 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc---
Confidence 999999999999999999999988877777666544334343 468999999999987 59999987 888877
Q ss_pred hcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 309 SSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 309 ~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
|+||...+|..... ...+|..|.
T Consensus 305 ---hp~f~~~~~~~~~~-~~~~~~~~~ 327 (382)
T cd05625 305 ---HPFFKTIDFSSDLR-QQSAPYIPK 327 (382)
T ss_pred ---CCCcCCcChHHHHh-cCCCCccCc
Confidence 99999988875432 233444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=357.41 Aligned_cols=268 Identities=18% Similarity=0.283 Sum_probs=217.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||+|+++.... ........++. .++...+|+||+.+++++..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~-~i~~~~~~~~i~~~~~~~~~~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGD------IYAMKVMKKSVLLAQETVSFFEEER-DILSISNSPWIPQLQYAFQDK 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceeeEEecC
Confidence 479999999999999999999877664 899999975432 11222222322 355678999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..||||||++ |+|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999998 466666653 3467999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCC---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEV---RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
..... .......||+.|+|||++.... ...++.++|||||||++|||++|+.||...+..+.+..+........+
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (330)
T cd05601 153 TANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230 (330)
T ss_pred CCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCC
Confidence 43211 1223457999999999986321 235788999999999999999999999998888888777655443333
Q ss_pred C--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 275 P--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 275 p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
| ..+++++.+|+.+||. +|.+||++.++++ |+|+...+|.....
T Consensus 231 ~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~------h~~~~~~~~~~~~~ 276 (330)
T cd05601 231 PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC------HPFFSKIDWNNIRN 276 (330)
T ss_pred CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC------CCCcCCCCHHHHhh
Confidence 4 3579999999999997 9999999999988 99999988876553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.35 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=224.2
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+.++++.+++++.||+|-||.||+|.+..+. .||+|.++...... ..+.++ . -+++.++|++||+|+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-------~vavk~ik~~~m~~-~~f~~E-a-~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGST-------KVAVKTIKEGSMSP-EAFLRE-A-QIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCC-------cccceEEeccccCh-hHHHHH-H-HHHHhCcccCeEEEE
Confidence 3456688899999999999999999999998765 49999998754332 233322 2 366779999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
++|..++.+||||||++ |+|++.+....+..+...+.+.++.|||+|++||+++++|||||-..|||++++..+||+||
T Consensus 268 gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 268 GVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred EEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccc
Confidence 99999889999999999 99999998656688999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||||...+.....+ ....-...|.|||.+. .+.++.+||||||||+||||+| |+.||.+.+..++++.+..+.
T Consensus 348 GLAr~~~d~~Y~~~--~~~kfPIkWtAPEa~~---~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy- 421 (468)
T KOG0197|consen 348 GLARLIGDDEYTAS--EGGKFPIKWTAPEALN---YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY- 421 (468)
T ss_pred ccccccCCCceeec--CCCCCCceecCHHHHh---hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC-
Confidence 99995543222111 1223346899999998 6789999999999999999999 999999999999999887655
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.+.|..||+++-+++..||+.+|++|||+..+...|+...
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 55569999999999999999999999999998888777643
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=357.83 Aligned_cols=266 Identities=19% Similarity=0.302 Sum_probs=215.2
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-HHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-LNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
+.||+|+||.||+|++..++. .||+|++.+............ .+..++..++||||+.+++++..++..||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGR------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence 469999999999999876654 899999975432111111111 1122566789999999999999999999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 126 KFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 126 Ey~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
||++| +|.+.+. ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 E~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--- 149 (325)
T cd05594 75 EYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--- 149 (325)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---
Confidence 99995 5555443 34679999999999999999999997 79999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
........||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+... ...+|..+++++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~ 224 (325)
T cd05594 150 GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAK 224 (325)
T ss_pred CcccccccCCcccCCHHHHcc---CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHH
Confidence 122335679999999999974 46889999999999999999999999998888887776543 4557888999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 284 ~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
+++.+||+.||++|+ ++.++++ |+|+....|.....+...++..+
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~------h~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQ------HKFFAGIVWQDVYEKKLVPPFKP 274 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhc------CCCcCCCCHHHHHhCCCCCCcCC
Confidence 999999999999997 8999987 99999998887666555555444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.30 Aligned_cols=269 Identities=19% Similarity=0.268 Sum_probs=215.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||++++..++. .||+|++.+..... .......+ ..++...+|++|+.+++++...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~~~i~~~~~~~~~~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK------VFAMKILNKWEMLKRAETACFREE-RDVLVNGDNQWITTLHYAFQDE 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC------EEEEEEEeHHHHHHhhHHHHHHHH-HHHHhhCCCCCEeeEEEEEecC
Confidence 479999999999999999999876654 89999986432111 11112222 2345668999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++ |+|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999998 577766653 3467899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.... .......+||+.|||||++.+. ....++.++|+|||||++|||++|+.||.+.+..+.+..+........+|
T Consensus 153 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (332)
T cd05623 153 MEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230 (332)
T ss_pred ccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCC
Confidence 4321 1122345799999999998632 12358889999999999999999999999999888888887654433333
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 276 ---SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 276 ---~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
..+++++++|+.+||..++.+ |+++.++++ |+||...+|.....
T Consensus 231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~------h~~f~~~~~~~~~~ 279 (332)
T cd05623 231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ------HPFFTGIDWDNIRN 279 (332)
T ss_pred CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC------CCCcCCCCHHHHhh
Confidence 467999999999999665544 688999988 99999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.43 Aligned_cols=266 Identities=18% Similarity=0.269 Sum_probs=211.0
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHH--HHHHHHHHhc--CCCCceeeEEEEEECCEEEEE
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE--RLNDLFLKCQ--GVEGICWLQGISVINGKICII 124 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~--~~~~~ll~~~--~hpnIv~l~~~~~~~~~~~LV 124 (627)
||+|+||.||+|++..++. .||||++.+........... .+..++.... +||||+.+++.+...+..|+|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv 74 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR------IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV 74 (330)
T ss_pred CCCCCceEEEEEEECCCCC------EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence 6999999999999877664 89999986532211111111 1222333333 799999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--- 149 (330)
T cd05586 75 TDYMSGGELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--- 149 (330)
T ss_pred EcCCCCChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---
Confidence 999985 6655554 4567999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC-CCCCHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP-SGLPPAV 282 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p-~~~s~~l 282 (627)
.......+||+.|||||++.+. ..++.++|+|||||++|+|++|..||.+.+..+++..+.... ..++ ..+++++
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~ 225 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDE--KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEG 225 (330)
T ss_pred CCCccCccCCccccCHHHHcCC--CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHH
Confidence 1223456899999999998642 247889999999999999999999999998888887776443 2333 3579999
Q ss_pred HHHHHHhhhcCCCCCC----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 283 ENVLLGCFEYDLRSRP----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 283 ~~li~~cL~~dP~~RP----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
.+++.+||+.||.+|| ++.++++ |+|+...+|.......+.++..+.
T Consensus 226 ~~li~~~L~~~P~~R~~~~~~~~~ll~------h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGAHRDAVELKE------HPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred HHHHHHHcCCCHHHCCCCCCCHHHHhc------CccccCCCHHHHHhCCCCCCccCC
Confidence 9999999999999998 4666665 999999888877766666665554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.04 Aligned_cols=270 Identities=25% Similarity=0.328 Sum_probs=215.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||++++.... ..+..||+|++...............+..++..++||||+++++++..++..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP---DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 57999999999999875322 235689999997543221111111112235677899999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++ |+|.+.+. +...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++..... ..
T Consensus 79 ~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---~~ 153 (318)
T cd05582 79 FLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---EK 153 (318)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC---CC
Confidence 998 56666654 3467899999999999999999999999999999999999999999999999998765332 12
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~l 285 (627)
......||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+... ...+|..+++++.++
T Consensus 154 ~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l 228 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSL 228 (318)
T ss_pred ceecccCChhhcCHHHHcC---CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 2345689999999999874 35788999999999999999999999998888888777543 355778899999999
Q ss_pred HHHhhhcCCCCCCCHHH-----HHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 286 LLGCFEYDLRSRPLMTD-----ILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 286 i~~cL~~dP~~RPs~~e-----il~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
|.+||+.||++||++.+ +++ |+||...+|.........++..+.
T Consensus 229 i~~~l~~~P~~R~~a~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T cd05582 229 LRALFKRNPANRLGAGPDGVEEIKR------HPFFSTIDWNKLYRREIKPPFKPA 277 (318)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhC------CCCcCCCCHHHHHhcCCCCCcCCC
Confidence 99999999999999544 444 999999888876665555555443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.20 Aligned_cols=280 Identities=27% Similarity=0.376 Sum_probs=229.6
Q ss_pred CCccchhccccCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHH
Q 006887 20 DSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLND 97 (627)
Q Consensus 20 d~~~l~~~~~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~ 97 (627)
+.+.....-+..+...+.|..++..+.++||+|+||+||+|+++. .||||+++-.... ..+.+..+.
T Consensus 371 ~~~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEV-- 439 (678)
T KOG0193|consen 371 DKISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEV-- 439 (678)
T ss_pred cccccccccCCccccccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHH--
Confidence 333333333444456778999999999999999999999999986 4999999865443 233333322
Q ss_pred HHHHhcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 98 ~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
..++..+|.||+-+.|++..... .||+.+|+|+.+....+....+|.....+.|+.||++|+.|||.++|||||||..|
T Consensus 440 a~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnN 518 (678)
T KOG0193|consen 440 AVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNN 518 (678)
T ss_pred HHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccc
Confidence 35677899999999999997776 99999999976666666677889999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~ 257 (627)
|++.+++.|||+||||+..-.- -..........|...|||||+++.+...+|++.+||||||+++|||+||..||....
T Consensus 519 IFl~~~~kVkIgDFGLatvk~~-w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 519 IFLHEDLKVKIGDFGLATVKTR-WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred eEEccCCcEEEecccceeeeee-eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence 9999999999999999865322 122333446678899999999997767899999999999999999999999999888
Q ss_pred HHHHHHHHHhccCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 258 VDEIYDAVVRRQEIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.++++..+-.+...++ ....++.++++|+..||..++++||.+.+|+..|..++.
T Consensus 598 ~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 598 RDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 8888877766633333 346788999999999999999999999999997776554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=359.99 Aligned_cols=272 Identities=22% Similarity=0.267 Sum_probs=217.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++...... .......+. .++..++|++|+++++.+..+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~~~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGH------IYAMKILRKADMLEKEQVAHIRAER-DILVEADGAWVVKMFYSFQDK 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHH-HHHHhCCCCCEeeEEEEEEcC
Confidence 479999999999999999999877664 89999997532211 111222222 245667999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+||||||++| +|.+.+. ..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999999985 6666654 3467999999999999999999999999999999999999999999999999998755
Q ss_pred cCCCCC--------------------------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHH
Q 006887 198 LGIPLP--------------------------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245 (627)
Q Consensus 198 ~~~~~~--------------------------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLye 245 (627)
...... .......+||+.|||||++.+ ..++.++|+|||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvilye 228 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC---CCCCCcceeccccceeee
Confidence 321100 001124579999999999974 468899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHHHhcccccCCCCCC
Q 006887 246 MLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS--GLPPAVENVLLGCFEYDLRSRPL---MTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 246 lltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~--~~s~~l~~li~~cL~~dP~~RPs---~~eil~~L~~~~~~~~~~~~w 320 (627)
|++|++||.+.+..+.+..+........+|. .++++++++|.+|+ .||.+|++ +.++++ |+||...+|
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~------hp~f~~~~~ 301 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS------HPFFEGVDW 301 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc------CCCCCCCCH
Confidence 9999999999998888888775443444443 47899999999987 49999985 667776 999999999
Q ss_pred CCCCcccCCCC
Q 006887 321 TGHGSRILPDK 331 (627)
Q Consensus 321 ~~~~~~~~~~~ 331 (627)
..........|
T Consensus 302 ~~~~~~~~~~~ 312 (360)
T cd05627 302 GHIRERPAAIP 312 (360)
T ss_pred HHHhcCCCCCC
Confidence 88766544444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.94 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=207.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+.++|++.++||+|+||.||+|++..++. .||+|+++............++. .+++.++||||+++++++..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREV-SLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCC------EEEEEEecccccCCcchhHHHHH-HHHHhCCCCCEeeEEEEEcCC
Confidence 45789999999999999999999876654 89999987543322221222222 245678999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..++||||++|+|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 99999999999988877754 34568999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP------ 272 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~------ 272 (627)
.. ........||+.|||||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+......+
T Consensus 155 ~~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 155 VP---TKTYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred CC---CccccCceecccccChHHhcCC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 21 1223345789999999998642 358889999999999999999999999888776665544321110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 ----------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 ----------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.....+++++.+||.+||+.||.+|||+.++++ |+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~------hp~f 288 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR------HSYF 288 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc------CCCC
Confidence 011346889999999999999999999999998 8875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=347.12 Aligned_cols=273 Identities=19% Similarity=0.289 Sum_probs=219.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||++.+..++ +.||+|++......... .....+. .+++.++|+||+.+++.+..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG------KMYACKKLEKKRIKKRKGEAMALNEK-QILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC------ceEEEEEEehhhhhhhhhHHHHHHHH-HHHHhcCCCCEeeeeeeecCCC
Confidence 4899999999999999999987655 48999999754322111 1111222 2556779999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.......+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999985 66666654344679999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR--RQEIPPIPS 276 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~--~~~~~~~p~ 276 (627)
.. .......||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+.......+.. ......++.
T Consensus 154 ~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 154 EG----ETIRGRVGTVGYMAPEVVKN---ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226 (285)
T ss_pred CC----CccccccCCCCccCcHHhcC---CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc
Confidence 21 12234579999999999873 4688999999999999999999999998765433322221 122344667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
.+++.+.+|+.+||..||.+|| ++.++++ |+|+...+|.........+|..|
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA------HPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc------CcCccCCCHHHHhhCCCCCCCCC
Confidence 7999999999999999999999 8888887 99999999998887777777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.76 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=212.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||++++..++. .||+|++.+..... .......+ ..++...+|++|+.+++++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTER------IYAMKILNKWEMLKRAETACFREE-RNVLVNGDCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEeHHHHHhhHHHHHHHHH-HHHHHhCCCCCEeeEEEEEEcC
Confidence 579999999999999999999876654 89999987532111 11112222 2356678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..||||||++| +|.+.+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++..
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 999999999985 66666643 3467899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
..... .......||+.|||||++.+.. .+.++.++|+|||||++|||++|+.||.+.+..+.+..+.......++|
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 153 NQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred cCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 43211 1123457999999999986421 1357889999999999999999999999988888887776544333344
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCC
Q 006887 276 ---SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHG 324 (627)
Q Consensus 276 ---~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~ 324 (627)
..+++++++++.+||..++++ |+++.++++ |+||...+|....
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~------h~~f~~~~~~~~~ 278 (331)
T cd05624 231 SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK------HAFFEGIDWENIR 278 (331)
T ss_pred CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc------CCCcCCCCHHHHh
Confidence 346899999999999865544 457888877 9999999997664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.08 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=204.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHH--HHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLF--LKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~l--l~~~~hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|++..++ ++.||+|+++...... ......++..++ +....||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCC-----CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 47999999999999999999985443 2479999987543211 111111222222 233579999999998853
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 118 -----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 118 -----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
...+++||||++|++.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 76 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 76 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred ccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999999999888876555678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++..... .......||+.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..+.+..+......+
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQ----MALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred ceEeccCC----cccccccccccccChHHHhC---CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99865431 22345679999999999863 468889999999999999999999999988777766665422111
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 -------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 -------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+...+++.+++++.+||+.||++||++.++++ |+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~------hp~f 290 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYF 290 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc------CCCC
Confidence 011357888999999999999999999999998 8775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=358.79 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=215.2
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH---------H----HHHHHHHHHHH
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM---------R----VLLERLNDLFL 100 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~---------~----~~~~~~~~~ll 100 (627)
.+.....++|++++.||+|.||.|-+|++..+++ .||||++++...... . ....++. .++
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~------l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EI-ail 162 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGK------LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREI-AIL 162 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCc------EEEEEeechhhhhhhcccccccccccCcHHHHHHHH-HHH
Confidence 3455677899999999999999999999877765 899999976322111 0 1122222 367
Q ss_pred HhcCCCCceeeEEEEEE--CCEEEEEEecCCCCHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 101 KCQGVEGICWLQGISVI--NGKICIIMKFYEGSVGDRMAQLKGGK-LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 101 ~~~~hpnIv~l~~~~~~--~~~~~LVmEy~~GsL~d~l~~~~~~~-ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+.++|||||+|+++..+ .+.+|||+|||.. +...-.-..++ +++.+++.|+.+++.||+|||.+|||||||||+|
T Consensus 163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~--G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSK--GEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred HhcCCcCeeEEEEeecCcccCceEEEEEeccC--CccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 78899999999999865 5679999999984 22222223455 8999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCC--CCCCccCCCCCcCCcccccCCCCCC-CCccCcchhHHHHHHHHHhCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPS--SDLPRRLGTPNYMAPEQWQPEVRGP-ISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~~~~-~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
+||+++|++||+|||.+.......... .......|||.|||||.+.+..... .+++.||||+||+||.|+.|+.||.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 999999999999999987663321111 1223468999999999998643222 3578899999999999999999999
Q ss_pred CCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 255 GRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 255 ~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+....+++++|.+.....+..+.+.+++++||++||++||++|.+..+|.. |+|..
T Consensus 321 ~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~------Hpwvt 376 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL------HPWVT 376 (576)
T ss_pred cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee------cceec
Confidence 999999999998876554444568999999999999999999999999877 88754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.07 Aligned_cols=261 Identities=23% Similarity=0.254 Sum_probs=216.1
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..++|+.+.+|++|+||.||+|+++.+++ .||+|.++...... .-.-.-++..++ ...+|||||.+..+...
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~e------IVALKr~kmekek~GFPItsLREIniL-l~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDE------IVALKRLKMEKEKEGFPITSLREINIL-LKARHPNIVEVKEVVVG 146 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcce------eEEeeecccccccCCCcchhHHHHHHH-HhcCCCCeeeeEEEEec
Confidence 34789999999999999999999999987 89999998654321 111112223334 44569999999988764
Q ss_pred --CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 --NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 --~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
-+.+|||||||+-+|..++.. -..+|+..+++.+..|++.||+|||.+.|+||||||+|+|++..|.+||+|||+||
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 456999999999988888875 34789999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--- 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--- 272 (627)
.+.. +....+..+-|.+|.|||.+.|. ..|+.+.|+||+|||+.||+++++.|.|.+..+.+.+|......|
T Consensus 226 ~ygs---p~k~~T~lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 226 EYGS---PLKPYTPLVVTLWYRAPELLLGA--KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhcC---CcccCcceEEEeeecCHHHhcCC--cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 8864 23456677899999999999975 369999999999999999999999999998887777776532221
Q ss_pred --------------------------CCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 --------------------------PIPS-GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 --------------------------~~p~-~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.++. .+++.-.+|+..+|.+||.+|.|+.+.|+ |.||...
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~------h~~F~e~ 367 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK------HEYFRET 367 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc------ccccccC
Confidence 0111 26688899999999999999999999998 9998864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.23 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=202.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
+|++.+.||+|+||.||+|++..++. .||||+++.... .....+.. +. .+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~hpniv~~~~~~~~~~ 72 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGE------KVAIKKINDVFEHVSDATRILR-EI-KLLRLLRHPDIVEIKHIMLPPS 72 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCC------EEEEEEechhhccchhHHHHHH-HH-HHHHhCCCCCEeeecceEeccC
Confidence 59999999999999999999876654 899999874322 11122222 22 256678999999999987643
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 119 ----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 119 ----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
...|+||||++++|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 73 RREFKDIYVVFELMESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred CCCCceEEEEEecCCCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence 3589999999998888775 3457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR------ 268 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~------ 268 (627)
+................||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+.......+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhcc-ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 8654322222222456799999999998642 246889999999999999999999999876644332221110
Q ss_pred --------------------cCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 269 --------------------QEIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 269 --------------------~~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
....+ ..+.+++.+.+++.+||+.||++||++.++++ |+||....
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~------hp~f~~~~ 297 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA------DPYFKGLA 297 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc------CchhhhcC
Confidence 00000 11356788999999999999999999999998 99987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=345.15 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=204.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++..+++ .||+|++....... .......+. .++..++||||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKE------IVAIKKFKDSEENEEVKETTLREL-KMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCc------EEEEEEEecccccccchhhHHHHH-HHHHhCCCccccchhhhEecCC
Confidence 479999999999999999999877664 89999987543221 111122222 3566789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||+++++++.+.. ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||+++....
T Consensus 74 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999999999888777654 345789999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
.. ........||+.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..+....+.....
T Consensus 153 ~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 153 GS--NANYTEYVATRWYRSPELLLG---APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cc--cccccccccccccCCcHHHcC---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 21 122234579999999999974 3588999999999999999999999998765544333221100
Q ss_pred ---C--------C----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 ---I--------P----------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ---~--------~----------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
. + .....++.++.+|+.+||+.||++||++.++++ |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~------hp~f 287 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN------HPAF 287 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc------CCCC
Confidence 0 0 011237889999999999999999999999998 8875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.52 Aligned_cols=283 Identities=19% Similarity=0.257 Sum_probs=222.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..++. .||+|++.+.... .......++ ..++...+||||++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~------~~aiK~i~~~~~~~~~~~~~~~~e-~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK------VYAMKLLSKFEMIKRSDSAFFWEE-RDIMAFANSPWVVQLF 109 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCc------EEEEEEEEHHHhhhhHHHHHHHHH-HHHHHhCCCCCCCeEE
Confidence 345667899999999999999999999887664 8999998643211 111112222 2356678999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+.+..++..|+||||++| +|.+.+. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999985 6665553 346899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCC-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++.+.... .......+||+.|||||++.+.. .+.++.++|+|||||++|||++|..||.+.+....+..+.....
T Consensus 187 G~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (371)
T cd05622 187 GTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264 (371)
T ss_pred CceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 9998764321 11224568999999999987532 23478899999999999999999999999998888888876544
Q ss_pred CCCCC--CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 271 IPPIP--SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 271 ~~~~p--~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
...+| ..++..++++|.+||..++.+ |+++.++++ |+|+....|.....+...+|..|.
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~------h~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T cd05622 265 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR------HLFFKNDQWAWETLRDTVAPVVPD 327 (371)
T ss_pred cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc------CcccCCCChhHHhcCCCCCCCCCC
Confidence 44444 468999999999999844433 778999888 999988766544444445554443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.86 Aligned_cols=268 Identities=21% Similarity=0.290 Sum_probs=214.1
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..++. .||+|++++.... ........+..++....+||+|+.+++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQ------IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence 469999999999999876654 8999999764322 11222333334455566899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 149 (327)
T cd05617 75 IEYVNGGDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--- 149 (327)
T ss_pred EeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence 999985 6655554 3467999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC------C-HHHHHHHHHhccCCCCCCC
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR------S-VDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~------~-~~e~~~~i~~~~~~~~~p~ 276 (627)
.......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||... . ...+...+.. ....+|.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~p~ 224 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPR 224 (327)
T ss_pred CCceecccCCcccCCHHHHCC---CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CCCCCCC
Confidence 122345689999999999974 46889999999999999999999999632 1 2234444432 2445788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLM------TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~------~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
.++..+.+++.+||+.||++|+++ .++++ |+||...+|+........++..+..
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~------h~~f~~~~~~~~~~~~~~~~~~~~~ 284 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS------HTFFRSIDWDLLEKKQVTPPFKPQI 284 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc------CCCCCCCCHHHHHhCCCCCCccCCC
Confidence 899999999999999999999985 46655 9999999999888777777776653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.72 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=205.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..++. .||||++.............++. .+++.++||||+++++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGK------LVALKVIRLQEEEGTPFTAIREA-SLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCC------EEEEEEeccccccccchhHHHHH-HHHhhCCCCCcCeEEEEEecCC
Confidence 4789999999999999999999876654 89999997543322211122222 3566789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||+++++.+.+.. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 77 TLTLVFEYVHTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred eEEEEEECCCcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9999999999999888764 346789999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC-----
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~~~----- 273 (627)
. ........||+.|||||++.+. ..++.++|+|||||++|+|++|..||.+... .+.+..+......+.
T Consensus 156 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 156 P---SHTYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred C---CccCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 1 1223456789999999998642 3578899999999999999999999987533 233332221100000
Q ss_pred ----------------CC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 274 ----------------IP---------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 274 ----------------~p---------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
.+ ..+++++.+|+.+||+.||++|||+.++++ |+||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~------h~~f~~~~ 295 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS------HEYFSDLP 295 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc------CcccccCC
Confidence 00 124578899999999999999999999998 99988653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.42 Aligned_cols=271 Identities=23% Similarity=0.310 Sum_probs=214.8
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|++..+++ .||+|++.+...... ......+...+++.++||||+++++.+...+..|+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGS------FYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCC------EEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence 469999999999999876654 899999975432111 111222223356778999999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+.+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (321)
T cd05603 75 LDYVNGGELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--- 149 (321)
T ss_pred EcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---
Confidence 999995 5555543 3467899999999999999999999999999999999999999999999999998753221
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+... ...+|...+.++.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 224 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRK---EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAAC 224 (321)
T ss_pred CCccccccCCcccCCHHHhcC---CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHH
Confidence 122345689999999999874 46889999999999999999999999999888888777643 4556778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
+++.+||+.||.+||++..-+. +-..|+|+...+|.........++..+.
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITPPYNPN 274 (321)
T ss_pred HHHHHHccCCHhhcCCCCCCHH--HHhCCCCcCCCCHHHHhcCCCCCCcCCC
Confidence 9999999999999997642211 1123899999998876665555555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=331.71 Aligned_cols=258 Identities=19% Similarity=0.252 Sum_probs=215.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHH-HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMR-VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.+|..+++||+|.||.||+|+++.+++ .||||+++..... ... ..++++ -+++.++|+||+.|+++|...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~------~VAIKKIkl~~~kdGi~~talREI--K~Lqel~h~nIi~LiD~F~~~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGK------RVAIKKIKLGNAKDGINRTALREI--KLLQELKHPNIIELIDVFPHK 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCc------EEEEEEeeccccccCccHHHHHHH--HHHHHccCcchhhhhhhccCC
Confidence 478889999999999999999988875 8999999865432 211 122222 267788999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+.+-||+||++-+|...+.. +.-.++..++..|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.
T Consensus 74 ~~l~lVfEfm~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 74 SNLSLVFEFMPTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred CceEEEEEeccccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 99999999999887777654 66789999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~----- 273 (627)
.. ....+..+-|.+|.|||.+.|. ..|+..+|+||.||++.||+.|.+-|.|.+.-+.+..|...-..|.
T Consensus 153 ~p---~~~~~~~V~TRWYRAPELLfGs--r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 153 SP---NRIQTHQVVTRWYRAPELLFGS--RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred CC---CcccccceeeeeccChHHhccc--hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 42 2333344789999999999975 4799999999999999999999999999988777776665332211
Q ss_pred ---------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 ---------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ---------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+-+..++++.+|+.+||.+||.+|+++.++++ |++|...
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~------~~yf~~~ 287 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK------HPYFKSL 287 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc------chhhhcC
Confidence 11346788899999999999999999999998 8887743
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.39 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=213.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||++++..++. .||+|++++..... .......+. .++...+|+||+.+++++..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQ------VYAMKILNKWEMLKRAETACFREER-DVLVNGDRRWITNLHYAFQDE 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHH-HHHHhCCCCCCCceEEEEecC
Confidence 479999999999999999999877664 89999997532211 111122222 355667999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 999999999985 66666643 3567999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
..... .......||+.|||||++.+.. .+.++.++|+|||||++|||++|+.||.+.+..+.+..+........++
T Consensus 153 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 153 LADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 43211 1122357999999999986321 2357889999999999999999999999988888887776544333333
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 276 ---SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 276 ---~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
..+++++++++.+||..++++ |+++.++++ |+||...+|.....
T Consensus 231 ~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~------hp~~~~~~~~~~~~ 279 (331)
T cd05597 231 PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD------HPFFEGIDWDNIRN 279 (331)
T ss_pred CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc------CCCCCCCCHHHHhh
Confidence 457999999999988654443 789999998 99999998876654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.64 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=215.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
..|...++||+|+-|.||.|+...+++ .||||.+........+..+.+. ..++..+|+|||.+++.+...+.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~------~VaiK~m~l~~Q~~keLilnEi--~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQ------EVAIKRMDLRKQPKKELLLNEI--LVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCc------eEEEEEEEeccCCchhhhHHHH--HHHHhccchHHHHHHHHhcccce
Confidence 568899999999999999999887775 7999999876655444444433 36677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|+||||++| +|.|.+. ...+++.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..
T Consensus 345 LWVVMEym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999995 6555553 45589999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-~~~~~~~p~~~ 278 (627)
.. ....+.+|||.|||||++. +..|++++||||||++++||+-|++||...++-..+..|.. +......+..+
T Consensus 422 ~~---~KR~TmVGTPYWMAPEVvt---rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~kl 495 (550)
T KOG0578|consen 422 EQ---SKRSTMVGTPYWMAPEVVT---RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKL 495 (550)
T ss_pred cc---CccccccCCCCccchhhhh---hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCcccc
Confidence 32 2445679999999999998 55799999999999999999999999997776655544443 33445577899
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
|+++++|+.+||+.|+++|+++.|+|+ |+|+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~------HpFl~ 527 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE------HPFLK 527 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc------Chhhh
Confidence 999999999999999999999999999 88864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.31 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=210.2
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-HHHHHHHhcCCCCceeeEEEEEECCEEEEEEec
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-LNDLFLKCQGVEGICWLQGISVINGKICIIMKF 127 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy 127 (627)
||+|+||.||++.+..+++ .||+|++.............. .+..+++.++|+||+.+.+++..++..|+||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGK------LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCc------EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence 6999999999999877664 899999875432221111111 112256778999999999999999999999999
Q ss_pred CCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 128 YEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 128 ~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
++| +|.+.+... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++..+....
T Consensus 75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--- 151 (280)
T cd05608 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--- 151 (280)
T ss_pred CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---
Confidence 985 555554332 34579999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCCCCCCCCCH
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD----EIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~----e~~~~i~~~~~~~~~p~~~s~ 280 (627)
.......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||...... +....+. .....++..+++
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 226 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL--NDSVTYPDKFSP 226 (280)
T ss_pred ccccccCCCcCccCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc--ccCCCCcccCCH
Confidence 12234579999999999974 46889999999999999999999999865432 2233222 123446678999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 281 AVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
++.+++.+||+.||++|| ++.++++ |+||....|........++|+.|
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~------h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT------HPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc------ChhhhcCCHhHHhhccCCCCCCC
Confidence 999999999999999999 6777777 99999999988877777777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.95 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=222.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|..++.+|+|+||.+++++++.... .|++|.+.-.......+.....+..+++.+.||||+.+.+.|..++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~------~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDK------LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCc------eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 4689999999999999999999877654 8999999765543322222222334666799999999999999888
Q ss_pred E-EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 120 K-ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 120 ~-~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
. +||||+||+ |++.+.+.+.++..|+++.++.|+.|++.|+.|||+++|+|||||+.||++++++.++|+|||+|+.+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 8 999999999 58888888777788999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .....+..|||.||+||.+.+ .+|+.++|||||||++|||++-+++|.+.+...+..+|.... ..++|..
T Consensus 157 ~~~---~~~a~tvvGTp~YmcPEil~d---~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ 229 (426)
T KOG0589|consen 157 NPE---DSLASTVVGTPYYMCPEILSD---IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSM 229 (426)
T ss_pred CCc---hhhhheecCCCcccCHHHhCC---CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCcc
Confidence 642 234567899999999999985 489999999999999999999999999999999999998765 5778999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRV 306 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~ 306 (627)
++.+++.++..||..+|+.||++.++|..
T Consensus 230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999999999999883
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.74 Aligned_cols=271 Identities=21% Similarity=0.300 Sum_probs=214.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..++. ......||+|+++.............+.+++....+|+||++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 445667899999999999999999999866543 2345689999997654333333333344444444489999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK----------------------------------------------------- 140 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 140 (627)
+...+..|+||||++ |+|.+.+....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999 57777664321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 141 ---------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 141 ---------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
..++++..++.++.||+.||.|||++||+||||||+|||+++++.++|+|||+++.+..... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YV 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-ee
Confidence 13578889999999999999999999999999999999999999999999999976543211 11
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......+++.|||||++. ...++.++|+|||||++|||++ |+.||......+.+............+..+++++.+
T Consensus 270 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (374)
T cd05106 270 VKGNARLPVKWMAPESIF---DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYS 346 (374)
T ss_pred eccCCCCccceeCHHHhc---CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHH
Confidence 112334567899999986 3468999999999999999997 999998876555444444444455567778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
++.+||+.||.+||++.++++.|+++
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=334.46 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=210.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|+.++|++.+.||+|+||.||+|.+.... ..+..||+|+++.............+. ..+..++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPS---KRELPVAIHTLRAGCSDKQRRGFLAEA-LTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCC---CceeeEEEEecCCCCCHHHHHHHHHHH-HHHhcCCCCCcCeEEEEEec
Confidence 56789999999999999999999875432 134689999998654333222222222 24556799999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++..||||||++|++++.+.......+++..++.++.||+.||+|||+++++||||||+|||++.++.++++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999965444443334567999999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
.... ........++..|+|||++.+ +.++.++|+|||||++||+++ |..||.+.+..++...+... ...+.+.
T Consensus 158 ~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (266)
T cd05064 158 KSEA--IYTTMSGKSPVLWAAPEAIQY---HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPR 231 (266)
T ss_pred cccc--hhcccCCCCceeecCHHHHhh---CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCC
Confidence 2211 111123346678999999873 468899999999999999775 99999998888877776543 3445678
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.++..+.+++.+||+.+|.+||++.++++.|..
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.37 Aligned_cols=278 Identities=19% Similarity=0.313 Sum_probs=222.5
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.++.++|++.+.||+|+||.||+|..+.... ......||+|.++.............+ ...++.++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNE-ASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHH-HHHHHhCCCCCeeeEEEEE
Confidence 35778899999999999999999998654221 123458999998654432222222222 2356778999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCe
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLK--------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~v 186 (627)
...+..|+||||++ |+|.+.+.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 99999999999998 68877775432 1345677889999999999999999999999999999999999999
Q ss_pred eeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006887 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i 265 (627)
+|+|||+++........ .......++..|+|||.+.+ +.++.++|+|||||++|||++ |..||.+.+..+....+
T Consensus 159 ~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~---~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD---GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EECcCCccccccccccc-cccCCCcccccccCHHHhcc---CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999865432211 11223356788999999873 468899999999999999998 89999998888877766
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
... .....+..+++.+.+++.+||+.||++||++.++++.|++..+++|.+.+|
T Consensus 235 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 235 MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 543 345567788999999999999999999999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=328.28 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=220.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
......++|++.+.||+|-||.||+|+.+.+.. .||+|++.+...... ...+.++. .+...++||||.+++
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~------IvalKVlfKsqi~~~~v~~qlrREi-EIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLF------IVALKVLFKSQILKTQVEHQLRREI-EIQSHLRHPNILRLY 88 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCc------EEEEeeeeHHHHHHhcchhhhhhee-EeecccCCccHHhhh
Confidence 345677899999999999999999999988875 899999976442221 11222222 246678999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
++|.++...||++||.+ |++...+...+.+++++..+..|+.|++.||.|+|.+++|||||||+|+|++..|.+||+||
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999998 78888777667788999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|.+..-. .....+.|||..|.+||+..+. .++..+|+|++|++.||++.|.+||...+..++++.|..- .
T Consensus 169 GwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~---~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~ 238 (281)
T KOG0580|consen 169 GWSVHAP-----SNKRKTLCGTLDYLPPEMVEGR---GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--D 238 (281)
T ss_pred CceeecC-----CCCceeeecccccCCHhhcCCC---CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--c
Confidence 9876432 3445678999999999999854 6889999999999999999999999999999999999654 5
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+|..++.+++++|.+|+.++|.+|....++++
T Consensus 239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 5678999999999999999999999999999988
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=338.99 Aligned_cols=269 Identities=20% Similarity=0.283 Sum_probs=209.1
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
||+|+||.||++++..+++ .||+|.+....... .......+ ..++..++||||+++++.+..+...|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~E-~~il~~l~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK------MYACKKLDKKRLKKKSGEKMALLE-KEILEKVNSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCc------EEEEEEEcHHHhhcchhhHHHHHH-HHHHHhcCCCcEEEEEEEEecCCeEEEEEe
Confidence 6999999999999877654 89999986432211 11111122 235667799999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+.......+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...... .
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~----~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----K 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC----c
Confidence 9985 6666665444456899999999999999999999999999999999999999999999999998765431 1
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCCHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV----DEIYDAVVRRQEIPPIPSGLPPA 281 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~----~e~~~~i~~~~~~~~~p~~~s~~ 281 (627)
......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+... .++........ .......++++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKE---EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccCCHH
Confidence 2234579999999999874 3588999999999999999999999976432 23333332221 11123468999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
+.+++.+||+.||.+||++.|+++.+. .|+||...+|+.......++|..+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~--~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPR--KHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhh--cChhhcCCCHHHHhcCcCCCCCCC
Confidence 999999999999999999977664333 399999999988777766666543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.00 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=201.4
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHH--HHHhcCCCCceeeEEEEEE-
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDL--FLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~--ll~~~~hpnIv~l~~~~~~- 117 (627)
+|++.+.||+|+||.||+|++..++. .||+|.++...... ......++..+ .+...+||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGH------FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCc------EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 58999999999999999999877654 89999987532211 11111111222 2334589999999998764
Q ss_pred ----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 118 ----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 118 ----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
....++||||+++++.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 75 RTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred cCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 3458999999999988887765556699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP- 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~- 272 (627)
++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+......+
T Consensus 155 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 155 ARIYSCQ----MALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred cccccCc----ccCCCccccccccCchHhhC---CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 9876431 12234578999999999874 468899999999999999999999998877666555543311000
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 ------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 ------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...+.++..+.+++.+||+.||++||++.+++. |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~------hp~f 288 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ------HPFF 288 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc------CCCC
Confidence 112357888999999999999999999999998 8775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.06 Aligned_cols=256 Identities=24% Similarity=0.286 Sum_probs=204.0
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
...+|++.+.||+|+||.||+|.+..+++ .||||++...... ..++. .+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~~~-----~~~Ei-~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDPQY-----KNREL-LIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEecCcch-----HHHHH-HHHHhcCCCCCcceeeeEeec
Confidence 34689999999999999999999876654 8999988543221 11222 356678999999998876432
Q ss_pred --------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-Cee
Q 006887 119 --------GKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAV 187 (627)
Q Consensus 119 --------~~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vk 187 (627)
..+++||||+++++.+.+... ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred ccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCcee
Confidence 257899999999988777543 346799999999999999999999999999999999999998665 699
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||+++.+... .......||+.|||||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+..+..
T Consensus 212 L~DFGla~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 212 LCDFGSAKNLLAG----QRSVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred eeccccchhccCC----CCcccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999876432 222345789999999998642 3588999999999999999999999998876655554433
Q ss_pred ccCC---------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 268 RQEI---------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 268 ~~~~---------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.... ..+|...++++.+||.+||.+||.+||++.++++ |+||...
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~------hp~f~~~ 357 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA------DPFFDDL 357 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC------ChhHHhh
Confidence 2110 0134467899999999999999999999999998 9998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.04 Aligned_cols=270 Identities=21% Similarity=0.295 Sum_probs=209.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..... .+.+..||||+++............++..++..+.+||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEecccc-CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 444566789999999999999999998643221 2344689999997654332222233333444444489999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK----------------------------------------------------- 140 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 140 (627)
+...+..++||||++ |+|.+.+....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999 57777664321
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 141 --------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 141 --------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 125788899999999999999999999999999999999999999999999999866432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
.. ........+++.|||||++.+ ..++.++|+|||||++|||++ |..||........+............+...+
T Consensus 268 ~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (375)
T cd05104 268 SN-YVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAP 343 (375)
T ss_pred cc-ccccCCCCCCcceeChhHhcC---CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCC
Confidence 11 111123345678999999974 468999999999999999998 9999987665443333443333445567788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.++.+|+.+||+.||++||++.++++.|++
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.41 Aligned_cols=253 Identities=19% Similarity=0.218 Sum_probs=199.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-.++|++.+.||+|+||.||+|.+..++. .||+|++...... ....... + ..+++.++||||+++++++.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~-E-~~~l~~l~h~niv~~~~~~~ 90 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGI------NVAVKKLSRPFQNQTHAKRAYR-E-LVLLKCVNHKNIISLLNVFT 90 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCc------eeEEEEecccccchhHHHHHHH-H-HHHHHhCCCCCEeeeeeeec
Confidence 35799999999999999999999877654 8999999754322 1222222 2 23567789999999999986
Q ss_pred ECC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 117 ING------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
..+ ..|+||||+++++.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMDANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cCCCccccceeEEEEeCCCcCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEec
Confidence 543 579999999998877653 3488999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 167 fg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 167 FGLARTACT----NFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred CCCcccccc----CccCCCCcccCCCCCchhccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999976432 122344579999999999974 3688899999999999999999999998765443332221110
Q ss_pred --------------------CCC--------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 271 --------------------IPP--------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 271 --------------------~~~--------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.+. .....++++++||.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~----- 314 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR----- 314 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc-----
Confidence 000 11234678999999999999999999999998
Q ss_pred ccccCC
Q 006887 311 QNSVHS 316 (627)
Q Consensus 311 ~~~~~~ 316 (627)
|+|+.
T Consensus 315 -hp~~~ 319 (359)
T cd07876 315 -HPYIT 319 (359)
T ss_pred -Cchhh
Confidence 88865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=334.46 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=211.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|.|+.||++.+..++ +.+|+|+++..... ...+.++++.+ +-+.++|||||+|++.+...+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg------~~fa~kiin~~k~~~~~~e~l~rEar-IC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTG------LEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccch------HHHHHHHhhhhhhccccHHHHHHHHH-HHHhcCCCcEeehhhhhcccc
Confidence 57889999999999999999987766 48999998754321 12223333332 456689999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeeccCCccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~DFGla~ 195 (627)
..|||+|++.| +|...+.. .-.+++..+..+++||++||.|+|.++|||||+||+|+|+-. .--+||+|||+|.
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred eeEEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999997 33333332 245789999999999999999999999999999999999943 3458999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--PP 273 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--~~ 273 (627)
.+.+ ......+.|||.|||||++. +.+|+..+|||+.||+||-||.|.+||.+.+...+++.|+..... ++
T Consensus 162 ~l~~----g~~~~G~~GtP~fmaPEvvr---kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 162 EVND----GEAWHGFAGTPGYLSPEVLK---KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred EeCC----ccccccccCCCcccCHHHhh---cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc
Confidence 8763 34455789999999999998 458999999999999999999999999999999999999876643 33
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..+.+++++++|+++||..||.+|.|+.|.|+ |+|..
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~------HpWi~ 271 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALK------HPWIC 271 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhC------Cchhc
Confidence 56789999999999999999999999999988 77754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.70 Aligned_cols=256 Identities=16% Similarity=0.233 Sum_probs=208.5
Q ss_pred cCCCCeEEE--eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEE
Q 006887 38 IKPSALKLR--HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 38 i~~~~y~i~--~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
|+.++++.. ..||+|++|.||+|.+. ++.||||+++........ ....++. ..+..++||||+++++
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFN--------NKEVIIRTFKKFHKGHKVLIDITENEI-KNLRRIDSNNILKIYG 85 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEEC--------CEEEEEEeccccccccHHHHHHHHHHH-HHHHhcCCCCEEEEee
Confidence 344444444 67999999999999873 247999999765433211 1122222 2566789999999999
Q ss_pred EEEE----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCee
Q 006887 114 ISVI----NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 114 ~~~~----~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vk 187 (627)
++.+ ....++||||++| +|.+.+. ....+++.....++.|++.||.|||+. +++||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~k 163 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLK 163 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEE
Confidence 9877 4578999999995 6666664 345789999999999999999999984 999999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||+++.+.. ......||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+..+++..+..
T Consensus 164 l~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 164 IICHGLEKILSS------PPFKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred EcccchHhhhcc------ccccccCcccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 999999986532 11345789999999998642 24689999999999999999999999999998888888876
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
....+++|..+++.+.+++.+||+.||++||++.++++.|+..+
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 66667777789999999999999999999999999999888754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.14 Aligned_cols=272 Identities=18% Similarity=0.289 Sum_probs=215.8
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.|+..+.||+|+||.||++.+..++. .||+|.+.+....... .....+. .+++.++|++|+.+++.+..++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGESMALNEK-QILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCc------eEEEEEEehhhccchHHHHHHHHHH-HHHHhCCCCCeeeeeEEEecCC
Confidence 47888999999999999999887664 8999998754322111 1111222 2566789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.......+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999985 66666655444579999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---EIYDAVVRRQEIPPIP 275 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---e~~~~i~~~~~~~~~p 275 (627)
.. .......||+.|||||++.+ ..++.++|+|||||++|+|++|+.||...... +....+... ....++
T Consensus 154 ~~----~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~ 225 (285)
T cd05630 154 EG----QTIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYS 225 (285)
T ss_pred CC----ccccCCCCCccccChHHHcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcC
Confidence 21 12234579999999999973 46889999999999999999999999865421 222222211 123456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
..+++++.+|+.+||+.||++||+ +.++++ |+||...+|........++++.|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~------h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE------HPLFKQINFKRLEAGMLEPPFKP 283 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc------ChhhhccCHHHHhcCCCCCCCCC
Confidence 778999999999999999999999 889888 99999888887766666666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.56 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=205.5
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCc----------CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCC
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTE----------DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e----------d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpn 107 (627)
+..++|++.++||+|+||.||+|.+..... ....+..||+|++.............++.. ++..++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHH-HHhhcCCCC
Confidence 456789999999999999999998654321 012335799999986543332222223322 456679999
Q ss_pred ceeeEEEEEECCEEEEEEecCC-CCHHHHHHHhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 006887 108 ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLK-----------------GGKLSLSNVFRYAIDLAQGILQLHSKGIL 169 (627)
Q Consensus 108 Iv~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~-----------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIv 169 (627)
|+++++++...+..|+||||++ |+|.+.+.... ...+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999998 57777664321 13467889999999999999999999999
Q ss_pred ecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-
Q 006887 170 VLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT- 248 (627)
Q Consensus 170 HrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt- 248 (627)
||||||+|||++.++.+||+|||+++.+..... ........+++.|||||++. .+.++.++|+|||||++|||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECIL---MGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHh---cCCCCchhhhHHHHHHHHHHHHc
Confidence 999999999999999999999999986543211 11123345688999999987 3468999999999999999986
Q ss_pred -CCCCCCCCCHHHHHHHHHhc------cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 249 -GVQPRCGRSVDEIYDAVVRR------QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 249 -G~~Pf~~~~~~e~~~~i~~~------~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+..||...+..+....+... ......++.++..+.+|+.+||+.||.+||++.++.+.|+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67889887776665544321 1122345678999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.28 Aligned_cols=273 Identities=19% Similarity=0.290 Sum_probs=217.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.|+..+.||+|+||+||+|.+..+++ .||+|.+........ ......+. .++..++|+||+.+++.+..++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGK------MYACKRLEKKRIKKRKGESMALNEK-QILEKVNSQFVVNLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCc------EEEEEEeehhhhhhhhHHHHHHHHH-HHHHHcCCcCceeEEEEEecCC
Confidence 47888999999999999999877654 899999875432211 11122222 2556679999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.......+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999999995 56556554444579999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR--QEIPPIPS 276 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~--~~~~~~p~ 276 (627)
.. .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+... .....++.
T Consensus 154 ~~----~~~~~~~g~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05632 154 EG----ESIRGRVGTVGYMAPEVLNN---QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226 (285)
T ss_pred CC----CcccCCCCCcCccChHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc
Confidence 21 12234579999999999873 46889999999999999999999999887655433333221 12234567
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
.+++++.+|+..||+.||++||+ +.++++ |+|+....|.........++..|
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR------HPFFRNMNFKRLEAGMLDPPFVP 283 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc------ChhhhcCCHHHHhcCcCCCCCCC
Confidence 78999999999999999999999 667776 99999888887777777766655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.34 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=208.5
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..++|++.+.||+|+||.||+|++..+++ .||+|.++............++. ..++.++|+||+++++++..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCC------eEEEEEeeccccCCcchhHHHHH-HHHHhCCCCCcceEEEEEeeC
Confidence 45789999999999999999999876654 89999987543322221122222 245667999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..|+||||+++++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 77 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 77 KSLTLVFEYLDKDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CeEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 99999999999988877754 34568999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI------- 271 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~------- 271 (627)
.. ........+|+.|+|||++.+. ..++.++|+|||||++|+|+||++||.+.+..+....+......
T Consensus 156 ~~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 156 VP---TKTYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred CC---ccccccccccccccCCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 21 1222345789999999998642 35788999999999999999999999988776555444321110
Q ss_pred -------------C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 -------------P--------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 -------------~--------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+ .....+++++.++|.+||+.||.+||++.++++ |+||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------h~~~~~~ 292 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK------HAYFRSL 292 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc------Chhhhhc
Confidence 0 011357889999999999999999999999998 8888753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.74 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=205.4
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++.+.||+|+||.||++++..++. .||+|+++............++.. +++.++||||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGL------IMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCc------EEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEE
Confidence 456899999999999999999999877664 899999976533332222333322 4566799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
++..++||||++| +|.+.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999995 6666654 345689999999999999999999986 69999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-------- 267 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-------- 267 (627)
.+.. .......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||...+..++...+..
T Consensus 153 ~~~~-----~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 153 QLID-----SMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccc-----cccccCCCCcCcCCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccC
Confidence 6532 22234579999999999974 3688999999999999999999999987665444322110
Q ss_pred -------------------------------------ccCCCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 268 -------------------------------------RQEIPPI-PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 268 -------------------------------------~~~~~~~-p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
....+.. ...+++++++||.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~---- 300 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN---- 300 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc----
Confidence 0011111 1247899999999999999999999999998
Q ss_pred cccccCCCC
Q 006887 310 SQNSVHSDG 318 (627)
Q Consensus 310 ~~~~~~~~~ 318 (627)
|+|+...
T Consensus 301 --h~~~~~~ 307 (331)
T cd06649 301 --HTFIKRS 307 (331)
T ss_pred --ChHHhhc
Confidence 8887643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=348.84 Aligned_cols=281 Identities=19% Similarity=0.281 Sum_probs=231.5
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.++.+.|+.-++||+||||.||-++-..|+. .||.|.+.+....... ..+...+..++...+.+.||.+-..|
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGK------MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGK------MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchh------hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3566789999999999999999999877764 8999999765432221 22222334467778899999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
++.+.+|+||..|+| +|--.+....+.-|++..+.+|+++|+.||++||..+||+|||||+|||||+.|+++|+|.|||
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 999999999999996 4333333334467999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDEIYDAVVRRQE 270 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e~~~~i~~~~~ 270 (627)
..+.. .......+||.+|||||++..+ .|+...|+|||||+||||+.|+.||.... .+++-+.+.. .
T Consensus 335 vei~~----g~~~~~rvGT~GYMAPEvl~ne---~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~ 405 (591)
T KOG0986|consen 335 VEIPE----GKPIRGRVGTVGYMAPEVLQNE---VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--D 405 (591)
T ss_pred EecCC----CCccccccCcccccCHHHHcCC---cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--c
Confidence 88765 3344456999999999999854 59999999999999999999999998643 2344444443 2
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-----HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMT-----DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~-----eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
...++..+|+++++|.+.+|++||.+|...+ ++.+ |+||...+|..+....+.||+.|+...
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~------HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE------HPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh------CcccccCCHhHHhccCCCCCCCCCccc
Confidence 4557899999999999999999999998654 4444 999999999999999999999997543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.34 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=212.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
...|+.+++||+|+||.||+|.+..+++ .||+|++...........++++. .++.+++++||..+|+.+..+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k------~vAiKii~Le~~~deIediqqei-~~Ls~~~~~~it~yygsyl~g~ 84 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKK------VVAIKIIDLEEAEDEIEDIQQEI-SVLSQCDSPNITEYYGSYLKGT 84 (467)
T ss_pred ccccccchhccccccceeeeeeeccccc------eEEEEEechhhcchhhHHHHHHH-HHHHhcCcchHHhhhhheeecc
Confidence 3568888999999999999999988875 89999998765544333344433 3567788999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.++++||||. |++++++. .+..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.
T Consensus 85 ~LwiiMey~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred cHHHHHHHhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999 57777775 34455889999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
.. .....+++|||.|||||++.+. .|+.++||||||++.|||++|.+||....+...+..|- +...|.+...+
T Consensus 163 ~~---~~rr~tfvGTPfwMAPEVI~~~---~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~ 235 (467)
T KOG0201|consen 163 NT---VKRRKTFVGTPFWMAPEVIKQS---GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDF 235 (467)
T ss_pred ch---hhccccccccccccchhhhccc---cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCcccccc
Confidence 42 2233688999999999999843 69999999999999999999999999988876655443 33455566789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.+++|+..||.+||+.||++.++|+
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 999999999999999999999999988
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.94 Aligned_cols=284 Identities=21% Similarity=0.250 Sum_probs=244.9
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+..++++.+..||-||||.|=++....... .+|+|++++... ..+++....+.++++. ...|.||+|
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~-~~s~fIvrL 485 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKA------TFALKILKKKHIVDTKQQEHVFSERNIMME-CRSDFIVRL 485 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccch------HHHHHHHhHhhccchhHHHHHHhHHHHHHh-cCchHHHHH
Confidence 4556778899999999999999999998765432 589999987432 2222233333445555 458999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
|-.|.++.++||.||-|-| .+...+. ..+.|...++.+|+..+++|++|||++|||+|||||+|+|++.+|.+||.|
T Consensus 486 YrTfrd~kyvYmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 486 YRTFRDSKYVYMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred HHHhccchhhhhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEee
Confidence 9999999999999999985 5555553 457899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+|+.+.. ....+++||||.|.|||++.. ...+.++|.||||+++||||+|.+||.+.++...|..|+.+-.
T Consensus 564 FGFAKki~~----g~KTwTFcGTpEYVAPEIILn---KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 564 FGFAKKIGS----GRKTWTFCGTPEYVAPEIILN---KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID 636 (732)
T ss_pred hhhHHHhcc----CCceeeecCCcccccchhhhc---cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence 999998864 456789999999999999984 3578899999999999999999999999999999999999988
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCccc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEW 339 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~ 339 (627)
...+|..++....+||++++..+|.+|.. +.+|.+ |.||...+|.++.++.++||..++..++
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk------H~Wf~gfdweglr~~~L~pPi~~~va~p 704 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK------HRWFEGFDWEGLRSRTLPPPIIPSVANP 704 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh------hhhhhcCChhhhhhccCCCCccccCCCc
Confidence 89999999999999999999999999986 345544 9999999999999999999999987766
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.09 Aligned_cols=265 Identities=22% Similarity=0.381 Sum_probs=215.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+...+. ......||+|.+.............++.. .+..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHH-HHHhcCCcccceEEEEEcC
Confidence 456789999999999999999999765542 22345799999975544333322333322 4566799999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKG--------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~--------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
.+..|++|||++ |+|.+.+..... ..+++..++.++.|++.||.|||+++++||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 999999999998 577777654211 56889999999999999999999999999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~ 261 (627)
++.++|+|||+++....... ........+|+.|||||.+. .+.++.++|+|||||++|||++ |..||.+.+..++
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAIL---YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhc---cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999986543221 11223456789999999986 3468899999999999999998 9999999988888
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
...+... ..+..+..+++++.+|+.+||+.||.+||++.++++.|++
T Consensus 236 ~~~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSR-QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcC-CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8777643 3455678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=343.88 Aligned_cols=253 Identities=19% Similarity=0.219 Sum_probs=201.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-.++|++.+.||+|+||.||+|.+..++. .||||++...... ....... + ..+++.++||||+.+++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~-E-~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILER------NVAIKKLSRPFQNQTHAKRAYR-E-LVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCc------EEEEEEeCccccCchhHHHHHH-H-HHHHHhcCCCCccccceeec
Confidence 35789999999999999999999876654 7999999754322 1122222 2 23567789999999999875
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 117 IN------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
.. ...|+||||+++++.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred ccccccccCeEEEEEeCCCCCHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEe
Confidence 43 3579999999998887764 2478999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 170 fG~a~~~~~----~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 170 FGLARTAGT----SFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred CCCccccCC----CCcccCCcccCCcCCHHHHhC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999976532 122234579999999999974 3688999999999999999999999998887666655543211
Q ss_pred CC----------------------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 271 IP----------------------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 271 ~~----------------------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.+ ......+..+++||.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~----- 317 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ----- 317 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc-----
Confidence 10 001123567899999999999999999999998
Q ss_pred ccccCC
Q 006887 311 QNSVHS 316 (627)
Q Consensus 311 ~~~~~~ 316 (627)
|+|+.
T Consensus 318 -hp~~~ 322 (364)
T cd07875 318 -HPYIN 322 (364)
T ss_pred -Ccccc
Confidence 88875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=356.36 Aligned_cols=248 Identities=27% Similarity=0.353 Sum_probs=215.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.|..+....++-||+|+.|.||+|+.+. +.||||+++..++..+ .-++.++|+||+.+.|+
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~n--------etVAVKKV~elkETdI---------KHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLHN--------ETVAVKKVRELKETDI---------KHLRKLKHPNIITFKGV 180 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeeccC--------ceehhHHHhhhhhhhH---------HHHHhccCcceeeEeee
Confidence 555777888888999999999999998754 3799998853332221 13466899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
|.+...+|||||||. |-|.+.+. .+.++.......|..+||.|+.|||.+.|||||||.-||||..+..+||+|||.
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 999999999999999 76666664 567889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
++...+ .++...++||..|||||+|+.+ +.+.++|||||||+|||||||..||.+-+...++.-+-......+
T Consensus 259 S~e~~~----~STkMSFaGTVaWMAPEvIrne---PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp 331 (904)
T KOG4721|consen 259 SKELSD----KSTKMSFAGTVAWMAPEVIRNE---PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP 331 (904)
T ss_pred hHhhhh----hhhhhhhhhhHhhhCHHHhhcC---CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc
Confidence 998765 2455688999999999999854 789999999999999999999999998888777776766667788
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.|..+|+.++-||++||+..|.+||++++|+..|+
T Consensus 332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 99999999999999999999999999999987544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=348.76 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=201.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+...+|++++.||+|+||.||+|.+..+++ .||+|...... . .++. .+++.++||||++++++
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~------~vaiK~~~~~~------~-~~E~-~il~~l~HpnIv~~~~~ 151 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCE------HVVIKAGQRGG------T-ATEA-HILRAINHPSIIQLKGT 151 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECCCCC------EEEEechhhhh------h-HHHH-HHHHhCCCCCCCCEeEE
Confidence 344667889999999999999999999887764 89999754211 1 1222 35677899999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
+..+...|+|||++.++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 152 ~~~~~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 152 FTYNKFTCLILPRYKTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EEECCeeEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 999999999999999988877753 356899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-------VDEIYDAVVR 267 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-------~~e~~~~i~~ 267 (627)
+...... ........||+.|+|||++.+ ..++.++|+|||||++|||++|..||.... ....+..+..
T Consensus 230 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~ 304 (391)
T PHA03212 230 CFPVDIN--ANKYYGWAGTIATNAPELLAR---DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304 (391)
T ss_pred ccccccc--ccccccccCccCCCChhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence 7543211 122345689999999999974 468999999999999999999998875421 1111111111
Q ss_pred c--------------------------cCC-C-CCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 268 R--------------------------QEI-P-PIP-----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 268 ~--------------------------~~~-~-~~p-----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
. ... + ..+ ..++.++.+||.+||+.||.+||++.|+++ |+|
T Consensus 305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~------hp~ 378 (391)
T PHA03212 305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD------FAA 378 (391)
T ss_pred HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc------Chh
Confidence 0 000 0 000 135678999999999999999999999998 888
Q ss_pred CCCC
Q 006887 315 HSDG 318 (627)
Q Consensus 315 ~~~~ 318 (627)
|...
T Consensus 379 f~~~ 382 (391)
T PHA03212 379 FQDI 382 (391)
T ss_pred hccC
Confidence 8653
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=355.99 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=210.0
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
-+||+|.||+||-|++..++. .+|||-+........+-..+++ .+.+.+.|.|||+++|.+..++.+-|.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqv------rIaIKEIpekdsr~~QPLhEEI--aLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQV------RIAIKEIPEKDSREVQPLHEEI--ALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EEeecCceeEEEeecccccee------EEEeeecccccchhhccHHHHH--HHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 369999999999999988874 8999999766555555444443 36788999999999999999999999999
Q ss_pred cCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-cCCCeeeccCCccccccCCCCC
Q 006887 127 FYEGSVGDRMAQLKGGKL--SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-EADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 127 y~~GsL~d~l~~~~~~~l--s~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~ 203 (627)
-++|+.+..+.+.+-+++ .+.+.-+|..||++||.|||++.|||||||-+|+|++ -.|.+||+|||.++.+.+.+
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-- 730 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-- 730 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--
Confidence 999644444445566788 8899999999999999999999999999999999996 57899999999999987643
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCCCCCCHHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAVVRRQEIPPIPSGLPPAV 282 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i~~~~~~~~~p~~~s~~l 282 (627)
....++.||..|||||++....+ .|+.++|||||||++.||.||++||... ++...+.++..-+..|++|..++.++
T Consensus 731 -P~TETFTGTLQYMAPEvIDqG~R-GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 731 -PCTETFTGTLQYMAPEVIDQGPR-GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEA 808 (1226)
T ss_pred -ccccccccchhhhChHhhccCCc-CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHH
Confidence 23457789999999999985534 5999999999999999999999999854 34444455655667899999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 006887 283 ENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 283 ~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+.||.+|+..||..||++.++|.
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999988
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.32 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=211.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|++++|++.+.||+|+||.||+|++..+++ ....+|+|.++.............+. ..+..++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEec
Confidence 467899999999999999999999865542 23479999987654333322333332 24566799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..|+||||++| +|.+.+.. ....+++.+++.++.|++.||.|||+++++||||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999985 66666543 446789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...............++..|+|||++.+ ..++.++|+|||||++||+++ |..||...+..+....+... ...+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 231 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAP 231 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc---CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCC
Confidence 6542221112222344678999999973 468899999999999999886 99999988877777766544 334556
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..+++.+.+++.+|++.+|.+||++.++++.|+.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 7789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.35 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=221.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc-------hhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-------EDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~-------~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
+.|.-.+.||+|..++|-++.+..++. ++|+|++.... ...+.+.-..+..++.+..+||+|+.+++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~------e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGK------EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhccccc------ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 357778899999999999999887764 79999986421 22333333445566788899999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+++.+..+++|+|+|+ |.|.|.+. ..-.+|+..+.+|++|+++|++|||.++||||||||+|||+|++.+++|+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999 88888886 34579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCC---CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
++..+.. .......||||+|+|||.+.+. ....|+..+|+||+||+||.||.|.+||......-++..|++++
T Consensus 169 Fa~~l~~----GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 169 FACQLEP----GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred eeeccCC----chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 9987753 4455678999999999999864 24468899999999999999999999999888888888888776
Q ss_pred CCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 270 EIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 270 ~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.... -..+++...++||.+||+.||.+|.|+.|+|. |+||...
T Consensus 245 yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La------Hpff~q~ 289 (411)
T KOG0599|consen 245 YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA------HPFFIQI 289 (411)
T ss_pred cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc------ChHHHHH
Confidence 5443 34678999999999999999999999999998 8887533
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=342.39 Aligned_cols=253 Identities=19% Similarity=0.204 Sum_probs=199.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-.++|++.+.||+|+||.||+|.+..++ +.||||++....... .....+ + ..+++.++||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E-~~~l~~l~h~niv~~~~~~~ 86 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD------RNVAIKKLSRPFQNQTHAKRAYR-E-LVLMKCVNHKNIISLLNVFT 86 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCC------ceEEEEEeCCcccChHHHHHHHH-H-HHHHHHhCCCchhceeeeee
Confidence 3478999999999999999999987655 489999997543222 122222 2 23567789999999999886
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 117 IN------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
.. ...|+||||+++++.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 87 PQKSLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred ccccccccceeEEEhhhhcccHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEee
Confidence 53 3579999999998877664 2588999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 163 fg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 163 FGLARTAGT----SFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred CcccccCCC----ccccCCccccCCccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999976532 122334679999999999974 3688999999999999999999999998775544433322110
Q ss_pred C----------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 271 I----------------------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 271 ~----------------------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
. ...+...+.++++||.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~----- 310 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ----- 310 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc-----
Confidence 0 0011224577899999999999999999999998
Q ss_pred ccccCC
Q 006887 311 QNSVHS 316 (627)
Q Consensus 311 ~~~~~~ 316 (627)
|+|+.
T Consensus 311 -hp~~~ 315 (355)
T cd07874 311 -HPYIN 315 (355)
T ss_pred -Ccchh
Confidence 88875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.73 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||+|+++.............+....++..+||||+++++++..++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGT------IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCc------EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence 479999999999999999999876654 89999987653322111222223345677899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 121 ICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.|+||||++|++.+.+... ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||+++.+
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999888777653 335789999999999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCC-CCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVR-GPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~-~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i~~~~~~~~~p 275 (627)
... .......|+..|+|||++.+... ..++.++|+|||||++|+|++|+.||... ...+.+..+... ..+.++
T Consensus 155 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 229 (283)
T cd06617 155 VDS----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLP 229 (283)
T ss_pred ccc----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCC
Confidence 331 12233578999999999865322 45788999999999999999999999753 222333333332 223333
Q ss_pred -CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 -SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 -~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+|.++.++|.+||..+|++||++.++++ |+|+...
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~------~~~~~~~ 267 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ------HPFFELH 267 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc------Cchhhhc
Confidence 458899999999999999999999999988 8887654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.09 Aligned_cols=270 Identities=22% Similarity=0.302 Sum_probs=223.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||++.+..++ +.||+|++........ ......+. .+++.+.||||+++++++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG------KYYALKILSKAKIVKLKQVEHVLNEK-RILQSIRHPFLVNLYGSFQDD 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC------CEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCccceeeEEEcC
Confidence 47999999999999999999987655 4899999875432111 11112222 256677899999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++ |+|.+.+.. ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||+++..
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 99999999996 677777653 367999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+..+.+.. ....+|..
T Consensus 152 ~~~------~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~ 220 (290)
T cd05580 152 KGR------TYTLCGTPEYLAPEIILS---KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKVRFPSF 220 (290)
T ss_pred CCC------CCCCCCCccccChhhhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCccCCcc
Confidence 432 344579999999999874 3578899999999999999999999998887777776653 34567788
Q ss_pred CCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
+++.+++++.+||..||.+|+ ++.++++ |+||...+|.......+..|..+..
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN------HPWFAGIDWIALLQRKIEAPFIPKV 278 (290)
T ss_pred CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc------CcccccCCHHHHhhccCCCCccCCC
Confidence 899999999999999999999 7778777 9999999998887777776666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.85 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=204.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.....++|+.++.||+|+||.||+|++..+++ .||||++.............++. .+++.++|+||+++++++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~ 141 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGR------LYALKVIYGNHEDTVRRQICREI-EILRDVNHPNVVKCHDMF 141 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCC------EEEEEEEecCCcHHHHHHHHHHH-HHHHhCCCCCcceeeeEe
Confidence 44556889999999999999999999876654 89999997654433333333333 246678999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++.+|+||||+.|+.+.. ....++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 142 ~~~~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 142 DHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred ccCCeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999643321 2345678888999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---EIYDAVVRRQE 270 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---e~~~~i~~~~~ 270 (627)
.+... ........||+.|+|||++.... ....+.++|||||||++|||++|+.||...... .....+. ...
T Consensus 217 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~ 292 (353)
T PLN00034 217 ILAQT---MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQ 292 (353)
T ss_pred ecccc---cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccC
Confidence 76432 11223457999999999985321 112456899999999999999999999743322 2222222 223
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.+..+..++.++.+||.+||+.||++||++.++++ |+|+...
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~------hp~~~~~ 334 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ------HPFILRA 334 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc------CcccccC
Confidence 45567789999999999999999999999999998 8887653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=345.12 Aligned_cols=258 Identities=20% Similarity=0.247 Sum_probs=205.4
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++++.||+|+||.||+|.+..++ +.||||++...... ....... +. .++..++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~niv~~~~~~~~~~ 72 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDG------KRVALKKMPNVFQNLVSCKRVFR-EL-KMLCFFKHDNVLSALDILQPPH 72 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCC------CEEEEEeccccccchHHHHHHHH-HH-HHHHhCCCCCcCCHhheecCCC
Confidence 5789999999999999999986655 48999998654222 2222222 22 2566779999999999998776
Q ss_pred -----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 120 -----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 120 -----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..|+||||+.+++.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 73 IDPFEEIYVVTELMQSDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred ccccceEEEEeeccccCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccce
Confidence 799999999998887764 4567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---- 270 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~---- 270 (627)
+...... ........+|+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+.+..+.....
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 151 RVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred eecccCc--cccCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 8653221 1223345789999999998753 2478899999999999999999999998877665554432110
Q ss_pred -------------------CC-------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 271 -------------------IP-------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 271 -------------------~~-------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
.+ ......++++.+||.+||+.||++||++.++++ |+|+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~------hp~~~~~~ 295 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA------HPYLDEGR 295 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc------CHhhCCCc
Confidence 01 123456889999999999999999999999988 88877653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=341.30 Aligned_cols=271 Identities=20% Similarity=0.317 Sum_probs=210.4
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.+..++|++.+.||+|+||.||+|.+..++. ...++.||+|+++.............+...+.+..+|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEK-SASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEecccccccc-ccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 34566799999999999999999998765432 33457899999875433222222223333444545899999999987
Q ss_pred EE-CCEEEEEEecCCC-CHHHHHHHhc-----------------------------------------------------
Q 006887 116 VI-NGKICIIMKFYEG-SVGDRMAQLK----------------------------------------------------- 140 (627)
Q Consensus 116 ~~-~~~~~LVmEy~~G-sL~d~l~~~~----------------------------------------------------- 140 (627)
.. +..++++|||++| +|.+.+....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999995 6666654321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCC
Q 006887 141 ------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214 (627)
Q Consensus 141 ------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~ 214 (627)
..++++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++.+..... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 13688999999999999999999999999999999999999999999999999987643211 11223445678
Q ss_pred CcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcC
Q 006887 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYD 293 (627)
Q Consensus 215 ~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~d 293 (627)
.|||||++.+ ..++.++|||||||++|||++ |..||.+....+.+............+..+++++.+++.+||+.+
T Consensus 240 ~y~aPE~~~~---~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 240 KWMAPESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred cccCcHHhcC---CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 8999999873 468999999999999999998 999998766555444444444455567788999999999999999
Q ss_pred CCCCCCHHHHHHHHHhcc
Q 006887 294 LRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 294 P~~RPs~~eil~~L~~~~ 311 (627)
|++||++.++++.|+...
T Consensus 317 p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 317 PEDRPTFSELVEILGDLL 334 (337)
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.54 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=208.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
...++|++.+.||+|+||.||+|++..++. .||||++......... .....+. ..+...+|+||++++..+.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~Ei-~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGE------PFAVKVVDMEGMSEADKNRAQAEV-CCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCC------EEEEEEEecccCCHHHHHHHHHHH-HHHhcCCCCcEEEeeccee
Confidence 445799999999999999999999876654 8999999764322211 1112222 2455678999999988765
Q ss_pred ECC--------EEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 117 ING--------KICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 117 ~~~--------~~~LVmEy~~-GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
..+ .+++||||++ |+|.+.+... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence 432 3789999999 5777776542 2357899999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
+||+|||+++.+.... ........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+
T Consensus 182 vkL~DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~---~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRR---KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EEEEecccCeeccccc-cccccccccCCcceeCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999998764321 1222345689999999999974 46899999999999999999999999999888888777
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.... ..+++..+++++.+++.+||+.||.+||++.++++
T Consensus 258 ~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 6543 34578889999999999999999999999999987
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.51 Aligned_cols=271 Identities=20% Similarity=0.277 Sum_probs=212.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...++.++|++.+.||+|+||.||+|++..... ......||||++.+............+..++..+..||||++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSR-SQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCC-CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 455678899999999999999999999765432 1234579999997654433333333333444444469999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc-----------------------------------------------------
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK----------------------------------------------------- 140 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~----------------------------------------------------- 140 (627)
+...+..|||||||+ |+|.+.+....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999998 57766654321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 141 -----------------------------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 141 -----------------------------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
...+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124788889999999999999999999999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCH
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSV 258 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~ 258 (627)
++.++.++|+|||+++.+..... ........+++.|||||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFD---NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999999987643221 112234467889999999874 468899999999999999997 9999987655
Q ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 259 ~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.+..............+..++.++.+++.+||+.||++||++.++.+.|+..
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 4443333334445566788999999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.50 Aligned_cols=271 Identities=19% Similarity=0.278 Sum_probs=217.0
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
....++.++|++.+.||+|+||.||++.+....+ ......+|+|++..............+...+....+|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3566788899999999999999999999865442 223458999999765433322223333334444448999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQL--------------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~--------------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++..++..+++|||++ |+|.+.+... ....+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 9999999999999998 5777776532 235789999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.++|+|||+++.+..... ........+++.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhcc---CCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999987653221 111122345678999999863 468889999999999999997 999999988
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..+.+..+... .....+..++..+.+|+.+||..||++||++.++++.|+..
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 VEELFKLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 88887766543 34556778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.33 Aligned_cols=266 Identities=19% Similarity=0.314 Sum_probs=210.4
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+...+|++.+.||+|+||.||+|++..+++ .....||+|+++.............+. ..++.++||||+++++++.
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGE--KVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICL 79 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCC--ccceeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEc
Confidence 3567789999999999999999999865543 123459999997543322222222222 3567789999999999987
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.. ..++|+||++ |+|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 64 5789999998 677777654 34568899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+...... .......++..|||||++. ...++.++|+|||||++|||++ |+.||.+....++...+ ......+.
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~apE~~~---~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~ 232 (316)
T cd05108 158 LLGADEKE-YHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQ 232 (316)
T ss_pred cccCCCcc-eeccCCccceeecChHHhc---cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCC
Confidence 76432211 1112234567899999987 3468899999999999999998 99999988777765443 44445566
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+..++.++.+++.+||+.+|.+||++.+++..+.....
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 77889999999999999999999999999998877644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.71 Aligned_cols=258 Identities=23% Similarity=0.393 Sum_probs=211.4
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.|+.++|++.++||+|+||.||+|.+..+ ..||+|.+...... ...+..+ . .+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~-------~~v~iK~~~~~~~~-~~~~~~e-~-~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNS-------TKVAVKTLKPGTMS-VQAFLEE-A-NLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCC-------ceEEEEEccCCchh-HHHHHHH-H-HHHHhCCCCCeeeEEEEE
Confidence 357889999999999999999999986543 36999998754332 2222222 2 255678999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
...+..+++|||++ |+|.+.+.......+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999998 58877776555677899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+....... .......++..|+|||++.+ +.++.++|+|||||++|+|++ |..||.+....+....+... ...+
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~ 224 (261)
T cd05072 151 RVIEDNEY--TAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224 (261)
T ss_pred eecCCCce--eccCCCccceecCCHHHhcc---CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 87643211 11223456778999999863 468889999999999999998 99999988887777766543 3344
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.+..++.++.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 556789999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.96 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=209.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
..|.+.+.||+|+||.||+|....+. +..||+|.+......... ....+. .++..++||||+++++++..++.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~-----~~~vv~K~~~~~~~~~~~-~~~~E~-~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDP-----KEKVVAKFVMLNDERQAA-YARSEL-HCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCC-----CeEEEEEEcccCCHHHHH-HHHHHH-HHHHhCCCCCEeEEEEEEEECCE
Confidence 45999999999999999999876652 247899987554433322 222222 35677899999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.||||||++ |+|.+.+... ...++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 5777666432 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.... ........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+.... ..+.+..
T Consensus 220 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~ 294 (478)
T PTZ00267 220 SDSV-SLDVASSFCGTPYYLAPELWER---KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCP 294 (478)
T ss_pred CCcc-ccccccccCCCccccCHhHhCC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcc
Confidence 4321 1122345689999999999874 468899999999999999999999999988888888776543 3456778
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+++++.++|.+||+.||++||++.+++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 9999999999999999999999999876
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.28 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=212.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|++++|++.+.||+|+||.||+|.+..++. ....||||+++.............+. ..+..++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEA-SIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHH-HHHHhCCCCCcceEeEEEec
Confidence 467899999999999999999999865432 23579999987654433322222222 24567799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..|+||||++| +|.+.+.. ..+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999985 66666543 345799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+... ...+.+
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 230 (266)
T cd05033 156 LEDSEAT-YTTKGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPP 230 (266)
T ss_pred ccccccc-eeccCCCCCccccChhhhcc---CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCC
Confidence 7421111 11112345678999999874 468889999999999999998 99999888888877776543 234556
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..+++.+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 78899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=364.91 Aligned_cols=270 Identities=23% Similarity=0.364 Sum_probs=232.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...|..++.+..+.||+|+||+||+|+...-.. ....+.||||.++....++.+...+++. .++..++|||||+|+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p-~~~~~lVAVK~LKd~a~~~~~~dF~REa-eLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLP-GQDEQLVAVKALKDKAENQARQDFRREA-ELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCC-CccceehhHhhhcccccHHHHHHHHHHH-HHHHhccCCCeEEEEEE
Confidence 345778889999999999999999998766542 3456799999999888776666666654 35677899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc--------C----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK--------G----GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~--------~----~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
|..++..|||+|||. |+|-+.+.... + .+++..+.+.++.|||.|++||-++.+|||||-..|.||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999999 88877775431 1 2388899999999999999999999999999999999999
Q ss_pred cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHH
Q 006887 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260 (627)
Q Consensus 182 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e 260 (627)
++..|||+||||+|-+...+..... ....-..+||+||.|. ++.|+.+||||||||+|||+++ |+.||.+.+.+|
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIl---y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESIL---YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhh---cCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 9999999999999988764432221 1223357999999998 7789999999999999999999 999999999999
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+++.|..++. .+.|..+|.++.+||..||+.+|.+||+++||-..|+...
T Consensus 714 VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 9999987765 7789999999999999999999999999999999888753
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.63 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=213.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+.|++++.||+|+||.||+|++..++. .||+|++..........+..+. ..++.++|+||+++++.+..++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~--~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGA------LAAAKVIETKSEEELEDYMVEI--EILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCc------eEEEEEeccCCHHHHHHHHHHH--HHHHhCCCCcEeeeEEEEEeCC
Confidence 3669999999999999999999876654 8999999766544444433332 2456678999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||++|++++.+.......+++..+..++.|++.+|.|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999997555544433456799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPS 276 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~ 276 (627)
. ........+++.|+|||++.+. ....++.++|+|||||++|||++|.+||...+..+.+..+..... ....+.
T Consensus 163 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 163 T---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred c---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence 1 1222345789999999998532 134578899999999999999999999988776665555533221 223456
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
.++.++.+++.+||+.+|++||++.++++ |+|+....|..
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~~~~~~ 279 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLE------HPFVSSVTSNR 279 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhc------Cccccccccch
Confidence 78899999999999999999999999988 89887776654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.49 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=207.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--H--HHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--M--RVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~--~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+++|++.+.||+|++|.||+|.+..++ +.||+|.+....... . .....++. ..++.++||||+++++++
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~~~------~~~~lk~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~ 73 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVDTG------RELAVKQVPFDPDSPETKKEVNALECEI-QLLKNLQHERIVQYYGCL 73 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcCCC------cEEEEEEEeecccchhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEE
Confidence 357999999999999999999976655 489999987543211 1 11122222 256678999999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..++..++||||++| +|.+.+. ..+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 74 RDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred ccCCeEEEEEEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 999999999999985 6666664 3456899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
+................|++.|+|||++.+. .++.++|+||||+++|||++|+.||...+..+....+........+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGE---GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccC---CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCC
Confidence 7654322111212345788999999999853 5889999999999999999999999887776666666555556677
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+..++..+.+++.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 8889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.02 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=213.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHH--HHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLL--ERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~--~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.+|++.+.||+|.||.|-+|+.+.++ +.||||.+++......+... +++.+ ++..++||||+.++.+|+..
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sg------R~VAiKsIrKdkIkdeqDlvhIRREIe-IMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSG------REVAIKSIRKDKIKDEQDLVHIRREIE-IMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCC------cEeehhhhhhhhcccHHHHHHHHHHHH-HHhhcCCCceeehhhhhcCC
Confidence 57999999999999999999987665 58999999886554333333 33332 56778999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+.+.|||||.. |.|.|.+. ..+.+++.++.++++||..|+.|+|.++++|||||.+|||+|.|+++||+||||+.++
T Consensus 126 dKIvivMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred ceEEEEEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999998 68888886 4567999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPI-SFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~-s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
.+ .....++||+|.|.+||++.|. +| ++.+|.||||++||.|+.|..||.|.+...++..|..+.... +
T Consensus 204 ~~----~kfLqTFCGSPLYASPEIvNG~---PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P 273 (668)
T KOG0611|consen 204 AD----KKFLQTFCGSPLYASPEIVNGT---PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---P 273 (668)
T ss_pred cc----ccHHHHhcCCcccCCccccCCC---CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---C
Confidence 54 3456789999999999999865 44 578999999999999999999999999999998887665432 3
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.-|.++.-||+.||..||++|.|+.+|..
T Consensus 274 ~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 274 ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 45678899999999999999999999987
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=330.58 Aligned_cols=269 Identities=20% Similarity=0.248 Sum_probs=216.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.+..... .......+. ..+..+.|+||+++++.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG------KLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC------cEEEEEEEeccccchHHHHHHHHHHH-HHHHhCCCCCchhheeeeecC
Confidence 47999999999999999999987655 489999997654332 111122222 256677899999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||+.| +|.+.+.......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999985 7777766544578999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCC--------------------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCC
Q 006887 198 LGIPLP--------------------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ 251 (627)
Q Consensus 198 ~~~~~~--------------------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~ 251 (627)
...... ........||..|+|||++.+ ..++.++|+|||||++|+|++|..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG---DGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC---CCCCchHHHHHHHHHHHHHhhCCC
Confidence 322110 011123478999999999874 357889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 252 PRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPL----MTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 252 Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs----~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
||.+.+..+.+..+.......+....+++++.+++.+||+.||++||+ +.++++ |+||...+|.....
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~------~~~~~~~~~~~~~~ 302 (316)
T cd05574 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ------HPFFRGVNWALIRH 302 (316)
T ss_pred CCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc------CchhhcCChhhccc
Confidence 999888877776665443322223347999999999999999999999 777776 99999888877665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.39 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=208.5
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..++|++.+.||+|+||.||+|++..+++ .||+|.+..............+. ..++.++|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDN------LVALKEIRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCc------EEEEEEEecccccCchhHHHHHH-HHHHhcCCCCcceEEEEEecC
Confidence 35789999999999999999999876654 89999987543322211122222 256677999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..|+||||+++++.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++...
T Consensus 77 ~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 77 KSLTLVFEYLDKDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CeEEEEEeccccCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 99999999999988877754 34578999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI------- 271 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~------- 271 (627)
.. ........+++.|+|||++.+. ..++.++|+|||||++|||++|++||.+.+..+....+......
T Consensus 156 ~~---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 156 IP---TKTYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred CC---CCcccccceeecccCcHHHhCC--CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 21 1222345679999999998642 35788999999999999999999999988776655444321110
Q ss_pred -------------CC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 -------------PP--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 -------------~~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+. ....+++.+++||.+||+.||.+||++.++++ |+||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~------h~~f~~~ 292 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK------HPYFHCL 292 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc------Ccccccc
Confidence 00 11357889999999999999999999999998 9988643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=321.12 Aligned_cols=259 Identities=20% Similarity=0.374 Sum_probs=212.7
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.++..+|++.+.||+|+||.||+|.+..++. .||+|++...... ...+..+ . .++..+.|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~------~~~~K~~~~~~~~-~~~~~~e-~-~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDTME-VEEFLKE-A-AVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCc------eEEEEEecCCchH-HHHHHHH-H-HHHHhCCCCChhheEEEEc
Confidence 4677889999999999999999999876553 7999998754322 2222222 2 2456679999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++..++||||++ |+|.+.+.......+++..++.++.|++.||.|||+++++||||||+||++++++.++|+|||+++
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999998 577777755445678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
........ ......+++.|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+..+....+... .....
T Consensus 153 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 226 (263)
T cd05052 153 LMTGDTYT--AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMER 226 (263)
T ss_pred ccccceee--ccCCCCCccccCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCC
Confidence 76432211 1112334678999999874 368889999999999999998 99999998888877776543 34567
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+..++.++.+++.+||+.||++||++.++++.|+..
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 788999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.99 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=218.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
...|++.+.||+|.||.||+++...++. .+|+|++.+...... .....++.+++.....||||+.+++.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~------~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGK------EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCc------eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 3579999999999999999999988764 899999987554322 23444555555555559999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC----CCeeeccCC
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA----DRAVLGDVG 192 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~----g~vkL~DFG 192 (627)
.+.+++|||++. |.|.|.+... .+++.++..++.|++.++.|||+.||+||||||+|+|+... +.++++|||
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999 5888888764 39999999999999999999999999999999999999533 479999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI- 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~- 271 (627)
++..... .......+|||.|+|||++.. .+|+..+|+||+||++|.|++|.+||.+.+..+....+......
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~---~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG---RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC---CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 9988754 345667899999999999973 47999999999999999999999999999999988888766542
Q ss_pred -CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 -PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 -~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.+....++..+++++..||..||..|+++.++|+ |+|...
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~------HpWi~~ 298 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ------HPWIKS 298 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc------CccccC
Confidence 2344678999999999999999999999999998 888554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.59 Aligned_cols=265 Identities=21% Similarity=0.333 Sum_probs=214.0
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.|..++|++.+.||+|+||.||+|.+..... ......||+|.+..............+. ..+..++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEA-SVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEc
Confidence 4677899999999999999999999875442 2344689999987544322222222222 2456679999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLK--------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
.....|+||||++ |+|.+.+.... ...+++..++.++.|++.||.|||+.+++||||||+|||++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999998 67777765422 23478889999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~ 266 (627)
|+|||+++.+..... ........+|..|+|||++. .+.++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 160 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 160 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLK---DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred ECCcccchhhccCcc-cccCCCCCccccccCHHHHh---cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 999999886543221 11223446788999999986 3468889999999999999998 999999988888877766
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.......|..++.++.+++.+||+.+|++||++.++++.|+
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 34456678889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=324.08 Aligned_cols=264 Identities=22% Similarity=0.397 Sum_probs=211.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+..++. ..+..||+|.+..............+. .+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGM--DHAQLVAIKTLKDINNPQQWGEFQQEA-SLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCC--CCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCCeeeEEEEEec
Confidence 456789999999999999999998754432 234689999997544332222222232 25667899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLK---------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
.+..|+||||++ |+|.+.+.... ...+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 999999999998 57776664221 13478889999999999999999999999999999999999
Q ss_pred cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHH
Q 006887 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260 (627)
Q Consensus 182 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e 260 (627)
.++.++|+|||+++....... ........++..|+|||++.+ +.++.++|+|||||++|||++ |.+||.+.+..+
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred CCCcEEeccccccccccCCcc-eecccCCCccceecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999987643221 112234456788999999863 468899999999999999998 999999888777
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+...+... ...+.+..+++++.+++.+||+.||.+||++.++++.|+.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKR-QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 77666543 3455678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.80 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=200.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|++.+.||+|+||.||+|++..++. .||+|.++...... .......+. .++..++||||+++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ------IVAMKKIRLESEEEGVPSTAIREI-SLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc------EEEEEEeccccccCCchHHHHHHH-HHHHhcCCCCEeeeEEEEeeCCe
Confidence 58999999999999999999876654 89999986543221 111122222 35566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||+++++.+.+..... ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 74 ~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 999999999998888765433 6799999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
.........+++.|+|||++.+. ..++.++|+|||||++|+|+||++||.+.+..+....+.....
T Consensus 154 ---~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 154 ---PVRVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred ---CcccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 11222344678999999998643 2478899999999999999999999987665433222211000
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 ------------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ------------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.......+++++.++|.+||+.||++||++.++++ |+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~------~~~~ 285 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN------HPYF 285 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc------CCCC
Confidence 00112357899999999999999999999999988 7764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=328.68 Aligned_cols=272 Identities=22% Similarity=0.343 Sum_probs=213.9
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+..++|++.+.||+|+||.||+|.+..... ......||+|+++.............+...+.+..+|+||+++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSK-SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCC-CCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 3566778899999999999999999998743221 223458999998765433322223333334434338999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++...+..|+||||++ |+|.+.+.......+++.+++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999998 577777654344458999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.+..... ........+++.|+|||++.+ +.++.++|+|||||++|||++ |..||.+....+.+.........
T Consensus 187 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 262 (302)
T cd05055 187 LARDIMNDSN-YVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262 (302)
T ss_pred ccccccCCCc-eeecCCCCcccccCCHhhhcc---CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence 9986643221 111223456789999999873 468889999999999999998 99999887766555444444334
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
...+...++++.+++.+||..+|++||++.++++.|++.
T Consensus 263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 445667899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.14 Aligned_cols=265 Identities=20% Similarity=0.330 Sum_probs=208.7
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.+.||+|+||.||+|.+.....+ ..+..||+|+++.............+. .+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEA-SVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCC-CceeEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEc
Confidence 45678899999999999999999987543221 234679999986543222221122222 2556689999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLK--------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
.++..++||||++ |+|.+.+.... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 8999999999999 47766664322 12357788999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~ 266 (627)
|+|||+++........ .......+++.|||||++.+ +.++.++|+|||||++|||++ |..||.+.+..+....+.
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 160 IGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred ECCCCCccccCCccee-ecCCCCccCHhhcChhHhhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999998765432211 11123356789999999873 468899999999999999999 799999888887777665
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.. ..+..+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus 236 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 EG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 43 345567889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.20 Aligned_cols=265 Identities=20% Similarity=0.355 Sum_probs=212.9
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+..+.. ......||||+++.............+. .++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEA-MMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHH-HHHhcCCCCCcCeEEEEEcC
Confidence 566789999999999999999998865431 2234689999997654433322223222 35667899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQL--------------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~--------------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
.+..++++||+.+ +|.+.+... ....+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999984 666665321 1245888999999999999999999999999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~ 261 (627)
++.+||+|||+++....... ........+++.|||||++. .+.++.++|+|||||++|||++ |..||.+....++
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIM---YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCceEecccccccccccchh-eeeccCccCCccccCHHHHh---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999887643221 11223445688999999986 3468889999999999999998 9999999888888
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..+.... ..+.+..++..+.+++.+||+.+|.+||++.+++..|+.
T Consensus 236 ~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 88776543 445678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=328.35 Aligned_cols=273 Identities=19% Similarity=0.278 Sum_probs=214.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc-CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTE-DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e-d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.+.+..++|.+.+.||+|+||.||+|++..... .......+|+|.++.............+...+....+|+||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 445666899999999999999999998754322 1123357999999865332222222223334444448999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++..++..|+||||++ |+|.+.+.... ...+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999998 57877776432 13588999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.++|+|||+++........ .......+++.|||||++.+ ..++.++|+|||||++|||++ |..||.+.+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc---CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999998765432111 11122235578999999874 357889999999999999998 999999888
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..++...+... .....+..++.++.+++.+||..+|++||++.++++.|+.+..
T Consensus 248 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 248 VEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 87777666443 3455678899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.20 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=210.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
...|..++.||+|+||.|..|.++.+++ .||||++...............+-.+++.++|+||+.+.+++..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~------~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGE------KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCC------EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 4567778999999999999999988875 89999997544333322222112236788899999999998865
Q ss_pred ---CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 ---NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 ---~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
-+.+|+|+|+|+-+|...+. .+..++.+.+..++.||+.||+|+|+.+|+||||||+|+|++.+..+||+|||+|
T Consensus 95 ~~~f~DvYiV~elMetDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 95 RDKFNDVYLVFELMETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ccccceeEEehhHHhhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence 34589999999766665554 3445999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---- 270 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~---- 270 (627)
|..... ......+..+.|.+|.|||.+.. ...|+.+.||||+|||+.||++|++.|.|.+.-+.++.|.....
T Consensus 173 R~~~~~-~~~~~mTeYVaTRWYRAPElll~--~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 173 RYLDKF-FEDGFMTEYVATRWYRAPELLLN--SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred eecccc-CcccchhcceeeeeecCHHHHhc--cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 987543 22334467789999999999864 45799999999999999999999999999876555544433211
Q ss_pred --------------------CCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 271 --------------------IPPI-----PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 271 --------------------~~~~-----p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.++. -+..++.+.+|+.+||..||.+|+|+.|+|+ ||++...
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~------hPYl~~~ 316 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA------HPYLAPY 316 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc------Chhhhhh
Confidence 1111 1578899999999999999999999999998 8876543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.70 Aligned_cols=264 Identities=19% Similarity=0.262 Sum_probs=209.2
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|..++|++.+.||+|+||.||+|.+..++. ...+|+|.+.............++...+.+..+|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCc----eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 56788999999999999999999999865542 12568888765433322223333333444545899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
..++..|+||||++ |+|.+.+.... ...+++..++.++.||+.||+|||++|++||||||+|||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 99999999999998 57777765421 1358899999999999999999999999999999999999
Q ss_pred ecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHH
Q 006887 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVD 259 (627)
Q Consensus 181 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~ 259 (627)
+.++.++|+|||+++..... .......++..|+|||++.+ ..++.++|+|||||++|||+| |..||.+.+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred cCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhc---cCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999998643211 11112235678999999863 357889999999999999998 99999988887
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+....+.. ......+..+++++.+|+.+||+.+|++||++.+++..|..+.
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHHHHHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 77766543 2234456678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.77 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=206.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+++++|++.+.||+|+||.||+|.+... ..+|+|.+....... ..+.. +. .+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~a~K~~~~~~~~~-~~~~~-e~-~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQ-------IKVAIKAINEGAMSE-EDFIE-EA-KVMMKLSHPKLVQLYGVCTQ 70 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccC-------ceEEEEecccCCccH-HHHHH-HH-HHHHHCCCCCceeEEEEEcc
Confidence 4678899999999999999999987543 369999986543322 22222 22 25667899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||++ |+|.+.+.. ..+.+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 71 ~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 71 QKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CCCEEEEEEcCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999998 567666543 335689999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... .......++..|+|||++.+ ..++.++|+||||+++|||++ |+.||...+..+.+..+.... ....|
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~ 223 (256)
T cd05114 150 VLDDEY--TSSSGAKFPVKWSPPEVFNF---SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRP 223 (256)
T ss_pred cCCCce--eccCCCCCchhhCChhhccc---CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCC
Confidence 543211 11122345678999999874 358889999999999999999 999999988888887776543 34456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
...+.++.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 67889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.25 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=210.4
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|.+++|+..+.||+|+||.||+|++..++. ....+|+|.+..............+. .++..+.|+||+++.+++..
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEA-SIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEcc
Confidence 567899999999999999999999865432 23479999987653332222222222 25567799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||+++ +|.+.+. ...+.+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLR-DHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999996 5555543 3456799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
................++.|+|||++.+ +.++.++|+|||||++|||++ |..||...+..+....+... ...+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~ 232 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAP 232 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhc---CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCC
Confidence 6432211111112234567999999873 457889999999999999998 99999988888877777543 344456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 67899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.61 Aligned_cols=272 Identities=18% Similarity=0.270 Sum_probs=215.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc-CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTE-DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e-d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.+.+..++|++.+.||+|+||.||+|++..... .......||+|.+..............+...+....+||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 456778899999999999999999998643221 1223457999998754332222223333333333348999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++...+..|+||||++ |+|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999998 57776665421 23578889999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.++|+|||+++........ .......+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999876432211 11223456788999999874 358889999999999999998 899999988
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..++...+.... ....+..++.++.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 VEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 888887775433 44557789999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=343.61 Aligned_cols=294 Identities=21% Similarity=0.268 Sum_probs=225.0
Q ss_pred ccCCCCC-CcccccccCCccchhccccCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC
Q 006887 5 VAAGQPA-DFEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV 83 (627)
Q Consensus 5 ~~~~~~~-~~~~~~~~d~~~l~~~~~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~ 83 (627)
+.++.++ .++|.+. |+..+ +.+..+.+..++|.+.+.||+|+||.||+|+++.... ......||+|+++..
T Consensus 7 ~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~ 78 (401)
T cd05107 7 VIESVSSDGHEYIYV-DPMQL------PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSH-SQSTMKVAVKMLKST 78 (401)
T ss_pred EeeeeccCCceEEEE-CCCCC------CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCC-CCCceEEEEEecCCC
Confidence 3444454 5666665 44333 3344677889999999999999999999999764321 223458999999765
Q ss_pred chhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEecCC-CCHHHHHHHhcC---------------------
Q 006887 84 KEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKG--------------------- 141 (627)
Q Consensus 84 ~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~--------------------- 141 (627)
...........+..++..+..||||+++++++...+..|+||||++ |+|.+.+.....
T Consensus 79 ~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (401)
T cd05107 79 ARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGS 158 (401)
T ss_pred CChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccc
Confidence 4333222223333344443349999999999999999999999999 688777754211
Q ss_pred ---------------------------------------------------------------------------CCCCH
Q 006887 142 ---------------------------------------------------------------------------GKLSL 146 (627)
Q Consensus 142 ---------------------------------------------------------------------------~~ls~ 146 (627)
..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (401)
T cd05107 159 TPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSY 238 (401)
T ss_pred ccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCH
Confidence 23677
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCC
Q 006887 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226 (627)
Q Consensus 147 ~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 226 (627)
..+..++.||+.||.|||+.+++||||||+|||+++++.++|+|||+++.+..... ........+++.|||||++.+
T Consensus 239 ~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-- 315 (401)
T cd05107 239 MDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN-YISKGSTFLPLKWMAPESIFN-- 315 (401)
T ss_pred HHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccc-cccCCCcCCCCceeChHHhcC--
Confidence 78899999999999999999999999999999999999999999999986543211 111223467889999999873
Q ss_pred CCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 227 RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 227 ~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++.++|+|||||++|||++ |..||......+...........+..|..++.++.+++.+||+.+|.+||++.++++
T Consensus 316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 468889999999999999998 899998766655544444444455677889999999999999999999999999999
Q ss_pred HHHhc
Q 006887 306 VFKSS 310 (627)
Q Consensus 306 ~L~~~ 310 (627)
.|+.+
T Consensus 395 ~L~~~ 399 (401)
T cd05107 395 LVGDL 399 (401)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=334.34 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=202.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++.++||+|+||.||+|.+..++. .+|+|++..............+.+ +++.++|+||+++++++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGL------IMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCc------EEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCcccceeEEEEE
Confidence 556899999999999999999999876654 799999876533322222223322 4566789999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
++..|+||||++| +|.+.+. ..+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 9999999999985 7766664 345689999999999999999999985 79999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV--------- 266 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~--------- 266 (627)
.+.. .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..++...+.
T Consensus 153 ~~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 153 QLID-----SMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred hhhh-----hccccCCCCccccCHHHhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 6532 12234579999999999974 358889999999999999999999998655433321110
Q ss_pred ----------------------------------hccCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 267 ----------------------------------RRQEIPPIP-SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 267 ----------------------------------~~~~~~~~p-~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.....+..+ ...+.++++|+.+||++||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~------ 298 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV------ 298 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh------
Confidence 011111122 236789999999999999999999999988
Q ss_pred cccCCC
Q 006887 312 NSVHSD 317 (627)
Q Consensus 312 ~~~~~~ 317 (627)
|+|+..
T Consensus 299 h~~~~~ 304 (333)
T cd06650 299 HAFIKR 304 (333)
T ss_pred CHHHhc
Confidence 887654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.48 Aligned_cols=255 Identities=22% Similarity=0.238 Sum_probs=202.0
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-+++|++++.||+|+||.||+|.+..++. .||||++....... ..... ++. ..++.++|+||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~-~E~-~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQ------KVAVKKLSRPFQSLIHARRTY-REL-RLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCC------EEEEEEeCchhhhhHHHHHHH-HHH-HHHHhcCCCchhhhhhhhc
Confidence 35789999999999999999999876654 89999987543221 11222 222 3566789999999998875
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 117 IN------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
.. ...|++|+++.+++.+.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 85 PATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccccccccCcEEEEeecCCCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcC
Confidence 43 4579999999888876653 45799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 162 fg~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07878 162 FGLARQADD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233 (343)
T ss_pred CccceecCC------CcCCccccccccCchHhcCC--ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 999986532 22445799999999998642 3588899999999999999999999988766554444332111
Q ss_pred C---------------------CCC--------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 271 I---------------------PPI--------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 271 ~---------------------~~~--------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. +.. ....++.+.+|+.+||+.||.+||++.++++ |+||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~------hp~~~~~ 304 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA------HPYFSQY 304 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc------Ccchhcc
Confidence 0 001 1245677899999999999999999999998 9988653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.18 Aligned_cols=258 Identities=19% Similarity=0.337 Sum_probs=204.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
+.|++.+.||+|+||.||+|.+..++ +.||+|++....... .. ...+...+....+|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~~~~-~~-~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTG------QLAAIKVMDVTGDEE-EE-IKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCC------cEEEEEEEEcCCccH-HH-HHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 46889999999999999999987665 489999986543322 22 222333444445899999999998753
Q ss_pred ----CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 119 ----GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 119 ----~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
...|+||||+++ +|.+.+.......+++..++.++.|++.||.|||+++|+||||||+||++++++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 468999999985 777777654556799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
++..... ........|++.|+|||++.+.. ...++.++|+|||||++|||++|..||...........+......
T Consensus 158 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 158 SAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred ceecccc---cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 8765321 12234567999999999986321 336888999999999999999999999876665554444333323
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...+..++.++.+|+.+||..||.+||++.++++ |+|+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~------~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK------HPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh------CCCC
Confidence 3334568899999999999999999999999988 7764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.40 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=206.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|.+.+.||+|+||.||+|.+..+++ .||+|.+..... ........+. ..++.++||||+++++++..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~--~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKR------VYAMKQIDLSKMNRREREEAIDEA--RVLAKLDSSYIIRYYESFLDKG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCc------EEEEEEeehhhCCHHHHHHHHHHH--HHHHhcCCCCeehheeeeccCC
Confidence 58899999999999999999876654 899999865322 2222222222 2466789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.+.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999999984 77777765445789999999999999999999999999999999999999999999999999988764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
... .......|++.|+|||++.+ +.++.++|+|||||++|+|++|+.||...+..+....+... ..+.++..+
T Consensus 153 ~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08529 153 DNT---NFANTIVGTPYYLSPELCED---KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMY 225 (256)
T ss_pred Ccc---chhhccccCccccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCcccc
Confidence 321 12234578999999999873 46788999999999999999999999988877777766543 345566688
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.23 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=207.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+|++.+.||+|+||.||++.+..++. .||+|.++.............+. ..+..++|+||+++++.+..++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQ------KYAMKEIRLPKSSSAVEDSRKEA-VLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCc------eEEEEEEEcCcchHHHHHHHHHH-HHHHhCCCCCcceEEEEEEECCEE
Confidence 58999999999999999999876654 89999986543222222222222 246678999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++ |++.+.+.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999998 57777776545667899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
. .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+... ...+.+..++.
T Consensus 154 ~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (255)
T cd08219 154 G---AYACTYVGTPYYVPPEIWEN---MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-SYKPLPSHYSY 226 (255)
T ss_pred c---cccccccCCccccCHHHHcc---CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-CCCCCCcccCH
Confidence 1 12234578999999999874 35888999999999999999999999988877777666543 34456778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+.+++.+||+.||++||++.+++.
T Consensus 227 ~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 227 ELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.92 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=204.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE-CC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI-NG 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-~~ 119 (627)
.|++.+.||.|++|.||++.+..+++ .||+|.+....... .......+ ..+++.++|+|++++++.+.. ++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK------QYVIKKLNLRNASRRERKAAEQE-AQLLSQLKHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc------EEEEEEEehhhcCHHHHHHHHHH-HHHHHhCCCCCeeeeeeeecCCCC
Confidence 48999999999999999999876654 79999986543221 11122222 235677799999999988763 55
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.+|+||||++| ++.+.+.......+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 78999999985 67777765455679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
... .......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+... ..+..+..+
T Consensus 154 ~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (257)
T cd08223 154 NQC---DMASTLIGTPYYMSPELFSN---KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-KLPPMPKDY 226 (257)
T ss_pred ccC---CccccccCCcCccChhHhcC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCcccc
Confidence 321 22335578999999999874 46788999999999999999999999988877766655443 334567789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++++.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.46 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=215.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCC-ceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEG-ICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpn-Iv~l~~~~~~ 117 (627)
...|+.+++||+|+||+||+|+...+++ .||+|++.....+ ..-....++ ..+++.++|+| |+.|++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~------~VALKkirl~~~~EG~P~taiRE-isllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGK------FVALKKIRLEFEEEGVPSTAIRE-ISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCC------EEEEEEEeccccccCCCchhhHH-HHHHHHhCCCcceEEEEeeeee
Confidence 5578888999999999999999988875 8999999866542 111111111 23677889999 9999999998
Q ss_pred CC------EEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 NG------KICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 ~~------~~~LVmEy~~GsL~d~l~~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
.+ .++||+||+.-+|-+.+..... ..++...++.++.||+.||+|||+++|+||||||.||||+++|.+||+
T Consensus 83 ~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 83 SNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred cccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence 77 8999999999998888876543 357788999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|||+|+... .+....+..++|..|.|||++.+.. .|+..+||||+|||++||+++++.|.+.+..+.+..|....
T Consensus 163 DFGlAra~~---ip~~~yt~evvTlWYRaPEvLlGs~--~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 163 DFGLARAFS---IPMRTYTPEVVTLWYRAPEVLLGST--SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred ccchHHHhc---CCcccccccEEEeeccCHHHhcCCC--cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 999999653 2345567788999999999998753 59999999999999999999999999999888777776533
Q ss_pred CCCC----------------CC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 270 EIPP----------------IP------------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 270 ~~~~----------------~p------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..|. ++ +..+++..+++.+||+++|.+|.++..++. |++|...
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~------h~yf~~~ 308 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT------HPYFSEL 308 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc------Chhhccc
Confidence 3221 11 123458899999999999999999999998 8887755
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=348.93 Aligned_cols=256 Identities=19% Similarity=0.220 Sum_probs=194.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHH-HHHhcCCCCceeeEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDL-FLKCQGVEGICWLQGIS 115 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~-ll~~~~hpnIv~l~~~~ 115 (627)
..++|++.+.||+|+||.||+|.+..+++ .||||+++....... .........+ .....+|.+++.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~------~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKE------YCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCe------EEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 35789999999999999999999876654 899999965322111 1111111111 11223456788898888
Q ss_pred EEC-CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCC---------
Q 006887 116 VIN-GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEAD--------- 184 (627)
Q Consensus 116 ~~~-~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g--------- 184 (627)
... +.+|||||++.++|.+.+.. .+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 754 57999999999999888763 4679999999999999999999998 5999999999999998765
Q ss_pred -------CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 006887 185 -------RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257 (627)
Q Consensus 185 -------~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~ 257 (627)
.+||+|||++.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~------~~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER------HSRTAIVSTRHYRSPEVVLG---LGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccCCCCceEEECCCCccccCc------cccccccCCccccCcHHhhc---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875421 22345689999999999974 468999999999999999999999999877
Q ss_pred HHHHHHHHHhccCCC-------------------------CC-C--------------CCCCHHHHHHHHHhhhcCCCCC
Q 006887 258 VDEIYDAVVRRQEIP-------------------------PI-P--------------SGLPPAVENVLLGCFEYDLRSR 297 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~-------------------------~~-p--------------~~~s~~l~~li~~cL~~dP~~R 297 (627)
..+.+..+....... .. + ...++.+.+||.+||++||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 655544332211100 00 0 0114567899999999999999
Q ss_pred CCHHHHHHHHHhcccccCCC
Q 006887 298 PLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 298 Ps~~eil~~L~~~~~~~~~~ 317 (627)
|++.|+|+ |+|+..
T Consensus 430 ~ta~e~L~------Hp~~~~ 443 (467)
T PTZ00284 430 LNARQMTT------HPYVLK 443 (467)
T ss_pred CCHHHHhc------Cccccc
Confidence 99999998 999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.61 Aligned_cols=264 Identities=23% Similarity=0.383 Sum_probs=211.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|.+.+.||+|+||.||+|.+..... ......||||+++............++.+ ++..+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEP-ENDKELVAVKTLKETASNDARKDFEREAE-LLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccC-cCCcceEEEEeecccCCHHHHHHHHHHHH-HHHhcCCCCchheeeEEec
Confidence 446789999999999999999998765421 12346899999976554423223333332 4566789999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLK------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g 184 (627)
.+..|+||||++| +|.+.+.... ...+++..+..++.|++.||.|||+++++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 9999999999984 6666664321 24578899999999999999999999999999999999999999
Q ss_pred CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 006887 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~ 263 (627)
.++|+|||+++.+..... ........+++.|+|||++.+ +.++.++|+|||||++|||++ |..||.+.+..+...
T Consensus 160 ~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred eEEECCcccceecccCcc-eecCCCCcccceecChhhhcc---CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999876533211 111223456789999999873 468899999999999999998 999999888888777
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 264 ~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.+... .....+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 77643 334456789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.11 Aligned_cols=273 Identities=21% Similarity=0.289 Sum_probs=215.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.+.+..++|.+.+.||+|+||.||+|++...... ......||+|+++.............+..++....+||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4556778999999999999999999987543221 123457999998754433222222233334444447999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++..++..|+||||++ |+|.+.+.... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999998 57777765421 24588999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.++|+|||+++........ .......+++.|||||++.+ +.++.++|+|||||++|||++ |..||.+.+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFD---RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHcc---CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999866432111 11122345578999999873 468899999999999999999 999999988
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+++..+... .....+..++.++.+++.+||..+|++||++.++++.|+....
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 242 VEELFKLLREG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 88888776543 3445677889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.88 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=203.3
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
|++.+.||+|+||+||++++..+++ .||+|++...............+..++..++||||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~------~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQ------KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTE------EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCe------EEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence 8999999999999999999887764 8999999887655444322122223455569999999999999999999
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 123 IIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 123 LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
+||||+++ +|.+.+. ....+++..++.++.||+.||.+||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-- 150 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-- 150 (260)
T ss_dssp EEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 99999998 7777776 456789999999999999999999999999999999999999999999999999875411
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCC--CCC
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV---DEIYDAVVRRQEIPP--IPS 276 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~---~e~~~~i~~~~~~~~--~p~ 276 (627)
.........+|+.|+|||++.. ...++.++|+||||+++|+|++|..||..... ...+........... ...
T Consensus 151 -~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T PF00069_consen 151 -NNENFNPFVGTPEYMAPEVLQQ--GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR 227 (260)
T ss_dssp -TTSEBSSSSSSGGGSCHHHHTT--TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred -cccccccccccccccccccccc--cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence 1233445688999999999861 23578899999999999999999999998733 333333322111111 112
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
..+..+.+++.+||+.||++||++.++++ |+||
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~------~~~~ 260 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK------HPWF 260 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT------SGGG
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc------CCCC
Confidence 23489999999999999999999999998 7764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.37 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=209.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+..++. ....||||++..............+. ..++.+.||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCC---CceeEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCcCcceEEEEECC
Confidence 356789999999999999999999876553 23479999997653332222223332 24566899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..++||||++| +|.+.+. ...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999996 5555443 3456789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCccC--CCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 197 LLGIPLPSSDLPRRL--GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~--GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
............... .+..|+|||++. .+.++.++|+|||||++|||++ |..||...+..+....+... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~ 231 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLP 231 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhc---cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCC
Confidence 643221111111111 245799999987 3468899999999999999886 99999988888777776533 3445
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.+..++..+.+++.+||+.+|++||++.+++..|++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 567889999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.55 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=209.0
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.++.++|++.+.||+|+||.||+|.+..+ ..||+|.++..... ...+.. +. ..++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~v~iK~~~~~~~~-~~~~~~-e~-~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNT-------TPVAVKTLKPGTMD-PKDFLA-EA-QIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCC-------eEEEEEeeCCCccc-HHHHHH-HH-HHHHHCCCCCccceeEEEe
Confidence 36778899999999999999999986443 36999999764432 122222 22 2456678999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..|+||||++ ++|.+.+.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 9999999999996 678777765444578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
....... ........+..|+|||++.+ ..++.++|+|||||++|||++ |+.||.+.+..++...+... ...+.
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 225 (261)
T cd05068 152 VIKEDIY--EAREGAKFPIKWTAPEAALY---NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC 225 (261)
T ss_pred EccCCcc--cccCCCcCceeccCcccccc---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence 7653211 11112223468999999874 368889999999999999999 99999998888777766543 33456
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 67889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=317.59 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=198.6
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
.||+|+||.||+|.+.... .+..||+|+++....... ......+. .+++.+.|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK----SEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCC----CceEEEEEEccCCCCcHHHHHHHHHHH-HHHHhCCCCCcceEEEEEc-CCCcEEEEe
Confidence 5899999999999764322 235899999875443221 11122222 3566789999999999875 456799999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|+++ +|.+.+. ....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..........
T Consensus 76 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 76 LAELGPLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9995 6666664 345789999999999999999999999999999999999999999999999999987643222111
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......+++.|||||.+. ...++.++|+|||||++|||++ |..||.+.+..++...+... ..++.|..+++++.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~ 229 (257)
T cd05116 154 AKTHGKWPVKWYAPECMN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYD 229 (257)
T ss_pred ecCCCCCCccccCHhHhc---cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHH
Confidence 122334568999999986 3468889999999999999998 99999988888887776543 456678889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+|.+||+.||++||++.+|.+.|+.
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHhccCchhCcCHHHHHHHHhc
Confidence 9999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.52 Aligned_cols=256 Identities=19% Similarity=0.354 Sum_probs=204.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|++..++. .||||.++.... .....+..+ . .+++.++||||+++++++..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~~e-~-~~l~~l~h~~i~~~~~~~~~ 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDAKARQDCVKE-I-DLLKQLNHPNVIKYLDSFIE 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCC------EEEEEEeeccccCCHHHHHHHHHH-H-HHHHhCCCcceeeeeeeEEE
Confidence 689999999999999999999876654 899998865322 111222222 2 35677899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.+..++||||++| +|.+.+... ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 9999999999995 776666543 2356899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS--VDEIYDAVVRRQEIP 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~--~~e~~~~i~~~~~~~ 272 (627)
....... .......|++.|+|||.+.+ ..++.++|+||||+++|||++|+.||.... ..+....+......+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 154 RFFSSKT---TAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred eeccchh---HHHhcCCCCccccChhhhcc---CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 8754321 11234578999999999874 357889999999999999999999997643 345555444332222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..+..++..+.+++.+||..+|++||++.++++.++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 22346789999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.33 Aligned_cols=264 Identities=19% Similarity=0.332 Sum_probs=209.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++.+.||+|+||.||+|++..++.. ....||+|++..............+. ..+...+|+||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEA-YVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHH-HHHHhcCCCCCceEEEEEcC
Confidence 5678999999999999999999998765531 12458999987544333222222222 24566899999999999875
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
...+++|||++ |++.+.+.. ..+.+++..++.++.|++.||.|||+++|+||||||+|||+++++.++|+|||+++.
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 45789999998 677776653 345799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... ........+++.|||||++.+ ..++.++|+|||||++|||++ |..||......++...+.. ....+.+
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 233 (279)
T cd05109 159 LDIDET-EYHADGGKVPIKWMALESILH---RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLPQP 233 (279)
T ss_pred cccccc-eeecCCCccchhhCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCC
Confidence 643211 111122345678999999873 468899999999999999998 9999988877776665543 3445557
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..++.++.+++.+||+.||++||++.++++.|..+.
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 789999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.69 Aligned_cols=253 Identities=19% Similarity=0.222 Sum_probs=200.1
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--CE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN--GK 120 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~--~~ 120 (627)
|++.+.||+|+||.||+|.+..++. .||+|+++.............+...+....+|+||+++++++.++ +.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~------~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 74 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGK------YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR 74 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCc------EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence 6789999999999999999876554 899999876432222111122233344555799999999999987 88
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.++||||++|++.+.+.. ....+++..++.++.|++.||.|||+.+++||||||+||+++. +.++|+|||+++.+...
T Consensus 75 ~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 75 LALVFELMDMNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999999999998888764 3357899999999999999999999999999999999999999 99999999999876432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--------- 271 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--------- 271 (627)
.......+|+.|+|||++.. .+.++.++|+|||||++|||++|.+||.+.+..+.+..+......
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 ----PPYTEYISTRWYRAPECLLT--DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred ----CCcCCCCCCcccCChhHhhc--CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 12233468999999998653 235688999999999999999999999988766655444321100
Q ss_pred -------CCC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 272 -------PPI-----------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 272 -------~~~-----------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
..+ ...++..+.++|.+||+.+|++||++.++++ |+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~------~~~~ 282 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR------HPYF 282 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh------CCCC
Confidence 011 2356899999999999999999999999998 7764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.04 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=208.2
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.|++.+.||+|+||.||+|.+..++. .+|+|.+..........+..+. ..++.+.|+||+++++.+..++..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~--~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGV------LAAAKVIDTKSEEELEDYMVEI--DILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCe------EEEEEEeCCCCHHHHHHHHHHH--HHHHHCCCCCeeeEEEEEeeCCEE
Confidence 46888999999999999999876653 7899998765544444333322 245667999999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
|+||||++|+.++.+......++++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~- 156 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 156 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence 9999999975554443334567999999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGL 278 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~~ 278 (627)
........||+.|+|||++... ....++.++|+|||||++|||++|++||...+..+....+.... .....+..+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 157 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred --ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcccc
Confidence 1222345799999999998532 13457889999999999999999999999887766655554332 123346678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+.++.++|.+||+.||.+||++.++++ |+|+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~ 267 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQ------HPFVTV 267 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc------CCCEec
Confidence 999999999999999999999999988 887653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.16 Aligned_cols=260 Identities=19% Similarity=0.267 Sum_probs=206.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|.+..++. ...+|+|.++.............+...+.+..+||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 689999999999999999998865542 1247899887533222222223333344454589999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 121 ICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
.|+||||++ |+|.+.+.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 999999998 57777775421 135889999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDA 264 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~ 264 (627)
++|+|||++...... ........+..|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..+....
T Consensus 158 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNY---SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred EEECCcCCCccccce----eccCCCCcCccccCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999998643211 11111233567999999873 468899999999999999997 9999999888888777
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 265 i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+... .....+..++.++.+|+.+||+.+|.+||++.++++.|+.+..
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 6543 3445677899999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.32 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=213.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|+..+|.+.+.||+|+||.||++....... ......+|+|.+..........+.. +. ..+..+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~-e~-~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHR-EA-ELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCC-CCcceEEEEEecCCcCHHHHHHHHH-HH-HHHHhCCCCCcceEEEEEec
Confidence 567789999999999999999998644221 1233579999987654433333333 22 24566789999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLK-----------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~-----------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
.+..++||||++ |+|.+.+.... ...+++..++.++.|++.||+|||++|++||||||+|||+++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999998 57766665321 135899999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDA 264 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~ 264 (627)
++|+|||+++....... ........+++.|+|||++.+ ..++.++|+|||||++|+|++ |.+||...+..+....
T Consensus 159 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred EEeccCCccccccCCce-eecCCCCCccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999986543211 111223456789999999874 358889999999999999998 9999998888887777
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 265 i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+.... ....+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 235 i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 235 ITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 76543 344567789999999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=318.86 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=200.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..++ ..||+|++........... ..+. .++...+||||+++++.+..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~------~~~aik~~~~~~~~~~~~~-~~e~-~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG------ELAAVKIIKLEPGDDFSLI-QQEI-FMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC------eEEEEEEEecCccchHHHH-HHHH-HHHHhcCCCCeeeeeEEEEeCC
Confidence 468999999999999999999986655 3899999975543332222 2222 3567789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||+++ +|.+.+. ...++++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.+.
T Consensus 80 ~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999995 6666654 34578999999999999999999999999999999999999999999999999998663
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---CC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP---IP 275 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~---~p 275 (627)
.. ........|++.|+|||.+.......++.++|+|||||++|||++|..||...+..+....+......++ .+
T Consensus 158 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 158 AT---IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred cc---ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccc
Confidence 21 1122345789999999998644345678899999999999999999999976654433322222211111 22
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++..+.+++.+||..+|++||++.++++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 457899999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.31 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=211.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||.|+||.||+|.+.. + ..+|+|++..........+..+ . ..++.++|+||+++++++...+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~------~~~~~k~~~~~~~~~~~~~~~e-~-~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-R------VRVAIKILKSDDLLKQQDFQKE-V-QALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-C------CcEEEEeccccchhhHHHHHHH-H-HHHhcCCCcchhheeeeEecCC
Confidence 3579999999999999999999866 3 3799999876554333333222 2 2456779999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..++||||++| +|.+.+.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999985 88777765555678999999999999999999999999999999999999999999999999997764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .......++..|++||++. ...++.++|+||||+++|+|++ |+.||.+.+..+.+..+... ...+.+..
T Consensus 156 ~~~---~~~~~~~~~~~~~~PE~~~---~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (261)
T cd05148 156 EDV---YLSSDKKIPYKWTAPEAAS---HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAK 228 (261)
T ss_pred Ccc---ccccCCCCceEecCHHHHc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCC
Confidence 321 1122345678899999986 3468889999999999999998 89999998888888777643 34566788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+++++.+++.+||+.||.+||++.++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 99999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.85 Aligned_cols=274 Identities=19% Similarity=0.282 Sum_probs=216.7
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCc-ccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDC-DEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~-~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+.+...+|++.+.||+|+||.||+|++...+.+. .....||+|+++.............+...+.+..+|+||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 456677789999999999999999999876543321 2335799999875443332223333333444444899999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+++..++..+++|||++ |+|.+.+.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999998 57777775421 2357888999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
||++.++.++|+|||+++........ .......++..|||||++.+ ..++.++|+|||||++|||++ |..||.+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EEEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc---CCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999866432111 11122345678999999874 468889999999999999998 89999998
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+..+....+... .....+..++.++.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 241 PVEELFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 888887776543 3445677889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.28 Aligned_cols=267 Identities=21% Similarity=0.346 Sum_probs=213.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+...+|.+.+.||+|+||.||+|.+..... ......+|+|.+..........+.. +. ..+..++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~-e~-~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSP-TKDKMLVAVKALKDPTLAARKDFQR-EA-ELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCC-CCcceeeEEEecCCccHHHHHHHHH-HH-HHHhcCCCCCcceEEEEEcc
Confidence 456789999999999999999998654332 2234579999987655443333333 22 24566799999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
.+..++||||++ |+|.+.+.... .+.+++..++.++.||+.||.|||+++|+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999998 57766665321 245889999999999999999999999999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~ 261 (627)
++.++|+|||+++....... ........+++.|||||++.+ ..++.++|+|||||++|||+| |..||...+..+.
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred CCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999876543211 111233467889999999874 358889999999999999999 9999998888877
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+.+.. ...+..+..++..+.+++.+||+.||++||++.+++++|++...
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 776643 33444567789999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.65 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=210.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.++||.|+||.||+|.+..++. .||+|++..........+..+. .+++.++|+||+++++.+..++.
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~e~--~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGL------FAAAKIIQIESEEELEDFMVEI--DILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCc------EEEEEEEeeCCHHHHHHHHHHH--HHHHhCCCCceeEEEEEEecCCe
Confidence 579999999999999999999876553 8999999765544444333332 25566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||++|+.++.+.......+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999974444444434567999999999999999999999999999999999999999999999999988665321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSG 277 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~ 277 (627)
........||+.|+|||++..+ ...+++.++|+|||||++|+|++|++||.+.+..+.+..+..... ....+..
T Consensus 157 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (280)
T cd06611 157 ---LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK 233 (280)
T ss_pred ---ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCccc
Confidence 1222345799999999997532 133578899999999999999999999998877766655543221 2234567
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
++.++.+++.+||+.+|.+||++.++++ |+|+...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~~ 268 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLK------HPFVSDQ 268 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhc------Chhhccc
Confidence 8999999999999999999999999988 8876643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=339.25 Aligned_cols=285 Identities=20% Similarity=0.199 Sum_probs=224.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...++.+-|..++.||-|+||.|-+++...+. ..||+|.|.+.+. ...+......++-++.....+-||+|+.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~------~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTR------ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchh------hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 34678889999999999999999999977665 4899999987543 2222222223334566677788999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.|++++.+|+||+|++| ++-.++. +-+-|.+..+.+|++++..|+++.|..|+|||||||+|||||.+|++||+|||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecc
Confidence 99999999999999996 4444443 45789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC---------CCCC------------------------------CCCCccCCCCCcCCcccccCCCCCCCCcc
Q 006887 193 IPHLLLGI---------PLPS------------------------------SDLPRRLGTPNYMAPEQWQPEVRGPISFE 233 (627)
Q Consensus 193 la~~~~~~---------~~~~------------------------------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~ 233 (627)
||.-+... +... ......+||+.|+|||++. +..|+..
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~---r~g~~q~ 851 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA---RTGYTQL 851 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc---ccCcccc
Confidence 99765310 0000 0112347999999999998 4468999
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCC---HHHHHHHHH
Q 006887 234 TDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPL---MTDILRVFK 308 (627)
Q Consensus 234 sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs---~~eil~~L~ 308 (627)
+|+||.|||||||+.|++||.+.++.+.-.++++......++ ..+++++.++|.+++ .+++.|.. +.++..
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKa--- 927 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKA--- 927 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhc---
Confidence 999999999999999999999988887766676655555554 579999999998877 47888874 333444
Q ss_pred hcccccCCCCCCCCCCcccCCCCCCCCCccc
Q 006887 309 SSQNSVHSDGGWTGHGSRILPDKSSSGYTEW 339 (627)
Q Consensus 309 ~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~ 339 (627)
|+||..++|..+ ++...+..|..+..
T Consensus 928 ---HpfFkgIDfssl--Rkq~ApYIP~ItHp 953 (1034)
T KOG0608|consen 928 ---HPFFKGIDFSSL--RKQRAPYIPRITHP 953 (1034)
T ss_pred ---CccccccchHhh--hhccCCcCccccCC
Confidence 999999999884 44566677665544
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.80 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=200.2
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|++.+.||+|+||.||+|++..+++ .||+|.++....... ......+. .+++.++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~------~~~~k~~~~~~~~~~~~~~~~~ei-~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCc------EEEEEEeecccccccCccchhHHH-HHHHhcCCCCeeeHHHHhccCCc
Confidence 58999999999999999999877664 899999875432211 11111122 25566799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||+++++.+.+.. ..+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||+++.....
T Consensus 74 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 74 LTLVFEYCDQDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred eEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 999999999998887754 3467999999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccC---------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR-CGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf-~~~~~~e~~~~i~~~~~--------- 270 (627)
........+++.|+|||++.+. ..++.++|+|||||++|+|++|..|| .+.+..+.+..+.....
T Consensus 153 ---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 153 ---VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ---CCCcCCCccccCCcChHHHhCC--cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 1222345688999999998643 24788999999999999999988885 45555444444322110
Q ss_pred ---------CC---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 ---------IP---------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ---------~~---------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+ .....+++++.++|.+||+.||.+|||+.++++ |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~------h~~f 284 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ------HPYF 284 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc------CCCC
Confidence 00 112357899999999999999999999999988 7775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.33 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=208.5
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.+.||+|+||.||+|.+.....+ .....||+|.+..............+. ..++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEA-LIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCC-CCceeEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEc
Confidence 35567899999999999999999998652211 123589999886544332222222222 2556789999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---Cee
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKG-----GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAV 187 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vk 187 (627)
..+..++||||++ |+|.+.+..... ..+++..++.++.||+.||.|||+++++||||||+||+++.++ .++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 8899999999998 577777765331 2589999999999999999999999999999999999998765 589
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~ 266 (627)
|+|||+++.+...... ........++.|||||++. .+.++.++|||||||++|||++ |..||.+.+..++...+.
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFL---DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHh---cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999876432111 1112234457899999986 3468999999999999999997 999999988888776654
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
. ......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 G-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3 3455667889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=318.68 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=201.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..++|++.+.||+|+||.||+|++..++. .||+|+++...........++. .++..++||||+++++.+...
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~e~--~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGE------LAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCc------EEEEEEEecCchhHHHHHHHHH--HHHHhCCCCCeeeEEEEEEeC
Confidence 34689999999999999999999876654 8999998765443332222222 356677999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+. ..+.+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred CEEEEEEeccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 999999999995 6666654 3457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC---
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI--- 274 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~--- 274 (627)
... ........||+.|+|||++.....+.++.++|+|||||++|+|++|..||..................++.
T Consensus 157 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 157 TAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred cCc---ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 321 12223457999999999975333446888999999999999999999999766544433333222222211
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
...++..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1247789999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.46 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=204.3
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
|++.+.||+|+||.||+|.+..... ....||+|+++..... ....+..+ . ..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e-~-~~l~~l~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG---SQLKVAVKTMKLDIHTYSEIEEFLSE-A-ACMKDFDHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC---CcceEEEEEeccCcCCHHHHHHHHHH-H-HHHHhCCCCCeeeEEeeeccCCc
Confidence 5788999999999999998765331 2357999998754322 12222222 2 25566899999999998866444
Q ss_pred ------EEEEEecCC-CCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 121 ------ICIIMKFYE-GSVGDRMAQLK----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 121 ------~~LVmEy~~-GsL~d~l~~~~----~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
.+++|||++ |+|.+.+.... ...+++..++.++.|++.||.|||+++++||||||+||++++++.++|+
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 799999999 56666654322 2468999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||+++........ .......++..|+|||++.+ ..++.++|+|||||++|||++ |.+||.+.+..++++.+...
T Consensus 156 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05035 156 DFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231 (273)
T ss_pred Cccceeeccccccc-cccccccCCccccCHhhccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999876532211 11222345778999999863 468899999999999999999 99999988888888776543
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.....+..+++++.+++.+||+.||++||++.++++.|+..
T Consensus 232 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 35567888999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.32 Aligned_cols=270 Identities=20% Similarity=0.324 Sum_probs=207.0
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
....++|++.+.||+|+||.||+|.+..... ...++.||||+++.............+...+....+|+||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCc-cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3456789999999999999999998754332 234568999999764433222223333344555558999999999876
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhc------------------------------------------------------
Q 006887 117 I-NGKICIIMKFYE-GSVGDRMAQLK------------------------------------------------------ 140 (627)
Q Consensus 117 ~-~~~~~LVmEy~~-GsL~d~l~~~~------------------------------------------------------ 140 (627)
. +...++||||++ |+|.+.+....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 456899999999 57777664321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCc
Q 006887 141 -----------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209 (627)
Q Consensus 141 -----------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 209 (627)
...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++....... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 240 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGD 240 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCC
Confidence 12467888899999999999999999999999999999999999999999999976533211 111223
Q ss_pred cCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Q 006887 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLG 288 (627)
Q Consensus 210 ~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~ 288 (627)
..+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||......+..............|..+++++.+++.+
T Consensus 241 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (343)
T cd05103 241 ARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 317 (343)
T ss_pred CCCCcceECcHHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 356778999999864 368899999999999999997 9999987654433333333444455677788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHhcc
Q 006887 289 CFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 289 cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
||+.||.+||++.++++.|+.+.
T Consensus 318 cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 318 CWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.19 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=205.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
.+.|++.+.||.|+||.||+|.+..+++ .||+|++....... .....+...+....+|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~a~K~~~~~~~~~--~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTEDEE--EEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCc------EEEEEEEecChHHH--HHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4689999999999999999999876654 89999986543222 1223333344555589999999999853
Q ss_pred ----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 118 ----NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 118 ----~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.+..|++|||+++ +|.+++.......+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 4678999999985 77777766556678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
++...... ........|++.|+|||++.... ...++.++|+|||||++|||++|..||......+....+.....
T Consensus 167 ~~~~~~~~---~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 167 VSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred chhhhhcc---ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 98765321 12234567999999999975321 34678899999999999999999999987766554444433322
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
....+..++.++.++|.+||+.||.+||++.++++ |+|+
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~------~~~~ 282 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK------HPFI 282 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc------CCCC
Confidence 22234568999999999999999999999999988 7664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=320.17 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=201.8
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
.+.+.||.|.||.||+|.+... ....+..|+||+++...... ...+..+. . .+..++||||+++++++...+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~--~~~~~~~V~vk~~~~~~~~~~~~~~~~e~-~-~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQK--DNDKNQPVAVKILKPSSSEEEEEEFLNEI-Q-ILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEEST--TTSSEEEEEEEEESTTSSHHHHHHHHHHH-H-HHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcc--cCCCCEEEEEEEeccccccccceeeeecc-c-cccccccccccccccccccccccc
Confidence 5789999999999999999831 12345789999996644332 33343332 3 344559999999999999878899
Q ss_pred EEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 123 IIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 123 LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
+||||++ |+|.+.+.......+++..+..++.||+.||.|||+++++|+||+++||+++.++.+||+|||+++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998 688888876546789999999999999999999999999999999999999999999999999998763211
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
. ........+...|+|||.+.+. .++.++||||||+++|||++ |+.||...+..++...+.. ......+..++.
T Consensus 158 ~-~~~~~~~~~~~~~~aPE~~~~~---~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (259)
T PF07714_consen 158 K-YKNDSSQQLPLRYLAPEVLKDG---EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ-GQRLPIPDNCPK 232 (259)
T ss_dssp S-EEESTTSESGGGGS-HHHHHHS---EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT-TEETTSBTTSBH
T ss_pred c-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc-cccceeccchhH
Confidence 1 1112234567889999998743 48899999999999999999 7899999999888888854 445667888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
.+.+++.+||+.||++||++.++++.|
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.92 Aligned_cols=252 Identities=17% Similarity=0.277 Sum_probs=197.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+...+|++++.||+|+||.||+|++..++. .||+|+....... . +..+++.++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~valK~~~~~~~~-------~-E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPD------PVVLKIGQKGTTL-------I-EAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCc------eEEEEeCCccccH-------H-HHHHHHhCCCCCCcChhheEEe
Confidence 445679999999999999999999876654 7999986443221 1 1235677899999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.+..|+||||+.|++.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++..
T Consensus 129 ~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 129 GAITCMVLPHYSSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred CCeeEEEEEccCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999999999999998888754 4567999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC-CCCCH----------HHHHHHHH
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR-CGRSV----------DEIYDAVV 266 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf-~~~~~----------~e~~~~i~ 266 (627)
.. ........||+.|+|||++.+ ..++.++|+|||||++|||+++..|+ ..... ..+...+.
T Consensus 208 ~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 208 VV----APAFLGLAGTVETNAPEVLAR---DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cc----CcccccccccccccCCeecCC---CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 32 122234679999999999974 46889999999999999999865554 33111 11111111
Q ss_pred hcc-CCCCCC------------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 267 RRQ-EIPPIP------------------------------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 267 ~~~-~~~~~p------------------------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
... ....++ ..++.++.+||.+||+.||++||++.++++ |+||
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~------hp~f 354 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN------YPMF 354 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc------Cchh
Confidence 100 000111 245677888999999999999999999998 9987
Q ss_pred CC
Q 006887 316 SD 317 (627)
Q Consensus 316 ~~ 317 (627)
..
T Consensus 355 ~~ 356 (357)
T PHA03209 355 AQ 356 (357)
T ss_pred cc
Confidence 64
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.85 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=199.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|.+..++. .||+|++..............+.. .+..++||||+++++.+...+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELE-ILYKCDSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCc------EEEEEEEecCCChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEECCE
Confidence 468999999999999999999876654 899999875432222222222222 4566799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.++||||++|..++.. ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+..
T Consensus 74 ~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~- 147 (279)
T cd06619 74 ISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN- 147 (279)
T ss_pred EEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-
Confidence 9999999997555443 3578899999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-------DEIYDAVVRRQEIPP 273 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-------~e~~~~i~~~~~~~~ 273 (627)
.......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..... .+....+.... .+.
T Consensus 148 ----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 219 (279)
T cd06619 148 ----SIAKTYVGTNAYMAPERISG---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV 219 (279)
T ss_pred ----ccccCCCCChhhcCceeecC---CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCC
Confidence 22344689999999999974 3588999999999999999999999975321 22333332221 222
Q ss_pred C-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 I-PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ~-p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. ....++++.+++.+||+.+|++||++.++++ |+|+...
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~------~~~~~~~ 259 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD------HPFIVQY 259 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc------Ccccccc
Confidence 2 3457899999999999999999999999998 7876543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.67 Aligned_cols=264 Identities=20% Similarity=0.297 Sum_probs=209.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+|++.+.||+|+||.||+|.+..... ......+|+|.+..............+.. .+..++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG-RAGYTTVAVKMLKENASSSELRDLLSEFN-LLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC-CCcceeEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998754332 22335799999875543222222222222 55678999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 122 CIIMKFYE-GSVGDRMAQLK----------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 122 ~LVmEy~~-GsL~d~l~~~~----------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
+++|||++ |+|.+.+.... ...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999 57766654321 13578899999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|+++++.++|+|||+++........ .......++..|+|||++.+ ..++.++|+|||||++|||++ |..||.+..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc---CCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999865432211 11223456788999999863 358899999999999999998 999999988
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..++...+... .....+..++.++.+++.+||+.+|++||++.++++.|+++.+
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFNLLKTG-YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 88877766533 3445678899999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=317.78 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=209.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++..+|++.++||+|+||.||++....... ...+..+|+|.+..........+.. +. ..+..+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~-e~-~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQR-EA-ELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCC-CCCceEEEEEecCcCCHHHHHHHHH-HH-HHHhcCCCCCCceEEEEEec
Confidence 566789999999999999999997643221 2234579999987655443333333 22 25566799999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKG-------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA 183 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~-------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~ 183 (627)
.+..+++|||++ |+|.+.+..... ..+++..++.++.||+.||+|||+.+++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999998 577776654221 358899999999999999999999999999999999999999
Q ss_pred CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 006887 184 DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262 (627)
Q Consensus 184 g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~ 262 (627)
+.++|+|||+++....... ........+++.|+|||++.+ ..++.++|+|||||++|||++ |.+||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY---RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 9999999999876533211 111223346789999999874 358899999999999999998 99999888877777
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 263 ~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
..+... .....+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 666543 334567789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.35 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=203.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||.|+||.||+|.+..++. .+|+|++..........+..+. .+++.++||||+++++++...+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~e~--~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGE------LVAIKVIKLEPGDDFEIIQQEI--SMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCC------EEEEEEEEcCchhhHHHHHHHH--HHHHhCCCCChhceEEEEEeCC
Confidence 3689999999999999999999876553 7999999765544333333322 2566789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.+|++|||++|+.++.+......++++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999996444444333446799999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---CCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP---PIPS 276 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~---~~p~ 276 (627)
. ........++..|+|||.+.+.....++.++|+|||||++|+|++|.+||.+.+..+....+......+ ..+.
T Consensus 154 ~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 154 T---IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred h---hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 1 112234578999999999874323368889999999999999999999999877665544443331111 1234
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+.++.+++.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 56788999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.98 Aligned_cols=259 Identities=15% Similarity=0.160 Sum_probs=198.8
Q ss_pred EEeEEeee--CCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 45 LRHRIGRG--PFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 45 i~~~LG~G--~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+++.||+| +|++||++++..+++ .||+|+++.... +.......++. .+++.++||||+++++++..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGE------YVTVRRINLEACTNEMVTFLQGEL-HVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecccCc------EEEEEEechhhccHHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEECCEE
Confidence 56789999 789999999887765 899999976432 22223333332 356678999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++ |++.+.+.......+++..++.++.|++.||.|||+++|+||||||+|||++.++.++++||+.+......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999 57777776544566899999999999999999999999999999999999999999999999865443321
Q ss_pred CCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----
Q 006887 201 PLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI----- 271 (627)
Q Consensus 201 ~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~----- 271 (627)
.... .......++..|||||++.+. ...++.++|+|||||++|||++|+.||......+...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 1111 011234578889999998643 235889999999999999999999999876554433332211100
Q ss_pred ---------------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 ---------------------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ---------------------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+....+++++.+|+.+||+.||++||++.++++ |
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~------~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN------H 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc------C
Confidence 0112245788999999999999999999999998 8
Q ss_pred ccCCC
Q 006887 313 SVHSD 317 (627)
Q Consensus 313 ~~~~~ 317 (627)
+||..
T Consensus 308 p~f~~ 312 (327)
T cd08227 308 SFFKQ 312 (327)
T ss_pred hhhhh
Confidence 88764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.02 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=208.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
+|..++|++.++||+|+||.||+|....+ ..||+|.+....... ..+.. +. .+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~-------~~~a~K~~~~~~~~~-~~~~~-E~-~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGH-------TKVAIKSLKQGSMSP-EAFLA-EA-NLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCC-------ceEEEEEecCCCCcH-HHHHH-HH-HHHHhcCCcCeeeEEEEEc
Confidence 56778999999999999999999986433 379999987544332 22222 22 2566778999999998864
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+..|++|||+. |+|.+.+.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 567899999998 578877765555678999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
....... .......++..|+|||++.. +.++.++|+||||+++|||++ |++||.+.+..+....+... ...+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~ 224 (260)
T cd05067 151 LIEDNEY--TAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224 (260)
T ss_pred ecCCCCc--ccccCCcccccccCHHHhcc---CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCCCC
Confidence 7642211 11123356788999999873 468889999999999999999 99999988887777666433 34456
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..++.++.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 77889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.26 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=197.6
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|++..++ +.||+|.+..............+.+ +++.++||||+++++++...+..|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN------TPVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCC------ceEEEEecCccCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 36999999999999987655 3899998865433322222223322 4566799999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+.. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 74 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 151 (252)
T cd05084 74 LVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-AS 151 (252)
T ss_pred eccCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-cc
Confidence 9985 66655543 445689999999999999999999999999999999999999999999999999876532111 11
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......++..|+|||.+.+ +.++.++|+|||||++|||++ |..||...+..+....+.. ......+..++..+.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 227 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNY---GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYR 227 (252)
T ss_pred cCCCCCCceeecCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHH
Confidence 1112233567999999873 468889999999999999998 9999988777666555543 3345567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
++.+||+.+|++||++.+++++|+
T Consensus 228 li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 228 LMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.09 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=206.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.++||+|+||.||+|++..+. .||+|++....... ..+.. +.. .+..++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~valK~~~~~~~~~-~~~~~-E~~-~l~~l~~~~i~~~~~~~~ 71 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTMSP-EAFLQ-EAQ-VMKKLRHEKLVQLYAVVS 71 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCc-------eEEEEecccCccCH-HHHHH-HHH-HHHhCCCCCcceEEEEEC
Confidence 366789999999999999999999875443 59999997543322 22222 222 456678999999999875
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+..|+||||++ |+|.+.+.......+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+++
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 72 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred -CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 456899999999 577777765445568999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..... .......++..|+|||+.. .+.++.++|+|||||++|||++ |..||.+....++...+... ...+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~PE~~~---~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~ 224 (262)
T cd05071 151 LIEDNEY--TARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPC 224 (262)
T ss_pred ecccccc--ccccCCcccceecCHhHhc---cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCC
Confidence 6543211 1112345677899999986 3468899999999999999999 89999988887777766543 23445
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..++..+.+++.+|++.||++||++.++++.|+.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 67789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=324.71 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=207.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--C
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN--G 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~--~ 119 (627)
.|+-.+.+|+|+||.||+|....+.+ .||||..-...... .++.+ +++.+.|||||+|..+|... .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~------~vAIKKv~~d~r~k-----nrEl~-im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEE------EVAIKKVLQDKRYK-----NRELQ-IMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCc------eeEEEEecCCCCcC-----cHHHH-HHHhcCCcCeeeEEEEEEecCCC
Confidence 58899999999999999999887754 89999986544322 22222 34578999999998887652 2
Q ss_pred ---EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccCCc
Q 006887 120 ---KICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDVGI 193 (627)
Q Consensus 120 ---~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DFGl 193 (627)
...+||||++-+|.+.+.+. .+..++.-.++-|..||++||.|||+.||+||||||.|||+|.+ |.+||+|||.
T Consensus 93 d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred chhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 35799999999999888753 35778999999999999999999999999999999999999966 9999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP- 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~- 272 (627)
|+.+... ....+...|..|.|||.+.|. ..|+.+.||||.||++.||+.|++.|.|.+..+.+..|..--..|
T Consensus 173 AK~L~~~----epniSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 173 AKVLVKG----EPNISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred ceeeccC----CCceeEEEeccccCHHHHcCc--cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 9988653 233455778999999999975 479999999999999999999999999988766555554311111
Q ss_pred ----------------------C----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 ----------------------P----IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ----------------------~----~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. +...+++++.+|+.++|.++|.+|.++.+++. |+||...
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~------h~fFdel 312 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA------HPFFDEL 312 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc------chhhHHh
Confidence 0 23467899999999999999999999999988 8887644
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.70 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=207.1
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.++||+|+||.||+|.+.... .||+|.+....... ..+.. +. .+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~~k~~~~~~~~~-~~~~~-E~-~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNT-------KVAVKTLKPGTMSP-ESFLE-EA-QIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCc-------eeEEEEecCCCCCH-HHHHH-HH-HHHHhcCCCceEEEEeEEC
Confidence 467789999999999999999999865432 69999997654432 22222 22 2566689999999999875
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+..|++|||++| +|.+.+.......+++..++.++.|++.||.|||+++|+||||||+||++++++.++|+|||++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 4568999999984 77777655445678999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..... .......++..|+|||++. ...++.++|+||||+++|+|++ |.+||.+.+..+....+.. ....+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 224 (260)
T cd05070 151 LIEDNEY--TARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPC 224 (260)
T ss_pred eccCccc--ccccCCCCCccccChHHHh---cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCC
Confidence 6543211 1112234567899999986 3468889999999999999999 9999998888777776654 334556
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+...+..+.+++.+||..+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 77889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=313.77 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=205.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh----HHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED----RMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~----~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.+|+..+.||+|+||.||+|.+..++ ..||+|++...... ........+. ..++.++||||+.+++++
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~ 73 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTG------RELAAKQVQFDPESPETSKEVSALECEI-QLLKNLQHERIVQYYGCL 73 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCC------cEEEEEEeecCcCCchhHHHHHHHHHHH-HHHHHcCCCCeeeEEEEE
Confidence 357999999999999999999987655 48999998653221 1111222222 256667999999999988
Q ss_pred EE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 116 VI--NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 116 ~~--~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.. .+..+++|||++| +|.+.+. ....+++...+.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~l~~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 74 RDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EcCCCCEEEEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 75 4678999999985 6666664 34568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.+..............++..|+|||++.+ ..++.++|+|||||++|||++|+.||......+....+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISG---EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCC---CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC
Confidence 98765432222222234568999999999874 357889999999999999999999998877666555555444456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.++..+++.+++++ +||..+|++||++.++++ |+||.
T Consensus 229 ~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~------hp~~~ 265 (266)
T cd06651 229 QLPSHISEHARDFL-GCIFVEARHRPSAEELLR------HPFAQ 265 (266)
T ss_pred CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc------Ccccc
Confidence 67788899999999 677789999999999998 88764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.99 Aligned_cols=260 Identities=24% Similarity=0.310 Sum_probs=204.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
..+|++++.||+|+||.||+|...... .+..||+|.+...... .++. .+++.++||||+++++++...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~----~~~~v~vK~~~~~~~~------~~E~-~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDE----QRKKVIVKAVTGGKTP------GREI-DILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCc----cceeEEEEeccccccH------HHHH-HHHHhcCCCCccceeeeEeeCC
Confidence 357999999999999999999865322 2358999998653221 1222 2456679999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+|||++.+++.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+..
T Consensus 160 ~~~lv~e~~~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEEehhcCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999999999999888873 456799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc-------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---EIYDAVVRRQ------- 269 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---e~~~~i~~~~------- 269 (627)
... ........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.... ..+..+....
T Consensus 238 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 238 HPD-TPQCYGWSGTLETNSPELLAL---DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccc-cccccccccccCccCHhHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 221 122235679999999999974 46889999999999999999999999765421 1111111100
Q ss_pred ------------------CCCC--CC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 270 ------------------EIPP--IP-----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 270 ------------------~~~~--~p-----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
..++ .+ ..++.++.++|.+||..||++||++.+++. |+||....|..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~------~p~f~~~~~~~ 385 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS------LPLFTKEPINL 385 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh------Cchhhccchhh
Confidence 0010 11 235678999999999999999999999999 99988766544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.25 Aligned_cols=253 Identities=18% Similarity=0.283 Sum_probs=204.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+++++|++.+.||+|+||.||+|.+... ..||+|.+...... ...+..+. ..+..++||||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~-------~~~aik~~~~~~~~-~~~~~~e~--~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSMS-EDEFIEEA--KVMMKLSHEKLVQLYGVCTK 70 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCC-------CcEEEEEcCCCccc-HHHHHHHH--HHHhcCCCCCeeeEEEEEcc
Confidence 4678899999999999999999986542 25999998754322 22233322 24567789999999999998
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 8899999999985 66666543 334789999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... .......++..|+|||++.+ +.++.++|+|||||++|+|++ |..||...+..+....+.... ....+
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 223 (256)
T cd05113 150 VLDDEY--TSSVGSKFPVRWSPPEVLLY---SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRP 223 (256)
T ss_pred cCCCce--eecCCCccChhhCCHHHHhc---CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCC
Confidence 543211 11122345678999999873 358889999999999999998 999999888877777776543 34456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
...++.+.+++.+||+.+|.+||++.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 67899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.38 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=216.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
.=|.+.+.||+|-|++|-+|++.-+++ .||||++.+.+.+....-.-..+-.-+++..|||||+||++...+..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGe------kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGE------KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccc------eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 469999999999999999999988886 89999999877655433222222235678899999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE-ecCCCeeeccCCcccccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl-d~~g~vkL~DFGla~~~~ 198 (627)
+|||+|+-. |+|.|.+.. ....++++.+.+|+.||+.|+.|+|..++|||||||+|+.+ .+-|.+||.|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEEecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999998 588888876 44568999999999999999999999999999999999865 678999999999886553
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCC-ccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPIS-FETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s-~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
+.....+.||+..|-|||++.|. .|+ +++||||||||||.|++|++||+..+..+.+..|+... -.+|..
T Consensus 171 ----PG~kL~TsCGSLAYSAPEILLGD---sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--YtvPsh 241 (864)
T KOG4717|consen 171 ----PGKKLTTSCGSLAYSAPEILLGD---SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPSH 241 (864)
T ss_pred ----CcchhhcccchhhccCchhhhcC---ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--ccCchh
Confidence 45667889999999999999975 344 68999999999999999999999999999999998764 457899
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.++++||..||..||.+|.+..+|..
T Consensus 242 vS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 242 VSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9999999999999999999999999987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.95 Aligned_cols=254 Identities=20% Similarity=0.230 Sum_probs=190.0
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--CCEEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--NGKICI 123 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~~~~~L 123 (627)
..+||+|+||.||+|++.... .++.||+|.+....... .. .++. .+++.++||||+++++++.. +...|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~----~~~~~aiK~~~~~~~~~--~~-~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK----DDRDYALKQIEGTGISM--SA-CREI-ALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCC----CCceEEEEEECCCCCcH--HH-HHHH-HHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 357999999999999975432 23589999986543221 11 2222 35667899999999998854 467899
Q ss_pred EEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE----ecCCCeeeccCC
Q 006887 124 IMKFYEGSVGDRMAQLK-------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL----NEADRAVLGDVG 192 (627)
Q Consensus 124 VmEy~~GsL~d~l~~~~-------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl----d~~g~vkL~DFG 192 (627)
||||+++++.+.+.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99999999888775421 2358999999999999999999999999999999999999 456789999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV---------DEIYD 263 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~---------~e~~~ 263 (627)
+++.+..............||+.|||||++.+. ..++.++|+|||||++|||++|++||.+... .+.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 998765432222334456899999999998742 3578899999999999999999999975332 11111
Q ss_pred HHHhccCCC------------------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 264 AVVRRQEIP------------------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 264 ~i~~~~~~~------------------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
.+......+ ......+.++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~-- 313 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ-- 313 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc--
Confidence 111100000 001123567889999999999999999999998
Q ss_pred HhcccccC
Q 006887 308 KSSQNSVH 315 (627)
Q Consensus 308 ~~~~~~~~ 315 (627)
|+||
T Consensus 314 ----hp~f 317 (317)
T cd07868 314 ----DPYF 317 (317)
T ss_pred ----CCCC
Confidence 8875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.37 Aligned_cols=256 Identities=20% Similarity=0.352 Sum_probs=203.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|++..++. .||||.+....... ...+.. +. .+++.++|+||+++++++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~~-e~-~~l~~~~h~~i~~~~~~~~~ 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGV------PVALKKVQIFDLMDAKARADCIK-EI-DLLKQLNHPNVIKYYASFIE 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCc------eEEEEeeeehhhhhHHHHHHHHH-HH-HHHHHccCCchhhhhheeEe
Confidence 578999999999999999999876654 89999886533221 122222 22 25666799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
++..+++|||++| +|.+.+... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999999995 776666532 2356899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV--DEIYDAVVRRQEIP 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~--~e~~~~i~~~~~~~ 272 (627)
....... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+... .+....+......+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 154 RFFSSKT---TAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred hccccCC---cccccccCCcCccCHHHhcC---CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 7654321 12234578999999999874 3578899999999999999999999976543 34444443322222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..+..+++++.+++.+||..||.+||++.++++.++++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 22346889999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.64 Aligned_cols=253 Identities=20% Similarity=0.320 Sum_probs=204.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|++.+|++.+.||+|+||.||+|.+... ..+|+|++....... ..+..+. .+++.++|+||+++++++..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~-------~~~~iK~~~~~~~~~-~~~~~e~--~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGK-------IDVAIKMIREGAMSE-DDFIEEA--KVMMKLSHPNLVQLYGVCTK 70 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCC-------ccEEEEEeccCCCCH-HHHHHHH--HHHHhCCCCCEEEEEEEEcC
Confidence 4567899999999999999999987532 269999986543322 2222222 24566799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||++| +|.+.+.. ....+++..++.++.||+.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 71 QRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred CCceEEEEecCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCccccee
Confidence 9999999999985 67766653 345789999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
..+... .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||...+..+....+... .....+
T Consensus 150 ~~~~~~--~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 223 (256)
T cd05059 150 VLDDQY--TSSQGTKFPVKWAPPEVFDY---SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRP 223 (256)
T ss_pred cccccc--cccCCCCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCC
Confidence 543211 11112234568999999874 368889999999999999999 89999988887777766543 344567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
..++.++.+++.+||..+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 77899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=311.57 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=205.4
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
+.||+|+||.||+|.+...+. ....||||.+...... ....+..+. ..++.++|+||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGG---KVIPVAVKCLKSDKLSDIMDDFLKEA--AIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCC---CceEEEEeecCCcccHHHHHHHHHHH--HHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 468999999999999865321 2346999999876553 222232222 25667899999999999887 8999999
Q ss_pred ecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 126 KFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 126 Ey~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
||++ |+|.+.+.......+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9998 577777765333578999999999999999999999999999999999999999999999999998765422211
Q ss_pred CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
.......++..|+|||++.+ ..++.++|+|||||++|||++ |..||...+..++...+.........+..++..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRT---RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIY 231 (257)
T ss_pred ecccCCCCCceecCHHHhcc---cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHH
Confidence 22224567889999999873 358889999999999999999 99999988888887777655555566778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 284 NVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+++.+||+.+|++||++.++++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=342.77 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=212.8
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHH-HHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~-ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|.-++.||.|+||.||-|++..+.+ .||||.+.-...+........+.++ ++..+.|||++.+.+||..+...
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~e------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccc------eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence 6667889999999999999988876 8999999755444444333333333 78899999999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
|||||||-|+..|++.- ..+++-+.++..|..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.+.
T Consensus 102 WLVMEYClGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---- 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---- 176 (948)
T ss_pred HHHHHHHhccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----
Confidence 99999999998888865 4568999999999999999999999999999999999999999999999999988764
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC-CCCCH
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP-SGLPP 280 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p-~~~s~ 280 (627)
....+++|||.|||||+|.....|.|+-++||||||++..||...++|+..++....+-.|.+. ..|.++ ..++.
T Consensus 177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs~eWS~ 252 (948)
T KOG0577|consen 177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSD 252 (948)
T ss_pred ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCCchhHH
Confidence 3456789999999999998877889999999999999999999999999888876654445433 233333 56889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+..|+..||++-|.+|||..++++
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 9999999999999999999999887
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=335.10 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=195.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING- 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~- 119 (627)
++|.-...||+|+||.||+|..... ..||||.+..........+..+.. ++..++|||+++|+|+|.+.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-------~~vAVK~~~~~~~~~~~eF~~Ei~--~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-------TVVAVKRLSSNSGQGEREFLNEVE--ILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-------CEEEEEEecCCCCcchhHHHHHHH--HHhcCCCcCcccEEEEEecCCc
Confidence 5778889999999999999986543 479999887655442222433332 456677999999999999988
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccCCCcEEEecCCCeeeccCCccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG---ILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g---IvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+||+||++ |+|.+.+......+++|..+++|+.++|.||+|||... ||||||||+|||||+++.+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999999 78888886533228999999999999999999999854 9999999999999999999999999996
Q ss_pred cccCCCCCCCCCCcc-CCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhc
Q 006887 196 LLLGIPLPSSDLPRR-LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---VDEIYD---AVVRR 268 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~-~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---~~e~~~---~i~~~ 268 (627)
..... .....+. .||.+|+|||++. .+..+.++||||||++|+||+||+.|..... ...+.. .....
T Consensus 226 ~~~~~---~~~~~~~~~gt~gY~~PEy~~---~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 226 LGPEG---DTSVSTTVMGTFGYLAPEYAS---TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCCcc---ccceeeecCCCCccCChhhhc---cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 65321 1111222 8999999999997 4679999999999999999999998877432 111222 11111
Q ss_pred c-----CCCCCC-CCCC-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 269 Q-----EIPPIP-SGLP-----PAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 269 ~-----~~~~~p-~~~s-----~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
. ..+.+. ...+ ..+..+..+|++.+|..||+|.+++++|+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 1 112222 2223 2356788999999999999999999988553
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.61 Aligned_cols=256 Identities=23% Similarity=0.258 Sum_probs=203.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|++++.||.|+||.||+|++..++. .||||.+....... .......+. ..++.++||||+++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAIREI-SLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC------EEEEEEccccccccccchHHHHHH-HHHHhcCCCCCcchhhhcccCCc
Confidence 58999999999999999999876654 89999986543211 111112222 25667799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.++||||+.+++.+.+.......+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||+++.....
T Consensus 74 ~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 74 LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999988888876655678999999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-------- 272 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-------- 272 (627)
........+++.|+|||++.+. ..++.++|+|||||++|+|+||+.||.+.+..+....+......+
T Consensus 154 ---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 154 ---VRTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ---ccccccccccccccCCeEEecC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 1222344678999999988642 246788999999999999999999998876554443333211110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 -------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 -------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.....+++++.++|.+||+.||.+||++.++++ |+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~------~~~f 284 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA------HPFF 284 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc------CCCC
Confidence 112357889999999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.54 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=207.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++.+.||+|+||.||+|.+..++.. ....||+|.+..............+ ...+..+.||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~-~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDH-MLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHH-HHHHhcCCCCCcceEEEEEC-
Confidence 4567899999999999999999998665431 1124788887543222111111111 12446779999999999875
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
....+++|||++ |+|.+.+.. ..+.+++..++.++.||+.||.|||+++++||||||+|||++.++.++|+|||+++.
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 456789999998 677777654 446799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... ........++..|+|||++. .+.++.++|+|||||++|||++ |..||.+....++.+.+ .....+..+
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~---~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 233 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESIL---FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQP 233 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhc---cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCC
Confidence 643221 11223456778999999987 3468999999999999999998 99999988777665544 344445556
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..++.++.+++.+||..||++||++.++++.|..+.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 778899999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.46 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=198.7
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEec
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKF 127 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy 127 (627)
.||+|+||.||+|.+.... .+..||+|++.............++. .+++.++|+||+++++++. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~-~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREA-EIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHH-HHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 3899999999999875332 22469999997654333322233333 2556689999999999876 4578999999
Q ss_pred CCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCC
Q 006887 128 YEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206 (627)
Q Consensus 128 ~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 206 (627)
++| +|.+.+. .....+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||+++.+.........
T Consensus 76 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLS-GKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 985 5555543 34567999999999999999999999999999999999999999999999999999865432221111
Q ss_pred CCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHH
Q 006887 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285 (627)
Q Consensus 207 ~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~l 285 (627)
.....+++.|+|||++.. ..++.++|+|||||++|||++ |..||.+....++...+.. ......+..+++++.++
T Consensus 155 ~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l 230 (257)
T cd05115 155 RSAGKWPLKWYAPECINF---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECPPEMYAL 230 (257)
T ss_pred cCCCCCCcccCCHHHHcc---CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHHHH
Confidence 222344678999999873 358889999999999999996 9999999888877766644 34556788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 286 LLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 286 i~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+.+||..+|++||++.++.+.|+.
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhh
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.97 Aligned_cols=269 Identities=19% Similarity=0.255 Sum_probs=210.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||++.+..++. .||+|.+......... .....+. .+++..+||||+++++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQ------RFAMKKINKQNLILRNQIQQVFVER-DILTFAENPFVVSMFCSFETK 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCc------EEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEecC
Confidence 479999999999999999999876654 8999998765322111 1112222 256678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+. ..+.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred CEEEEEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 999999999996 6655554 3357899999999999999999999999999999999999999999999999998742
Q ss_pred cCCCCC------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 198 LGIPLP------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 198 ~~~~~~------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
...... ........|++.|+|||.+.+ ..++.++|+|||||++|||++|..||.+.+..+++..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111000 001123468899999999863 46889999999999999999999999998888888776
Q ss_pred HhccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCC
Q 006887 266 VRRQE-IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHG 324 (627)
Q Consensus 266 ~~~~~-~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~ 324 (627)
..... .+.....++.++.++|.+||+.||++||+..++++.++ ++||...+|....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~---~~~~~~~~~~~~~ 285 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ---HRFFLGLDWNGLL 285 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh---CccccCCCHHHHh
Confidence 65432 22233468999999999999999999998544444333 8998888776644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=320.71 Aligned_cols=255 Identities=19% Similarity=0.259 Sum_probs=206.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..|++.+.||+|+||.||+|.+..++ +.||+|++...... ....+.. +. .+++.++||||+++++++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~-Ei-~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTN------EVVAIKKMSYSGKQSNEKWQDIIK-EV-RFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCC------cEEEEEEEeccccCcHHHHHHHHH-HH-HHHHhCCCCCEEEEEEEEEe
Confidence 46999999999999999999987655 38999998643322 1122222 22 25667899999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++..|+||||+.|++.+.+.. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 87 EHTAWLVMEYCLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred CCeEEEEHHhhCCCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999999999999998887764 3457999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. .....|++.|+|||++.+...+.++.++|+||||+++|||++|++||.+.+.......+.........+..
T Consensus 166 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 166 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred CC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 32 23457889999999986433456889999999999999999999999888776655444432222222345
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++..+.+++.+||+.+|++||++.+++. |+|+..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~ 272 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLK------HRFVLR 272 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhc------Chhhcc
Confidence 7889999999999999999999999987 666553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=314.40 Aligned_cols=256 Identities=19% Similarity=0.269 Sum_probs=201.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++..+++ .||+|++...... ........+. .++....|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQ------IVAIKKFVESEDDPVIKKIALREI-RMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCc------EEEEEEEeecccCccccHHHHHHH-HHHHhCCCCCEeeeeeEEeeCC
Confidence 479999999999999999999876554 8999998654321 1111222222 2556678999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..++||||+++++++.+.. ....+++..++.++.||+.||.|||+.+++||||||+||+++.++.++|+|||++.....
T Consensus 74 ~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999999999877776654 345689999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
... ......++..|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+....+.....
T Consensus 153 ~~~---~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 153 PGD---DYTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred Ccc---cccCcccccccCCHHHHhCC--CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 221 22344688999999998642 3578899999999999999999999998766544333221100
Q ss_pred -----------CCC---------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 -----------IPP---------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 -----------~~~---------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+. ....++..+.+|+.+||+.+|++||++.+++. |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~------~~~f 286 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE------HPYF 286 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc------CCCC
Confidence 000 01356888999999999999999999999988 7765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.16 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=208.4
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcC----------cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCc
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTED----------CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed----------~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnI 108 (627)
..++|++.+.||+|+||.||+|.+..++.. ......||+|++..............+.+ .+..++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK-ILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHH-HHHhcCCCCE
Confidence 456899999999999999999988654421 12345799999976544332322333322 4566799999
Q ss_pred eeeEEEEEECCEEEEEEecCCC-CHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 109 CWLQGISVINGKICIIMKFYEG-SVGDRMAQLK---------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 109 v~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~---------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
+++++++..++..++||||+++ +|.+.+.... ...+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999984 6666665422 12689999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh--CCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT--GVQPRCGR 256 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt--G~~Pf~~~ 256 (627)
+++.++.++|+|||+++....... ........+|+.|||||++.+ +.++.++|+|||||++|||++ +..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLL---GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhc---CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999886543221 112234467889999999873 468899999999999999998 78899887
Q ss_pred CHHHHHHHHHhc------cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 257 SVDEIYDAVVRR------QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 257 ~~~e~~~~i~~~------~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+..+++..+... ....+.+..++.++.+++.+||+.||.+||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 777776665432 1122345667899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=311.50 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=207.1
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
++..++|++.+.||+|+||.||+|.+..+. .+|+|.+....... ..+.. +. .+++.+.|+|++++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~lK~~~~~~~~~-~~~~~-E~-~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTT-------KVAIKTLKPGTMMP-EAFLQ-EA-QIMKKLRHDKLVPLYAVVS 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCc-------eEEEEEcccCCccH-HHHHH-HH-HHHHhCCCCCeeeEEEEEc
Confidence 366788999999999999999999875543 59999987544321 22222 22 2566789999999998875
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+..|+||||+++ +|.+.+.......+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 4568999999985 88887765445568999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
....... .......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+....+....+... ...+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 224 (260)
T cd05069 151 LIEDNEY--TARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPC 224 (260)
T ss_pred EccCCcc--cccCCCccchhhCCHHHhcc---CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence 6543211 11123356778999998863 468889999999999999999 99999988887777666543 34456
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..++..+.+++.+||+.||++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 77889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.23 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=204.6
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--H-HHHHHHHH-HHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--R-MRVLLERL-NDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~-~~~~~~~~-~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
.||+|+||.||+|.+..++ +.||+|++.+.... . ........ ...+.....||+|+.+++++...+..|+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 74 (278)
T ss_pred CcccCCCeEEEEEEEecCC------CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence 3899999999999986655 48999998764321 1 11111111 1113344689999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||++| +|.+.+. ..+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.+..
T Consensus 75 v~e~~~g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~--- 149 (278)
T cd05606 75 ILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 149 (278)
T ss_pred EEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc---
Confidence 9999996 5544443 446799999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCCCCCCC
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
.......||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+. ...+..... ......++..++
T Consensus 150 --~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s 223 (278)
T cd05606 150 --KKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFS 223 (278)
T ss_pred --cCCcCcCCCcCCcCcHHhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCC
Confidence 122345799999999998632 24788999999999999999999999876 333332222 223455677789
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCC
Q 006887 280 PAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDK 331 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~ 331 (627)
.++.+++.+||..+|.+|| ++.++++ |+|+...+|........+++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~------~~~~~~~~~~~~~~~~~~~~ 274 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------HPFFRSLDWQMVFLQKYPPP 274 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh------CccccCCCchHhhhcccCCC
Confidence 9999999999999999999 9999987 99999998877765554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.17 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=204.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
.+|++.+.||+|+||.||+|.+..++ +.||+|.+..........+..+. ..++...|+||+++++.+..+..
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~e~--~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATG------QEVAIRQMNLQQQPKKELIINEI--LVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCC------cEEEEEEEecCCcchHHHHHHHH--HHHHhCCCCCEeeEEEEEEeCCE
Confidence 68999999999999999999976655 48999998765544333333222 24567899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+. ...+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEEeecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999985 6666553 34689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-~~~~~~~p~~~ 278 (627)
.. .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.. .......+..+
T Consensus 169 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06654 169 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (296)
T ss_pred cc---cccCcccCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcccc
Confidence 11 12234578999999999874 3578899999999999999999999988766443333322 22222345678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+..+.+++.+||..+|++||++.++++ ++|+.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~------~~~~~ 274 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ------HQFLK 274 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh------Chhhh
Confidence 899999999999999999999999998 77654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=316.87 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=200.8
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--H-HHHHHHHH-HHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--R-MRVLLERL-NDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~-~~~~~~~~-~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
.||+|+||.||++.+..++ +.||+|.+.+.... . .....+.. ...+....+|++|+.+++.+..++..|+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG------KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF 74 (279)
T ss_pred CcccCCCeEEEEEEECCCC------cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence 3899999999999987655 48999998754321 1 11111111 1113334579999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||++| +|.+.+. ..+.+++..+..++.|++.||.|||+++|+||||||+|||+++++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 75 ILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred EEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 9999995 5544443 3467999999999999999999999999999999999999999999999999998755321
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCCCCCCCCCCH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD--EIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~--e~~~~i~~~~~~~~~p~~~s~ 280 (627)
......||+.|||||.+.. ...++.++|+|||||++|+|++|..||...... +...... ......++..+++
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (279)
T cd05633 151 ---KPHASVGTHGYMAPEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSP 224 (279)
T ss_pred ---CccCcCCCcCccCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCH
Confidence 2234579999999999853 234788999999999999999999999754321 1222221 2234456778999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCC
Q 006887 281 AVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDK 331 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~ 331 (627)
++.++|.+||..||.+|| +++++++ |+||...+|........++|
T Consensus 225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~------h~~~~~~~~~~~~~~~~~~~ 274 (279)
T cd05633 225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE------HVFFKGIDWQQVYLQKYPPP 274 (279)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh------CccccCCCHhHHhcCCCCCC
Confidence 999999999999999999 5999888 99999888766543333333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=315.61 Aligned_cols=259 Identities=22% Similarity=0.279 Sum_probs=196.4
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--CCE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--NGK 120 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~~~ 120 (627)
|++++.||+|+||.||++...... ...+..||+|+++............++.+ .++.++||||+++++++.. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPAN--DGTGEMVAVKTLKRECGQQNTSGWKKEIN-ILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEcccc--CCCCceEEEEEeccccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCCce
Confidence 499999999999999998754322 12446899999976543222222222322 5667799999999998765 346
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.++||||+++ +|.+.+. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 8999999995 6655553 24699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH--H------------HHHHH
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD--E------------IYDAV 265 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~--e------------~~~~i 265 (627)
............++..|+|||++.+ ..++.++|+|||||++|||++|..||...... + .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE---NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc---cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 2211111223356678999999863 46888999999999999999999998643211 0 11111
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.......+.+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 122233445678899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.34 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=201.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch----hHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE----DRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~----~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.+|++.+.||+|+||.||+|.+..++ ..||||.+..... .........+. ..++.+.|+||+++++++
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~ 73 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTG------RELAVKQVQFDPESPETSKEVNALECEI-QLLKNLLHERIVQYYGCL 73 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCC------cEEEEEEeecCcCCcccHHHHHHHHHHH-HHHHhcCCCCeeeEEeEe
Confidence 468999999999999999999987655 4899998864221 11111222222 246677999999999988
Q ss_pred EE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 116 VI--NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 116 ~~--~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.+ ...++++|||++| +|.+.+. ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 74 RDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred ccCCCceEEEEEEecCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 76 3578999999985 6666654 33568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++................||..|+|||++.+ ..++.++|+|||||++|||++|+.||...+.......+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISG---EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcC---CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCC
Confidence 98866432222223344579999999999874 357889999999999999999999998876665555554444455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..|..++..+.+++.+|+ .+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 567788899999999999 49999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=309.77 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=204.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-|+..+|++.+.||+|+||.||++.... ..||+|.+..... ...+.. +. ..++.++|+|++++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~k~~~~~~~--~~~~~~-e~-~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDAT--AQAFLA-EA-SVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcC--------CcEEEEEeCCCch--HHHHHH-HH-HHHHhCCCCCeeeEEEEEE
Confidence 3677899999999999999999997642 3699999865432 122222 22 2566679999999999764
Q ss_pred -ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 117 -INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 117 -~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.++..++||||++ |+|.+.+.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred cCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccc
Confidence 4567999999998 57777776544456899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+..... .....++..|||||++.+ ..++.++|+|||||++|||++ |+.||...+..++...+... ..+.
T Consensus 150 ~~~~~~------~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 219 (256)
T cd05082 150 KEASST------QDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 219 (256)
T ss_pred eecccc------CCCCccceeecCHHHHcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCC
Confidence 765321 123345678999999873 368889999999999999998 99999988887777666543 3455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.+..+++.+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 677899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.81 Aligned_cols=264 Identities=21% Similarity=0.345 Sum_probs=208.7
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
||+|+||.||+|.+..++ +.||+|++........ ......+ ..+++.++||||+.+++.+...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATG------KMYACKKLDKKRLKKRKGEQMALNE-KKILEKVSSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCC------cEEEEEEEehhhhhhhhhhHHHHHH-HHHHHhCCCCCEeeeeeEEecCCeEEEEEe
Confidence 689999999999877655 4899999875332111 1111122 235677789999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+.......+++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||++..... ..
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~----~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG----GK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc----CC
Confidence 9995 777666554445799999999999999999999999999999999999999999999999999876533 12
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCCHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV----DEIYDAVVRRQEIPPIPSGLPPA 281 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~----~e~~~~i~~~~~~~~~p~~~s~~ 281 (627)
......++..|+|||++.+ +.++.++|+|||||++|+|++|+.||..... .++...+. ......+..+++.
T Consensus 150 ~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQG---EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcC---CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--cccccCCccCCHH
Confidence 2234568899999999874 3588899999999999999999999987543 22322222 1234466778999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 282 VENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 282 l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
+.++|.+||+.||.+|| ++.++++ |+|+...+|.........+|+.+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~------h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE------HPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh------ChhhhcCChhhhhcCCCCCCCCC
Confidence 99999999999999999 6666776 99999999988876666666554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.24 Aligned_cols=267 Identities=21% Similarity=0.294 Sum_probs=224.6
Q ss_pred CcCC-CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKP-SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~-~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.+++ +.|.|+..||.|+||.||+|..+.++- .-|.|++..........++..+. ++..+.||+|++|++.|
T Consensus 27 dlnP~d~WeIiGELGDGAFGKVyKA~nket~~------lAAaKvIetkseEELEDylVEIe--ILa~CdHP~ivkLl~ay 98 (1187)
T KOG0579|consen 27 DLNPRDHWEIIGELGDGAFGKVYKAVNKETKL------LAAAKVIETKSEEELEDYLVEIE--ILAECDHPVIVKLLSAY 98 (1187)
T ss_pred cCCHHHHHHHHhhhcCccchhhhhhhcccchh------hhhhhhhcccchhHHhhhhhhhh--hhhcCCChHHHHHHHHH
Confidence 3444 568999999999999999999876553 67889988777776666655543 45556799999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++.++|..|||+|+.-|.+..--+..+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+-
T Consensus 99 y~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 99 YFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred hccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence 99999999999999887787766567889999999999999999999999999999999999999999999999999875
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-QEIP 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~-~~~~ 272 (627)
.... ......+++|||.|||||+..++ ...||++++||||||++|.||..+.+|....++..++-+|... ....
T Consensus 179 Kn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL 255 (1187)
T KOG0579|consen 179 KNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 255 (1187)
T ss_pred cchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc
Confidence 4321 12234578999999999998874 3568999999999999999999999999999998887776532 2223
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
-.|..++..+.+|+.+||.+||+.||++.++++ |+|+.....
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~------Hpfv~~~~S 297 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK------HPFVQNAPS 297 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh------CcccccCCc
Confidence 357889999999999999999999999999998 888875543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.25 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=203.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+.++|+..+.||+|+||.||++.+..++ +.||+|.+..............+...+.+...|+||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSG------TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCC------CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 3457778889999999999999987665 4899999876443322222333333444555699999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 119 GKICIIMKFYEGSVGDRMAQ---LKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~---~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
+..+++|||+.+++.++... .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 76 ~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 76 GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999999999877665432 2346799999999999999999999985 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~~~ 273 (627)
+.+... .......||+.|+|||++.+.....++.++|+|||||++|+|++|++||..... .+....+... ..+.
T Consensus 156 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 230 (288)
T cd06616 156 GQLVDS----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPI 230 (288)
T ss_pred HHhccC----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCc
Confidence 765432 122334689999999998743223588899999999999999999999976542 1222222211 1122
Q ss_pred C----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 274 I----PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 274 ~----p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
+ +..++.++.+|+.+||+.+|++||++.++++ |+|+....
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~------~~~~~~~~ 274 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE------HPFIKDYE 274 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc------Chhhhchh
Confidence 2 2357899999999999999999999999998 88876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.10 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=204.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|++.+.||+|+||.||+|.+..++. .||+|++..... .........+. .+++..+|+||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGE------TVALKKVALRRLEGGIPNQALREI-KALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCc------eEEEEEEEcccccchhhHHHHHHH-HHHHhCCCCCCcceeeEEecCCe
Confidence 58999999999999999999876653 899999976542 11111222222 25566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||+.++|.+.+.. ....+++..++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 74 ~~~v~e~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 74 FVLVMEYMPSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred eEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999999997788777654 3467999999999999999999999999999999999999999999999999998876432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-------- 272 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-------- 272 (627)
.. .......|+..|+|||++.+. ..++.++|+|||||++|||++|.+||.+.+..+.+..+......+
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 153 EP--RLYSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CC--CccccccCcccccCceeeecc--ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhc
Confidence 11 223345799999999998642 356889999999999999999999998877666555544321111
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 --------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 --------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...+..+.++.+++.+||..+|++||++.++++ |+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~------h~~~ 285 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR------HPYF 285 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh------CcCc
Confidence 011356789999999999999999999999998 8876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.96 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=206.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||++++..++ +.||+|.+..... ...... ..+. ..++.++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~-~~e~-~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG------KQYVIKEINISKMSPKEREES-RKEV-AVLSNMKHPNIVQYQESFEENG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC------CEEEEEEEEhHhCChHHHHHH-HHHH-HHHHhCCCCCeeeeEeeecCCC
Confidence 5899999999999999999987654 4899999864321 122222 2222 2567789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||+.| +|.+.+.......+++..++.++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++....
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 99999999985 77777765444578999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
... .......|++.|+|||++.+ +.++.++|+|||||++|+|++|+.||...+..+....+... ..+..+..+
T Consensus 153 ~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08218 153 STV---ELARTCIGTPYYLSPEICEN---RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-SYPPVSSHY 225 (256)
T ss_pred cch---hhhhhccCCccccCHHHhCC---CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-CCCCCcccC
Confidence 321 11223468999999999874 35788999999999999999999999988888877776543 345567889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+.++.++|.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.31 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=199.9
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc--hhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC---
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK--EDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN--- 118 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~--~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~--- 118 (627)
.+.+.||+|+||.||+|.+..++. ...||+|.++... ......+.. +. ..++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~----~~~~a~k~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDS----ILKVAVKTMKIAICTRSEMEDFLS-EA-VCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCC----eeeEEEEecccCcCCHHHHHHHHH-HH-HHHHhCCCCCcceEEEEEccCCcc
Confidence 467889999999999999765542 1369999987542 222222222 22 245667999999999987532
Q ss_pred ---CEEEEEEecCC-CCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 119 ---GKICIIMKFYE-GSVGDRMAQL----KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 119 ---~~~~LVmEy~~-GsL~d~l~~~----~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
...+++|||++ |+|.+.+... ....+++..++.++.||+.||.|||+++|+||||||+|||+++++.++|+|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECC
Confidence 24789999998 5666655322 224589999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~ 269 (627)
||+++....... ........+++.|++||+..+ ..++.++|+|||||++|||++ |+.||.+....+++..+...
T Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 230 (272)
T cd05075 156 FGLSKKIYNGDY-YRQGRIAKMPVKWIAIESLAD---RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG- 230 (272)
T ss_pred CCcccccCcccc-eecCCcccCCcccCCHHHccC---CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 999987643221 111223356788999999873 468889999999999999999 89999988888877766543
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.....+..++..+.+++.+||+.||++||++.++++.|+.
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 3445677899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.54 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=206.0
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|.+.... ..+..||+|+++.............+.. .+..++|+||+++++++..++..++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEAR-VMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHH-HHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46999999999999987541 1235899999987654432222222222 4555679999999999999999999999
Q ss_pred cCC-CCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 127 FYE-GSVGDRMAQLK-------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 127 y~~-GsL~d~l~~~~-------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
|++ |+|.+.+.... ...+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 996 67777765431 4679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.... ........+++.|+|||.+.. ..++.++|+|||||++|+|++ |..||...+..++...+.. ......+..
T Consensus 157 ~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (262)
T cd00192 157 DDDY-YRKKTGGKLPIRWMAPESLKD---GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEY 231 (262)
T ss_pred cccc-cccccCCCcCccccCHHHhcc---CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 4321 122334568899999999874 368899999999999999999 6999999988888877765 345567888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
+++++.+++.+||..+|++||++.++++.|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.50 Aligned_cols=264 Identities=21% Similarity=0.331 Sum_probs=211.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++++.||+|+||.||+|+...+.+ ......||+|.+..............+.+ ++..++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELD-MFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHH-HHHhcCCcceeeeEEEECC
Confidence 455789999999999999999999865543 23446899999876544322222233322 4566799999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKG-------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~-------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
.+..|+||||++ |+|.+.+..... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 899999999999 577777654331 268999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||+++...... ........+++.|+|||.+.+ +.++.++|+||||+++|+|++ |..||.+....+.+..+...
T Consensus 160 ~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~ 234 (275)
T cd05046 160 LLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQE---DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234 (275)
T ss_pred ccccccccCccc--ccccCCceeEEeecChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC
Confidence 999987543211 112234467788999999873 357889999999999999998 89999888777777776654
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
......+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 4444556788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.55 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=207.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||.|+||.||+|....++ ..+|+|++.............++.. .++.+.|+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN------EKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC------cEEEEEEeccCCcchHHHHHHHHHH-HHHhcCCCCEEEEEEEEeeCCE
Confidence 47999999999999999999976654 3899999975443322222222222 4566899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.++||||++| ++.+.+..... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..+.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999985 66666654332 578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCC-CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--
Q 006887 199 GIPLPS-SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP-- 275 (627)
Q Consensus 199 ~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p-- 275 (627)
...... .......|++.|+|||++... ..++.++|+|||||++|+|++|+.||...+..+.+..+.... .+.++
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 230 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETG 230 (267)
T ss_pred cCccccccccccccCChhhcChHHHccc--cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCc
Confidence 433221 122345799999999998743 257889999999999999999999999887776666655432 22222
Q ss_pred ---CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 276 ---SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 276 ---~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
..+++++.+++.+||+.||++||++.++++ |+||
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~------~p~~ 267 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK------HKFF 267 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh------CCCC
Confidence 367899999999999999999999999998 7765
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.49 Aligned_cols=249 Identities=20% Similarity=0.345 Sum_probs=204.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|++.+.||+|+||.||+|.+..++ ..+|+|.+...... ........+. ..++.++|+||+.+++.+..++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ------KLVIIKQIPVEQMTKDERLAAQNEC-QVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC------cEEEEEEEeccccccHHHHHHHHHH-HHHhhCCCCchhheeeeEecCCE
Confidence 5899999999999999999987655 48999998754321 1111222222 25677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCcccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla~~~~ 198 (627)
.++||||++| +|.+.+.......+++..++.++.|++.+|.|||+++++|+||||+||+++.++ .++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 9999999985 777777654456689999999999999999999999999999999999998654 57999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
.. .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+... ...+++..+
T Consensus 154 ~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 225 (256)
T cd08220 154 SK----SKAYTVVGTPCYISPELCEG---KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-TFAPISDRY 225 (256)
T ss_pred CC----ccccccccCCcccCchhccC---CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCCCCc
Confidence 32 22234578999999999874 35788999999999999999999999988877777666543 334567789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++++.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 999999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.59 Aligned_cols=264 Identities=20% Similarity=0.311 Sum_probs=212.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+...+|++.+.||+|+||.||+|.+..+++ .....||+|.+..............+. ..++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGE--KVKIPVAIKVLREETSPKANKEILDEA-YVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCC--CcceEEEEEeccCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEec
Confidence 456789999999999999999999876543 123479999987654432222222222 24566799999999999886
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
...++||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+.+++||||||+||+++.++.++|+|||+++.
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 78999999998 577766653 345689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
+....... ......++..|+|||.+. ...++.++|+|||||++||+++ |+.||.+.+..++...+.. ....+.+
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~---~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~ 233 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESIL---HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQP 233 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhh---cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCC
Confidence 64321111 111233467899999986 3468899999999999999998 9999999888888776654 3345567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..++..+.+++.+||..||..||++.++++.|++..
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.32 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=209.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.++.++|++.+.||+|+||.||+|.+..+ +.||||.+....... ..+..+. ..++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~-------~~~~vK~~~~~~~~~-~~~~~e~--~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGT-------TKVAVKTLKPGTMSP-EAFLQEA--QIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCC-------ceEEEEEecCCccCH-HHHHHHH--HHHhhCCCCCEeeeeeeee
Confidence 36788999999999999999999986533 369999997644322 2222222 2556688999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+...++||||++| +|.+.+.......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 88999999999985 77777765444678999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..... .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+..+.+..+... ...+.
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 225 (261)
T cd05034 152 LIEDDEY--TAREGAKFPIKWTAPEAANY---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR 225 (261)
T ss_pred eccchhh--hhhhccCCCccccCHHHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCC
Confidence 6643111 11112335678999999874 358889999999999999998 99999988888877776543 34455
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 67789999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.34 Aligned_cols=264 Identities=21% Similarity=0.336 Sum_probs=208.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...++.++|++.+.||+|+||.||+|.+..++ +.||||.++.............+...+.....|+||++++++
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTG------HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCC------eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 55678899999999999999999999987654 489999997643322222222222345555679999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+......|+||||+++++.+++.. ....+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||+
T Consensus 83 ~~~~~~~~~v~e~~~~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 83 FITDSDVFICMELMSTCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred eecCCeEEEEeeccCcCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 999999999999999887777665 34589999999999999999999997 5999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCC-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEI 271 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~ 271 (627)
+..+... .......+++.|+|||++.+.. .+.++.++|+||||+++|+|++|+.||..... .+.+..+.... .
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~ 236 (296)
T cd06618 162 SGRLVDS----KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-P 236 (296)
T ss_pred chhccCC----CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-C
Confidence 8765431 1223346889999999987542 34588899999999999999999999976433 34444444332 2
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 PPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+..+ ..++.++.+++.+||+.||.+||++.++++ ++|+.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~------~~~~~ 277 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ------HPFIR 277 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc------Chhhh
Confidence 2222 347899999999999999999999999988 66654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.18 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=199.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|.+..++. .||||++..... ........ +. .+++.++|+||+++++++..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~~~~~~ 86 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQ------NVAIKKLSRPFQNVTHAKRAYR-EL-VLMKLVNHKNIIGLLNVFTP 86 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCC------EEEEEecCccccChhHHHHHHH-HH-HHHHhcCCCCCcceeeeecc
Confidence 4789999999999999999999877654 899999865322 12222222 22 35677899999999998864
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 118 N------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 118 ~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
. ...|+||||+.+++.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 87 QKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CCCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccC
Confidence 3 35799999999998887753 2899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+....+..+......
T Consensus 163 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 163 GLARTAGTS----FMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred ccceeCCCC----CCCCCCcccccccCHHHHhC---CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999865331 12234578999999999974 46889999999999999999999999877655444433221110
Q ss_pred CC----------------------------------C-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 272 PP----------------------------------I-------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 272 ~~----------------------------------~-------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+. + +...++.+.++|.+||+.||++||++.++|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~----- 310 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ----- 310 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc-----
Confidence 00 0 1134667899999999999999999999998
Q ss_pred ccccCC
Q 006887 311 QNSVHS 316 (627)
Q Consensus 311 ~~~~~~ 316 (627)
|+|+.
T Consensus 311 -~~~~~ 315 (353)
T cd07850 311 -HPYIN 315 (353)
T ss_pred -ChhHh
Confidence 88765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=334.99 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=207.0
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc-----CCCCceeeEEEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ-----GVEGICWLQGISV 116 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~-----~hpnIv~l~~~~~ 116 (627)
+|.+++.||+|+||.|.+|.++.+++ .||||++++...-..+...+ ..++.... +--|+|+++++|.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e------~VAIKIiKN~k~f~~Q~~~E--i~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGE------IVAIKIIKNKKRFLRQAQIE--IRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCc------EEEEEeeccChHHHHHHHHH--HHHHHHHhccCCCCCeeEEEeeeccc
Confidence 68999999999999999999999887 89999998765433222211 11222222 2247999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC--CCeeeccCCcc
Q 006887 117 INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA--DRAVLGDVGIP 194 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~--g~vkL~DFGla 194 (627)
..+..|||+|++.-+|.+++..++-..|++..+..++.||+.||.+||+.+|||.|||||||||..- ..+||+|||.+
T Consensus 259 fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 259 FRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred cccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999999999999999998877889999999999999999999999999999999999999643 47999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-- 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-- 272 (627)
..... ...+.+-+..|.|||++.| .+|+.+.||||||||+.||++|.+.|.|.+..+.+..|.+-...|
T Consensus 339 c~~~q------~vytYiQSRfYRAPEVILG---lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 339 CFESQ------RVYTYIQSRFYRAPEVILG---LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred cccCC------cceeeeeccccccchhhcc---CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 77532 3336678889999999985 589999999999999999999999999998877766665411110
Q ss_pred ------------------------------------------------CCC-----------CCCCHHHHHHHHHhhhcC
Q 006887 273 ------------------------------------------------PIP-----------SGLPPAVENVLLGCFEYD 293 (627)
Q Consensus 273 ------------------------------------------------~~p-----------~~~s~~l~~li~~cL~~d 293 (627)
..| ..-...+.+||.+||..|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 011 012355789999999999
Q ss_pred CCCCCCHHHHHHHHHhcccccCCCC
Q 006887 294 LRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 294 P~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|.+|++..++|+ |+|+...
T Consensus 490 P~~R~tp~qal~------Hpfl~~~ 508 (586)
T KOG0667|consen 490 PAERITPAQALN------HPFLTGT 508 (586)
T ss_pred chhcCCHHHHhc------Ccccccc
Confidence 999999999998 9998754
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.60 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=207.4
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|+.++.||.|+||.||.+++..+++ .+++|.+..... .....+. .+. ..++.++|+||+++++++...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~-~e~-~~l~~~~h~~i~~~~~~~~~~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDS------LVVWKEVNLTRLSEKERRDAL-NEI-VILSLLQHPNIIAYYNHFMDDN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCc------EEEEEEEeecccchhHHHHHH-HHH-HHHHhCCCCCeeEEEeEEecCC
Confidence 59999999999999999999876654 899999865432 2222222 222 2566679999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..+++|||++ |+|.+.+.......+++..+..++.|++.+|.|||+.+++|+||||+||++++++.++|+|||+++...
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 9999999998 577777765445678999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
... .......|++.|+|||++.+. .++.++|+|||||++|||++|..||...+..+....+.... ....+..+
T Consensus 153 ~~~---~~~~~~~~~~~y~ape~~~~~---~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (256)
T cd08221 153 SEY---SMAETVVGTPYYMSPELCQGV---KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVY 225 (256)
T ss_pred ccc---ccccccCCCccccCHhhcCCC---CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCcccc
Confidence 322 123456799999999998743 57789999999999999999999999988888877776443 33455778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+.++.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.33 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=207.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+.++|++.+.||+|+||.||+|.+..+++ .||+|.++....... ......+. .+++.++|+||+++++++..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGE------IVALKKVRMDNERDGIPISSLREI-TLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCc------EEEEEEEEeccCCCCCcchhhHHH-HHHHhCCCCCCcceEEEEec
Confidence 56799999999999999999999876664 899999875432211 11111122 25567899999999999875
Q ss_pred C--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 N--GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~--~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
. +..++||||+.++|.+.+... ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 78 KHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred CCCCeEEEEEecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 4 568999999999888887653 3678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--- 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--- 272 (627)
...... .......+++.|+|||++.+. ..++.++|+|||||++|||++|++||.+.+..+.+..+......+
T Consensus 157 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 157 TYGLPA---KPMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred ecCCcc---CCCCcccccccccChhhhcCC--CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 764321 122333568899999998642 357889999999999999999999999988877776665422110
Q ss_pred --------------CC-----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 --------------PI-----------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 --------------~~-----------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.. ....++++.++|.+||+.||++||++.++++ |+||...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~------h~~f~~~ 296 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE------SSYFKEK 296 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc------ChhhccC
Confidence 00 0235888999999999999999999999998 9988754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=310.59 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=216.6
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...++++.+.+..||.|+.|.|++++.+.++. ..|||.+...... +..+.+. -..+++++...|+||+.+|+
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~------iiAVK~M~rt~Nkee~kRILm-Dldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGH------IIAVKQMRRTGNKEENKRILM-DLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccce------EEEEEeecccCCHHHHHHHHH-hhhHHhhccCCCeeeeeeeE
Confidence 34566788899999999999999999988764 8999999875443 3333333 23456777778999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
|..+..++|.||.|.-- .+.+...-.+++++..+-++...++.||.||-+ ++|||||+||+|||+|+.|++||+|||+
T Consensus 160 Fi~n~dV~IcMelMs~C-~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 160 FITNTDVFICMELMSTC-AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred EeeCchHHHHHHHHHHH-HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccc
Confidence 99999999999998743 444444456789999999999999999999986 5799999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~~~~ 272 (627)
+..+.+. ...+...|.+.|||||.+.......|+.++|+||||++++||.||..||.+.+ ..+++.++.+. ..|
T Consensus 239 sGrlvdS----kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-ePP 313 (391)
T KOG0983|consen 239 SGRLVDS----KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EPP 313 (391)
T ss_pred cceeecc----cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CCC
Confidence 9887652 23344589999999999987656679999999999999999999999999854 56777777763 345
Q ss_pred CCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 273 PIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 273 ~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.++ ..+|+.+.+|+..||.+|+.+||.+.++++ |+|..
T Consensus 314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~------h~Fi~ 353 (391)
T KOG0983|consen 314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE------HPFIK 353 (391)
T ss_pred CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc------Cccee
Confidence 555 347999999999999999999999999998 87754
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.17 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=207.9
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|... ++.||+|.+..... ....+..+. .++..++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~e~--~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--------GQKVAVKCLKDDST-AAQAFLAEA--SVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--------CcEEEEEEeccchh-HHHHHHHHH--HHHHhcCCcceeeeEEEEcC
Confidence 56789999999999999999999864 24799999976544 222333322 25666789999999999998
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||++ ++|.+.+.......+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 899999999999 5777777654445799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.... .....++..|+|||++. .+.++.++|+||||+++|||++ |..||...+..++...+... .....+
T Consensus 152 ~~~~------~~~~~~~~~~~ape~~~---~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 221 (256)
T cd05039 152 ASQG------QDSGKLPVKWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAP 221 (256)
T ss_pred cccc------cccCCCcccccCchhhc---CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCc
Confidence 6321 11234567899999986 3468889999999999999997 99999988887777666543 344567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..+++++.+++.+||..+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 7889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.02 Aligned_cols=255 Identities=21% Similarity=0.411 Sum_probs=204.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DR-MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|.+..++ +.||+|.++.... .. ..... .+. .+++.++|+||+.+++.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-~ei-~~l~~~~~~~i~~~~~~~~~ 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG------RVVALKKVQIFEMMDAKARQDCL-KEI-DLLKQLDHPNVIKYLASFIE 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC------CEEEEEEeecccccchhhHHHHH-HHH-HHHHhCCCCCeeeeeeeeec
Confidence 58999999999999999999987555 4899999864322 11 22222 222 25566799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
++..++||||++| +|.+.+... ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 9999999999995 777766543 2356899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS--VDEIYDAVVRRQEIP 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~--~~e~~~~i~~~~~~~ 272 (627)
+...... .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+....+.... .+
T Consensus 154 ~~~~~~~---~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~ 226 (267)
T cd08224 154 RFFSSKT---TAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-YP 226 (267)
T ss_pred eeccCCC---cccceecCCccccCHHHhcc---CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-CC
Confidence 7654321 12234578999999999873 358889999999999999999999996543 334444444322 33
Q ss_pred CCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 273 PIPS-GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 273 ~~p~-~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+.+. .++.++.++|.+||..+|++||++.+++++|+++
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 3444 7889999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.39 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=200.8
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
++||+|+||.||+|.+...+. ....||+|.+..............+. ..++.+.|+||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREA-SVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHH-HHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 469999999999998765441 22489999997655432222222222 2456679999999999876 456899999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++ |+|.+.+.. ...+++..++.++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++..........
T Consensus 76 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 76 LAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred eCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 998 577777653 34789999999999999999999999999999999999999999999999999987643222111
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......++..|+|||.+. ...++.++|+|||||++|+|++ |.+||...+..++...+... .....+..++..+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 229 (257)
T cd05060 154 ATTAGRWPLKWYAPECIN---YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYS 229 (257)
T ss_pred cccCccccccccCHHHhc---CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCCCCCCHHHHH
Confidence 122233457899999986 3468899999999999999998 99999988887777666543 344567889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
++.+||..+|++||++.++++.|+..
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.87 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=201.8
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HH---HHHHHHHHHHHHhcCCCCceeeEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MR---VLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~---~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
+|.+...||+|+||.||+|.+..++ +.||+|.+....... .. .....+. .++..++||||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~ 73 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG------ELMAVKQVELPSVSASSKDRKRSMLDALAREI-ALLKELQHENIVQYLG 73 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC------cEEEEEEecCCCcccchhHHHHHHHHHHHHHH-HHHHhcCCCCeeeEEE
Confidence 4778899999999999999976554 489999886543211 11 1111221 2566789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++...+..++||||++| +|.+.+. ..+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 74 SSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred EEEeCCccEEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccC
Confidence 99999999999999986 6666654 33678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCC---CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 193 IPHLLLGIPLPS---SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 193 la~~~~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
+++......... .......|++.|+|||.+.+ +.++.++|+|||||++|+|++|+.||...+..+.+..+.. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~ 227 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ---TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-N 227 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhcc---CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-c
Confidence 998775321111 11224568999999999873 4678899999999999999999999988766555554443 3
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+..+..++..+.++|.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 355677889999999999999999999999999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.50 Aligned_cols=252 Identities=20% Similarity=0.242 Sum_probs=198.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
...|.+.+.||+|+||.||+|.+..++ +.||||...... .. .+. .+++.++|+||+++++++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~------~~vavK~~~~~~------~~-~E~-~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP------QRVVVKAGWYAS------SV-HEA-RLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC------CEEEEecccccC------HH-HHH-HHHHHCCCCCCCcEEEEEEECC
Confidence 457999999999999999999987665 489999643211 11 122 3566789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|||||++.|+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+++.+..
T Consensus 234 ~~~lv~e~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEEEEEccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9999999999998888754 345799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhccCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR--------SVDEIYDAVVRRQEI 271 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~--------~~~e~~~~i~~~~~~ 271 (627)
... ........||+.|||||++.+ ..++.++|||||||+||||++|..|+... ...++.+.+......
T Consensus 313 ~~~-~~~~~~~~GT~~Y~APE~~~~---~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 313 SWS-TPFHYGIAGTVDTNAPEVLAG---DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ccc-cccccccCCCcCCcCHHHHcC---CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 211 112234679999999999974 36889999999999999999987664322 123333333221110
Q ss_pred -CCCC-------------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 -PPIP-------------------------------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 -~~~p-------------------------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..++ ..++.++.+||.+||+.||.+||++.|+|+ |+||.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~------hp~f~ 459 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR------LPLFQ 459 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh------CcccC
Confidence 0000 134568999999999999999999999999 88875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.68 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=201.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|.+..++. .||+|.++...... .......+..++....+|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc------EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 479999999999999999999876654 89999986543211 11122223334445457799999999988766
Q ss_pred E-----EEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeecc
Q 006887 120 K-----ICIIMKFYEGSVGDRMAQLK---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGD 190 (627)
Q Consensus 120 ~-----~~LVmEy~~GsL~d~l~~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~D 190 (627)
. .|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+|
T Consensus 75 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 75 KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEee
Confidence 5 89999999999888776533 246899999999999999999999999999999999999998 88999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.+... ........+++.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 155 fg~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 155 LGLGRAFSIP---VKSYTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred cccceecCCC---ccccCCcccccCCCChHHhhCC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 9998765321 1122334678999999988642 3578899999999999999999999998776655444432111
Q ss_pred CC--------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 IP--------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ~~--------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+ ...+.+++++.++|.+||..||.+||++.+++. |+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~------~~~~ 294 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT------HPYF 294 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc------CCCc
Confidence 00 011357899999999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.70 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=199.0
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEec
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKF 127 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy 127 (627)
.||+|+||.||+|++..++. ...+|+|.++.............+.+.+.+..+||||+++++++...+..|+||||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred cCCCCCCceEEEEEEcCCCC----eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 58999999999999876542 13579998875433222222333333444545899999999999999999999999
Q ss_pred CC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 128 YE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 128 ~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++ |+|.+.+.... ...+++..++.++.|++.||+|||+.+++||||||+|||++.++.++|+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 98 57777775422 1357899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.... .........+..|+|||++.. ..++.++|+|||||++|||++ |..||.+.+..+.+..+... ..
T Consensus 158 l~~~~~~----~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 229 (270)
T cd05047 158 LSRGQEV----YVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YR 229 (270)
T ss_pred Cccccch----hhhccCCCCccccCChHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CC
Confidence 9863321 011112234678999999863 468899999999999999997 99999988887777766433 33
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
...+..++.++.+++.+||..||.+||++.+++..|+.+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 4456778999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=316.96 Aligned_cols=257 Identities=23% Similarity=0.217 Sum_probs=203.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|.+..++ +.+|+|.++........ ....++. ..+..++||||+.+++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTG------EIVALKKLKMEKEKEGFPITSLREI-NILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCC------cEEEEEEEeeccccccchhhHHHHH-HHHHhcCCCCEEEEEEEEEec
Confidence 358999999999999999999987655 38999999754332111 1111222 245667899999999998877
Q ss_pred --CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 --GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 --~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+..|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+++++|+||||+||+++.++.++|+|||+++.
T Consensus 77 ~~~~~~lv~e~~~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 77 NLDKIYMVMEYVEHDLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred CCCcEEEEehhcCcCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 88999999999988887764 334799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE------ 270 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~------ 270 (627)
..... .......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||...+..+.+..+.....
T Consensus 156 ~~~~~---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 156 YGSPL---KPYTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred ccCCc---cccccccccccccCchhhcCC--ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 64321 222345688999999998643 2467899999999999999999999998877665555432110
Q ss_pred -----------------------CCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 -----------------------IPPIPSG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 -----------------------~~~~p~~-~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...++.. +++.+.++|.+||+.+|++||++.|+++ |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~------~~~f 293 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK------HPYF 293 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc------CCCC
Confidence 0112223 5889999999999999999999999998 7664
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.13 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=205.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
.+|++.+.||.|+||.||+|.+..+++ .||+|.+..........+..+. ..++.++|+||+.+++.+...+.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQ------EVAIKQINLQKQPKKELIINEI--LVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCc------EEEEEEEecccCchHHHHHHHH--HHHHhcCCCceeeeeeeEecCce
Confidence 579999999999999999999876654 8999998754443333332222 24566799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+ ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 91 LFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEEecCCCcHHHHH---HhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999996 444444 234689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-QEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~-~~~~~~p~~~ 278 (627)
.. .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+... ......+..+
T Consensus 168 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06655 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (296)
T ss_pred cc---ccCCCcCCCccccCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccC
Confidence 21 12234578999999999873 35788999999999999999999999988765544444322 2223356678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++.+.++|.+||..||.+||++.+++. |+|+..
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~------~~~~~~ 274 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ------HPFLKL 274 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh------ChHhhh
Confidence 999999999999999999999999998 887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.15 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=199.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
...|++++.||+|+||.||+|+....+ ...+..||+|.++............++.. .++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCC--CCccceEEEEEcCccccHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEecCC
Confidence 346899999999999999999864321 12346899999976543333223333332 56678999999999998775
Q ss_pred -CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 -GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 -~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
...++||||++| +|.+.+.. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 568999999985 66555543 334689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---------------CHHHH
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---------------SVDEI 261 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---------------~~~e~ 261 (627)
+..............|+..|+|||++.+ ..++.++|+|||||++|||+++..|+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQ---SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhcc---CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 6432221112234567788999999863 46888999999999999999987764321 01111
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.. ........+.+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VR-VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 2222333445677899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=315.08 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=201.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|.+..+++ .||+|++....... .......+. .++..++||||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQ------IVAIKKFLESEDDKMVKKIAMREI-RMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCC------EEEEEeHhhccCcchhhHHHHHHH-HHHHhcCCcchhhHHHhcccCC
Confidence 479999999999999999999876554 89999986543222 111122222 2566689999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||+++++++.+.. ....+++..++.++.||+.||.|||+.+++|+||+|+||++++++.++|+|||++..+..
T Consensus 74 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred eEEEEEecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999999877766554 334589999999999999999999999999999999999999999999999999887643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
.. .......++..|+|||++.+. ..++.++|+|||||++|||++|++||...+..+....+.....
T Consensus 153 ~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 153 PG---EVYTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred Cc---cccCcccceeeccCcHHhccc--cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 22 223345689999999998642 3477899999999999999999999987665443333321100
Q ss_pred -----------CC---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 -----------IP---------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 -----------~~---------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+ ...+.++..+.+++.+||+.+|++||++.++++ |+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~------~~~~ 286 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH------HEFF 286 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc------CCCC
Confidence 00 012467899999999999999999999999988 7764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.43 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=200.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|.+..++ +.||+|++....... .. ...+...+.+...|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~-~~-~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTG------QLVAIKIMDIIEDEE-EE-IKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCC------cEEEEEEEecCchhH-HH-HHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 378999999999999999999987655 389999987654422 22 2233334444458999999999997644
Q ss_pred ------EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 120 ------KICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 120 ------~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
..|+||||+++ +|.+.+.... +..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999995 6666665433 57899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
||++...... ........|++.|+|||++.+.. ...++.++|+|||||++|+|++|.+||...........+...
T Consensus 157 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 157 FGVSAQLDST---LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred Cccceecccc---hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 9998765331 12223457999999999875421 235778999999999999999999999876655554444332
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 269 QE-IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 269 ~~-~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.. ....+..++.++.+++.+||..||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 21 11223347889999999999999999999999988
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.27 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=200.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.++||+|+||.||++.+..++. .||+|.++.............+.+ .+..++||||+++++++..++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELK-VLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCe------EEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCE
Confidence 479999999999999999999877654 799999875433222222222222 4566799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.|+||||++| +|.+.+. ..+++++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 74 ~~lv~ey~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 74 ISICMEHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEEEeeccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999985 6666654 33678999999999999999999998 599999999999999999999999999987653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR---------- 268 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~---------- 268 (627)
. .......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 152 ~-----~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 152 D-----SMANSFVGTRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred c-----cccccCCCCcCccChhHhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 2 12245679999999999864 35788999999999999999999999765544332222110
Q ss_pred -------------------------cCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 269 -------------------------QEIPPIP-SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 269 -------------------------~~~~~~p-~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+..| ..++.++++++.+||..+|++||++.++++ |+|+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~------~~~~~~ 292 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK------HPFIKR 292 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc------Chhhhh
Confidence 0111122 236789999999999999999999999998 887754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.82 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=204.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcC--------cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCcee
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTED--------CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICW 110 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed--------~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~ 110 (627)
..++|++.+.||+|+||.||+|++..+++. ......||+|.+++............+.+ .+..++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCcCe
Confidence 456899999999999999999987543210 11224699999976543333222333332 456789999999
Q ss_pred eEEEEEECCEEEEEEecCCC-CHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 111 LQGISVINGKICIIMKFYEG-SVGDRMAQLK----------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~----------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
+++++...+..|+||||++| +|.+.+.... ...+++..++.++.|++.||.|||+++++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99999999999999999995 6766664321 124688899999999999999999999999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh--CCCCCCCCC
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT--GVQPRCGRS 257 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt--G~~Pf~~~~ 257 (627)
++.++.++|+|||+++....... ........+++.|+|||++. .+.++.++|+|||||++|+|++ +..||...+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhc---cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999976543211 11122345678999999987 3468999999999999999988 778998877
Q ss_pred HHHHHHHHHh------ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 258 VDEIYDAVVR------RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 258 ~~e~~~~i~~------~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
..+....+.. .......+..+++.+.+|+.+||+.||++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 7766655432 11123345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.90 Aligned_cols=285 Identities=21% Similarity=0.313 Sum_probs=216.9
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|+..+.||+|+||.||+|.+..+++. ....||+|.+..............+. .++..++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGET--VKIPVAIKILNETTGPKANVEFMDEA-LIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCc--ceeeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcccEEEEEc
Confidence 35667899999999999999999998766531 12368999987654332222222222 3566779999999999987
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.. ..+++|||++ |++.+.+.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 54 5789999999 677777653 34568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..... ........++..|||||++.+ ..++.++|+|||||++|||++ |..||.+....+....+. .....+.
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~ 232 (303)
T cd05110 158 LLEGDEK-EYNADGGKMPIKWMALECIHY---RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQ 232 (303)
T ss_pred cccCccc-ccccCCCccccccCCHHHhcc---CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCC
Confidence 7643221 111223456789999999863 468889999999999999997 999998877666655443 3444555
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDK 331 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~ 331 (627)
+..++..+.+++.+||..+|++||++.++++.|..+.+.......+.......++.|
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 289 (303)
T cd05110 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSP 289 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccCCcCCCCCC
Confidence 677889999999999999999999999999999887655433333333333333333
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.87 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=198.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|.+..++ +.||||.+..............+. .+++.++|+||+++++++..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTG------QLVALKEIRLEHEEGAPFTAIREA-SLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCC------cEEEEEEEecccccCCchhHHHHH-HHHhhCCCcceeeEEEEEecCC
Confidence 578999999999999999999986655 489999987543222111111222 2566779999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||++++|.+.+.. ....+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++....
T Consensus 77 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 77 TLTLVFEYLDTDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred eEEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 9999999999998887764 335789999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIP------ 272 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~~~~------ 272 (627)
. ........+++.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.. ..+....+......+
T Consensus 156 ~---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 156 P---SKTYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred C---CccccccccccccCCcHHhhcC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 1 1122234578999999998642 357889999999999999999999997665 333322221110000
Q ss_pred ----------------------CCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 ----------------------PIPSGLP--PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 ----------------------~~p~~~s--~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.....++ .++.+++.+||+.+|++||++.+++. |+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~------~~~f 291 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK------HPYF 291 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc------CCCC
Confidence 0001234 88899999999999999999999987 6664
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.01 Aligned_cols=251 Identities=21% Similarity=0.249 Sum_probs=207.2
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
||.|+||.||+|++..++ ..||+|++.+.... ........+. .+++.++||||+++++.+..++..|+|||
T Consensus 1 lg~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN------RTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCC------cEEEEEEEehhcchhhhHHHHHHHHH-HHHHhCCCCCEeeeeeeEEcCCccEEEEe
Confidence 689999999999987654 48999999764322 1222222222 25567799999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+. +...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||+++......
T Consensus 74 ~~~~~~L~~~l~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 74 YCLGGELWTILR--DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 9985 6666664 33568999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCCHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS--VDEIYDAVVRRQEIPPIPSGLPPAVE 283 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~--~~e~~~~i~~~~~~~~~p~~~s~~l~ 283 (627)
......|++.|++||.+.+ ..++.++|+||||+++|+|++|..||.... ..+.+..+........+|..+++++.
T Consensus 148 ~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILN---KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAK 224 (262)
T ss_pred ccccccCCcCccChhHhcC---CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHH
Confidence 2234578999999999863 357889999999999999999999998776 66777776654556777888899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCC
Q 006887 284 NVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWT 321 (627)
Q Consensus 284 ~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~ 321 (627)
++|.+||+.+|++||+ +.|+++ |+||...+|+
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~ 261 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc------ChhhhCCCCC
Confidence 9999999999999999 788887 9999988875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.86 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=202.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
+.||+|+||.||+|.+..++. .||+|++.+........ ....+...+.....|+|++++++++..++..|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD------YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC------eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence 569999999999999876653 89999987543221111 1122223345566899999999999999999999
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++| +|.+++. ..+++++..+..++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++....
T Consensus 76 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 76 MEYLNGGDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred EeccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999985 6666654 335789999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCCHH
Q 006887 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--PPIPSGLPPA 281 (627)
Q Consensus 204 ~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--~~~p~~~s~~ 281 (627)
.....|++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.+..+...... ......++++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGV---GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred ---cccCCCCcCccChhhhcCC---CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHH
Confidence 2345689999999998743 4788999999999999999999999988888877766544322 2234568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCC
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWT 321 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~ 321 (627)
+.+++.+||+.+|++||++..+.+.+. |+|+...+|+
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~---~~~~~~~~~~ 260 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKS---HPFFKSINWD 260 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHc---ChHhhcCCCC
Confidence 999999999999999996653333222 8999888875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.66 Aligned_cols=255 Identities=20% Similarity=0.319 Sum_probs=197.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE---
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV--- 116 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~--- 116 (627)
.++|++.+.||+|+||.||+|.+..++. .||+|++....... .....+..++....+|+||+++++++.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGS------KAAVKILDPIHDID--EEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCc------eeEEEeeccccchH--HHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 4689999999999999999999876653 89999986533221 122223333444447999999999874
Q ss_pred --ECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 117 --INGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 117 --~~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
.++..++||||++| +|.+.+... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 34679999999985 666655422 3457899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|+++...... .......||+.|+|||++... ....++.++|+|||||++|||++|+.||...+..+.+..+....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 169 GVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred CceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 9987664321 122345799999999998532 12457889999999999999999999998776544443332221
Q ss_pred -CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 270 -EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 270 -~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.....+..++..+.+++.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112234567889999999999999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.15 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=207.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||.|+||.||+|.+..+++ .||+|++..............+. .+++.++|+||+++++++..+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQ------VVAIKVIDLEEAEDEIEDIQQEI-QFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCe------EEEEEEeeccccchHHHHHHHHH-HHHHHcCCCCeeeeeEEEEECCe
Confidence 478999999999999999999876654 89999987543222212222222 24566789999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+.. .++++..++.++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999985 66666543 3789999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC-C
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG-L 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~-~ 278 (627)
.. .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+... ..+..+.. +
T Consensus 151 ~~---~~~~~~~~~~~y~~PE~~~~~---~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 223 (274)
T cd06609 151 TM---SKRNTFVGTPFWMAPEVIKQS---GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEGNKF 223 (274)
T ss_pred cc---cccccccCCccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCCCccccc
Confidence 21 223456789999999999743 5889999999999999999999999887766666555433 23444444 8
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+.++.+++.+||..+|++||++.++++ |+|+...
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~------~~~~~~~ 257 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK------HKFIKKA 257 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh------ChhhcCC
Confidence 999999999999999999999999988 8876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=319.26 Aligned_cols=253 Identities=21% Similarity=0.235 Sum_probs=189.1
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--CCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--NGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~~~~~LV 124 (627)
.+||+|+||.||+|++.... .+..||+|.+....... .. .++. .+++.++||||+++++++.. +...|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~----~~~~~a~k~~~~~~~~~--~~-~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTGISM--SA-CREI-ALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eEeccCCCeeEEEEEecCCC----ccceEEEEEecCCCCcH--HH-HHHH-HHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 67999999999999875432 23589999987543221 11 2222 35667899999999998854 5678999
Q ss_pred EecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE----ecCCCeeeccCCc
Q 006887 125 MKFYEGSVGDRMAQLK-------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL----NEADRAVLGDVGI 193 (627)
Q Consensus 125 mEy~~GsL~d~l~~~~-------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl----d~~g~vkL~DFGl 193 (627)
|||+++++.+.+.... ...+++..+..++.||+.||.|||+.+|+||||||+|||+ +.++.++|+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9999999888775321 2358899999999999999999999999999999999999 5667999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---------HHHHH
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---------EIYDA 264 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---------e~~~~ 264 (627)
++................||+.|+|||++.+. ..++.++|+|||||++|||+||++||...... ..+..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 98765433222333456799999999998642 35788999999999999999999999753321 01111
Q ss_pred HHhccC------------C------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 265 VVRRQE------------I------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 265 i~~~~~------------~------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+..... . .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~--- 313 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ--- 313 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc---
Confidence 100000 0 0011123567889999999999999999999998
Q ss_pred hcccccC
Q 006887 309 SSQNSVH 315 (627)
Q Consensus 309 ~~~~~~~ 315 (627)
|+||
T Consensus 314 ---hp~f 317 (317)
T cd07867 314 ---DPYF 317 (317)
T ss_pred ---CCCC
Confidence 8875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.55 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=207.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.+.||+|+||.||+|.+.... .+|+|.+..... ....+.. +. .+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~-------~~~iK~~~~~~~-~~~~~~~-e~-~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHT-------KVAVKTMKPGSM-SVEAFLA-EA-NVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCc-------cEEEEecCCChh-HHHHHHH-HH-HHHHhcCCCCcceEEEEEc
Confidence 467789999999999999999999864432 599998875432 2222222 22 2566789999999999987
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
. ...+++|||++ |+|.+.+.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 6 77899999998 588888765555678899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..... .......++..|+|||++.. +.++.++|+|||||++|+|++ |..||.+.+..++...+... ...+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 224 (260)
T cd05073 151 VIEDNEY--TAREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224 (260)
T ss_pred eccCCCc--ccccCCcccccccCHhHhcc---CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCC
Confidence 6543211 11123346678999999873 468889999999999999999 99999988877777666543 34445
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 67889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.65 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=202.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCc----------CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCce
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTE----------DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGIC 109 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~e----------d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv 109 (627)
.++|++.+.||+|+||.||++.+..... .......||+|++..............+.. .++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK-IMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCcc
Confidence 4579999999999999999997543211 011234799999976543332222223322 45667999999
Q ss_pred eeEEEEEECCEEEEEEecCC-CCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 110 WLQGISVINGKICIIMKFYE-GSVGDRMAQLKG---------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 110 ~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
++++++..++..|+||||++ |+|.+.+..... ..+++..+..++.|++.||+|||+++++||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999998 577766654221 24778899999999999999999999999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh--CCCCCCCCC
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT--GVQPRCGRS 257 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt--G~~Pf~~~~ 257 (627)
++.++.++|+|||+++.+..... ........+++.|++||+.. .+.++.++|+|||||++|||++ |..||...+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~---~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESIL---LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHh---cCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999986543211 11122334578899999876 3468999999999999999998 789998877
Q ss_pred HHHHHHHHHh------ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 258 VDEIYDAVVR------RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 258 ~~e~~~~i~~------~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
..+....... .....+.+..+++.+.+|+.+||+.||.+||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7665544321 11122345678899999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.00 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=204.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+|++.++||.|++|.||+|++..++. .||||+++.............+. ..++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGE------IVALKEIHLDAEEGTPSTAIREI-SLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCe------EEEEEEecccccccchHHHHHHH-HHHHhhcCCCEeeeeeeEeeCCcE
Confidence 58999999999999999999876654 89999987654322112222222 245567899999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEGSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
++||||++|++.+.+.... ..++++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+++.....
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9999999999888776433 256899999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-------- 272 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-------- 272 (627)
........+|+.|++||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 154 ---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 154 ---VNTFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred ---ccccccccccccccChHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 1122345678999999998642 246889999999999999999999999887766655544321100
Q ss_pred --------C-----------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 273 --------P-----------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 273 --------~-----------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
. +.+.++..+.+++.+||+.||.+||++.++++ ++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~------~~~f 284 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ------HPWF 284 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc------CCCC
Confidence 0 11346788999999999999999999999987 7765
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.24 Aligned_cols=264 Identities=19% Similarity=0.317 Sum_probs=208.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+.... +...+..||+|++..............+. ..+..+.||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~ei-~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREA-ALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccC-CCCcceeEEEEecCCCcCHHHHHHHHHHH-HHHHhcCCCchheEEEEEcC
Confidence 45678999999999999999999875311 11234589999997654333222233222 24566799999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCC
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLK--------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPF 176 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~--------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~ 176 (627)
++..|+||||++ |+|.+.+.... ...+++..++.++.|++.||.|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999 57777765321 124788899999999999999999999999999999
Q ss_pred cEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCC
Q 006887 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCG 255 (627)
Q Consensus 177 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~ 255 (627)
||+++.++.++|+|||+++.+..... ........+++.|+|||++.+ ..++.++|+|||||++|||++ |..||.+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999876543211 111222345678999999863 468899999999999999998 8899998
Q ss_pred CCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 256 RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 256 ~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.+..+....+... ...+.+..++.++.+|+.+||+.||.+||++.|+++.|+
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEEVIYYVRDG-NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8888877766543 334457788999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.09 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=197.5
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEE-ECCEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISV-INGKICII 124 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~-~~~~~~LV 124 (627)
+.||+|+||.||+|.+..... ....||+|.+...... ....+.. +. .+++.++||||+++++++. .++..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLK-EG-IIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCC---ceEEEEEEecCccCCHHHHHHHHH-HH-HHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 368999999999998754321 2357999998653322 2222222 22 2567789999999999765 45678999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||+. |+|.+.+.. ....+++..++.++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++........
T Consensus 76 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999 566666543 3445678888999999999999999999999999999999999999999999999765432111
Q ss_pred C-CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHH
Q 006887 204 S-SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281 (627)
Q Consensus 204 ~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~ 281 (627)
. .......+++.|+|||++.+ ..++.++|+|||||++|||++ |.+||...+..++...+.. ...+..+..+++.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDP 230 (262)
T ss_pred eecccccCcCCccccChhHhcc---CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHH
Confidence 1 11123456788999999863 468889999999999999999 5777887777777666543 3344556778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.+++.+||..+|++||++.++++.|+...
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.41 Aligned_cols=259 Identities=19% Similarity=0.320 Sum_probs=203.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++++.||+|+||.||+|.+..++ ..||+|.+....... ...+.. +. ..+..++|+||+++++.+..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~-e~-~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTG------VTMAMKEIRLELDESKFNQIIM-EL-DILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCC------cEEEEEEeecccCHHHHHHHHH-HH-HHHHhcCCCcHHhhhhheecCC
Confidence 47899999999999999999987655 489999886543222 222222 22 2456679999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..|+||||++|..++.+.... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999999974444433322 2478999999999999999999997 5999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCC---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEV---RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR--RQEI 271 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~---~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~--~~~~ 271 (627)
+.. .......|++.|+|||++.+.. ...++.++|+|||||++|+|++|+.||...........+.. ....
T Consensus 153 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 153 LVA-----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred ccC-----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 532 2223457899999999986421 23468899999999999999999999987665554433221 2334
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+.++..+++++.++|.+||+.+|++||++.++++ |+|+...
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~------~~~~~~~ 268 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE------HPWLVKY 268 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc------Chhhhhc
Confidence 5567789999999999999999999999999988 7776543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.70 Aligned_cols=269 Identities=21% Similarity=0.325 Sum_probs=231.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...|+++...|.+.||.|.||.|++|+.+..++ ....||||.++....+..+...-.+. -++.+..||||++|.|+
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgk---re~~VAIKTLK~GytekqrrdFL~EA-sIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGK---REITVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCC---cceeEEEeeeccCccHHHHhhhhhhh-hhcccCCCCcEEEEEEE
Confidence 556899999999999999999999999987664 45789999999877655544333333 25677899999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
......++||+|||+...+|.+.+...+.|...+..-.++.|+.|++||-++++|||||...|||++.+-.+|++||||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999965567777777788999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCC--CCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 195 HLLLGIPLPSSDLPRRLG--TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~G--T~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|.+.++. ....++.-| ..+|.|||.|. ++.++.++|+||||++|||.++ |..||.+++.++++..|.+..+
T Consensus 779 Rvledd~--~~~ytt~GGKIPiRWTAPEAIa---~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR- 852 (996)
T KOG0196|consen 779 RVLEDDP--EAAYTTLGGKIPIRWTAPEAIA---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR- 852 (996)
T ss_pred eecccCC--CccccccCCccceeecChhHhh---hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-
Confidence 9886544 222233333 36999999998 6789999999999999999666 9999999999999999987654
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
.+-|..||..|.+|+..||++|..+||.+.+|+..|+++...
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 555999999999999999999999999999999999987643
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.07 Aligned_cols=260 Identities=21% Similarity=0.251 Sum_probs=203.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|++|.||+|.+..+++ .||+|.+....... .......+. ..++.++|+||+++++++..++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNE------TIALKKIRLEQEDEGVPSTAIREI-SLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCc------EEEEEehhhccccccchHHHHHHH-HHHHhccCCCEeeEEEEEecCC
Confidence 589999999999999999999876654 89999986543221 111112222 3556679999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~~~~ 198 (627)
..|+||||+++++.+.+.......+++..+..++.||+.||+|||+++++||||||+||+++. ++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 75 RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred eEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999999998888876544455788899999999999999999999999999999999985 5578999999997653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP------ 272 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~------ 272 (627)
.. ........+++.|+|||++.+. ..++.++|+|||||++|+|+||.+||...+..+.+..+......+
T Consensus 155 ~~---~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 155 IP---VRTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP 229 (294)
T ss_pred CC---ccccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 21 1222344678999999998642 357889999999999999999999998876655544433211100
Q ss_pred -------------C--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 -------------P--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 -------------~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. ....+++++.+++.+||+.+|++||++.++++ |+||.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~------~~~~~~~ 290 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE------HEYFKDL 290 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc------CchHhHH
Confidence 0 12457889999999999999999999999998 8887654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.56 Aligned_cols=260 Identities=20% Similarity=0.231 Sum_probs=200.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
++|++.+.||+|+||.||+|++..++. .||+|++.+............+. .+++.++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGV------KVAIKKISPFEHQTFCQRTLREI-KILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCC------eEEEEEecccccchhHHHHHHHH-HHHHhCCCCCcCchhheeecccc
Confidence 689999999999999999999877664 89999987533222211122222 256667899999999887643
Q ss_pred ---CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 119 ---GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 119 ---~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...|+||||+++++.+.+ ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+++
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred cccceEEEEehhcccCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 358999999999877665 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE----- 270 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~----- 270 (627)
................||+.|||||.+.+ ...++.++|+|||||++|+|++|++||.+.+.......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLN--SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 76443222222234578999999998753 23578899999999999999999999987665433322211000
Q ss_pred -------------------CCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 271 -------------------IPP-----IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 271 -------------------~~~-----~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
... ..+..++++.+++.+||+.||++||++.++++ |+|+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~------hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA------HPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc------Ccccccc
Confidence 000 11346788999999999999999999999998 8887643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.56 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=225.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
-+.++.++.++...||+|.||.||.|.......+.. ...||||.+.+....+.....-++ .++++..+||||++++|+
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~E-a~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKE-ALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHH-HHHHhcCCCcceeeEEEe
Confidence 355778999999999999999999999876554322 467999999887654443333333 346788999999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK-----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~-----~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
+.+....+|++|||. |+|+..+...+ ...++..+.+.++.|||.|+.||+++++|||||..+|+||+....+||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999 57776665532 356889999999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~ 267 (627)
+||||||-+.+.+....... ..-...|||||.+. ++.++.++|||||||+|||++| |..||.+.+..+++..+..
T Consensus 844 aDFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~---d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLK---DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE 919 (1025)
T ss_pred cccchhHhhhhchheeccCc-cccceecCCHHHHh---hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence 99999995554332221111 12335899999998 5689999999999999999999 9999999999999987777
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.. +.+.|..||+.+.++|.+||+.+|++||++..|++.+....
T Consensus 920 gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 66 77889999999999999999999999999999999766643
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.69 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=200.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|.+..+++ .||+|.++...... .......+. ..++.+.|+||+.+++++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~------~v~vK~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGE------IVAIKKFKESEDDEDVKKTALREV-KVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCc------EEEEehhhhhcccccchhHHHHHH-HHHHhcCCCCeeehhheEEECC
Confidence 479999999999999999999876654 89999987543221 111222222 2456678999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..++||||+++++++.+.. ....+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++.....
T Consensus 74 ~~~iv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 74 RLYLVFEYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999999999988877654 345689999999999999999999999999999999999999999999999999887654
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
... .......++..|+|||++.+. ..++.++|+||||+++|+|++|++||.+.+..+....+.....
T Consensus 153 ~~~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07833 153 RPA--SPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228 (288)
T ss_pred Ccc--ccccCcccccCCcCCchhcCC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhh
Confidence 321 122345789999999998743 2578899999999999999999999987665443332221000
Q ss_pred -----------C----------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 271 -----------I----------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 271 -----------~----------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
. ..++..++.++.+||.+||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0123345899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.45 Aligned_cols=263 Identities=21% Similarity=0.339 Sum_probs=198.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
-.+|++.+.||+|+||.||+|...... ...+..||+|.++.........+..+ .+ .+..+.||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~e-~~-~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQ--DNTGEVVAVKKLQHSTAEHLRDFERE-IE-ILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCc--CCCCcEEEEEEeccCCHHHHHHHHHH-HH-HHHhCCCCCeeEEEEEEccCC
Confidence 458999999999999999999853211 12345899999876654444333332 22 4566899999999998754
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
....++||||++ |+|.+.+.. ....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 346899999998 577766643 345689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH---------------H
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE---------------I 261 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e---------------~ 261 (627)
...............++..|+|||++.+ ..++.++|+|||||++|||++|..|+......- .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc---CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 6432211111112234456999999873 468889999999999999999877754332110 0
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+..+.......+.+..++.++.+|+.+||..+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1112223334455678899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.78 Aligned_cols=276 Identities=19% Similarity=0.291 Sum_probs=213.0
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++.+.||.|+||.||+|++.... ..+..||+|++...... ........+..++....+|+||+.+++++..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH---DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC---CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence 5899999999999999999875422 23468999998753321 11122233333444444799999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 999999999995 66666643 456899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDEIYDAVVRRQEIPP 273 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e~~~~i~~~~~~~~ 273 (627)
.... ........|+..|+|||.+.+. ...++.++|+||||+++|+|++|..||.... ..++...+.. ..++
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 230 (290)
T cd05613 156 HEDE--VERAYSFCGTIEYMAPDIVRGG-DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPP 230 (290)
T ss_pred cccc--ccccccccCCcccCChhhccCC-CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--cCCC
Confidence 4321 1222345799999999998643 2346789999999999999999999997432 2334433332 2345
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSS 333 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~ 333 (627)
++..+++.+.+++.+||+.||++|| ++.++++ |+||...+|+.......+.|++
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~------~~~~~~~~~~~~~~~~~~~~~~ 289 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK------HPFFQKINWDDLAAKKVPAPFK 289 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc------CcccccCCHHHHhhccCCCCCC
Confidence 6778999999999999999999997 6778877 9999998887765554444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.61 Aligned_cols=265 Identities=18% Similarity=0.238 Sum_probs=210.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||+|.+..+. ......||+|++..............+. ..++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~--~~~~~~v~~k~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK--PGKEEEVFVKTVKDHASEIQVTLLLQES-CLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC--CCceeEEEEEEccCCCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEec
Confidence 56789999999999999999999987632 1123579999987544333222222222 24566799999999998766
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 -NGKICIIMKFYE-GSVGDRMAQLKG------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 -~~~~~LVmEy~~-GsL~d~l~~~~~------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
+...++++||++ |+|.+.+..... ..+++..++.++.|++.||.|||+++++||||||+||++++++.++|+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 567899999998 577776654322 468999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||+++.+...... .......++..|+|||++.+ ..++.++|+|||||++||+++ |++||...+..++...+...
T Consensus 160 d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 160 DNALSRDLFPMDYH-CLGDNENRPVKWMALESLVN---KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCCcccccCCceE-EeCCCCCcchhccCHHHHhc---CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 99999865432211 11123356778999999874 358899999999999999999 99999988887777665543
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.....+..+++++.+++.+||..||++||++.++++.|+..
T Consensus 236 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 236 -YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 33445667899999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=306.50 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=207.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
+++.++|.+.+.||+|+||.||+|.+..... ....||||................+. ..++.+.|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPEN---EKIAVAVKTCKNCTSPSVREKFLQEA-YIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCC---CCcceEEEecCCcCCHHHHHHHHHHH-HHHHhCCCCchhceeEEEc
Confidence 3566789999999999999999998765421 22469999987654322222222222 2566778999999999887
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
. +..|+||||++ |+|.+.+.. ....+++..++.++.|++.||.|||+.+++||||||+|||++.++.++|+|||+++
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceee
Confidence 5 56789999998 567666643 34468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
....... .......+++.|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+... .....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~ 229 (270)
T cd05056 156 YLEDESY--YKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPM 229 (270)
T ss_pred ecccccc--eecCCCCccccccChhhhcc---CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCC
Confidence 7644321 11122345678999999863 358899999999999999986 99999988877777665543 34566
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+..++..+.+++.+|+..+|++||++.++++.|+..
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=315.84 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=204.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..|+..+.||+|+||.||+|++..++. .||+|++.......... ....+. ..++.++|+|++++++++..+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEV-KFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCc------EEEEEEEecCCCCchHHHHHHHHHH-HHHHhCCCCCEEEEEEEEeeC
Confidence 347889999999999999999876654 89999987543222111 112222 255667899999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..++||||+.|++.+.+.. ...++++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~lv~e~~~g~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 HTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CeEEEEEeCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 99999999999998887754 45678999999999999999999999999999999999999999999999999886542
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
. .....|++.|+|||++.....+.++.++|+|||||++|||++|..||...+..+....+.........+..+
T Consensus 177 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T cd06635 177 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW 249 (317)
T ss_pred C-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccc
Confidence 1 234578999999999854324568889999999999999999999998877766666665444333345568
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.+.+++.+||+.+|.+||++.++++
T Consensus 250 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 250 SDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred cHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 899999999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=306.01 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+++.....||+|+||.||+|++..++ ..||+|.+..........+..+. .+++.++|+||+++++++..++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~~k~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQ------VRIAIKEIPERDSRYVQPLHEEI--ALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCC------cEEEEEEecCCCHHHHHHHHHHH--HHHHhcCCCCeeeeeeeeccCC
Confidence 344445568999999999999976654 48999998766544443333332 2556789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKL--SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~l--s~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~ 195 (627)
..++||||++| +|.+.+.. ....+ ++..+..++.||+.||.|||+++|+||||||+||+++. ++.++|+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEEecCCCCCHHHHHHH-hcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999985 66665543 33445 78889999999999999999999999999999999976 6799999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~ 274 (627)
...... .......|++.|+|||++.+. ...++.++|+||||+++|+|++|+.||...... ............+.+
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 158 RLAGIN---PCTETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred ecccCC---CccccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 654321 122334689999999998643 224788999999999999999999999764322 222222222334567
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
+..+++++.+++.+||+.+|.+||++.++++ |+|+
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~------~~~~ 268 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ------DPFL 268 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh------CCCC
Confidence 7889999999999999999999999999998 7764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=310.53 Aligned_cols=256 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|.+..++. .||+|++..............+. ..++.++|+||+++++++..++.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQ------LVALKVISMKTEEGVPFTAIREA-SLLKGLKHANIVLLHDIIHTKET 77 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCc------EEEEEEecccCcCCCcHHHHHHH-HHHHhcCCCCEeEEEEEEecCCe
Confidence 689999999999999999999876654 89999986543322211122222 24566799999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||+++++++.+.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++.++.++|+|||+++.....
T Consensus 78 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEEEEecccCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999999999988887654 3356788899999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccC---------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQE--------- 270 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~--------- 270 (627)
........+++.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+. .+.+..+.....
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 157 ---SQTYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ---CCCCCCccccccccCCceeecC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 1222345689999999998642 2477899999999999999999999986543 222222211000
Q ss_pred ---CC---------CCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 ---IP---------PIP---------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ---~~---------~~p---------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+ ..+ ...++++.+++.+|++.||++||++.+++. |+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~------h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL------HPYF 291 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc------CCCC
Confidence 00 000 123578999999999999999999999988 7764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.26 Aligned_cols=258 Identities=19% Similarity=0.221 Sum_probs=204.2
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh----HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED----RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~----~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+|++.+.||+|+||.||+|.+..++ +.||||.+...... ........+. ..++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG------RIVAIKKIKLGERKEAKDGINFTALREI-KLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC------cEEEEEEEeccccccccchhhHHHHHHH-HHHhhcCCCCChhhhheeec
Confidence 5889999999999999999987665 38999999764432 1111111222 25566789999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++..++||||+.|+|.+.+.. ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus 74 ~~~~~lv~e~~~~~L~~~i~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 74 KSNINLVFEFMETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred CCEEEEEEcccCCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999999999997788777753 2247999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP----- 272 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~----- 272 (627)
.... .......+++.|+|||.+.+ ...++.++|+|||||++|||++|.+||.+.+..+.+..+......+
T Consensus 153 ~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 153 GSPN---RKMTHQVVTRWYRAPELLFG--ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred cCCC---ccccccccceeeeCHHHHhC--CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 4321 22233467889999999853 2357889999999999999999999898877665554443221100
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 ---------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ---------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
......+..+.++|.+||+.||++||++.++++ |+||.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~------~~~~~~~ 288 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE------HPYFSND 288 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh------CccccCC
Confidence 011345788999999999999999999999999 8887754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=302.74 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=200.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||+|.+..++ +.||+|.++..... ....+..+. ..++.++|+||+++++.+...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~--~~~~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG------ELMAVKEIRIQDNDPKTIKEIADEM--KVLELLKHPNLVKYYGVEVHRE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC------cEEEEEEEECcccchHHHHHHHHHH--HHHHhCCCCChhheeeeEecCC
Confidence 5899999999999999999976655 48999999765543 222222222 2566779999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..++|+||++| +|.+.+. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++....
T Consensus 73 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred EEEEEEecCCCCcHHHHHh--hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 99999999995 6666554 33568899999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCC-CCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCCC
Q 006887 199 GIPLPSSD-LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 199 ~~~~~~~~-~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~~~~p~ 276 (627)
........ .....+++.|+|||++.+.....++.++|+||||+++|+|++|+.||...+. ......+. ....+.+|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 229 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPD 229 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCc
Confidence 43322221 2245789999999998754223478899999999999999999999976533 33332232 233444555
Q ss_pred CC--CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GL--PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~--s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.. ++.+.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 44 899999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.70 Aligned_cols=246 Identities=19% Similarity=0.294 Sum_probs=190.8
Q ss_pred EEeeeCCeEEEEEEEcCCCc------------------CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCce
Q 006887 48 RIGRGPFGEVWLATHYLSTE------------------DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGIC 109 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~e------------------d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv 109 (627)
.||+|+||.||+|....++. +......||+|++..........+.+. ..+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~--~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFET--ASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHH--HHHHhcCCCCCee
Confidence 59999999999998643221 122335699999875443332233222 2356778999999
Q ss_pred eeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-----
Q 006887 110 WLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----- 184 (627)
Q Consensus 110 ~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----- 184 (627)
++++++..++..++||||++|+.++.+.....+.+++..++.++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999997555555444557899999999999999999999999999999999999998654
Q ss_pred --CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHH-hCCCCCCCCCHHHH
Q 006887 185 --RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML-TGVQPRCGRSVDEI 261 (627)
Q Consensus 185 --~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyell-tG~~Pf~~~~~~e~ 261 (627)
.++++|||++..... .....+++.|+|||++.+. ..++.++|+|||||++|||+ +|..||.+....+.
T Consensus 160 ~~~~kl~d~g~~~~~~~-------~~~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 160 SPFIKLSDPGVSFTALS-------REERVERIPWIAPECVPGG--NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cceeeecCCcccccccc-------ccccccCCcccCchhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 379999998764322 1233678899999998642 35789999999999999984 69999988776655
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
...... ....+...++.+.++|.+||+.+|++||++.++++.|
T Consensus 231 ~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ERFYEK---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHh---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 433322 2334555678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=352.03 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=197.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
...++|++++.||+|+||.||+|.+..++. .||+|++...... ....+.. +. .++..+.||||+++++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~------~vAlKvIk~~~l~e~~~~~~~~-EI-~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQE------FFCWKAISYRGLKEREKSQLVI-EV-NVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCe------EEEEEEEeccccCHHHHHHHHH-HH-HHHHHcCCCCcCeEEEEE
Confidence 345689999999999999999999877654 8999998754322 2222222 22 356778999999999988
Q ss_pred EE--CCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecccCCCcEEEecC
Q 006887 116 VI--NGKICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSK-------GILVLNLKPFNFILNEA 183 (627)
Q Consensus 116 ~~--~~~~~LVmEy~~-GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~-------gIvHrDLKP~NILld~~ 183 (627)
.. ...+||||||++ |+|.+.+... ....+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 54 467999999999 5787777543 236799999999999999999999985 49999999999999642
Q ss_pred -----------------CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHH
Q 006887 184 -----------------DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246 (627)
Q Consensus 184 -----------------g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyel 246 (627)
+.++|+|||+++.+... .......||+.|||||++.+. ...++.++|||||||+||||
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge-~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHE-TKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhcc-CCCCCchhHHHHHHHHHHHH
Confidence 34899999999865321 222345799999999998643 23588899999999999999
Q ss_pred HhCCCCCCCCCHH-HHHHHHHhccCCCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 247 LTGVQPRCGRSVD-EIYDAVVRRQEIPPI-PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 247 ltG~~Pf~~~~~~-e~~~~i~~~~~~~~~-p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++|..||...+.. +++..+. .. +.+ ....+.++.+||..||..+|.+||++.++|.
T Consensus 237 LTGk~PF~~~~~~~qli~~lk-~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 237 CSGKTPFHKANNFSQLISELK-RG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHCCCCCCcCCcHHHHHHHHh-cC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999866544 3443332 22 222 2457899999999999999999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.20 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=204.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.............+ . ..++..+|+||+++++++..++.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e-~-~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQ------EVAIKQMNLQQQPKKELIINE-I-LVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCC------EEEEEEEecCccchHHHHHHH-H-HHHHhCCCCCEeeEEEEEecCCE
Confidence 689999999999999999999766554 899999976544333322222 2 35667899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| ++.+.+. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999985 5555543 35689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-~~~~~~~p~~~ 278 (627)
.. .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.. .......+..+
T Consensus 168 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred Cc---cCcCcccCCccccCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 21 12234578999999999874 3578899999999999999999999987665443322222 22223356678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+..+.+++.+||+.+|++||++.++++ |+|+..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~ 274 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQ------HPFLKL 274 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc------Cchhcc
Confidence 899999999999999999999999998 887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.46 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=198.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc---hhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~---~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.|++.+.||+|+||.||+|.+... ..+..||+|.+.... ......... +. .++..++||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACR-EI-ALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHH-HH-HHHHhcCCCCccceEEEEeCC
Confidence 488999999999999999998662 123589999997633 111122222 22 256667999999999999988
Q ss_pred --CEEEEEEecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec----CCCeeec
Q 006887 119 --GKICIIMKFYEGSVGDRMAQLKG---GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE----ADRAVLG 189 (627)
Q Consensus 119 --~~~~LVmEy~~GsL~d~l~~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~----~g~vkL~ 189 (627)
+..|+||||+++++.+.+..... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.++|+
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 88999999999998887754322 37899999999999999999999999999999999999999 8999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH---------
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE--------- 260 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e--------- 260 (627)
|||+++................+|+.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.....
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 999998764432212223345789999999988642 357889999999999999999999998654321
Q ss_pred HHHHHHh------------------------ccCCCCCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 261 IYDAVVR------------------------RQEIPPIP-----------SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 261 ~~~~i~~------------------------~~~~~~~p-----------~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+..+.. ......++ ...+.++.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111100 00011111 156778999999999999999999999998
Q ss_pred HHHhcccccC
Q 006887 306 VFKSSQNSVH 315 (627)
Q Consensus 306 ~L~~~~~~~~ 315 (627)
|+||
T Consensus 313 ------~~~f 316 (316)
T cd07842 313 ------HPYF 316 (316)
T ss_pred ------CCCC
Confidence 7775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.98 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=199.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..++|++.+.||+|+||.||+|.+..++ ..||||++........ ......+. .+++.+.||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~------~~~aik~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTK------QIVALKKVLMENEKEGFPITALREI-KILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCC------cEEEEEEEeccCCcCCchhHHHHHH-HHHHhCCCCCccceEEEEec
Confidence 4578999999999999999999987665 4899999865332211 11111122 35667799999999998876
Q ss_pred CC--------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 NG--------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 ~~--------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
.+ ..|+||||+.+++.+.+.. ....+++.+++.++.||+.||.|||+++++|+||||+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEHDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ccccccCCCceEEEEEcCCCcCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence 43 4599999999988877754 34578999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCC-CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLP-SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||++..+...... ........++..|+|||++.+. ..++.++|+||||+++|||++|++||.+.+..+....+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999876432211 1122345688999999988643 24678999999999999999999999887765544333221
Q ss_pred cCC--C---------------CC-------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 269 QEI--P---------------PI-------------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 269 ~~~--~---------------~~-------------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
... + .. +...++.+.++|.+||..||.+||++.++++ |+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~------h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN------HDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc------CCCC
Confidence 100 0 00 1123567889999999999999999999998 7775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.43 Aligned_cols=279 Identities=19% Similarity=0.284 Sum_probs=215.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++.+.||+|+||.||++++..... .+..||||++.+..... .......+...+....+|+||+.+++.+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~ 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHD---AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEecccc---CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence 58999999999999999998654322 34589999987543211 1112222333444445799999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||++| +|.+.+. ....+++..+..++.|++.+|.|||+.+++||||||+||+++.++.++|+|||+++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred CEEEEEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999985 6665554 3457899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDEIYDAVVRRQEIPP 273 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e~~~~i~~~~~~~~ 273 (627)
.... ........|++.|+|||.+.+.. ...+.++|+||||+++|||++|..||.... ..++.+.+.. ..++
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~ 230 (288)
T cd05583 156 LAEE--EERAYSFCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SKPP 230 (288)
T ss_pred cccc--ccccccccCCccccCHHHhcCCC-CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cCCC
Confidence 4321 11123456899999999986431 236789999999999999999999996432 2333333322 2355
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSS 333 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~ 333 (627)
.+..++..+.+++.+||+.||++||++.++.+.|+ |+|+...+|+.+.++...+++.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN---HPFFQGIDWDDLAAKRIPAPFK 287 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc---CcccccCCHHHHhhhccCCCCC
Confidence 67789999999999999999999999876655444 8999999998888877777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=302.66 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=205.0
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
+++.+.||+|+||.||++.+...+. .....||+|++..............+.. .+..++|+||+++++.+...+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREAR-IMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCeeE
Confidence 3577899999999999999876541 1235899999976654322222222222 445569999999999999999999
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 123 IIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 123 LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
++|||++| ++.+.+.......+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999985 66666654333338999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
.... ....+++.|+|||.+. ...++.++|+|||||++|+|++ |.+||...+..++.+.+.... ....+..++.
T Consensus 158 ~~~~--~~~~~~~~y~~Pe~~~---~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (258)
T smart00219 158 YYKK--KGGKLPIRWMAPESLK---DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPP 231 (258)
T ss_pred cccc--ccCCCcccccChHHhc---cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCH
Confidence 1111 1234788999999985 3468889999999999999998 899999888888887776543 4556777999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILRV 306 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~~ 306 (627)
++.+++.+||..||++||++.++++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 99999999999999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=304.71 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=198.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HH---HHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RM---RVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~---~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
+|++.+.||+|+||.||+|... + ++.+|+|.+...... .. .....++. ..++.++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-Q------GQLIAVKQVELDTSNVLAAEKEYEKLQEEV-DLLKSLKHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-C------CCeEEEEEeecCccchhhHHHHHHHHHHHH-HHHHhcCCCCEeeEeeEee
Confidence 4788999999999999999753 2 247999998653211 11 11122222 2556778999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..|+||||++| +|.+.+. +..++++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 99999999999986 6655554 33578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCC---CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCC
Q 006887 196 LLLGIPLP---SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-QEI 271 (627)
Q Consensus 196 ~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~-~~~ 271 (627)
........ ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE---SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM 227 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcC---CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence 65321111 112234578999999999874 35788999999999999999999999876655444333332 334
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+..+..++.++.++|.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 5577889999999999999999999999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=313.29 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=205.4
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
|...+.||+|+||.||+|++..++ ..||+|++...... ....+.. +. ..++.++|+|++.+++++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~------~~v~ik~~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTN------EVVAVKKMSYSGKQTNEKWQDIIK-EV-KFLQQLKHPNTIEYKGCYLKEH 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCC------cEEEEEEEeccccCchHHHHHHHH-HH-HHHHhCCCCCCccEEEEEEeCC
Confidence 777888999999999999986655 38999998754322 2122222 22 2566678999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|+||||+.|++.+.+.. ...++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~~lv~e~~~~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred EEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 9999999999998887754 45678999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
......|+..|+|||++.....+.++.++|+|||||++|+|++|.+||...+.......+............++
T Consensus 173 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
T cd06633 173 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWT 246 (313)
T ss_pred ------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence 22345789999999998543345688899999999999999999999988776665555543332222345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..+++++.+||+.+|.+||++.+++. |+|+..
T Consensus 247 ~~l~~li~~~l~~~P~~Rp~~~~~l~------~~~~~~ 278 (313)
T cd06633 247 DSFRGFVDYCLQKIPQERPASAELLR------HDFVRR 278 (313)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc------CcccCC
Confidence 89999999999999999999999998 777664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.61 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=203.2
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+++++|++.+.||+|+||.||+|.+... ..+|+|.+....... ..+..+ . ..++.+.||||+++++++..
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~k~~~~~~~~~-~~~~~e-~-~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEK-------RKVAIKTIREGAMSE-EDFIEE-A-QVMMKLSHPKLVQLYGVCTE 70 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCC-------CeEEEEECCCCCCCH-HHHHHH-H-HHHHhCCCCCeeeEEEEEcc
Confidence 4678999999999999999999987532 369999987543322 222222 2 24566799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
....|+||||++| +|.+.+. ...+.++++.+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHH-hCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence 9999999999996 5555543 3446789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... .......++..|+|||++.+ +.++.++|+||||+++|||++ |..||......++...+.... ....+
T Consensus 150 ~~~~~~--~~~~~~~~~~~~~aPe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 223 (256)
T cd05112 150 VLDDQY--TSSTGTKFPVKWSSPEVFSF---SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKP 223 (256)
T ss_pred cccCcc--cccCCCccchhhcCHhHhcc---CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-CCCCC
Confidence 543211 11122345678999999873 468889999999999999998 999999888877777665432 33345
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
...+.++.+|+.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 66889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=300.96 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=197.2
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|.... + ..||+|.++.............+.. .+..++||||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~------~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-K------TPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecC-C------cEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 368999999999998542 2 3799999876544333222223322 4556799999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus 73 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~ 149 (250)
T cd05085 73 LVPGGDFLSFLRK-KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--S 149 (250)
T ss_pred CCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--c
Confidence 9985 66655543 345689999999999999999999999999999999999999999999999999875432111 1
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......+++.|+|||++. .+.++.++|+|||||++|+|++ |..||.+....+....+.. ......+..++..+.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 150 SSGLKQIPIKWTAPEALN---YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYK 225 (250)
T ss_pred cCCCCCCcccccCHHHhc---cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 112234567899999986 3468889999999999999998 9999998887777666543 3344567789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
++.+||+.+|++||++.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.95 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=190.1
Q ss_pred eEEeeeCCeEEEEEEEcCCCcC------cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 47 HRIGRGPFGEVWLATHYLSTED------CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed------~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.||+|+||.||+|+......+ ......||+|.+..........+.+. ..++..++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~--~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET--ASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHH--HHHHHhCCCCCEeeEEEEEecCCC
Confidence 3689999999999986432211 12334689999876543332222222 235667899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC-------eeeccCCc
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR-------AVLGDVGI 193 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~-------vkL~DFGl 193 (627)
.++||||++++.++.+......++++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999976666665545677999999999999999999999999999999999999987664 89999998
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML-TGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyell-tG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+..... .....|+..|||||++.. ...++.++|||||||++|||+ +|..||......+..... .. ..
T Consensus 159 ~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~--~~ 226 (262)
T cd05077 159 PITVLS-------RQECVERIPWIAPECVED--SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EG--QC 226 (262)
T ss_pred CccccC-------cccccccccccChhhhcC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hc--Cc
Confidence 865432 123468899999998863 235888999999999999997 599999876655443221 11 12
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
......++++.+||.+||+.||++||++.+|++.+
T Consensus 227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 23334568899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.26 Aligned_cols=246 Identities=18% Similarity=0.270 Sum_probs=190.6
Q ss_pred eEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
+.||+|+||.||+|.+...+.. ......||+|.+..........+.+. ..+++.+.||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e--~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEA--ASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHH--HHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3699999999999998654431 12234689998865433322222222 23567789999999999999989999999
Q ss_pred ecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC--------eeeccCCcccc
Q 006887 126 KFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR--------AVLGDVGIPHL 196 (627)
Q Consensus 126 Ey~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~--------vkL~DFGla~~ 196 (627)
||++| +|.+.+. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++++|||++..
T Consensus 79 e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99996 5544443 34457899999999999999999999999999999999999987765 58999998765
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
... .....+++.|||||++.+. ..++.++|+|||||++|||++| .+||...+......... ....+|
T Consensus 158 ~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (258)
T cd05078 158 VLP-------KEILLERIPWVPPECIENP--QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQLP 225 (258)
T ss_pred cCC-------chhccccCCccCchhccCC--CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---ccccCC
Confidence 422 2335688999999998742 2478899999999999999998 57777666555433222 234567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
...+.++.+++.+||+.||++||++.++++.|
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 77789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.09 Aligned_cols=270 Identities=20% Similarity=0.279 Sum_probs=210.3
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...-+|+.++|++.+.||+|||+-||+++...+. +.||+|++.....+.....+++. ...+..+|||+++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~------~~YAlKkI~c~~~~~~e~~~rEi--d~~rkf~s~~vl~l~ 84 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTG------HLYALKKILCHSQEDIEEALREI--DNHRKFNSPNVLRLV 84 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcc------cchhhheeeccchHHHHHHHHHH--HHHHhhCCcchHHHH
Confidence 3466799999999999999999999999966555 48999999877655444443333 356778999999998
Q ss_pred EEEEEC-----CEEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEec
Q 006887 113 GISVIN-----GKICIIMKFYE-GSVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNE 182 (627)
Q Consensus 113 ~~~~~~-----~~~~LVmEy~~-GsL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~ 182 (627)
++...+ ...||+++|+. |+++|.+...+ +..+++.+++.|+.+|++||++||+.. +.||||||.|||+.+
T Consensus 85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~ 164 (302)
T KOG2345|consen 85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD 164 (302)
T ss_pred HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence 765443 34999999998 89999987753 457999999999999999999999998 999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCC------CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSS------DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR 256 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~------~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~ 256 (627)
.+.++|.|||.+....-.-.... .......|..|.|||.+....+...+.++|||||||+||+|+.|..||...
T Consensus 165 ~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 165 SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 99999999998765421110011 011235788999999999887888999999999999999999999999631
Q ss_pred CHH--HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 257 SVD--EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 257 ~~~--e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
-.. .+.-.+...+...+-...+|+.+.++|+.||+.||.+||++.+++..++..
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 110 011111111122222344899999999999999999999999999877654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=302.20 Aligned_cols=248 Identities=22% Similarity=0.381 Sum_probs=202.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-----hHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-----DRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-----~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
+|+..+.||+|+||.||+|.+..+++ .||+|.+..... +....+ ..+. .+++..+|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~-~~e~-~~l~~~~h~~i~~~~~~~~ 72 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGD------FFAVKEVSLADDGQTGQEAVKQL-EQEI-ALLSKLQHPNIVQYLGTER 72 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCc------EEEEEEEEEccccccchHHHHHH-HHHH-HHHHhcCCCCchheeeeEe
Confidence 47788999999999999999875553 899999865432 111222 2222 2556779999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++..|++|||++| +|.+.+. ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 73 EEDNLYIFLELVPGGSLAKLLK--KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred cCCeEEEEEEecCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999999986 6655554 33568999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... ......|++.|++||.+... ..++.++|+|||||++|+|++|+.||......+....+......+.++
T Consensus 151 ~~~~~~----~~~~~~~~~~y~~pe~~~~~--~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd06632 151 QVVEFS----FAKSFKGSPYWMAPEVIAQQ--GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIP 224 (258)
T ss_pred eccccc----cccccCCCcceeCHHHhcCC--CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcC
Confidence 754322 23455789999999998643 137889999999999999999999998776655555554434556677
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+++++.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 889999999999999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=312.12 Aligned_cols=259 Identities=13% Similarity=0.118 Sum_probs=192.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HH------HHHHH-HHHHhcCCCCc
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LL------ERLND-LFLKCQGVEGI 108 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~------~~~~~-~ll~~~~hpnI 108 (627)
+..++|++.+.||+|+||.||+|.+..+.. ....+|+|+........... .. ..... .......|++|
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~---~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC---INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcc---cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 455789999999999999999999876521 12367777654322211110 00 00000 12345689999
Q ss_pred eeeEEEEEECC----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC
Q 006887 109 CWLQGISVING----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 109 v~l~~~~~~~~----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g 184 (627)
+++++++.... ..+++|+++..++.+.+... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 99998766543 45899999988877776542 3467888999999999999999999999999999999999999
Q ss_pred CeeeccCCccccccCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HH
Q 006887 185 RAVLGDVGIPHLLLGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VD 259 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~ 259 (627)
.++|+|||+|+.+...... ........||+.|||||++.+ ..++.++|||||||++|||++|.+||.+.. ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~---~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG---ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999876432111 112234579999999999874 368999999999999999999999998763 22
Q ss_pred HHH--------HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 260 EIY--------DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 260 e~~--------~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
+.. ..+... ......+++++.+++..|+..+|++||++.++++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEG---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhh---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 222 222111 112456789999999999999999999999998865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.46 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=202.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch----hHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE----DRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~----~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.+|++.+.||+|+||.||+|++..++. .||+|.+..... .........+. ..++.++|+||+++++++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~ei-~~l~~l~h~~i~~~~~~~ 73 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGR------ELAVKQVPFDPDSQETSKEVNALECEI-QLLKNLRHDRIVQYYGCL 73 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCC------EEEEEEEecCcccchhhHHHHHHHHHH-HHHHHcCCCCcceEEEEE
Confidence 4689999999999999999999876654 899998754211 11111112222 256677999999999998
Q ss_pred EEC--CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 116 VIN--GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 116 ~~~--~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
... +.++++|||++| +|.+.+. ..+.+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 74 RDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EcCCCCEEEEEEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccc
Confidence 763 568999999985 6666664 33568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++................|+..|+|||++.+. .++.++|+|||||++|+|++|++||......+....+......+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE---GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCC---CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCC
Confidence 998754322112222345789999999998743 57889999999999999999999999877666666665555556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+|..+++++.+++.+||. +|..||++.+++.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 6888999999999999998 5799999999887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.30 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=202.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
.++|++.+.||+|+||.||+|.+..++. .+|+|++....... .....+..++.+..+|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~------~~aik~~~~~~~~~--~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGS------LAAVKILDPISDVD--EEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCC------EEEEEEecccccHH--HHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 4689999999999999999999876554 89999986543221 12223333444445899999999998753
Q ss_pred ----CEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 119 ----GKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 119 ----~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+..|+||||++| +|.+++... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 368999999985 666665432 3467899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|+++....... ......|+..|+|||++.... ...++.++|+|||||++|||++|++||...+..+.+..+....
T Consensus 173 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 173 GVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 99876543211 123457899999999986421 1236789999999999999999999998877655554443322
Q ss_pred C-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 270 E-IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 270 ~-~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
. ....+...+..+.++|.+||+.+|++||++.++++ |+|+
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------~~~~ 290 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE------HPFI 290 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc------Cccc
Confidence 1 11234567789999999999999999999999998 7775
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.99 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=203.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEE--C
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVI--N 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~ 118 (627)
+|++++.||.|+||.||+|.+..++. .||+|+++....... ......+. ..++.++|+||+++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGK------ILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCC------EEEEEEEecccCCHHHHHHHHHHH-HHHHhcCCCccceeeeeeecCCC
Confidence 58999999999999999999876653 799999875432221 11122222 25677899999999997754 4
Q ss_pred CEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecccCCCcEEEecCCCeeecc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLH-----SKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLH-----s~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
...|++|||++| +|.+.+... ...++++..++.++.||+.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 568999999984 777776543 2467999999999999999999999 89999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||++....... .......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..++.+.+.. ..
T Consensus 154 ~g~~~~~~~~~---~~~~~~~~~~~~~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~ 226 (265)
T cd08217 154 FGLAKILGHDS---SFAKTYVGTPYYMSPEQLNH---MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GK 226 (265)
T ss_pred ccccccccCCc---ccccccccCCCccChhhhcC---CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CC
Confidence 99988764321 11234578999999999874 3578899999999999999999999998887777666654 34
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+.++..++.++.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 45677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.92 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=198.3
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
|++.+.||.|++|.||+|.+..++. .||+|++....... ...+..+. ..++..+|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~--~~l~~l~~~~iv~~~~~~~~~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE------IVALKKIRLETEDEGVPSTAIREI--SLLKELNHPNIVRLLDVVHSENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC------EEEEEEeecccccccchhHHHHHH--HHHHhcCCCCccCHhheeccCCe
Confidence 6788999999999999999876554 89999987543221 12222222 24566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|++|||+++++.+.+.......+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||+++.....
T Consensus 73 ~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 73 LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred EEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 99999999998888876544457899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---------- 270 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~---------- 270 (627)
........+++.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+....+.....
T Consensus 153 ---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 153 ---VRTYTHEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred ---ccccCccccccCCCCCceeecC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1222334678999999988642 3478899999999999999999999987766544333322100
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 271 -----------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 271 -----------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.......++.++.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01123567789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.79 Aligned_cols=272 Identities=22% Similarity=0.372 Sum_probs=222.6
Q ss_pred CCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc---hhHHHHHHHHHHHHHHHhcCCCC
Q 006887 31 SNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 31 ~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~---~~~~~~~~~~~~~~ll~~~~hpn 107 (627)
..+..+.+.-++..+.++||+|+||.||+|+....+.. ....||||..+... .+....++. +.+ +++.++|||
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~-EAr-vMr~l~H~N 222 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMK-EAR-VMRQLNHPN 222 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHH-HHH-HHHhCCCCC
Confidence 33456678888999999999999999999998765320 11239999997522 233333333 222 556699999
Q ss_pred ceeeEEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCe
Q 006887 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 108 Iv~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~v 186 (627)
|++++|+...+..++||||+|.| +|.+.+.. ....++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeE
Confidence 99999999999999999999995 77777764 33469999999999999999999999999999999999999999999
Q ss_pred eeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006887 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i 265 (627)
||+|||+++.-.... .....-.-...|+|||.+. .+.|+.++|||||||++||+++ |..||.+....++...|
T Consensus 302 KISDFGLs~~~~~~~---~~~~~~klPirWLAPEtl~---~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYV---MKKFLKKLPIRWLAPETLN---TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred EeCccccccCCccee---eccccccCcceecChhhhc---cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 999999987643111 1111113457899999998 5579999999999999999999 89999999999999999
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
.....+.+.|...|.++..++.+|+..+|+.||+|.++.+.++.....
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 777777778889999999999999999999999999999988875443
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=303.08 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=200.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+ +.. .++.++|+||+++++.+..+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~--~~~~~~-e~~-~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETG------QVVAIKVVPVEED--LQEIIK-EIS-ILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCC------cEEEEEEeecHHH--HHHHHH-HHH-HHHhCCCCcEeeeeeeeecCC
Confidence 368999999999999999999987654 4899999865432 222222 222 455669999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|++|||++| +|.+.+. .....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++....
T Consensus 72 ~~~l~~e~~~~~~L~~~l~-~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMK-ITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred cEEEEEecCCCCcHHHHHH-hCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 99999999996 5555553 345678999999999999999999999999999999999999999999999999988764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~ 277 (627)
... .......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+....+.... .....+..
T Consensus 151 ~~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 151 DTM---AKRNTVIGTPFWMAPEVIQE---IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred cCc---cccccccCCccccCHHHHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 321 12234568999999999874 368889999999999999999999998776655443332211 11223456
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.++.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 7889999999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.73 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|++.........+..+|||.+..............+. ..++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEA-HLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHH-HHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 35899999999999986544223344689999986543222222222222 25677899999999999999999999999
Q ss_pred cCC-CCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-----CeeeccCCccc
Q 006887 127 FYE-GSVGDRMAQLK-----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-----RAVLGDVGIPH 195 (627)
Q Consensus 127 y~~-GsL~d~l~~~~-----~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-----~vkL~DFGla~ 195 (627)
|++ |+|.+.+.... ...+++..++.++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 998 57777765432 23478899999999999999999999999999999999999887 89999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
....... ........++..|+|||++. .+.++.++|+|||||++|||++ |..||...+..+....+.. ......
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~ 234 (269)
T cd05044 160 DIYKSDY-YRKEGEGLLPVRWMAPESLL---DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQK 234 (269)
T ss_pred ccccccc-cccCcccCCCccccCHHHHc---cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCC
Confidence 6543211 11122345678999999987 3468899999999999999998 9999988887777666543 234456
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+..+|..+.++|.+||+.+|.+||++.++++.|+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7788999999999999999999999999998775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.96 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=198.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||++.+..++ ..||+|++..............+.+ ++..++||||+++++.+..
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCC------cEEEEEEEEecCcchHHHHHHHHHH-HHHHcCCCCcceEeeeEec
Confidence 45578999999999999999999987655 4899999875443322222222222 4556799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+.+|+||||++| +|.+.+. ..+.+++..+..++.|++.+|.|||+ .+++||||||+||++++++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 9999999999996 5544443 34678999999999999999999997 689999999999999999999999999986
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-----------HHHHH
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-----------EIYDA 264 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-----------e~~~~ 264 (627)
.... .......||..|+|||++.+ +.++.++|+|||||++|+|++|+.||...... +....
T Consensus 153 ~~~~-----~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 153 ELIN-----SIADTFVGTSTYMSPERIQG---GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred chhh-----hccCccccCcccCCHHHHcc---CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 5432 12234579999999999863 46888999999999999999999999865442 23333
Q ss_pred HHhccCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 265 VVRRQEIPPIPS-GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 265 i~~~~~~~~~p~-~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+... ..+.++. .++.++.+|+.+||+.||++||++.++++
T Consensus 225 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 225 IVQE-PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred Hhhc-cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3322 2233333 37889999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.41 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=201.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc--CCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ--GVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~--~hpnIv~l~~~~~~~~ 119 (627)
.|++.+.||+|+||.||+|.+..++. .||+|.++.............+..++.... .|||++++++++..+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR------VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc------EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence 58889999999999999999876654 899999875433222222222322332222 5999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+. .+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEEEEEecCCCCcHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999986 5555543 3478999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC-C
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS-G 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~-~ 277 (627)
... .......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+... ..+.++. .
T Consensus 153 ~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 226 (277)
T cd06917 153 QNS---SKRSTFVGTPYWMAPEVITEG--KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNG 226 (277)
T ss_pred CCc---cccccccCCcceeCHHHhccC--CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCccc
Confidence 422 222345799999999998632 24788999999999999999999999887766555433222 2333444 3
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++.++.+++.+||+.||++||++.++++ ++|+..
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~------~~~~~~ 260 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLK------SKWIKA 260 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhh------ChHhhc
Confidence 8899999999999999999999999988 777643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.64 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=201.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++.++|++.+.||+|+||.||++... +..||+|.++..... ..+.. +. ..+..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~--------~~~~~iK~~~~~~~~--~~~~~-e~-~~l~~~~~~~i~~~~~~~~~ 70 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYT--------GQKVAVKNIKCDVTA--QAFLE-ET-AVMTKLHHKNLVRLLGVILH 70 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccC--------CCceEEEeecCcchH--HHHHH-HH-HHHHhCCCCCcCeEEEEEcC
Confidence 46688999999999999999998642 236999998654322 22222 22 24567899999999999875
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+ ..++||||++ |+|.+.+.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.
T Consensus 71 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 71 N-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred C-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 4 4799999998 5887777654445689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
... .......+..|+|||++. .+.++.++|+|||||++|||++ |++||...+..+....+... .....+
T Consensus 150 ~~~------~~~~~~~~~~y~~pe~~~---~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 219 (254)
T cd05083 150 GSM------GVDNSKLPVKWTAPEALK---HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPP 219 (254)
T ss_pred ccc------cCCCCCCCceecCHHHhc---cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCC
Confidence 432 112234467899999986 3468889999999999999997 99999998888777666543 334456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..+++.+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 7789999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.17 Aligned_cols=254 Identities=19% Similarity=0.245 Sum_probs=192.0
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|...... ....+|+|.+.............++.. .++.++|+||+++++.+...+..|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM----SKARVVVKELRASATPDEQLLFLQEVQ-PYRELNHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCC----CCeEEEEeecCccCChHHHHHHHHHHH-HHHhCCCCCcceEEEEECCCCceEEEEE
Confidence 35899999999999754332 234789998765433222222222222 4556799999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 127 FYE-GSVGDRMAQLKG---GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 127 y~~-GsL~d~l~~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
|++ |+|.+.+..... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 998 577777654332 3356788899999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCccCCCCCcCCcccccCC----CCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC----CCC
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPE----VRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE----IPP 273 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~----~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~----~~~ 273 (627)
. .......+++.|+|||++... ....++.++|+|||||++|||++ |..||......+....+..... .+.
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 156 Y-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred e-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 111334567889999997531 12356789999999999999999 8899988877766655544322 233
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
.+..+++.+.+++..|+ .||++||++.++++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 45578899999999999 5999999999999865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.33 Aligned_cols=250 Identities=18% Similarity=0.228 Sum_probs=198.6
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHH--HHhcCCCCceeeEEEEEECC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLF--LKCQGVEGICWLQGISVING 119 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~l--l~~~~hpnIv~l~~~~~~~~ 119 (627)
|++.+.||+|+||.||+|++..++ ..||+|+++...... .......+...+ +....|+||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG------RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC------CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 688999999999999999987654 489999997543221 111111122222 23457999999999998877
Q ss_pred E-----EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 120 K-----ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 120 ~-----~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
. .+++|||+++++.+.+.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 75 TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred CCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 6 99999999999888776544457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-- 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-- 272 (627)
..+... .......+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+.+..+......+
T Consensus 155 ~~~~~~----~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 155 RIYSFE----MALTSVVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eeccCC----cccccccccccccChHHhcc---CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 776432 12223458899999999874 367889999999999999999999999988777766665421110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 -----------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 -----------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.....+++.+.+++.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 001235678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=303.28 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=201.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---H--HHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---R--MRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
+|+..+.||+|+||.||+|.+..+++ .||+|++...... . .......+. ..++.++|+||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~------~~alk~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGT------LMAVKQVTYVRNTSSEQEEVVEALRKEI-RLMARLNHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCc------EEEEEEeecccCCchhHHHHHHHHHHHH-HHHHHcCCCceehhhceec
Confidence 58889999999999999999866654 8999998754311 1 111112221 2566789999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCcc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIP 194 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla 194 (627)
..+..++||||++| +|.+.+. ..+++++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 99999999999996 6666554 345789999999999999999999999999999999999998776 5899999998
Q ss_pred ccccCCCCCCC-CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccC
Q 006887 195 HLLLGIPLPSS-DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---EIYDAVVRRQE 270 (627)
Q Consensus 195 ~~~~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---e~~~~i~~~~~ 270 (627)
........... ......||..|+|||++.+ ..++.++|+|||||++|+|++|..||...... .....+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC
Confidence 77654321111 1224578999999999864 35788999999999999999999999754432 23323333344
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+..+..+++++.+++.+||..+|.+||++.++++ |+||
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~------~~~~ 267 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK------HPVF 267 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc------Cccc
Confidence 56677889999999999999999999999999998 7765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=303.01 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=201.9
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
||+|+||.||++++..+++ .||+|++......... .....+. ..+..++|+||+++++.+..++..|+|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD------IYAIKVIKKADMIRKNQVDQVLTER-DILSQAQSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCC------EEEEEEecchhhhhhhHHHHHHHHH-HHHHhCCCcchhHHHHheecCcEEEEEEe
Confidence 6899999999999876554 8999999764432111 1111111 25666789999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC--
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP-- 203 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~-- 203 (627)
|++| +|.+.+.. .+.+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++.........
T Consensus 74 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 74 YLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9985 66666653 347899999999999999999999999999999999999999999999999998765432110
Q ss_pred ---CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC--
Q 006887 204 ---SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL-- 278 (627)
Q Consensus 204 ---~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~-- 278 (627)
........+++.|++||.... ..++.++|+||||+++|+|++|..||......+.+..+.... ...+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 226 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILG---QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEV 226 (265)
T ss_pred ccccccccCcccCccccCHHHhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccC
Confidence 112234568899999999874 347889999999999999999999999988888887776533 3334444
Q ss_pred CHHHHHHHHHhhhcCCCCCCCH---HHHHHHHHhcccccCCCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLM---TDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~---~eil~~L~~~~~~~~~~~~w 320 (627)
+..+.+++.+||+.+|++||++ .++++ ++||...+|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~------~~~~~~~~~ 265 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN------HPFFKGIDW 265 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc------CccccCCCC
Confidence 9999999999999999999999 66665 999998877
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.94 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=203.4
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecC-CchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-VKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~-~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.+....|+++++||+||-+.||++.....+ .||+|.+.. ...+....-...+...+.++.+|.+|+.|+++-
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-------iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQ-------IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCc-------chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 466788999999999999999999865443 477776643 333333333334445677888999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++++||||||-+-+|...+.. +...++...+++|..||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|.
T Consensus 430 v~d~~lYmvmE~Gd~DL~kiL~k-~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 430 VTDGYLYMVMECGDIDLNKILKK-KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred ccCceEEEEeecccccHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence 99999999999988887766654 444455458999999999999999999999999999999985 6799999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCC--------CCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRG--------PISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVV 266 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~--------~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~ 266 (627)
.+..... .-...+.+||+.||+||.+...... ..++++||||||||||+|+.|++||.... ...-+..|.
T Consensus 508 aI~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 508 AIQPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred ccCcccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 7754322 2223466899999999998754222 36789999999999999999999997643 233334443
Q ss_pred hccCCCCCCCCCCHH-HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 267 RRQEIPPIPSGLPPA-VENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~-l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.-....++|..-+.. +.++++.||++||.+||++.++|+ |+|...
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq------hpFl~~ 632 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ------HPFLQI 632 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc------Cccccc
Confidence 222222444433333 999999999999999999999998 887554
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.07 Aligned_cols=255 Identities=19% Similarity=0.223 Sum_probs=191.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|...... ....+|+|.++............++. .+++.++||||+++++++......++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGY----TPAQVVVKELRVSASVQEQMKFLEEA-QPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCC----CceEEEEEecCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 35899999999999865322 23479999987654332222222222 35677899999999999998889999999
Q ss_pred cCC-CCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 127 FYE-GSVGDRMAQLK---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 127 y~~-GsL~d~l~~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
|++ |+|.+.+.... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999 57767665422 23456778889999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCCccCCCCCcCCcccccCCCC----CCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-C---CCC
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVR----GPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ-E---IPP 273 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~----~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~-~---~~~ 273 (627)
........|++.|+|||++.+... ..++.++|+|||||++|||++ |+.||......+......... . .+.
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 -YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred -eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 111234567889999999864211 236789999999999999996 999998877666544333221 1 122
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
.....++.+.+++.+|+ .+|++||++.+++..|.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 33467889999999999 68999999999998653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.33 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=200.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..+++ .||+|++....... ...... +. ..++.++|+||+++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGR------VVALKKILMHNEKDGFPITALR-EI-KILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCc------EEEEEEEEeccCCCCcchhHHH-HH-HHHHhcCCCCccchhhheec
Confidence 4799999999999999999999876654 79999986533211 111122 22 25567799999999988754
Q ss_pred C--------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 N--------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 ~--------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
. ..+++||||+.+++...+.. ....+++..+..++.||++||.|||++||+||||||+||++++++.++|+
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMDHDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred ccccccccCceEEEEEecCCcCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence 3 35799999999988777653 34579999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCC--------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHH
Q 006887 190 DVGIPHLLLGIPLPS--------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEI 261 (627)
Q Consensus 190 DFGla~~~~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~ 261 (627)
|||+++......... .......|++.|+|||++.+. ..++.++|+|||||++|||++|++||.+.+..+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999998664322111 112344678999999988642 3578899999999999999999999998877665
Q ss_pred HHHHHhccCCC---------------------CC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 262 YDAVVRRQEIP---------------------PI-------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 262 ~~~i~~~~~~~---------------------~~-------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
...+......+ .. ...+++.+.+++.+||+.||.+||++.+++. |+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~------~~ 309 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE------HP 309 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc------CC
Confidence 55543321110 00 1234578899999999999999999999988 77
Q ss_pred cC
Q 006887 314 VH 315 (627)
Q Consensus 314 ~~ 315 (627)
||
T Consensus 310 ~f 311 (311)
T cd07866 310 YF 311 (311)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.87 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=202.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
..+|++.+.||+|+||.||+|++...+ ...+..||+|++..............+.. .++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~ei~-~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIE-ILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCC--CCCceEEEEEEeccccchHHHHHHHHHHH-HHHhCCCCChheEEeeeecCC
Confidence 457899999999999999999876442 12346899999986554412222222222 4566799999999999877
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
....++||||++| ++.+.+.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 5679999999985 77666643 334689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH--------------HH
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE--------------IY 262 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e--------------~~ 262 (627)
...............++..|++||.+.+ ..++.++|+|||||++|||++|..|+....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT---SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc---CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 6532211111122345667999999863 368889999999999999999999987532211 11
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 263 ~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..........+.+..++.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222223333445677889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.05 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=199.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++.+.||.|+||.||+|.+..+++ .||+|++...... ....+..+ . ..++.++||||+.+++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e-~-~~l~~l~h~~i~~~~~~~~~~ 72 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKK------MFAMKYMNKQKCVEKGSVRNVLNE-R-RILQELNHPFLVNLWYSFQDE 72 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCc------EEEEEEEehhhhcchhHHHHHHHH-H-HHHHhCCCCChHHHHHhhcCC
Confidence 58999999999999999999876654 8999999754322 12222222 2 245678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
+..|+||||+.| +|.+.+.. ..++++..+..++.||+.||.|||+++++|+||||+||++++++.++|+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 999999999986 55555543 257999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV---DEIYDAVVRRQEIPPI 274 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~---~e~~~~i~~~~~~~~~ 274 (627)
.... ......|+..|+|||++.+. .++.++|+||||+++|+|++|..||...+. .++...... .....
T Consensus 151 ~~~~----~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 221 (258)
T cd05578 151 TPDT----LTTSTSGTPGYMAPEVLCRQ---GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLY 221 (258)
T ss_pred CCCc----cccccCCChhhcCHHHHccc---CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccC
Confidence 4321 22345789999999998743 478899999999999999999999998763 444333221 45667
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLM--TDILR 305 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~--~eil~ 305 (627)
|..++..+.++|.+||+.||.+||++ .++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 88899999999999999999999999 77766
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.56 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=202.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||+|.+..++. .||+|.+..... ...... ..+. ..++.++|+||+++++.+..++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~-~~E~-~~l~~~~h~~i~~~~~~~~~~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSE------HCVIKEIDLTKMPVKEKEAS-KKEV-ILLAKMKHPNIVTFFASFQENG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCc------eEEEEEeeHhhccchhhHHH-HHHH-HHHHhCCCCChhhhhheeccCC
Confidence 58999999999999999999876654 799999865322 111222 2222 2566779999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC-eeeccCCccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR-AVLGDVGIPHLL 197 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~-vkL~DFGla~~~ 197 (627)
..|+||||++| +|.+.+.......+++..+..++.|++.||.|||+.+++|+||||+||++++++. ++|+|||.+...
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999999985 7777776544456899999999999999999999999999999999999998864 699999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.... .......|++.|+|||++.+ ..++.++|+|||||++|||++|..||...+..+....+... .....+..
T Consensus 153 ~~~~---~~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 225 (257)
T cd08225 153 NDSM---ELAYTCVGTPYYLSPEICQN---RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG-YFAPISPN 225 (257)
T ss_pred cCCc---ccccccCCCccccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-cCCCCCCC
Confidence 4321 12233468999999999863 46888999999999999999999999988777766655433 23445667
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.++.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 8899999999999999999999999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.33 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=205.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
..|+.++.||.|+||.||+|.+..++. .||+|++..............+. ..+..+.|+||+++++++..++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQ------VVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCE------EEEEEEEeccccHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEECCE
Confidence 357888999999999999999876654 89999987543322222222222 24566799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+. .+++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 77 LWIIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEEecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999985 6666553 35789999999999999999999999999999999999999999999999999977643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
.. .......++..|+|||++.+ ..++.++|+|||||++|||++|..||...+..+....+. ....+.++..++
T Consensus 154 ~~---~~~~~~~~~~~y~apE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (277)
T cd06640 154 TQ---IKRNTFVGTPFWMAPEVIQQ---SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFS 226 (277)
T ss_pred Cc---cccccccCcccccCHhHhcc---CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhh
Confidence 22 12234568899999999873 357889999999999999999999999887766655443 233455666788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..+.+++.+||+.+|++||++.+++. |+|+..
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~------~~~~~~ 258 (277)
T cd06640 227 KPFKEFIDACLNKDPSFRPTAKELLK------HKFIVK 258 (277)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHh------ChHhhh
Confidence 99999999999999999999999988 666543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=313.53 Aligned_cols=255 Identities=19% Similarity=0.291 Sum_probs=203.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|.....||+|+||.||++.+..++. .||||.+..........+..+. ..+..++|+||+.+++.+...+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~--~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGK------QVAVKKMDLRKQQRRELLFNEV--VIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCC------EEEEEEEecchHHHHHHHHHHH--HHHHhCCCCcHHHHHHheecCCe
Confidence 445666889999999999999866554 8999998654433333332222 24566799999999999999999
Q ss_pred EEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEGS-VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~Gs-L~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++|+ +.+.+ ..+.+++..++.++.||+.||.|||+++|+||||||+||++++++.++|+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 94 LWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEEeCCCCCcHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 99999999964 44443 335689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~~ 278 (627)
. ........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||...+..+.+..+..... .......+
T Consensus 171 ~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06658 171 E---VPKRKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKV 244 (292)
T ss_pred c---cccCceeecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccccccc
Confidence 2 122234578999999999863 3688899999999999999999999998877766655543211 11223457
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+..+.+++.+||..||.+||++.++++ |+||...
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~------~~~~~~~ 278 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQ------HPFLKLA 278 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh------Chhhhcc
Confidence 899999999999999999999999998 7777643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=344.75 Aligned_cols=260 Identities=22% Similarity=0.232 Sum_probs=197.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.++||+|+||.||+|++..++. .||||++...... .......++. .++..++||||+++++++.++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~------~VAIK~I~~~l~~~e~~~~rflrEi-~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSR------RVALKKIREDLSENPLLKKRFLREA-KIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCc------EEEEEEECcccccCHHHHHHHHHHH-HHHHhCCCcCcCeEEEEEeeC
Confidence 689999999999999999999876654 8999999754321 1122222222 256678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLK---------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~---------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
+..|+||||++| +|.+.+.... ...++...++.++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEE
Confidence 999999999995 7766664321 134566788999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCC---------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC
Q 006887 189 GDVGIPHLLLGIPLP---------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR 253 (627)
Q Consensus 189 ~DFGla~~~~~~~~~---------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf 253 (627)
+|||+++........ .......+||+.|||||++.+ .+++.++|+|||||++|||+||+.||
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g---~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG---VPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC---CCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 999999876211100 011123579999999999874 46889999999999999999999999
Q ss_pred CCCCHHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhc
Q 006887 254 CGRSVDEIYDAVVRRQE-IPPIPSGLPPAVENVLLGCFEYDLRSRPL-MTDILRVFKSS 310 (627)
Q Consensus 254 ~~~~~~e~~~~i~~~~~-~~~~p~~~s~~l~~li~~cL~~dP~~RPs-~~eil~~L~~~ 310 (627)
...+..++......... .......+++.+.+++.+||+.||++||+ +.++++.|+..
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 87665444322111110 01112468899999999999999999975 55666666654
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=296.23 Aligned_cols=249 Identities=25% Similarity=0.444 Sum_probs=207.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||++.+..++ ..||+|++...... ...... .+. ..++.++|+|++++.+.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~-~e~-~~l~~l~~~~~~~~~~~~~~~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG------KLYVLKEIDLSNMSEKEREDAL-NEV-KILKKLNHPNIIKYYESFEEKG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC------cEEEEEEeecccCChHHHHHHH-HHH-HHHHhcCCCChhheEEEEecCC
Confidence 5899999999999999999987655 38999999765432 222222 222 2456678999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..++||||++| +|.+.+.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 99999999995 7777665533 47899999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
..... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..++....... ....++.
T Consensus 153 ~~~~~---~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 225 (258)
T cd08215 153 LSSTV---DLAKTVVGTPYYLSPELCQN---KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-QYPPIPS 225 (258)
T ss_pred cccCc---ceecceeeeecccChhHhcc---CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCC
Confidence 64321 12334578999999999873 35888999999999999999999999988887777766543 3556777
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.++.++.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.06 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=205.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..|+..+.||+|+||.||+|++..+++ .||+|.+..... .....+..+ . .+++.++|+|++++++++..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e-~-~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKE-V-RFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCc------EEEEEEEecccccChHHHHHHHHH-H-HHHHhCCCCCcccEEEEEEc
Confidence 357888999999999999999876554 799999864322 222222222 2 25666799999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.+..++||||+.|++.+.+.. ...++++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999999999999988777654 4467899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. .....|++.|+|||++.+...+.++.++|+|||||++|+|++|..||...+..+....+.........+..
T Consensus 166 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 166 AP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred cC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 32 23456899999999985432345788999999999999999999999887665555444433322223457
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++..+.++|.+||..+|.+||++.++++ ++|+..
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~------~~~~~~ 272 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK------HRFVLR 272 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhh------Cccccc
Confidence 8899999999999999999999999998 666543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.03 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=203.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|.+..+++ .||+|.+..............+.. +++.+.||||+++++.+..++.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGK------IMAVKTIRLEINEAIQKQILRELD-ILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCc------EEEEEEEecccChHHHHHHHHHHH-HHHHCCCCchhhhheeeecCCE
Confidence 468889999999999999999876654 899999876543322222222222 4456679999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.+++|||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 74 ISICMEYMDGGSLDKILKE-VQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEEEecCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999 577666654 33689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-----SVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-----~~~e~~~~i~~~~~~~~ 273 (627)
... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||... ...+..+.+... ..+.
T Consensus 153 ~~~-----~~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 223 (265)
T cd06605 153 NSL-----AKTFVGTSSYMAPERIQGN---DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPR 223 (265)
T ss_pred HHH-----hhcccCChhccCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCC
Confidence 211 1126789999999998743 6889999999999999999999999754 233444444332 2344
Q ss_pred CCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 274 IPSG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 274 ~p~~-~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.+.. +++++.++|.+||..||++||++.+++. ++||.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~------~~~~~ 261 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE------HPFIK 261 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh------Cchhh
Confidence 4444 8999999999999999999999999998 88874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.84 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=198.0
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch------hHHHHH---HHHHHHHHHHhcCCCCceeeE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------DRMRVL---LERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~------~~~~~~---~~~~~~~ll~~~~hpnIv~l~ 112 (627)
+|.+.+.||+|+||.||+|.+..++ +.||+|.++.... ...... ...+. ..++.++|+||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG------EMMAVKQVELPATIAGRHDSRQKDMVKALRSEI-ETLKDLDHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC------ceeeeeeeechhhhhcccchHHHHHHHHHHHHH-HHHHhcCCCCcceEE
Confidence 5889999999999999999976655 4899998864221 111111 11121 256778999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..++||||++| +|.+.+.. .+++++..+..++.||+.||.|||+++++||||||+||+++.++.++|+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeec
Confidence 999999999999999985 66666543 367899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++...... .........|+..|+|||++.... ..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 153 GISKKSDDIY-DNDQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred cccccccccc-cccccccccCCccccCHHHhcccc-CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 9987653211 111223456899999999987432 24788999999999999999999999876655544443333223
Q ss_pred CCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 PPIP----SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~~~p----~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++ ..++.++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 3333 356899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=314.49 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=207.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||+|++..+++ .||||++..... .....+..+ . ..++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e-~-~~l~~l~~~~i~~~~~~~~~~~ 72 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR------KVAIKKISNVFDDLIDAKRILRE-I-KLLRHLRHENIIGLLDILRPPS 72 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc------EEEEEeeccccccchhhhhHHHH-H-HHHHhcCCcchhhhhhhhcccC
Confidence 58999999999999999999876554 899999976442 122222222 2 2456678999999999988765
Q ss_pred -----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 120 -----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 120 -----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..|+||||+++++.+.+. ...++++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~~~~~lv~e~~~~~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 73 PEDFNDVYIVTELMETDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred cccccceEEEecchhhhHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 789999999988777765 3458999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP- 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~- 273 (627)
.................+|+.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSS--SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecc--cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 8765432111223455789999999999753 1688899999999999999999999998887776666554221111
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 ----------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ----------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....++.++.++|.+||+.+|++||++.+++. |+||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~------~~~~~~~ 295 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA------HPYLAQL 295 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh------CccHHhh
Confidence 12346889999999999999999999999998 8887654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.92 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=197.0
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcC-CCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQG-VEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~-hpnIv~l~~~~~~~~~~ 121 (627)
|++.+.||+|+||.||+|....+++ .||||.+.............++... +.... |+||+.+++++..++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~-l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE------LVAIKKMKKKFYSWEECMNLREVKS-LRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc------EEEEEEehhhccchhHHHHHHHHHH-HHhccCCCCchhHHHHhhcCCcE
Confidence 6788999999999999999876653 8999998654332111111222223 34445 99999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
|+||||++|++.+.+.......+++..++.++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||+++.....
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~- 152 (283)
T cd07830 74 YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR- 152 (283)
T ss_pred EEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-
Confidence 9999999999988887644467899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--------- 272 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--------- 272 (627)
.......|+..|+|||++... ..++.++|+||||++++||++|++||...+..+.+..+......+
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 153 ---PPYTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred ---CCcCCCCCcccccCceeeecC--cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 122345689999999988532 357889999999999999999999998876655444332211000
Q ss_pred -------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 -------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 -------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
......+.++.++|.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 011233688999999999999999999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.80 Aligned_cols=255 Identities=18% Similarity=0.197 Sum_probs=199.1
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..++|++.+.||+|+||.||+|.+..++ +.||+|+++...... .......+. .+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~e~-~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTG------ELVALKKVRLDNEKEGFPITAIREI-KILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCC------cEEEEEEEeecccccCchHHHHHHH-HHHHhCCCCCeeeeeheecC
Confidence 3468999999999999999999987655 389999997543211 111111121 24566799999999998876
Q ss_pred CC----------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 118 NG----------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 118 ~~----------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
.. ..|+||||++|++.+.+.. ....+++..+..++.||+.||.|||+.+|+||||||+||++++++.++
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cchhhhccccCCcEEEEEcccCccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 54 7999999999988777654 345789999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||++..+..... .......+++.|+|||++.+. ..++.++|+|||||++|||++|++||...+..+.+..+..
T Consensus 157 l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 157 LADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred eCcccccccccCCcc--cccccceeccCccChHHhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999987643221 122234568899999988632 2467899999999999999999999987766555544433
Q ss_pred ccCCC----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 268 RQEIP----------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 268 ~~~~~----------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
....+ .....++..+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 21110 012347899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=315.47 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=202.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
++|++.+.||+|+||.||+|.+..++. .||+|++...... ....... +. .++..++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~iv~~~~~~~~~ 76 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGK------KVAIKKIPHAFDVPTLAKRTLR-EL-KILRHFKHDNIIAIRDILRPP 76 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCC------EEEEEEeccccccccchHHHHH-HH-HHHHhcCCCCccCHHHhcccc
Confidence 689999999999999999999877664 8999998764321 1222222 22 25666789999999987753
Q ss_pred ---CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 ---NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 ---~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
....|+||||+.|++.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 77 GADFKDVYVVMDLMESDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred CCCCceEEEEEehhhhhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 35689999999998877764 3456999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC-CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----
Q 006887 195 HLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ---- 269 (627)
Q Consensus 195 ~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~---- 269 (627)
+......... .......|+..|+|||.+.+. ..++.++|+|||||++|||++|+.||.+.+....+..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCC--cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 7764322211 122345799999999998632 357889999999999999999999998876544333222110
Q ss_pred --------------------CCCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 270 --------------------EIPPI-----PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 270 --------------------~~~~~-----p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..... ....++++.++|.+||+.+|++||++.+++. |+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~------~~~~~~ 299 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ------HPFLAQ 299 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh------Chhhhh
Confidence 01111 2457899999999999999999999999998 888763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=316.29 Aligned_cols=256 Identities=19% Similarity=0.228 Sum_probs=200.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..++. .||||.++..... ...... .+. ..+..++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~-~E~-~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNE------KVAIKKIANAFDNRIDAKRTL-REI-KLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCC------eEEEEEecccccccchhHHHH-HHH-HHHHhcCCCCccchHHheecc
Confidence 579999999999999999999876654 8999998753221 122222 222 245667999999999987654
Q ss_pred -----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 119 -----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 119 -----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
...|+||||+.++|.+.+. ..+++++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 3489999999998887775 346799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--- 270 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--- 270 (627)
++...... .......+|..|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+.....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 155 ARTTSEKG---DFMTEYVVTRWYRAPELLLNC--SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred ccccCCCc---ccccccccccCccChHHHhcC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 98654321 222345789999999998632 2478899999999999999999999987665433332221000
Q ss_pred -----------------------C---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 -----------------------I---PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 -----------------------~---~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
. ....+.+++++.++|.+||+.+|++||++.++++ |+|+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~------h~~~~~ 296 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA------HPYLAS 296 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc------Ccchhh
Confidence 0 0122468899999999999999999999999998 888764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.51 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=197.3
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
+.||+|+||.||+|.+.. + +.||+|.+..............+. .+++.+.|+||+.+++++...+..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~------~~v~~K~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N------TEVAVKTCRSTLPPDLKRKFLQEA-EILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-C------CcEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 469999999999999765 3 379999987654432222222222 25667899999999999999999999999
Q ss_pred cCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++| +|.+.+.. ....+++..++.++.|++.||.|||+++++||||||+|||++.++.++|+|||+++....... ..
T Consensus 73 ~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 150 (251)
T cd05041 73 LVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TV 150 (251)
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-ee
Confidence 9985 56555543 345789999999999999999999999999999999999999999999999999876542111 11
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~ 284 (627)
......++..|+|||.+.+ +.++.++|+|||||++|||++ |..||...........+... .....+..++.++.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 226 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNY---GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYR 226 (251)
T ss_pred ccccCcceeccCChHhhcc---CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHH
Confidence 1112234667999999863 468899999999999999999 89999888777666665433 344557788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 285 VLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 285 li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
++.+||..+|.+||++.++++.|+
T Consensus 227 li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.82 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=200.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
++|++.+.||.|+||.||+|.+..++. .||+|++.............+. .+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~------~v~iK~i~~~~~~~~~~~~~Ei--~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDK------RVAVKKIVLTDPQSVKHALREI--KIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCc------EEEEEEEecCCCchHHHHHHHH--HHHHhcCCCcchhhHhhhccccc
Confidence 689999999999999999999876654 8999998765544333333322 245667999999998766543
Q ss_pred ------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCC
Q 006887 119 ------------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADR 185 (627)
Q Consensus 119 ------------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~ 185 (627)
...|+||||+++++.+.+. ...+++..++.++.||+.||.|||+.||+||||||+||+++. ++.
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccccccccceEEEEeecccccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCce
Confidence 3589999999988776653 357899999999999999999999999999999999999974 557
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
++|+|||+++.+..............||..|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+....+
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCc--cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8999999997653321111122234688999999987532 35788999999999999999999999877665544433
Q ss_pred HhccC-----------------------CC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 266 VRRQE-----------------------IP-----PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 266 ~~~~~-----------------------~~-----~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..... .. .....++.++.+|+.+||..||.+||++.+++. |+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~------h~~~~~ 305 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM------HPYMSC 305 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC------CCcccc
Confidence 22110 00 012357889999999999999999999999998 898864
Q ss_pred C
Q 006887 318 G 318 (627)
Q Consensus 318 ~ 318 (627)
.
T Consensus 306 ~ 306 (342)
T cd07854 306 Y 306 (342)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.87 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=204.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch----------hHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE----------DRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~----------~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
+|++.+.||+|+||.||+|.+..+. +..+|+|.+..... ....... .+...+.+..+|+||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~-----~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~-~e~~~l~~~~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNG-----QNLLALKEINVHNPAFGKDKRERDKSIGDIV-SEVTIIKEQLRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCC-----CceeeeeEeeccccccccccccchHHHHHHH-HHHHHHhhcCCCCCeeeE
Confidence 4888999999999999999987622 24899998864221 1111122 222234456799999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCee
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vk 187 (627)
++++..++..|+||||++| ++.+.+... ....+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++.++
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence 9999999999999999985 777776443 34578999999999999999999996 7899999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||++....... ......|+..|++||++.+ +.++.++|+||||+++|+|++|++||...+.......+..
T Consensus 155 l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 155 ITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN---EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred Eecccceeeccccc----ccccccCcccCcChhhhcC---CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence 99999997654321 3345678999999999973 4688999999999999999999999988877777766655
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
....+.....+++.+.+++.+||+.||++||++.++..++.
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 44333333467899999999999999999999999988664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.49 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=206.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|++|.||+|++..+++ .||+|++..............+.. .+..++|+||+++++++...+.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~------~~~vk~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGK------IYALKKIHVDGDEEFRKQLLRELK-TLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCc------EEEEEEeccCcchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEccCCe
Confidence 479999999999999999999877654 899999876554222222222222 3455679999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.++||||++ ++|.+.+.. ..++++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999 577666653 3679999999999999999999999 999999999999999999999999999988764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~i~~~~~~~~~p 275 (627)
... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||... ...+....+. ....+..+
T Consensus 152 ~~~---~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (264)
T cd06623 152 NTL---DQCNTFVGTVTYMSPERIQG---ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLP 224 (264)
T ss_pred cCC---CcccceeecccccCHhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCC
Confidence 322 11224578999999999874 36888999999999999999999999876 4455555554 33345556
Q ss_pred CC-CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 276 SG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 276 ~~-~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.. ++..+.+++.+||+.+|++||++.++++ ++|+.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~------~~~~~ 260 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ------HPFIK 260 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh------CHHHH
Confidence 66 8999999999999999999999999998 66654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.50 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=205.0
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
-|++.+.||+|+||.||+|.+..+++ .||+|++..............+. ..+..++|+||+++++.+..++..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc------EEEEEEeccccchHHHHHHHHHH-HHHHhcCCCCEeEEEEEEEeCCeE
Confidence 47888999999999999998876654 89999986543322222222222 245668999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++| ++.+.+ ....+++..+..++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~lv~e~~~~~~l~~~i---~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 78 WIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEeCCCCcHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999996 555444 3457899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. ...+.++..++.
T Consensus 155 ~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 227 (277)
T cd06641 155 Q---IKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSK 227 (277)
T ss_pred h---hhhccccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCH
Confidence 1 12234578999999999863 3578899999999999999999999988777666665533 334556778899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
++.+++.+||+.+|.+||++.++++ |+|+..
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~~l~------~~~~~~ 258 (277)
T cd06641 228 PLKEFVEACLNKEPSFRPTAKELLK------HKFIVR 258 (277)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHh------CHHHhh
Confidence 9999999999999999999999998 666543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=292.05 Aligned_cols=247 Identities=24% Similarity=0.411 Sum_probs=200.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+|++.+.||+|++|.||++.+..+++ .+++|+++.........+..+. ..++.+.|+|++.+++++..++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~--~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGK------EVAIKVIKLESKEKKEKIINEI--QILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCc------EEEEEEecccchhHHHHHHHHH--HHHHhCCCCCEeEEEEEEecCCeE
Confidence 58899999999999999999876553 8999999776543333333332 245667799999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
+++|||++| +|.+.+.. ....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......
T Consensus 73 ~l~~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEEEecCCCCcHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999994 66655543 3367999999999999999999999999999999999999999999999999998776432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC--CC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS--GL 278 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~--~~ 278 (627)
.. .....|+..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....... ...+..+. .+
T Consensus 152 ~~----~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 223 (253)
T cd05122 152 KA----RNTMVGTPYWMAPEVINGK---PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKW 223 (253)
T ss_pred cc----ccceecCCcccCHHHHcCC---CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCccccc
Confidence 11 3456789999999998743 478899999999999999999999988765554444433 22233333 34
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+..+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 899999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.66 Aligned_cols=268 Identities=23% Similarity=0.361 Sum_probs=221.8
Q ss_pred cCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCc
Q 006887 30 TSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGI 108 (627)
Q Consensus 30 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnI 108 (627)
.+.-.+-.|..+...+.+.||.|-||.||.|..+...+ .+..-||||..+.+.. +..+.++.+. .+++...||||
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~k--ge~iaVAvKtCK~d~t~d~tekflqEa--~iMrnfdHphI 453 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEK--GERIAVAVKTCKTDCTPDDTEKFLQEA--SIMRNFDHPHI 453 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEeccccc--CcceeeeeehhccCCChhhHHHHHHHH--HHHHhCCCcch
Confidence 34445667888888889999999999999999876532 2345799999987443 4444444432 46788999999
Q ss_pred eeeEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 109 CWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 109 v~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
++|+|+|.. ...|||||+++ |.|...+.. ....++......|+.||+.||.|||+..+|||||-..|||+.....+|
T Consensus 454 ikLIGv~~e-~P~WivmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 454 IKLIGVCVE-QPMWIVMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred hheeeeeec-cceeEEEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence 999999985 57999999999 888777765 446789999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~ 266 (627)
|+|||++|.+.+...... +...-...|||||.+. ...++.++|+|.|||+|||+|. |..||.+-...+++..+.
T Consensus 532 LaDFGLSR~~ed~~yYka--S~~kLPIKWmaPESIN---fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE 606 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKA--SRGKLPIKWMAPESIN---FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE 606 (974)
T ss_pred ecccchhhhccccchhhc--cccccceeecCccccc---hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec
Confidence 999999998866443222 2233456899999997 5679999999999999999877 999999988888876665
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
...+++.|+.||+.+..|+.+||+++|.+||.+.++...|..
T Consensus 607 -nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 -NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred -CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 456788899999999999999999999999999998775544
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.88 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=199.1
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc--hhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK--EDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~--~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
|++.+.||+|+||.||+|++..+++ .||+|++.... ......+.. +. ..++.++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~------~~~~K~~~~~~~~~~~~~~~~~-e~-~~l~~l~~~~i~~~~~~~~~~~~ 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGE------LVALKKIRMENEKEGFPITAIR-EI-KLLQKLRHPNIVRLKEIVTSKGK 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCe------EEEEEEEecccccccchHHHHH-HH-HHHHhccCCCeeeheeeEecCCC
Confidence 6789999999999999999876553 89999998653 111122222 22 245667899999999999888
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..++||||+++++.+.+.. ....+++..++.++.||+.||+|||+.+++|+||||+||++++++.++|+|||++....
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 73 GSIYMVFEYMDHDLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred CcEEEEeccccccHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 89999999999988777754 33579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~----- 273 (627)
.... .......++..|+|||.+.+. ..++.++|+||||+++|||++|+.||...+..+.+..+......+.
T Consensus 152 ~~~~--~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 152 KRNS--ADYTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred CCCc--ccccccccccccCCceeeEcc--ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 4221 122344678899999987642 2578899999999999999999999998877665555443211110
Q ss_pred ------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 274 ------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 274 ------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+...+++++.+++.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01113889999999999999999999999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=311.08 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=202.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
..|.....||+|+||.||+|.+..++ ..||+|++..........+.. +. ..+..++||||+++++++..++.
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~-e~-~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSG------RQVAVKMMDLRKQQRRELLFN-EV-VIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCC------CEEEEEEEEecccchHHHHHH-HH-HHHHhCCCCchhhhhhheeeCCe
Confidence 34555668999999999999987655 389999986544333222222 22 24566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||++|..+..+. ....+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+...
T Consensus 93 ~~iv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 93 LWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEEEecCCCCCHHHHH--hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 99999999964333332 3356899999999999999999999999999999999999999999999999998755321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSGLP 279 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~~s 279 (627)
........|++.|+|||++.+ ..++.++|+|||||++|||++|+.||...+..+.+..+..... ....+..++
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 171 ---VPKRKSLVGTPYWMAPEVISR---TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244 (297)
T ss_pred ---cccccceecCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCC
Confidence 112234679999999999874 3688899999999999999999999998877666655543221 122345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..+.++|.+||+.+|.+||++.++++ |+|+..
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~------~~~~~~ 276 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLD------HPFLLQ 276 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhh------Chhhcc
Confidence 99999999999999999999999998 777653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.47 Aligned_cols=245 Identities=19% Similarity=0.279 Sum_probs=193.6
Q ss_pred CeEEEeEE--eeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRI--GRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~L--G~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.+ |+|+||.||++++..++. .+|+|++......... ... .....+|+||+++++.+...+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~e----~~~--~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQK------LFVQKIIKAKNFNAIE----PMV--HQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCc------EEEEEEEehhhcchhh----HHH--HHHhhcCCCEEEEEEEEecCC
Confidence 55565555 999999999999877664 7999998754322111 111 111237999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIPHLL 197 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla~~~ 197 (627)
..|+||||++ |+|.+.+.. ..++++..++.++.|++.||.|||+.+++||||||+||+++.++ .++|+|||+++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999998 577776653 34899999999999999999999999999999999999999998 9999999998765
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH-HHH-HhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY-DAV-VRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~-~~i-~~~~~~~~~p 275 (627)
.. .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.......+. ... .........+
T Consensus 161 ~~-------~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T PHA03390 161 GT-------PSCYDGTLDYFSPEKIKG---HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230 (267)
T ss_pred CC-------CccCCCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc
Confidence 32 123468999999999974 46888999999999999999999999865433221 111 1112233456
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhcccccCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPL-MTDILRVFKSSQNSVHS 316 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs-~~eil~~L~~~~~~~~~ 316 (627)
..+++.+.++|.+||+.+|.+||+ +.++++ |+|+.
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~------h~~~~ 266 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK------HPFLK 266 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhc------CCccc
Confidence 679999999999999999999996 699987 88865
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.24 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=199.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.|+..+.||+|+||.||+|.+..++ ..||+|.+..............+. ..++.++|+||+++++++..++..
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTK------EVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCC------eEEEEEEeccccchHHHHHHHHHH-HHHHcCCCCccHhhhcccccCCce
Confidence 4667788999999999999976554 489999987544333222233332 245667999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++| ++.+.+ ....+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++..+...
T Consensus 78 ~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 78 WIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEEEEccCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999996 555444 3467899999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
. .......|+..|+|||++.+ ..++.++|+|||||++|||++|+.||...........+.. ...+..+..++.
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 227 (277)
T cd06642 155 Q---IKRNTFVGTPFWMAPEVIKQ---SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSK 227 (277)
T ss_pred c---hhhhcccCcccccCHHHhCc---CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCH
Confidence 1 12234568999999999874 3578899999999999999999999987766655544432 233445667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=303.27 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=203.8
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
+|.-.+.||+|++|.||++.+..++ ..+|+|.++.........+.++. ..+...+|+||+++++++...+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~~e~--~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTG------RQVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCC------CEEEEEEEeccchhHHHHHHHHH--HHHHHcCCCChheEEEEEEcCCeE
Confidence 4556689999999999999986655 38999998654433333333222 256678999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++| +|.+.+.. .++++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999985 66555542 57899999999999999999999999999999999999999999999999988765432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSGLP 279 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~~s 279 (627)
. .......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.+..+..... ....+..++
T Consensus 169 ~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 169 V---PRRKSLVGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred C---cccccccCCccccCHHHhcC---CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCC
Confidence 1 12234579999999999874 3688899999999999999999999998887777766654321 111233478
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..+.+++.+||+.+|++||++.++++ |+|+..
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~------~~~~~~ 274 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN------HPFLAK 274 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc------Cccccc
Confidence 99999999999999999999999998 887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.44 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=206.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcC-CCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQG-VEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~-hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|.+..++ ..||+|++.+... .........+..+ +..+. |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~e~~~-~~~l~~~~~i~~~~~~~~~ 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN------KEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGHPGIIKLYYTFQD 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC------CEEEEEEechHhccchHHHHHHHHHHHH-HHhcccCCCchhHHHHhcC
Confidence 47999999999999999999987655 4899999875322 1112222233333 34455 9999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..++||||++ ++|.+.+.. .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 999999999996 577776653 45799999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCC-----------------CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH
Q 006887 197 LLGIPLP-----------------SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD 259 (627)
Q Consensus 197 ~~~~~~~-----------------~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~ 259 (627)
....... ........|+..|+|||+..+ ..++.++|+||||++++++++|+.||...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE---KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC---CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 6543221 012234568999999999873 35788999999999999999999999988877
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHHHHHhcccccC
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM----TDILRVFKSSQNSVH 315 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~----~eil~~L~~~~~~~~ 315 (627)
..+..+.. ....++..+++.+.+++.+||+.+|.+||++ .++++ |+||
T Consensus 229 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~------~~~~ 280 (280)
T cd05581 229 LTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA------HPFF 280 (280)
T ss_pred HHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc------CCCC
Confidence 77666653 3455778889999999999999999999999 88877 7764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=335.87 Aligned_cols=266 Identities=18% Similarity=0.246 Sum_probs=211.5
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE-
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI- 114 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~- 114 (627)
..+..-++++.+.|-+|||+.||+|.+...+ ..||+|++-..++... ....++..++..+.+|+|||.+++.
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~------~~~AlKrm~~~de~~L-~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGG------KKYALKRMYVNDEEAL-NAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCC------ceeeeeeeecCCHHHH-HHHHHHHHHHHHhcCCCceeeEeccc
Confidence 4456678899999999999999999987764 3799999876644443 4455556677777889999999993
Q ss_pred EEE---C---CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCCC
Q 006887 115 SVI---N---GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEADR 185 (627)
Q Consensus 115 ~~~---~---~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g~ 185 (627)
... + -.++|.||||. |+|.|.|.......|++.++++|+.|+++|+.+||... |||||||-|||||+.+|+
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 221 1 24789999999 69999998766677999999999999999999999987 999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCC------CccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDL------PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD 259 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~------~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~ 259 (627)
.||||||.+....-........ -...-|+.|.|||+|.--...+++.|+|||+|||+||-|+....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 9999999876433211100000 0124689999999987444457899999999999999999999999875443
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
. |+......+-.+.++..+++||..||+.||++||++-+++..+..+.+
T Consensus 265 a----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 A----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred e----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 3 333433444346789999999999999999999999999998777655
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=358.16 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=206.0
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|+-..+||.|.||.||-|.+..+++ ..|+|-++-....... ....+ +.-.+..++|||+|+++|+-...+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGe------llAvKEI~iq~~~~k~~~~i~e-Em~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGE------LLAVKEIKIQDSDHKTFKLIAE-EMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccc------hhhhhhhhcCccccccCcchHH-HHHHHHhccCccccccCceeecHHH
Confidence 57778899999999999999887776 7899988654333111 11111 1225677899999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.+|-||||. |+|.+++.+ ++..++.....|..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|..+.+
T Consensus 1309 v~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999 577777753 34566777788899999999999999999999999999999999999999999988765
Q ss_pred CCC-CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCC
Q 006887 200 IPL-PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 200 ~~~-~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~p~~ 277 (627)
... -........|||.|||||++.+........++|||||||+++||+||+.||...+.+ .++-.+. -...|.+|..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPER 1465 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchh
Confidence 310 111123568999999999999865445667999999999999999999999876544 4443443 4557889999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++++-++||.+||+.||++|.++.++++
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 9999999999999999999999999988
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=298.23 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=192.0
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEec
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKF 127 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy 127 (627)
.||+|+||.||+|....... ...+++|.+.............++. ..+..++||||+++++.+......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG----VARVVVKELKANASSKEQNEFLQQG-DPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC----cceEEEEEecCCCChHHHHHHHHHH-HHHhccCCcchhheEEEecCCCccEEEEec
Confidence 59999999999997654321 2357788776544322222222222 245668999999999999999999999999
Q ss_pred CC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCC
Q 006887 128 YE-GSVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204 (627)
Q Consensus 128 ~~-GsL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~ 204 (627)
++ |+|.+.+.... ...+++..+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++........ .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 155 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-I 155 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-h
Confidence 99 57777765432 24567778889999999999999999999999999999999999999999999864322111 1
Q ss_pred CCCCccCCCCCcCCcccccCCC----CCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC----CCCCC
Q 006887 205 SDLPRRLGTPNYMAPEQWQPEV----RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE----IPPIP 275 (627)
Q Consensus 205 ~~~~~~~GT~~YmAPE~~~~~~----~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~----~~~~p 275 (627)
.......|++.|+|||++.... ...++.++|+|||||++|||++ |..||...+..+.+..+..... .+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1223457899999999985321 2246789999999999999997 6889988777777666543321 23445
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
..+++.+.+++..|| .+|++||++.++++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 568899999999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.13 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=202.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
+|++.+.||+|++|.||+|.+..++ ..|++|++..... .....+.. +. ..++.++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~-e~-~~l~~l~~~~i~~~~~~~~~~~ 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG------ELMAVKSVELSGDSEEELEALER-EI-RILSSLQHPNIVRYYGSERDEE 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC------cEEEEEEeeccccchHHHHHHHH-HH-HHHHHcCCCCEeeEEEEEecCC
Confidence 5889999999999999999987655 3899999876543 22222222 22 256677899999999999988
Q ss_pred -CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 -GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 -~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+..++||||++ ++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 73 KNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred CCeEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 89999999997 566666653 23899999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~~~~~~p 275 (627)
....... .......++..|++||.+.+. .++.++|+||||+++|+|++|..||...+ .......+......+.++
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 151 LGDIETG-EGTGSVRGTPYWMAPEVIRGE---EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred ccccccc-ccccCCCCCccccCHhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 6543210 112345789999999998743 47889999999999999999999998765 333333443334556678
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++..+.+++.+|++.||++||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 888999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.34 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=223.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.-.|..++.++.+.||+|.||.|++|.|+..+. ....||||++...... .+..++.+. . .+..+.|+|+++|||
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psg---k~V~VAVKclr~d~l~~~mddflrEa-s-~M~~L~H~hliRLyG 178 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSG---KHVNVAVKCLRDDSLNAIMDDFLREA-S-HMLKLQHPHLIRLYG 178 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCC---cEEeEEEEeccCCccchhHHHHHHHH-H-HHHhccCcceeEEee
Confidence 344666778899999999999999999987543 3468999999887665 444444443 2 345689999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+..+ ....||||+++ |+|+|.+.......|.....+.|+.||+.|+.||.++++|||||-..|+|+-....+||+|||
T Consensus 179 vVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 179 VVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred eecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence 9886 78999999999 899999987666889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|.|-+..............-...|+|||.++ ++.++.++|+|+|||+||||+| |+.||.|.+..++++.|- ..+.
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr---h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~er 333 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLR---HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGER 333 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhc---cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cccc
Confidence 9998865433232223344567899999998 6789999999999999999999 999999999999999887 6667
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+.|..|++++.+++..||..+|.+||++..|.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 7889999999999999999999999999999864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.14 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=203.3
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|++|.||+|++..++. .||+|.+..... .....+..+. ..+..++|+|++++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~--~~l~~l~~~~i~~~~~~~~~~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD------FVAIKQISLEKIKEEALKSIMQEI--DLLKNLKHPNIVKYIGSIETSD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc------EEEEEEecccccCHHHHHHHHHHH--HHHHhCCCCCccEEEEEEEeCC
Confidence 58899999999999999999876553 899999976543 2222222222 2456678999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..+++|||++| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred EEEEEEecCCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 99999999986 66666543 3679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
.... ......++..|+|||...+. .++.++|+||||+++|+|++|..||...+......... ....+.++..+
T Consensus 151 ~~~~---~~~~~~~~~~y~~pe~~~~~---~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (254)
T cd06627 151 DVSK---DDASVVGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGI 223 (254)
T ss_pred CCcc---cccccccchhhcCHhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCC
Confidence 4221 12345789999999998743 47889999999999999999999998776655554443 33455677889
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++.+.+++.+||..+|++||++.+++.
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.63 Aligned_cols=257 Identities=16% Similarity=0.165 Sum_probs=193.6
Q ss_pred eEEeee--CCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEE
Q 006887 47 HRIGRG--PFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICI 123 (627)
Q Consensus 47 ~~LG~G--~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~L 123 (627)
..||+| +||+||+|.+..++. .||+|++....... ......++. .+++.++||||+++++++..++..|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGT------LVTVRITDLENCTEEHLKALQNEV-VLSHFFRHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCc------EEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcceEeeeEecCCceEE
Confidence 456766 999999999876654 89999987543222 112222222 35667899999999999999999999
Q ss_pred EEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 124 IMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 124 VmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
||||+.+ ++.+.+.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 9999994 777777654455689999999999999999999999999999999999999999999999986543322111
Q ss_pred CCC----CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------
Q 006887 203 PSS----DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-------- 270 (627)
Q Consensus 203 ~~~----~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-------- 270 (627)
... ......++..|||||++.+. ...++.++|+|||||++|||++|++||.+....+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 110 01123456789999998753 23578899999999999999999999987765544333322110
Q ss_pred -------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 271 -------------------------------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 271 -------------------------------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
..+.+..+++.+.+|+.+||+.||++||++.++++ |+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~------~~ 309 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS------HA 309 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh------CH
Confidence 00112346678999999999999999999999998 77
Q ss_pred cCCC
Q 006887 314 VHSD 317 (627)
Q Consensus 314 ~~~~ 317 (627)
|+..
T Consensus 310 ~~~~ 313 (328)
T cd08226 310 FFKQ 313 (328)
T ss_pred HHHH
Confidence 7653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.73 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=200.0
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC-
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVING- 119 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~- 119 (627)
|++.+.||+|+||.||+|.+.... ..++.||||++..... .....+.. +. ..++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED---GSFQKVAVKMLKADIFSSSDIEEFLR-EA-ACMKEFDHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC---CCceEEEEEEeccccCChHHHHHHHH-HH-HHHhcCCCCCcceEEEEEccCCC
Confidence 567889999999999999875432 1346899999875432 22222222 22 2566789999999999886532
Q ss_pred -----EEEEEEecCC-CCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 120 -----KICIIMKFYE-GSVGDRMAQLK----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 120 -----~~~LVmEy~~-GsL~d~l~~~~----~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
..+++++|+. |++.+.+.... ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 3578999998 56655543321 1357889999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||+++....... ........+++.|++||.+.. ..++.++|+|||||++|+|++ |++||.+.+..+++..+...
T Consensus 156 dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~---~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 156 DFGLSKKIYSGDY-YRQGCASKLPVKWLALESLAD---NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred cccccccccCCcc-eecCCCccCchhhcCHhHHhc---CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999986643211 111223456788999999873 357889999999999999999 99999988887777766543
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 232 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 -NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 23445667889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.19 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=207.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+-|.++.+||+|+||.||+|.++.++ +.+|||.+.-... .++.+.++ . +++.+..|++|++||.+.....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG------~v~AIK~VPV~sD--LQEIIKEI-S-IMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESG------HVLAIKKVPVDTD--LQEIIKEI-S-IMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccC------cEEEEEecCccch--HHHHHHHH-H-HHHHcCCchhhhhhhhhccCCc
Confidence 35788999999999999999988776 4899999864332 22222222 2 4566788999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|||||||. |+..|.+. .+++++++.++..++...+.||+|||...-||||||..|||++.+|++||+|||.|..+.+
T Consensus 103 LWIVMEYCGAGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eEeehhhcCCCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 999999999 78777765 5888999999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~~ 278 (627)
. -....+..|||-|||||++.. -.|..++||||||++..||..|++||.+..+...+..|-... ....-|+.+
T Consensus 182 T---MAKRNTVIGTPFWMAPEVI~E---IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 182 T---MAKRNTVIGTPFWMAPEVIEE---IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEW 255 (502)
T ss_pred h---HHhhCccccCcccccHHHHHH---hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhh
Confidence 2 223457799999999999983 358899999999999999999999999877665443332111 112246778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+.++.+|+++||-++|++|-++.++++ |+|..
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~------H~Fik 287 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCE------HTFIK 287 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhh------hhhhc
Confidence 999999999999999999999998887 66644
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.82 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=199.8
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|++.+.||+|++|.||+|.+..++ ..+|+|.++..... ........+. ..++.++|+||+++++++..++..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG------EIVAIKKIKLRFESEGIPKTALREI-KLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC------cEEEEEEeccccccchhHHHHHHHH-HHHHHhcCCCcchHHHhhccCCCE
Confidence 667889999999999999986555 48999998764432 1111222222 245667899999999999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
++||||+++++.+.+.. ....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 74 ~~v~e~~~~~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 74 YLVFEFMDTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred EEEEeccCCCHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 99999999988877765 34689999999999999999999999999999999999999999999999999987764422
Q ss_pred CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Q 006887 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--------- 272 (627)
Q Consensus 202 ~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--------- 272 (627)
.......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.+.+..+.+..+......+
T Consensus 153 ---~~~~~~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 ---RPYTHYVVTRWYRAPELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ---ccccCccCcccccCcHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 122335688999999998642 257889999999999999999999998877666554443321110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 -------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 -------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.....++.++.++|.+||+.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 112347889999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=309.50 Aligned_cols=260 Identities=18% Similarity=0.211 Sum_probs=203.5
Q ss_pred CeE-EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-------------HHHHHHHHHHHHhcCCCC
Q 006887 42 ALK-LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-------------VLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 42 ~y~-i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-------------~~~~~~~~~ll~~~~hpn 107 (627)
+|. +.+.||+|+||.||+|.+..++ +.||||++......... .....+. ..+..++|+|
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~ 81 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTG------KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL-KIMNEIKHEN 81 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCC------CeEEEEEeeccccccccccchhhhcccccchhHHHHH-HHHHhCCCcc
Confidence 454 5677999999999999987655 48999998653322100 0111121 2566789999
Q ss_pred ceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 108 ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 108 Iv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
|+++++++...+..|+||||+.|++.+.+. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccccCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 999999999999999999999999888875 345689999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCC-----------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 006887 188 LGDVGIPHLLLGIPL-----------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR 256 (627)
Q Consensus 188 L~DFGla~~~~~~~~-----------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~ 256 (627)
|+|||+++....... .........+++.|+|||++.+. ..++.++|+|||||++|||++|.+||.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999976642110 01122234578899999998643 24788999999999999999999999988
Q ss_pred CHHHHHHHHHhccCCCC--------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 257 SVDEIYDAVVRRQEIPP--------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~--------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+..+.+..+......+. ....++.++.++|.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~----- 312 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK----- 312 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc-----
Confidence 87766655543211110 11345788999999999999999999999998
Q ss_pred ccccCCCC
Q 006887 311 QNSVHSDG 318 (627)
Q Consensus 311 ~~~~~~~~ 318 (627)
|+||...
T Consensus 313 -~~~~~~~ 319 (335)
T PTZ00024 313 -HEYFKSD 319 (335)
T ss_pred -CcccCCC
Confidence 8888744
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=310.17 Aligned_cols=256 Identities=22% Similarity=0.240 Sum_probs=201.3
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
-.++|++.+.||+|+||.||+|.+..++ ..||||++....... .......+. .+++.++|+||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTG------AKVAIKKLYRPFQSELFAKRAYREL-RLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCC------cEEEEEEecccccchHHHHHHHHHH-HHHHhcCCCCccceeeeecC
Confidence 3578999999999999999999987665 489999986532221 111122222 35677899999999999876
Q ss_pred CC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 118 NG------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 118 ~~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+. ..|+||||+.+++.+.+. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 86 DLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred CccccccceEEEEEecCCCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 43 469999999777766653 357999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|++..... ......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+....+..+......
T Consensus 163 g~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDS------EMTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred cccccccc------CccccccCCcccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99876532 22345789999999998642 24788999999999999999999999887655444433321110
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 -----------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 -----------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
......+++++.++|.+||+.||++||++.+++. |+||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~------~~~~~~~ 304 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA------HPYFEEF 304 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc------CccHhhh
Confidence 0122467889999999999999999999999998 8887644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.15 Aligned_cols=262 Identities=19% Similarity=0.192 Sum_probs=189.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEec--------------CC--chhHHHHHHHHHHHHHHHhcC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--------------PV--KEDRMRVLLERLNDLFLKCQG 104 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~--------------~~--~~~~~~~~~~~~~~~ll~~~~ 104 (627)
++|++++.||+|+||.||+|..+..... .+++|.+. +. ........+..+. .++..++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei-~il~~l~ 221 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEE-----AEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEI-LALGRLN 221 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchh-----hhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHH-HHHHhCC
Confidence 6899999999999999999986544321 12222110 00 0011111122222 2566789
Q ss_pred CCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 105 hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
|+||+++++++...+..|+||+++.+++.+.+.... ........+..++.||+.||.|||++||+||||||+|||++
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999999998887765321 12344677889999999999999999999999999999999
Q ss_pred cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC-CCCC--CH
Q 006887 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGR--SV 258 (627)
Q Consensus 182 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P-f~~~--~~ 258 (627)
.++.+||+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..+ |.+. ..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAG---DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999999998764321 112234689999999999974 4688999999999999999998754 4322 22
Q ss_pred HHHHHHHHhccC---------------------CCCC---------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 259 DEIYDAVVRRQE---------------------IPPI---------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 259 ~e~~~~i~~~~~---------------------~~~~---------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
...+..+..... .... ...++.++.++|.+||+.||.+||++.|++.
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~--- 453 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA--- 453 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh---
Confidence 222211111000 0000 1235677888999999999999999999998
Q ss_pred hcccccCCCCC
Q 006887 309 SSQNSVHSDGG 319 (627)
Q Consensus 309 ~~~~~~~~~~~ 319 (627)
|+||....
T Consensus 454 ---hp~f~~~~ 461 (501)
T PHA03210 454 ---LPLFSAEE 461 (501)
T ss_pred ---ChhhhcCC
Confidence 99887543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.32 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=199.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhc-CCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQ-GVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~-~hpnIv~l~~~~~~ 117 (627)
++|++.+.||+|+||.||+|.+..++. .||+|.+..... ...... ..+.. ++..+ +|+||+++++++..
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~-~~E~~-~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKE------VVALKKIFDAFRNATDAQRT-FREIM-FLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCe------EEEEEeeccccCcchhhhhh-hHHHH-HHHHhcCCCCccceeeeecc
Confidence 579999999999999999999876553 899998864321 122222 22222 44555 99999999998865
Q ss_pred C--CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 N--GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~--~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
. ...|+||||++++|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred CCCceEEEEecccccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 3 36899999999988776643 378899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC--CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--
Q 006887 196 LLLGIPLP--SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI-- 271 (627)
Q Consensus 196 ~~~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~-- 271 (627)
.+...... ........||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeecc--ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 76543221 1122345789999999988642 35788999999999999999999999877655544333221110
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 ---------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 ---------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
......++.++.++|.+||+.||++||++.++++ ++|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~------~~~~~~ 300 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE------HPYVAQ 300 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh------Chhhhh
Confidence 0112347899999999999999999999999998 666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.65 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=199.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--C
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--N 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~ 118 (627)
++|+..++||.|++|.||+|.+..++ +.||+|.+.............++.+ .++.++||||+++++++.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG------MIFALKTITTDPNPDLQKQILRELE-INKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC------eEEEEEEEecCCchHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEccCC
Confidence 47999999999999999999987655 4899999875443222222222222 5566799999999998865 3
Q ss_pred CEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
+.+|+||||++| +|.+.+... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 478999999985 776665432 34668999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhccC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-----SVDEIYDAVVRRQE 270 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-----~~~e~~~~i~~~~~ 270 (627)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... ...+....+... .
T Consensus 154 ~~~~~-----~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 224 (287)
T cd06621 154 ELVNS-----LAGTFTGTSFYMAPERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-P 224 (287)
T ss_pred ccccc-----ccccccCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-C
Confidence 65321 1224468889999999873 46888999999999999999999999865 233444444321 1
Q ss_pred CCCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 IPPIP------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 ~~~~p------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.+..+ ..+++++.+++.+||+.+|.+||++.++++ |+|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~------~~~~~~ 271 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE------HPWIKA 271 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh------Cccccc
Confidence 12211 235688999999999999999999999998 888653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.86 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=202.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||++.+..++ ..||+|.+..........+..+. .+++..+||||+.+++.+...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~e~--~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATG------QEVAIKQMNLQQQPKKELIINEI--LVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCC------CEEEEEEeccccchHHHHHHHHH--HHHhhcCCCCeeehhheeeeCCc
Confidence 68999999999999999999876554 47999998654433333332222 24566789999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| ++.+.+. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEEEEecCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999985 5555543 34688999999999999999999999999999999999999999999999998876543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-QEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~-~~~~~~p~~~ 278 (627)
.. .......|++.|++||.+.+ +.++.++|+|||||++|+|++|+.||...+..+....+... ......+..+
T Consensus 168 ~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd06647 168 EQ---SKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241 (293)
T ss_pred cc---cccccccCChhhcCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcccc
Confidence 21 12234578999999999873 46788999999999999999999999877654443333211 1122234567
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+..+.+++.+||..+|++||++.+++. |+||..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~------h~~~~~ 274 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQ------HPFLKI 274 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc------CHHHhc
Confidence 889999999999999999999999998 777653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=295.58 Aligned_cols=245 Identities=20% Similarity=0.298 Sum_probs=187.4
Q ss_pred eEEeeeCCeEEEEEEEcCCCcC----cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTED----CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed----~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
+.||+|+||.||+|.+..+... ......+++|++...... ...+.++. .+++.++|+||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~--~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETA--SLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHH--HHHHcCCCcchhheeeEEec-CCcE
Confidence 4699999999999998765521 111235888887654332 22222222 25667899999999999887 7789
Q ss_pred EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-------CeeeccCCcc
Q 006887 123 IIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-------RAVLGDVGIP 194 (627)
Q Consensus 123 LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-------~vkL~DFGla 194 (627)
+||||++| +|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .++|+|||++
T Consensus 77 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 77 MVEEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999995 55555543 333789999999999999999999999999999999999999888 7999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
..... .....++..|+|||++.+. ...++.++|+|||||++|+|++ |..||...+..+....... ...
T Consensus 156 ~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~---~~~ 224 (259)
T cd05037 156 ITVLS-------REERVERIPWIAPECIRNG-QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---QHR 224 (259)
T ss_pred ccccc-------ccccccCCCccChhhhcCC-CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc---CCC
Confidence 76532 2234577889999998743 1368889999999999999999 6888887765444433322 122
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L 307 (627)
.+......+.+++.+||..+|.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2333348999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.64 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=199.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|.+.+.||+|+||.||+|++..+++ .||+|++...... ........+. .++..+.|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGE------KVAIKKLSRPFQSEIFAKRAYREL-TLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCc------EEEEEEecCccccccchhHHHHHH-HHHHhcCCCCccchhheeccc
Confidence 3689999999999999999999876554 8999998753221 1111112222 255667999999999988754
Q ss_pred ------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 ------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
...|+||||+.+++.+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 346999999987655443 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI- 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~- 271 (627)
+++.... ......+|+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+....+..+......
T Consensus 163 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 163 LARHADA------EMTGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCcCCCC------CCCCceeeecccChhhhcCc--cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9876422 22345788999999998642 35788999999999999999999999987765555443321100
Q ss_pred --------------------CC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 272 --------------------PP--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 272 --------------------~~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
+. ..+..++.+.++|.+||+.||.+||++.+++. |+||....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~------h~~f~~~~ 304 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE------HPYFDSFR 304 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc------Ccchhhcc
Confidence 00 11346788999999999999999999999998 88887653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.09 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=198.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
+|++.+.||+|+||.||++++..+. .+..||+|.+....... .......+..++....+|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 5899999999999999999987651 13489999986532211 1111222333444445799999999875432
Q ss_pred --CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 --GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 --~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
...|++|+|++++|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 77 ~~~~~~~~~e~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 77 NFNELYLYEELMEADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred cCCcEEEEEecccCCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 4589999999998887775 456799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC-CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----
Q 006887 197 LLGIPLP-SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE----- 270 (627)
Q Consensus 197 ~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~----- 270 (627)
+...... ........||+.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 6432211 1122345799999999987632 3578899999999999999999999987765544433322110
Q ss_pred ---------------------CC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 271 ---------------------IP---PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 271 ---------------------~~---~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.. .....++..+.+++.+||+.||.+||++.+++. |+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~------~~~~~ 296 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE------HPYLA 296 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc------Chhhh
Confidence 00 112346889999999999999999999999987 77764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.43 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=207.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+.|+....||+|+||.||+|.+..++ ..||+|++..... ....+..+. ..+..++|+||+++++.+...+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~-~~~~~~~e~--~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATG------KEVAIKKMRLRKQ-NKELIINEI--LIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCC------cEEEEEEEecCch-hHHHHHHHH--HHHHHCCCCCeeEEEEEEEECC
Confidence 356899999999999999999987554 3899999976544 222222222 2556779999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQ-NFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEEEeccCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999 577777654 22479999999999999999999999999999999999999999999999999886654
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-CCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-PIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-~~p~~ 277 (627)
... .......+++.|++||++.+ ..++.++|+|||||++|+|++|..||...+.......+....... ..+..
T Consensus 168 ~~~---~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 168 KEK---SKRNSVVGTPYWMAPEVIKR---KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred cch---hhhccccCCcccCCHhHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 321 12234468899999999874 368899999999999999999999999877766555554332211 22334
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
++.++.++|.+||+.+|.+||++.++++ ++|+....|
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~------~~~~~~~~~ 278 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ------HPFLKKACP 278 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh------ChHhhccCc
Confidence 8899999999999999999999999998 777766443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=322.50 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=215.5
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHH-HHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL-LERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~-~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.....|.++..||+|.|+.|.+|++..++ ..||||++++...+..... ..++.. .++.++|||||+++.+..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~------~~VaiK~idkt~ln~~~~~k~~rev~-imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTG------TEVAIKIIDKTQLNPSKRQKLGREVD-IMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCC------ceEEEEEehhcccChHHHHHHHHHHH-HHHhcCCcceeeeeeeee
Confidence 34468999999999999999999998876 4899999998765544322 222322 466789999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
....+|+||||+.| .+.+.+. +.+.+.+..+..++.|+..|++|||+++|+|||||.+||||+.+.++||+|||++.
T Consensus 126 t~~~lylV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ecceeEEEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence 99999999999984 6666665 45678889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.+.. .....++||++.|.|||++.+.. ..++.+|+||+|++||.|+.|.+||.+.+..++-..++.. ...+|
T Consensus 204 ~~~~----~~~lqt~cgsppyAaPEl~~g~~--y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp 275 (596)
T KOG0586|consen 204 FFDY----GLMLQTFCGSPPYAAPELFNGKK--YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIP 275 (596)
T ss_pred eecc----cccccccCCCCCccChHhhcCcc--cCCcceehhhhhhhheeeeecccccCCcccccccchheee--eeccc
Confidence 8753 34456789999999999999753 3568999999999999999999999999988887777654 45577
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++.+++++|+++|-.+|.+|+++.++.+
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 889999999999999999999999999877
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.87 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=203.7
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-.++|++.+.||+|+||.||+|++..++. .||+|++...... ...... .+. .+++.+.|+||+.+++++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~-~E~-~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGR------KVAIKKLSRPFQSAIHAKRTY-REL-RLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCc------EEEEEecccccchhhHHHHHH-HHH-HHHHhccCCCHHHHHHHhh
Confidence 35689999999999999999999877654 8999998653221 112222 222 2456679999999988776
Q ss_pred ECCE------EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 117 INGK------ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~~~------~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
..+. .|+||||++++|.+.+. ..++++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 85 PASSLEDFQDVYLVTHLMGADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccccccccccEEEEEecCCCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcc
Confidence 5544 89999999888887775 35799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||++..... ......+|+.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 162 fg~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 162 FGLARHTDD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred ccccccccc------cccCCcccccccCHHHHhCC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 999876532 12345789999999998642 2578899999999999999999999988777666555543221
Q ss_pred CC-----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 271 IP-----------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 271 ~~-----------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.+ .....+++++.++|.+||+.||.+||++.+++. |+|+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~------h~~~~~~ 304 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA------HPYLAEY 304 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc------CCCcccc
Confidence 11 011346899999999999999999999999988 8887743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.71 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=203.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|++.+.||+|+||.||++.+..+++ .+|+|.+....... ...... + ...++.++|+||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~-e-~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ------FYALKEVDLGSMSQKEREDAVN-E-IRILASVNHPNIISYKEAFLDGN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC------EEEEEEEehhhccHHHHHHHHH-H-HHHHHhCCCCCchhhhhhhccCC
Confidence 58999999999999999999876654 79999987543221 122222 1 12556678999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..|+||||++| +|.+.+... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 99999999985 666655442 236789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
.... ......|++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+.. ...+..+.
T Consensus 153 ~~~~-----~~~~~~~~~~~~~Pe~~~~---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 223 (256)
T cd08530 153 LKKN-----MAKTQIGTPHYMAPEVWKG---RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPP 223 (256)
T ss_pred hccC-----CcccccCCccccCHHHHCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCch
Confidence 6542 2223568999999999874 4678899999999999999999999999888777666643 34455667
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.++.++.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 89999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.26 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=200.2
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
+...++|++.+.||+|+||.||+|.+..+++ .||+|++....... ..... ++. ..+..++|+||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~-~Ei-~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTY-REL-RLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCe------EEEEEEecCcchhhHHHHHHH-HHH-HHHHHcCCCcccceeee
Confidence 3445789999999999999999999876554 89999997543221 12222 222 35667899999999998
Q ss_pred EEEC------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 115 SVIN------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 115 ~~~~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
+... +..|++++++.+++.+.+. ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 8643 3478999999888876654 346899999999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+++.... ......||+.|+|||.+.+ ...++.++|+|||||++|+|++|+.||.+.+..+.+..+...
T Consensus 162 ~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD------EMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred ecccccccccc------cccccccCCCccCHHHHhC--ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999876422 2234578999999999864 235788999999999999999999999877665544433221
Q ss_pred cCC---------------------CC--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 269 QEI---------------------PP--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 269 ~~~---------------------~~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
... +. .....++++.++|.+||+.||.+||++.++++ |+||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------h~~f~~ 305 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFAQ 305 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc------Chhhhh
Confidence 110 00 11246788999999999999999999999998 888764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=332.40 Aligned_cols=147 Identities=21% Similarity=0.277 Sum_probs=122.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|+++++||+|+||.||+|.+..++ +.||||+++..... ........+. .++..++|+||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~------~~vAiKvi~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~ 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNS------KLYAVKVVKKADMINKNMVHQVQAER-DALALSKSPFIVHLYYSLQS 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC------cEEEEEEEehhhccCHHHHHHHHHHH-HHHHhcCCCCcCeEEEEEEE
Confidence 468999999999999999999987655 48999999754321 1112222222 24567899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+.+||||||+.| +|.+++. ..+.+++..++.|+.||+.||.|||+++|+||||||+||||+.++.++|+|||+++
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~--~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999974 6766664 34578999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.43 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=208.5
Q ss_pred eEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|++. +.||+|+|+.|--+....++. +||||++.+.......+.. ++.+.+..++.|+||+.|+++|+++.++
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~------EYAVKiidKq~gHsR~Rvf-REVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGK------EYAVKIIDKQPGHSRSRVF-REVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccch------hhhhhhhhcCCchHHHHHH-HHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4443 679999999999999888774 8999999987544444433 4445788999999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eeeccCCccccc
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVLGDVGIPHLL 197 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL~DFGla~~~ 197 (627)
|||||-+.| .|+..+. +...|++.++.++..+|+.||.+||.+||.||||||+|||-...++ +||+||.|....
T Consensus 152 YLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999995 7777665 4567999999999999999999999999999999999999976654 699999887554
Q ss_pred cCCCC----CCCCCCccCCCCCcCCccccc---CCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-------------
Q 006887 198 LGIPL----PSSDLPRRLGTPNYMAPEQWQ---PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS------------- 257 (627)
Q Consensus 198 ~~~~~----~~~~~~~~~GT~~YmAPE~~~---~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~------------- 257 (627)
..... ......+.+|+-.|||||+.. ++ ..-|+.++|.||||||||-||.|.+||.|.-
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~q-A~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ-ATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccc-cccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 32211 112234778999999999864 33 2358899999999999999999999998632
Q ss_pred --HHHHHHHHHhccCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 258 --VDEIYDAVVRRQEIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 258 --~~e~~~~i~~~~~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
...+++.|.++....+ -...+|.+.++++..+|..|+.+|.++..+++ |||+....
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln------hPw~~~~~ 368 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN------HPWVQRCA 368 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC------Cccccccc
Confidence 2356777765543222 12468999999999999999999999988887 88877553
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.14 Aligned_cols=268 Identities=20% Similarity=0.353 Sum_probs=228.1
Q ss_pred cCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCce
Q 006887 30 TSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGIC 109 (627)
Q Consensus 30 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv 109 (627)
.++...+.++..+....++||.|.||.||.|.|+...- .||||.++.+. ....+++.+ ..+++.++|||+|
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkysl------TvAVKtLKEDt-MeveEFLkE--AAvMKeikHpNLV 326 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDT-MEVEEFLKE--AAVMKEIKHPNLV 326 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeeccce------eeehhhhhhcc-hhHHHHHHH--HHHHHhhcCccHH
Confidence 34456788999999999999999999999999987653 79999996443 333444443 2467889999999
Q ss_pred eeEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 110 WLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 110 ~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
+|+++|..+..+|||+|||. |+|+|.+.......++.-..+..+.||..|++||..+++|||||-..|.|+.++..+|+
T Consensus 327 qLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 327 QLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred HHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999999 99999998866677788888899999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~ 267 (627)
+||||++++.++...... ...-.+.|.|||-+. +..++.++|+|+|||+|||+.| |-.||.+.+..++|..+..
T Consensus 407 ADFGLsRlMtgDTYTAHA--GAKFPIKWTAPEsLA---yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLA---YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred eccchhhhhcCCceeccc--CccCcccccCccccc---ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 999999998764332221 112246799999987 5579999999999999999999 9999999999999987765
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
. .+-.-|..||+.+.+|++.||+++|..||++.|+-+.|+.+.+
T Consensus 482 g-yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 482 G-YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred c-ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 4 4455699999999999999999999999999999988877654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.51 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=201.2
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
|.....||+|+||.||++.+..+++ .||||.+..........+..+. ..+..++|+||+++++.+..++..|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGK------LVAVKKMDLRKQQRRELLFNEV--VIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCe------EEEEEEecccchhHHHHHHHHH--HHHHhcCCcchhheeeEEEeCCEEE
Confidence 3344679999999999999876654 8999998644333222222222 2556789999999999999999999
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 123 IIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 123 LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
+||||++|..+..+. ....+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~- 170 (292)
T cd06657 94 VVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 170 (292)
T ss_pred EEEecCCCCcHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-
Confidence 999999974444333 34568999999999999999999999999999999999999999999999999887654321
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCCHH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGLPPA 281 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~~s~~ 281 (627)
.......||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.... ........+++.
T Consensus 171 --~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06657 171 --PRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS 245 (292)
T ss_pred --ccccccccCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHH
Confidence 12234578999999999863 457889999999999999999999999887776665554322 112233567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+.+++.+||..+|.+||++.++++ |+|+...
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~------~~~~~~~ 276 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK------HPFLAKA 276 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc------ChHHhcc
Confidence 999999999999999999999998 8887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=324.00 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=204.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+.|.+...+|.|+|+.|-++.+..++. ..++|++.+...+.. .+..+.+...+||||+.+++.+.++.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~------~~~vkii~~~~~~~~-----~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQ------EPAVKIISKRADDNQ-----DEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeecccccc------chhheeccccccccc-----cccchhhhhcCCCcceeecceecCCc
Confidence 5689999999999999999999887764 799999987633322 22335667789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE-ecCCCeeeccCCccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRAVLGDVGIPHLL 197 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl-d~~g~vkL~DFGla~~~ 197 (627)
..|+|||++.| .+++.+. ..+....++..|++||+.|+.|||++|+|||||||+|||+ +..++++|+|||.++..
T Consensus 390 ~~~~v~e~l~g~ell~ri~---~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIR---SKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeeehhccccHHHHHHH---hcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999997 4444443 3333447888999999999999999999999999999999 69999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~p~ 276 (627)
... ..+.+-|..|.|||+.. ...|+.++||||||++||+||+|+.||...... +++..+ ..+++..
T Consensus 467 ~~~------~~tp~~t~~y~APEvl~---~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~ 533 (612)
T KOG0603|consen 467 ERS------CDTPALTLQYVAPEVLA---IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSE 533 (612)
T ss_pred chh------hcccchhhcccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCcccc
Confidence 532 44567889999999998 347999999999999999999999999876655 555544 3455568
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
.+|+++++|+.+||+.||.+||++.+++. |+|+
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~------h~w~ 566 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA------HPWF 566 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc------Ccch
Confidence 99999999999999999999999999988 8887
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.97 Aligned_cols=253 Identities=22% Similarity=0.255 Sum_probs=200.8
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
|++.+.||+|+||.||+|++..+++ .||+|++...... ....... +. ..++.++|+||+++++++...+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~-e~-~~l~~~~~~~i~~~~~~~~~~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE------IVALKKIRLDNEEEGIPSTALR-EI-SLLKELKHPNIVKLLDVIHTERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc------EEEEEEeccccccccccHHHHH-HH-HHHHhcCCCCHHHHHhhhhcCCc
Confidence 6778899999999999999876654 8999999865321 1112222 22 24566789999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.++||||++++|.+.+... ...+++..+..++.|++.||.|||+++|+||||+|+||++++++.++|+|||+++.....
T Consensus 73 ~~~v~e~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 73 LYLVFEYCDMDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred eEEEecCcCcCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 9999999999988887653 257999999999999999999999999999999999999999999999999998775432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--------- 271 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--------- 271 (627)
........++..|+|||.+.+. ..++.++|+|||||++|||++|++||.+.+..+.+..+......
T Consensus 152 ---~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 152 ---LRTYTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred ---ccccCccccCcCcCChHHhcCC--cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 1122344568889999998642 26788999999999999999999999887766555444321100
Q ss_pred ----------C--------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 272 ----------P--------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 272 ----------~--------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
+ ...+.++..+.+++.+||..||++||++.+++. |+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~------~p~~ 282 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK------HPYF 282 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh------CcCC
Confidence 0 011235788999999999999999999999998 7764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=297.89 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=205.1
Q ss_pred CCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 41 SALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 41 ~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
++|++. ++||-|-.|.|-.+.++.|++ .+|+|++..... .+++.++-.....|||||.+++++.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~e------kfALKvL~Ds~K------ARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQE------KFALKVLLDSPK------ARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchh------hhHHHHHhcCHH------HHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 456655 679999999999999999887 799999863222 12333445566799999999998865
Q ss_pred --CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeeccC
Q 006887 118 --NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGDV 191 (627)
Q Consensus 118 --~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~DF 191 (627)
...+.+|||.++| .|+.++.......|++.++..|..||+.|+.|||+.+|.||||||+|+|... |..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 3457899999995 6666666656688999999999999999999999999999999999999964 456899999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV----DEIYDAVVR 267 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~----~e~~~~i~~ 267 (627)
|+|+.-.. .....+.|-||.|.|||++..+ .|+..+|+||+||+||-||+|.+||+...- ..+..+|..
T Consensus 209 GFAK~t~~----~~~L~TPc~TPyYvaPevlg~e---KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQE----PGDLMTPCFTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ccccccCC----CccccCCcccccccCHHHhCch---hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 99987542 3455678999999999999754 589999999999999999999999986432 345566666
Q ss_pred ccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 268 RQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 268 ~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.....+-| ..+|++.+++|+.+|..+|.+|.++.++++ |+|.+.
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~------hpwi~~ 327 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD------HPWINQ 327 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc------Cchhcc
Confidence 55444333 568999999999999999999999999998 888553
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=301.39 Aligned_cols=254 Identities=20% Similarity=0.243 Sum_probs=197.2
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..++|++.+.||.|+||.||+|.+..++. .||+|++.+... .........+. ..+..++||||+++++++..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQ------NVAIKKIMKPFSTPVLAKRTYREL-KLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCC------EEEEEEecccccccchhHHHHHHH-HHHHhcCCCCeeeEeeeEec
Confidence 45689999999999999999999877664 899998864322 11111122222 25667799999999999865
Q ss_pred -CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 -NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 -~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||+++++.+.+. ..++++..+..++.||+.||.|||+++|+||||||+|||+++++.++|+|||++..
T Consensus 81 ~~~~~~lv~e~~~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 81 PLEDIYFVTELLGTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CCCcEEEEeehhccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 56799999999888766653 45688999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-------- 268 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~-------- 268 (627)
... ......+++.|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+....+..+...
T Consensus 158 ~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 158 QDP------QMTGYVSTRYYRAPEIMLTW--QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred cCC------CcCCCcccccccCceeeecc--CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 421 22345678999999987531 35788999999999999999999999876653322221110
Q ss_pred ----------------cCCCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 269 ----------------QEIPP-----IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 269 ----------------~~~~~-----~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..... ....+++++.++|.+||+.+|++||++.+++. ++|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~------~~~~~ 292 (328)
T cd07856 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA------HPYLA 292 (328)
T ss_pred HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc------CCccc
Confidence 00011 11357899999999999999999999999988 77765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.52 Aligned_cols=256 Identities=16% Similarity=0.141 Sum_probs=187.9
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LV 124 (627)
.+.+|.| |.||.++...++ ..||||+++.... .........+. ..++.++|+||+++++++..++..|++
T Consensus 7 ~~~~~~~--~~v~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~Ei-~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 7 GKCFEDL--MIVHLAKHKPTN------TLVAVKKINLDSCSKEDLKLLQQEI-ITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hHhhcCC--ceEEEEEecCCC------CEEEEEEEeccccchhHHHHHHHHH-HHHHhcCCcchhhhhheeecCCeEEEE
Confidence 3344444 455555554444 4899999976522 11112222222 245667899999999999999999999
Q ss_pred EecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC
Q 006887 125 MKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203 (627)
Q Consensus 125 mEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~ 203 (627)
|||++ |++.+.+.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+..+......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999 56666666544567899999999999999999999999999999999999999999999999988765432211
Q ss_pred ----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 006887 204 ----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--------- 270 (627)
Q Consensus 204 ----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~--------- 270 (627)
........++..|+|||++.+. ...++.++|+|||||++|||++|..||...+.............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQN-LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccccCHHHhcCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 1112344678899999998743 23578899999999999999999999987654433221111100
Q ss_pred -----------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 -----------------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 -----------------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
....+..++.++.+|+.+||+.||++||++.++++ |+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~------~p~~~~ 300 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN------HSFFKQ 300 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc------CchHhh
Confidence 00111234578899999999999999999999998 888763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=287.52 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=199.5
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
||+|+||.||++.+..++ ..||+|++....... .......+. ..++.++|+||+.+++.+..++..|+|||
T Consensus 1 lg~G~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG------KLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCC------cEEEEEEeehhhhcchHHHHHHHHHH-HHHHHcCCCcHHHHHHHeecCCeeEEEEe
Confidence 689999999999986654 489999987643321 111222222 25667789999999999999999999999
Q ss_pred cCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCC
Q 006887 127 FYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205 (627)
Q Consensus 127 y~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~ 205 (627)
|++ ++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++....... .
T Consensus 74 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 148 (250)
T cd05123 74 YAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---S 148 (250)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC---C
Confidence 996 677777653 3468999999999999999999999999999999999999999999999999987764321 1
Q ss_pred CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHH
Q 006887 206 DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENV 285 (627)
Q Consensus 206 ~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~l 285 (627)
......++..|++||.+.+. ..+.++|+||||+++|+|++|..||...+..+....+.. ....++..++..+.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~---~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~ 223 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGK---GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDL 223 (250)
T ss_pred cccCCcCCccccChHHhCCC---CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHH
Confidence 23455789999999998743 477899999999999999999999988887777777754 4566788889999999
Q ss_pred HHHhhhcCCCCCCCH---HHHHHHHHhcccccC
Q 006887 286 LLGCFEYDLRSRPLM---TDILRVFKSSQNSVH 315 (627)
Q Consensus 286 i~~cL~~dP~~RPs~---~eil~~L~~~~~~~~ 315 (627)
+.+||..||++||++ .++++ |+||
T Consensus 224 i~~~l~~~p~~R~~~~~~~~l~~------~~~f 250 (250)
T cd05123 224 ISGLLQKDPTKRLGSGGAEEIKA------HPFF 250 (250)
T ss_pred HHHHhcCCHhhCCCcccHHHHHh------CCCC
Confidence 999999999999999 66665 7665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=291.29 Aligned_cols=250 Identities=24% Similarity=0.421 Sum_probs=197.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|.+.+.||+|+||.||++.+..... .+++|+++.... ..........+..++..++||||+++++.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVA------EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCC------cceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence 58999999999999999999876543 466666653221 111111111112356678999999999999988
Q ss_pred CEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...|+||||++| ++.+.+... ....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||+++
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~ 153 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSR 153 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCcee
Confidence 899999999995 666665432 3467999999999999999999999999999999999999975 579999999988
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.. ...+..+
T Consensus 154 ~~~~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (260)
T cd08222 154 LLMGSC---DLATTFTGTPYYMSPEALKH---QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLP 226 (260)
T ss_pred ecCCCc---ccccCCCCCcCccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCc
Confidence 764321 12234578999999999863 3578899999999999999999999988777666666543 3345567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..++.++.++|.+||..+|++||++.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=319.69 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=205.4
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc----hhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK----EDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~----~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.+....||+|+|-+||+|.|..++ .+||--.++... ....+++..+. .+++.++|+||++++..+.+.
T Consensus 42 ~k~~evLGrGafKtVYka~De~~g------iEVAWnqvk~~d~~q~~~~leR~~~Ev--~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEG------IEVAWNQVKIRDVTQSPEELERLYSEV--HLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred eehhhhcccccceeeeeccccccc------hhhHHHHHhHHHhhcChHHHHHHHHHH--HHHccCCCCceeeeeeheecC
Confidence 477789999999999999975544 577765544322 22223333322 378889999999999999875
Q ss_pred CE--EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEec-CCCeeeccCC
Q 006887 119 GK--ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNE-ADRAVLGDVG 192 (627)
Q Consensus 119 ~~--~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~-~g~vkL~DFG 192 (627)
.. +.+|+|++. |+|...+. +.+.++...++.|++||+.||.|||++. |||||||.+||+|+. .|.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 54 889999999 77766655 4567889999999999999999999984 999999999999974 5899999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~ 271 (627)
||..... +.....+|||.|||||++.. .|+..+||||||++|+||+|+..||.- .++.++|+++..+..+
T Consensus 192 LAtl~r~-----s~aksvIGTPEFMAPEmYEE----~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 192 LATLLRK-----SHAKSVIGTPEFMAPEMYEE----NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred HHHHhhc-----cccceeccCccccChHHHhh----hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 9988753 33345799999999999963 599999999999999999999999985 5788999999877655
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+..--.+++++||.+||.. .+.||++.|+|+ ++||...
T Consensus 263 ~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~------d~Ff~~d 302 (632)
T KOG0584|consen 263 AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK------DPFFDED 302 (632)
T ss_pred HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh------Chhhccc
Confidence 555566689999999999998 999999999999 8888765
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.57 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=207.3
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
.+.||+|.||+||-|.++.++. .||||++.+.+....++..-+.+-.+++.+.||+||.|.-.|++.++++.||
T Consensus 569 devLGSGQFG~VYgg~hRktGr------dVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGR------DVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccCc------eeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 3789999999999999988774 7999999886543333322333334678899999999999999999999999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---CeeeccCCccccccCCCC
Q 006887 126 KFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 126 Ey~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vkL~DFGla~~~~~~~~ 202 (627)
|-+.|+.++.+.....+.+++....+++.||+.||.|||.++|+|.||||+|||+.... ++||+|||+||++.+
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--- 719 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--- 719 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence 99999999999988889999999999999999999999999999999999999996553 689999999999865
Q ss_pred CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCCCCCCCCHH
Q 006887 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAVVRRQEIPPIPSGLPPA 281 (627)
Q Consensus 203 ~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i~~~~~~~~~p~~~s~~ 281 (627)
.+...+.+|||.|+|||+++. ..|...-|+||+|||+|--|.|..||... +..+.++... ....+.-...++++
T Consensus 720 -ksFRrsVVGTPAYLaPEVLrn---kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 720 -KSFRRSVVGTPAYLAPEVLRN---KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSEISPE 794 (888)
T ss_pred -hhhhhhhcCCccccCHHHHhh---ccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhhcCHH
Confidence 334456799999999999984 46899999999999999999999999642 3333333221 11223334679999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+.+||..+|+..-++|.+....+. |+|..
T Consensus 795 AidlIn~LLqVkm~kRysvdk~ls------h~Wlq 823 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLS------HPWLQ 823 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhcc------chhhh
Confidence 999999999999999999888776 66644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.47 Aligned_cols=262 Identities=20% Similarity=0.287 Sum_probs=214.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..+...+.++||+|-||.|.++.... ...||+|++++............+..++. +++||||++|+++|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLs-qLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILS-RLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHh-ccCCCCeeEEEeeee
Confidence 4556788999999999999999998533 35899999999887776555555554544 459999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++.+||||||++ |+|...+....-..+.-.....++.||+.|++||.+.++|||||.+.|+|++.++++||+|||++|
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999 788777765433334455667899999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhccC---
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT--GVQPRCGRSVDEIYDAVVRRQE--- 270 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt--G~~Pf~~~~~~e~~~~i~~~~~--- 270 (627)
.+...+.. ......+-..+|||+|.+. -+.++.++|+|+||+++||+++ ...||...+.+++.+....-..
T Consensus 686 ~lysg~yy-~vqgr~vlpiRwmawEsil---lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 686 NLYSGDYY-RVQGRAVLPIRWMAWESIL---LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccCCce-eeecceeeeeeehhHHHHH---hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 77654321 1222345567999999997 5689999999999999999654 8999999988888776543221
Q ss_pred ---CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 271 ---IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 271 ---~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
-+..|.-|+..+.++|.+||..|-.+||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2346788999999999999999999999999998877653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=317.15 Aligned_cols=259 Identities=21% Similarity=0.376 Sum_probs=217.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE---
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--- 117 (627)
+-|++.+.||.|.||.||+++...++ +..|+|+++.....+. ..+.+.+++....+|||++.+++++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~------~~aa~kI~~~~~d~de--EiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTG------QLAAIKIMDPTEDEEE--EIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecC------ceeeeEeecCCccccH--HHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 46899999999999999999987766 4799999987655433 334444567777899999999999875
Q ss_pred --CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 118 --NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 118 --~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
++.+|||||||. |+.-|++....+..+.|+.+..|++.++.||.+||.+.++|||||-.|||++.++.+||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 578999999999 68889988888889999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-C
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-I 271 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~ 271 (627)
..+.. ......+.+|||.|||||++.++ ....|+..+|+||||++..||..|.+|+.++.+...+-.|-.... .
T Consensus 171 aQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 87653 23445678999999999999864 234577899999999999999999999999888766555532211 1
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..-|...+.++.++|..||.+|..+||++.++++ |+|..
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~------hpFi~ 286 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK------HPFIT 286 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc------CCccc
Confidence 1235678999999999999999999999999987 66654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=285.40 Aligned_cols=228 Identities=18% Similarity=0.211 Sum_probs=181.8
Q ss_pred eCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEecCCC-
Q 006887 52 GPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEG- 130 (627)
Q Consensus 52 G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~G- 130 (627)
|.||.||++++..+++ .||+|.+....... .+. .......||||+++++++...+..|+||||++|
T Consensus 4 g~~~~v~~~~~~~~~~------~~~~K~i~~~~~~~------~~~-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQ------TFILKGLRKSSEYS------RER-LTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCc------EEEEEeecchhhhh------hHH-HHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 8999999999887764 89999997643211 111 122334699999999999999999999999995
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCcc
Q 006887 131 SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210 (627)
Q Consensus 131 sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 210 (627)
+|.+.+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..... .....
T Consensus 71 ~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~------~~~~~ 142 (237)
T cd05576 71 KLWSHISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGE 142 (237)
T ss_pred CHHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc------ccccC
Confidence 77777653 34689999999999999999999999999999999999999999999999998765532 12334
Q ss_pred CCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhh
Q 006887 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCF 290 (627)
Q Consensus 211 ~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL 290 (627)
.++..|||||++.+ ..++.++|+||+||++|||++|+.|+...... ........+|..+++.++++|.+||
T Consensus 143 ~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 143 AVENMYCAPEVGGI---SEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred CcCccccCCcccCC---CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHc
Confidence 56788999999863 46788999999999999999999887643221 1111223467788999999999999
Q ss_pred hcCCCCCCCH-----HHHHHHHHhcccccC
Q 006887 291 EYDLRSRPLM-----TDILRVFKSSQNSVH 315 (627)
Q Consensus 291 ~~dP~~RPs~-----~eil~~L~~~~~~~~ 315 (627)
+.||++||++ .++++ |+||
T Consensus 214 ~~dp~~R~~~~~~~~~~~~~------h~~~ 237 (237)
T cd05576 214 QFNPTERLGAGVAGVEDIKS------HPFF 237 (237)
T ss_pred cCCHHHhcCCCccchHHHHc------CCCC
Confidence 9999999986 55554 7764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.84 Aligned_cols=260 Identities=21% Similarity=0.240 Sum_probs=208.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
....+.++.+-+..||.|+||+|++-.++.++. ..|||.++....+..+..+..+....++..+.||||+++|.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~------~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGK------LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCc------EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 444667788889999999999999999988774 89999998766544333334444456777899999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeecc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQ---LKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~---~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
+..++..||.||+|.-|+..+... .....+++..+-.|..-.+.||.||-. ..|||||+||+|||++..|.+||+|
T Consensus 132 ~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 999999999999999776544433 245779999999999999999999986 5799999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~ 269 (627)
||++..+.+. -..+.-.|...|||||.+..... .|+.+||+||||++|||+.||..||.+-+ ..+.+..+..+.
T Consensus 212 FGIcGqLv~S----iAkT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd 286 (361)
T KOG1006|consen 212 FGICGQLVDS----IAKTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD 286 (361)
T ss_pred ccchHhHHHH----HHhhhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC
Confidence 9999877542 12234478999999999986533 59999999999999999999999998744 344444444332
Q ss_pred CC-CCCCC---CCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 270 EI-PPIPS---GLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 270 ~~-~~~p~---~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+ ...+. ..+..+..+|..||.+|.+.||.+.++++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 11222 37899999999999999999999999887
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.45 Aligned_cols=269 Identities=21% Similarity=0.264 Sum_probs=210.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+...|+++..||+|.||.||+|...+++. .....+|||.++..+.. ....-..++ ..+.+.++||||+.|..++..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~--kr~k~yAiKkfk~~kd~tGiS~SAcRE-iaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTND--KRTKEYAIKKFKGEKDGTGISMSACRE-IALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCc--ccchhhHHHHHhccCCCCCcCHHHHHH-HHHHHHhcCCcchhHHHHHhc
Confidence 34689999999999999999997766552 12347999999765331 111111222 236677899999999999887
Q ss_pred -CCEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC----CCeeec
Q 006887 118 -NGKICIIMKFYEGSVGDRMAQLK---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA----DRAVLG 189 (627)
Q Consensus 118 -~~~~~LVmEy~~GsL~d~l~~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~----g~vkL~ 189 (627)
+..++|++||.+-+|+..+...+ .+.++...+..|+.||+.|+.|||++=|+||||||.|||+..+ |.+||+
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 88899999999999999887653 3678999999999999999999999999999999999999766 899999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH---------HH
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV---------DE 260 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~---------~e 260 (627)
|||++|.+.+.-.+.......+-|..|.|||.+.|.. .|+.+.|+||.|||+.||||-++.|.+... .+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~--hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR--HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccc--cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999876555444555678899999999999863 699999999999999999999998876432 12
Q ss_pred HHHHHHhccCCCC---------CC--------------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 261 IYDAVVRRQEIPP---------IP--------------------------SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 261 ~~~~i~~~~~~~~---------~p--------------------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.+++|.+--..|. +| ..-++...+|+.+||++||.+|.++.++++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 3333333211110 11 112455779999999999999999999998
Q ss_pred HHHhcccccCCCC
Q 006887 306 VFKSSQNSVHSDG 318 (627)
Q Consensus 306 ~L~~~~~~~~~~~ 318 (627)
|++|...
T Consensus 337 ------h~yF~~d 343 (438)
T KOG0666|consen 337 ------HPYFTED 343 (438)
T ss_pred ------ccccccC
Confidence 8888765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=267.04 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=211.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-H-HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-M-RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+|.-.++||+|.||+||+|++..+.| .||+|.++....++ . ...+++ .-+++.++|.||++++++...++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e------ivalkrvrlddddegvpssalre--icllkelkhknivrl~dvlhsdk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE------IVALKRVRLDDDDEGVPSSALRE--ICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc------eEEEEEEeccCCCCCCcHHHHHH--HHHHHHhhhcceeehhhhhccCc
Confidence 56677899999999999999888876 89999987654332 1 112222 13678889999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.+-+|+|||..+|-..+.. .++.+..+.+..++.|++.||.++|++++.||||||.|+||+.+|.+||+|||+++.+.
T Consensus 75 kltlvfe~cdqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg- 152 (292)
T KOG0662|consen 75 KLTLVFEFCDQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG- 152 (292)
T ss_pred eeEEeHHHhhHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC-
Confidence 9999999999877766654 56789999999999999999999999999999999999999999999999999998763
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC-----
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~----- 273 (627)
.+....+..+-|..|.+|.++.+. .-|+...|+||.||++.|+.. |++.|.+.+..+.+.+|...-..+.
T Consensus 153 --ipvrcysaevvtlwyrppdvlfga--kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 153 --IPVRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred --CceEeeeceeeeeeccCcceeeee--ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 344455667889999999999975 358999999999999999987 8888999998888777765322211
Q ss_pred -------------CC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 -------------IP---------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 -------------~p---------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+| +.+...-++++.++|..+|.+|.++.+.++ |++|.+.
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq------hpyf~d~ 289 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ------HPYFSDF 289 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc------Ccccccc
Confidence 11 123445579999999999999999999887 9988754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=321.71 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=189.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE---
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--- 117 (627)
++|+.++.||+||||.||+++++-++ +.||||++.....+..-..+.++. .++..++|||||+++..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDG------r~YAIKKIpl~~s~~~~skI~rEV-k~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDG------REYAIKKIPLKASDKLYSKILREV-KLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccc------hhhhhhhccCchHHHHHHHHHHHH-HHHhhcCCcceeeeehhhhccCC
Confidence 57888999999999999999988765 589999997655332222222222 36788999999999832211
Q ss_pred --------------------------------------------------------------------------------
Q 006887 118 -------------------------------------------------------------------------------- 117 (627)
Q Consensus 118 -------------------------------------------------------------------------------- 117 (627)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred ----------------------------C--------CEEEEEEecCCCCHHHHHHHhcCCCC-CHHHHHHHHHHHHHHH
Q 006887 118 ----------------------------N--------GKICIIMKFYEGSVGDRMAQLKGGKL-SLSNVFRYAIDLAQGI 160 (627)
Q Consensus 118 ----------------------------~--------~~~~LVmEy~~GsL~d~l~~~~~~~l-s~~~~~~i~~qIa~aL 160 (627)
+ -.+||-||||+-+++..+.. .+... ....++++++||++||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~-~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR-RNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH-hcccchhhHHHHHHHHHHHHHH
Confidence 0 13689999999877777664 33333 4678999999999999
Q ss_pred HHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc----CC-----------CCCCCCCCccCCCCCcCCcccccCC
Q 006887 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL----GI-----------PLPSSDLPRRLGTPNYMAPEQWQPE 225 (627)
Q Consensus 161 ~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~----~~-----------~~~~~~~~~~~GT~~YmAPE~~~~~ 225 (627)
.|+|++|||||||||.||+|++++.|||+|||+|.... .. .......+..+||--|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999998732 00 0111244577899999999999876
Q ss_pred CCCCCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 006887 226 VRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTD 302 (627)
Q Consensus 226 ~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~e 302 (627)
....|+.|+|+||||++++||+ .||.. +....++..+.....+.+ +...--+.-+.+|+.|++.||.+|||+.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 5557999999999999999999 46653 233344444432211111 11223355679999999999999999999
Q ss_pred HHH
Q 006887 303 ILR 305 (627)
Q Consensus 303 il~ 305 (627)
+|+
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=308.19 Aligned_cols=270 Identities=16% Similarity=0.112 Sum_probs=177.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+....++|++.+.||+|+||.||+|++..+.. ..+..||+|++......... ..++. ....+.++..+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~~e~~-~~e~l-----~~~~~~~~~~~~~~ 197 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGAVEIW-MNERV-----RRACPNSCADFVYG 197 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccchhHHH-HHHHH-----HhhchhhHHHHHHh
Confidence 455677899999999999999999999877621 22458999998654322111 11111 11111111111111
Q ss_pred ------EEECCEEEEEEecCCC-CHHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 006887 115 ------SVINGKICIIMKFYEG-SVGDRMAQLKG------------------GKLSLSNVFRYAIDLAQGILQLHSKGIL 169 (627)
Q Consensus 115 ------~~~~~~~~LVmEy~~G-sL~d~l~~~~~------------------~~ls~~~~~~i~~qIa~aL~yLHs~gIv 169 (627)
...+...+|||||+++ +|.+.+..... .......+..++.||+.||.|||+++|+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 2456779999999994 67666643210 0112344667999999999999999999
Q ss_pred ecccCCCcEEEec-CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCC-------------------CC
Q 006887 170 VLNLKPFNFILNE-ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVR-------------------GP 229 (627)
Q Consensus 170 HrDLKP~NILld~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~-------------------~~ 229 (627)
||||||+|||++. ++.+||+|||+++.+.... .......+||+.|||||.+..... ..
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 9999999999986 6799999999998653221 122345689999999997642211 12
Q ss_pred CCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------CCC----------CCCCCCHHHHHHHHHhh
Q 006887 230 ISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---------IPP----------IPSGLPPAVENVLLGCF 290 (627)
Q Consensus 230 ~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~---------~~~----------~p~~~s~~l~~li~~cL 290 (627)
++.++|||||||+||||+++..|+... .......+..... .+. .....+....+||.+||
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 345679999999999999977664321 1111111111000 000 01112334568999999
Q ss_pred hcCCCCCCCHHHHHHHHHhcccccCCCCCCC
Q 006887 291 EYDLRSRPLMTDILRVFKSSQNSVHSDGGWT 321 (627)
Q Consensus 291 ~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~ 321 (627)
++||++||++.++++ |+||....+.
T Consensus 435 ~~dP~kR~ta~e~L~------Hpff~~~~~~ 459 (566)
T PLN03225 435 RFKGRQRISAKAALA------HPYFDREGLL 459 (566)
T ss_pred cCCcccCCCHHHHhC------CcCcCCCCcc
Confidence 999999999999998 9999876554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=307.06 Aligned_cols=270 Identities=20% Similarity=0.316 Sum_probs=223.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.+.++.++.++.+.||+|.||.|++|........ ......||||+++..........+..+...+.....|+||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 6778888889999999999999999986543321 123568999999876665555555555566777788999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhc------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLK------------G--GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~------------~--~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++...+.+++|+||+. |+|++.+...+ . ..++..+.+.++.||+.|++||++..+|||||-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999 89888887655 0 1388999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCC--CCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG--TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCG 255 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~G--T~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~ 255 (627)
|+.++..+||+|||+|+........... ...| ...|||||.+.. ..|+.++||||||++|||++| |..||.+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~--~~~~~LP~kWmApEsl~~---~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTK--SSAGTLPVKWMAPESLFD---RVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEec--CCCCccceeecCHHHhcc---CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999976543322111 1122 235999999984 479999999999999999999 9999998
Q ss_pred CC-HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 256 RS-VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 256 ~~-~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.. ..++++.+. ...+...|..+++++.++++.||+.+|++||++.++.+.|...
T Consensus 525 ~~~~~~l~~~l~-~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPTEELLEFLK-EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 66 677776554 4456677999999999999999999999999999999988873
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.49 Aligned_cols=261 Identities=21% Similarity=0.349 Sum_probs=217.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
...+..++||+|+||+||+|.+...++ .-..+||||++........ .+++++ +..+..+.|||+++|++++..+.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege--~vKipVaiKvl~~~t~~~~s~e~Lde--Al~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGE--NVKIPVAIKVLIEFTSPKASIELLDE--ALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCc--eecceeEEEEeeccCCchhhHHHHHH--HHHHhcCCCchHHHHhhhcccch
Confidence 445667899999999999999987654 2357899999976544322 223332 24567899999999999998665
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+.||++|++ |.|+|.+.. ...++.....+.|..||++|+.|||.++++||||-..|+|+.+-.++|+.|||+++.+.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred -HHHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 899999999 799998876 45688999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.+...... ....-.+.|||-|.+. ...|+.++|||||||++||++| |..||.+.+.+++-+.+.. ..+.+.|+.
T Consensus 850 ~d~~ey~~-~~gK~pikwmale~i~---~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-geRLsqPpi 924 (1177)
T KOG1025|consen 850 PDEKEYSA-PGGKVPIKWMALESIR---IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-GERLSQPPI 924 (1177)
T ss_pred cccccccc-cccccCcHHHHHHHhh---ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-cccCCCCCC
Confidence 54322221 2223356899999987 5689999999999999999999 9999999999998876654 455888999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
++-++..++.+||..|+..||+++++...+..+..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999988877543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=285.70 Aligned_cols=256 Identities=19% Similarity=0.230 Sum_probs=200.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcC-CCC----ceeeEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQG-VEG----ICWLQGI 114 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~-hpn----Iv~l~~~ 114 (627)
.++|.+...+|+|.||.|-.+.++.+++ .||||+++..........++. +.+.+... -|+ ++.+.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~------~vAlKIik~V~kYreAa~iEi--~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKE------HVALKIIKNVDKYREAALIEI--EVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCc------eehHHHHHHHHHHhhHHHHHH--HHHHHHHhcCCCCceEEEeeehh
Confidence 4689999999999999999999987754 899999976544433332222 12222212 222 6778888
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec------------
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE------------ 182 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~------------ 182 (627)
|...+..|||+|.++-|+.|.+..+...+++...+..++.||++++++||+.+++|-||||+|||+-+
T Consensus 160 FdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 160 FDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 99999999999999989999998777789999999999999999999999999999999999999832
Q ss_pred --------CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCC
Q 006887 183 --------ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 183 --------~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
+-.++|+|||.|+.... .-++.+.|..|.|||++.+. .++..+||||+||||+|+.||...|+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViLgL---GwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVILGL---GWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchheecc---CcCCccCceeeeeEEEEeeccceecc
Confidence 22478999999876532 23667899999999999864 69999999999999999999999999
Q ss_pred CCCHHH---HHHHHHhcc----------------CCCCCCC-------------------------CCCHHHHHHHHHhh
Q 006887 255 GRSVDE---IYDAVVRRQ----------------EIPPIPS-------------------------GLPPAVENVLLGCF 290 (627)
Q Consensus 255 ~~~~~e---~~~~i~~~~----------------~~~~~p~-------------------------~~s~~l~~li~~cL 290 (627)
..+..| +++.|.... ....++. ....+|.+||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 876544 333332100 0001110 11245789999999
Q ss_pred hcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 291 EYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 291 ~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..||.+|+|+.|+|. |+||...
T Consensus 391 ~fDP~~RiTl~EAL~------HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALS------HPFFARL 412 (415)
T ss_pred ccCccccccHHHHhc------CHHhhcC
Confidence 999999999999998 9998743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=301.48 Aligned_cols=245 Identities=24% Similarity=0.333 Sum_probs=187.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING- 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~- 119 (627)
..|...+.||+|+||.||+++++.+++ .||||.+++.........+.++.++ ++.++|+|||+++++-....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~------~vAvK~~~~~~~~r~~e~~~~Eiei-lkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGR------LVAVKTFNKESSLRPRERWCREIEI-LKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeeccccccc------chhHHhhhhhcccchHHHHHHHHHH-HHHcCchhhhhhcccCCcccc
Confidence 346777899999999999999988875 8999999886554445555555545 45567999999998865433
Q ss_pred -----EEEEEEecCCC-CHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--cCCC--eee
Q 006887 120 -----KICIIMKFYEG-SVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--EADR--AVL 188 (627)
Q Consensus 120 -----~~~LVmEy~~G-sL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~~g~--vkL 188 (627)
...+|||||.| +|...+..=.+ ..+++.+.+.++..+..||.|||++||+||||||.||++- .+|. -||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 47899999995 55555443222 5689999999999999999999999999999999999983 3343 589
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHHHHHH
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDEIYDA 264 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e~~~~ 264 (627)
+|||.||.+.+ .+...+..||+.|.+||.... .+.|+..+|.|||||++|+++||..||.... ..++...
T Consensus 166 tDfG~Arel~d----~s~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 166 TDFGAARELDD----NSLFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred ecccccccCCC----CCeeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 99999998865 346678899999999999974 2579999999999999999999999986432 2233333
Q ss_pred HHhccC-------------------CCCCCCCCCHHHH----HHHHHhhhcCCCCCC
Q 006887 265 VVRRQE-------------------IPPIPSGLPPAVE----NVLLGCFEYDLRSRP 298 (627)
Q Consensus 265 i~~~~~-------------------~~~~p~~~s~~l~----~li~~cL~~dP~~RP 298 (627)
+..++. ..++|..+++.+. ..+..+|..+|++|-
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 322221 1234555555544 567778889999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=284.75 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=201.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHH--HHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERL--NDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~--~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|-+++.||+|||+.||+|.+... .++||+|+-+..... ....+.... +..+.+.+.||.||++++++
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~E------qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTE------QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccch------hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 6899999999999999999986544 469999986543221 111111111 11256788999999999998
Q ss_pred E-ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeecccCCCcEEEe---cCCCeeec
Q 006887 116 V-INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK--GILVLNLKPFNFILN---EADRAVLG 189 (627)
Q Consensus 116 ~-~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--gIvHrDLKP~NILld---~~g~vkL~ 189 (627)
. +.+.+|-|+|||+|+.+|.... ..+.+++.++..|+-||+.||.||... .|||-||||.||||- .-|.+||+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 6 4677999999999988888764 556799999999999999999999976 599999999999995 34789999
Q ss_pred cCCccccccCCCCCCC----CCCccCCCCCcCCccccc-CCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHH
Q 006887 190 DVGIPHLLLGIPLPSS----DLPRRLGTPNYMAPEQWQ-PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYD 263 (627)
Q Consensus 190 DFGla~~~~~~~~~~~----~~~~~~GT~~YmAPE~~~-~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~ 263 (627)
||||++.+.+...... ..+...||.+|++||++. +.....++.++||||+|||+|.++.|+.||.... ..++++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999999876554322 234678999999999986 2223357889999999999999999999997643 334433
Q ss_pred H--HHhccC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 264 A--VVRRQE-IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 264 ~--i~~~~~-~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
. |+.... ..+.-+.+++++++||++||++.-+.|.+..++.. ++++.+
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~------dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC------DPYLLP 746 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc------Cccccc
Confidence 2 221111 11223578999999999999999999988877765 666543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=290.41 Aligned_cols=274 Identities=14% Similarity=0.133 Sum_probs=186.4
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc----------CcccccEEEEEEecCCchhHHHHHHH------------
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTE----------DCDEYHEVAVKILHPVKEDRMRVLLE------------ 93 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e----------d~~~~~~VAVK~l~~~~~~~~~~~~~------------ 93 (627)
..++.++|++.++||+|+||.||+|.+...+. +...++.||||.++.........+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 34678899999999999999999998643321 11234689999987543322222111
Q ss_pred HHHHHHHHhcCCCC-----ceeeEEEEEE--------CCEEEEEEecCC-CCHHHHHHHhc-------------------
Q 006887 94 RLNDLFLKCQGVEG-----ICWLQGISVI--------NGKICIIMKFYE-GSVGDRMAQLK------------------- 140 (627)
Q Consensus 94 ~~~~~ll~~~~hpn-----Iv~l~~~~~~--------~~~~~LVmEy~~-GsL~d~l~~~~------------------- 140 (627)
..+..++..++|.+ ++.+++++.. .+..+|||||++ |+|.+.+....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 01111233344443 4566666543 356899999999 57777664311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcC
Q 006887 141 ---GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217 (627)
Q Consensus 141 ---~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~Ym 217 (627)
...+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.++|+|||+++...... ........+|+.|+
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--NFNPLYGMLDPRYS 377 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC--ccCccccCCCccee
Confidence 1234567888999999999999999999999999999999999999999999987543211 11112234589999
Q ss_pred CcccccCCCCCC-----------------CC--ccCcchhHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHH
Q 006887 218 APEQWQPEVRGP-----------------IS--FETDSWGFACSIIEMLTGVQ-PRCGRSVD-----------EIYDAVV 266 (627)
Q Consensus 218 APE~~~~~~~~~-----------------~s--~~sDiwSlGviLyelltG~~-Pf~~~~~~-----------e~~~~i~ 266 (627)
|||.+......+ |+ .+.|+||+||++|+|++|.. ||.+.... ..+..+.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999975321100 11 34799999999999999876 77542111 1111111
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHHHHHHhcccccCCC
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDL---RSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP---~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
............++..++|+.+||..+| .+|+++.++|+ |+||..
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~------Hp~f~~ 505 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS------HRFFLP 505 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC------CCCcCC
Confidence 1112222345678999999999999866 68999999999 999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=276.93 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=208.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
+.....+.|.-..+||+|.||.||+|+...++. .||+|++--.++.. -...+++. .++..+.|+|++.++
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~k------kvalkkvlmeneKeGfpitalrei--kiL~~lkHenv~nli 82 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGK------KVALKKVLMENEKEGFPITALREI--KILQLLKHENVVNLI 82 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccc------hhHHHHHHHhccccCCcHHHHHHH--HHHHHhcchhHHHHH
Confidence 344566889999999999999999999877664 68988764322111 11112221 256778999999888
Q ss_pred EEEEE--------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC
Q 006887 113 GISVI--------NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 113 ~~~~~--------~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g 184 (627)
++|.. ...+||||.+|+-+|.-++.. ...++++.++..++.+++.||.|+|++.|+|||+||+|+||+.+|
T Consensus 83 Eic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 83 EICRTKATPTNRDRATFYLVFDFCEHDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG 161 (376)
T ss_pred HHHhhccCCcccccceeeeeHHHhhhhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc
Confidence 77653 345899999999888777753 556899999999999999999999999999999999999999999
Q ss_pred CeeeccCCccccccCCC-CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 006887 185 RAVLGDVGIPHLLLGIP-LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~-~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~ 263 (627)
.++|+|||+++.+.... ......+..+-|..|.+||.+.|. ..|+++.|+|+.||+|.||.|+.+.+++.+..+.+.
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~--r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~ 239 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD--REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH 239 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcc--cccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence 99999999997765432 223345667889999999999975 479999999999999999999999999988877666
Q ss_pred HHHhccC--------------------CCCCCC-------------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 264 AVVRRQE--------------------IPPIPS-------------GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 264 ~i~~~~~--------------------~~~~p~-------------~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.|...-. .+++|. .-+++..+|+.++|..||.+|+++.++++
T Consensus 240 ~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln----- 314 (376)
T KOG0669|consen 240 LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN----- 314 (376)
T ss_pred HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc-----
Confidence 5543110 011111 12457889999999999999999999998
Q ss_pred ccccCCC
Q 006887 311 QNSVHSD 317 (627)
Q Consensus 311 ~~~~~~~ 317 (627)
|.||..
T Consensus 315 -h~~F~k 320 (376)
T KOG0669|consen 315 -HDFFWK 320 (376)
T ss_pred -hhhhhc
Confidence 777654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=259.07 Aligned_cols=236 Identities=26% Similarity=0.382 Sum_probs=189.2
Q ss_pred CCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEecCCC-
Q 006887 53 PFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEG- 130 (627)
Q Consensus 53 ~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~G- 130 (627)
+||.||+|.+..++ +.+|+|++....... ...+.. +.+ .++.++|+||+++++.+......+++|||+++
T Consensus 1 ~~g~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~-e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 72 (244)
T smart00220 1 SFGKVYLARDKKTG------KLVAIKVIKKEKIKKKRERILR-EIS-ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGG 72 (244)
T ss_pred CceEEEEEEECCCC------cEEEEEEecccccccHHHHHHH-HHH-HHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence 68999999987655 389999998655433 222222 222 44556999999999999999999999999997
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCcc
Q 006887 131 SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210 (627)
Q Consensus 131 sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 210 (627)
+|.+.+.. ...+++..+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 73 ~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~ 146 (244)
T smart00220 73 DLFDLLKK--RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTF 146 (244)
T ss_pred CHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccc
Confidence 77776653 2238999999999999999999999999999999999999999999999999988765321 33455
Q ss_pred CCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCC-CCHHHHHHHHH
Q 006887 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSG-LPPAVENVLLG 288 (627)
Q Consensus 211 ~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~~~~p~~-~s~~l~~li~~ 288 (627)
.+++.|++||.+. ...++.++|+||||+++++|++|..||.. .+...+.+.+............ ++.++.+++.+
T Consensus 147 ~~~~~~~~pE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 147 VGTPEYMAPEVLL---GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred cCCcCCCCHHHHc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHH
Confidence 7899999999987 34678899999999999999999999987 5555555555433222211111 88999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 006887 289 CFEYDLRSRPLMTDILR 305 (627)
Q Consensus 289 cL~~dP~~RPs~~eil~ 305 (627)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=284.47 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=208.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH-HHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF-LKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l-l~~~~hpnIv~l~~ 113 (627)
++-.+....++.+.||+|.||.||+|.... +.||||++.....+... .+.+++ +-.+.|+||+.+++
T Consensus 204 spl~~l~pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp~~~kqs~~----~Ek~Iy~lp~m~h~nIl~Fi~ 271 (534)
T KOG3653|consen 204 SPLLELDPLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFPEQEKQSFQ----NEKNIYSLPGMKHENILQFIG 271 (534)
T ss_pred cccccCCchhhHHHhhcCccceeehhhccC--------ceeEEEecCHHHHHHHH----hHHHHHhccCccchhHHHhhc
Confidence 556677889999999999999999998754 48999999754433322 223332 34679999999998
Q ss_pred EEEECC----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecccCCCcEE
Q 006887 114 ISVING----KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK---------GILVLNLKPFNFI 179 (627)
Q Consensus 114 ~~~~~~----~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~---------gIvHrDLKP~NIL 179 (627)
.-.... .++||++|.+ |+|-+.+. ...+++...++++..++.||+|||+. .|+|||||..|||
T Consensus 272 ~ekr~t~~~~eywLVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 272 AEKRGTADRMEYWLVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred hhccCCccccceeEEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 876554 7999999999 89888885 46789999999999999999999974 5999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCC---CCccCcchhHHHHHHHHHhCC------
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGP---ISFETDSWGFACSIIEMLTGV------ 250 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~---~s~~sDiwSlGviLyelltG~------ 250 (627)
+.++++..|+|||+|..+.. ..+.......+||.+|||||++.+...-. .-.+.||||+|.+||||++.-
T Consensus 349 vK~DlTccIaDFGLAl~~~p-~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~ 427 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEP-GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG 427 (534)
T ss_pred EccCCcEEeeccceeEEecC-CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence 99999999999999988763 33344445689999999999998753211 114689999999999998742
Q ss_pred ------CCCC-----CCCHHHHHHHHHhccCCCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 251 ------QPRC-----GRSVDEIYDAVVRRQEIPPIPSG-----LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 251 ------~Pf~-----~~~~~e~~~~i~~~~~~~~~p~~-----~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
+||. ..+.+++...+..++.+|.+|.. -..-+.+.+..||..|++.|.|+.=+-+++..+.+.+
T Consensus 428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 428 PVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 2343 23456777778888888887754 2466889999999999999999987777777765543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=259.05 Aligned_cols=226 Identities=23% Similarity=0.309 Sum_probs=186.1
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+..+..++..-+..||+|+||.|-+-++..++. ..|+|.+...-..+.+..+-....+...+...|++|+++
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~------imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~Fy 111 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGT------IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFY 111 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCe------EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEee
Confidence 34567777888889999999999999999988774 899999976554444444444445667788899999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeec
Q 006887 113 GISVINGKICIIMKFYEGSVGDRMAQ--LKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~GsL~d~l~~--~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~ 189 (627)
|.....+..+|.||.|.-|+..+..+ .+++.+++..+-+++..+..||.|||++ .+||||+||+||||+.+|++|++
T Consensus 112 Ga~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 112 GALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEc
Confidence 99988999999999999765544433 2568899999999999999999999986 89999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCC-CCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVR 267 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~-~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~ 267 (627)
|||++..+.+. -..+.-.|...|||||.+..+... .|+.++||||||++++||.+++.||.. .++.+.+..+.+
T Consensus 192 DFGIsG~L~dS----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 192 DFGISGYLVDS----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ccccceeehhh----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 99999887542 112235788999999999865443 799999999999999999999999974 577788877775
Q ss_pred c
Q 006887 268 R 268 (627)
Q Consensus 268 ~ 268 (627)
.
T Consensus 268 e 268 (282)
T KOG0984|consen 268 E 268 (282)
T ss_pred C
Confidence 4
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.85 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=202.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
..+.++.+.||+|.||.||+|.++.. .||||++....+....++-+..+.. .++|+||..+++....++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe--------~VAVKiF~srdE~SWfrEtEIYqTv---mLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGE--------DVAVKIFSSRDERSWFRETEIYQTV---MLRHENILGFIAADNKDN 278 (513)
T ss_pred hheeEEEEEecCccccceeeccccCC--------ceEEEEecccchhhhhhHHHHHHHH---HhccchhhhhhhccccCC
Confidence 36899999999999999999998754 5999999876665544433333322 468999999998765442
Q ss_pred ----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCcEEEecCCCe
Q 006887 120 ----KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK--------GILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 120 ----~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------gIvHrDLKP~NILld~~g~v 186 (627)
.+|||++|.+ |||.|.+.+ ..++....++++..++.||++||.. .|.|||||..|||+.+++.+
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 5899999999 999999865 5789999999999999999999964 49999999999999999999
Q ss_pred eeccCCccccccCCC-CCCCCCCccCCCCCcCCcccccCCCCCC---CCccCcchhHHHHHHHHHhC----------CCC
Q 006887 187 VLGDVGIPHLLLGIP-LPSSDLPRRLGTPNYMAPEQWQPEVRGP---ISFETDSWGFACSIIEMLTG----------VQP 252 (627)
Q Consensus 187 kL~DFGla~~~~~~~-~~~~~~~~~~GT~~YmAPE~~~~~~~~~---~s~~sDiwSlGviLyelltG----------~~P 252 (627)
.|+|+|||....... .-.-.....+||.+|||||++....... --..+||||||.++||++.. ++|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998876542 2222345679999999999987532211 11358999999999998752 678
Q ss_pred CCC-----CCHHHHHHHHHhccCCCCCCCCCC-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 253 RCG-----RSVDEIYDAVVRRQEIPPIPSGLP-----PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 253 f~~-----~~~~e~~~~i~~~~~~~~~p~~~s-----~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
|.+ .+.+++.+-+...+.+|.+|.... ..+..+++.||..+|.-|.++-.+.+.|.++.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 875 455667666666667777775443 33568899999999999999988888777654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=316.42 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=182.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.|+..+.||+|+||.||+|++..++ ..||||.++........ +. ..++.++||||+++++++...+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~-----~~-~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNG------MQFVVKEINDVNSIPSS-----EI-ADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCC------cEEEEEEccCCccccHH-----HH-HHHhhCCCCCcceEEEEEEcCCCC
Confidence 4667789999999999999986655 48999998654332211 11 234567999999999999999999
Q ss_pred EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 122 CIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH---SKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 122 ~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLH---s~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
|+||||++ |+|.+.+. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+...
T Consensus 759 ~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999 56666663 3889999999999999999999 6699999999999999998888775 6655433
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcc------
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV--DEIYDAVVRRQ------ 269 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~--~e~~~~i~~~~------ 269 (627)
.. .....||+.|||||++.+ ..++.++|||||||++|||+||+.||..... ..+........
T Consensus 833 ~~-------~~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 833 CT-------DTKCFISSAYVAPETRET---KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred cc-------CCCccccccccCcccccC---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 21 123378999999999873 4689999999999999999999999853211 11111111000
Q ss_pred --CCCCC------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 270 --EIPPI------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 270 --~~~~~------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+.. +.....++.+++.+||+.||++||++.++++.|+...
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 00111 1112235778999999999999999999999998754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=299.84 Aligned_cols=253 Identities=21% Similarity=0.228 Sum_probs=195.2
Q ss_pred eEEEeEEeeeCCe-EEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFG-EVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG-~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|.-.+.+|.|+-| .||+|.. ++++||||.+-... ..+..++...+.....||||+++++.-.+....
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--------e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--------EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--------CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 4445678999887 5999986 34689999885332 334455666677788999999999999999999
Q ss_pred EEEEecCCCCHHHHHHHh-cC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---C--CCeeeccCCcc
Q 006887 122 CIIMKFYEGSVGDRMAQL-KG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---A--DRAVLGDVGIP 194 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~-~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~--g~vkL~DFGla 194 (627)
||..|+|..+|.|++... .. ....-......+.|++.||++||+.+||||||||.||||+. + ..++|+|||+|
T Consensus 579 YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 579 YIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999999999998762 11 11111456778899999999999999999999999999976 3 46889999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+.+...........+..||-+|+|||++... .-+.++|||||||++|+.++ |..||.+.-..+. .|+.......
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~---~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~ 733 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLRED---RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLV 733 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhcc---ccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCcccee
Confidence 9988766555566778899999999999854 34569999999999999888 5999976433321 2222221111
Q ss_pred -CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 -IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 -~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+.+....++.+||.+|++.+|..||++.++|. ||+|...
T Consensus 734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~------HPlFW~~ 773 (903)
T KOG1027|consen 734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN------HPLFWDS 773 (903)
T ss_pred eeccCchHHHHHHHHHhcCCCcccCCCHHHHhC------CCccCCh
Confidence 11111228999999999999999999999999 9998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=295.86 Aligned_cols=356 Identities=21% Similarity=0.238 Sum_probs=269.2
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHH-HHHHhcCCCCceeeEEEEEECCEEEEEEec
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND-LFLKCQGVEGICWLQGISVINGKICIIMKF 127 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~-~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy 127 (627)
+|.|+||.|++++-... .+.++.||+|++++.............++ ++....+||.++.++..++.+...+++++|
T Consensus 2 lg~g~~gkvfLvrk~~g---~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGG---ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCcCCCcchHHHHHhcc---ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 79999999999874432 24678899999987543221111222222 344445699999999999999999999999
Q ss_pred CCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCC
Q 006887 128 YEGSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206 (627)
Q Consensus 128 ~~GsL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 206 (627)
+.| ++++.+.. ...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++.......
T Consensus 79 ~rg--g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 79 LRG--GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred ccc--chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 997 44554443 46678889999999999999999999999999999999999999999999999998764321
Q ss_pred CCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHH
Q 006887 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286 (627)
Q Consensus 207 ~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li 286 (627)
.|||..|||||++. ....++|+||||++++||+||..||.. ++...|... .+.+|..++..+++++
T Consensus 153 ---~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~--~~~~p~~l~~~a~~~~ 218 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA--ELEMPRELSAEARSLF 218 (612)
T ss_pred ---cccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh--ccCCchhhhHHHHHHH
Confidence 19999999999996 366799999999999999999999988 566666432 4668899999999999
Q ss_pred HHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCccccCCCccccCCCCCCCCCCCC
Q 006887 287 LGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKVDDVVRSRKPPNSFKPEN 365 (627)
Q Consensus 287 ~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~p~~~~~p~~ 365 (627)
.+++..+|.+|.... +.+..+++ |.++..++|..+..+..++|++|..... .+..++++..++..|..++.-..
T Consensus 219 ~~l~~r~p~nrLg~~~~~~~eik~--h~f~~~i~~~~l~~r~~~~~fkp~~~~e---~~~~~fd~eft~~~P~dsp~~~~ 293 (612)
T KOG0603|consen 219 RQLFKRNPENRLGAGPDGVDEIKQ--HEFFQSIDWNELEARSRPPPFKPGSITE---RDVAQFDPEFTSQVPADSPLLSA 293 (612)
T ss_pred HHHHhhCHHHHhccCcchhHHHhc--cchheeeeHhhHhhcCCCCCCCCcccch---hhhhhcCchhccCCcccCCCCCC
Confidence 999999999998653 33333333 9999999999999999999998875443 55667777777777776432100
Q ss_pred CCCCCCceeeeecCCCCcceEEEEecccCCCCCCCCccccceeeeeccCceeecccccCCCCCcccceeeccCCceEEee
Q 006887 366 MDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVRLKEEDRRHSPVGILHSIQRDGSVAVGF 445 (627)
Q Consensus 366 ~~~~~~~~v~~~~~~~~~~~~~v~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 445 (627)
.+.+ -..+ +....+..++.+. -.+-++...|
T Consensus 294 --~~s~-------~~if-------------------~g~sfva~~il~~---------------------~~~~~~~~~y 324 (612)
T KOG0603|consen 294 --SGSD-------HTIF-------------------SGPSFVAPGVLED---------------------AVTAPFTESY 324 (612)
T ss_pred --Cccc-------cchh-------------------cCCCccChHHhhc---------------------cccCCcchhh
Confidence 0000 0001 1111222222211 1224467889
Q ss_pred eeecccccccCcccccccccccccEEEeeecccccc
Q 006887 446 LGLETLWKGHFSELQMAESYCVGQFVRLKANVVSPQ 481 (627)
Q Consensus 446 ~~~~~~~~g~~~~~~~~~~~~~g~~v~~k~~~~~~~ 481 (627)
...+.++.|+||.|+.|+++.++|..+||..-.+++
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~ 360 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD 360 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheecccccc
Confidence 999999999999999999999999999998766633
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=250.92 Aligned_cols=258 Identities=19% Similarity=0.333 Sum_probs=200.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
-.|-+.++|++.+++|+|-|+.||.|....+++ .++||++++....... ++..++..+.+||||++|+++
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~e------K~ViKiLKPVkkkKIk----REikIL~nL~gg~NIi~L~Di 101 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNE------KCVIKILKPVKKKKIK----REIKILQNLRGGPNIIKLLDI 101 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCc------eEEEeeechHHHHHHH----HHHHHHHhccCCCCeeehhhh
Confidence 455677899999999999999999999887776 8999999876654443 344456666789999999998
Q ss_pred EEE--CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccC
Q 006887 115 SVI--NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDV 191 (627)
Q Consensus 115 ~~~--~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DF 191 (627)
..+ .....||+||+.......+. ..++..++..|+.|++.||.|+|++||+|||+||.|++||.. -.++|+|+
T Consensus 102 V~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 102 VKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred hcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence 865 45689999999974333332 357888999999999999999999999999999999999865 46899999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh---
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC-GRSVDEIYDAVVR--- 267 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~-~~~~~e~~~~i~~--- 267 (627)
|+|.++.. .....-.+.+..|--||.+.. ...|+.+-|+|||||++..|+..+.||. |.+..+.+-+|..
T Consensus 178 GLAEFYHp----~~eYnVRVASRyfKGPELLVd--y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 178 GLAEFYHP----GKEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred chHhhcCC----CceeeeeeehhhcCCchheee--chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 99988753 334445567778889999874 3468889999999999999999988865 4443322211111
Q ss_pred ------------------------ccCCCCC--------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 268 ------------------------RQEIPPI--------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 268 ------------------------~~~~~~~--------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...+.++ ..-.++++.+|+.++|.+|-.+|||++|++. |++|
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~------HpyF 325 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA------HPYF 325 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc------CchH
Confidence 1111110 0124699999999999999999999999988 8887
Q ss_pred CCC
Q 006887 316 SDG 318 (627)
Q Consensus 316 ~~~ 318 (627)
...
T Consensus 326 ~~~ 328 (338)
T KOG0668|consen 326 APV 328 (338)
T ss_pred HHH
Confidence 643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-31 Score=285.51 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=208.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|.+++++|+|.||.||+|+++.+++ ..|+|+++....+......+++ .+++..+||||+.+++.+...+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~e------laavkvVkLep~dd~~~iqqei--~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGE------LAAVKVVKLEPGDDFSGIQQEI--GMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCc------hhhheeeeccCCccccccccce--eeeecCCCcChHHHHhhhhhhc
Confidence 3689999999999999999999998886 7899999877666555444433 3567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.++|.||||.|+.++-+.+ -.+++++.++....++.+++|.|||+.|-+|||||-.|||+++.|.+||+|||.+-.+..
T Consensus 86 klwicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred CcEEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 9999999999654544443 457899999999999999999999999999999999999999999999999998866543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---CCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP---IPS 276 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~---~p~ 276 (627)
.......+.|||.|||||+..-+..+.|...+|+|++|+...|+..-.+|..+..+...+.........++ -+.
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 22334578999999999998766678899999999999999999998888776666655443332222222 235
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDIL 304 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil 304 (627)
..++.+.+|++.||.++|.+||++..+|
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 6789999999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=253.05 Aligned_cols=258 Identities=19% Similarity=0.225 Sum_probs=201.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.....+.+|.-++.+|.|.- .|--|.+..++ ++||+|.+.....+......+..+-.++.+..|+||++++.+
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~------~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ 83 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLG------RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNV 83 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhcc------CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeec
Confidence 34455678999999999998 67777765544 589999986554332222222222236788999999999999
Q ss_pred EEECC------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 115 SVING------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 115 ~~~~~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
+.-.. ..|+||||+.+++-..+.. .+.-.++..++.|++.|++|||+.||+||||||+||++..+..+||
T Consensus 84 ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 84 FTPQKTLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred cCccccHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheee
Confidence 87543 4799999999988777652 3567889999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
.|||+|+.-.. .-..+..+.|..|.|||++.+. .|...+||||+||++.||++|+..|.|.+.-+.+.++.+.
T Consensus 160 ~dfg~ar~e~~----~~~mtpyVvtRyyrapevil~~---~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 160 LDFGLARTEDT----DFMMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred ccchhhcccCc----ccccCchhheeeccCchheecc---CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 99999986432 2344567899999999999864 4889999999999999999999999988766555544432
Q ss_pred cCCC-----------------------------CCC-----------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 269 QEIP-----------------------------PIP-----------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 269 ~~~~-----------------------------~~p-----------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
...+ .+| ..-+..+++++.+||-.||++|.+++++|+
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--- 309 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--- 309 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc---
Confidence 2111 011 122456789999999999999999999999
Q ss_pred hcccccCC
Q 006887 309 SSQNSVHS 316 (627)
Q Consensus 309 ~~~~~~~~ 316 (627)
||++.
T Consensus 310 ---HPY~~ 314 (369)
T KOG0665|consen 310 ---HPYIK 314 (369)
T ss_pred ---CCeee
Confidence 99877
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=260.45 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=196.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc-----CCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ-----GVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~-----~hpnIv~l~~~~ 115 (627)
++|.+....|+|-|++|.+|.+..-+ ..||||++.........-.. +.+++.++. ..-|+++|+-.|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~------~~vAiKIIRnNE~M~KtGl~--EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARG------QEVAIKIIRNNEVMHKTGLK--ELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCC------CeeEEEEeecchHHhhhhhH--HHHHHHHhhccCchhhhHHHHHHHHh
Confidence 56888899999999999999976544 48999999865433222221 222332222 123678888888
Q ss_pred EECCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccCCc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDVGI 193 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DFGl 193 (627)
...+.+|||+|-+.-+|.+.+... .+-.|.+..+..|+.|+..||..|-..||+|.||||+|||+++. ..+||||||.
T Consensus 504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 889999999999999999888764 23457788999999999999999999999999999999999875 4679999998
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP- 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~- 272 (627)
|..... ...+....+.-|.|||++.|. +|+...|+||+||+||||.||+..|.|.+..+++...+......
T Consensus 584 A~~~~e-----neitPYLVSRFYRaPEIiLG~---~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 584 ASFASE-----NEITPYLVSRFYRAPEIILGL---PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cccccc-----ccccHHHHHHhccCcceeecC---cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 876643 233444566779999999864 79999999999999999999999999998877776554322110
Q ss_pred ------------------------------------------------------CCCC---CCCHHHHHHHHHhhhcCCC
Q 006887 273 ------------------------------------------------------PIPS---GLPPAVENVLLGCFEYDLR 295 (627)
Q Consensus 273 ------------------------------------------------------~~p~---~~s~~l~~li~~cL~~dP~ 295 (627)
.+|. ..-..|++|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 0110 0124578999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCC
Q 006887 296 SRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 296 ~RPs~~eil~~L~~~~~~~~~ 316 (627)
+|.+..++|. |||+.
T Consensus 736 KRit~nqAL~------HpFi~ 750 (752)
T KOG0670|consen 736 KRITVNQALK------HPFIT 750 (752)
T ss_pred hcCCHHHHhc------CCccc
Confidence 9999999988 99875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=231.54 Aligned_cols=280 Identities=19% Similarity=0.263 Sum_probs=219.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
+..|-...|+++++||+|+||.+|+|....+++ .||||+-........-.. +..++..+.+-.+|+++..+
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge------~VAiK~Es~~a~hpqL~y---EskvY~iL~~g~GiP~i~~y 79 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGE------EVAIKLESSKAKHPQLLY---ESKVYRILQGGVGIPHIRHY 79 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCc------eEEEEeecccCCCcchhH---HHHHHHHhccCCCCchhhhh
Confidence 556778899999999999999999999988876 899999876544433222 22334444566778888888
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC---CCeeeccC
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA---DRAVLGDV 191 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~---g~vkL~DF 191 (627)
+.+..+..|||+++..+|.+++.. ....|+..+++.++.|++.-++|+|.+++|||||||+|+|..-+ ..+.|+||
T Consensus 80 ~~e~~ynvlVMdLLGPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 80 GTEKDYNVLVMDLLGPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred ccccccceeeeeccCccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 888999999999999999998875 66789999999999999999999999999999999999998543 46789999
Q ss_pred CccccccCCCC----CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---HHHHHHH
Q 006887 192 GIPHLLLGIPL----PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---VDEIYDA 264 (627)
Q Consensus 192 Gla~~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---~~e~~~~ 264 (627)
|+|+.+.+... +........||.+|.+-..+.+. ..+.+.|+-|+|.+|.++..|.+||++.. ..+-+++
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~---eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI---EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhh---hhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 99998876432 22233456799999998887643 46789999999999999999999999864 3456666
Q ss_pred HHhccCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc----cccCCCCCCCCCCccc
Q 006887 265 VVRRQEIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ----NSVHSDGGWTGHGSRI 327 (627)
Q Consensus 265 i~~~~~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~----~~~~~~~~w~~~~~~~ 327 (627)
|.+....-+ +...+|.++...+..|-..-.++-|++.-+-+.+..+. +...--.+|+.+....
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 665443322 45789999999999999999999999887766555433 3333344787665443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=261.56 Aligned_cols=201 Identities=20% Similarity=0.215 Sum_probs=164.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHH-----HHHHHHHH--HHHhcCCCCcee
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRV-----LLERLNDL--FLKCQGVEGICW 110 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~-----~~~~~~~~--ll~~~~hpnIv~ 110 (627)
.++|..++.+|+|+||.|++|.++... .+|+||++.+.+. +...+ -.-.+.++ .+....|+||++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~------~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENN------YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred cccceeeeeccccccceEEEeeecccc------eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 467999999999999999999998764 4899999976432 11000 00112223 334446999999
Q ss_pred eEEEEEECCEEEEEEecCC-C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 111 LQGISVINGKICIIMKFYE-G-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~-G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
++++|++++++||+||-.. | +|.|.+. ....+++.++..|+.|++.|+++||+.||||||||-+|+.++.+|.+||
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence 9999999999999999887 4 5666655 3456999999999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~ 255 (627)
+|||.+..... ..+..+.||..|.|||++.|+. -.+...|||++|++||.++....||+.
T Consensus 712 idfgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~--y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEK--YLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcC-----CCcceeeeeccccchhhhCCCc--cCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998876543 4556789999999999998763 246788999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=247.22 Aligned_cols=250 Identities=18% Similarity=0.250 Sum_probs=190.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+.+-.+.||-|+||.||.+++..+ ++.||+|++...... ....+.... .++...+|.|+...+++.+-.+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRd------grrvalkK~pnvfq~L~s~krvFre~--kmLcfFkHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRS------GKRVALKKMPNVFQNLASCKRVFREI--KMLSSFRHDNVLSLLDILQPAN 125 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCC------ccchhHhhcchHHHHHHHHHHHHHHH--HHHHhhccccHHHHHHhcCCCC
Confidence 344457899999999999986544 468999998653321 122222222 2667789999988887765432
Q ss_pred -----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 120 -----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 120 -----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.+|.++|++..+|-..+. ...+++.+.++-++.||+.||+|||+.+|.||||||.|+|++.|..+||+|||++
T Consensus 126 ~dfFqEiYV~TELmQSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred chHHHHHHHHHHHHHhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccc
Confidence 367888988876554443 4568999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-- 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~-- 272 (627)
+.... .....++..+-|..|.|||.+.|. ..|+.+.||||+|||+.|||..+..|+..++-+.++.|...-..+
T Consensus 204 Rvee~--d~~~hMTqEVVTQYYRAPEiLMGa--RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 204 RTWDQ--RDRLNMTHEVVTQYYRAPELLMGA--RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred cccch--hhhhhhHHHHHHHHhccHHHhhcc--hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 86532 223345567789999999999986 369999999999999999999999999888777666554422111
Q ss_pred ----------------------CCC--------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 273 ----------------------PIP--------SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 273 ----------------------~~p--------~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.++ ..-..+...++.++|..||+.|.+..+.+.
T Consensus 280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111 122345667888889999999998887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=236.66 Aligned_cols=276 Identities=19% Similarity=0.268 Sum_probs=220.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...+-.-+|++.++||+|+||.+++|++..+++ +||||.-...... +...+. +.+..+...++|+..+.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne------~VAIKfEPrkS~APQLrdEY----r~YKlL~g~~GIP~vYY 91 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNE------PVAIKFEPRKSEAPQLRDEY----RTYKLLGGTEGIPQVYY 91 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCc------eEEEEeccccCCcchHHHHH----HHHHHHcCCCCCCceee
Confidence 444566799999999999999999999988876 8999987654433 222222 22334457899999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-----CCeee
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-----DRAVL 188 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-----g~vkL 188 (627)
+...+.+..||||++.-+|.|++.. ++.+|+..+++.++.|++.-++|+|++.+|+|||||+|+||..- ..+.|
T Consensus 92 FGqeG~~NiLVidLLGPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 92 FGQEGKYNILVIDLLGPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred eccccchhhhhhhhhCcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEE
Confidence 9999999999999999999999875 78899999999999999999999999999999999999999654 35789
Q ss_pred ccCCccccccCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHH
Q 006887 189 GDVGIPHLLLGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEI 261 (627)
Q Consensus 189 ~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~ 261 (627)
+|||+|+.+.+.... .+...+..||-+||+-..+.|. ..+.+.|+-|||-+++++|.|.+||++. +..+-
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr---EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR---EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccc---hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 999999998764322 2223356899999999998754 6788999999999999999999999974 56677
Q ss_pred HHHHHhccCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc----ccCCCCCCCCCC
Q 006887 262 YDAVVRRQEIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN----SVHSDGGWTGHG 324 (627)
Q Consensus 262 ~~~i~~~~~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~----~~~~~~~w~~~~ 324 (627)
+++|-+....-+ +..++|.++...+...-..+..+-|++.-+...+.++.. ......+|..+.
T Consensus 248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 888876554433 447899999999999999999999999877666555433 233344665543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-26 Score=220.74 Aligned_cols=211 Identities=30% Similarity=0.488 Sum_probs=172.2
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEecC
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFY 128 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~ 128 (627)
||+|++|.||++....++ +.+++|++.............++. ..++.+.|++|+.+++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG------KKVAIKIIKKEDSSSLLEELLREI-EILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCC------cEEEEEEeccccchhHHHHHHHHH-HHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999986544 489999998765432112222222 2455678899999999999989999999999
Q ss_pred C-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCccccccCCCCCCCC
Q 006887 129 E-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPHLLLGIPLPSSD 206 (627)
Q Consensus 129 ~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~~~~~~~~~~~~ 206 (627)
+ ++|.+.+.. ....+++..+..++.+++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 74 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~ 149 (215)
T cd00180 74 EGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---L 149 (215)
T ss_pred CCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---h
Confidence 9 576666553 2246899999999999999999999999999999999999999 89999999999887643211 1
Q ss_pred CCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHH
Q 006887 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286 (627)
Q Consensus 207 ~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li 286 (627)
.....++..|++||.+... ..++.++|+|++|+++++| ..+.+++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l 194 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGK--GYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194 (215)
T ss_pred hhcccCCCCccChhHhccc--CCCCchhhhHHHHHHHHHH---------------------------------HHHHHHH
Confidence 3345688899999998642 2577899999999999998 7889999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 006887 287 LGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 287 ~~cL~~dP~~RPs~~eil~ 305 (627)
.+|++.+|++||++.++++
T Consensus 195 ~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHhhCCcccCcCHHHHhh
Confidence 9999999999999999886
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-26 Score=242.97 Aligned_cols=261 Identities=20% Similarity=0.225 Sum_probs=198.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc---CCCCceeeEEEE-EE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ---GVEGICWLQGIS-VI 117 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~---~hpnIv~l~~~~-~~ 117 (627)
+|++.+.||+|+||.||+|.+..++ ...+|+|+.......... .+..+...+.... ..++++.+++.+ ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 8999999999999999999987654 237999988764322211 1122222222222 346899999999 57
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-----CCeeeccCC
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-----DRAVLGDVG 192 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-----g~vkL~DFG 192 (627)
....||||+++.-+|.++......+.|+..++++++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 889999999999999998876666899999999999999999999999999999999999999765 358999999
Q ss_pred ccc--cccCCCC----CCCC-CCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 193 IPH--LLLGIPL----PSSD-LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 193 la~--~~~~~~~----~~~~-~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
+++ .+..... .... ...+.||..|++++++.+ ...+++.|+||++.++.|++.|.+||.+.........+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~---~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG---IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC---CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999 4332221 1111 234669999999999984 46888999999999999999999999876533222222
Q ss_pred Hh---ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 266 VR---RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 266 ~~---~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.. ...........+.++..+...+-..+...+|.+..+...++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 22 11111134556788999999999999999999999988776543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-26 Score=224.75 Aligned_cols=213 Identities=27% Similarity=0.351 Sum_probs=169.3
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|.+.+.||+|++|.||++.+..++ ..+|+|.+...... ....+ ..+.. .+...+|+|++++++.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~------~~~~iK~~~~~~~~~~~~~~-~~e~~-~~~~~~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG------ELVAVKVLKKEKTEKQREEF-LREIR-ILKKLKHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC------cEEEEEeeccccchHHHHHH-HHHHH-HHHhCCCCChhhheeeeecCCce
Confidence 578899999999999999987654 38999999865443 22222 22222 44556899999999999988999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
+++|||+++ +|.+.+.... ..+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 73 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEEEeccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999997 7777665422 22889999999999999999999999999999999999999999999999998876542
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC-CC-HHHHHHHHHhc
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RS-VDEIYDAVVRR 268 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~-~~e~~~~i~~~ 268 (627)
. ........++..|++||.+. ...+++.++|+|+||+++++|++|+.||.. .+ ..++.+.+...
T Consensus 152 ~--~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 152 L--AALLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred c--cccccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 2 01223457888999999984 134678899999999999999999999987 34 44666666543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.19 Aligned_cols=265 Identities=16% Similarity=0.223 Sum_probs=207.5
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+...++++...+-+|.||.||+|.++... ++...+.|-+|.++....+-+...+-.+ ..++....|||+..+.+++.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEd-t~n~~q~v~vKTvk~~AS~iQv~~~L~e-s~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREED-TYNDCQEVLVKTVKQHASQIQVNLLLQE-SMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccC-CcchHHHHHHHHHHhcccHHHHHHHHHH-HHHHhcCcCCCccceeEEEe
Confidence 355577889999999999999999876433 2333457888888654433222222222 23455667999999999876
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 117 I-NGKICIIMKFYE-GSVGDRMAQLKG------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 117 ~-~~~~~LVmEy~~-GsL~d~l~~~~~------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
. ....+.++.++. |+|-..+...+. +.++-.+....+.|++.|++|||++++||.||...|.+||+.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 5 456888899998 777666653221 34666778889999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~ 267 (627)
+|=.++|-+...+... .-...-....||+||.+.. ..|+.++|+|||||+||||+| |+.||...++.|+...+..
T Consensus 438 tDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n---~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQN---SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred ccchhccccCcccccc-cCCCCCCcccccCHHHHhh---hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999998776433211 1122234568999999984 479999999999999999999 9999999999999988876
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+. +...|-+||+++..++..||+..|++||++.++..-|.
T Consensus 514 Gy-RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 514 GY-RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred cc-eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 54 56679999999999999999999999999999876554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=238.58 Aligned_cols=141 Identities=21% Similarity=0.318 Sum_probs=111.5
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHh-------cCC
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC-------QGV 105 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~-------~~h 105 (627)
..-......+|-+.++||=|-|++||+|.+++.. +.||+|+.+........ .+.++ .++.+. .+.
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~------r~VAlKVvKSAqhYtEa-AlDEI-klL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNK------RYVALKVVKSAQHYTEA-ALDEI-KLLQQVREGDPNDPGK 141 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeeccCC------eEEEEEEEehhhHHHHH-HHHHH-HHHHHHHhcCCCCCCC
Confidence 3445566689999999999999999999998776 58999999754332221 11221 122221 122
Q ss_pred CCceeeEEEEEE----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEE
Q 006887 106 EGICWLQGISVI----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFIL 180 (627)
Q Consensus 106 pnIv~l~~~~~~----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILl 180 (627)
.+||+|++.|.. +..+|||+|++..+|+.++.....+-+++..++.|+.||+.||.|||.. ||||-||||+|||+
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 359999999875 4579999999999999999987778899999999999999999999965 99999999999999
Q ss_pred e
Q 006887 181 N 181 (627)
Q Consensus 181 d 181 (627)
.
T Consensus 222 ~ 222 (590)
T KOG1290|consen 222 C 222 (590)
T ss_pred e
Confidence 4
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=277.78 Aligned_cols=181 Identities=16% Similarity=0.213 Sum_probs=134.3
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---------------
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE--------------- 182 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~--------------- 182 (627)
...++++|||++++|.+.+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~ 130 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDS 130 (793)
T ss_pred cchhhhhhccCCccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcc
Confidence 346888999999999888853 3466999999999999999999999999999999999999954
Q ss_pred ----CCCeeeccCCccccccCCCC-------------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHH
Q 006887 183 ----ADRAVLGDVGIPHLLLGIPL-------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245 (627)
Q Consensus 183 ----~g~vkL~DFGla~~~~~~~~-------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLye 245 (627)
++.+|++|||+++....... .........||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 131 ~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~sDVwSlGviL~E 207 (793)
T PLN00181 131 GSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG---SSSNCASDVYRLGVLLFE 207 (793)
T ss_pred cccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc---CCCCchhhhhhHHHHHHH
Confidence 44566777777664321000 0000112468999999999874 468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 246 MLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 246 lltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
|++|.+|+.... ..+..+.... .++......+...+++.+||+.+|.+||++.++++
T Consensus 208 Ll~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 208 LFCPVSSREEKS--RTMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhhCCCchhhHH--HHHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999998875422 2222222221 12211223456778999999999999999999987
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=242.50 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=191.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|..+++||+|.|++||+|.+... ....+.||+|.+........ ...+.+.+....++.||+.+.+++..++.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~p~r---i~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSSPSR---ILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccCchH---HHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4799999999999999999987652 11346899999876544322 22333345666789999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCcccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~~~~ 198 (627)
.++||||++- ...++.. .++...+..|+..++.||.++|.+|||||||||.|+|.+. .+.-.|.|||+|....
T Consensus 110 v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999995 3334433 3778999999999999999999999999999999999974 5778899999997221
Q ss_pred CCC-------------CC-----------------C-----------CCCCccCCCCCcCCcccccCCCCCCCCccCcch
Q 006887 199 GIP-------------LP-----------------S-----------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSW 237 (627)
Q Consensus 199 ~~~-------------~~-----------------~-----------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiw 237 (627)
... .+ . .......||++|.|||++.. ....+.++|+|
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k--~~~QttaiDiw 262 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR--CPRQTTAIDIW 262 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh--ccCcCCcccee
Confidence 100 00 0 00012469999999999974 34567899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCH-----HHHHH---------------H--HHhccC------------C------------
Q 006887 238 GFACSIIEMLTGVQPRCGRSV-----DEIYD---------------A--VVRRQE------------I------------ 271 (627)
Q Consensus 238 SlGviLyelltG~~Pf~~~~~-----~e~~~---------------~--i~~~~~------------~------------ 271 (627)
|.|||++-+++++.||..... .++.. . +.+... .
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 999999999999999864221 11110 0 000000 0
Q ss_pred ----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 ----PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ----~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.......+..+.+|+.+||+.||.+|.+++++|+ |+||...
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk------HpFF~~~ 387 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK------HPFFDEA 387 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc------CcCCcch
Confidence 0011234567889999999999999999999998 9998844
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=227.49 Aligned_cols=246 Identities=18% Similarity=0.235 Sum_probs=181.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE-EEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG-ISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~-~~~~~~ 119 (627)
+.|.+.+.||+|.||.+-+++++.++. .+++|.++..... ...+.+++. .-..+..|.||+.-++ .|+..+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t------~ivlKavp~p~tt-~~dF~rEfh-Y~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKT------RIVLKAVPRPQTT-QADFVREFH-YSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCce------EEEeeccCcchhh-HHHHHHHhc-cceeeccchhhhHHHHHHhhcCc
Confidence 679999999999999999999998875 8999998754332 233333322 2233457888887765 477888
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--cCCCeeeccCCcccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--EADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~~g~vkL~DFGla~~ 196 (627)
.++++|||++ |+|...+ ....+.+.....++.|+++||.|+|++++||||||.+||||- +...+||+|||+.+.
T Consensus 96 ~YvF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eEEEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999999 6665444 345678899999999999999999999999999999999993 334799999998765
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCC--CCCccCcchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcc
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRG--PISFETDSWGFACSIIEMLTGVQPRCGRSVD-----EIYDAVVRRQ 269 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~--~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-----e~~~~i~~~~ 269 (627)
.. ......--+..|.+||.+.....+ ...+.+|+|.||+++|.+|||.+||+..... +..+.. +.
T Consensus 173 ~g------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~--~r 244 (378)
T KOG1345|consen 173 VG------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL--KR 244 (378)
T ss_pred cC------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--cc
Confidence 42 222333456789999987643222 3457899999999999999999999854322 122211 22
Q ss_pred CCCCCC---CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 270 EIPPIP---SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 270 ~~~~~p---~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+..| ..+++.+..+.++-|..++++|--..+..+
T Consensus 245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 233334 457899999999999999999954444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=213.89 Aligned_cols=160 Identities=16% Similarity=0.186 Sum_probs=126.5
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCc
Q 006887 130 GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209 (627)
Q Consensus 130 GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 209 (627)
|+|.+.+.. .+.++++..+..++.||+.||.|||+++ ||+|||++.++.+++ ||+++.... ..
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~--------~~ 63 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP--------EQ 63 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc--------cc
Confidence 677777754 4567999999999999999999999998 999999999999999 999886533 12
Q ss_pred cCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCC-----CCCCCCCH--H
Q 006887 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEIP-----PIPSGLPP--A 281 (627)
Q Consensus 210 ~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~~-----~~p~~~s~--~ 281 (627)
..||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ...+..+....... ..+..++. +
T Consensus 64 ~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 64 SRVDPYFMAPEVIQG---QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred CCCcccccChHHhcC---CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 268999999999974 4688999999999999999999999976543 23333333222111 11223333 6
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 282 VENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 282 l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+.+++.+||..+|.+||++.++++.+..
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 9999999999999999999999985543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-22 Score=204.39 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=191.4
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCC-CceeeEEEEEECC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVE-GICWLQGISVING 119 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hp-nIv~l~~~~~~~~ 119 (627)
|.+.+.||.|+||.||++.+. ..+|+|.+........ .....++.. ....+.|+ +|+++.+.+....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQ-ILASLNHPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHH-HHHHccCCcceeeEEEEEecCC
Confidence 788999999999999999976 2689999987554332 222333332 34555666 7999999998788
Q ss_pred EEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCcccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLKG--GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla~~ 196 (627)
..+++++++.|..+..+..... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 8899999999644433332222 2789999999999999999999999999999999999999988 799999999986
Q ss_pred ccCCCCCCC---CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcc
Q 006887 197 LLGIPLPSS---DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV----DEIYDAVVRRQ 269 (627)
Q Consensus 197 ~~~~~~~~~---~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~----~e~~~~i~~~~ 269 (627)
+........ ......||..|++||.+.+.....++...|+||+|++++++++|..||..... .+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 544322221 34677899999999998742103578899999999999999999999887763 45555554433
Q ss_pred CC-C--CCCCCC----CHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 270 EI-P--PIPSGL----PPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 270 ~~-~--~~p~~~----s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.. . ...... ...+.+++..|+..+|..|.+..+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 22 1 111222 257899999999999999999887665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=216.30 Aligned_cols=169 Identities=19% Similarity=0.121 Sum_probs=122.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc----hhHHHHHHHHHHHHHHHhcCCCCcee-eEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK----EDRMRVLLERLNDLFLKCQGVEGICW-LQG 113 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~----~~~~~~~~~~~~~~ll~~~~hpnIv~-l~~ 113 (627)
-.++|++.+.||+|+||.||+|++..+.. +.||||++.... .........++. .+++.++|+|++. +++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~E~-~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPG-----TARAVRRRVSEVPWWSKPLARHLAAREI-RALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCC-----eEEEEEEecccccccccHHHHHHHHHHH-HHHHhccCCCCCcEEEE
Confidence 34689999999999999999999875322 368999875331 122222333333 2456678989874 443
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccc-CCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNL-KPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDL-KP~NILld~~g~vkL~DFG 192 (627)
.+..||||||++|..+..+. . .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||
T Consensus 90 ----~~~~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 ----TGKDGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred ----cCCcEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 24689999999975444221 1 11 1467889999999999999999999 9999999999999999999
Q ss_pred ccccccCCCCCC-----CCCCccCCCCCcCCcccccCC
Q 006887 193 IPHLLLGIPLPS-----SDLPRRLGTPNYMAPEQWQPE 225 (627)
Q Consensus 193 la~~~~~~~~~~-----~~~~~~~GT~~YmAPE~~~~~ 225 (627)
+|+.+....... ....+..+++.|+|||.+..+
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999775432111 122466799999999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=206.33 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=189.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCc-----------------------------ccccEEEEEEecCCch
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDC-----------------------------DEYHEVAVKILHPVKE 85 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~-----------------------------~~~~~VAVK~l~~~~~ 85 (627)
......++|++.+.||+|.-+.||.|+....+.+. ...-+.|||++-....
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 34455679999999999999999999875432210 0112467777654322
Q ss_pred hH-HHHHHHHHHHH--------H----------------HHhcCCCCceeeEEEEEE-----------------------
Q 006887 86 DR-MRVLLERLNDL--------F----------------LKCQGVEGICWLQGISVI----------------------- 117 (627)
Q Consensus 86 ~~-~~~~~~~~~~~--------l----------------l~~~~hpnIv~l~~~~~~----------------------- 117 (627)
+. ....+..+-.. + ..+-.||||++++..|.+
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 11 11111111000 0 112479999999987765
Q ss_pred ----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--cCC--Ceeec
Q 006887 118 ----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--EAD--RAVLG 189 (627)
Q Consensus 118 ----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~~g--~vkL~ 189 (627)
...+|+||.-++.+|...+.. ...+......++.|+++|+.|||.+||.|||||.+|||+. +++ .+.|+
T Consensus 311 g~g~~~tlylvMkrY~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ccCCCceEEEehhcchhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 246899999999988877743 4567788889999999999999999999999999999994 343 46799
Q ss_pred cCCccccccCCCCC---CCCCCccCCCCCcCCcccccCCCCCCCC----ccCcchhHHHHHHHHHhCCCCCCCCCHHHHH
Q 006887 190 DVGIPHLLLGIPLP---SSDLPRRLGTPNYMAPEQWQPEVRGPIS----FETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262 (627)
Q Consensus 190 DFGla~~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~~~~~s----~~sDiwSlGviLyelltG~~Pf~~~~~~e~~ 262 (627)
|||.|---...... .+..-..-|.-.-||||+.... .|+.- .++|.|+.|.+.||+++...||++.....+-
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~-PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV-PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcC-CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 99987532221111 1111234577789999998643 23221 4799999999999999999999985443333
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 263 ~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
..-.++...|.+|+.+++.+++++..+|+.||++|++..=..+.|.
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 3334455678899999999999999999999999998765555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=228.80 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=173.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
-..++|..++.|..|+||.||+++++.+.. .+|+|+ ++.+ ++++ ||..+
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trq------rfa~ki-Nkq~-------------lilR-----nilt~------ 128 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQ------RFAMKI-NKQN-------------LILR-----NILTF------ 128 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeecccccc------chhhcc-cccc-------------hhhh-----ccccc------
Confidence 345789999999999999999999987764 789954 2211 1111 11111
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.+..+.| |+-.+++.. -++++.+ ++.+++|||+.||+|||+||+|.+|..-|++|++|||+.+..
T Consensus 129 a~npfvv-----gDc~tllk~--~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 129 AGNPFVV-----GDCATLLKN--IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred cCCccee-----chhhhhccc--CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 1222222 544444432 2444443 378999999999999999999999999999999999998765
Q ss_pred cCCCCCCC------------CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 198 LGIPLPSS------------DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 198 ~~~~~~~~------------~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
........ .....||||.|+|||++.. ..|+..+|||++|+|+||++.|..||.+.++++++..+
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr---qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v 270 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 270 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh---hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh
Confidence 43211110 1124589999999999984 46899999999999999999999999999999999887
Q ss_pred Hhcc-CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 266 VRRQ-EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 266 ~~~~-~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
+... ..+.-...++++++++|.++|+.+|..|......+ +-.+|.+|...+|..+..
T Consensus 271 isd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~---evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 271 ISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL---EVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred hhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh---hhhhccceeecccchhhh
Confidence 6533 22333466889999999999999999997544333 334499999999985544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=230.01 Aligned_cols=245 Identities=17% Similarity=0.209 Sum_probs=189.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc-hhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-EDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~-~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+|...+.||++.|=+|.+|+++.. .|+||++-+.. .-....+.++++++-....++||.+.+.-+...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--------~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--------LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--------eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHH
Confidence 688889999999999999986542 59999986644 445566666666666677899999999888777888
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|||-+|+..+|.|++. ....+.+.+.+.|+.||+.||..+|..||+|+|||.+||||+..+-+.|+||.--+...-.
T Consensus 96 AylvRqyvkhnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHhhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 99999999999999985 3345677888999999999999999999999999999999999999999999876554322
Q ss_pred CCCCCCCCccC----CCCCcCCcccccCCC-------CCC-CCccCcchhHHHHHHHHHh-CCCCCCC-----------C
Q 006887 201 PLPSSDLPRRL----GTPNYMAPEQWQPEV-------RGP-ISFETDSWGFACSIIEMLT-GVQPRCG-----------R 256 (627)
Q Consensus 201 ~~~~~~~~~~~----GT~~YmAPE~~~~~~-------~~~-~s~~sDiwSlGviLyellt-G~~Pf~~-----------~ 256 (627)
..+...++.+. .-.+|+|||.+.... ..+ .+++.||||+||++.||++ |++||.- .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD 253 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence 22223333232 335899999886411 112 6789999999999999988 8998851 1
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
+.+.+++.| -+..++.++..|++.||++|.++.+.|+...
T Consensus 254 ~~e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 254 DPEQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred CHHHHHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 222222222 1347999999999999999999999988543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=230.16 Aligned_cols=261 Identities=18% Similarity=0.155 Sum_probs=185.2
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHH--HHHhcCCCCceeeEEEEEECCEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL--FLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~--ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.....+|.|++|.|+.+......+. .....+++| ..+. ............. +-..+.|+|++.......+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~-~~~~~~r~~-~~~~--~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKS-FPEKEFRVR-VKPT--ESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCcc-chhhhhhcc-cCCc--ccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 5678899999998888876655431 111222333 1111 1111111111112 34567899987766665555555
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~ 201 (627)
.-+||||+++|..++.. .+.+...++..++.|++.|+.|||+.||.||||||+|+++..+|.+||+|||.+..+.-..
T Consensus 397 ~~~mE~~~~Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 397 LQSMEYCPYDLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhhhcccHHHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 55599999977766653 3578999999999999999999999999999999999999999999999999887654322
Q ss_pred CC-CCCCCccCCCCCcCCcccccCCCCCCCC-ccCcchhHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-----ccCCC
Q 006887 202 LP-SSDLPRRLGTPNYMAPEQWQPEVRGPIS-FETDSWGFACSIIEMLTGVQPRCGRSVDEIY--DAVVR-----RQEIP 272 (627)
Q Consensus 202 ~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s-~~sDiwSlGviLyelltG~~Pf~~~~~~e~~--~~i~~-----~~~~~ 272 (627)
.. ......++|+..|+|||++.+. .|. +..||||.|++++.|.+|+.||......+.. ..... .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~---~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGK---EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred chhhhhhcCcccCCcCcCccccccc---ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 11 1334578999999999999854 454 4689999999999999999999864433221 11100 11112
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
.+...++.+.+.+|.+||+.||.+|.++.+|++ .+|+..+.
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~------d~W~~~i~ 592 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN------DEWIRSIE 592 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh------ChHhhhcc
Confidence 234568899999999999999999999999998 67766553
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-22 Score=197.19 Aligned_cols=257 Identities=22% Similarity=0.275 Sum_probs=204.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHH-HHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRM-RVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~-~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..-|+.+++.++-+|.+...|..|+|++..+. ++.|+++-..- ... +.+.+++ -.++...||||+.++
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd--------ivakil~vr~~t~risrdfneef--p~lrifshpnilpvl 253 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGND--------IVAKILNVREVTARISRDFNEEF--PALRIFSHPNILPVL 253 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcc--------hhhhhhhhhhcchhhcchhhhhC--cceeeecCCchhhhh
Confidence 45688888999999999999999999987653 67788753221 111 1121211 245667999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCCCeeec
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g~vkL~ 189 (627)
+.|.....+.++..|++ |+|...+....+--+...++.+++.+++.|++|||+.. |.---|....++||++.+++|+
T Consensus 254 gacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 254 GACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred hhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee
Confidence 99999999999999999 88888887655556778899999999999999999975 4444688899999999887764
Q ss_pred --cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 190 --DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 190 --DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|--++- ......-.|.||+||.++......--.++|+|||++++|||.|...||.+.++.+.-.++..
T Consensus 334 mad~kfsf----------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial 403 (448)
T KOG0195|consen 334 MADTKFSF----------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL 403 (448)
T ss_pred cccceeee----------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh
Confidence 322211 11223457899999999854222233679999999999999999999999999999888888
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+..+..+|++++..+..|+.-|+..||.+||.+..++-.|++++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 88899999999999999999999999999999999888877653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.2e-21 Score=195.92 Aligned_cols=237 Identities=20% Similarity=0.229 Sum_probs=145.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcC---------CCCce
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQG---------VEGIC 109 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~---------hpnIv 109 (627)
.+.....||.|+++.||.+++..+++ ++|+|+....... ..+...++...+ ....+ |-.++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~------~~avkvf~~~~~~~~~~~~~~~~e~l~~-~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGE------EFAVKVFLLPADASANEYEQLKEEQLAI-TLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEEEESSTTHTTHHHHHHHHHHGG-GGSTT--SHHHHHHHH-B-
T ss_pred EEEEccccccCCceEEEEEEEccCCc------eEEEEEEecccccchHHHHHHHHHHHHh-hhhccCCCHHHHHHhceEE
Confidence 46788999999999999999988776 8999997543321 222222211111 00000 11122
Q ss_pred eeEEEEEE---------C---C-----EEEEEEecCCCCHHHHHHHhcC---CC--CCHHHHHHHHHHHHHHHHHHHHCC
Q 006887 110 WLQGISVI---------N---G-----KICIIMKFYEGSVGDRMAQLKG---GK--LSLSNVFRYAIDLAQGILQLHSKG 167 (627)
Q Consensus 110 ~l~~~~~~---------~---~-----~~~LVmEy~~GsL~d~l~~~~~---~~--ls~~~~~~i~~qIa~aL~yLHs~g 167 (627)
..++.... . . ..+++|+-+.++|.+.+..... .. +.....+.+..|++..+++||+.|
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 22222221 1 1 2478999999998887654321 11 122233455689999999999999
Q ss_pred CeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCC-----CCCCCCccCcchhHHHH
Q 006887 168 ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE-----VRGPISFETDSWGFACS 242 (627)
Q Consensus 168 IvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-----~~~~~s~~sDiwSlGvi 242 (627)
++|+||||+|++++.+|.++|+||+....... .......+..|.+||..... ..-.++.+.|.|+||++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~------~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT------RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTE------EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCc------eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999997665422 11113455789999987532 12357889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 006887 243 IIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297 (627)
Q Consensus 243 LyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~R 297 (627)
+|.|.+|+.||........... .......+|+.++.||.++|+.||++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986544322211 111223789999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=182.43 Aligned_cols=140 Identities=20% Similarity=0.124 Sum_probs=98.8
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-------------------------HHHHHHHHHHH
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-------------------------VLLERLNDLFL 100 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-------------------------~~~~~~~~~ll 100 (627)
...||+|+||.||+|.+. ++ +.||||++++....... .....+. ..+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g------~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l 73 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG------EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEM-RNL 73 (190)
T ss_pred CCccccccceEEEEEECC-CC------CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHH-HHH
Confidence 467999999999999875 44 48999999764321000 0111122 233
Q ss_pred HhcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCcEE
Q 006887 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL-HSKGILVLNLKPFNFI 179 (627)
Q Consensus 101 ~~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~gIvHrDLKP~NIL 179 (627)
..+.++++.....+... ..+|||||++|+.+.... ....++++..+..++.|++.+|.|| |+.||+||||||+|||
T Consensus 74 ~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl 150 (190)
T cd05147 74 KRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPR-LKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL 150 (190)
T ss_pred HHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchh-hhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 44455555333322222 238999999985433221 2446799999999999999999999 7999999999999999
Q ss_pred EecCCCeeeccCCccccc
Q 006887 180 LNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~ 197 (627)
++ ++.++|+|||+|...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 578999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=175.63 Aligned_cols=141 Identities=18% Similarity=0.133 Sum_probs=102.1
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--H-------------------HH---HHHHHHHHHHHH
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--R-------------------MR---VLLERLNDLFLK 101 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~-------------------~~---~~~~~~~~~ll~ 101 (627)
...||+|+||.||+|++. ++ +.||||++++.... . .. ......+...+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 74 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG------EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK 74 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC------CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence 467999999999999865 33 48999999865311 0 00 001111122344
Q ss_pred hcCCCCceeeEEEEEECCEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEE
Q 006887 102 CQGVEGICWLQGISVINGKICIIMKFYEGS-VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFI 179 (627)
Q Consensus 102 ~~~hpnIv~l~~~~~~~~~~~LVmEy~~Gs-L~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NIL 179 (627)
.+.++++.....+.... .||||||++|. +.... .....++...+..++.|++.+|.+||+ .||+||||||+|||
T Consensus 75 ~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~--l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 75 RLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPR--LKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred HHHhCCCCCceEEEecC--CEEEEEEecCCCchhhh--hhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 56677765444433322 48999999985 32222 134568889999999999999999999 99999999999999
Q ss_pred EecCCCeeeccCCcccccc
Q 006887 180 LNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~ 198 (627)
++ ++.++|+|||+++.+.
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 8999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=178.87 Aligned_cols=170 Identities=14% Similarity=0.105 Sum_probs=121.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHH--------HHHHHHHHHHhcCCCCceee
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL--------LERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~--------~~~~~~~ll~~~~hpnIv~l 111 (627)
.++|++++.||.|+||.||++.. .. ..+|||++++......... .+++.. .+..+.|++|..+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~-------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~-~l~rL~~~GI~~~ 100 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DY-------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIV-QTDRVRSEGLASL 100 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CC-------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHH-HHHHHHHCCCCcc
Confidence 47899999999999999999754 22 2599999986544332221 122222 3455689999999
Q ss_pred EEEEEEC--------CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 112 QGISVIN--------GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 112 ~~~~~~~--------~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
.+++... +..+|||||++| +|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 8886543 358999999998 443331 2333 24569999999999999999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML 247 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyell 247 (627)
+| ++|+|||..+...... .. ..+.. ...|..++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~----a~-----------d~~vl---er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRK----AK-----------DRIDL---ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchh----hH-----------HHHHH---HhHhcccccccceeEeehHHH
Confidence 88 9999999876542210 00 00121 224667999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=202.12 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=180.7
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH---HHHHHHHHHHHHHhcCCCCcee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM---RVLLERLNDLFLKCQGVEGICW 110 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~---~~~~~~~~~~ll~~~~hpnIv~ 110 (627)
....+....|.|.+.||+|+||.||+|...+ ++.||+|+-++...-.. .....++. ..--+.|..
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~WEfYI~~q~~~RLk-----~~~~~~~~~ 758 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPWEFYICLQVMERLK-----PQMLPSIMH 758 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCceeeeehHHHHHhhc-----hhhhcchHH
Confidence 3455677889999999999999999998655 35899999887653221 11122221 122355666
Q ss_pred eEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-------
Q 006887 111 LQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE------- 182 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~------- 182 (627)
+..++...+..+||+||.+ |+|+|++. ..+.+++..+++++.|++..++.||..+|||+||||+|+||..
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 6666777888999999999 99999997 5677899999999999999999999999999999999999942
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~ 262 (627)
+-.++|+|||.+--+.- -.....+...++|-.+-++|+..| .++++..|.|.|+.+++-||.|+.-
T Consensus 837 ~~~l~lIDfG~siDm~l-fp~~~~F~~~~~td~f~C~EM~~g---rpWtYq~DyfGlAa~~h~mLFG~y~---------- 902 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKL-FPDGTKFKAVWHTDLFDCIEMREG---RPWTYQIDYFGLAATVHVMLFGKYM---------- 902 (974)
T ss_pred ccceEEEecccceeeeE-cCCCcEEeeeeccccchhHHHhcC---CCCchhhhhHHHHHHHHHHHHHHHH----------
Confidence 34589999998754321 112345567789999999999985 4899999999999999999999632
Q ss_pred HHHHhccCCCC----CCCCCCHH-HHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 263 DAVVRRQEIPP----IPSGLPPA-VENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 263 ~~i~~~~~~~~----~p~~~s~~-l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+ ... ..... ++.....+ .-+|...+|..|...=|...++...|+..
T Consensus 903 q-~~~-g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 903 E-VKN-GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred H-hcC-CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 1 111 11111 22222233 34677788876666667777776666553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=170.06 Aligned_cols=190 Identities=13% Similarity=0.080 Sum_probs=131.9
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RM-RVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
....|++|+||+||++.. .++.++.+.+.....- .. .....++.+++.++.++++++.++++ +..
T Consensus 6 ~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~ 73 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR 73 (218)
T ss_pred cceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence 457899999999997753 2346777777544331 11 11234444555555567889999886 347
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccc-CCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNL-KPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDL-KP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|++|||+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||++......
T Consensus 74 ~lvmeyI~G~~L~~~~-------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP-------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred EEEEeeecCccHHhhh-------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999999985443221 111 2357889999999999999999999 799999999999999999999854321
Q ss_pred CC-----CCCC-----CCccCCCCCcCCcccccCCCCCCCC-ccCcchhHHHHHHHHHhCCCCCCCC
Q 006887 201 PL-----PSSD-----LPRRLGTPNYMAPEQWQPEVRGPIS-FETDSWGFACSIIEMLTGVQPRCGR 256 (627)
Q Consensus 201 ~~-----~~~~-----~~~~~GT~~YmAPE~~~~~~~~~~s-~~sDiwSlGviLyelltG~~Pf~~~ 256 (627)
.. ...+ ......++.|++|+...-. . ..+ ...++++.|+-+|.++|+..++.+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~-~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-K-RTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-c-cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0000 0112378899999875421 1 222 4568889999999999999887643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.7e-17 Score=159.82 Aligned_cols=135 Identities=16% Similarity=0.150 Sum_probs=95.7
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc----CCCCceeeEEEEEECC-
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ----GVEGICWLQGISVING- 119 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~----~hpnIv~l~~~~~~~~- 119 (627)
-.+.||+|+||.||. +..+. ..+||++.......... ..++...+..+. .||||+++++++.++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~-------~k~IKv~~~~~~~~~~~-~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDA-------QRCIKIVYHRGDGGDKE-IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CcceecCCCceEEEE--CCCCc-------CeEEEEEeccccchHHH-HHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 346799999999995 44333 24799987643322222 233333333332 6899999999998863
Q ss_pred --EEE-EEEecCC---CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecccCCCcEEEecC----CCeee
Q 006887 120 --KIC-IIMKFYE---GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGI-LQLHSKGILVLNLKPFNFILNEA----DRAVL 188 (627)
Q Consensus 120 --~~~-LVmEy~~---GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL-~yLHs~gIvHrDLKP~NILld~~----g~vkL 188 (627)
..+ +||||.. |+|.+.+.. +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 434 8999944 577777743 346655 35678888887 99999999999999999999743 37999
Q ss_pred ccCCcc
Q 006887 189 GDVGIP 194 (627)
Q Consensus 189 ~DFGla 194 (627)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995533
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-17 Score=176.33 Aligned_cols=208 Identities=21% Similarity=0.255 Sum_probs=161.5
Q ss_pred HhcCCCCceeeEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecccCCCcE
Q 006887 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGI-LVLNLKPFNF 178 (627)
Q Consensus 101 ~~~~hpnIv~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gI-vHrDLKP~NI 178 (627)
+.+.|.|+.++++.+.++...++|.+||. |+|.|.+.. ....++..-...+.++|+.||.|||...| .|+.|+..|.
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 34689999999999999999999999998 899998875 44566777777789999999999998876 9999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCC----CCccCcchhHHHHHHHHHhCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGP----ISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~----~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
++|..+.+||+|||+........ .........-..-|.|||.+....... .+.+.|+||||++++|+++...||.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred eeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999987764310 011111222345689999998642222 4678999999999999999999998
Q ss_pred C----CCHHHHHHHHHhccCCCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 255 G----RSVDEIYDAVVRRQEIPPIP-----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 255 ~----~~~~e~~~~i~~~~~~~~~p-----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
. .++.++...+......+..| ...++++..++.+||..+|..||++..+-..++..
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 5 23456666665523222222 14566899999999999999999999987766554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.8e-17 Score=163.67 Aligned_cols=143 Identities=19% Similarity=0.142 Sum_probs=101.1
Q ss_pred CeEEEeEEeeeCCeEEEEEE-EcCCCcCcccccEEEEEEecCCchh-----------------------HHHHHHHHHHH
Q 006887 42 ALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKED-----------------------RMRVLLERLND 97 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~-~~~s~ed~~~~~~VAVK~l~~~~~~-----------------------~~~~~~~~~~~ 97 (627)
.|++.+.||+|+||.||+|. +..++ +.||||+++..... ........+..
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g------~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSG------KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCC------cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 58899999999999999998 44443 48999999754211 01111222332
Q ss_pred HHHHhcCC--CCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecccC
Q 006887 98 LFLKCQGV--EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG-ILVLNLK 174 (627)
Q Consensus 98 ~ll~~~~h--pnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g-IvHrDLK 174 (627)
.+.. +.+ ..++.+++. ...+|||||++|..+.... .....+....+..++.||+.+|.+||+.| |+|||||
T Consensus 103 ~L~~-L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 103 NLQR-LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR-LKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred HHHH-HHhcCCCCCeeeEe----cCceEEEEEecCCcccccc-cccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 3333 333 234444442 2358999999984433222 13345666778899999999999999999 9999999
Q ss_pred CCcEEEecCCCeeeccCCccccc
Q 006887 175 PFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 175 P~NILld~~g~vkL~DFGla~~~ 197 (627)
|+||+++ ++.++|+|||++...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999987653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=154.22 Aligned_cols=134 Identities=20% Similarity=0.277 Sum_probs=100.1
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHH-----HHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMR-----VLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~-----~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+.||+|++|.||+|.+.. ..|++|+..+... .... .....+. ..+..+.|++|.....++...+
T Consensus 2 ~~l~~G~~~~vy~~~~~~--------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG--------IKAVIKWRIPKRYRHPELDERIRRERTRREA-RIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEeeCC--------CceEEEEeCCcCCcChHHHHHHHHHHHHHHH-HHHHHHHHCCCCCCeEEEEeCC
Confidence 579999999999998622 3689998764321 1111 1111222 2445567788877777777778
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..++||||++| +|.+.+.. . .. ....++.+++.+|.+||+.+++|||++|.|||++ ++.++|+|||+++.
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~-~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINS-N----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHh-c----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 89999999997 66555532 1 12 7889999999999999999999999999999999 88999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-17 Score=175.03 Aligned_cols=173 Identities=20% Similarity=0.240 Sum_probs=128.0
Q ss_pred CEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.++||.|++|. ++|.+.+.+.+ ...-++...+.++.|++.|++| ++.+|||+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35899999999 67777776432 2456788899999999999999 9999999999999999999999999999876
Q ss_pred ccCCCC---CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 197 LLGIPL---PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 197 ~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
...... .....+...||..||+||++.++ .|+.++||||||.+|+|+++ =..+|. ....+..+.....++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~---~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ---QYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhh---hhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCCh
Confidence 544321 12234567899999999999855 69999999999999999997 222222 112222332222221
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMT 301 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~ 301 (627)
.+.... +.-..|+.+++.+.|.+||++.
T Consensus 480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 480 EFLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 222233 3446899999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=148.59 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=95.2
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HH-------------------HHHHHHHHHHHHH
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RM-------------------RVLLERLNDLFLK 101 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~-------------------~~~~~~~~~~ll~ 101 (627)
|.+.+.||+|+||.||++... ++ +.||||+++..... .. ......+. ..+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~ 88 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DG------NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF-AALK 88 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CC------CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH-HHHH
Confidence 778899999999999999864 23 48999997653210 00 00011111 1233
Q ss_pred hcCCC--CceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 102 CQGVE--GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 102 ~~~hp--nIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
.+.++ .++..++ .+..++||||++|..+..+.. ......++.+++.++.++|+.||+||||||+||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 34444 3444433 245699999999844333211 1345678899999999999999999999999999
Q ss_pred EecCCCeeeccCCccccc
Q 006887 180 LNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~ 197 (627)
+++++.++|+|||++...
T Consensus 158 l~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 158 VDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EcCCCcEEEEECCccccC
Confidence 999999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-17 Score=184.92 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=191.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
...|.+.+.||+|+|+.|-+.......+ ..+|+|.+..... .........+..+-....+|+|++++++.....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~-----~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPE-----SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCc-----ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC
Confidence 4578888999999999999988755544 3678887765431 111111111111112223499999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeecccCCCcEEEecCC-CeeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGG-KLSLSNVFRYAIDLAQGILQLH-SKGILVLNLKPFNFILNEAD-RAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~-~ls~~~~~~i~~qIa~aL~yLH-s~gIvHrDLKP~NILld~~g-~vkL~DFGla 194 (627)
+..++.++|..| ++.+.+.. ... ..+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999886 44444321 222 5677889999999999999999 99999999999999999999 9999999999
Q ss_pred ccccCCCCCCCCCCccCC-CCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccC--
Q 006887 195 HLLLGIPLPSSDLPRRLG-TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE-IYDAVVRRQE-- 270 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~G-T~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e-~~~~i~~~~~-- 270 (627)
..+.............+| ++.|+|||...+. .......|+||.|+++.-|++|..||....... .+........
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccch--hhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 887653333444456788 9999999998752 234568999999999999999999998654332 2122222211
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.......++....+++.+++..+|..|.+..++..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 23445778999999999999999999999888765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.5e-15 Score=165.39 Aligned_cols=135 Identities=19% Similarity=0.197 Sum_probs=98.9
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC--chhH----H-HHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV--KEDR----M-RVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~--~~~~----~-~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.|...+.||+|+||.||+|.+.... +++|+.... .... . ......+ ..++..+.|++++....+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--------~v~k~~~~~~~~~~~~~~~~~~~~~~~E-~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--------AVIKERVPKGYRHPELDERLRTERTRAE-ARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--------ceeEEEecccccchhHHHHHHHHHHHHH-HHHHHhhcccCCCeeEEE
Confidence 3456899999999999999865432 444443221 1111 1 1111222 225666789999888777
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+......++||||++| +|.+.+. ....++.|++.+|.|||+.+++||||||+|||+ .++.++|+|||+
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7777788999999996 5544442 356789999999999999999999999999999 678999999999
Q ss_pred ccc
Q 006887 194 PHL 196 (627)
Q Consensus 194 a~~ 196 (627)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=143.03 Aligned_cols=129 Identities=20% Similarity=0.248 Sum_probs=91.3
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHH--H---HHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRM--R---VLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~--~---~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
||+|+||.||+|.+.. ..|++|+...... ... . .....+. .++..+.|+++.....++...+..
T Consensus 2 ig~G~~~~vy~~~~~~--------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i~~p~~~~~~~~~~ 72 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLG--------LKAVIKERVPKSYRHPELDERIRRERTRNEA-RLLSRARKAGVNTPVVYDVDPDNK 72 (199)
T ss_pred CCCCceEEEEEeecCC--------ccEEEEEecCCcCcCchHHHHHHHHHHHHHH-HHHHHHHHCCCCCCEEEEEECCCC
Confidence 7999999999998422 3699998654321 111 1 1111222 234445566655555555566778
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++||||++| ++.+.+.. .. ..++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||+++.
T Consensus 73 ~lv~e~~~g~~l~~~~~~--~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEE--GN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhh--cH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999997 55444422 11 07889999999999999999999999999999 89999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.5e-15 Score=142.90 Aligned_cols=135 Identities=19% Similarity=0.208 Sum_probs=90.3
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHH---------------------HHHHHHHHHh
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLL---------------------ERLNDLFLKC 102 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~---------------------~~~~~~ll~~ 102 (627)
.+.||+|+||.||+|.+. ++ +.||||++.+..... ..... ..+... +..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~ 73 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG------EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN-LKR 73 (187)
T ss_pred CcccccccceeEEEEECC-CC------CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH-HHH
Confidence 467999999999999865 33 489999987643211 11110 111111 111
Q ss_pred cCCC--CceeeEEEEEECCEEEEEEecCCCC-HH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCc
Q 006887 103 QGVE--GICWLQGISVINGKICIIMKFYEGS-VG-DRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFN 177 (627)
Q Consensus 103 ~~hp--nIv~l~~~~~~~~~~~LVmEy~~Gs-L~-d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~N 177 (627)
..+. .+...+++ ...++||||++|+ +. ..+.... .. ..+..++.+++.++.++|+ .+|+||||||+|
T Consensus 74 l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 74 LYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred HHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222 24444443 2469999999972 11 1111100 11 6778899999999999999 999999999999
Q ss_pred EEEecCCCeeeccCCccccc
Q 006887 178 FILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~ 197 (627)
|+++ ++.++|+|||.+...
T Consensus 146 ili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CCcEEEEECcccccc
Confidence 9999 999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=127.33 Aligned_cols=133 Identities=17% Similarity=0.089 Sum_probs=100.7
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCC-CCceeeEEEEEECCEEEE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV-EGICWLQGISVINGKICI 123 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~h-pnIv~l~~~~~~~~~~~L 123 (627)
+.+.||+|.++.||++.... ..+++|....... ......+...+....++ .++++++......+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 45789999999999998643 3699999876543 11122222233222223 678888888887788999
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 124 IMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK---GILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 124 VmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~---gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+|||++|.....+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||+++.
T Consensus 71 v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999998433221 5567778899999999999985 699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-14 Score=164.06 Aligned_cols=276 Identities=16% Similarity=0.182 Sum_probs=199.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
....++.+.+.+-+-+|+++.++.+.-..++ +..++|+...... +..+..... ........+|.++...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sg------h~~~~~v~~~ap~i~~~~~~s~r~~--s~~~i~p~~P~v~~~~ 870 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSG------HTRPSKVHGLAPKIRTNDYESIRSK--SNILITPRSPAVVRSF 870 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccc------cccchhhhccchhhccccccccCCc--cCccccCCCCceeccc
Confidence 3467889999999999999999998765554 3556665433221 111100000 0011123445566555
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..+......+|+|+|+.| ++..++. ..++.+.+-+.-++..+..+++|||+..+.|||++|.|+|+..+++.++.||
T Consensus 871 ~s~~~rsP~~L~~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 871 PSFPCRSPLPLVGHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCCCCCcchhhHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcc
Confidence 555556779999999985 4444443 2346777788888899999999999999999999999999999999999999
Q ss_pred CccccccCCCC----------------------------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHH
Q 006887 192 GIPHLLLGIPL----------------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSI 243 (627)
Q Consensus 192 Gla~~~~~~~~----------------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviL 243 (627)
|+......... .........||+.|.+||...+. .....+|+|++|+++
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~---~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR---RHGSAADWWSSGVCL 1025 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc---cCCCcchhhhhhhhh
Confidence 84433221100 00112245799999999999854 456689999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 244 IEMLTGVQPRCGRSVDEIYDAVVRRQEIP-PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 244 yelltG~~Pf~~~~~~e~~~~i~~~~~~~-~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
+|.++|.+||.....+++++.+......+ .-+...+.+.++++..++..++.+|..+....+ .-.|++|...+|+.
T Consensus 1026 ~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e---~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE---VKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc---cccCCccCCCCccc
Confidence 99999999999999999998887654333 245678999999999999999999988763222 23389999999987
Q ss_pred CCccc
Q 006887 323 HGSRI 327 (627)
Q Consensus 323 ~~~~~ 327 (627)
+....
T Consensus 1103 l~~q~ 1107 (1205)
T KOG0606|consen 1103 LALQK 1107 (1205)
T ss_pred ccccc
Confidence 65544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-12 Score=133.27 Aligned_cols=144 Identities=17% Similarity=0.163 Sum_probs=96.2
Q ss_pred CcCCCCeEEE-eEEe-eeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch------h------HHHHHHHHHHHHHHHh
Q 006887 37 WIKPSALKLR-HRIG-RGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------D------RMRVLLERLNDLFLKC 102 (627)
Q Consensus 37 ~i~~~~y~i~-~~LG-~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~------~------~~~~~~~~~~~~ll~~ 102 (627)
+.+++.+... ..|| .||.|+||.+... +..++||.+..... . .......++. .++..
T Consensus 26 ~~~~~~~~~~~~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~-~ll~~ 96 (239)
T PRK01723 26 LFDPDFWQQQARVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEF-RLLAQ 96 (239)
T ss_pred hcCHHHHhhcCceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHH-HHHHH
Confidence 4555554433 4577 8899999998753 23799998854211 0 0001111122 24445
Q ss_pred cCCCCc--eeeEEEEEEC-C---EEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Q 006887 103 QGVEGI--CWLQGISVIN-G---KICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLK 174 (627)
Q Consensus 103 ~~hpnI--v~l~~~~~~~-~---~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLK 174 (627)
+.|++| +..+++.... . ..+||||+++| +|.+.+. ..+++... +.||+.+|.+||+.||+|||||
T Consensus 97 L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~---~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlk 169 (239)
T PRK01723 97 LYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQ---EAPLSEEQ----WQAIGQLIARFHDAGVYHADLN 169 (239)
T ss_pred HHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHh---cCCCCHHH----HHHHHHHHHHHHHCCCCCCCCC
Confidence 566664 6666654332 2 23699999996 5555543 34555543 5689999999999999999999
Q ss_pred CCcEEEecCCCeeeccCCcccc
Q 006887 175 PFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 175 P~NILld~~g~vkL~DFGla~~ 196 (627)
|+|||++.++.++|+|||.+..
T Consensus 170 p~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 170 AHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred chhEEEcCCCCEEEEECCCccc
Confidence 9999999999999999997754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.8e-13 Score=145.35 Aligned_cols=255 Identities=17% Similarity=0.109 Sum_probs=182.7
Q ss_pred CCeEEEeEEee--eCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHH-HHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGR--GPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE-RLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~--G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~-~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..+.+.+.+|. |.+|.||.+.... ......+|+|.-+............ +...-..+...|++.++.+..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 45778899999 9999999998632 1234589999854322111111111 111112344568899998899999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecccCCCcEEEecC-CCeeeccCC
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQ----GILQLHSKGILVLNLKPFNFILNEA-DRAVLGDVG 192 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~----aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DFG 192 (627)
.+..|+-+|++..++...... ....++...+..++.+... ||..+|+.+++|-|+||+||++..+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeeccccchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999999777666543 4455788888999999999 9999999999999999999999988 789999999
Q ss_pred ccccccCCCCCCCCC--CccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 193 IPHLLLGIPLPSSDL--PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 193 la~~~~~~~~~~~~~--~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
+...+.......... ....|..-|++||..++ -++..+|+|++|.++.+-.++..+....-... +..+.....
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~----l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~i 343 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG----LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYI 343 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc----ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccC
Confidence 988876544222211 12357788999999864 58899999999999999888766544321000 001111112
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
...+....+.++...+.+++..+|..|++.+.+..
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 23345566788888999999999999999887765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.1e-11 Score=136.83 Aligned_cols=141 Identities=20% Similarity=0.168 Sum_probs=90.1
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH--------------------------------
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-------------------------------- 94 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-------------------------------- 94 (627)
+.||+|++|.||+|+.+. |+.||||+.++.........+..
T Consensus 123 ~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred cceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 469999999999998653 34899999987543222111100
Q ss_pred -------HH---HHHHHhc-CCCCceeeEEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHH
Q 006887 95 -------LN---DLFLKCQ-GVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQ-GIL 161 (627)
Q Consensus 95 -------~~---~~ll~~~-~hpnIv~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~-aL~ 161 (627)
+. ..+.... +++++.-..-+.......+|||||++| ++.+.... ....+ ....++.+++. .+.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGL---DRKALAENLARSFLN 271 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCC---CHHHHHHHHHHHHHH
Confidence 00 0011112 334433222222234457999999997 44443322 21122 23445566655 478
Q ss_pred HHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 162 yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
.+|..|++|+|+||.||+++.++.++|+|||++..+.
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-11 Score=135.99 Aligned_cols=143 Identities=17% Similarity=0.224 Sum_probs=87.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH------------------------------
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV------------------------------ 90 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~------------------------------ 90 (627)
++|+. +.||+|++|.||+|+.+.++ +.||||++++.-......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G------~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNG------REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCC------CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 34565 68999999999999987644 489999998753221110
Q ss_pred HHH---------HHHH---HHHHhcCCCCceeeEEEE-EECCEEEEEEecCCC-CHHHHHHHhcCC-----CCCHHHHHH
Q 006887 91 LLE---------RLND---LFLKCQGVEGICWLQGIS-VINGKICIIMKFYEG-SVGDRMAQLKGG-----KLSLSNVFR 151 (627)
Q Consensus 91 ~~~---------~~~~---~ll~~~~hpnIv~l~~~~-~~~~~~~LVmEy~~G-sL~d~l~~~~~~-----~ls~~~~~~ 151 (627)
+.. ++.. .+.....+...+.+-.++ ......+|||||+.| .+.+ +...... .+....+..
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d-~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSD-VAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHh-HHHHHhcCCCHHHHHHHHHHH
Confidence 000 0000 011122232222222222 224567899999998 4433 2222222 233333334
Q ss_pred HHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----CeeeccCCcccccc
Q 006887 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLGDVGIPHLLL 198 (627)
Q Consensus 152 i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~DFGla~~~~ 198 (627)
++.| +...|++|+|+||.||+++.++ .++++|||++..+.
T Consensus 272 ~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4444 4469999999999999999888 99999999988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-10 Score=110.05 Aligned_cols=128 Identities=18% Similarity=0.015 Sum_probs=83.9
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVm 125 (627)
++.|+.|.++.||+++.. +..|++|+..+....... ...+...+........+++++... ....++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~~~~~--~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTELLIN--RENEAENSKLAAEAGIGPKLYYFD--PETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--------CeEEEEEeCCCCcccccC--HHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEE
Confidence 467899999999999853 237999998654321111 111111221111122244555543 33458999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecccCCCcEEEecCCCeeeccCCccc
Q 006887 126 KFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGI-----LVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 126 Ey~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gI-----vHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
||++|...... . .....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 71 e~i~G~~l~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99998432211 0 1123456799999999999985 9999999999999 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.3e-10 Score=110.74 Aligned_cols=145 Identities=15% Similarity=0.091 Sum_probs=92.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch------------------------hHHHHHH-HHHHHHHHH
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------------------------DRMRVLL-ERLNDLFLK 101 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~------------------------~~~~~~~-~~~~~~ll~ 101 (627)
..||.|--+.||.|...........+..+|||+.+.... ....... +++...+.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543100011235899999853110 0011111 122222222
Q ss_pred hcCC-CCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCcEE
Q 006887 102 CQGV-EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL-HSKGILVLNLKPFNFI 179 (627)
Q Consensus 102 ~~~h-pnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~gIvHrDLKP~NIL 179 (627)
+... -+++.++++ ...+|||||++|+..-. ...+...++...+..+..+++.+|..| |..||+|+||++.|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~-~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPA-PKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccc-hhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 2221 345666654 45789999998742111 111333456667778889999999998 8999999999999999
Q ss_pred EecCCCeeeccCCccccc
Q 006887 180 LNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~ 197 (627)
++ ++.+.|+|||.+...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 97 578999999977543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=119.25 Aligned_cols=193 Identities=16% Similarity=0.135 Sum_probs=132.9
Q ss_pred hcCCCCceeeEEEEEECC-----EEEEEEecCC-CCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CCeec
Q 006887 102 CQGVEGICWLQGISVING-----KICIIMKFYE-GSVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSK--GILVL 171 (627)
Q Consensus 102 ~~~hpnIv~l~~~~~~~~-----~~~LVmEy~~-GsL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~--gIvHr 171 (627)
.+.|.||++++.++.+.. +..+++||+. |++-..+.+.+ ...++.....+|+.||+.||.|||+. .|+|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 356889999999887643 4789999998 78777776543 36688889999999999999999987 49999
Q ss_pred ccCCCcEEEecCCCeeeccCCccccccCCC-CCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCC
Q 006887 172 NLKPFNFILNEADRAVLGDVGIPHLLLGIP-LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGV 250 (627)
Q Consensus 172 DLKP~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~ 250 (627)
++..+.|++..+|-+|+.----........ ..........+-++|.+||.-. ....+.++|||+||.+.+||..+.
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~---~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT---TTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc---ccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999888875322110000000 0000111234678999999854 224567899999999999998875
Q ss_pred CC-CCCCC---HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 251 QP-RCGRS---VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 251 ~P-f~~~~---~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.- -.+.+ .++....+.... -...-+.++.+|++..|..||+|++++.
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL--------ENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhhhhhheeec--------cCccccCcCcccccCCCCCCcchhhhhc
Confidence 43 22222 122222221111 1122357889999999999999998875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.2e-09 Score=118.31 Aligned_cols=161 Identities=18% Similarity=0.240 Sum_probs=114.8
Q ss_pred cEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHH
Q 006887 73 HEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRY 152 (627)
Q Consensus 73 ~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i 152 (627)
.+|.|...+.... .......+ ..-.++.++||||++++..++.++..|||+|-+.- +...+.. ++.......
T Consensus 38 ~~vsVF~~~~~~~-~~~~~~~~-A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~-----l~~~~v~~G 109 (690)
T KOG1243|consen 38 GPVSVFVYKRSNG-EVTELAKR-AVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE-----LGKEEVCLG 109 (690)
T ss_pred CceEEEEEeCCCc-hhhHHHHH-HHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH-----hHHHHHHHH
Confidence 3678887766554 11111111 11256778999999999999999999999999984 2233332 235677778
Q ss_pred HHHHHHHHHHHH-HCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCC
Q 006887 153 AIDLAQGILQLH-SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPIS 231 (627)
Q Consensus 153 ~~qIa~aL~yLH-s~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s 231 (627)
+.||+.||.||| +.+++|++|.-+.++++..|..||++|-++....+.+... ....---.|..|+.+. +-.
T Consensus 110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~---~~~~~~~s~~~P~~~~-----~s~ 181 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA---KSLYLIESFDDPEEID-----PSE 181 (690)
T ss_pred HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc---ccchhhhcccChhhcC-----ccc
Confidence 899999999998 5689999999999999999999999999876554322111 1111112356676654 112
Q ss_pred ccCcchhHHHHHHHHHhC
Q 006887 232 FETDSWGFACSIIEMLTG 249 (627)
Q Consensus 232 ~~sDiwSlGviLyelltG 249 (627)
-..|.|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 356999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-10 Score=127.93 Aligned_cols=246 Identities=17% Similarity=0.089 Sum_probs=170.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHH-HHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE-RLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~-~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..+|.++..||.|.|+.|+.......+ +-.|++|.+.+........... .+..+...+..|.+++.+...+...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~-----~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEG-----DCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCC-----CceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 357889999999999999998733222 2479999886543322221111 1111233455788888888888888
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccCCccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDVGIPHLL 197 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DFGla~~~ 197 (627)
...||-.|||.|....+.. .....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+..+
T Consensus 339 r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 8888999999864444433 233467888899999999999999999999999999999999886 77789999988643
Q ss_pred cCCCCCCCCCCccCCCCCcC-CcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYM-APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~Ym-APE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P-f~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.- .......+-+++ ..|.+.. ..++..+.|++|||..+++.+++... +.+.... .+. ...-+..
T Consensus 418 ~~------~~~~~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----~i~--~~~~p~~ 483 (524)
T KOG0601|consen 418 AF------SSGVFHHIDRLYPIAEILLE--DYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----TIR--SGDTPNL 483 (524)
T ss_pred ce------ecccccccccccccchhhcc--ccccccccccccccccccccccCcccCcccccce----eee--cccccCC
Confidence 21 111223344455 2555543 34678899999999999999998643 2221111 111 1112233
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.....++..+.+.++..++..||.+.++..
T Consensus 484 ~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 484 PGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred CchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 444588999999999999999999887755
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.7e-09 Score=98.58 Aligned_cols=143 Identities=19% Similarity=0.159 Sum_probs=96.3
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC--chhHHHH-----HHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV--KEDRMRV-----LLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~--~~~~~~~-----~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.+..|-+|+-+.|+++.+. |+.+.||.=.+. ....... ....+..++.++ .--+|+-..-++.+
T Consensus 11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEe
Confidence 5677889999999999753 345677753221 1111111 111222233333 33366655666777
Q ss_pred CCEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---CeeeccCC
Q 006887 118 NGKICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAVLGDVG 192 (627)
Q Consensus 118 ~~~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vkL~DFG 192 (627)
...-+|+|||++| ++.+.+...........-....+.+|-+.+.-||.++|||+||..+||+|..++ .+.++|||
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeec
Confidence 7788999999999 666666554444444444467888999999999999999999999999997655 34799999
Q ss_pred cccc
Q 006887 193 IPHL 196 (627)
Q Consensus 193 la~~ 196 (627)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 8743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-08 Score=105.40 Aligned_cols=248 Identities=20% Similarity=0.246 Sum_probs=158.1
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCc----eeeEEEE---EEC
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI----CWLQGIS---VIN 118 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnI----v~l~~~~---~~~ 118 (627)
...||+|+-+.+|-.-.. .-.+-|+.+...........+ .+.+.-.||-+ ++..... ...
T Consensus 16 gr~LgqGgea~ly~l~e~---------~d~VAKIYh~Pppa~~aqk~a----~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV---------RDQVAKIYHAPPPAAQAQKVA----ELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CccccCCccceeeecchh---------hchhheeecCCCchHHHHHHH----HhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 466999999999965322 124668887654433222222 23333444432 2211111 112
Q ss_pred CEEEEEEecCCCC--HHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 GKICIIMKFYEGS--VGDRMAQ----LKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~~~~LVmEy~~Gs--L~d~l~~----~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
....+.|..++|- +.+.+.- .....+.+.-+++.++.|+.+...||..|.+-+|+.++|+|+++++.+.|.|=.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 3378889999872 2222211 112456789999999999999999999999999999999999999999998744
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCccccc-C-CCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCC-------HHH--
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ-P-EVRGPISFETDSWGFACSIIEMLTG-VQPRCGRS-------VDE-- 260 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~-~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~-------~~e-- 260 (627)
.-..- .+.......+|.+.|.+||... + ...-.-+...|.|.||++++++|.| +.||.+.. +.|
T Consensus 163 sfqi~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 163 SFQIN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred ceeec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 22111 1234445678999999999865 1 1112345678999999999998885 99998632 112
Q ss_pred HH------HHHHhccCC---CCCC-CCCCHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHhc
Q 006887 261 IY------DAVVRRQEI---PPIP-SGLPPAVENVLLGCFEYD--LRSRPLMTDILRVFKSS 310 (627)
Q Consensus 261 ~~------~~i~~~~~~---~~~p-~~~s~~l~~li~~cL~~d--P~~RPs~~eil~~L~~~ 310 (627)
+. ......... ..+| .-++++++.+..+|+... +.-||+++..+..|...
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 10 011000000 1122 357899999999999653 56899998776665543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.6e-08 Score=107.06 Aligned_cols=212 Identities=15% Similarity=0.180 Sum_probs=151.5
Q ss_pred CeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE----CCEEEEEEecCC
Q 006887 54 FGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI----NGKICIIMKFYE 129 (627)
Q Consensus 54 fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~----~~~~~LVmEy~~ 129 (627)
-.+.|++....++. .|++|+++-........ .....+ ..+.+.|.|+|.+.+++.. +..+++|++|++
T Consensus 289 ~~Ttyk~~s~~DG~------~YvLkRlhg~r~~~~nk-~t~lve-~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSNVDGN------AYVLKRLHGDRDQSTNK-DTSLVE-AWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeeccCCc------eeeeeeeccccccCccc-chHHHH-HHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 35789998776654 79999995433322211 111111 3456789999999998873 456999999999
Q ss_pred --CCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 130 --GSVGDRMAQLK-------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 130 --GsL~d~l~~~~-------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
++|+++..... +...++..++.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+-.|+.
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 47888764321 234678999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhccCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVDEI-YDAVVRRQEIP 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P-f~~~~~~e~-~~~i~~~~~~~ 272 (627)
..+..+. + |-+. --.+-|.=.||.+++-|.||..- +......+. ...
T Consensus 441 Dvl~~d~----------~-------~~le------~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------- 489 (655)
T KOG3741|consen 441 DVLQEDP----------T-------EPLE------SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------- 489 (655)
T ss_pred eeecCCC----------C-------cchh------HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------
Confidence 6654321 0 1121 11256888999999999999543 222223332 222
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRV 306 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~ 306 (627)
+...++.++++++..+...++++ -+..+++.+
T Consensus 490 -I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 -ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 24457889999999999988887 566676653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2e-08 Score=96.77 Aligned_cols=131 Identities=19% Similarity=0.189 Sum_probs=86.8
Q ss_pred EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecC--CchhHHHHHHH----HHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--VKEDRMRVLLE----RLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 48 ~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~--~~~~~~~~~~~----~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.+++|+-+.+|++.+.. ..+++|.=.+ .........+. ..+..++....--+|+...-+..+.+..
T Consensus 3 ~i~~GAEa~i~~~~~~g--------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~ 74 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG--------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG 74 (204)
T ss_pred hhhCCcceeEEeeeccC--------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence 57889999999996532 2466665322 12222222222 1122233333344565555566667788
Q ss_pred EEEEecCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 122 CIIMKFYEGSVGD-RMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 122 ~LVmEy~~GsL~d-~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.|+|||++|.++. .+.. . ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 75 ~I~me~I~G~~lkd~l~~-~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE-A--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh-c--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999996654 3332 1 245566777778889999999999999999998665 99999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-07 Score=98.20 Aligned_cols=78 Identities=15% Similarity=0.056 Sum_probs=64.0
Q ss_pred CEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-------CCCeeec
Q 006887 119 GKICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-------ADRAVLG 189 (627)
Q Consensus 119 ~~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-------~g~vkL~ 189 (627)
...+||||+++| ++.+.+......+.+......++.+++..+..||..||+|+||+++|||++. +..+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 357899999998 5666664322345667778899999999999999999999999999999985 4678999
Q ss_pred cCCcccc
Q 006887 190 DVGIPHL 196 (627)
Q Consensus 190 DFGla~~ 196 (627)
||+.++.
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9997753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-08 Score=98.01 Aligned_cols=139 Identities=15% Similarity=0.063 Sum_probs=89.9
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcC--CCCceeeEEEEEEC---CEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQG--VEGICWLQGISVIN---GKI 121 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~--hpnIv~l~~~~~~~---~~~ 121 (627)
+.|+.|..+.||+++... +..+++|+...............+... +..+. +..+++++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~-~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRV-LRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHH-HHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 568999999999998643 236999998654321011112222222 22222 23456667666543 367
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS------------------------------------ 165 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs------------------------------------ 165 (627)
++||||++|..+.... ....+++.....++.+++.+|.+||+
T Consensus 76 ~~v~e~i~G~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 76 FYVMERVDGRVLRDRL--LRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred eEEEEEeCCEecCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 8999999984322211 11346667777777777777777773
Q ss_pred --------------------CCCeecccCCCcEEEec--CCCeeeccCCccc
Q 006887 166 --------------------KGILVLNLKPFNFILNE--ADRAVLGDVGIPH 195 (627)
Q Consensus 166 --------------------~gIvHrDLKP~NILld~--~g~vkL~DFGla~ 195 (627)
..++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5668899999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-07 Score=91.62 Aligned_cols=90 Identities=19% Similarity=0.249 Sum_probs=57.4
Q ss_pred HHhcCCC--CceeeEEEEEECCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecccC
Q 006887 100 LKCQGVE--GICWLQGISVINGKICIIMKFYE--GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ-LHSKGILVLNLK 174 (627)
Q Consensus 100 l~~~~hp--nIv~l~~~~~~~~~~~LVmEy~~--GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~y-LHs~gIvHrDLK 174 (627)
+..+..- +++.++++. ..+|||||++ |..+..+... .++.+....++.+++..+.. +|..||+|+||.
T Consensus 62 L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs 134 (188)
T PF01163_consen 62 LKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLS 134 (188)
T ss_dssp HHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-S
T ss_pred HHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence 3444443 466666543 3479999999 7555444331 12244566777888885555 689999999999
Q ss_pred CCcEEEecCCCeeeccCCccccc
Q 006887 175 PFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 175 P~NILld~~g~vkL~DFGla~~~ 197 (627)
+.|||++++ .+.++|||.+...
T Consensus 135 ~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 135 EYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp TTSEEEETT-CEEE--GTTEEET
T ss_pred hhhEEeecc-eEEEEecCcceec
Confidence 999999987 9999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.1e-08 Score=111.01 Aligned_cols=149 Identities=17% Similarity=0.163 Sum_probs=107.9
Q ss_pred HHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCccccccCCC-CCCCCC-----CccCCCCCcCCcccccCCC
Q 006887 154 IDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP-LPSSDL-----PRRLGTPNYMAPEQWQPEV 226 (627)
Q Consensus 154 ~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~-----~~~~GT~~YmAPE~~~~~~ 226 (627)
.+++.||.|+|.. ++||+.|.|++|.++.++..||+.|+.+....+.. .+.... ....-...|.|||++...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~- 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT- 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence 3455999999965 79999999999999999999999999886654411 111111 112345689999999853
Q ss_pred CCCCCccCcchhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 006887 227 RGPISFETDSWGFACSIIEML-TGVQPRCGRSVDEIYDAVVR--RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303 (627)
Q Consensus 227 ~~~~s~~sDiwSlGviLyell-tG~~Pf~~~~~~e~~~~i~~--~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~ei 303 (627)
..+.++|+||+||++|.+. .|+.-+.+......+..... ......+...+|+++++=+.+++..+..-||++..+
T Consensus 185 --~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 185 --TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred --cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 4678999999999999988 56655555433333322221 112233557899999999999999999999988777
Q ss_pred HH
Q 006887 304 LR 305 (627)
Q Consensus 304 l~ 305 (627)
+.
T Consensus 263 ~~ 264 (700)
T KOG2137|consen 263 LS 264 (700)
T ss_pred hc
Confidence 65
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=85.56 Aligned_cols=87 Identities=23% Similarity=0.209 Sum_probs=68.3
Q ss_pred ceeeEEEEEEC----CEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 108 ICWLQGISVIN----GKICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 108 Iv~l~~~~~~~----~~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
.+..+++.... ...+||||+++| +|.+.+.... ..+......++.+++..+.-||+.||+|+|+++.|||++
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~ 152 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVD 152 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEe
Confidence 44455555442 246899999997 4555554322 256777889999999999999999999999999999999
Q ss_pred cCC---CeeeccCCcccc
Q 006887 182 EAD---RAVLGDVGIPHL 196 (627)
Q Consensus 182 ~~g---~vkL~DFGla~~ 196 (627)
.++ .+.|+||+.++.
T Consensus 153 ~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 153 PDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCCceeEEEEcchhcee
Confidence 887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=1e-05 Score=80.43 Aligned_cols=139 Identities=13% Similarity=-0.009 Sum_probs=91.7
Q ss_pred EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc------hhHHHHHHHHHHHH-HHHhcCCCCceeeEEEEEE----
Q 006887 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK------EDRMRVLLERLNDL-FLKCQGVEGICWLQGISVI---- 117 (627)
Q Consensus 49 LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~------~~~~~~~~~~~~~~-ll~~~~hpnIv~l~~~~~~---- 117 (627)
-|+||.+.|++..... ..+-+|.-...- ......+..+...+ .+...+-| ++.+......
T Consensus 26 ~~rgG~SgV~r~~~~g--------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~ 96 (216)
T PRK09902 26 YRRNGMSGVQCVERNG--------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEG 96 (216)
T ss_pred cCCCCcceEEEEEeCC--------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCC
Confidence 4678888899876421 257788764110 11222333333322 23333444 4444422222
Q ss_pred CCEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC--eeeccCCc
Q 006887 118 NGKICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR--AVLGDVGI 193 (627)
Q Consensus 118 ~~~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~--vkL~DFGl 193 (627)
....+||+|-++| +|.+.+....-.+.+......++.+++..|.-||+.|+.|+|+-+.|||++.++. +.++||.-
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 2347899999985 6666654322345577777899999999999999999999999999999987777 89999996
Q ss_pred ccc
Q 006887 194 PHL 196 (627)
Q Consensus 194 a~~ 196 (627)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.7e-06 Score=85.73 Aligned_cols=136 Identities=19% Similarity=0.152 Sum_probs=88.7
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--------------------hHHHHHHHHHHHHHHHh
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--------------------DRMRVLLERLNDLFLKC 102 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--------------------~~~~~~~~~~~~~ll~~ 102 (627)
+.+...||-|--+.||.|.+.. +.++|||.=+-... ........+.+..++.+
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~ 165 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR 165 (304)
T ss_pred HhhccccccCccceEEEEECCC-------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence 3567889999999999998643 34799997432100 01111111111123333
Q ss_pred cCCC--CceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 103 QGVE--GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 103 ~~hp--nIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
+... .++..++ .++-++||||++|-.+..+ ++..+.+-.++..|+.-+.-+-..||||+|+.+-||++
T Consensus 166 L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV 235 (304)
T COG0478 166 LYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV 235 (304)
T ss_pred hhhcCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE
Confidence 3333 4555544 3578999999999333222 22344555566666666666668999999999999999
Q ss_pred ecCCCeeeccCCccc
Q 006887 181 NEADRAVLGDVGIPH 195 (627)
Q Consensus 181 d~~g~vkL~DFGla~ 195 (627)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999998554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.8e-06 Score=92.17 Aligned_cols=143 Identities=21% Similarity=0.221 Sum_probs=88.3
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHH------------------------------H
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL------------------------------N 96 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~------------------------------~ 96 (627)
+-|+.++-|.||+|+.+. |+.||||+.++.-......-+..+ .
T Consensus 131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 458999999999999765 348999999874332221111100 0
Q ss_pred ------------HHHHH-hcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 006887 97 ------------DLFLK-CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163 (627)
Q Consensus 97 ------------~~ll~-~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yL 163 (627)
+.+.. ..+.+++.-..=+.+..+.-.|+|||++|--.+.+..++...++...+...+.++. +..+
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~ 281 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQL 281 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHH
Confidence 00111 11334433333333445678999999999333333323334455444333332222 3344
Q ss_pred HHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 164 Hs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
=..|++|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 45899999999999999999999999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.1e-05 Score=75.85 Aligned_cols=139 Identities=15% Similarity=0.113 Sum_probs=86.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH-----HHHHH-----HHhcCCCCc
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-----LNDLF-----LKCQGVEGI 108 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-----~~~~l-----l~~~~hpnI 108 (627)
-..+|++.+.+-......|.+..-. +..+.+|...+......+.+... ..+++ ....+--..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 3468999999988888888887632 23699998876443332222211 01111 111122223
Q ss_pred eeeEEEEEE-----CCEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 109 CWLQGISVI-----NGKICIIMKFYEGS-VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 109 v~l~~~~~~-----~~~~~LVmEy~~Gs-L~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
..++.+... ....+|+|||++|- +.+.. .+++ .+...+.+++..||+.|+.|+|..|.|++++.
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN 170 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC
Confidence 332222221 23467999999992 22221 1222 24567788899999999999999999999985
Q ss_pred CCCeeeccCCcccc
Q 006887 183 ADRAVLGDVGIPHL 196 (627)
Q Consensus 183 ~g~vkL~DFGla~~ 196 (627)
+ .++++||+..+.
T Consensus 171 ~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 171 N-GIRIIDTQGKRM 183 (229)
T ss_pred C-cEEEEECccccc
Confidence 5 599999986553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.3e-05 Score=74.04 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=71.6
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH--HHhcCCCCceeeEEEE---EECCE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF--LKCQGVEGICWLQGIS---VINGK 120 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l--l~~~~hpnIv~l~~~~---~~~~~ 120 (627)
++.|+.|..+.||++.... + .+++|..... ........+...+ +..... .+++++... .....
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-------~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~-pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-------RYVLKFYRPP---DAAERLRREAAVLRQLAEHGI-PVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-------EEEEEEESSH---HHHHHHHHHHHHHHHHHHTTS-BS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC-c-------EEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCC-CCceEEeeccccccccc
Confidence 4679999999999998654 2 6999997655 1111222222222 221211 355666543 33456
Q ss_pred EEEEEecCCCCHHHH-----------------HHHhcC-----CCCCHHH---------HHHH------------HHHHH
Q 006887 121 ICIIMKFYEGSVGDR-----------------MAQLKG-----GKLSLSN---------VFRY------------AIDLA 157 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~-----------------l~~~~~-----~~ls~~~---------~~~i------------~~qIa 157 (627)
.+++|++++|..... +..... ..+.... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 899999999853333 111100 1111100 0000 11122
Q ss_pred H-HHHHHHH-------CCCeecccCCCcEEEe-cCCCeeeccCCccc
Q 006887 158 Q-GILQLHS-------KGILVLNLKPFNFILN-EADRAVLGDVGIPH 195 (627)
Q Consensus 158 ~-aL~yLHs-------~gIvHrDLKP~NILld-~~g~vkL~DFGla~ 195 (627)
. .+..+++ ..++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 2333332 3599999999999999 66666799999654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.7e-05 Score=77.78 Aligned_cols=138 Identities=18% Similarity=0.156 Sum_probs=88.5
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH----------------------H-HHHHHHHHH-HH
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR----------------------V-LLERLNDLF-LK 101 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~----------------------~-~~~~~~~~l-l~ 101 (627)
...|..|--+.||+|... .+..+|+|+.......... . ..+.+...+ ..
T Consensus 53 ~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~ 125 (268)
T COG1718 53 VGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRA 125 (268)
T ss_pred EeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 346777888899999742 2357999998643211110 0 001111111 11
Q ss_pred hcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEE
Q 006887 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFIL 180 (627)
Q Consensus 102 ~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILl 180 (627)
...+-.++..+.+. ...|||||++.. +...-.++.-.+...++..+..++++.+.-|-. .++||+||+.-|||+
T Consensus 126 ~eAGVrvP~Pi~~~----~nVLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 126 YEAGVRVPEPIAFR----NNVLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred HHcCCCCCCceeec----CCeEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 11222344444443 358999999854 222222344445555788888999999888877 899999999999999
Q ss_pred ecCCCeeeccCCcccc
Q 006887 181 NEADRAVLGDVGIPHL 196 (627)
Q Consensus 181 d~~g~vkL~DFGla~~ 196 (627)
. ++.+.++|||-|..
T Consensus 201 ~-~~~p~iID~~QaV~ 215 (268)
T COG1718 201 H-DGEPYIIDVSQAVT 215 (268)
T ss_pred E-CCeEEEEECccccc
Confidence 9 88999999997654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=8.4e-05 Score=75.10 Aligned_cols=135 Identities=15% Similarity=0.094 Sum_probs=74.2
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCC-CCceeeEEEEEECCEEEEEE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV-EGICWLQGISVINGKICIIM 125 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~h-pnIv~l~~~~~~~~~~~LVm 125 (627)
..||+|..+.||+.. + ..+++|..++...... ..++.+.+...... -.+++.+++....+...+||
T Consensus 7 ~~i~~G~t~~~y~~~----~------~~~VlR~~~~~~~~~~---i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----T------GKWMLKLYNPGFDKET---IKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEec----C------CCEEEEeCCCCCCHHH---HHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence 568999999999841 1 2478898876432111 12222222221122 12566777777788889999
Q ss_pred ecCCCCH-H---------------HHHHH----hcC---CCCCHHHH-HHHHHH----------HHH-HHHHHHH----C
Q 006887 126 KFYEGSV-G---------------DRMAQ----LKG---GKLSLSNV-FRYAID----------LAQ-GILQLHS----K 166 (627)
Q Consensus 126 Ey~~GsL-~---------------d~l~~----~~~---~~ls~~~~-~~i~~q----------Ia~-aL~yLHs----~ 166 (627)
|+++|.. . ..+.. ... ...+.... ..+..+ +.. ...+|.+ .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 9999941 1 11111 111 11111110 111100 111 1222221 2
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.6e-05 Score=90.27 Aligned_cols=190 Identities=13% Similarity=0.071 Sum_probs=123.8
Q ss_pred HHHHhcCCCCceeeEEEEEECCEEE----EEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 006887 98 LFLKCQGVEGICWLQGISVINGKIC----IIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLN 172 (627)
Q Consensus 98 ~ll~~~~hpnIv~l~~~~~~~~~~~----LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrD 172 (627)
..+....|+|++.++.+.......- +..+++.+ ++...+. .-+.++..+.+.+..++..||.|+|+....|.=
T Consensus 234 ~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~ 311 (1351)
T KOG1035|consen 234 ESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSLSLEHVV 311 (1351)
T ss_pred HHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHhccceeE
Confidence 3566788999999988876543322 33456654 4444443 236788999999999999999999999666555
Q ss_pred cCCC---cEEEecCCCeeec--cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHH
Q 006887 173 LKPF---NFILNEADRAVLG--DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML 247 (627)
Q Consensus 173 LKP~---NILld~~g~vkL~--DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyell 247 (627)
|..+ +-..+..+.+.++ ||+..+.+..... .....-+..+.++|..... ..+.+...|+|.+|..+..+.
T Consensus 312 L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 312 LSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred EecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccc-cchhhhhhHHHHHHHHHhhhh
Confidence 5444 3344455566655 8887776543221 1122334557778876532 223445579999999999998
Q ss_pred hCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 248 TGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 248 tG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.|..+-... .....+ .+........+.+.+|+..++++|+++.+++.
T Consensus 387 ~~~~i~~~~---~~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 387 QGEDISEKS---AVPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hcCcccccc---cchhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 876542110 011111 12222237889999999999999999999988
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=82.46 Aligned_cols=141 Identities=17% Similarity=0.177 Sum_probs=88.3
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHH--------------------------------
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER-------------------------------- 94 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~-------------------------------- 94 (627)
+.||.-+.|.||+|+.+. + ..||||+-++.-.......+..
T Consensus 167 ~piaaASlaQVhrA~L~~-G------~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL 239 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-G------EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL 239 (538)
T ss_pred chhhhcchhheEEEEecC-C------CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence 459999999999999766 3 4799999987433221110000
Q ss_pred -------HHHHHHHhcCCCC------ceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 006887 95 -------LNDLFLKCQGVEG------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161 (627)
Q Consensus 95 -------~~~~ll~~~~hpn------Iv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~ 161 (627)
..+.+.....|-+ |++++-.+ .....|+||||+|--.+-+.......++...+...+.+... .
T Consensus 240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~ 315 (538)
T KOG1235|consen 240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--E 315 (538)
T ss_pred chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--H
Confidence 0011233333433 44444333 34679999999982222222234455777766555544332 3
Q ss_pred HHHHCCCeecccCCCcEEEec----CCCeeeccCCcccccc
Q 006887 162 QLHSKGILVLNLKPFNFILNE----ADRAVLGDVGIPHLLL 198 (627)
Q Consensus 162 yLHs~gIvHrDLKP~NILld~----~g~vkL~DFGla~~~~ 198 (627)
.|=..|++|.|=.|.||+++. ++.+.+.|||+...+.
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 344578999999999999984 5689999999887654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=72.44 Aligned_cols=29 Identities=14% Similarity=-0.036 Sum_probs=25.6
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999987778899999654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=7.9e-06 Score=91.18 Aligned_cols=186 Identities=19% Similarity=0.141 Sum_probs=131.5
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCC-ceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG-ICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpn-Iv~l~~~~~~~~~~ 121 (627)
|...+.+++|+++.+++.+...+.. ...+.+... +..+....++...+||| .++.++-++.+...
T Consensus 244 s~~fh~fvK~altknpKkRptaekl-------L~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKL-------LQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhh-------eeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 5566778999999999998655542 335554322 22233334677789999 77777777778899
Q ss_pred EEEEecCCCC--HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 122 CIIMKFYEGS--VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 122 ~LVmEy~~Gs--L~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+++|+++.+. ..+.+.. ..-.+..-+...+.+.-+.+|+|||+..=+||| ||+..+ +..+++||+....+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred chhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 9999999853 2222211 111122333444556677889999998888998 877765 6889999998876654
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~ 255 (627)
. ....+..+|+.++|||+.. .+.+....|.|++++-..+|.-|-+|-..
T Consensus 384 ~----~~~~t~~~~~~~~~pev~~---~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 384 T----MKPRTAIGTPEPLAPEVIQ---ENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c----cccccCCCCCCCCCchhhc---ccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 2 2345778999999999887 34688899999999988888888877543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00048 Score=82.43 Aligned_cols=82 Identities=15% Similarity=0.116 Sum_probs=49.2
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCC--ceeeEEEEEEC---CE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG--ICWLQGISVIN---GK 120 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpn--Iv~l~~~~~~~---~~ 120 (627)
++.|+.|.+..+|+......+ ....+++|+..+...........++.+.+.....|.+ +++++.++.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~----~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG----SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC----cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 577899999999998754321 1135788876543321112223333333333323454 47777777653 46
Q ss_pred EEEEEecCCCC
Q 006887 121 ICIIMKFYEGS 131 (627)
Q Consensus 121 ~~LVmEy~~Gs 131 (627)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 89999999985
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0013 Score=65.06 Aligned_cols=128 Identities=20% Similarity=0.278 Sum_probs=85.0
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc-------------------hhHHHHHHHHHHHHH-HHhcCCC
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-------------------EDRMRVLLERLNDLF-LKCQGVE 106 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~-------------------~~~~~~~~~~~~~~l-l~~~~hp 106 (627)
..||+|+.=.||.--+ + ....||++.+.. ......+......+. .....+.
T Consensus 7 ~~i~~G~~R~cy~HP~--d-------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~ 77 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD--D-------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS 77 (199)
T ss_pred cccccCCCceEEECCC--C-------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence 5689999998986321 1 247999998766 222223333333232 3344577
Q ss_pred CceeeEEEEEECCEEEEEEecCC---CC----HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 107 GICWLQGISVINGKICIIMKFYE---GS----VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 107 nIv~l~~~~~~~~~~~LVmEy~~---Gs----L~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
+|.+++|..+++.-..+|+|.+. |+ |.+.+ ..+.++. . +...+-+-..||-+++|+.+||+|+||+
T Consensus 78 ~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l---~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 78 HIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYL---KEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIV 150 (199)
T ss_pred ccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHH---HcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEE
Confidence 89999999999999999999985 43 33333 3344555 3 3333444566888999999999999999
Q ss_pred EecCC----Ceeecc
Q 006887 180 LNEAD----RAVLGD 190 (627)
Q Consensus 180 ld~~g----~vkL~D 190 (627)
+..+. .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 96432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0045 Score=61.34 Aligned_cols=126 Identities=20% Similarity=0.227 Sum_probs=83.9
Q ss_pred CCeEEEeEEeeeCC-eEEEEEEEcCCCcCcccccEEEEEEecC---Cch-------h--H---------HHHHHHHHHHH
Q 006887 41 SALKLRHRIGRGPF-GEVWLATHYLSTEDCDEYHEVAVKILHP---VKE-------D--R---------MRVLLERLNDL 98 (627)
Q Consensus 41 ~~y~i~~~LG~G~f-G~Vy~a~~~~s~ed~~~~~~VAVK~l~~---~~~-------~--~---------~~~~~~~~~~~ 98 (627)
.+++.++.||.|.- |.||+++.. ++.||+|+... ... . . ..-+. .+-++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~-~ECRA 107 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN-CECRA 107 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH-HHHHh
Confidence 78999999999999 999999853 34799999321 100 0 0 00111 11222
Q ss_pred --HHHhcCCCCc--eeeEEEEEEC------------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHH
Q 006887 99 --FLKCQGVEGI--CWLQGISVIN------------------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156 (627)
Q Consensus 99 --ll~~~~hpnI--v~l~~~~~~~------------------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qI 156 (627)
.++..++.++ ++.+|+..-. ....||.||++..- .++. .-+.+|
T Consensus 108 fgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~ 173 (207)
T PF13095_consen 108 FGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQM 173 (207)
T ss_pred hHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHH
Confidence 2445566677 7888876332 12467888777522 1222 235677
Q ss_pred HHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 157 a~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.+-|..+|..||+-+|+|+.|.. .-+|+|||.+
T Consensus 174 ~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 88899999999999999999997 4589999954
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0022 Score=63.05 Aligned_cols=95 Identities=19% Similarity=0.151 Sum_probs=70.5
Q ss_pred HHHhc-CCCCceeeEEEEEECCEEEEEEecCC-CCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecc
Q 006887 99 FLKCQ-GVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHS---KGILVLN 172 (627)
Q Consensus 99 ll~~~-~hpnIv~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs---~gIvHrD 172 (627)
+++.+ ..+++++++|.|- -++|+||.+ +++....... .--.-+|..+.+++.++++.+.+|+. ..+.-.|
T Consensus 12 ll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD 87 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD 87 (188)
T ss_pred HHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence 34434 3469999999982 366889998 4443210000 11235899999999999999999997 3477789
Q ss_pred cCCCcEEEecCCCeeeccCCccccc
Q 006887 173 LKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 173 LKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++|+|+-+++++++|++|...+...
T Consensus 88 v~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 88 VSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cchHHeEEeCCCcEEEEechhcchh
Confidence 9999999999999999999866543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0088 Score=63.18 Aligned_cols=30 Identities=13% Similarity=0.131 Sum_probs=25.2
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999966555799999653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0015 Score=66.11 Aligned_cols=29 Identities=17% Similarity=0.181 Sum_probs=24.4
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
+++|+|+.|.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876556799999653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0087 Score=63.03 Aligned_cols=29 Identities=17% Similarity=0.254 Sum_probs=26.1
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.+++|+|+.+.||+++.++...|+||+.+
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccc
Confidence 57999999999999998877789999965
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0048 Score=59.68 Aligned_cols=131 Identities=18% Similarity=0.208 Sum_probs=80.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
..+..+.|++|.+|.||++.+... .+|+|+-..++.... ++.+.+++.....-..-+.++.+.. .
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~--------~~a~Kvrr~ds~r~~---l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGG--------EVALKVRRRDSPRRN---LEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCc--------eEEEEEecCCcchhh---HHHHHHHHHHhhhcCCCceEEEech----h
Confidence 345668899999999999987543 699998876544322 2222222222222223344555543 4
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC-CCcEEEecCCCeeeccCCcccc
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLK-PFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLK-P~NILld~~g~vkL~DFGla~~ 196 (627)
++.|||+.| .|.+.... . . .+-+..+++.---|-..||-|..|. |..++|-.++.+.|+||..|++
T Consensus 88 ~i~me~i~G~~L~~~~~~---~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG---G--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhc---c--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 566999999 44443321 0 1 2223445555555667899999886 5555555566999999998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.016 Score=58.28 Aligned_cols=29 Identities=21% Similarity=0.062 Sum_probs=25.8
Q ss_pred CCeecccCCCcEEEec-CCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNE-ADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~-~g~vkL~DFGla~ 195 (627)
.++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999999664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.014 Score=60.78 Aligned_cols=139 Identities=17% Similarity=0.217 Sum_probs=74.7
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE------EEEECC
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG------ISVING 119 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~------~~~~~~ 119 (627)
.+.|..|....+|+..... ..+++|+...........+..... .+...+.| +++++. +...++
T Consensus 19 i~~i~~G~~n~~y~v~~~~--------~~~vLr~~~~~~~~~~~~e~~~l~--~L~~~g~~-vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS--------GRYVLTLFEKVSAEELPFFLALLD--HLAERGLP-VPRPIADRDGEYLSELAG 87 (296)
T ss_pred eecccCccccceEEEEeCC--------CcEEEEEcCCCChHhccHHHHHHH--HHHHCCCC-CCccccCCCCcEeeeeCC
Confidence 5667778878999986321 258999886532222222222111 12222222 334332 223456
Q ss_pred EEEEEEecCCCCHHH------------HHHHh----cC--CC------CCHHHH--H--------HHHHHHHHHHHHHHH
Q 006887 120 KICIIMKFYEGSVGD------------RMAQL----KG--GK------LSLSNV--F--------RYAIDLAQGILQLHS 165 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d------------~l~~~----~~--~~------ls~~~~--~--------~i~~qIa~aL~yLHs 165 (627)
..++||+|++|...+ .+... .. .. ..+... . .....+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 789999999984321 11111 00 00 011000 0 011123344455543
Q ss_pred -------CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 -------KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 -------~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999987777899999653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.042 Score=57.87 Aligned_cols=78 Identities=9% Similarity=0.089 Sum_probs=46.3
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCC--CCceeeEEEEEE---
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV--EGICWLQGISVI--- 117 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~h--pnIv~l~~~~~~--- 117 (627)
..-.+.||.|..+.||+...... .+.+|..+...... ....+...+.....+ -.++++++++..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~--------~~~~k~~~~~~~~~---~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG--------NPMPLMARSFSTPG---VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC--------CEEEEEecccccch---HHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34457799999999999863221 36778754321211 122222222222222 357778877654
Q ss_pred CCEEEEEEecCCCC
Q 006887 118 NGKICIIMKFYEGS 131 (627)
Q Consensus 118 ~~~~~LVmEy~~Gs 131 (627)
.+..+||||+++|.
T Consensus 85 ~g~~~LVmE~i~G~ 98 (297)
T PRK10593 85 PGPDVLLLERLRGV 98 (297)
T ss_pred CCCeEEEEeccCCE
Confidence 46799999999973
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.012 Score=60.12 Aligned_cols=28 Identities=14% Similarity=0.247 Sum_probs=24.7
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.|.||+++.++ +.|+||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999877 7899999664
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.084 Score=57.91 Aligned_cols=76 Identities=12% Similarity=0.041 Sum_probs=44.5
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---h----HHHHHHHHHHHHHHHh--cCCCCceeeEEEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---D----RMRVLLERLNDLFLKC--QGVEGICWLQGISV 116 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~----~~~~~~~~~~~~ll~~--~~hpnIv~l~~~~~ 116 (627)
.+.||.|.+..||++...... +.|+||.-.+... + ...+ ...+.+.+... ....++++++.+.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~------~svIVKqa~p~~r~~g~~wpl~~eR-~~~Eae~L~~l~~~~p~~VPkV~~~D- 102 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGG------KSVIVKQALPYVRVVGESWPLTLDR-ARIEAEALKIQAKYVPDLVPKVYHYD- 102 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCC------eEEEEEecCcccccccccccccHHH-HHHHHHHHHHHHhhCCCCCCeEEEEC-
Confidence 467999999999999874321 3699998543211 0 1111 11111222221 1224577777764
Q ss_pred ECCEEEEEEecCCC
Q 006887 117 INGKICIIMKFYEG 130 (627)
Q Consensus 117 ~~~~~~LVmEy~~G 130 (627)
.+..++||||+++
T Consensus 103 -~~~~~lVME~L~~ 115 (401)
T PRK09550 103 -EELAVTVMEDLSD 115 (401)
T ss_pred -CCCCEEEEecCCC
Confidence 4557899999985
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.1 Score=56.22 Aligned_cols=29 Identities=17% Similarity=0.183 Sum_probs=25.3
Q ss_pred CCeecccCCCcEEEec-CCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNE-ADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~-~g~vkL~DFGla~ 195 (627)
.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4679999999764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.0011 Score=80.68 Aligned_cols=249 Identities=12% Similarity=-0.078 Sum_probs=144.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHH-HH--HHHhcCCCCceeeEEEEE--
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN-DL--FLKCQGVEGICWLQGISV-- 116 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~-~~--ll~~~~hpnIv~l~~~~~-- 116 (627)
+++..--+|-|. -+++.+....-+ -+-+|+.+...-+...+-+.++. .. ..+...|+++.....-..
T Consensus 1230 ~~EV~l~i~~~~---~~R~k~Lr~kid-----~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1230 HSEVNLGISNHF---HFRNKWLRSKID-----WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred hhheeeecccce---eeccchHhhhhc-----eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence 344443344333 345555444322 35667665544333322222110 00 122245666655443322
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC-----CCeecccCCCcEEEecCCCeee
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKG--GKLSLSNVFRYAIDLAQGILQLHSK-----GILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~-----gIvHrDLKP~NILld~~g~vkL 188 (627)
.+...+.+|+|+. |.+.+.+..... .++...-+...-.+...+..-+|+. -.+|++||+-|-+|..+..+++
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence 2344688999998 566666654221 2233333333333447777777754 2799999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+++|+.+.... .........+++-||.|+... +-.++.++|+|..++.+|+...|..+|-...... .+.+...
T Consensus 1382 gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N---~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~-Lkgiidn 1454 (2724)
T KOG1826|consen 1382 GKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKN---EIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPA-LKGIIDN 1454 (2724)
T ss_pred cccccccccCc---hHhhhhhhhCCHHHHHHHHHH---HHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHH-HcCcccc
Confidence 99999983321 123334567888999999876 3467778999999999999998887764322221 2222223
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
.....++.-.|.+.-.....+|-....+||.-...+.
T Consensus 1455 ~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1455 HTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred cccccccccCCCcccHHHHHHHHHHhhhcchhhhhcc
Confidence 3333444444555555555555566677776555443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.049 Score=58.38 Aligned_cols=142 Identities=20% Similarity=0.174 Sum_probs=90.4
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC------------------------chhHHHHHHHHHHHHH
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV------------------------KEDRMRVLLERLNDLF 99 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~------------------------~~~~~~~~~~~~~~~l 99 (627)
.+..+|.-|--+.||.|... .|..+|||+.+.. +...+...+.+-+..-
T Consensus 147 ~inGCiSTGKEANVYHat~~-------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RN 219 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRN 219 (520)
T ss_pred ecccccccCccceeEeeecC-------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHH
Confidence 35567888989999998743 3346999998531 1112222222222222
Q ss_pred HHhcCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCcE
Q 006887 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL-HSKGILVLNLKPFNF 178 (627)
Q Consensus 100 l~~~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~gIvHrDLKP~NI 178 (627)
+++++..+|+-..-+... .-.|||+|+.++-. ....++.-.++...+..+-.|++.-+.-| |..++||.||.--|+
T Consensus 220 LkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw-~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 220 LKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGW-AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred HHHHHhcCCCCCCceeee--cceEeeeeccCCCC-cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 333444444333222222 35799999984312 12223566788888888888888877776 456899999999999
Q ss_pred EEecCCCeeeccCCcccc
Q 006887 179 ILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~ 196 (627)
|+- +|.+.++|.+-+..
T Consensus 297 Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred eEE-CCEEEEEEcccccc
Confidence 885 67899999986543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.19 Score=52.49 Aligned_cols=29 Identities=21% Similarity=0.132 Sum_probs=25.7
Q ss_pred CCeecccCCCcEEEecC----CCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEA----DRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~----g~vkL~DFGla~ 195 (627)
.++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999975 889999999664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.012 Score=62.11 Aligned_cols=135 Identities=15% Similarity=0.206 Sum_probs=82.7
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch----------------h----HHHHHHHHHHHHHHHh
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE----------------D----RMRVLLERLNDLFLKC 102 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~----------------~----~~~~~~~~~~~~ll~~ 102 (627)
+.+.++||-|--+.||.+-+.. |.+.++|.=..... . ...++....+-.+++.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred hhhccccccccccceEEEecCC-------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 5677899999999999997543 44788886321110 0 0011111111123332
Q ss_pred c-CCCC-ceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 103 Q-GVEG-ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 103 ~-~hpn-Iv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
+ .|-. ++..++ .++-|+|||++.|--+..+.+ ...+-.+...+..-+.-|-.+|+||+|..-=||++
T Consensus 167 L~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 167 LYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred HHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 2 2222 444444 356899999999832222211 11223344455556677888999999999999999
Q ss_pred ecCCCeeeccCCccc
Q 006887 181 NEADRAVLGDVGIPH 195 (627)
Q Consensus 181 d~~g~vkL~DFGla~ 195 (627)
++++.++++||--+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999998543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.18 Score=54.39 Aligned_cols=29 Identities=14% Similarity=0.126 Sum_probs=23.7
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++|+||.+.|||++.+ .++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 358999999999999765 47799988654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.49 Score=49.89 Aligned_cols=29 Identities=10% Similarity=0.085 Sum_probs=26.7
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
+++|+|+.++|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.35 Score=51.67 Aligned_cols=28 Identities=21% Similarity=0.160 Sum_probs=24.6
Q ss_pred CeecccCCCcEEEec-CCCeeeccCCccc
Q 006887 168 ILVLNLKPFNFILNE-ADRAVLGDVGIPH 195 (627)
Q Consensus 168 IvHrDLKP~NILld~-~g~vkL~DFGla~ 195 (627)
++|.|+-+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999664
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.39 Score=52.77 Aligned_cols=75 Identities=12% Similarity=0.075 Sum_probs=44.3
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---h----HHHHHHHHHHHHHHH--hcCCCCceeeEEEE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---D----RMRVLLERLNDLFLK--CQGVEGICWLQGIS 115 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~----~~~~~~~~~~~~ll~--~~~hpnIv~l~~~~ 115 (627)
..+.||.|....||+..+. . ..|+||.-.+... . ...+...+ .+.+.. .....++++++.++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~-------~svVVKqa~p~~r~vga~wpl~~~R~~~E-a~aL~~~~~~~p~~VPkVy~~d 106 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-S-------GSFVIKQALPYIRCIGESWPMTKERAYFE-ATALREHGRLCPDHVPEVYHFD 106 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-C-------ccEEEEeCCccccCCCccccCCccHHHHH-HHHHHHhhhcCCCCCCeEEEEC
Confidence 4677899999999998752 1 2589998753111 0 11111111 111111 11224688888887
Q ss_pred EECCEEEEEEecCCC
Q 006887 116 VINGKICIIMKFYEG 130 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G 130 (627)
. +..+++||++++
T Consensus 107 e--d~~vlvME~L~~ 119 (418)
T PLN02756 107 R--TMALIGMRYLEP 119 (418)
T ss_pred C--CCCEEEEeecCC
Confidence 6 457889999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.73 Score=48.40 Aligned_cols=79 Identities=13% Similarity=0.071 Sum_probs=42.2
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
.+-.+.++.|....+|+.. .+ +..+.||+-......-...+.+-+. .+.....-.+++.+++...++..|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~------~~~~FvK~~~~~~~~~f~~Ea~gL~--~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TD------GGSYFVKVNSESGRDMFEGEAEGLK--ALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TT------S-EEEEEEEEGGGCCHHHHHHHHHH--HHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeeEecCCCChhheEEEE--CC------CccEEEEecChhhHHHHHHHHHHHH--HHHhcCCCCCCeEEEEEeecCCce
Confidence 4566789989999999986 22 2479999876333222222222221 222234456888899888888889
Q ss_pred EEEecCCCC
Q 006887 123 IIMKFYEGS 131 (627)
Q Consensus 123 LVmEy~~Gs 131 (627)
|||||++..
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999843
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.34 Score=50.51 Aligned_cols=29 Identities=21% Similarity=0.201 Sum_probs=24.3
Q ss_pred CCeecccCCCcEEEecCCCe-eeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRA-VLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~v-kL~DFGla~ 195 (627)
.++|+|+.|.|||++.++.+ -|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 38999999999999975654 599999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.12 Score=57.73 Aligned_cols=146 Identities=21% Similarity=0.364 Sum_probs=86.5
Q ss_pred HHHhcCCCCceeeEEEEEE-CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 99 FLKCQGVEGICWLQGISVI-NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 99 ll~~~~hpnIv~l~~~~~~-~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+++...|+|++.++++... ..+..+|||++.-++.|...... +-.... . .+++.| -|
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~---l~~~s~-------~-------~~~~~~-----~~ 92 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN---LKDESL-------L-------AHGVLH-----LN 92 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc---cchhhh-------c-------ccccce-----eh
Confidence 6677889999999888754 34589999999999888875422 111110 0 222222 12
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~ 257 (627)
| .+.+| .+.. . | |- +..+++||||+|.++.|+..|...|....
T Consensus 93 ~-------~~~td----~~~t-------~---------~--~~--------~~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 93 I-------IYITD----HFLT-------K---------Y--PS--------PIGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred h-------hhccc----cccc-------c---------C--CC--------CCCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 22333 0000 0 0 11 12249999999999999999987766544
Q ss_pred HHHHHHHHHhccCCC----------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 006887 258 VDEIYDAVVRRQEIP----------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~----------~~p~~~s~~l~~li~~cL~~dP~~RPs~~ei 303 (627)
..+....+..-...+ .+-..++..+..+...|+-..|..||...++
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 444333332211110 1112456677788899999999988865544
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.20 E-value=0.35 Score=51.48 Aligned_cols=30 Identities=17% Similarity=0.208 Sum_probs=27.1
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.++|+|+.+.||+++.++-+-+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999988899999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.30 E-value=2.4 Score=45.18 Aligned_cols=28 Identities=14% Similarity=-0.009 Sum_probs=23.3
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++||+|+.+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.7 Score=50.63 Aligned_cols=27 Identities=7% Similarity=0.076 Sum_probs=22.9
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.++|+||.|.|||++++ ..|++|.-++
T Consensus 228 aLlHGDlHtGSI~v~~~-~~kvIDpEFA 254 (409)
T PRK12396 228 ALIHGDLHTGSVFVKND-STKVIDPEFA 254 (409)
T ss_pred hhccCcCCCCCEEecCC-ceEEEccccc
Confidence 58999999999999976 5788887755
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.25 Score=53.17 Aligned_cols=74 Identities=12% Similarity=0.026 Sum_probs=56.6
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..+.|++|++..+.+. .+ .....+++..++.+.+..+.-+..+ .+=|||+.-.||||+ +|++-|+||-++|.
T Consensus 298 ~~y~yl~~kdhgt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4467889998776543 22 1235677788888877777666654 589999999999999 99999999999986
Q ss_pred cc
Q 006887 197 LL 198 (627)
Q Consensus 197 ~~ 198 (627)
-.
T Consensus 371 ~~ 372 (488)
T COG5072 371 SY 372 (488)
T ss_pred cc
Confidence 43
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.14 E-value=1.4 Score=54.34 Aligned_cols=30 Identities=20% Similarity=0.335 Sum_probs=25.1
Q ss_pred CCCeecccCCCcEEEecCC--Cee-eccCCccc
Q 006887 166 KGILVLNLKPFNFILNEAD--RAV-LGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g--~vk-L~DFGla~ 195 (627)
.++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.67 E-value=2 Score=47.02 Aligned_cols=28 Identities=11% Similarity=-0.149 Sum_probs=23.1
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
...+|.||-+.|||.+ ++.+.++||-.|
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccc
Confidence 4579999999999875 456999999855
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.18 E-value=0.65 Score=50.72 Aligned_cols=61 Identities=15% Similarity=0.127 Sum_probs=39.7
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecccCCCcEEEecC
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL-HSKGILVLNLKPFNFILNEA 183 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~gIvHrDLKP~NILld~~ 183 (627)
...|+=+|.+| ++...+. ....+++....++.-.+.||..+ --.+++|.|+.|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~---~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK---WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhh---cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 35677777777 4443333 33345555666666566665443 45689999999999999644
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=90.83 E-value=0.37 Score=50.35 Aligned_cols=29 Identities=14% Similarity=0.215 Sum_probs=25.2
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=89.21 E-value=2.3 Score=43.29 Aligned_cols=54 Identities=7% Similarity=0.142 Sum_probs=33.9
Q ss_pred cEEEEEEecCCchhHHHHHHHHHHHH-HHHhcCCCCceeeEEEEEECCEEEEEEecCC
Q 006887 73 HEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVEGICWLQGISVINGKICIIMKFYE 129 (627)
Q Consensus 73 ~~VAVK~l~~~~~~~~~~~~~~~~~~-ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~ 129 (627)
.+|-+|+=... ....+..+...+ .+...+.-.+.+++.+....+..|+||||++
T Consensus 40 ~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 40 DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 47888874321 112222222212 3444455678888888888999999999998
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=87.71 E-value=0.97 Score=45.66 Aligned_cols=72 Identities=18% Similarity=0.135 Sum_probs=48.9
Q ss_pred CCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecccCCCcEEEecC
Q 006887 106 EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS--KGILVLNLKPFNFILNEA 183 (627)
Q Consensus 106 pnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs--~gIvHrDLKP~NILld~~ 183 (627)
-+|++|..- ....+.++.|+|-.- . +. ...++.-=+.+|.-.|+ .+.+|+|-.|+|||-|..
T Consensus 116 hGilrL~ND--n~~~yGvIlE~Cy~~-~----------i~---~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~ 179 (308)
T PF07387_consen 116 HGILRLKND--NNYKYGVILERCYKI-K----------IN---FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF 179 (308)
T ss_pred hheeEeecC--CCceeEEEEeeccCc-c----------cc---hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCC
Confidence 357777643 455678999988630 0 00 01111111456788895 369999999999999999
Q ss_pred CCeeeccCCc
Q 006887 184 DRAVLGDVGI 193 (627)
Q Consensus 184 g~vkL~DFGl 193 (627)
|.+||.|-+.
T Consensus 180 G~lKlVDP~~ 189 (308)
T PF07387_consen 180 GYLKLVDPVC 189 (308)
T ss_pred CCEEecChhh
Confidence 9999999873
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=87.40 E-value=5.8 Score=41.18 Aligned_cols=28 Identities=14% Similarity=0.125 Sum_probs=23.7
Q ss_pred CeecccCCCcEEEecC--C---CeeeccCCccc
Q 006887 168 ILVLNLKPFNFILNEA--D---RAVLGDVGIPH 195 (627)
Q Consensus 168 IvHrDLKP~NILld~~--g---~vkL~DFGla~ 195 (627)
++|+|++..|||+..+ | .+++.||-+++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999654 3 58899998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=85.33 E-value=1.1 Score=48.09 Aligned_cols=76 Identities=20% Similarity=0.212 Sum_probs=43.4
Q ss_pred EEEEEecCCCCHHHHHHH--hcCCCCCH-HHHHHHHHHHHHHHHHHH----HCCCeecccCCCcEEEecCC---------
Q 006887 121 ICIIMKFYEGSVGDRMAQ--LKGGKLSL-SNVFRYAIDLAQGILQLH----SKGILVLNLKPFNFILNEAD--------- 184 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~--~~~~~ls~-~~~~~i~~qIa~aL~yLH----s~gIvHrDLKP~NILld~~g--------- 184 (627)
..||+.+..++....-.. ...|-.+. +-++.++.||+.-.--+- -..++|-||||+|||+=+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 468888887653222111 11122222 345566677665432232 23699999999999983222
Q ss_pred ---------CeeeccCCcccc
Q 006887 185 ---------RAVLGDVGIPHL 196 (627)
Q Consensus 185 ---------~vkL~DFGla~~ 196 (627)
.++|.||.+++.
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred eEEEecccceeeecccCHHHh
Confidence 245778887754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 627 | ||||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-04 |
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 58/292 (19%), Positives = 103/292 (35%), Gaps = 45/292 (15%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV------- 90
I L ++ GE+W + + + VK+L +
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGR-WQGND-------IVVKVLKVRDWSTRKSRDFNEEC 58
Query: 91 -LLERLND----LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKL 144
L + L G C S +I + GS+ + + + +
Sbjct: 59 PRLRIFSHPNVLPVL------GAC----QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV 108
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLN--LKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
S ++A+D+A+G+ LH+ L+ L + +++E A + +
Sbjct: 109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF------- 161
Query: 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDE 260
S P R+ P ++APE Q + D W FA ++ E++T P S E
Sbjct: 162 -SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFA--VLLWELVTREVPFADLSNME 218
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312
I V P IP G+ P V ++ C D RP I+ + + Q+
Sbjct: 219 IGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 65/301 (21%), Positives = 119/301 (39%), Gaps = 46/301 (15%)
Query: 29 ATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH-EVAVKILHPVKED 86
+ + + W I + + RIG G FG V+ +H +VAVK+L+
Sbjct: 11 GSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGK----------WHGDVAVKMLNVTAPT 60
Query: 87 RMRV--------LLERLND----LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD 134
++ +L + LF+ G ++ I+ ++ EGS
Sbjct: 61 PQQLQAFKNEVGVLRKTRHVNILLFM------GYS-------TAPQLAIVTQWCEGSSLY 107
Query: 135 RMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194
K + + A A+G+ LH+K I+ +LK N L+E + +GD G+
Sbjct: 108 HHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQP 252
S + G+ +MAPE + + P SF++D + F I+ E++TG P
Sbjct: 168 TEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG--IVLYELMTGQLP 224
Query: 253 RCG-RSVDEIYDAVV---RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
+ D+I + V ++ + S P ++ ++ C + RP IL +
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
Query: 309 S 309
Sbjct: 285 E 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 52/272 (19%), Positives = 90/272 (33%), Gaps = 36/272 (13%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE-------------R 94
IG G FG+V+ A H + + +K VK + + E
Sbjct: 18 LIGSGGFGQVFKAKHRIDGK------TYVIKR---VKYNNEKAEREVKALAKLDHVNIVH 68
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
N + + I M+F + G++ + + +G KL
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ +G+ +HSK ++ +LKP N L + + +GD G+ L R GT
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGKRTRSKGT 184
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
YM+PEQ E D + + E+L + + +
Sbjct: 185 LRYMSPEQIS---SQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLRD----GI 235
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
I + +L RP ++ILR
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 57/306 (18%), Positives = 115/306 (37%), Gaps = 43/306 (14%)
Query: 25 RTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH-EVAVKILHP 82
R A TS W I L++ IG+G FG+V+ +H EVA++++
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGR----------WHGEVAIRLIDI 65
Query: 83 VKEDRMRV--------LLERL---NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGS 131
+++ ++ + N + G + + II +G
Sbjct: 66 ERDNEDQLKAFKREVMAYRQTRHEN-----------VVLFMGACMSPPHLAIITSLCKGR 114
Query: 132 VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191
+ + L ++ + A ++ +G+ LH+KGIL +LK N + + V+ D
Sbjct: 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDF 173
Query: 192 GI--PHLLLGIPLPSSDLPRRLGTPNYMAPE------QWQPEVRGPISFETDSWGFACSI 243
G+ +L L + G ++APE E + P S +D +
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 244 IEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
E+ P + + I + + G+ + ++LL C+ ++ RP T +
Sbjct: 234 YELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293
Query: 304 LRVFKS 309
+ + +
Sbjct: 294 MDMLEK 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 49/319 (15%)
Query: 19 DDSDHLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH--EV 75
D + D + I L ++ +IG G FG V A +H +V
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAE----------WHGSDV 63
Query: 76 AVKILHPVKEDRMRV--------LLERL---NDLFLKCQGVEGICWLQGISVINGKICII 124
AVKIL RV +++RL N I G + I+
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPN-----------IVLFMGAVTQPPNLSIV 112
Query: 125 MKFYE-GSVGDRMAQLKGG-KLSLSNVFRYAIDLAQGILQLHSKGILVL--NLKPFNFIL 180
++ GS+ + + +L A D+A+G+ LH++ ++ NLK N ++
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
++ + D G+ L L S GTP +MAPE + E P + ++D + F
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDE---PSNEKSDVYSFG 226
Query: 241 CSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
+I E+ T QP + ++ AV + + IP L P V ++ GC+ + RP
Sbjct: 227 --VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 299 LMTDILRVFKSSQNSVHSD 317
I+ + + S
Sbjct: 285 SFATIMDLLRPLIKSAVPP 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 55/275 (20%), Positives = 106/275 (38%), Gaps = 48/275 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH----PVKEDRMRV----LLERLN---- 96
IG G FG+ L ++ + +K ++ KE +L +
Sbjct: 32 IGEGSFGKAILVKST------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 97 ----DLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFR 151
+ F + NG + I+M + E G + R+ KG +
Sbjct: 86 VQYRESFEE----------------NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-R 210
+ + + + +H + IL ++K N L + LGD GI +L + +L R
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS----TVELARAC 185
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270
+GTP Y++PE + + P + ++D W C + E+ T S+ + ++
Sbjct: 186 IGTPYYLSPEICENK---PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS- 241
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
PP+ + +++ F+ + R RP + IL
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 58/302 (19%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
+ + ++ +IG+G FG V VA+K L + ++E+
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSV------VAIKSLILGDSEGETEMIEKFQ 68
Query: 97 D-----------------LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQ 138
+ G+ ++M+F G + R+
Sbjct: 69 EFQREVFIMSNLNHPNIVKLY------GLMH--------NPPRMVMEFVPCGDLYHRLLD 114
Query: 139 LKGGKLSLSNVFRYAIDLAQGILQLHSKGILVL--NLKPFNFILNEADRAV-----LGDV 191
K + S R +D+A GI + ++ ++ +L+ N L D + D
Sbjct: 115 -KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTG 249
G+ + LG +MAPE E + + D++ FA +I +LTG
Sbjct: 174 GLSQQS------VHSVSGLLGNFQWMAPETIGAE-EESYTEKADTYSFA--MILYTILTG 224
Query: 250 VQPRCGRSVDEI--YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
P S +I + + P IP PP + NV+ C+ D + RP + I++
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
Query: 308 KS 309
Sbjct: 285 SE 286
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 62/263 (23%), Positives = 98/263 (37%), Gaps = 27/263 (10%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV---KEDRMRVLLERLNDLFLKCQG 104
R+G G +GEV+ AVK +DR R L E K
Sbjct: 64 RLGHGSYGEVFKVRSKEDGR------LYAVKRSMSPFRGPKDRARKLAEV--GSHEKVGQ 115
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH 164
L+ G + + + S+ G L + V+ Y D + LH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLH 174
Query: 165 SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-RLGTPNYMAPEQWQ 223
S+G++ L++KP N L R LGD G L + L ++ + G P YMAPE Q
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFG-----LLVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQ-PRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
G D + +I+E+ ++ P G ++ + P +GL +
Sbjct: 230 ----GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP----PEFTAGLSSEL 281
Query: 283 ENVLLGCFEYDLRSRPLMTDILR 305
+VL+ E D + R +L
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLA 304
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 51/295 (17%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I + L L IG G FG+V+ A ++ E VAVK ++ + +E
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAF-WIGDE-------VAVKAARHDPDEDISQTIEN--- 52
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLS 147
+ E I L+G+ + +C++M+F G G L G ++
Sbjct: 53 -VRQ----EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG--GPLNRVLSGKRIPPD 105
Query: 148 NVFRYAIDLAQGILQLHSKGILVL---NLKPFNFILNEADRAV--------LGDVGIPHL 196
+ +A+ +A+G+ LH + I+ + +LK N ++ + + D G
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG---- 161
Query: 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRC 254
L + G +MAPE + S +D W + ++ E+LTG P
Sbjct: 162 -LAREWHRTTKMSAAGAYAWMAPEVIRAS---MFSKGSDVWSYG--VLLWELLTGEVPFR 215
Query: 255 GRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
G + V + PIPS P ++ C+ D SRP T+IL +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 50/279 (17%), Positives = 101/279 (36%), Gaps = 44/279 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKI--LHPVKEDRMRVL------LERLNDLFL 100
IG G +V+ + ++ A+K L + L +L
Sbjct: 64 IGSGGSSKVFQVLN-------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ---- 112
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGI 160
Q + I L + + I ++M+ + + K + Y ++ + +
Sbjct: 113 --QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAV 168
Query: 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVG----IPHLLLGIPLPSSDLPRRLGTPNY 216
+H GI+ +LKP NF++ + L D G + + S +G NY
Sbjct: 169 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQ-----VGAVNY 222
Query: 217 MAPE--------QWQPEVRGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYDAVV 266
M PE + + + IS ++D W C + M G P + + +++ A++
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AII 281
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P +++VL C + D + R + ++L
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 50/277 (18%), Positives = 105/277 (37%), Gaps = 40/277 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKI--LHPVKEDRMRVL------LERLNDLFL 100
IG G +V+ + ++ A+K L + L +L
Sbjct: 36 IGSGGSSKVFQVLN-------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ--- 85
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGI 160
+ I L + + I ++M+ + + K + Y ++ + +
Sbjct: 86 ---HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAV 140
Query: 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR--LGTPNYMA 218
+H GI+ +LKP NF++ + L D GI + + ++ + + +GT NYM
Sbjct: 141 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ---MQPDTTSVVKDSQVGTVNYMP 196
Query: 219 PE--------QWQPEVRGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYDAVVRR 268
PE + + + IS ++D W C + M G P + + +++ A++
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDP 255
Query: 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P +++VL C + D + R + ++L
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV----LLE 93
I +++ +GRG FG V A + + + VA+K + E + + L
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAK-WRAKD-------VAIKQIESESERKAFIVELRQLS 56
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKG-GKLSLSNVFR 151
R+N I L G + +C++M++ E GS+ + + + + ++
Sbjct: 57 RVNH--------PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 152 YAIDLAQGILQLHS---KGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDL 207
+ + +QG+ LHS K ++ +LKP N +L + + D G + + +
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI------QTHM 160
Query: 208 PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEI-YDA 264
G+ +MAPE ++ S + D + + II E++T +P
Sbjct: 161 TNNKGSAAWMAPEVFEGS---NYSEKCDVFSWG--IILWEVITRRKPFDEIGGPAFRIMW 215
Query: 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314
V PP+ LP +E+++ C+ D RP M +I+++
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 51/282 (18%), Positives = 108/282 (38%), Gaps = 40/282 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKI--LHPVKEDRMRVL------LERL 95
+ +IG G +V+ + ++ A+K L + L +L
Sbjct: 12 SILKQIGSGGSSKVFQVLN-------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
Q + I L + + I ++M+ + + K + Y +
Sbjct: 65 Q------QHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKN 116
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR--LGT 213
+ + + +H GI+ +LKP NF++ + L D GI + + ++ + + +GT
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ---MQPDTTSVVKDSQVGT 172
Query: 214 PNYMAPE--------QWQPEVRGPISFETDSWGFACSIIEMLTGVQP--RCGRSVDEIYD 263
NYM PE + + + IS ++D W C + M G P + + +++
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH- 231
Query: 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
A++ P +++VL C + D + R + ++L
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/286 (20%), Positives = 103/286 (36%), Gaps = 42/286 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLE--------- 93
++G G F V L H A+K + ++DR E
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDG------HFYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 94 ----RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLK--GGKLSL 146
RL L+ +G + +++ F++ G++ + + +LK G L+
Sbjct: 86 PNILRLVAYCLRERGA------------KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS- 205
+ + + +G+ +H+KG +LKP N +L + + VL D+G + S
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 206 -----DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVD 259
D + T +Y APE + + I TD W C + M+ G P
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ V+ Q P A+ +L D RP + +L
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 36/300 (12%), Positives = 79/300 (26%), Gaps = 53/300 (17%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-------------RMR 89
L +G+ AT + E V + + + R+R
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 90 VLLERLN-----------------DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSV 132
+L N K + + + + V++ + + ++
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS--RFFLYPRMQSNL 191
Query: 133 GDRMAQL-----KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187
L L + + + + + LH G++ L+P + +L++
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 251
Query: 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ--WQPEVRGPISFETDSWGFACSIIE 245
L + P A + ++F D+W +I
Sbjct: 252 LTGFEHLVRDGASAVSPIGRG--FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 246 MLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ P + + + R +P V +L G Y R L +
Sbjct: 310 IWCADLPNTDDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 53/285 (18%), Positives = 89/285 (31%), Gaps = 57/285 (20%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLE----------- 93
IG G +G S + K L ++ ++ E
Sbjct: 13 TIGTGSYGRCQKIRR-KSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 94 --RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD-----RMAQLKGGKLSL 146
R D + N + I+M++ EG GD + L
Sbjct: 67 IVRYYDRIIDRT--------------NTTLYIVMEYCEG--GDLASVITKGTKERQYLDE 110
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLN-----LKPFNFILNEADRAVLGDVGIPHLLLGIP 201
V R L + + H + LKP N L+ LGD G+ +L
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--- 167
Query: 202 LPSSDLPR-RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE 260
+ + +GTP YM+PEQ + ++D W C + E+ + P S E
Sbjct: 168 -HDTSFAKTFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ + + IP + ++ RP + +IL
Sbjct: 224 LAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 42/284 (14%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKI--LHPVKEDRMRVLLE------------ 93
+GRG FG V+ A + D Y A+K L + R +V+ E
Sbjct: 12 CLGRGGFGVVFEAKN---KVDDCNY---AIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 94 -RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGK-LSLSNVF 150
R + +L+ + S + I M+ ++ D M + S
Sbjct: 66 VRYFNAWLE----KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL---------LGIP 201
+ +A+ + LHSKG++ +LKP N D +GD G+ + L
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEI 261
+ ++GT YM+PEQ S + D + + E+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLILFELLYP--FSTQMERVRT 236
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
VR + PP+ + P ++ RP +I+
Sbjct: 237 LTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 57/304 (18%), Positives = 107/304 (35%), Gaps = 47/304 (15%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR------VL 91
+PS L +G+G FG+ TH + E + +K L E+ R +
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEV------MVMKELIRFDEETQRTFLKEVKV 60
Query: 92 LERL---NDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLS 147
+ L N + G+ + ++ I ++ + G++ + + + S
Sbjct: 61 MRCLEHPN-----------VLKFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWS 108
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI----------PHLL 197
+A D+A G+ LHS I+ +L N ++ E V+ D G+ P L
Sbjct: 109 QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 198 LGIPLPSSDLPR-RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRC 254
+ P +G P +MAPE + D + F I+ E++ V
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMIN---GRSYDEKVDVFSFG--IVLCEIIGRVNADP 223
Query: 255 G-RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313
+ VR P PP+ + + C + D RP + ++ +
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
Query: 314 VHSD 317
+
Sbjct: 284 LAGH 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 59/286 (20%), Positives = 111/286 (38%), Gaps = 54/286 (18%)
Query: 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL----HPVKEDRMRV-----LLERLN- 96
+IGRG F EV+ A L VA+K + + R LL++LN
Sbjct: 38 KKIGRGQFSEVYRAACLLDGV------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 97 -------DLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLK--GGKLSL 146
F++ + ++ I+++ + G + + K +
Sbjct: 92 PNVIKYYASFIE----------------DNELNIVLELADAGDLSRMIKHFKKQKRLIPE 135
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
V++Y + L + +HS+ ++ ++KP N + LGD+G+ +
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS----KTT 191
Query: 207 LPR-RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG--RSVDEIYD 263
+GTP YM+PE+ +F++D W C + EM P G ++ +
Sbjct: 192 AAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
Query: 264 AVVRRQEIPPIPSG-LPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
+ + + PP+PS + ++ C D RP +T + V K
Sbjct: 249 KIE-QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 38/310 (12%), Positives = 82/310 (26%), Gaps = 64/310 (20%)
Query: 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE------------- 85
+P L +G+ AT + E V + + +
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 86 DRMRVLLERLN-----------------DLFLKCQGVEGICWLQGISVINGKICIIMKFY 128
R+R+L N K + + + + V++ +
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS--RFFLYPRM 182
Query: 129 EGSVGDRMAQL-----KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA 183
+ ++ L L + + + + + LH G++ L+P + +L++
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
Query: 184 DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--------RGPISFETD 235
L + + + PE R ++F D
Sbjct: 243 GGVFLTG-------FEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 236 SWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLR 295
+W I + P + + + R +P V +L G Y
Sbjct: 296 AWALGLVIYWIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKE 349
Query: 296 SRPLMTDILR 305
R L +
Sbjct: 350 DRLLPLQAME 359
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 38/233 (16%), Positives = 79/233 (33%), Gaps = 20/233 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ H +G G F +V+ AT D + +K+ P + + + L K
Sbjct: 68 YVHHLLGEGAFAQVYEATQ-GDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL--KPS 124
Query: 104 GVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLK---GGKLSLSNVFRYAIDLAQG 159
+ ++ + Y G++ + + K + V +A+ +
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL----------LGIPLPSSDLPR 209
I Q+H I+ ++KP NFIL + + L + + +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262
+ T + E + P +++ D +G A ++ ML G + E
Sbjct: 245 KCETSGFQCVEMLSNK---PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 73/332 (21%), Positives = 112/332 (33%), Gaps = 35/332 (10%)
Query: 1 MAGKVAAGQPADFEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLA 60
+ K+ P + E ++ L+ + W+ + R+GRG FGEV
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT-----HQPRVGRGSFGEVHRM 77
Query: 61 THYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVIN 118
+ + AVK + ++ R+ V L+ I L G
Sbjct: 78 KDKQTGF------QCAVKKV-RLEVFRVEELVACAGLSS--------PRIVPLYGAVREG 122
Query: 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177
+ I M+ E GS+G + + G L Y +G+ LH++ IL ++K N
Sbjct: 123 PWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180
Query: 178 FILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRR--LGTPNYMAPEQWQPEVRG-PISFE 233
+L+ L D G L L S L GT +MAPE V G P +
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV----VMGKPCDAK 236
Query: 234 TDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEY 292
D W C ++ ML G P I IP P +
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296
Query: 293 DLRSRPLMTDILR-VFKSSQNSVHSDGGWTGH 323
+ R ++ R V K+ Q W G
Sbjct: 297 EPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 65/292 (22%), Positives = 104/292 (35%), Gaps = 38/292 (13%)
Query: 19 DDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK 78
++ D + + + R +G+G +G V+ + +A+K
Sbjct: 6 EEGDCESDLLEYDYEYDENGD------RVVLGKGTYGIVYAGRDLSNQV------RIAIK 53
Query: 79 ILHPVKEDRMRVL------LERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GS 131
+ + L + L + I G NG I I M+ GS
Sbjct: 54 EIPERDSRYSQPLHEEIALHKHLKH--------KNIVQYLGSFSENGFIKIFMEQVPGGS 105
Query: 132 VGDRMAQLKGGKLSLS-NVFR-YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV-L 188
+ + + K G L + Y + +G+ LH I+ ++K N ++N + +
Sbjct: 106 LSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI 164
Query: 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT 248
D G L GI + GT YMAPE RG D W C+IIEM T
Sbjct: 165 SDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMAT 220
Query: 249 GVQP--RCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
G P G ++ V + P IP + + +L CFE D R
Sbjct: 221 GKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 43/306 (14%), Positives = 81/306 (26%), Gaps = 52/306 (16%)
Query: 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM----RVLLER 94
LKL + G V+L E + A+K+ E+ R+
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLE------DFALKVFTMGAENSRSELERLHEAT 113
Query: 95 LNDLFLKCQGVEGICWLQGISV-----------------------INGKICIIMKFYEGS 131
L + E + + + ++M
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 132 VGDRMAQLK-----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186
+ + L G + + L + L SKG++ + P N + R
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233
Query: 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
+LGDV P AP ++ + ++W SI +
Sbjct: 234 MLGDVSALW-------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 247 LTGVQPRCGRSVDEIYDAVVRRQEIP-------PIPSGLPPAVENVLLGCFEYDLRSRPL 299
P + +P + LP V+ ++ +D R R L
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
Query: 300 MTDILR 305
+ +
Sbjct: 347 PLEAME 352
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 44/275 (16%), Positives = 83/275 (30%), Gaps = 30/275 (10%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVK-ILHPVKEDRMRVLLERLNDLFLKCQGVE 106
+IG G FG V+ L A+K P+ R
Sbjct: 18 KIGSGEFGSVFKCVKRLDGC------IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 107 GICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLS--NVFRYAIDLAQGILQL 163
+ + + I ++ GS+ D +++ + + + +G+ +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL------------LGIPLPSSDLPRRL 211
HS ++ +++KP N ++ LG S
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 212 GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ-PRCGRSVDEIYDAVVRRQE 270
G ++A E Q + D + A +++ PR G EI R+
Sbjct: 192 GDSRFLANEVLQENY--THLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-----RQGR 244
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+P IP L +L D RP +++
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 52/286 (18%), Positives = 97/286 (33%), Gaps = 43/286 (15%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE-------------R 94
+G+G FG+V A + L + A+K + +E +L E R
Sbjct: 13 VLGQGAFGQVVKARNALDSR------YYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
+ + I M++ E G++ D + + +R
Sbjct: 67 YYAAW---LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLF 122
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI-----------PHLLLGIPL 202
+ + + +HS+GI+ +LKP N ++E+ +GD G+ +P
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262
S +L +GT Y+A E G + + D + EM+ G I
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG--TGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238
Query: 263 DAVVRRQEI---PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+R I P + ++ ++D RP +L
Sbjct: 239 K-KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 19 DDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK 78
DD + L T ++ ++K IGRG F V+ D + EVA
Sbjct: 9 DDIEELETKAVGMSNDGRFLK-----FDIEIGRGSFKTVYKGL------DTETTVEVAWC 57
Query: 79 IL---HPVKEDRMRVLLE--RLNDL----FLKCQGVEGICWLQGISVINGKICIIMKFYE 129
L K +R R E L L ++ W + I ++ +
Sbjct: 58 ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD----SWESTVKG-KKCIVLVTELMT 112
Query: 130 -GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVL--NLKPFNFILNEADRA 186
G++ + + + + + + + +G+ LH++ ++ +LK N + +
Sbjct: 113 SGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170
Query: 187 V-LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245
V +GD+G L +S +GTP +MAPE ++ + D + F ++E
Sbjct: 171 VKIGDLG-----LATLKRASFAKAVIGTPEFMAPEMYEEKY----DESVDVYAFGMCMLE 221
Query: 246 MLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
M T P ++ +IY V + P V+ ++ GC + R + D+L
Sbjct: 222 MATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
Query: 305 R 305
Sbjct: 282 N 282
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 56/312 (17%), Positives = 107/312 (34%), Gaps = 55/312 (17%)
Query: 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH--EVAVKILHPVKEDRMRVLLER 94
+ L+ IG+G FGEVW + EVAVKI +E E
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGK----------WRGEEVAVKIFSSREERSWFREAEI 87
Query: 95 LNDLFLKCQGV---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVF 150
+ L+ + + + + ++ ++E GS+ D L +++ +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQ--LWLVSDYHEHGSLFD---YLNRYTVTVEGMI 142
Query: 151 RYAIDLAQGILQLHSKGILVL--------NLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
+ A+ A G+ LH + + +LK N ++ + + D+G+
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 203 PSSDLPR-RLGTPNYMAPEQWQPEVRGPISFETDSWG--FACSII--EMLTGVQPRCGR- 256
P R+GT YMAPE + FE+ +A ++ E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSIN-MKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 257 --------------SVDEIYDAVVRRQEIPPIPSGL-----PPAVENVLLGCFEYDLRSR 297
SV+E+ V ++ P IP+ + ++ C+ + +R
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
Query: 298 PLMTDILRVFKS 309
I +
Sbjct: 322 LTALRIKKTLSQ 333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 48/283 (16%), Positives = 95/283 (33%), Gaps = 31/283 (10%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
L++R + G F V+ A S E A+K L E+ + + K
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSG------REYALKRL-LSNEEEKNRAIIQEVCFMKKL 82
Query: 103 QGVEGICWLQGISVI--------NGKICIIMKFYEGSVGDRMAQLK-GGKLSLSNVFRYA 153
G I + I + ++ + +G + + + +++ G LS V +
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 154 IDLAQGILQLHSKGILVLN--LKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS------ 205
+ + +H + +++ LK N +L+ L D G + P S
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 206 ---DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262
+ R TP Y PE PI + D W C + + P + I
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262
Query: 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ IPP + +++ + + R + +++
Sbjct: 263 NGKYS---IPPHDT-QYTVFHSLIRAMLQVNPEERLSIAEVVH 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/303 (18%), Positives = 110/303 (36%), Gaps = 49/303 (16%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
+ L +G+G +GEVW + + VAVKI E E N + L+
Sbjct: 10 ITLLECVGKGRYGEVWRGS-WQGE-------NVAVKIFSSRDEKSWFRETELYNTVMLRH 61
Query: 103 QGVEG-ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGI 160
+ + G I + ++ +I ++E GS+ D L+ L + R + +A G+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY---LQLTTLDTVSCLRIVLSIASGL 118
Query: 161 LQLHSKGILVLN--------LKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-RL 211
LH + LK N ++ + + + D+G+ + R+
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 212 GTPNYMAPE--QWQPEVRGPISFE-TDSWGFACSII--EMLTGVQPRCGR---------- 256
GT YMAPE +V S++ D +A ++ E+ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDI--WAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236
Query: 257 -----SVDEIYDAVVRRQEIPPIPSGL-----PPAVENVLLGCFEYDLRSRPLMTDILRV 306
S +++ V Q+ P IP+ ++ ++ C+ + +R I +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 307 FKS 309
Sbjct: 297 LTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 50/311 (16%), Positives = 106/311 (34%), Gaps = 53/311 (17%)
Query: 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
+++ +IG+G +GEVW+ E +VAVK+ +E E
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKW------RGE--KVAVKVFFTTEEASWFRETEIYQ 84
Query: 97 DLFLKCQGV---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRY 152
+ ++ + + + ++ +I ++E GS+ D LK L ++ +
Sbjct: 85 TVLMRHENILGFIAAD--IKGTGSWTQLYLITDYHENGSLYD---YLKSTTLDAKSMLKL 139
Query: 153 AIDLAQGILQLHSKGILVLN--------LKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204
A G+ LH++ LK N ++ + + D+G+ +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 205 SDLPR-RLGTPNYMAPE--QWQPEVRGPISFE-TDSWGFACSII--EMLTGVQPRCGR-- 256
P R+GT YM PE S+ D ++ +I E+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM--YSFGLILWEVARRCVSGGIVEE 257
Query: 257 -------------SVDEIYDAVVRRQEIPPIPSGL-----PPAVENVLLGCFEYDLRSRP 298
S +++ + V ++ P P+ + ++ C+ ++ SR
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 299 LMTDILRVFKS 309
+ +
Sbjct: 318 TALRVKKTLAK 328
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 61/309 (19%), Positives = 118/309 (38%), Gaps = 59/309 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ L+L RG FG VW A +E VAVKI + + E +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQL------LNE--YVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 98 LFLKCQGV---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
+K + + G + + ++ + +I F+E GS+ D LK +S + + A
Sbjct: 73 PGMKHENILQFIGAE--KRGTSVDVDLWLITAFHEKGSLSD---FLKANVVSWNELCHIA 127
Query: 154 IDLAQGILQLHSKGILVLN----------LKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203
+A+G+ LH + + +K N +L A + D G+ L
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA-LKFEAGKS 186
Query: 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWG----FACSII--EMLTGVQPRCGR- 256
+ D ++GT YMAPE G I+F+ D++ +A ++ E+ + G
Sbjct: 187 AGDTHGQVGTRRYMAPEVL----EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 257 ---------------SVDEIYDAVVRRQEIPPIPSGLPP-----AVENVLLGCFEYDLRS 296
S++++ + VV +++ P + + + C+++D +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 297 RPLMTDILR 305
R +
Sbjct: 303 RLSAGCVGE 311
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 46/259 (17%), Positives = 85/259 (32%), Gaps = 17/259 (6%)
Query: 58 WLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117
WL T ++ + + + + + + + S
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 118 NGKICIIMKFYE-GSVGDRMAQLKGGK-LSLSNVFRYAIDLAQGILQLHSKGILVLNLKP 175
+ I M+ ++ D M + + I +A+ + LHSKG++ +LKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 176 FNFILNEADRAVLGDVGI---------PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
N D +GD G+ +L + ++GT YM+PEQ
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH--- 249
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286
S + D + + E+L + R I VR + P + + P ++
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITD-VRNLKFPLLFTQKYPQEHMMV 306
Query: 287 LGCFEYDLRSRPLMTDILR 305
RP TDI+
Sbjct: 307 QDMLSPSPTERPEATDIIE 325
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 58/275 (21%), Positives = 103/275 (37%), Gaps = 50/275 (18%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-VKED---RMRVLLE-----R 94
+LR +GRG G+V+ A + VA+K++ + D R R+ E R
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERI------VALKLMSETLSSDPVFRTRMQREARTAGR 90
Query: 95 LNDLFLKCQGVEGICWLQGISV-----INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSN 148
L + + + + I+G++ + M+ G + + + G L+
Sbjct: 91 LQE--------PHV-----VPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPR 135
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
+ + H+ G ++KP N +++ D A L D GI L
Sbjct: 136 AVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN- 194
Query: 209 RRLGTPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267
+GT YMAPE+ ++ D + C + E LTG P G + + +
Sbjct: 195 -TVGTLYYMAPER----FSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-- 247
Query: 268 RQEIPPIPS----GLPPAVENVLLGCFEYDLRSRP 298
+ P PS G+P A + V+ + R
Sbjct: 248 -NQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 49/326 (15%), Positives = 93/326 (28%), Gaps = 74/326 (22%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH--EVAVKILHPVKEDRMR-----V 90
+ LKL IGRG +G V+ + VAVK+
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGS----------LDERPVAVKVFSFANRQNFINEKNIY 59
Query: 91 LLERLND----LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS 145
+ + F+ + + + ++M++Y GS+ L
Sbjct: 60 RVPLMEHDNIARFI------VGD-ERVTADGRMEYLLVMEYYPNGSLXK---YLSLHTSD 109
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLN---------LKPFNFILNEADRAVLGDVGIPHL 196
+ R A + +G+ LH++ + L N ++ V+ D G+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 197 LLGIPLPSSDLP-----RRLGTPNYMAPE----QWQPEVRGPISFETDSWGFACSIIEML 247
L G L +GT YMAPE + D + E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 248 TGVQPRC------------------GRSVDEIYDAVVRRQEIPPIP------SGLPPAVE 283
+ +++ V R ++ P P S +++
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 284 NVLLGCFEYDLRSRPLMTDILRVFKS 309
+ C++ D +R
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 52/271 (19%), Positives = 97/271 (35%), Gaps = 56/271 (20%)
Query: 44 KLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVK--EDRMRVLLE-----RL 95
+++ I G G ++LA ++ V +K L E + + E +
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRP------VVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 96 N--------DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLS 147
+ + I +M++ G + + KG KL ++
Sbjct: 137 VHPSIVQIFN-----FVEHTDRHGDPVGYI------VMEYVGGQS---LKRSKGQKLPVA 182
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
Y +++ + LHS G++ +LKP N +L E ++ L D+G + +
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRI-------NSF 234
Query: 208 PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267
GTP + APE VR + TD + ++ + + R GR VD +
Sbjct: 235 GYLYGTPGFQAPEI----VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------ 284
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRP 298
E P+ + +L + D R R
Sbjct: 285 -PEDDPVLK-TYDSYGRLLRRAIDPDPRQRF 313
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 29/259 (11%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMR-VLLERLNDLFLKCQG 104
IGRG FGEV+ D + + A+K L + L ER +
Sbjct: 197 IGRGGFGEVYGCRK----ADTGKMY--AMKCLDKKRIKMKQGETLALNER--IMLSLVST 248
Query: 105 VEG--ICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGIL 161
+ I + K+ I+ G GD L + G S +++ YA ++ G+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
+H++ ++ +LKP N +L+E + D+G L +GT YMAPE
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMAPEV 361
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQP---RCGRSVDEIYDAVVRRQEIPPIPSGL 278
Q V D + C + ++L G P + EI + +P
Sbjct: 362 LQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSF 417
Query: 279 PPAVENVLLGCFEYDLRSR 297
P + ++L G + D+ R
Sbjct: 418 SPELRSLLEGLLQRDVNRR 436
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 40/269 (14%), Positives = 88/269 (32%), Gaps = 19/269 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +G G G + + + +VAVK + P +R L +
Sbjct: 27 CPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPECFS----FADREVQLLRESD 75
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+ I ++ ++ + + Q K G+ L
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHL 134
Query: 164 HSKGILVLNLKPFNFILNEAD-----RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
HS I+ +LKP N +++ + +A++ D G+ L S GT ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--PPIPS 276
PE + + ++ D + C +++ G+S+ + ++ +
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305
++ D + RP +L+
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 37/261 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
+G+G FG+V+LA + +++ A+K L + +D + RVL
Sbjct: 25 LGKGSFGKVFLAEF----KKTNQFF--AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL C Q + +M++ G GD M + K LS YA ++
Sbjct: 79 FL----THMFCTFQ----TKENLFFVMEYLNG--GDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
G+ LHSKGI+ +LK N +L++ + D G + + GTP+Y
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG----MCKENMLGDAKTNTFCGTPDY 184
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE + + D W F + EML G P G+ +E++ ++ P P
Sbjct: 185 IAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPR 239
Query: 277 GLPPAVENVLLGCFEYDLRSR 297
L +++L+ F + R
Sbjct: 240 WLEKEAKDLLVKLFVREPEKR 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 61/297 (20%), Positives = 110/297 (37%), Gaps = 61/297 (20%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-VKED---RMRVLLE-----R 94
K+ ++G G V+LA D +VA+K + +E R E +
Sbjct: 14 KIVDKLGGGGMSTVYLAE------DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 95 LN--------DLFLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLS 145
L+ D E ++M++ EG ++ + + G LS
Sbjct: 68 LSHQNIVSMID-----VDEED-----------DCYYLVMEYIEGPTLSEYIES--HGPLS 109
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
+ + + GI H I+ ++KP N +++ + D GI L L +
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 206 DLPRRLGTPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCGRSVDEI-YD 263
+ LGT Y +PEQ +G TD + + EML G P G + I
Sbjct: 170 NH--VLGTVQYFSPEQ----AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223
Query: 264 AVVRRQEIPPIPS----GLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQ 311
+ + +P + + +P ++ NV+L E D +R + D+ V ++
Sbjct: 224 HI--QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 57/271 (21%), Positives = 97/271 (35%), Gaps = 53/271 (19%)
Query: 49 IGRGPFGEVWLATH----------YLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL 98
IG+G FG+V + Y++ + C E +EV + KE +++ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR----NVFKE---LQIMQGLEHP 75
Query: 99 FLKCQGVEGICWLQGISVIN--------GKICIIMKFYEGSVGDRMAQL-KGGKLSLSNV 149
FL +N + +++ G GD L + V
Sbjct: 76 FL----------------VNLWYSFQDEEDMFMVVDLLLG--GDLRYHLQQNVHFKEETV 117
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
+ +L + L ++ I+ ++KP N +L+E + D I +L ++
Sbjct: 118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---- 173
Query: 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP---RCGRSVDEIYDAVV 266
GT YMAPE + SF D W + E+L G +P R S EI
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+ PS + ++L E + R
Sbjct: 234 --TTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 56/256 (21%), Positives = 100/256 (39%), Gaps = 34/256 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
IGRG FGEV + ++ D+ A+KIL +K R +L + +
Sbjct: 82 IGRGAFGEVAVVKL----KNADKVF--AMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLSNVFRYAIDLA 157
+ Q + + ++M +Y G GD + L +L Y ++
Sbjct: 136 I----TTLHYAFQD----DNNLYLVMDYYVG--GDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
I +H + ++KP N +++ L D G L+ S + +GTP+Y+
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYI 243
Query: 218 APE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---IP 272
+PE Q +G E D W + EML G P S+ E Y ++ +E P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303
Query: 273 PIPSGLPPAVENVLLG 288
+ + ++++
Sbjct: 304 TQVTDVSENAKDLIRR 319
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 36/258 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
IGRG F EV + + + A+KI+ +K + R +L + +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVY------AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLSNVFRYAIDLA 157
+ + Q + ++M++Y G GD + L G ++ Y ++
Sbjct: 123 I----TQLHFAFQD----ENYLYLVMEYYVG--GDLLTLLSKFGERIPAEMARFYLAEIV 172
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
I +H G + ++KP N +L+ L D G L S + +GTP+Y+
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA--VGTPDYL 230
Query: 218 APE----QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE--- 270
+PE G E D W EM G P S E Y +V +E
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290
Query: 271 IPPIPSGLPPAVENVLLG 288
+P + G+P + +
Sbjct: 291 LPLVDEGVPEEARDFIQR 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 68/289 (23%), Positives = 106/289 (36%), Gaps = 45/289 (15%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ L L +IGRG FGEV+ VAVK +E L +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTL------VAVKSC---RETLPPDLKAK--- 158
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLS 145
FL+ E I L G+ I I+M+ +G GD + L+ G +L
Sbjct: 159 -FLQ----EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG--GDFLTFLRTEGARLR 211
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
+ + + D A G+ L SK + +L N ++ E + + D G +
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG-----MSREEADG 266
Query: 206 DLPRRLGTPNY----MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260
G APE G S E+D W F + E + G P S +
Sbjct: 267 VYAASGGLRQVPVKWTAPEALN---YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ V + +P P P AV ++ C+ Y+ RP + I + +S
Sbjct: 324 TREFVEKGGRLPC-PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 44/246 (17%), Positives = 83/246 (33%), Gaps = 58/246 (23%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE---------- 93
+ +GRG FG V S++ K + D++ V E
Sbjct: 8 MIAEDLGRGEFGIVHRCVE-TSSK-----KTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 94 ---RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLS 147
L++ F E ++ +I +F G +R+ +L+
Sbjct: 62 NILHLHESF------ES----------MEELVMIFEFISG--LDIFERINT-SAFELNER 102
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL--GDVGIPHLLLGIPLPSS 205
+ Y + + + LHS I +++P N I + + + G L P
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGD 158
Query: 206 DLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEI 261
+ P Y A PEV +S TD W + + +L+G+ P + +I
Sbjct: 159 NFRLLFTAPEYYA-----PEVHQHDVVSTATDMW--SLGTLVYVLLSGINPFLAETNQQI 211
Query: 262 YDAVVR 267
+ ++
Sbjct: 212 IENIMN 217
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 37/252 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
+G+G FG+V L+ + DE + AVKIL +++D + RVL
Sbjct: 349 LGKGSFGKVMLSER----KGTDELY--AVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL + Q ++ +M++ G GD M + + G+ + YA ++A
Sbjct: 403 FL----TQLHSCFQ----TMDRLYFVMEYVNG--GDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
G+ L SKGI+ +LK N +L+ + D G + + + GTP+Y
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFCGTPDY 508
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE P D W F + EML G P G DE++ +++ P
Sbjct: 509 IAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPK 563
Query: 277 GLPPAVENVLLG 288
+ + G
Sbjct: 564 SMSKEAVAICKG 575
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 51/243 (20%), Positives = 93/243 (38%), Gaps = 39/243 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH------PVKEDRMRVLLERLND 97
++G G +GEV L + E A+K++ D + + + +
Sbjct: 39 FKVRKLGSGAYGEVLLCKE-KNGHS-----EKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 98 LF-----LKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNV 149
++ LK I L + ++ +FYEG G +++ + K +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG--GELFEQI--INRHKFDECDA 148
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSD 206
+ GI LH I+ ++KP N +L N+ + D G+
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS----KDYK 204
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDA 264
L RLGT Y+APE ++ + + D W +C +I +L G P G++ +I
Sbjct: 205 LRDRLGTAYYIAPEV----LKKKYNEKCDVW--SCGVIMYILLCGYPPFGGQNDQDIIKK 258
Query: 265 VVR 267
V +
Sbjct: 259 VEK 261
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 62/301 (20%), Positives = 108/301 (35%), Gaps = 45/301 (14%)
Query: 15 YEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHE 74
+ + DS + + + + + +G+G FGEV + +
Sbjct: 158 FADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQV----RATGKMY- 212
Query: 75 VAVKIL---HPVKEDRM------RVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIM 125
A K L K + +LE++N F+ V + +C+++
Sbjct: 213 -ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV----VSLAYAYE----TKDALCLVL 263
Query: 126 KFYEGSVGDRMAQL-KGGKLSLSN---VFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181
G GD + G+ VF YA ++ G+ LH + I+ +LKP N +L+
Sbjct: 264 TLMNG--GDLKFHIYHMGQAGFPEARAVF-YAAEICCGLEDLHRERIVYRDLKPENILLD 320
Query: 182 EADRAVLGDVGIPHLLLGIPLPSSDLPR-RLGTPNYMAPEQWQPEVRGPISFETDSWGFA 240
+ + D+G L + +P + R+GT YMAPE + E +F D W
Sbjct: 321 DHGHIRISDLG-----LAVHVPEGQTIKGRVGTVGYMAPEVVKNE---RYTFSPDWWALG 372
Query: 241 CSIIEMLTGVQPRCGR----SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRS 296
C + EM+ G P R +E+ V P ++ D
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAE 430
Query: 297 R 297
R
Sbjct: 431 R 431
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 37/261 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
+G+G FG+V LA ++ + + AVK+L +++D + R+L N
Sbjct: 31 LGKGSFGKVMLARV----KETGDLY--AVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL + C Q ++ +M+F G GD M + K + + YA ++
Sbjct: 85 FL----TQLFCCFQ----TPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEII 134
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
++ LH KGI+ +LK N +L+ L D G + + + GTP+Y
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGICNGVTTATFCGTPDY 190
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE Q D W + EML G P + D++++A++ + P+
Sbjct: 191 IAPEILQ---EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYPT 245
Query: 277 GLPPAVENVLLGCFEYDLRSR 297
L +L + R
Sbjct: 246 WLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 37/261 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
+G+G FG+V L+ + DE + AVKIL +++D + RVL
Sbjct: 28 LGKGSFGKVMLSER----KGTDELY--AVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL + Q ++ +M++ G GD M + + G+ + YA ++A
Sbjct: 82 FL----TQLHSCFQ----TMDRLYFVMEYVNG--GDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
G+ L SKGI+ +LK N +L+ + D G + + + GTP+Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG----MCKENIWDGVTTKTFCGTPDY 187
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE P D W F + EML G P G DE++ +++ P
Sbjct: 188 IAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPK 242
Query: 277 GLPPAVENVLLGCFEYDLRSR 297
+ + G R
Sbjct: 243 SMSKEAVAICKGLMTKHPGKR 263
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 34/232 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVLLERLNDLFLKCQGV 105
+GRG F V + + E A K L ++ R +L E + +
Sbjct: 37 LGRGKFAVVRQCISKSTGQ------EYAAKFLKKRRRGQDCRAEILHEI--AVLELAKSC 88
Query: 106 EGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
+ L + +I +I+++ G G +S ++V R + +G+
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAG--GEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 163 LHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
LH I+ L+LKP N +L + + D G+ + + +L +GTP Y+A
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG----HACELREIMGTPEYLA- 201
Query: 220 EQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAVVR 267
PE+ PI+ TD W II +LT P G E Y + +
Sbjct: 202 ----PEILNYDPITTATDMW--NIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 35/236 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH----PVKEDRMRVLLERLNDLF 99
K + +G+G FGEV L T E AVK++ K D+ +L E
Sbjct: 29 KGQRVLGKGSFGEVILCKD-KITG-----QECAVKVISKRQVKQKTDKESLLREVQL--- 79
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAIDL 156
LK I L G ++ + Y G G D + + + S + R +
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG--GELFDEI--ISRKRFSEVDAARIIRQV 135
Query: 157 AQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGT 213
GI +H I+ +LKP N +L +++ A + D G+ S + ++GT
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE----ASKKMKDKIGT 191
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVR 267
Y+APE + G + D W + +I +L+G P G + +I V +
Sbjct: 192 AYYIAPEV----LHGTYDEKCDVW--STGVILYILLSGCPPFNGANEYDILKKVEK 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 54/235 (22%), Positives = 91/235 (38%), Gaps = 34/235 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVLLERLNDLFL 100
+ ++G G +GEV L T E A+KI+ ++L E L
Sbjct: 40 QRVKKLGSGAYGEVLLCRD-KVTHV-----ERAIKIIRKTSVSTSSNSKLLEEVAV---L 90
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAIDLA 157
K I L ++M+ Y+G G D + + K + + +
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKG--GELFDEI--IHRMKFNEVDAAVIIKQVL 146
Query: 158 QGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGTP 214
G+ LH I+ +LKP N +L ++ A++ D G+ + + RLGT
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE----NQKKMKERLGTA 202
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVR 267
Y+APE +R + D W + +I +L G P G++ EI V +
Sbjct: 203 YYIAPEV----LRKKYDEKCDVW--SIGVILFILLAGYPPFGGQTDQEILRKVEK 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 56/247 (22%), Positives = 91/247 (36%), Gaps = 59/247 (23%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLE--------- 93
+ +G G FG V +T K ++ P D+ V E
Sbjct: 54 DILEELGSGAFGVVHRCVE-KATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 94 ----RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSL 146
L+D F E ++ +I++F G G DR+A + K+S
Sbjct: 108 PKLINLHDAF------ED----------KYEMVLILEFLSG--GELFDRIAA-EDYKMSE 148
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVLGDVGIPHLLLGIPLPS 204
+ V Y +G+ +H I+ L++KP N + +A + D G+ L P
Sbjct: 149 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPD 204
Query: 205 SDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDE 260
+ T + A PE+ R P+ F TD W A ++ +L+G+ P G E
Sbjct: 205 EIVKVTTATAEFAA-----PEIVDREPVGFYTDMW--AIGVLGYVLLSGLSPFAGEDDLE 257
Query: 261 IYDAVVR 267
V R
Sbjct: 258 TLQNVKR 264
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 32/259 (12%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVLLER-----LNDLFL 100
+G+G FG+V+L ++ Y A+K+L DR+R +ER +N F+
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLY---AMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQG 159
V+ Q GK+ +I+ F G GD +L K + +V Y +LA
Sbjct: 89 ----VKLHYAFQ----TEGKLYLILDFLRG--GDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYMA 218
+ LHS GI+ +LKP N +L+E L D G L + GT YMA
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG----LSKESIDHEKKAYSFCGTVEYMA 194
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278
PE R + D W F + EMLTG P G+ E +++ + +P L
Sbjct: 195 PEVVN---RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFL 249
Query: 279 PPAVENVLLGCFEYDLRSR 297
P +++L F+ + +R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 26/280 (9%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
AW I +L+L ++G+G FGEVW+ T + VA+K L P L E
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGT-------WNGTTRVAIKTLKPGTMSPEAFLQEA 230
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
L+ E + L + V I I+ ++ GS+ D + G L L + A
Sbjct: 231 QVMKKLRH---EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD---LPRR 210
+A G+ + + +L+ N ++ E + D G+ L+ + P +
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269
+ APE G + ++D W F + E+ T G P G E+ D V R
Sbjct: 347 -----WTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+P P P ++ +++ C+ + RP + +
Sbjct: 399 RMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 37/261 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
IG+G FG+V LA H + + ++ AVK+L +K+ VLL+ +
Sbjct: 46 IGKGSFGKVLLARH----KAEEVFY--AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL V Q K+ ++ + G G+ L + YA ++A
Sbjct: 100 FL----VGLHFSFQ----TADKLYFVLDYING--GELFYHLQRERCFLEPRARFYAAEIA 149
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
+ LHS I+ +LKP N +L+ VL D G L + + GTP Y
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG----LCKENIEHNSTTSTFCGTPEY 205
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+APE + P D W + EML G+ P R+ E+YD ++ + +
Sbjct: 206 LAPEVLH---KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLKP 260
Query: 277 GLPPAVENVLLGCFEYDLRSR 297
+ + ++L G + D R
Sbjct: 261 NITNSARHLLEGLLQKDRTKR 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 52/245 (21%), Positives = 93/245 (37%), Gaps = 55/245 (22%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVK-ILHPVKEDRMRVLLE--------- 93
+ +G G FG V T + A K ++ P + D+ V E
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 94 ----RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSL 146
L+D F E + ++ +I +F G G +++A + K+S
Sbjct: 214 PTLVNLHDAF------ED----------DNEMVMIYEFMSG--GELFEKVAD-EHNKMSE 254
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVLGDVGIPHLLLGIPLPS 204
Y + +G+ +H + L+LKP N + ++ L D G+ L P
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPK 310
Query: 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIY 262
+ GT + APE + + P+ + TD W + ++ +L+G+ P G + DE
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGK---PVGYYTDMW--SVGVLSYILLSGLSPFGGENDDETL 365
Query: 263 DAVVR 267
V
Sbjct: 366 RNVKS 370
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 38/267 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM--------RVLLERLND 97
+G G +G+V+L + Y A+K+L V++ + +VL
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLY---AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDL 156
FL V Q K+ +I+ + G G+ L + + + V Y ++
Sbjct: 119 PFL----VTLHYAFQ----TETKLHLILDYING--GELFTHLSQRERFTEHEVQIYVGEI 168
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL--LGIPLPSSDLPRRLGTP 214
+ LH GI+ ++K N +L+ VL D G L + + GT
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG----LSKEFVADETERAYDFCGTI 224
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP----RCGRSVDEIYDAVVRRQE 270
YMAP+ + G D W + E+LTG P S EI +++ +
Sbjct: 225 EYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE- 282
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSR 297
PP P + ++++ D + R
Sbjct: 283 -PPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 26/280 (9%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
AW I +L+L ++G+G FGEVW+ T + VA+K L P L E
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGT-------WNGTTRVAIKTLKPGTMSPEAFLQEA 313
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
L+ E + L + V I I+ ++ GS+ D + G L L + A
Sbjct: 314 QVMKKLRH---EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 369
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD---LPRR 210
+A G+ + + +L+ N ++ E + D G+ L+ + P +
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269
+ APE G + ++D W F + E+ T G P G E+ D V R
Sbjct: 430 -----WTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+P P P ++ +++ C+ + RP + +
Sbjct: 482 RMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 47/256 (18%), Positives = 85/256 (33%), Gaps = 51/256 (19%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+++ R+G G FG V H + E +VA+K + R
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGE------QVAIKQCRQELSPKNRERWCL--------- 61
Query: 104 GVEGICWLQGIS-----------------VINGKICIIMKFYE-GSVGDRMAQL-KGGKL 144
E I ++ ++ N + M++ E G + + Q L
Sbjct: 62 --E-IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV---LGDVGIPHLLLGIP 201
+ D++ + LH I+ +LKP N +L + + + D+G L
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--- 175
Query: 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVD 259
+GT Y+APE + + D W + + E +TG +P
Sbjct: 176 -QGELCTEFVGTLQYLAPELLEQKKYTV---TVDYW--SFGTLAFECITGFRPFLPNWQP 229
Query: 260 EIYDAVVRRQEIPPIP 275
+ VR + I
Sbjct: 230 VQWHGKVREKSNEHIV 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 56/292 (19%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-VKED---RMRVLLE-----R 94
+L +G G EV LA D ++ +VAVK+L + D +R E
Sbjct: 15 ELGEILGFGGMSEVHLAR------DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 95 LN--------DLFLKCQGVEGICWLQGISVINGKIC-IIMKFYEG-SVGDRMAQLKGGKL 144
LN D G G + I+M++ +G ++ D + G +
Sbjct: 69 LNHPAIVAVYD-----TGEA--------ETPAGPLPYIVMEYVDGVTLRDIVHT--EGPM 113
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204
+ D Q + H GI+ ++KP N +++ + + D GI +
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 205 SDLPRRLGTPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263
+ +GT Y++PEQ RG + +D + C + E+LTG P G S +
Sbjct: 174 TQTAAVIGTAQYLSPEQ----ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-- 227
Query: 264 AVVRRQEIPPIPS----GLPPAVENVLLGCFEYDLRSRP-----LMTDILRV 306
A +E P PS GL ++ V+L + +R + D++RV
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 52/260 (20%), Positives = 103/260 (39%), Gaps = 36/260 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
+G+G FG+V L + Y+ A+KIL + +D + +L+ F
Sbjct: 13 LGKGTFGKVILVRE----KATGRYY--AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
L Q + ++C +M++ G G+ L + + Y ++
Sbjct: 67 L----TALKYAFQ----THDRLCFVMEYANG--GELFFHLSRERVFTEERARFYGAEIVS 116
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNYM 217
+ LHS+ ++ ++K N +L++ + D G L + + GTP Y+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG----LCKEGISDGATMKTFCGTPEYL 172
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE + D WG + EM+ G P + + +++ ++ + P
Sbjct: 173 APEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRT 227
Query: 278 LPPAVENVLLGCFEYDLRSR 297
L P +++L G + D + R
Sbjct: 228 LSPEAKSLLAGLLKKDPKQR 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 58/270 (21%), Positives = 102/270 (37%), Gaps = 46/270 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
IGRG + +V L + D + A++++ ++ + V + N
Sbjct: 60 IGRGSYAKVLLVRL----KKTDRIY--AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL V Q ++ ++++ G GD M + + KL + Y+ +++
Sbjct: 114 FL----VGLHSCFQ----TESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
+ LH +GI+ +LK N +L+ L D G + L D GTPNY
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNY 219
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP---------RCGRSVDEIYDAVVR 267
+APE + F D W + EM+ G P + D ++ ++
Sbjct: 220 IAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+Q IP L +VL D + R
Sbjct: 277 KQ--IRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/300 (19%), Positives = 111/300 (37%), Gaps = 35/300 (11%)
Query: 9 QPADFEYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTED 68
DF D+ + + + + +G+G FG+V L +
Sbjct: 116 AEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKE----KA 171
Query: 69 CDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLFLKCQGVEGICWLQGISVING 119
Y+ A+KIL V +D + +L+ FL Q +
Sbjct: 172 TGRYY--AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL----TALKYSFQ----THD 221
Query: 120 KICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFN 177
++C +M++ G G+ L + S Y ++ + LHS K ++ +LK N
Sbjct: 222 RLCFVMEYANG--GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279
Query: 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSW 237
+L++ + D G+ + GTP Y+APE + D W
Sbjct: 280 LMLDKDGHIKITDFGLCKEGIKDGATMKTF---CGTPEYLAPEVLE---DNDYGRAVDWW 333
Query: 238 GFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
G + EM+ G P + +++++ ++ + P L P +++L G + D + R
Sbjct: 334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 59/270 (21%), Positives = 102/270 (37%), Gaps = 46/270 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
IGRG + +V L + D + A+K++ ++ + V + N
Sbjct: 17 IGRGSYAKVLLVRL----KKTDRIY--AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
FL V Q ++ ++++ G GD M + + KL + Y+ +++
Sbjct: 71 FL----VGLHSCFQ----TESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTPNY 216
+ LH +GI+ +LK N +L+ L D G + L D GTPNY
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG----MCKEGLRPGDTTSTFCGTPNY 176
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP---------RCGRSVDEIYDAVVR 267
+APE + F D W + EM+ G P + D ++ ++
Sbjct: 177 IAPEILR---GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
+Q IP L +VL D + R
Sbjct: 234 KQ--IRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 59/242 (24%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-EDRMRVLLE-------------R 94
+G G FG+V +T ++A KI+ +D+ V E +
Sbjct: 97 LGGGRFGQVHKCEE-TATG-----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFR 151
L D F E I ++M++ +G G DR+ + L+ +
Sbjct: 151 LYDAF------ES----------KNDIVLVMEYVDG--GELFDRIID-ESYNLTELDTIL 191
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL--GDVGIPHLLLGIPLPSSDLPR 209
+ + +GI +H IL L+LKP N + D + D G+ P L
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----KPREKLKV 247
Query: 210 RLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAV 265
GTP ++A PEV +SF TD W + +I +L+G+ P G + E + +
Sbjct: 248 NFGTPEFLA-----PEVVNYDFVSFPTDMW--SVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 266 VR 267
+
Sbjct: 301 LA 302
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 38/237 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF---- 99
+ +G+G FGEV T+ E AVK++ ++ + + +
Sbjct: 25 NIVCMLGKGSFGEVLKCKD-RITQQ-----EYAVKVI-----NKASAKNKDTSTILREVE 73
Query: 100 -LKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAID 155
LK I L I + I+ + Y G G D + +K + S + R
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTG--GELFDEI--IKRKRFSEHDAARIIKQ 129
Query: 156 LAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLG 212
+ GI +H I+ +LKP N +L ++ + D G+ ++ + R+G
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----QNTKMKDRIG 185
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVR 267
T Y+APE +RG + D W + +I +L+G P G++ +I V
Sbjct: 186 TAYYIAPEV----LRGTYDEKCDVW--SAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 31/287 (10%)
Query: 26 TAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVK 84
A T +K + +G G G V+ +H S +A K++H +K
Sbjct: 18 EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIK 71
Query: 85 EDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGK 143
++ L L +C I G +G+I I M+ + GS+ + K G+
Sbjct: 72 PAIRNQIIRELQVLH-ECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGR 127
Query: 144 LSLSNVFRYAIDLAQGILQLHSKG-ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
+ + + +I + +G+ L K I+ ++KP N ++N L D G+
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--------- 178
Query: 203 PSSDLPRRL-----GTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257
S L + GT +YM+PE+ Q S ++D W S++EM G P
Sbjct: 179 -SGQLIDSMANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
E+ + E + P L F D R + ++L
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 55/267 (20%), Positives = 100/267 (37%), Gaps = 36/267 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV---------LLERLNDLF 99
+G+G FG V+LA S +A+K+L + ++ V + L
Sbjct: 17 LGKGKFGNVYLAREKQSK------FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
I L G ++ +I+++ G +L K K Y +LA
Sbjct: 71 --------ILRLYGYFHDATRVYLILEYAPL--GTVYRELQKLSKFDEQRTATYITELAN 120
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
+ HSK ++ ++KP N +L A + D G + PSS GT +Y+
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG-----WSVHAPSSRRTDLCGTLDYLP 175
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278
PE + + + D W E L G P + E Y + R + P +
Sbjct: 176 PEMIEGRMHDE---KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFV 230
Query: 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305
+++ +++ RP++ ++L
Sbjct: 231 TEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 32/260 (12%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM-------RVLLERLNDL 98
+G+G +G+V+ + A+K+L V+ + R +LE +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIF---AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLA 157
F+ V+ I Q GK+ +I+++ G G+ QL + G Y +++
Sbjct: 82 FI----VDLIYAFQ----TGGKLYLILEYLSG--GELFMQLEREGIFMEDTACFYLAEIS 131
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+ LH KGI+ +LKP N +LN L D G+ + + GT YM
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF---CGTIEYM 188
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE R + D W + +MLTG P G + + D +++ + +P
Sbjct: 189 APEILM---RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPY 243
Query: 278 LPPAVENVLLGCFEYDLRSR 297
L ++L + + SR
Sbjct: 244 LTQEARDLLKKLLKRNAASR 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 53/268 (19%), Positives = 91/268 (33%), Gaps = 44/268 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
+GRG FGEV+ + + + A K L K + +L +++ F
Sbjct: 193 LGRGGFGEVFACQM----KATGKLY--ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-----KGGKLSLSNVFRYAI 154
+ V + +C++M G GD + Y
Sbjct: 247 I----VSLAYAFE----TKTDLCLVMTIMNG--GDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR-RLGT 213
+ G+ LH + I+ +LKP N +L++ + D+G L + GT
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG----LAVELKAGQTKTKGYAGT 352
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR----SVDEIYDAVVRRQ 269
P +MAPE E F D + ++ EM+ P R E+ V+ +
Sbjct: 353 PGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSR 297
P PA ++ + D R
Sbjct: 410 --VTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 53/252 (21%), Positives = 101/252 (40%), Gaps = 30/252 (11%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
IGRG FGEV L H + + + A+K+L +K R ++ N +
Sbjct: 77 IGRGAFGEVQLVRH----KSTRKVY--AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
+ V+ Q + + ++M++ G GD + + + Y ++
Sbjct: 131 V----VQLFYAFQD----DRYLYMVMEYMPG--GDLVNLMSNYDVPEKWARFYTAEVVLA 180
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ +HS G + ++KP N +L+++ L D G + + D +GTP+Y++P
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISP 238
Query: 220 EQWQPE-VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG- 277
E + + G E D W + EML G P S+ Y ++ + P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 278 -LPPAVENVLLG 288
+ +N++
Sbjct: 299 DISKEAKNLICA 310
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 36/270 (13%), Positives = 65/270 (24%), Gaps = 68/270 (25%)
Query: 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYH--EVAVKILHPV----KEDRMRVLLE----- 93
L G P + W A D +VA+ + P + L
Sbjct: 35 LLIFHGGVPPLQFWQAL--------DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYA 153
R++ G+ + + ++ ++ G + ++ S R
Sbjct: 87 RIDK--------PGVARVLDVVHTRAGGLVVAEWIRGG---SLQEVADTSPSPVGAIRAM 135
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
LA H G+ + P ++ VL
Sbjct: 136 QSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------------------- 174
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR-QEIP 272
M + + D G S+ +L P V R P
Sbjct: 175 --TMPDA----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 273 PIPS----GLPPAVENVLLGCFEYDLRSRP 298
P+ +P + V + D R
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 28/238 (11%)
Query: 25 RTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-V 83
+T T + + L+ +G G G+VW + +AVK +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGH------VIAVKQMRRSG 62
Query: 84 KEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGK 143
++ + +L L+ + I G + N + I M+ +++ + G
Sbjct: 63 NKEENKRILMDLDVVLKSHDC-PYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGP 120
Query: 144 LSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
+ + + + + + + L K G++ ++KP N +L+E + L D GI
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI--------- 171
Query: 203 PSSDLPRRL------GTPNYMAPEQWQPEVR--GPISFETDSWGFACSIIEMLTGVQP 252
S L G YMAPE+ P D W S++E+ TG P
Sbjct: 172 -SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 42/265 (15%), Positives = 83/265 (31%), Gaps = 44/265 (16%)
Query: 44 KLRHRIGRGPFGEVWLATH---------------YLSTEDCDEYHEVA--VKIL----HP 82
L+ IG+G +G V +A + + + + V+++ HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 83 -------VKEDRMRVLL--ERLN--DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGS 131
V ED + L E + L K + +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 132 VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ----LHSKGILVLNLKPFNFILNEADRAV 187
+ L + ++ + I LH++GI ++KP NF+ +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 188 L--GDVGI-PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII 244
+ D G+ + + GTP ++APE + D+W + ++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-SYGPKCDAW--SAGVL 265
Query: 245 --EMLTGVQPRCGRSVDEIYDAVVR 267
+L G P G + + V+
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 47/278 (16%), Positives = 85/278 (30%), Gaps = 55/278 (19%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +G+G V+ H + + A+K+ + + R + R
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMR--------- 56
Query: 104 GVEGICWLQGIS---------VI----NGKICIIMKFYE-GSVGDRMAQL-KGGKLSLSN 148
E L+ ++ + +IM+F GS+ + + L S
Sbjct: 57 --E-FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV----LGDVGIPHLLLGIPLPS 204
D+ G+ L GI+ N+KP N + + L D G L
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE----DD 169
Query: 205 SDLPRRLGTPNYMAPE-----QWQPEVRGPISFETDSWGFACSIIEMLTGVQP----RCG 255
GT Y+ P+ + + + D W + TG P
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 256 RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYD 293
R E+ ++ + PSG V+ G ++
Sbjct: 230 RRNKEVMYKIITGK-----PSGAISGVQKAENGPIDWS 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 44/272 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G FG VW A + EV VK + + +VL + + + I
Sbjct: 32 LGSGAFGFVWTAVDKEKNK------EVVVKFI-----KKEKVLEDCWIEDPKLGKVTLEI 80
Query: 109 CWLQGIS---------VI--NGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDL 156
L + + G ++M+ + GS D A + + +L L
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
+ L K I+ ++K N ++ E L D G GT Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG----SAAYLERGKLFYTFCGTIEY 195
Query: 217 MAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
APE RGP E + W + + ++ P C ++E +A +
Sbjct: 196 CAPEVLMGNPYRGP---ELEMW--SLGVTLYTLVFEENPFCE--LEETVEAAIH------ 242
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P + + +++ G + R + ++
Sbjct: 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 65/308 (21%), Positives = 107/308 (34%), Gaps = 71/308 (23%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + L +G G FGEV+ + +VAVK L E + D
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL---PEVCSE---QDELD 79
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGD--------RMAQL 139
FL E I G+S+ + I+M+ G GD R
Sbjct: 80 -FLM----EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG--GDLKSFLRETRPRPS 132
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVGIPHL 196
+ L++ ++ A D+A G L +FI + A R L P
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEEN----------HFIHRDI--AARNCLLTCPGPGR 180
Query: 197 LLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWGFAC 241
+ I D + R + +Y M PE + + G + +TD+W F
Sbjct: 181 VAKI----GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF---MEGIFTSKTDTWSFGV 233
Query: 242 SIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM 300
+ E+ + G P +S E+ + V + P P P V ++ C+++ RP
Sbjct: 234 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNF 292
Query: 301 TDILRVFK 308
IL +
Sbjct: 293 AIILERIE 300
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 59/264 (22%), Positives = 105/264 (39%), Gaps = 42/264 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
+G G F V LA EY A+KIL H +KE+++ R ++ RL+ F
Sbjct: 38 LGEGSFSTVVLARE---LATSREY---AIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
V+ Q + K+ + + + G+ + + K G + Y ++
Sbjct: 92 F----VKLYFTFQD----DEKLYFGLSYAKN--GELLKYIRKIGSFDETCTRFYTAEIVS 141
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPN 215
+ LH KGI+ +LKP N +LNE + D G + P S R +GT
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG----TAKVLSPESKQARANSFVGTAQ 197
Query: 216 YMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
Y++PE + + +D W C I +++ G+ P + I+ +++ +
Sbjct: 198 YVSPELLTEKSACKS-----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YD 250
Query: 274 IPSGLPPAVENVLLGCFEYDLRSR 297
P P +++ D R
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKR 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 46/273 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLKCQGVE 106
+G+G F + + + + A KI+ + + R + E
Sbjct: 23 LGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSM-----------E 65
Query: 107 ----------GICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAID 155
+ G N + ++++ S+ + + L+ Y
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQ 123
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-GTP 214
+ G LH ++ +LK N LNE +GD G L + + L GTP
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVLCGTP 179
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
NY+APE + SFE D W + I +L G P + E Y + + +
Sbjct: 180 NYIAPEVLS---KKGHSFEVDVW--SIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--Y 232
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP + P +++ + D +RP + ++L
Sbjct: 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 58/295 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+K + K +G G FG V+ E VA+K L +E + N
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGL--WIPEGEKVKIPVAIKEL---REATS----PKANK 62
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSL 146
L E +C L GI + + +I + G + D + + +
Sbjct: 63 EILD----EAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGS 116
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
+ + + +A+G+ L + ++ +L N ++ + D G
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-------------- 162
Query: 207 LPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQP 252
L + LG MA E + ++D W + ++ E++T G +P
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 253 RCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
G EI + + + +P P V ++ C+ D SRP +++ F
Sbjct: 220 YDGIPASEISSILEKGERLPQ-PPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 40/286 (13%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W ++ + + ++H++G G +GEV+ + VAVK L KED M V
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGV-WKKYS-----LTVAVKTL---KEDTMEV---- 260
Query: 95 LNDLFLKCQGV------EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLS 147
+ FLK V + L G+ II +F G++ D + + ++S
Sbjct: 261 --EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 318
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG---IPLPS 204
+ A ++ + L K + NL N ++ E + D G+ L+ G
Sbjct: 319 VLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263
+ P + APE S ++D W F + E+ T G+ P G + ++Y+
Sbjct: 379 AKFPIKW-----TAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430
Query: 264 AVVR--RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+ + R E P G P V ++ C++++ RP +I + F
Sbjct: 431 LLEKDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 46/278 (16%), Positives = 84/278 (30%), Gaps = 55/278 (19%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +G+G V+ H + + A+K+ + + R + R
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMR--------- 56
Query: 104 GVEGICWLQGIS---------VI----NGKICIIMKFYE-GSVGDRMAQL-KGGKLSLSN 148
E L+ ++ + +IM+F GS+ + + L S
Sbjct: 57 --E-FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV----LGDVGIPHLLLGIPLPS 204
D+ G+ L GI+ N+KP N + + L D G
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG----AARELEDD 169
Query: 205 SDLPRRLGTPNYMAPE-----QWQPEVRGPISFETDSWGFACSIIEMLTGVQP----RCG 255
GT Y+ P+ + + + D W + TG P
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 256 RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYD 293
R E+ ++ + PSG V+ G ++
Sbjct: 230 RRNKEVMYKIITGK-----PSGAISGVQKAENGPIDWS 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/306 (19%), Positives = 105/306 (34%), Gaps = 67/306 (21%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + L +G G FGEV+ + +VAVK L E + D
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTL---PEVCSE---QDELD 120
Query: 98 LF--------LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD--------RMAQLKG 141
Q + + G+S+ + I+++ G GD R +
Sbjct: 121 FLMEALIISKFNHQNI--VR-CIGVSLQSLPRFILLELMAG--GDLKSFLRETRPRPSQP 175
Query: 142 GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVGIPHLLL 198
L++ ++ A D+A G L +FI + A R L P +
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEEN----------HFIHRDI--AARNCLLTCPGPGRVA 223
Query: 199 GIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWGFACSI 243
I D + R + Y M PE + + G + +TD+W F +
Sbjct: 224 KI----GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF---MEGIFTSKTDTWSFGVLL 276
Query: 244 IEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTD 302
E+ + G P +S E+ + V + P P P V ++ C+++ RP
Sbjct: 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAI 335
Query: 303 ILRVFK 308
IL +
Sbjct: 336 ILERIE 341
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 66/327 (20%), Positives = 125/327 (38%), Gaps = 83/327 (25%)
Query: 29 ATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR 87
A + + IK + L+ +G G FG+V+LA + + VAVK L K+
Sbjct: 2 AMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAE-CYNLSPTKDKMLVAVKAL---KDPT 57
Query: 88 MRVLLERLNDL----FLKCQGVEGICWLQGISVINGKICIIMKF---------------Y 128
+ + + L+ + + + G+ + ++ ++
Sbjct: 58 LAARKDFQREAELLTNLQHEHI--VK-FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPD 114
Query: 129 EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADR 185
+ D + G+L LS + A +A G++ L S+ +F+ L A R
Sbjct: 115 AMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----------HFVHRDL--ATR 162
Query: 186 AVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPI 230
L VG +LL+ I D + R + + +Y M PE
Sbjct: 163 NCL--VG-ANLLVKI----GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE---------- 205
Query: 231 SF-------ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
S E+D W F + E+ T G QP S E+ + + + + + P P V
Sbjct: 206 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER-PRVCPKEV 264
Query: 283 ENVLLGCFEYDLRSRPLMTDILRVFKS 309
+V+LGC++ + + R + +I ++ +
Sbjct: 265 YDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 51/255 (20%), Positives = 83/255 (32%), Gaps = 68/255 (26%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-------PVKEDRMRVLLE--- 93
+ +G G F V ST E A K + R + E
Sbjct: 15 DIGEELGSGQFAIVKKCRE-KSTG-----LEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 94 ----------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLK 140
L+D++ E + +I++ G G D +AQ
Sbjct: 69 LRQVLHHNVITLHDVY------EN----------RTDVVLILELVSG--GELFDFLAQ-- 108
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVL--GDVGIPHL 196
LS + + G+ LH+K I +LKP N +L + D G+ H
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQP 252
+ + GTP ++A PE+ P+ E D W + +I +L+G P
Sbjct: 169 I----EDGVEFKNIFGTPEFVA-----PEIVNYEPLGLEADMW--SIGVITYILLSGASP 217
Query: 253 RCGRSVDEIYDAVVR 267
G + E +
Sbjct: 218 FLGDTKQETLANITS 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 65/342 (19%), Positives = 121/342 (35%), Gaps = 73/342 (21%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
A + + + + +G G FGEV L ++ VA+K L K E+
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK---EISVAIKTL---KVGYT----EK 88
Query: 95 LNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GG 142
FL E I L+G+ + + I+ ++ E G + L+
Sbjct: 89 QRRDFLG----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN--GSLDSFLRKHDA 142
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILNEADRAVLGDVG 192
+ ++ + +A G+ L G IL+ N + D G
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI----------NSNLVCKVSDFG 192
Query: 193 IPHLLLGIPLP-----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML 247
+ +L P +P R + +PE + +D W + + E++
Sbjct: 193 LGRVLEDDPEAAYTTRGGKIPIR-----WTSPEAIA---YRKFTSASDVWSYGIVLWEVM 244
Query: 248 T-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRV 306
+ G +P S ++ AV +PP P P A+ ++L C++ D +RP I+ +
Sbjct: 245 SYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 307 FKS---SQNSVHSDGGWTGHGSRILPDKSSSGYT------EW 339
+ S+ S +L D+S+ T +W
Sbjct: 304 LDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDW 345
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 30/280 (10%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
AW I +LKL ++G G FGEVW+AT +++ +VAVK + P L E
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMAT-------YNKHTKVAVKTMKPGSMSVEAFLAEA 234
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
L+ + + L + V I II +F GS+ D + +G K L + ++
Sbjct: 235 NVMKTLQH---DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD---LPRR 210
+A+G+ + + + +L+ N +++ + + D G+ ++ + + P +
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 211 LGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVR-- 267
+ APE G + ++D W F ++E++T G P G S E+ A+ R
Sbjct: 351 -----WTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
R P P P + N+++ C++ RP I V
Sbjct: 403 RM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 52/272 (19%), Positives = 95/272 (34%), Gaps = 44/272 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLKCQGVE 106
+G+G F + + + + A KI+ + + R + E
Sbjct: 49 LGKGGFAKCFEISDADTK------EVFAGKIVPKSLLLKPHQREKMSM-----------E 91
Query: 107 ----------GICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAID 155
+ G N + ++++ S+ + + L+ Y
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEARYYLRQ 149
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+ G LH ++ +LK N LNE +GD G L + GTPN
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG---LATKVEYDGERKKVLCGTPN 206
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
Y+APE + SFE D W + I +L G P + E Y + + +
Sbjct: 207 YIAPEVLS---KKGHSFEVDVW--SIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YS 259
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP + P +++ + D +RP + ++L
Sbjct: 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 60/286 (20%), Positives = 103/286 (36%), Gaps = 40/286 (13%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W I PS L IG G FG V L +VA+K + +E M
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGY-------WLNKDKVAIKTI---REGAMSE----- 47
Query: 96 NDLFLKCQGV------EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLS 147
+ F++ V + L G+ + IC++ +F E G L+ G +
Sbjct: 48 -EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH--GCLSDYLRTQRGLFAAE 104
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
+ +D+ +G+ L ++ +L N ++ E + D G + +
Sbjct: 105 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG-----MTRFVLDDQY 159
Query: 208 PRRLGTPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263
GT P +W PEV S ++D W F + E+ + G P RS E+ +
Sbjct: 160 TSSTGT---KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216
Query: 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ + P V ++ C+ RP + +LR
Sbjct: 217 DISTGFRLYK-PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 48/304 (15%), Positives = 89/304 (29%), Gaps = 60/304 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
I+ L +G+G F +++ + EV +K+L +
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSES--- 58
Query: 97 DLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKL 144
F + + G+ V + ++ +F + G LK +
Sbjct: 59 --FFE----AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKF--GSLDTYLKKNKNCI 110
Query: 145 SLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILNEADRAVLGDVGIP 194
++ A LA + L IL++ + L D GI
Sbjct: 111 NILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK--TGNPPFIKLSDPGIS 168
Query: 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQ-PEV---RGPISFETDSWGFACSIIEMLT-G 249
+ L W PE ++ TD W F ++ E+ + G
Sbjct: 169 ITV-------------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG 215
Query: 250 VQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+P R ++P P + N++ C +Y+ RP I+R S
Sbjct: 216 DKPLSALDSQRKLQFYEDRHQLPA-PK--AAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
Query: 310 SQNS 313
Sbjct: 273 LFTP 276
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 31/281 (11%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP-VKEDRMRVLLERLN 96
+K L+ +GRG +G V H S + +AVK + V + LL L
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQ------IMAVKRIRATVNSQEQKRLLMDL- 56
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAI 154
D+ ++ G G + I M+ + S+ Q+ KG + + + A+
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 155 DLAQGILQLHSKG-ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL-- 211
+ + + LHSK ++ ++KP N ++N + + D GI S L +
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI----------SGYLVDDVAK 166
Query: 212 ----GTPNYMAPEQWQPEVRG-PISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAV 265
G YMAPE+ PE+ S ++D W ++IE+ P + + V
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 266 VRRQEIPPIPSGL-PPAVENVLLGCFEYDLRSRPLMTDILR 305
V + P +P+ + C + + + RP ++++
Sbjct: 227 V-EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 71/306 (23%), Positives = 116/306 (37%), Gaps = 52/306 (16%)
Query: 32 NDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV 90
+ I L+L ++G G FG V VAVK L K D +
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGE--WDAPSGKTV-SVAVKCL---KPDVL-- 59
Query: 91 LLERLNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQL 139
D F++ E + L G+ V+ + ++ + GS+ DR+ +
Sbjct: 60 SQPEAMDDFIR----EVNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRL-RK 113
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199
G L + RYA+ +A+G+ L SK + +L N +L D +GD G
Sbjct: 114 HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG------- 166
Query: 200 IPLPSSDLPRRLGTPN--YMA------PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT 248
L R L + Y+ P W PE S +D+W F ++ EM T
Sbjct: 167 -------LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
Query: 249 -GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
G +P G + +I + + E P P P + NV++ C+ + RP +
Sbjct: 220 YGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 308 KSSQNS 313
+Q +
Sbjct: 280 LEAQPT 285
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 68/295 (23%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+L +G G +G+V+ H + + A+K++ V D + + +N L
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQ------LAAIKVM-DVTGDEEEEIKQEINMLKKYSH 79
Query: 104 --------GVEGICWLQG-ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS---LSNVF 150
G +++ ++ ++ ++M+F GSV D + KG L ++ +
Sbjct: 80 HRNIATYYG----AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
R ++ +G+ LH ++ ++K N +L E L D G+ L + RR
Sbjct: 136 R---EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------DRTVGRR 186
Query: 211 ---LGTPNYMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265
+GTP +MAPE F++D W + IEM G P C
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC----------- 235
Query: 266 VRRQEIPP------IPSGLPPAVE---------NVLLGCFEYDLRSRPLMTDILR 305
++ P IP P ++ + + C + RP +++
Sbjct: 236 ----DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 55/272 (20%), Positives = 92/272 (33%), Gaps = 37/272 (13%)
Query: 21 SDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL 80
S + S + + LK IGRG +G V H S + +AVK +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQ------IMAVKRI 55
Query: 81 HP-VKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGD---RM 136
V E + LL L+ + I G G I M+ S +
Sbjct: 56 RSTVDEKEQKQLLMDLDVVMRSSD-CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYV 114
Query: 137 AQLKGGKLSLSNVFRYAIDLAQGILQLHSKG-ILVLNLKPFNFILNEADRAVLGDVGIPH 195
+ + + + + + + L I+ ++KP N +L+ + L D GI
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-- 172
Query: 196 LLLGIPLPSSDLPRRL------GTPNYMAPEQWQPEVRGPI-SFETDSWGFACSIIEMLT 248
S L + G YMAPE+ P +D W ++ E+ T
Sbjct: 173 --------SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224
Query: 249 GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPP 280
G P + ++D + + + G PP
Sbjct: 225 GRFPYP--KWNSVFDQLTQ------VVKGDPP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 52/270 (19%), Positives = 89/270 (32%), Gaps = 38/270 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL-------HPVKEDRMRVLLE-RLNDLFL 100
+G+G FG V+ +VA+K++ D + LE L
Sbjct: 39 LGKGGFGTVFAGHRLTDRL------QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQG 159
G G+ L ++++ D + + G L + +
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
I HS+G++ ++K N +++ L D G LL P D GT Y
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVYSP 206
Query: 219 PEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275
PE W + I+ +M+ G P EI +A + P
Sbjct: 207 PEWISRHQYHAL---PATVW--SLGILLYDMVCGDIPFERD--QEILEAELH------FP 253
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ + P ++ C SRP + +IL
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 53/255 (20%), Positives = 88/255 (34%), Gaps = 68/255 (26%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-------PVKEDRMRVLLE--- 93
++ +G G F V T E A K + R + E
Sbjct: 8 EMGEELGSGQFAIVRKCRQ-KGTG-----KEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 94 ----------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLK 140
L+D+F E + +I++ G G D +A+
Sbjct: 62 LREIRHPNIITLHDIF------EN----------KTDVVLILELVSG--GELFDFLAE-- 101
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAV-LGDVGIPHL 196
L+ ++ + G+ LHSK I +LKP N +L N + + L D GI H
Sbjct: 102 KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQP 252
+ ++ GTP ++A PE+ P+ E D W + +I +L+G P
Sbjct: 162 I----EAGNEFKNIFGTPEFVA-----PEIVNYEPLGLEADMW--SIGVITYILLSGASP 210
Query: 253 RCGRSVDEIYDAVVR 267
G + E +
Sbjct: 211 FLGETKQETLTNISA 225
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 50/291 (17%), Positives = 98/291 (33%), Gaps = 53/291 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
IG+G +G V LA + A+K+L + +++ + +G
Sbjct: 21 IGKGSYGVVKLAYNENDNT------YYAMKVL-----SKKKLIRQAGFPRRPPPRGTRPA 69
Query: 109 CWLQGIS---------------------------VI----NGKICIIMKFYEGSVGDRMA 137
V+ + ++ + G M
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ--GPVME 127
Query: 138 QLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197
LS Y DL +GI LH + I+ ++KP N ++ E + D G+ +
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCG 255
G + L +GTP +MAPE + D W A + + G P
Sbjct: 188 KG---SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW--AMGVTLYCFVFGQCPFMD 242
Query: 256 RSVDEIYDAVVRRQ-EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ ++ + + E P P + +++++ + + SR ++ +I
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 48/255 (18%), Positives = 83/255 (32%), Gaps = 68/255 (26%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-------PVKEDRMRVLLE--- 93
+G G F V ST + A K + R + E
Sbjct: 14 DTGEELGSGQFAVVKKCRE-KSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 94 ----------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLK 140
L++++ E + +I++ G G D +A+
Sbjct: 68 LKEIQHPNVITLHEVY------EN----------KTDVILILELVAG--GELFDFLAE-- 107
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVL--GDVGIPHL 196
L+ + + G+ LHS I +LKP N +L + + D G+ H
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQP 252
+ ++ GTP ++A PE+ P+ E D W + +I +L+G P
Sbjct: 168 I----DFGNEFKNIFGTPEFVA-----PEIVNYEPLGLEADMW--SIGVITYILLSGASP 216
Query: 253 RCGRSVDEIYDAVVR 267
G + E V
Sbjct: 217 FLGDTKQETLANVSA 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 51/255 (20%), Positives = 83/255 (32%), Gaps = 68/255 (26%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-------PVKEDRMRVLLE--- 93
+ +G G F V ST E A K + R + E
Sbjct: 15 DIGEELGSGQFAIVKKCRE-KSTG-----LEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 94 ----------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLK 140
L+D++ E + +I++ G G D +AQ
Sbjct: 69 LRQVLHPNIITLHDVY------EN----------RTDVVLILELVSG--GELFDFLAQ-- 108
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVL--GDVGIPHL 196
LS + + G+ LH+K I +LKP N +L + D G+ H
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQP 252
+ + GTP ++A PE+ P+ E D W + +I +L+G P
Sbjct: 169 I----EDGVEFKNIFGTPEFVA-----PEIVNYEPLGLEADMW--SIGVITYILLSGASP 217
Query: 253 RCGRSVDEIYDAVVR 267
G + E +
Sbjct: 218 FLGDTKQETLANITA 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 59/313 (18%), Positives = 102/313 (32%), Gaps = 80/313 (25%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I L +G+G FG V A ++ + +VAVK+L K D + + +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQ---LKQEDGSFVKVAVKML---KADIIAS--SDIEE 71
Query: 98 LF--------LKCQGV---EGICWLQGISVINGKICIIMKFYEGSVGD-------RMAQL 139
V G+ +I+ F + GD
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH--GDLHAFLLASRIGE 129
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLG 189
L L + R+ +D+A G+ L S+ NFI L E +
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSR----------NFIHRDLAARNCMLAEDMTVCVA 179
Query: 190 DVGIPHLLLGIPLPSSDLPRRLGTPNY-------------MAPEQWQPEVRGPISFETDS 236
D G L R++ + +Y +A E + +D
Sbjct: 180 DFG--------------LSRKIYSGDYYRQGCASKLPVKWLALESLA---DNLYTVHSDV 222
Query: 237 WGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLR 295
W F ++ E++T G P G EIY+ ++ + P V +++ C+ D +
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ-PPECMEEVYDLMYQCWSADPK 281
Query: 296 SRPLMTDILRVFK 308
RP T + +
Sbjct: 282 QRPSFTCLRMELE 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 47/269 (17%), Positives = 96/269 (35%), Gaps = 40/269 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV---------LLERLNDLF 99
+G+G FG V+LA + +A+K+L + ++ V + L
Sbjct: 22 LGKGKFGNVYLAREKQNK------FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
I + +I ++++F G+ +L K G+ + +LA
Sbjct: 76 --------ILRMYNYFHDRKRIYLMLEFAPR--GELYKELQKHGRFDEQRSATFMEELAD 125
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
+ H + ++ ++KP N ++ + D G + PS GT +Y+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFG-----WSVHAPSLRRRTMCGTLDYLP 180
Query: 219 PEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
PE + + + D W ++ E L G+ P S E + +V P
Sbjct: 181 PEMIEGKTHDE---KVDLW--CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFPP 233
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305
L ++++ Y R + ++
Sbjct: 234 FLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 63/302 (20%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
I PS + + IG G FGEV+ L T + VA+K L K E+
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGM--LKTSSGKKEVPVAIKTL---KAGYT----EK 88
Query: 95 LNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GG 142
FL E I L+G+ + II ++ E G L+ G
Sbjct: 89 QRVDFLG----EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN--GALDKFLREKDG 142
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILNEADRAVLGDVG 192
+ S+ + +A G+ L + ILV N + D G
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----------NSNLVCKVSDFG 192
Query: 193 IPHLLLGIPLPS-----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEML 247
+ +L P + +P R + APE + +D W F + E++
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPIR-----WTAPEAIS---YRKFTSASDVWSFGIVMWEVM 244
Query: 248 T-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRV 306
T G +P S E+ A+ +P P P A+ +++ C++ + RP DI+ +
Sbjct: 245 TYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303
Query: 307 FK 308
Sbjct: 304 LD 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 47/219 (21%), Positives = 83/219 (37%), Gaps = 29/219 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND-LFLK- 101
IG G FG V+ A ++E VA+K + + + + + FL+
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLS---LSNVFRYAIDLAQ 158
+ +G + ++M++ GS D + ++ L ++ V Q
Sbjct: 111 LRH-PNTIQYRGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTH---GALQ 165
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPN 215
G+ LHS ++ ++K N +L+E LGD G +S + +GTP
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS----------ASIMAPANSFVGTPY 215
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254
+MAPE G + D W + IE+ P
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 54/238 (22%), Positives = 84/238 (35%), Gaps = 42/238 (17%)
Query: 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV 105
+ +G G G+V H T + A+K+L D + E D + G
Sbjct: 34 KQVLGLGVNGKVLECFH-RRTGQ-----KCALKLL----YDSPKARQE--VDHHWQASGG 81
Query: 106 EGICWLQGI----SVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFRYAID 155
I + + + IIM+ EG G R+ + + + + R D
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEG--GELFSRIQERGDQAFTEREAAEIMR---D 136
Query: 156 LAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLG 212
+ I LHS I ++KP N + ++ AVL D G + L
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG-----FAKETTQNALQTPCY 191
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAVVRR 268
TP Y+APE PE D W + +I +L G P + I + RR
Sbjct: 192 TPYYVAPEVLGPEKYDK---SCDMW--SLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 56/316 (17%), Positives = 101/316 (31%), Gaps = 87/316 (27%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + + +G+G FG V+ + VA+K + E ER+
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTV---NEAASMR--ERIE- 74
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEG---------SVGDRMAQ 138
FL E + L G+ +IM+
Sbjct: 75 -FLN----EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 139 LKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVGIPH 195
SLS + + A ++A G+ L++ F+ L A R + V
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN----------KFVHRDL--AARNCM--VA-ED 174
Query: 196 LLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISF-------E 233
+ I D + R + +Y M+PE S
Sbjct: 175 FTVKI----GDFGMTRDIYETDYYRKGGKGLLPVRWMSPE----------SLKDGVFTTY 220
Query: 234 TDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEY 292
+D W F + E+ T QP G S +++ V+ + P P + ++ C++Y
Sbjct: 221 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQY 279
Query: 293 DLRSRPLMTDILRVFK 308
+ + RP +I+ K
Sbjct: 280 NPKMRPSFLEIISSIK 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 48/251 (19%), Positives = 94/251 (37%), Gaps = 63/251 (25%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLE-------- 93
+ ++G G FG+V L S E +K ++ + ++ E
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGL------ERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 94 -----RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS 145
++ ++F E + I+M+ EG G +R+ + +
Sbjct: 79 HPNIIKIFEVF------ED----------YHNMYIVMETCEG--GELLERIVSAQARGKA 120
Query: 146 LSNVFRYAIDLAQGILQ----LHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLL 198
LS Y +L + ++ HS+ ++ +LKP N + + + + + D G+ L
Sbjct: 121 LSE--GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGR 256
GT YMAPE + ++F+ D W + ++ +LTG P G
Sbjct: 179 ----SDEHSTNAAGTALYMAPEV----FKRDVTFKCDIW--SAGVVMYFLLTGCLPFTGT 228
Query: 257 SVDEIYDAVVR 267
S++E+
Sbjct: 229 SLEEVQQKATY 239
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 9e-11
Identities = 54/286 (18%), Positives = 98/286 (34%), Gaps = 40/286 (13%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
+K + L +G G FG V L ++VAVK++ KE M
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGK-------WKGQYDVAVKMI---KEGSMSE----- 47
Query: 96 NDLFLKCQGV------EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLS 147
D F + + G+ I I+ ++ G + L+ G L S
Sbjct: 48 -DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN--GCLLNYLRSHGKGLEPS 104
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
+ D+ +G+ L S + +L N +++ + D G + +
Sbjct: 105 QLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG-----MTRYVLDDQY 159
Query: 208 PRRLGTPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263
+GT P +W PEV S ++D W F + E+ + G P + E+
Sbjct: 160 VSSVGT---KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216
Query: 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
V + + P + ++ C+ RP +L +
Sbjct: 217 KVSQGHRLYR-PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 54/295 (18%), Positives = 104/295 (35%), Gaps = 58/295 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+K + K +G G FG V+ E VA+K L +E + N
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGL--WIPEGEKVKIPVAIKEL---REATS----PKANK 62
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSL 146
L E +C L GI + + +I + G + D + + +
Sbjct: 63 EILD----EAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGS 116
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
+ + + +A+G+ L + ++ +L N ++ + D G
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-------------- 162
Query: 207 LPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQP 252
L + LG MA E + ++D W + ++ E++T G +P
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 253 RCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
G EI + + + +P P V +++ C+ D SRP +++ F
Sbjct: 220 YDGIPASEISSILEKGERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 65/325 (20%), Positives = 116/325 (35%), Gaps = 82/325 (25%)
Query: 30 TSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM 88
+D IK + L+ +G G FG+V+LA + + VAVK L KE
Sbjct: 29 YFSDACVHHIKRRDIVLKWELGEGAFGKVFLA-ECHNLLPEQDKMLVAVKAL---KEASE 84
Query: 89 RVLLERLNDL----FLKCQGVEGICWLQGISVINGKICIIMKF--------------YEG 130
+ + L+ Q + + G+ + ++ ++ +
Sbjct: 85 SARQDFQREAELLTMLQHQHI--VR-FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 131 SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAV 187
+ + G L L + A +A G++ L +F+ L A R
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----------HFVHRDL--ATRNC 189
Query: 188 LGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISF 232
L VG L++ I D + R + + +Y M PE S
Sbjct: 190 L--VG-QGLVVKI----GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE----------SI 232
Query: 233 -------ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVEN 284
E+D W F + E+ T G QP S E D + + +E+ P PP V
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER-PRACPPEVYA 291
Query: 285 VLLGCFEYDLRSRPLMTDILRVFKS 309
++ GC++ + + R + D+ ++
Sbjct: 292 IMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 53/279 (18%), Positives = 97/279 (34%), Gaps = 28/279 (10%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
+W I P L +G G FG V ++VA+K++ + E
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGK-------WRGQYDVAIKMIKEGSMSEDEFIEEA 70
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLSNVFRY 152
+ L E + L G+ I II ++ G + L+ + +
Sbjct: 71 KVMMNLSH---EKLVQLYGVCTKQRPIFIITEYMAN--GCLLNYLREMRHRFQTQQLLEM 125
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
D+ + + L SK L +L N ++N+ + D G L + + +G
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG-----LSRYVLDDEYTSSVG 180
Query: 213 TPNYMAPEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRR 268
+ P +W PEV S ++D W F + E+ + G P + E + + +
Sbjct: 181 S---KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
Query: 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+ P V ++ C+ RP +L
Sbjct: 238 LRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 60/307 (19%), Positives = 105/307 (34%), Gaps = 80/307 (26%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I + L +G G FGEV+ + ++ + VAVK K+D +
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGV--YTNHKGEKIN-VAVKTC---KKDCT----LDNKE 58
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLS 145
F+ E I L GI + IIM+ Y G+ L+ L
Sbjct: 59 KFMS----EAVIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPY--GELGHYLERNKNSLK 111
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPH 195
+ + Y++ + + + L S N + + + LGD G
Sbjct: 112 VLTLVLYSLQICKAMAYLESI----------NCVHRDIAVRNILVASPECVKLGDFG--- 158
Query: 196 LLLGIPLPSSDLPRRLGTPNY------------MAPEQWQPEVRGPISFETDSWGFACSI 243
L R + +Y M+PE + +D W FA +
Sbjct: 159 -----------LSRYIEDEDYYKASVTRLPIKWMSPESIN---FRRFTTASDVWMFAVCM 204
Query: 244 IEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTD 302
E+L+ G QP ++ + + +P P PP + ++ C++YD RP T+
Sbjct: 205 WEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDRPRFTE 263
Query: 303 ILRVFKS 309
++
Sbjct: 264 LVCSLSD 270
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 63/306 (20%), Positives = 109/306 (35%), Gaps = 78/306 (25%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I+ ++L IG G FG+V + VA+K K + + +
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTC---KNCTS----DSVRE 436
Query: 98 LFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSL 146
FL+ E I L G+ + + IIM+ G + + Q++ L L
Sbjct: 437 KFLQ----EALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFL-QVRKFSLDL 490
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPHL 196
+++ YA L+ + L SK F+ ++ D LGD G
Sbjct: 491 ASLILYAYQLSTALAYLESK----------RFVHRDIAARNVLVSSNDCVKLGDFG---- 536
Query: 197 LLGIPLPSSDLPRRLGTPNY------------MAPEQWQPEVRGPISFETDSWGFACSII 244
L R + Y MAPE + +D W F +
Sbjct: 537 ----------LSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMW 583
Query: 245 EMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
E+L GV+P G +++ + + +P P PP + +++ C+ YD RP T++
Sbjct: 584 EILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642
Query: 304 LRVFKS 309
+
Sbjct: 643 KAQLST 648
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 65/317 (20%), Positives = 112/317 (35%), Gaps = 81/317 (25%)
Query: 29 ATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR 87
A + T + I+ ++L IG G FG+V + VA+K K
Sbjct: 2 AMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTC---KNCT 55
Query: 88 MRVLLERLNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMA 137
+ + + FL+ E I L G+ + + IIM+ G+ +
Sbjct: 56 S----DSVREKFLQ----EALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTL--GELRS 104
Query: 138 QLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADR 185
L+ L L+++ YA L+ + L SK F+ ++ D
Sbjct: 105 FLQVRKYSLDLASLILYAYQLSTALAYLESK----------RFVHRDIAARNVLVSSNDC 154
Query: 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY------------MAPEQWQPEVRGPISFE 233
LGD G L R + Y MAPE +
Sbjct: 155 VKLGDFG--------------LSRYMEDSTYYKASKGKLPIKWMAPESIN---FRRFTSA 197
Query: 234 TDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEY 292
+D W F + E+L GV+P G +++ + + +P P PP + +++ C+ Y
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAY 256
Query: 293 DLRSRPLMTDILRVFKS 309
D RP T++ +
Sbjct: 257 DPSRRPRFTELKAQLST 273
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 63/321 (19%), Positives = 107/321 (33%), Gaps = 83/321 (25%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV------- 90
I SA++ +G FG+V+ ++ VA+K L E +R
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGH-LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 91 LLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKF---------------YEGSVGDR 135
L RL + L G+ + + +I + +
Sbjct: 65 LRARLQH--------PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 136 MAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVG 192
+ L + +A G+ L S + + L A R VL V
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----------HVVHKDL--ATRNVL--VY 162
Query: 193 IPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISF----- 232
L + I SD L R + +Y MAPE I +
Sbjct: 163 -DKLNVKI----SDLGLFREVYAADYYKLLGNSLLPIRWMAPEA--------IMYGKFSI 209
Query: 233 ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFE 291
++D W + + E+ + G+QP CG S ++ + + RQ +P P P V +++ C+
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWN 268
Query: 292 YDLRSRPLMTDILRVFKSSQN 312
RP DI ++ N
Sbjct: 269 EFPSRRPRFKDIHSRLRAWGN 289
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 30/137 (21%), Positives = 56/137 (40%), Gaps = 10/137 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
++ +IG G FGE+ L + + E VA+K+ L + +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNE------YVAIKLEPMKSRAPQ---LHLEYRFYKQLG 62
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+GI + ++++ S+ D + L SL V AI L + +
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 164 HSKGILVLNLKPFNFIL 180
HSK ++ ++KP NF++
Sbjct: 122 HSKNLIYRDVKPENFLI 138
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 51/275 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLERLNDLFLKCQGV 105
IG+G F +V LA H L+ EVA+KI+ + ++ E
Sbjct: 23 IGKGNFAKVKLARHILTG------REVAIKIIDKTQLNPTSLQKLFRE------------ 64
Query: 106 EGICWLQGIS---------VI--NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
+ ++ ++ VI + +IM++ G V D + G++
Sbjct: 65 --VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKF 120
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ + H K I+ +LK N +L+ + D G L G
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG----FSNEFTVGGKLDAFCGA 176
Query: 214 PNYMAPEQWQ-PEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQE 270
P Y APE +Q + GP E D W + +I +++G P G+++ E+ + V+R
Sbjct: 177 PPYAAPELFQGKKYDGP---EVDVW--SLGVILYTLVSGSLPFDGQNLKELRERVLR--G 229
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP + EN+L + R + I++
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 57/279 (20%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-CQGVE 106
+IG G G V LA S +VAVK++ K+ R +L + ++ Q
Sbjct: 52 KIGEGSTGIVCLAREKHSGR------QVAVKMMDLRKQQRRELLFNEVV--IMRDYQH-F 102
Query: 107 GICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS 165
+ + ++ ++ ++M+F + G++ D ++Q++ + ++ V + Q + LH+
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE---AVLQALAYLHA 159
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQW 222
+G++ ++K + +L R L D G + S D+P+R +GTP +MAPE
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKDVPKRKSLVGTPYWMAPEVI 213
Query: 223 QPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------IPS 276
R + E D W +IEM+ G P P +
Sbjct: 214 S---RSLYATEVDIWSLGIMVIEMVDGEPPYF---------------SDSPVQAMKRLRD 255
Query: 277 GLPPAVENV----------LLGCFEYDLRSRPLMTDILR 305
PP ++N L D + R ++L
Sbjct: 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 55/304 (18%), Positives = 100/304 (32%), Gaps = 78/304 (25%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLKCQGVE 106
+G+G F V+ A + EVA+K++ + + M ++ E
Sbjct: 19 LGKGSFAGVYRAESIHTG------LEVAIKMIDKKAMYKAGMVQRVQN-----------E 61
Query: 107 GICWLQGISVINGKICI--------IMKFYE-----------------GSVGDRMAQLKG 141
+ I I++ Y G + + +
Sbjct: 62 --------------VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RV 106
Query: 142 GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201
S + + + G+L LHS GIL +L N +L + D G L
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG-----LATQ 161
Query: 202 LPSSDLPRRL--GTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRS 257
L GTPNY++PE R E+D W + + +L G P +
Sbjct: 162 LKMPHEKHYTLCGTPNYISPEIAT---RSAHGLESDVW--SLGCMFYTLLIGRPPFDTDT 216
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR---VFKSSQNSV 314
V + VV +PS L ++++ + R ++ +L + ++S
Sbjct: 217 VKNTLNKVVLADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKS 274
Query: 315 HSDG 318
+G
Sbjct: 275 KDEG 278
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 52/253 (20%), Positives = 92/253 (36%), Gaps = 53/253 (20%)
Query: 29 ATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR 87
+ + W I +L+ IG G V A E +VA+K ++
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKE------KVAIKRIN------ 49
Query: 88 MRVLLERLNDLFLKCQGVEGICWLQGISV-----------------INGKICIIMKFYE- 129
LE+ ++ + L+ I + ++ ++MK
Sbjct: 50 ----LEKCQT------SMDEL--LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 130 GSVGDRMAQLKGGKLSLSNVFRYAI------DLAQGILQLHSKGILVLNLKPFNFILNEA 183
GSV D + + S V + ++ +G+ LH G + ++K N +L E
Sbjct: 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED 157
Query: 184 DRAVLGDVGIPHLLLGIPLPSSDLPRR--LGTPNYMAPEQWQPEVRGPISFETDSWGFAC 241
+ D G+ L + + R+ +GTP +MAPE + F+ D W F
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGI 215
Query: 242 SIIEMLTGVQPRC 254
+ IE+ TG P
Sbjct: 216 TAIELATGAAPYH 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+L +IG G FGE++L T+ + E EVA+K+ + + L + ++ Q
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNE------EVAIKLENVKTKHPQ---LLYESKIYRILQ 60
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
G GI ++ V ++M S+ D + KLSL V A + + +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 164 HSKGILVLNLKPFNFIL---NEADRAVLGDVGI 193
HSK L ++KP NF++ A++ + D G+
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 34/284 (11%), Positives = 92/284 (32%), Gaps = 52/284 (18%)
Query: 23 HLRTAVATSNDTNAWIKPSAL-KLRHRIGRGP--FGEVWLATHYLSTEDCDEYHEVAVKI 79
H ++++ +L IG+G V LA + + E V V+
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGE------YVTVRR 59
Query: 80 LHPVKEDRMRVLLERLNDL-----FLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVG 133
++ E + L K I + + + ++ ++ F GS
Sbjct: 60 INLEACSN-----EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 134 DRMAQLKGGKLS---LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190
D + ++ ++ + + + + + +H G + ++K + +++ + L
Sbjct: 115 DLICTHFMDGMNELAIAYILQ---GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSG 171
Query: 191 VGIPHLLLGI----PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246
+ ++ + + +++PE Q ++G ++D + + E+
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACEL 230
Query: 247 LTGVQPRCGRSVDEIYDAVVRRQEIPP------IPSGLPPAVEN 284
G P ++P +G P + +
Sbjct: 231 ANGHVPFK---------------DMPATQMLLEKLNGTVPCLLD 259
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 46/273 (16%), Positives = 84/273 (30%), Gaps = 46/273 (16%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ----- 103
+G G FG V+ VA+K + ++ R+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNL------PVAIKHV-----EKDRISDWGELPNGTRVPMEVVL 99
Query: 104 ------GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDL 156
G G+ L +I++ E D + + G L + +
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQV 158
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+ + H+ G+L ++K N +++ + L D G LL D GT
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTRV 213
Query: 216 YMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
Y PE + G W + I+ +M+ G P +EI V
Sbjct: 214 YSPPEWIRYHRYHGR---SAAVW--SLGILLYDMVCGDIPFEHD--EEIIRGQVF----- 261
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ ++++ C RP +I
Sbjct: 262 -FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 58/332 (17%), Positives = 115/332 (34%), Gaps = 59/332 (17%)
Query: 11 ADFEYEVFDDSDHLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDC 69
D++ ++ + D + + LK ++G+G FG V + + ++
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNT 69
Query: 70 DEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVEGICWLQGISVINGK--ICIIMK 126
E VAVK L E+ +R + L L+ + I +G+ G+ + +IM+
Sbjct: 70 GE--VVAVKKLQHSTEEHLRDFEREIEILKSLQH---DNIVKYKGVCYSAGRRNLKLIME 124
Query: 127 FYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKP 175
+ GS+ D + Q ++ + +Y + +G+ L +K ILV N
Sbjct: 125 YLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN--- 180
Query: 176 FNFILNEAD----RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPIS 231
+ D + + D + + P + APE S
Sbjct: 181 -ENRVKIGDFGLTKVLPQDKEYYKVKEP-----GESPIF-----WYAPESLT---ESKFS 226
Query: 232 FETDSWGFACSIIEMLT----------------GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
+D W F + E+ T G + V + + + +P P
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-P 285
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
G P + ++ C+ ++ RP D+
Sbjct: 286 DGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 45/298 (15%)
Query: 14 EYEVFDDSDHLRTAVATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYH 73
+ F + + +G G FG V L H ++ ++
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH----KESGNHY 69
Query: 74 EVAVKIL---HPVKEDRM------RVLLERLNDLFLKCQGVEGICWLQGISVINGKICII 124
A+KIL VK ++ + +L+ +N F + L+ N + ++
Sbjct: 70 --AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF--------LVKLEFSFKDNSNLYMV 119
Query: 125 MKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA 183
M++ G G+ + L + G+ S + YA + LHS ++ +LKP N ++++
Sbjct: 120 MEYVAG--GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 184 DRAVLGDVGIPHLLLGIPLPSSDLPRRL----GTPNYMAPEQWQPEVRGPISFETDSWGF 239
+ D G + + R GTP +APE + D W
Sbjct: 178 GYIQVTDFGF----------AKRVKGRTWTLCGTPEALAPEIIL---SKGYNKAVDWWAL 224
Query: 240 ACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
I EM G P +IY+ +V PS ++++L + DL R
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL--HPVKEDRMRVLLERLNDLFLKCQGVE 106
+G G FG+V LATHY + +VA+K + +K+ M + +ER E
Sbjct: 17 LGEGSFGKVKLATHYKTQ------QKVALKFISRQLLKKSDMHMRVER-----------E 59
Query: 107 GICWLQGIS---------VI--NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
I +L+ + VI I +++++ G + D + + +++ R+
Sbjct: 60 -ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQ 116
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+ I H I+ +LKP N +L++ + D G L I + L G+PN
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFG----LSNIMTDGNFLKTSCGSPN 172
Query: 216 YMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
Y APE ++ GP E D W +C I+ ML G P + ++ V +
Sbjct: 173 YAAPEVINGKLYAGP---EVDVW--SCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVY 225
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+P L P ++++ D R + +I R
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+L +IG G FG+++L T + E EVA+K+ L + ++ Q
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGE------EVAIKL---ECVKTKHPQLHIESKIYKMMQ 62
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
G GI ++ ++M+ S+ D + K SL V A + I +
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 164 HSKGILVLNLKPFNFIL 180
HSK + ++KP NF++
Sbjct: 122 HSKNFIHRDVKPDNFLM 138
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 48/290 (16%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W ++ + + ++H++G G +GEV+ VAVK L KED M V
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVW------KKYSLTVAVKTL---KEDTMEV---- 53
Query: 95 LNDLFLKCQGV------EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLS 147
+ FLK V + L G+ II +F G++ D + + ++S
Sbjct: 54 --EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 111
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
+ A ++ + L K + +L N ++ E + D G L
Sbjct: 112 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG--------------L 157
Query: 208 PRRLGTPNYMA------PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257
R + Y A P +W PE S ++D W F + E+ T G+ P G
Sbjct: 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+ ++Y+ + + + P G P V ++ C++++ RP +I + F
Sbjct: 218 LSQVYELLEKDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 10/137 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
K+ RIG G FG ++ T+ L+ + +VA+K L +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKF---EPRRSDAPQLRDEYRTYKLLA 63
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
G GI + +++ S+ D + L G K S+ V A + + +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 164 HSKGILVLNLKPFNFIL 180
H K ++ ++KP NF++
Sbjct: 123 HEKSLVYRDIKPDNFLI 139
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 62/263 (23%), Positives = 102/263 (38%), Gaps = 45/263 (17%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRM------RVLLERLNDLF 99
+G G FG V L Y+ A+K+L V+ ++ R++L + F
Sbjct: 14 LGTGSFGRVHLIRS----RHNGRYY--AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
+ + Q +I +IM + EG G+ + L K + YA ++
Sbjct: 68 I----IRMWGTFQD----AQQIFMIMDYIEG--GELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRL----GTP 214
+ LHSK I+ +LKP N +L++ + D G + +P GTP
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF----------AKYVPDVTYTLCGTP 167
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274
+Y+APE P + D W F I EML G P + + Y+ ++
Sbjct: 168 DYIAPEVVS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRF 222
Query: 275 PSGLPPAVENVLLGCFEYDLRSR 297
P V+++L DL R
Sbjct: 223 PPFFNEDVKDLLSRLITRDLSQR 245
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 38/237 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF---- 99
+ +G+G FGEV T+ E AVK++ ++ + + +
Sbjct: 25 NIVCMLGKGSFGEVLKCKD-RITQ-----QEYAVKVI-----NKASAKNKDTSTILREVE 73
Query: 100 -LKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAID 155
LK I L I + I+ + Y G G D + +K + S + R
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTG--GELFDEI--IKRKRFSEHDAARIIKQ 129
Query: 156 LAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLG 212
+ GI +H I+ +LKP N +L ++ + D G L ++ + R+G
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG----LSTCFQQNTKMKDRIG 185
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAVVR 267
T Y+APE +RG + D W + +I +L+G P G++ +I V
Sbjct: 186 TAYYIAPEV----LRGTYDEKCDVW--SAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 63/300 (21%), Positives = 103/300 (34%), Gaps = 62/300 (20%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
I+ S + + IG G GEV L + VA+K L K ER
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGR--LRVPGQRDV-PVAIKAL---KAGYT----ER 92
Query: 95 LNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GG 142
FL E I L+G+ I+ ++ E G L+ G
Sbjct: 93 QRRDFLS----EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN--GSLDTFLRTHDG 146
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILNEAD----RAVL 188
+ ++ + + G+ L G +LV + N + +D R +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS----NLVCKVSDFGLSRVLE 202
Query: 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT 248
D + G +P R + APE S +D W F + E+L
Sbjct: 203 DDPDAAYTTTG-----GKIPIR-----WTAPEAIA---FRTFSSASDVWSFGVVMWEVLA 249
Query: 249 -GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
G +P + ++ +V +P P G P A+ ++L C+ D RP + I+ V
Sbjct: 250 YGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 43/290 (14%), Positives = 88/290 (30%), Gaps = 54/290 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG- 107
+ +G F ++ L A+K ++ R + ND +
Sbjct: 39 LNQGKFNKIILCEK---DN-----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 108 ---ICWLQGIS---------VI--NGKICIIMKFYEG-------SVGDRMAQLKGGKLSL 146
+ + I +I ++ II ++ E + + + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 147 SNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSS 205
+ + +H+ K I ++KP N ++++ R L D G +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG-----ESEYMVDK 205
Query: 206 DLPRRLGTPNYMAPE--QWQPEVRGPISFETDSWGFACSII--EMLTGVQP-RCGRSVDE 260
+ GT +M PE + G + D W + I M V P S+ E
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGA---KVDIW--SLGICLYVMFYNVVPFSLKISLVE 260
Query: 261 IYDAVVRRQ-EIPPIPSGLPPAVENVLLGCFEY-------DLRSRPLMTD 302
+++ + + E P + + N C D L +
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 56/304 (18%), Positives = 107/304 (35%), Gaps = 58/304 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ LK ++G+G FG V + + ++ E VAVK L E+ +R +
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE--VVAVKKLQHSTEEHLRDFEREIEI 64
Query: 98 L-FLKCQGVEGICWLQGISVINGK--ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
L L+ + I +G+ G+ + +IM++ GS+ D + Q ++ + +Y
Sbjct: 65 LKSLQH---DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYT 120
Query: 154 IDLAQGILQLHSKG----------ILVLNLKPFNFILNEAD----RAVLGDVGIPHLLLG 199
+ +G+ L +K ILV N + D + + D +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVEN----ENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT----------- 248
+ P + APE S +D W F + E+ T
Sbjct: 177 -----GESPIF-----WYAPESLT---ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223
Query: 249 -----GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
G + V + + + +P P G P + ++ C+ ++ RP D+
Sbjct: 224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282
Query: 304 LRVF 307
Sbjct: 283 ALRV 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-C 102
+IG+G FGEV+ + + VA+KI+ ++E + + L C
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQK------VVAIKII-DLEEAEDEIEDIQQEITVLSQC 77
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS---LSNVFRYAIDLAQ 158
+ G + + K+ IIM++ GS D + + G L ++ + R ++ +
Sbjct: 78 DS-PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILR---EILK 130
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPN 215
G+ LHS+ + ++K N +L+E L D G+ L + +R +GTP
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL------TDTQIKRNTFVGTPF 184
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254
+MAPE + + + D W + IE+ G P
Sbjct: 185 WMAPEVIK---QSAYDSKADIWSLGITAIELARGEPPHS 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 53/280 (18%), Positives = 108/280 (38%), Gaps = 57/280 (20%)
Query: 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-CQGV 105
+IG+G G V+ A + + EVA++ ++ ++ + +++ + L ++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEI--LVMRENKN- 76
Query: 106 EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH 164
I ++ ++ ++M++ GS+ D + + + ++ V R + Q + LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---ECLQALEFLH 133
Query: 165 SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPNYMAPEQ 221
S ++ ++K N +L L D G + + + +R +GTP +MAPE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI------TPEQSKRSTMVGTPYWMAPEV 187
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------IP 275
R + D W IEM+ G P P I
Sbjct: 188 VT---RKAYGPKVDIWSLGIMAIEMIEGEPPYL---------------NENPLRALYLIA 229
Query: 276 SGLPPAVENV----------LLGCFEYDLRSRPLMTDILR 305
+ P ++N L C E D+ R ++L+
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 52/298 (17%), Positives = 105/298 (35%), Gaps = 59/298 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ IGRG FG V+ T L D + AVK L+ + + +
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGT--LLDNDGKK-IHCAVKSLNRITDIGEV------SQ 72
Query: 98 LFLKCQGVEG----------ICWLQGISVIN-GKICIIMKFYEGSVGDRMAQLK--GGKL 144
FL EG + L GI + + G +++ + + GD ++
Sbjct: 73 -FLT----EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH--GDLRNFIRNETHNP 125
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIP 194
++ ++ + + +A+G+ L SK F+ L+E + D G+
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASK----------KFVHRDLAARNCMLDEKFTVKVADFGLA 175
Query: 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQW-QPE--VRGPISFETDSWGFACSIIEMLT-GV 250
+ + P +W E + ++D W F + E++T G
Sbjct: 176 RDMY-----DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 251 QPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
P + +I +++ + + P P + V+L C+ RP ++++
Sbjct: 231 PPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 51/298 (17%), Positives = 102/298 (34%), Gaps = 59/298 (19%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
A K + L+ +G G FG V E V +K++ ++ +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGV--WIPEGESIKIPVCIKVI---EDK----SGRQ 57
Query: 95 LNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGK 143
I L G+ + ++ ++ GS+ D + + G
Sbjct: 58 SFQAVTD----HMLAIGSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHV-RQHRGA 111
Query: 144 LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP 203
L + + + +A+G+ L G++ NL N +L + + D G
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG----------- 160
Query: 204 SSDLPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-G 249
+ L + MA E G + ++D W + ++ E++T G
Sbjct: 161 ---VADLLPPDDKQLLYSEAKTPIKWMALESIH---FGKYTHQSDVWSYGVTVWELMTFG 214
Query: 250 VQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
+P G + E+ D + + + + P V V++ C+ D RP ++ F
Sbjct: 215 AEPYAGLRLAEVPDLLEKGERLAQ-PQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-C 102
++ +G G FG+V+ A + + A K++ E+ + + + L C
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGA------LAAAKVIETKSEEELEDYIVEIE--ILATC 73
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS---LSNVFRYAIDLAQ 158
I L G +GK+ I+++F G+V M L+ + V R + +
Sbjct: 74 DH-PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQML---E 128
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPN 215
+ LHSK I+ +LK N ++ L D G+ L +R +GTP
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN------LKTLQKRDSFIGTPY 182
Query: 216 YMAPE--QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254
+MAPE + P ++ D W ++IEM P
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 59/287 (20%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLE 93
W + LKL IG+G FG+V L Y +VAVK + K D + L
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGD-YRGN-------KVAVKCI---KNDATAQAFLA 235
Query: 94 RLNDL-FLKCQGV---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSN 148
+ + L+ + G+ + G + I+ ++ GS+ D + L
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEK-----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 290
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
+ ++++D+ + + L + +L N +++E + A + D G L
Sbjct: 291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG--------------LT 336
Query: 209 RRLGTPNYMA--PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262
+ + P +W PE S ++D W F + E+ + G P + ++
Sbjct: 337 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
Query: 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
V + ++ P G PPAV +V+ C+ D +RP + +
Sbjct: 397 PRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 51/272 (18%), Positives = 104/272 (38%), Gaps = 36/272 (13%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G +G+V + AVKIL + + L R+ + + E I
Sbjct: 13 LGEGSYGKVKEVLDSETLC------RRAVKIL-----KKKK--LRRIPNGEANVK-KE-I 57
Query: 109 CWLQGIS---------VING----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
L+ + V+ K+ ++M++ + + + + + + Y
Sbjct: 58 QLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
L G+ LHS+GI+ ++KP N +L + +G+ L G+P
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF-AADDTCRTSQGSPA 176
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
+ PE F+ D W + + + TG+ P G ++ ++++ + +
Sbjct: 177 FQPPEIANGL-DTFSGFKVDIW--SAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YA 231
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP P + ++L G EY+ R + I +
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 60/346 (17%), Positives = 113/346 (32%), Gaps = 98/346 (28%)
Query: 22 DHLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL 80
+ R + + + + ++ IG G FG V+ A + + VAVK+L
Sbjct: 27 MYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKML 85
Query: 81 HPVKEDRMRVLLERLNDLF--------LKCQGVEGICWLQGISVINGKICIIMKF----- 127
M+ D + + L G+ + +C++ ++
Sbjct: 86 KEEASADMQ------ADFQREAALMAEFDNPNI--VK-LLGVCAVGKPMCLLFEYMAYGD 136
Query: 128 ------------------YEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGIL 169
+ S R++ LS + A +A G+ L +
Sbjct: 137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 193
Query: 170 VLNLKPFNFI---LNEADRAVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------- 216
F+ L A R L VG ++++ I +D L R + + +Y
Sbjct: 194 -------KFVHRDL--ATRNCL--VG-ENMVVKI----ADFGLSRNIYSADYYKADGNDA 237
Query: 217 -----MAPEQWQPEVRGPISF-------ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263
M PE S E+D W + + E+ + G+QP G + +E+
Sbjct: 238 IPIRWMPPE----------SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 287
Query: 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
V + P P + N++ C+ RP I R+ +
Sbjct: 288 YVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 51/246 (20%), Positives = 89/246 (36%), Gaps = 42/246 (17%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +G G GEV LA + + +VA++I+ R
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCK------KVAIRIISK------RKFAIGSAREADPAL 185
Query: 104 GVEG-ICWLQGIS---VI-------NGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNV 149
VE I L+ ++ +I I+++ EG G D++ +L +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEG--GELFDKVVGN--KRLKEATC 241
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV---LGDVGIPHLLLGIPLPSSD 206
Y + + LH GI+ +LKP N +L+ + + D G I +S
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG----HSKILGETSL 297
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSII--EMLTGVQP-RCGRSVDEIYD 263
+ GTP Y+APE + D W + +I L+G P R+ + D
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW--SLGVILFICLSGYPPFSEHRTQVSLKD 355
Query: 264 AVVRRQ 269
+ +
Sbjct: 356 QITSGK 361
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 39/236 (16%), Positives = 75/236 (31%), Gaps = 52/236 (22%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV---LLERLND------LF 99
+G G G V + + VAVK + D + LL +D +
Sbjct: 23 LGYGSSGTVVFQGSF-------QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQ-----LKGGKLSLSNVFRYAI 154
+ + I ++ ++ D + N
Sbjct: 76 CSETT-------------DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEAD-------------RAVLGDVGI-PHLLLGI 200
+A G+ LHS I+ +LKP N +++ + R ++ D G+ L G
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 201 PLPSSDLPRRLGTPNYMAPEQ----WQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
++L GT + APE + + ++ D + C +L+ +
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 60/325 (18%), Positives = 110/325 (33%), Gaps = 95/325 (29%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W L L +G G FG+V +A + + E VAVK+L K+D +
Sbjct: 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATE---KD 129
Query: 95 LNDLFLKCQGVEG-----------ICWLQGISVINGKICIIMKF---------------Y 128
L+D + E I L G +G + +I+++
Sbjct: 130 LSD-LVS----EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 129 EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADR 185
+ ++ +++ ++ LA+G+ L S+ I L A R
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----------KCIHRDL--AAR 232
Query: 186 AVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPI 230
VL V + ++ I +D L R + +Y MAPE
Sbjct: 233 NVL--VT-ENNVMKI----ADFGLARDINNIDYYKKTTNGRLPVKWMAPE---------- 275
Query: 231 SF-------ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
+ ++D W F + E+ T G P G V+E++ + + P+ +
Sbjct: 276 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNEL 334
Query: 283 ENVLLGCFEYDLRSRPLMTDILRVF 307
++ C+ RP ++
Sbjct: 335 YMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 55/242 (22%), Positives = 85/242 (35%), Gaps = 37/242 (15%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-- 101
+ IGRG V H + E AVKI+ E LE + + +
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGH------EFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 102 --CQGVEG---ICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVF 150
+ V G I L + + ++ G D + + LS ++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK--GELFDYL--TEKVALSEKETRSIM 206
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
R L + + LH+ I+ +LKP N +L++ + L D G P L
Sbjct: 207 R---SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG----FSCHLEPGEKLREL 259
Query: 211 LGTPNYMAPE---QWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAV 265
GTP Y+APE E E D W AC +I +L G P R + +
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLW--ACGVILFTLLAGSPPFWHRRQILMLRMI 317
Query: 266 VR 267
+
Sbjct: 318 ME 319
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 53/254 (20%), Positives = 81/254 (31%), Gaps = 70/254 (27%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVLLE------- 93
+L +G+G F V L+ + E A I+ D ++ E
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQ------EYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 94 ------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKL 144
RL+D G +I G G + + +
Sbjct: 68 KHPNIVRLHDSI------SE----------EGHHYLIFDLVTG--GELFEDI--VAREYY 107
Query: 145 SLSNVFRYAIDLAQGILQ----LHSKGILVLNLKPFNFIL-NEADRA--VLGDVGIPHLL 197
S A Q IL+ H G++ NLKP N +L ++ A L D G+ +
Sbjct: 108 SE----ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
Query: 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPR 253
G GTP Y++ PEV + P D W AC +I +L G P
Sbjct: 164 EG---EQQAWFGFAGTPGYLS-----PEVLRKDPYGKPVDLW--ACGVILYILLVGYPPF 213
Query: 254 CGRSVDEIYDAVVR 267
+Y +
Sbjct: 214 WDEDQHRLYQQIKA 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W + LKL R+G G FGEVW+ + + +VAVK L K+ M
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGY-------YNGHTKVAVKSL---KQGSMSP---- 52
Query: 95 LNDLFLKCQGV------EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLS 147
D FL + + + L + V I II ++ E GS+ D + G KL+++
Sbjct: 53 --DAFLAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
+ A +A+G+ + + + +L+ N ++++ + D G L
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG--------------L 155
Query: 208 PRRLGTPNYMA------PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257
R + Y A P +W PE G + ++D W F + E++T G P G +
Sbjct: 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215
Query: 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
E+ + R + P P + ++ C++ RP + V +
Sbjct: 216 NPEVIQNLERGYRMVR-PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 45/238 (18%), Positives = 82/238 (34%), Gaps = 45/238 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G G+V + T++ + A+K+L +D + E +L + I
Sbjct: 70 LGLGINGKVLQIFN-KRTQE-----KFALKML----QDCPKARRE--VELHWRASQCPHI 117
Query: 109 CWLQGI----SVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFRYAIDLAQ 158
+ + + I+M+ +G G R+ + S + + + +
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDG--GELFSRIQDRGDQAFTEREASEIMK---SIGE 172
Query: 159 GILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGTPN 215
I LHS I ++KP N + ++ A+L D G + L TP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----FAKETTSHNSLTTPCYTPY 228
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQP----RCGRSVDEIYDAVVR 267
Y+APE PE D W + +I +L G P + +
Sbjct: 229 YVAPEVLGPEKYDK---SCDMW--SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 51/243 (20%), Positives = 88/243 (36%), Gaps = 42/243 (17%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF---- 99
+L IG+GPF V + T + AVKI+ DL
Sbjct: 27 ELCEVIGKGPFSVVRRCIN-RETG-----QQFAVKIVD--VAKFTSSPGLSTEDLKREAS 78
Query: 100 -LKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAID 155
I L +G + ++ +F +G + + S A
Sbjct: 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDG--ADLCFEIVKRADAGFVYSE--AVASH 134
Query: 156 LAQGILQ----LHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLP 208
+ IL+ H I+ ++KP +L ++ + A + G G+ L
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE---SGLVAG 191
Query: 209 RRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDA 264
R+GTP++MA PEV R P D W C +I +L+G P G + +++
Sbjct: 192 GRVGTPHFMA-----PEVVKREPYGKPVDVW--GCGVILFILLSGCLPFYGTK-ERLFEG 243
Query: 265 VVR 267
+++
Sbjct: 244 IIK 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 52/243 (21%), Positives = 80/243 (32%), Gaps = 38/243 (15%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-- 101
+ + +GRG V H T E AVKI+ +
Sbjct: 20 EPKEILGRGVSSVVRRCIH-KPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 102 ---CQGVEG---ICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNV 149
+ V G I L+ N ++ + G D + + LS +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK--GELFDYL--TEKVTLSEKETRKI 129
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
R L + I LH I+ +LKP N +L++ L D G L P L
Sbjct: 130 MR---ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKLRE 182
Query: 210 RLGTPNYMAPE---QWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDA 264
GTP+Y+APE + E D W + +I +L G P R +
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMW--STGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 265 VVR 267
++
Sbjct: 241 IMS 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 32/233 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-EDRMRVLLERLNDLFLKC 102
L + IGRG +GEV +A + A K + ED R E +K
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRI------RRAAKKIPKYFVEDVDRFKQEIEI---MKS 62
Query: 103 QGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAIDLAQG 159
I L N I ++M+ G G +R+ + S+ R D+
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTG--GELFERV--VHKRVFRESDAARIMKDVLSA 118
Query: 160 ILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
+ H + +LKP NF+ ++ + L D G+ P + ++GTP Y
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGKMMRTKVGTPYY 174
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDAVVR 267
++P+ + G E D W + ++ +L G P + E+ +
Sbjct: 175 VSPQV----LEGLYGPECDEW--SAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 55/304 (18%), Positives = 104/304 (34%), Gaps = 71/304 (23%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV--KEDRMRVLLERL 95
+ IGRG FG V+ T L D + H AVK L+ + + + L E +
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGT--LLDNDGKKIH-CAVKSLNRITDIGEVSQFLTEGI 142
Query: 96 NDLFLKCQGV---EGICWLQGISVINGKICIIMKFYEGSVGDRMA--QLKGGKLSLSNVF 150
V GIC G +++ + + GD + + ++ ++
Sbjct: 143 IMKDFSHPNVLSLLGIC-----LRSEGSPLVVLPYMKH--GDLRNFIRNETHNPTVKDLI 195
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPHLLLGI 200
+ + +A+G+ L SK F+ L+E + D G
Sbjct: 196 GFGLQVAKGMKFLASK----------KFVHRDLAARNCMLDEKFTVKVADFG-------- 237
Query: 201 PLPSSDLPRRLGTPNY---------------MAPEQWQPEVRGPISFETDSWGFACSIIE 245
L R + + MA E Q + ++D W F + E
Sbjct: 238 ------LARDMYDKEFDSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWE 288
Query: 246 MLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
++T G P + +I +++ + + P P + V+L C+ RP ++++
Sbjct: 289 LMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 347
Query: 305 RVFK 308
Sbjct: 348 SRIS 351
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 47/239 (19%), Positives = 90/239 (37%), Gaps = 41/239 (17%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+++ IG G + H + E AVKI+ K D E ++ L+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNM------EFAVKIIDKSKRDPTE---E--IEILLRYG 73
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFRYAIDLA 157
I L+ + + ++ + +G G D++ L+ S S V +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKG--GELLDKI--LRQKFFSEREASAVLF---TIT 126
Query: 158 QGILQLHSKGILVLNLKPFNFIL-NEADRAV---LGDVGIPHLLLGIPLPSSDLPRRLGT 213
+ + LH++G++ +LKP N + +E+ + D G + + L T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYT 183
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQP---RCGRSVDEIYDAVVR 267
N++APE + + D W + ++ MLTG P + +EI +
Sbjct: 184 ANFVAPEVLERQGYDA---ACDIW--SLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 61/321 (19%), Positives = 106/321 (33%), Gaps = 83/321 (25%)
Query: 36 AW-IKPSALKLRHR-IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLE 93
+ L L + +G G FG V + + VAVKIL K +
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKT----VAVKIL---KNEAND---P 59
Query: 94 RLNDLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGG 142
L D L E I + GI ++M+ E G L +
Sbjct: 60 ALKDELLA----EANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAEL--GPLNKYLQQNR 112
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVG 192
+ N+ ++ G+ L NF+ L A + D G
Sbjct: 113 HVKDKNIIELVHQVSMGMKYLEES----------NFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 193 IPHLLLGIPLPSSDLPRRLGTPN--YMA------PEQWQ-PEVRGPISF-----ETDSWG 238
L + L Y A P +W PE I++ ++D W
Sbjct: 163 --------------LSKALRADENYYKAQTHGKWPVKWYAPEC---INYYKFSSKSDVWS 205
Query: 239 FACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSR 297
F + E + G +P G E+ + + + + P+G P + +++ C+ YD+ +R
Sbjct: 206 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREMYDLMNLCWTYDVENR 264
Query: 298 PLMTDILRVFKSSQNSVHSDG 318
P + ++ V ++G
Sbjct: 265 PGFAAVELRLRNYYYDVVNEG 285
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 65/279 (23%), Positives = 107/279 (38%), Gaps = 48/279 (17%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLK 101
L +G G FG+V + H L+ H+VAVKIL+ ++ + ++R
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTG------HKVAVKILNRQKIRSLDVVGKIKR------- 60
Query: 102 CQGVEGICWLQGIS---------VI--NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNV 149
E I L+ VI ++M++ G + D + K G++
Sbjct: 61 ----E-IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEA 113
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
R + + H ++ +LKP N +L+ A + D G L + L
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG----LSNMMSDGEFLRT 169
Query: 210 RLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVV 266
G+PNY APE + GP E D W +C +I +L G P V ++ +
Sbjct: 170 SCGSPNYAAPEVISGRLYAGP---EVDIW--SCGVILYALLCGTLPFDDEHVPTLFKKIR 224
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP L +V +L+ + D R + DI
Sbjct: 225 GGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 58/292 (19%), Positives = 105/292 (35%), Gaps = 56/292 (19%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W + LKL IG+G FG+V L Y +VAVK + K D
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGD-YRGN-------KVAVKCI---KNDATA----- 58
Query: 95 LNDLF--------LKCQGV---EGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGG 142
L+ + G+ G + I+ ++ GS+ D +
Sbjct: 59 -QAFLAEASVMTQLRHSNLVQLLGVI-----VEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
L + ++++D+ + + L + +L N +++E + A + D G
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG---------- 162
Query: 203 PSSDLPRRLGTPNYMA--PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT-GVQPRCGR 256
L + + P +W PE S ++D W F + E+ + G P
Sbjct: 163 ----LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
+ ++ V + ++ P G PPAV V+ C+ D RP + +
Sbjct: 219 PLKDVVPRVEKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 60/318 (18%), Positives = 110/318 (34%), Gaps = 81/318 (25%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W L L +G G FG+V +A + + E VAVK+L K+D +
Sbjct: 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATE---KD 83
Query: 95 LNDLFLKCQGVEG-----------ICWLQGISVINGKICIIMKF---------------Y 128
L+D + E I L G +G + +I+++
Sbjct: 84 LSD-LVS----EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 129 EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADR 185
+ ++ +++ ++ LA+G+ L S+ I L A R
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----------KCIHRDL--AAR 186
Query: 186 AVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPI 230
VL V + ++ I +D L R + +Y MAPE
Sbjct: 187 NVL--VT-ENNVMKI----ADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL---FDRVY 236
Query: 231 SFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGC 289
+ ++D W F + E+ T G P G V+E++ + + P+ + ++ C
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-PANCTNELYMMMRDC 295
Query: 290 FEYDLRSRPLMTDILRVF 307
+ RP ++
Sbjct: 296 WHAVPSQRPTFKQLVEDL 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 56/309 (18%), Positives = 106/309 (34%), Gaps = 67/309 (21%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + L +G G FG V + + + D VA+K+L E +
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQID----VAIKVLKQGTEKADT-------E 381
Query: 98 LFLKCQGVEG------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVF 150
++ + I L G+ + ++M+ G + + K ++ +SNV
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVA 439
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPHLLLGI 200
++ G+ L K NF+ L A + D G
Sbjct: 440 ELLHQVSMGMKYLEEK----------NFVHRNLAARNVLLVNRHYAKISDFG-------- 481
Query: 201 PLPSSDLPRRLGTPN--YMA------PEQWQ-PEV--RGPISFETDSWGFACSIIEMLT- 248
L + LG + Y A P +W PE S +D W + ++ E L+
Sbjct: 482 ------LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535
Query: 249 GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
G +P E+ + + + + P PP + ++ C+ Y RP + + +
Sbjct: 536 GQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
Query: 309 SSQNSVHSD 317
+ S+ S
Sbjct: 595 ACYYSLASK 603
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 50/237 (21%), Positives = 78/237 (32%), Gaps = 43/237 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G F H + AVKI+ RM ++ C+G I
Sbjct: 19 LGEGSFSICRKCVH-KKSN-----QAFAVKII----SKRMEANTQKEITALKLCEGHPNI 68
Query: 109 CWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFRYAIDLAQGILQ 162
L + ++M+ G G +R+ K S S + R L +
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNG--GELFERI--KKKKHFSETEASYIMR---KLVSAVSH 121
Query: 163 LHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+H G++ +LKP N + +E D + D G P + L T +Y AP
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG---FARLKPPDNQPLKTPCFTLHYAAP 178
Query: 220 EQWQPEVRGPISFETDSWGFACSIIE--MLTGVQP-------RCGRSVDEIYDAVVR 267
E D W + +I ML+G P S EI + +
Sbjct: 179 ELLNQNGYDE---SCDLW--SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 35/230 (15%)
Query: 32 NDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-- 89
+ W +L ++GRG + EV+ A + + E +V VKIL PVK+ +++
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPVKKKKIKRE 80
Query: 90 -VLLERLNDLFLKCQGVEGICWLQGI--SVINGKICIIMKFYEGSVGDRMAQLKGGKLSL 146
+LE L +G I L I ++ ++ + + ++ Q L+
Sbjct: 81 IKILENL-------RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTD 129
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSS 205
++ Y ++ + + HS GI+ ++KP N +++ R + L D G L P
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQ 185
Query: 206 DLPRRLGTPNYMAPE---QWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252
+ R+ + + PE +Q + D W C + M+ +P
Sbjct: 186 EYNVRVASRYFKGPELLVDYQ-----MYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 55/313 (17%), Positives = 105/313 (33%), Gaps = 83/313 (26%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I + L L +G G FG V ++ +VAVK + K D + +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGN---LKQEDGTSLKVAVKTM---KLDNSS--QREIEE 82
Query: 98 LF--------LKCQGV---EGICWLQGISVINGKICIIMKFYEGSVGD-------RMAQL 139
V G+C ++ S K +I+ F + GD +
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVC-IEMSSQGIPKPMVILPFMKY--GDLHTYLLYSRLET 139
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAV-L 188
+ L + ++ +D+A G+ L ++ NF+ L + D V +
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNR----------NFLHRDLAARNCMLRD-DMTVCV 188
Query: 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNY-------------MAPEQWQPEVRGPISFETD 235
D G L +++ + +Y +A E + ++D
Sbjct: 189 ADFG--------------LSKKIYSGDYYRQGRIAKMPVKWIAIESLA---DRVYTSKSD 231
Query: 236 SWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDL 294
W F ++ E+ T G+ P G E+YD ++ + P + ++ C+ D
Sbjct: 232 VWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-PEDCLDELYEIMYSCWRTDP 290
Query: 295 RSRPLMTDILRVF 307
RP + +
Sbjct: 291 LDRPTFSVLRLQL 303
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 56/254 (22%), Positives = 87/254 (34%), Gaps = 71/254 (27%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLE------- 93
++ +G+G F V H +T E A KI++ K D ++ E
Sbjct: 32 DVKEELGKGAFSVVRRCVH-KTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 94 ------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKL 144
RL+D + ++ G G + + +
Sbjct: 86 QHPNIVRLHDSI------QE----------ESFHYLVFDLVTG--GELFEDIVA----RE 123
Query: 145 SLSNVFRYAIDLAQGILQ----LHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLL 197
S A Q IL+ HS GI+ NLKP N +L ++A A + D G+ +
Sbjct: 124 FYSE--ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPR 253
S GTP Y++ PEV + P S D W AC +I +L G P
Sbjct: 182 N----DSEAWHGFAGTPGYLS-----PEVLKKDPYSKPVDIW--ACGVILYILLVGYPPF 230
Query: 254 CGRSVDEIYDAVVR 267
+Y +
Sbjct: 231 WDEDQHRLYAQIKA 244
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 60/327 (18%), Positives = 116/327 (35%), Gaps = 69/327 (21%)
Query: 23 HLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH 81
+ + + + + + LK +G G FG+V L + ++ E +VAVK L
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGE--QVAVKSLK 59
Query: 82 PVKEDRMRV-------LLERLNDLFLKCQGVEGICWLQGISVINGK--ICIIMKFYE-GS 131
P +L L E I +GI +G I +IM+F GS
Sbjct: 60 PESGGNHIADLKKEIEILRNLYH--------ENIVKYKGICTEDGGNGIKLIMEFLPSGS 111
Query: 132 VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILN 181
+ + + K++L +YA+ + +G+ L S+ +LV + +
Sbjct: 112 LKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES----EHQVK 166
Query: 182 EAD----RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSW 237
D +A+ D + D P + APE + +D W
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDD-----RDSPVF-----WYAPECLM---QSKFYIASDVW 213
Query: 238 GFACSIIEMLT---------------GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
F ++ E+LT +V + + + + +P P P V
Sbjct: 214 SFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC-PPNCPDEV 272
Query: 283 ENVLLGCFEYDLRSRPLMTDILRVFKS 309
++ C+E+ +R +++ F++
Sbjct: 273 YQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-C 102
+ ++G G +G V+ A H + + VA+K + PV+ D ++ E ++ C
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQ------IVAIKQV-PVESDLQEIIKEIS---IMQQC 81
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS---LSNVFRYAIDLAQ 158
+ G N + I+M++ GSV D + +L+ L+ ++ + + +
Sbjct: 82 DS-PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQ---STLK 136
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR---LGTPN 215
G+ LH + ++K N +LN A L D G+ L + + +R +GTP
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL------TDTMAKRNTVIGTPF 190
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254
+MAPE Q + D W + IEM G P
Sbjct: 191 WMAPEVIQ---EIGYNCVADIWSLGITAIEMAEGKPPYA 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 70/276 (25%), Positives = 108/276 (39%), Gaps = 52/276 (18%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL--LERLNDLFLKCQGVE 106
+G G FG+V + H L+ H+VAVKIL+ K + V+ + R E
Sbjct: 24 LGVGTFGKVKVGKHELTG------HKVAVKILNRQKIRSLDVVGKIRR-----------E 66
Query: 107 GICWLQGIS---------VI--NGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRY 152
I L+ VI I ++M++ G G D + K G+L R
Sbjct: 67 -IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG--GELFDYIC--KNGRLDEKESRRL 121
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
+ G+ H ++ +LKP N +L+ A + D G L + L G
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG----LSNMMSDGEFLRTSCG 177
Query: 213 TPNYMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQPRCGRSVDEIYDAVVRRQ 269
+PNY APE + GP E D W + +I +L G P V ++ +
Sbjct: 178 SPNYAAPEVISGRLYAGP---EVDIW--SSGVILYALLCGTLPFDDDHVPTLFKKICD-- 230
Query: 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
I P L P+V ++L + D R + DI
Sbjct: 231 GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 56/304 (18%), Positives = 102/304 (33%), Gaps = 59/304 (19%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ LK ++G+G FG V L + VAVK L D+ R +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCR--YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 98 L-FLKCQGVEGICWLQGISVINGK--ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
L L + I +G+S G+ + ++M++ G + D + Q +L S + Y+
Sbjct: 78 LKALHS---DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYS 133
Query: 154 IDLAQGILQLHSKG----------ILVLNLKPFNFILNEADRAVLGDVGIPHLLLG---- 199
+ +G+ L S+ ILV + D G+ LL
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILV----------ESEAHVKIADFGLAKLLPLDKDY 183
Query: 200 -IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR- 256
+ P + APE S ++D W F + E+ T +
Sbjct: 184 YVVREPGQSPIF-----WYAPESLS---DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235
Query: 257 -------------SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDI 303
++ + + + Q +P P P V ++ C+ + RP + +
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSAL 294
Query: 304 LRVF 307
Sbjct: 295 GPQL 298
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 35/225 (15%)
Query: 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-EDRMRVLLERLNDLFLKCQG 104
+G G V + L T E AVKI+ R RV E ++ +CQG
Sbjct: 18 EDVLGEGAHARVQTCIN-LITSQ-----EYAVKIIEKQPGHIRSRVFREV--EMLYQCQG 69
Query: 105 VEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFRYAIDLAQ 158
+ L + ++ + G G + K + S V + D+A
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRG--GSILSHI--HKRRHFNELEASVVVQ---DVAS 122
Query: 159 GILQLHSKGILVLNLKPFNFIL-NEADRAVL--GD----VGIPHLLLGIPLPSSDLPRRL 211
+ LH+KGI +LKP N + + + + D GI P+ + +L
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 212 GTPNYMAPE--QWQPEVRGPISFETDSWGFACSIIE--MLTGVQP 252
G+ YMAPE + E D W + +I +L+G P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLW--SLGVILYILLSGYPP 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 57/309 (18%), Positives = 106/309 (34%), Gaps = 82/309 (26%)
Query: 38 IKPSALKL-RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLN 96
+K L + +G G FG V + + + D VA+K+L E
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID----VAIKVLKQGTEKADT------- 54
Query: 97 DLFLKCQGVEG----------ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLS 145
+ ++ E I L G+ + ++M+ G + + K ++
Sbjct: 55 EEMMR----EAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFL-VGKREEIP 108
Query: 146 LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPH 195
+SNV ++ G+ L K NF+ L A + D G
Sbjct: 109 VSNVAELLHQVSMGMKYLEEK----------NFVHRDLAARNVLLVNRHYAKISDFG--- 155
Query: 196 LLLGIPLPSSDLPRRLGTPN--YMA------PEQWQ-PEVRGPISF-----ETDSWGFAC 241
L + LG + Y A P +W PE I+F +D W +
Sbjct: 156 -----------LSKALGADDSYYTARSAGKWPLKWYAPEC---INFRKFSSRSDVWSYGV 201
Query: 242 SIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM 300
++ E L+ G +P E+ + + + + P PP + ++ C+ Y RP
Sbjct: 202 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDF 260
Query: 301 TDILRVFKS 309
+ + ++
Sbjct: 261 LTVEQRMRA 269
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 34/220 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-----LLERLNDLFLKCQ 103
+G G F VWLA +D VA+KI+ K LL+R+ND +
Sbjct: 27 LGWGHFSTVWLA------KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 104 GVEG----ICWLQGISVINGK---ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
G + L + + ++ + ++ + + + + L V + + L
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 157 AQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG--- 212
G+ +H + GI+ ++KP N +L E + + I LG +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPEN-VLMEIVDSPENLIQIKIADLGN---ACWYDEHYTNSI 196
Query: 213 -TPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTG 249
T Y + PEV P D W AC I E++TG
Sbjct: 197 QTREYRS-----PEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 50/251 (19%), Positives = 83/251 (33%), Gaps = 65/251 (25%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVLLE------- 93
++ +G+G F V H +T E A KI+ D ++ E
Sbjct: 9 DVKEELGKGAFSVVRRCVH-KTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 94 ------RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKL 144
RL+D + ++ G G + +
Sbjct: 63 QHPNIVRLHDSI------QE----------ESFHYLVFDLVTG--GELFEDIVAR--EFY 102
Query: 145 S---LSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLL 198
S S+ + + + I HS GI+ NLKP N +L ++A A + D G+ +
Sbjct: 103 SEADASHCIQ---QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159
Query: 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGR 256
S GTP Y++PE + + D W AC +I +L G P
Sbjct: 160 ----DSEAWHGFAGTPGYLSPEVLKKDPYSK---PVDIW--ACGVILYILLVGYPPFWDE 210
Query: 257 SVDEIYDAVVR 267
+Y +
Sbjct: 211 DQHRLYAQIKA 221
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/156 (15%), Positives = 50/156 (32%), Gaps = 11/156 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYH--EVAVKI------LHPVKEDRMRVLLERL 95
KL+ R G ++ A + + ++K+ L + R
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 96 NDLFLKCQGVE--GICWLQGISVINGKI-CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRY 152
+ + K I G V K +++ S+ + LS +V +
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188
A L + LH + N+ N ++ D++ +
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 65/319 (20%), Positives = 109/319 (34%), Gaps = 81/319 (25%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLAT-HYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W + L L +G G FG+V LA L + + +VAVK+L K D +
Sbjct: 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATE---KD 117
Query: 95 LNDLFLKCQGVEG-----------ICWLQGISVINGKICIIMKF---------------Y 128
L+D + E I L G +G + +I+++
Sbjct: 118 LSD-LIS----EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 172
Query: 129 EGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADR 185
+ +LS ++ A +A+G+ L SK I L A R
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----------KCIHRDL--AAR 220
Query: 186 AVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPI 230
VL V ++ I +D L R + +Y MAPE
Sbjct: 221 NVL--VT-EDNVMKI----ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL---FDRIY 270
Query: 231 SFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGC 289
+ ++D W F + E+ T G P G V+E++ + + PS + ++ C
Sbjct: 271 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDC 329
Query: 290 FEYDLRSRPLMTDILRVFK 308
+ RP ++
Sbjct: 330 WHAVPSQRPTFKQLVEDLD 348
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 52/247 (21%), Positives = 89/247 (36%), Gaps = 48/247 (19%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +G G GEV LA + + +VA+KI+ R
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCK------KVAIKIISK------RKFAIGSAREADPAL 60
Query: 104 GVEG-ICWLQGIS---VIN-------GKICIIMKFYEGSVG---DRMAQLKGGKLS---L 146
VE I L+ ++ +I I+++ EG G D++ +L
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEG--GELFDKVVG--NKRLKEATC 116
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRAVL--GDVGIPHLLLGIPLP 203
F + + LH GI+ +LKP N +L ++ + ++ D G I
Sbjct: 117 KLYFY---QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG----HSKILGE 169
Query: 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQP-RCGRSVDE 260
+S + GTP Y+APE + D W + +I L+G P R+
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW--SLGVILFICLSGYPPFSEHRTQVS 227
Query: 261 IYDAVVR 267
+ D +
Sbjct: 228 LKDQITS 234
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 56/310 (18%), Positives = 109/310 (35%), Gaps = 68/310 (21%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV------- 90
LK +G G FG+V L + + + E VAVK L + R
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGE--MVAVKALKADAGPQHRSGWKQEID 85
Query: 91 LLERLNDLFLKCQGVEGICWLQGISVINGK--ICIIMKFYEGSVGDRMAQLKGGKLSLSN 148
+L L E I +G G + ++M++ G L + L+
Sbjct: 86 ILRTLYH--------EHIIKYKGCCEDAGAASLQLVMEYVPL--GSLRDYLPRHSIGLAQ 135
Query: 149 VFRYAIDLAQGILQLHSKG----------ILVLNLKPFNFILNEAD----RAVLGDVGIP 194
+ +A + +G+ LH++ +L+ N + ++ D +AV
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN----DRLVKIGDFGLAKAVPEGHEYY 191
Query: 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT------ 248
+ D P + APE + + +D W F ++ E+LT
Sbjct: 192 RVRED-----GDSPVF-----WYAPECLK---EYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 249 ---------GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPL 299
+ +V + + + R + +P P P V +++ C+E + RP
Sbjct: 239 SPPTKFLELIGIAQGQMTVLRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPT 297
Query: 300 MTDILRVFKS 309
+++ + K+
Sbjct: 298 FENLIPILKT 307
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-07
Identities = 49/243 (20%), Positives = 92/243 (37%), Gaps = 52/243 (21%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH---PVKEDRMR---VLLERLND 97
+G G F EV+L L+ + A+K + ++ + +L+++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGK------LFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVG---DRMAQLKGGKLS---LSNVFR 151
E I L+ I ++M+ G G DR+ + G + S V +
Sbjct: 66 --------ENIVTLEDIYESTTHYYLVMQLVSG--GELFDRILER--GVYTEKDASLVIQ 113
Query: 152 YAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRA--VLGDVGIPHLLLGIPLPSSDLP 208
+ + LH GI+ +LKP N + + + ++ D G L + +
Sbjct: 114 ---QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG-----LSKMEQNGIMS 165
Query: 209 RRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIE--MLTGVQPRCGRSVDEIYDA 264
GTP Y+A PEV + P S D W + +I +L G P + ++++
Sbjct: 166 TACGTPGYVA-----PEVLAQKPYSKAVDCW--SIGVITYILLCGYPPFYEETESKLFEK 218
Query: 265 VVR 267
+
Sbjct: 219 IKE 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 61/328 (18%), Positives = 107/328 (32%), Gaps = 92/328 (28%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W L L +G G FG+V AT + Y VAVK+L KE+ L
Sbjct: 18 WEFPRKNLVLGKTLGEGEFGKVVKAT-AFHLKGRAGYTTVAVKML---KENASP---SEL 70
Query: 96 NDLF-----LKCQGVEGICWLQGISVINGKICIIMKF----------------------- 127
DL LK + L G +G + +I+++
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 128 YEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEAD 184
+ L++ ++ +A ++QG+ L + L A
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----------KLVHRDL--AA 178
Query: 185 RAVLGDVGIPHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGP 229
R +L V + I SD L R + + MA E
Sbjct: 179 RNIL--VA-EGRKMKI----SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE--------- 222
Query: 230 ISF-------ETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
S ++D W F + E++T G P G + +++ + + P
Sbjct: 223 -SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEE 280
Query: 282 VENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ ++L C++ + RP+ DI + +
Sbjct: 281 MYRLMLQCWKQEPDKRPVFADISKDLEK 308
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 46/280 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +G G +GEV LA + ++ E VAVKI+ + +++
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKK--------- 54
Query: 104 GVEGICWLQGIS---------VI--NGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNV 149
E IC + ++ + +++ G G DR+ + +
Sbjct: 55 --E-ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG--GELFDRIE--PDIGMPEPDA 107
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
R+ L G++ LH GI ++KP N +L+E D + D G+ + L +
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RERLLNK 166
Query: 210 RLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQP-RCGRSVDEIYDAV 265
GT Y+APE + D W +C I+ ML G P + Y
Sbjct: 167 MCGTLPYVAPELLKRREFHAE---PVDVW--SCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
++ + A +L + +R + DI +
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 23/158 (14%), Positives = 56/158 (35%), Gaps = 15/158 (9%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL---HPVKEDRMRVL------LER 94
K+ IG+G FG ++LA S+E VK+ + ++ +
Sbjct: 38 KVGLPIGQGGFGCIYLADM-NSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKI----CIIMKFYEGSVGDRMAQLKGGKLSLSNVF 150
+ + G+ G + + +IM + + + + + S V
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKTVL 155
Query: 151 RYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188
+ ++ + + +H + ++K N +LN + +
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 64/333 (19%), Positives = 109/333 (32%), Gaps = 91/333 (27%)
Query: 23 HLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH 81
H + T + + +K + IG G FG+V A + + A+K +
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRM- 60
Query: 82 PVKEDRMRVLLERLNDLFLKCQGVEG-----------ICWLQGISVINGKICIIMKF--- 127
KE + + D F E I L G G + + +++
Sbjct: 61 --KEYASK---DDHRD-FAG----ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 128 ------------YEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKP 175
E +A LS + +A D+A+G+ L K
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--------- 161
Query: 176 FNFI---LNEADRAVLGDVGIPHLLLGIPLPSSD-----------------LPRRLGTPN 215
FI L A R +L VG + + I +D LP R
Sbjct: 162 -QFIHRDL--AARNIL--VG-ENYVAKI----ADFGLSRGQEVYVKKTMGRLPVR----- 206
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274
+MA E V + +D W + + E+++ G P CG + E+Y+ + + +
Sbjct: 207 WMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK- 262
Query: 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
P V +++ C+ RP IL
Sbjct: 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 46/280 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +G G +GEV LA + ++ E VAVKI+ + +++
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKK--------- 54
Query: 104 GVEGICWLQGIS---------VI--NGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNV 149
E IC + ++ + +++ G G DR+ + +
Sbjct: 55 --E-ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG--GELFDRIE--PDIGMPEPDA 107
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209
R+ L G++ LH GI ++KP N +L+E D + D G+ + L +
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RERLLNK 166
Query: 210 RLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSII--EMLTGVQP-RCGRSVDEIYDAV 265
GT Y+APE + D W +C I+ ML G P + Y
Sbjct: 167 MCGTLPYVAPELLKRREFHAE---PVDVW--SCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
++ + A +L + +R + DI +
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 49/299 (16%), Positives = 98/299 (32%), Gaps = 71/299 (23%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-LLERLNDL-FL 100
IG+G FG V+ + + + A+K L + E + L + L
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 101 KCQGV---EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK--GGKLSLSNVFRYAID 155
V GI G +++ + GD + ++ ++ ++ + +
Sbjct: 80 NHPNVLALIGIMLPP-----EGLPHVLLPYMCH--GDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 156 LAQGILQLHSKGILVLNLKPFNFI----------LNEADRAVLGDVGIPHLLLGIPLPSS 205
+A+G+ L + F+ L+E+ + D G
Sbjct: 133 VARGMEYLAEQ----------KFVHRDLAARNCMLDESFTVKVADFG------------- 169
Query: 206 DLPRRLGTPNY---------------MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-G 249
L R + Y A E Q + ++D W F + E+LT G
Sbjct: 170 -LARDILDREYYSVQQHRHARLPVKWTALESLQ---TYRFTTKSDVWSFGVLLWELLTRG 225
Query: 250 VQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
P ++ + + + +P P P ++ V+ C+E D RP ++ +
Sbjct: 226 APPYRHIDPFDLTHFLAQGRRLPQ-PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 67/312 (21%), Positives = 106/312 (33%), Gaps = 66/312 (21%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-LLER 94
W + L +G G FG+V AT D VAVK+L P R L+
Sbjct: 18 WEFPRNRLSFGKTLGAGAFGKVVEAT-AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 95 LNDLFLKCQGV-EGICWLQGISVINGKICIIM-----------------KFYEGSVGDRM 136
L L G I L G I G +I F +
Sbjct: 77 LK--VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 137 AQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVGI 193
+ L L ++ ++ +A+G+ L SK N I L A R +L +
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK----------NCIHRDL--AARNIL--LT- 179
Query: 194 PHLLLGIPLPSSD--LPRRLGTPNY-------------MAPEQWQPEVRGPISFETDSWG 238
+ I D L R + + MAPE +FE+D W
Sbjct: 180 HGRITKI----CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF---NCVYTFESDVWS 232
Query: 239 FACSIIEMLT-GVQPRCGRSVD-EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRS 296
+ + E+ + G P G VD + Y + + P P + +++ C++ D
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLK 291
Query: 297 RPLMTDILRVFK 308
RP I+++ +
Sbjct: 292 RPTFKQIVQLIE 303
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 47/273 (17%), Positives = 82/273 (30%), Gaps = 62/273 (22%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKIL--------HPVKEDRMRVLLERL 95
+ ++G G F VWL+ D VA+K++ + E R+ L+ +
Sbjct: 40 HVIRKLGWGHFSTVWLS------WDIQGKKFVAMKVVKSAEHYTETALDEIRL---LKSV 90
Query: 96 NDLFLKCQGVEGICWLQG---ISVINGK-ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFR 151
+ E + L IS +NG IC++ + + + + L L V +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 152 YAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRR 210
+ QG+ LH+K I+ ++KP N +L+ ++ + P
Sbjct: 151 IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 211 LGTPNYMAPEQWQ--------------------------------------PEVR--GPI 230
P EV
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGY 270
Query: 231 SFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263
+ D W AC E+ TG S +E
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 26/159 (16%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +IG G FG ++LA E + VK+ E + L + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARH---VVKV-----EYQENGPLFSELKFYQRVA 91
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDR--------MAQL---------KGGKLSL 146
+ I ++ + I + + G + M +L + G
Sbjct: 92 KKDCIKKWIERKQLD-YLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK 150
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185
S V + I + + +H + ++K N +L +
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 67/539 (12%), Positives = 136/539 (25%), Gaps = 192/539 (35%)
Query: 64 LSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLKCQG------VEGIC-----WL 111
LS E+ D I+ L L Q VE + +L
Sbjct: 46 LSKEEIDH-------IIMSKDAVSGTLRLF----WTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 112 -QGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRY--AIDLAQGILQLHS--- 165
I + ++ + Y DR+ + NV R + L Q +L+L
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQR-DRLYN-DNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 166 ----------KGILVLNLKPFNFILNEADRAV----LGDVGIPHLLL------------- 198
K + L++ + + D + L + P +L
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 199 ---------GIPLPSSDLPRRLGTPNYMAPEQ-----------WQPEVRGPISFETDSWG 238
I L + L + + + +++
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAEL--RRLLKSKPYENCLLVLLNVQNAKA-------WNAFN 263
Query: 239 FACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL-PPAVENVL---LGCFEYDL 294
+C I+ + T R + D + A + L P V+++L L C DL
Sbjct: 264 LSCKIL-LTT----RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 295 RSR-----PLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKVD 349
P I+ I ++ W + + D
Sbjct: 319 PREVLTTNPRRLSII-------------------AESIRDGLATWDN--W----KHVNCD 353
Query: 350 DVVRSRK------PPNSFK---------PENMDVPEGRVVGV---EHNTEGESFVL---- 387
+ + P ++ P + +P ++ + + V+
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI-LLSLIWFDVIKSDVMVVVNKLH 412
Query: 388 -------------VRVHGIHDPLRVHVS---ALERVTFGLAAGDWVRLKEEDR--RHSPV 429
+ + I+ L+V + AL R + + +
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-----------SIVDHYNIPKTFDS 461
Query: 430 GILHSIQRDGSVAVGFLGLETLWKGHFSELQMAESYCVGQFVRLKANVVSPQFEWPRKR 488
L D +G H ++ E F + + F + ++
Sbjct: 462 DDLIPPYLDQYFY-SHIGH------HLKNIEHPERM--TLFRMVFLD-----FRFLEQK 506
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 9e-05
Identities = 65/469 (13%), Positives = 123/469 (26%), Gaps = 147/469 (31%)
Query: 152 YAIDLAQGILQLHSKGILVLNLKPF--NFILN---EADRAVLGD------VGIPH----- 195
+ +D G Q K IL + F NF + +++L +
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 196 -LLLGIPL--PSSDLPRRLGT---PNY--MAPEQWQPEVRGPISFETDSWGFACSIIEML 247
L L + + + NY + + E R P S T + +
Sbjct: 65 LRLFWTLLSKQEEMVQKFVEEVLRINYKFLM-SPIKTEQRQP-SMMTRM--YIEQRDRLY 120
Query: 248 TGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVF 307
Q + V R Q + L +LR +
Sbjct: 121 NDNQVFAKYN-------VSRLQPYLKLRQAL-------------LELRPAKNVL------ 154
Query: 308 KSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDLKVDDVVRSRKPPNSF------ 361
+ G +G K+ ++ + V+ + F
Sbjct: 155 ------IDGVLG-SG--------KTW-------VALDVCL-SYKVQCKMDFKIFWLNLKN 191
Query: 362 --KPEN-MDVPEGRVVGVEHNTEGESFVLVRVHGIHDPLRVHVSALERVTFGLAAGDWVR 418
PE +++ + + ++ N S H + LR+H + +R
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSD-----HSSNIKLRIH-----------SIQAELR 235
Query: 419 --LKEEDRRHSPVGILHSIQ------------------RDGSVAVGFLGLETLWKGHFSE 458
LK + + + +L ++Q R V FL T H S
Sbjct: 236 RLLKSKPYENCLL-VLLNVQNAKAWNAFNLSCKILLTTRFKQVT-DFLSAAT--TTHISL 291
Query: 459 LQMAESYCVGQFVRLKANVVS-PQFEWPRKREGVWATGRICMVVPNGCLIVRFPGRLTFG 517
+ + + L + + PR + P +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPR---------EVLTTNP---RRLS-----IIA 334
Query: 518 EQCSSFLADPAEVEVVTFNTCPGMVKK-YQHLEDLHWAVRPLFIALGLF 565
E LA + V + +++ LE R +F L +F
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE--YRKMFDRLSVF 381
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 49/247 (19%), Positives = 88/247 (35%), Gaps = 60/247 (24%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
++ +GRG V+ + + A+K+L D+ V E
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQK------PYALKVL-KKTVDKKIVRTE---------- 98
Query: 104 GVEGICWLQGISVIN-----------GKICIIMKFYEGSVG---DRMAQLKGGKLS---L 146
I L +S N +I ++++ G G DR+ + G S
Sbjct: 99 ----IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG--GELFDRIVEK--GYYSERDA 150
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL-NEADRA--VLGDVGIPHLLLGIPLP 203
++ + + + + LH GI+ +LKP N + A A + D G+ ++
Sbjct: 151 ADAVK---QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----H 203
Query: 204 SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE--MLTGVQPRCGRSVD-E 260
+ GTP Y APE + E D W + II +L G +P D
Sbjct: 204 QVLMKTVCGTPGYCAPEILR---GCAYGPEVDMW--SVGIITYILLCGFEPFYDERGDQF 258
Query: 261 IYDAVVR 267
++ ++
Sbjct: 259 MFRRILN 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 46/188 (24%), Positives = 69/188 (36%), Gaps = 44/188 (23%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
IG G FG L L+ E VAVK + + + ++R E I
Sbjct: 28 IGSGNFGVARLMRDKLTKE------LVAVKYIE--RGAAIDENVQR-----------E-I 67
Query: 109 CWLQGIS---------VI--NGKICIIMKFYEGSVG---DRMAQLKGGKLSLSNVFRYAI 154
+ + VI + IIM++ G G +R+ G+ S +
Sbjct: 68 INHRSLRHPNIVRFKEVILTPTHLAIIMEYASG--GELYERIC--NAGRFSEDEARFFFQ 123
Query: 155 DLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
L G+ HS I +LK N +L + A R + D G + S +G
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVG 179
Query: 213 TPNYMAPE 220
TP Y+APE
Sbjct: 180 TPAYIAPE 187
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 64/324 (19%), Positives = 109/324 (33%), Gaps = 72/324 (22%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
W + L+ +G G FG+V AT D +VAVK+L K +
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAVKML---KSTAH---ADE 92
Query: 95 LNDLF-----LKCQGV-EGICWLQGISVINGKICIIMKFYEG-------------SVGDR 135
L + G E I L G G + +I ++ D
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 136 MAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI---LNEADRAVLGDVG 192
+ S ++ ++ +AQG+ L SK N I + A R VL +
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASK----------NCIHRDV--AARNVL--LT 198
Query: 193 IPHLLLGIPLPSSD--LPRRL-GTPNY------------MAPEQWQPEVRGPISFETDSW 237
+ I D L R + NY MAPE + ++D W
Sbjct: 199 -NGHVAKI----GDFGLARDIMNDSNYIVKGNARLPVKWMAPESI---FDCVYTVQSDVW 250
Query: 238 GFACSIIEMLT-GVQPRCGRSVD-EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLR 295
+ + E+ + G+ P G V+ + Y V ++ P+ P + +++ C+ +
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPT 309
Query: 296 SRPLMTDILRVFKS--SQNSVHSD 317
RP I + ++ D
Sbjct: 310 HRPTFQQICSFLQEQAQEDRRERD 333
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 44/218 (20%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-------VLLERLNDLFLK 101
IG+G FG+V A D + VA+K++ K R +LE L
Sbjct: 105 IGKGSFGQVVKAY------DHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQD-- 154
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
+ + IC+ + ++ + + + K SL V ++A + Q +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 162 QLHSKGILVLNLKPFNFILNEADRAV--LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
LH I+ +LKP N +L + R+ + D G S +R+ T Y+
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRVYT--YI-- 260
Query: 220 EQWQ------PEV--RGPISFETDSWGFACSIIEMLTG 249
Q PEV D W C + E+LTG
Sbjct: 261 ---QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 19/57 (33%), Positives = 24/57 (42%), Gaps = 5/57 (8%)
Query: 33 DTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM 88
D + W LKL +GRG FG+V A + VAVK+L KE
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKML---KEGAT 70
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.11 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.09 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.23 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 91.09 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-57 Score=474.41 Aligned_cols=275 Identities=18% Similarity=0.249 Sum_probs=232.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+++|++++.||+|+||+||+|++..+++ .||||++++.... .......++. .+++.++||||++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~------~~AiK~i~k~~~~~~~~~~~~~~E~-~il~~l~HpnIv~l~~~ 100 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSR------EYAIKILEKRHIIKENKVPYVTRER-DVMSRLDHPFFVKLYFT 100 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHH-HHHTTCCCTTBCCEEEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCC------EEEEEEEEHHHCCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEE
Confidence 3456789999999999999999999988775 8999999754321 1112222332 25677899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+++.+|||||||+| +|.+.+.. .+.+++.++..|+.||+.||+|||++||+||||||+||||+.++++||+|||+
T Consensus 101 ~~~~~~~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 101 FQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 9999999999999995 88887753 46799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
|+.+.... ......+.+||+.|||||++.+. +|+.++|||||||++|||+||++||.+.+..+++..+... ...
T Consensus 179 a~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~ 252 (311)
T 4aw0_A 179 AKVLSPES-KQARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYD 252 (311)
T ss_dssp CEECCTTT-TCCCBCCCCSCGGGCCHHHHHHS---CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCC
T ss_pred ceecCCCC-CcccccCcccCcccCCHHHHcCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 99875322 22334577999999999999853 6899999999999999999999999999999999998765 456
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSR 326 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~ 326 (627)
+|..+++++++||.+||++||++||++.|++..-.-..|+||.+++|+.+..+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence 78899999999999999999999999998754333334999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=477.31 Aligned_cols=280 Identities=25% Similarity=0.321 Sum_probs=234.9
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+++++|++++.||+|+||+||+|++..++ ..++.||||++++.... ....+ .++. .+++.++||||+++
T Consensus 17 ~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~-~~E~-~il~~l~HpnIv~l 91 (304)
T 3ubd_A 17 GHEKADPSQFELLKVLGQGSFGKVFLVKKISGS---DARQLYAMKVLKKATLKVRDRVRT-KMER-DILVEVNHPFIVKL 91 (304)
T ss_dssp TCCCCCGGGEEEEEEEECGGGCEEEEEEECSST---TTTCEEEEEEEESEEEEEEECC--------CCCCCCCCTTEECE
T ss_pred ccccCCccccEEEEEEecCCCeEEEEEEEccCC---CCCEEEEEEEEehHHcChHHHHHH-HHHH-HHHHHCCCCCCCeE
Confidence 355678899999999999999999999986433 24468999999764321 11111 1221 25667899999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+++.+|||||||+ |+|.+.+.. .+.+++.++..|+.||+.||+|||++||+||||||+|||++.+|++||+|
T Consensus 92 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 92 HYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp EEEEEETTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEES
T ss_pred EEEEEECCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecc
Confidence 999999999999999999 577777753 46799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+|+..... .....+.+||+.|||||++.+ .+|+.++|||||||++|||+||++||.+.+..+++..+...
T Consensus 170 FGla~~~~~~---~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-- 241 (304)
T 3ubd_A 170 FGLSKESIDH---EKKAYSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-- 241 (304)
T ss_dssp SEEEEC--------CCCCSCCCCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred cccceeccCC---CccccccccCcccCCHHHhcc---CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--
Confidence 9999875432 233456799999999999974 46899999999999999999999999999999999988765
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
...+|..+|+++++||.+||++||++||++ .|+++ |+||...+|+.+..+.++||+.|
T Consensus 242 ~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~------Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 242 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR------HSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc------CccccCCCHHHHHhCCCCcCcCC
Confidence 456788999999999999999999999984 57766 99999999999999999988765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=463.57 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=215.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
..++|++++.||+|+||.||+|++..+++ .||||++++..... ......++. .+++.++||||+++++++.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGR------QYVIKEINISRMSSKEREESRREV-AVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCC------EEEEEEEECTTSCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEehHHCCHHHHHHHHHHH-HHHHHCCCCCCCcEEEEEEE
Confidence 45799999999999999999999987764 89999998654322 222222333 35677899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++.+|||||||+ |+|.+.+...+...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 999999999998 5888888765667789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
+... .....+.+||+.|||||++.+ .+|+.++|||||||+||||+||++||.+.+..+++..+.... .++++.
T Consensus 175 ~~~~---~~~~~~~~GT~~YmAPE~l~~---~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~ 247 (350)
T 4b9d_A 175 LNST---VELARACIGTPYYLSPEICEN---KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSL 247 (350)
T ss_dssp CCHH---HHHHHHHHSCCTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCT
T ss_pred ecCC---cccccccCCCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCc
Confidence 6421 112235689999999999985 369999999999999999999999999999999998887654 456788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.+|+++++||.+||++||++||++.++++ |+|+.
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~------hp~~~ 281 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILE------KGFIA 281 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc------CHHhh
Confidence 99999999999999999999999999988 77764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=446.04 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=204.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++++..... ......++.. +++.++||||+++++++.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQ------KVALKIINKKVLAKSDMQGRIEREIS-YLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCC------EEEEEEEECC------CHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEeHHHcCCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEE
Confidence 3689999999999999999999877664 89999997654322 1222233332 5667899999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++.+||||||++|+|.+.+. ..+++++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..
T Consensus 85 ~~~~~ivmEy~~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 85 KDEIIMVIEYAGNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp SSEEEEEEECCCEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred CCEEEEEEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999999999999998886 3568999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. .....+.+||+.|||||++.+. ..++.++|||||||++|||+||++||.+.+..++++.+... ...+|..
T Consensus 163 ~~----~~~~~~~~GT~~Y~APE~~~~~--~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~ 234 (275)
T 3hyh_A 163 TD----GNFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKF 234 (275)
T ss_dssp ----------------CTTSCHHHHSSS--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTT
T ss_pred CC----CCccCCeeECcccCChhhhcCC--CCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCC
Confidence 43 2233467999999999999854 12467999999999999999999999999999999888764 4567889
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+|+++++||.+||+.||++|||+.|+++ |+||.
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~------hpw~k 267 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQ------DDWFK 267 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH------CHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc------Ccccc
Confidence 9999999999999999999999999998 88875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=448.00 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=214.2
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
..+.|+.++|++.++||+|+||+||+|++.. .||||+++..... ....+. ++. .+++.++||||+++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~f~-~E~-~il~~l~HpNIV~l 97 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---------DVAVKILKVVDPTPEQFQAFR-NEV-AVLRKTRHVNILLF 97 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---------EEEEEECCCSSCCHHHHHHHH-HHH-HHHTTCCCTTBCCE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---------cEEEEEEEecCCCHHHHHHHH-HHH-HHHHhCCCCCEeeE
Confidence 4567999999999999999999999998532 5999999754332 222222 222 35678899999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++. ++.+|||||||+ |+|.+.+.. ...++++.+++.|+.||+.||+|||+++||||||||+||||++++.+||+|
T Consensus 98 ~g~~~-~~~~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~D 175 (307)
T 3omv_A 98 MGYMT-KDNLAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGD 175 (307)
T ss_dssp EEEEC-SSSCEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECC
T ss_pred EEEEE-CCeEEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEee
Confidence 99876 456899999999 577776653 456899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-~~ 269 (627)
||+|+...... ........+||+.|||||++.+...++|+.++|||||||+||||+||+.||.+.+..+.+..+.. ..
T Consensus 176 FGla~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~ 254 (307)
T 3omv_A 176 FGLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY 254 (307)
T ss_dssp CSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC
T ss_pred ccCceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC
Confidence 99998764322 12234567899999999999765566899999999999999999999999998765554444433 33
Q ss_pred CCC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 270 EIP---PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 270 ~~~---~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
..+ ..+..+|+++.+|+.+||+.||++||++.++++.|+.++|++
T Consensus 255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 332 356789999999999999999999999999999999888875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=455.81 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=217.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|+++++||+|+||.||+|++..+++ .||||+++.........+. ++. .+++.++||||+++++++.+++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~------~vAiK~i~~~~~~~~~~~~-~Ei-~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLF-NEV-VIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEGGGCSSGGGGH-HHH-HHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCC------EEEEEEEecCchhHHHHHH-HHH-HHHHhCCCCCCCcEEEEEEECCE
Confidence 569999999999999999999988775 8999999764433322222 232 25667899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|||||||+| +|.+.+.. +.+++.++..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 146 ~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999995 66666543 5799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~~ 278 (627)
. .....+.+||+.|||||++.+ .+|+.++|||||||++|||++|++||.+.+..+++..+..... ....+..+
T Consensus 223 ~---~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 296 (346)
T 4fih_A 223 E---VPRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 296 (346)
T ss_dssp S---SCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGS
T ss_pred C---CCcccccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccC
Confidence 2 233456799999999999974 4689999999999999999999999999999999888875432 22344679
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|+++++||.+||+.||++||++.|+++ |+||...
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~------Hp~~~~~ 330 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK------HPFLAKA 330 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhcCC
Confidence 999999999999999999999999988 9998743
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=448.74 Aligned_cols=255 Identities=23% Similarity=0.235 Sum_probs=213.5
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
..+.+.|++.++||+|+||.||+|++..++. .||||+++...... ++ ..+++.++|||||++++++.
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~------~vAiK~i~~~~~~~------~E-~~il~~l~HpnIV~l~~~~~ 120 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGF------QCAVKKVRLEVFRV------EE-LVACAGLSSPRIVPLYGAVR 120 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCT------HH-HHTTTTCCCTTBCCEEEEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCC------EEEEEEECHHHhHH------HH-HHHHHhCCCCCCCcEEEEEE
Confidence 3455789999999999999999999987764 89999997643321 12 23567789999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCcc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIP 194 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla 194 (627)
+++.+|||||||+ |+|.+++.. .+++++..++.|+.||+.||+|||+++||||||||+||||+.+| ++||+|||+|
T Consensus 121 ~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 121 EGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred ECCEEEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 9999999999999 588887753 46799999999999999999999999999999999999999987 6999999999
Q ss_pred ccccCCCCCCC--CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 006887 195 HLLLGIPLPSS--DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI- 271 (627)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~- 271 (627)
+.+........ .....+||+.|||||++.+ .+|+.++|||||||++|||+||++||.+.+..+++..+......
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~ 275 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG---KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI 275 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc
Confidence 98754322111 2235689999999999985 36999999999999999999999999998888888777765432
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..+|+.+|+++.+||.+||++||.+|||+.|+++.|..
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 24688999999999999999999999999999887664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=443.44 Aligned_cols=268 Identities=21% Similarity=0.340 Sum_probs=222.8
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..|+.++|.+.+.||+|+||.||+|++..... ...+..||||+++.......+.+.++ . .+++.++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E-~-~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHRE-A-ELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSCCHHHHHHHHHH-H-HHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCccc-CCCCEEEEEEEeCCCChHHHHHHHHH-H-HHHHhCCCCCCccEEEEE
Confidence 35778899999999999999999999865321 23457899999987655544444333 2 256778999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQL-----------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA 183 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~-----------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~ 183 (627)
.+++.+|||||||+ |+|.+.+... ....+++.+++.++.||+.||.|||+++||||||||+||||+++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999 6888877542 23579999999999999999999999999999999999999999
Q ss_pred CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 006887 184 DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIY 262 (627)
Q Consensus 184 g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~ 262 (627)
+.+||+|||+|+....... ........||+.|||||++.+ +.|+.++|||||||+||||+| |+.||.+.+..+++
T Consensus 165 ~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~---~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999987643221 112234579999999999984 479999999999999999999 99999999999999
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 263 ~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+.... .++.|..+|+++.+|+.+||+.||++||++.++++.|+.+.
T Consensus 241 ~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 241 ECITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8887654 56678999999999999999999999999999999888754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=442.17 Aligned_cols=270 Identities=21% Similarity=0.317 Sum_probs=218.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...|+.++|.+.++||+|+||.||+|+++.... ...++.||||+++.......+.+.++ . .+++.++|||||+++++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E-~-~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQRE-A-ELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC----CEEEEEEEESCCSHHHHHHHHHH-H-HHHTTCCCTTBCCEEEE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCccc-CCCCeEEEEEEECcCCHHHHHHHHHH-H-HHHHhCCCCCCCcEEEE
Confidence 445788899999999999999999999864321 23456899999987655544444333 2 25677899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQL-------------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~-------------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
|.+.+.+|||||||+ |+|.+.+... ..+++++.+++.|+.||+.||.|||+++||||||||+||||
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999 6777776542 12569999999999999999999999999999999999999
Q ss_pred ecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHH
Q 006887 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVD 259 (627)
Q Consensus 181 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~ 259 (627)
++++.+||+|||+++.+..... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~---~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY---RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp ETTTEEEECCCC-----------------CCCCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred CCCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcC---CCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999987643221 222345689999999999984 479999999999999999999 99999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+++..+... ..++.|..+|+++.+|+.+||+.||++||++.++++.|+.+..
T Consensus 268 ~~~~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 268 EAIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 999888764 3567889999999999999999999999999999999887643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=457.18 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=217.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|+++++||+|+||.||+|++..+++ .||||+++.........+. ++. .+++.++|||||++++++.+++.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~------~vAiK~i~~~~~~~~~~~~-~Ei-~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGK------LVAVKKMDLRKQQRRELLF-NEV-VIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEESTTCSSGGGHH-HHH-HHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCC------EEEEEEEeccchhHHHHHH-HHH-HHHHhCCCCCCCceEEEEEECCE
Confidence 569999999999999999999988775 8999999765443333332 232 25667899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|||||||+| +|.+++. .+.+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 223 ~~iVmEy~~gG~L~~~i~---~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEEECCTTEEHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEeCCCCCcHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999995 6666654 35699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~~~ 278 (627)
. .....+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+..... ....+..+
T Consensus 300 ~---~~~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 300 E---VPRRKSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp S---CCCBCCCEECTTTCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred C---CccccccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccC
Confidence 2 233456799999999999974 4689999999999999999999999999999999888876432 23345689
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
|+++++||.+||+.||++||++.|+|+ |+||..
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~------Hp~~~~ 406 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK------HPFLAK 406 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc------CHHhcC
Confidence 999999999999999999999999988 999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=441.18 Aligned_cols=268 Identities=20% Similarity=0.353 Sum_probs=221.5
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..|+.+++++.++||+|+||.||+|++.... +...++.||||+++............++. .++..++||||+++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~-~~~~~~~VAvK~l~~~~~~~~~~~f~~E~-~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPA-PGEQTQAVAIKTLKDKAEGPLREEFRHEA-MLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCc-cCCCCeEEEEEEECcccChHHHHHHHHHH-HHHHhCCCCCCCCcceEE
Confidence 4577889999999999999999999975432 12345689999997654433333333333 356678999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
..++.+|||||||+ |+|.+.+.... ...+++.+++.++.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999999 68888775421 2468999999999999999999999999999999999999
Q ss_pred ecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHH
Q 006887 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVD 259 (627)
Q Consensus 181 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~ 259 (627)
++++.+||+|||+++.+..... .......+||+.|||||++. .+.|+.++|||||||+||||+| |..||.+.+..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~---~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIM---YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHh---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999987654321 22334568999999999997 4579999999999999999998 89999999999
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+++..+... ..++.|..+|+++.+|+.+||+.||++||++.+|++.|++.
T Consensus 255 ~~~~~i~~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999888754 45667899999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=434.80 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=207.1
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE----
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI---- 117 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~---- 117 (627)
|++.++||+|+||.||+|++..++. .||+|++....... ......++. .+++.++|||||++++++..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEEEETT
T ss_pred EEeeeEEecCcCcEEEEEEECCCCe------EEEEEEEchhhCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEeeccCC
Confidence 4888999999999999999987764 89999997643322 122222222 35677899999999999875
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEe-cCCCeeeccCCc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILN-EADRAVLGDVGI 193 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld-~~g~vkL~DFGl 193 (627)
++.+|||||||+ |+|.+.+.. .+.+++..+..|+.||+.||+|||+++ ||||||||+||||+ .+|.+||+|||+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 356899999999 577777753 467999999999999999999999998 99999999999997 479999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~~~~ 272 (627)
|+.... ....+.+|||.|||||++. +.|+.++|||||||++|||+||++||.+.+ ..+++..+......+
T Consensus 179 a~~~~~-----~~~~~~~GTp~YmAPE~~~----~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 179 ATLKRA-----SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp GGGCCT-----TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred CEeCCC-----CccCCcccCccccCHHHcC----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence 986432 3345679999999999985 359999999999999999999999998654 556666665544444
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.++..+++++++||.+||+.||++|||+.++++ |+|+..
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~------Hp~~~~ 288 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQE 288 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC-
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc------CccccC
Confidence 567788999999999999999999999999998 999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=443.41 Aligned_cols=271 Identities=20% Similarity=0.312 Sum_probs=224.4
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.|+.++|++.+.||+|+||.||+|++..+++ ....+.||||+++............++..++.+..+|||||+++++|
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 45888999999999999999999999887653 34557899999987655444444444555566666779999999998
Q ss_pred EEC-CEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 116 VIN-GKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 116 ~~~-~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
... +.+|||||||+ |+|.+.+.... ...+++..++.|+.||+.||.|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 764 57899999999 58888776432 245899999999999999999999999999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCH
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSV 258 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~ 258 (627)
+++++.+||+|||+|+.+..... .......+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~---~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc---CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999987654221 122345689999999999984 479999999999999999998 9999998775
Q ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 259 ~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.+..+......++.|..+++++.++|.+||+.||++|||+.++++.|+.+.
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 55554555555677889999999999999999999999999999999887653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=468.77 Aligned_cols=281 Identities=20% Similarity=0.294 Sum_probs=234.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHH-HHHHHHHhcCCCCcee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLER-LNDLFLKCQGVEGICW 110 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~-~~~~ll~~~~hpnIv~ 110 (627)
+..++.++|++++.||+|+||.||+|++..+++ .||||++++... ........+ ....++...+||||++
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~------~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~ 256 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCC------EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeE
Confidence 445677899999999999999999999987775 899999975321 111111111 1112455679999999
Q ss_pred eEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 111 LQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
+++++.+.+.+|||||||+ |+|.+.+.. .+.|++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+
T Consensus 257 l~~~f~~~~~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999999 577777753 4679999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDAVV 266 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~i~ 266 (627)
|||+|+.+.. ....+.+|||.|||||++.+ ...|+.++|||||||+||||++|++||.+. +..++...+.
T Consensus 335 DFGlA~~~~~-----~~~~t~~GTp~YmAPEvl~~--~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 335 DLGLACDFSK-----KKPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp CCTTCEECSS-----CCCCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred ccceeeecCC-----CCCCCccCCcCccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence 9999987643 23456799999999999963 126899999999999999999999999864 3445666554
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
.. ...+|..+|+++++||.+||++||.+|++ +.++++ |+||..++|+.+..+.++||+.|....
T Consensus 408 ~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~------HpfF~~idW~~l~~~~~~pP~~P~~~~ 476 (689)
T 3v5w_A 408 TM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRSLDWQMVFLQKYPPPLIPPRGE 476 (689)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT------SGGGTTCCHHHHHTTCSCCSCCCCTTC
T ss_pred CC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc------CccccCCCHHHHHcCCCCcCccCCCCC
Confidence 43 46678899999999999999999999997 678877 999999999999999999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=438.34 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=214.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
++|++++.||+|+||.||+|+++.+++ .||||+++...... ..... ++. .+++.++||||+++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~------~vAiK~i~~~~~~~~~~~~~~-~Ei-~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQ------QVAIKKIPNAFDVVTNAKRTL-REL-KILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEETTTTSSHHHHHHHH-HHH-HHHHHCCCTTBCCEEEECCCS
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCC------EEEEEEECccccchHHHHHHH-HHH-HHHHhcCCCCcceEeeeeecc
Confidence 579999999999999999999988775 89999997644322 22222 222 25677899999999998764
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 118 -----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 118 -----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
.+.+|||||||+|+|.+.+. ..+++++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccCCEEEEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence 35789999999999888875 45789999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPL-PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~-~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+|+.+..... ......+.+||+.|||||++.+. ..|+.++||||+||++|||++|++||.+.+..+.+..|......
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~--~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL--HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCC--CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9987654322 22344578999999999998753 35789999999999999999999999999998888877654322
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 PP-----------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ~~-----------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
++ +.+.+++++.+||.+||.+||++|||+.|+|+ |+||...
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------Hp~f~~~ 351 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR------HPFLAKY 351 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGTTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc------CHhhCcC
Confidence 21 11357899999999999999999999999988 9998865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=423.54 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=191.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING- 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~- 119 (627)
++|++++.||+|+||.||+|+++.++. .||||+++....+.......++. .+++.++||||+++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~E~-~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDC------NYAIKRIRLPNRELAREKVMREV-KALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCC------EEEEEEEEECSSHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCC------EEEEEEEeccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEEecCc
Confidence 369999999999999999999987764 89999997655433333333333 2567789999999999987644
Q ss_pred -----------EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCe
Q 006887 120 -----------KICIIMKFYE-GSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 120 -----------~~~LVmEy~~-GsL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~v 186 (627)
.+|||||||+ |+|.+.+..... ...++..++.|+.||+.||+|||++||+||||||+||||+.++.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 3799999998 577777754221 234567789999999999999999999999999999999999999
Q ss_pred eeccCCccccccCCCCCC---------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 006887 187 VLGDVGIPHLLLGIPLPS---------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~---------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~ 257 (627)
||+|||+|+.+....... ...++.+||+.|||||++.+ .+|+.++|||||||++|||++ ||.+..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG---NSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC---CCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999998875432211 12245689999999999985 369999999999999999996 776532
Q ss_pred H-HHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 258 V-DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 258 ~-~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
. ...+..+.. ...++.+...++.+.+||.+||+.||++||++.++++ |+||.+.+|..
T Consensus 232 ~~~~~~~~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------h~~~~~~~~p~ 290 (299)
T 4g31_A 232 ERVRTLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE------NAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGCCC----
T ss_pred HHHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhCCCCCCC
Confidence 2 223333322 2222233455678899999999999999999999988 99999887743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=415.50 Aligned_cols=277 Identities=18% Similarity=0.298 Sum_probs=235.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
++.++|++++.||+|+||.||+|++..+++ .||||++++... ....... .+. .+++.++||||++++++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~-~E~-~~l~~l~hp~iv~l~~~ 73 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTV-TES-RVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHH-HHH-HHHHSCCCTTBCCEEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhhhHHHHHH-HHH-HHHHhCCCCcCcceEEE
Confidence 466899999999999999999999877664 899999975421 1112222 222 35667899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+...+.+||||||++| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999985 67666653 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
++..... .......+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+++..+... ...
T Consensus 152 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~ 223 (337)
T 1o6l_A 152 CKEGISD---GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIR 223 (337)
T ss_dssp CBCSCCT---TCCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred hhhcccC---CCcccccccChhhCChhhhcC---CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 9864321 223456789999999999974 46899999999999999999999999999999988888754 456
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
+|..+++++.+||.+||+.||.+|| ++.++++ |+||...+|..+..+.+.+|+.|....
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~------h~~f~~~~~~~~~~~~~~pp~~p~~~~ 287 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKPQVTS 287 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCSS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc------CCCcCCCCHHHHHhCCCCCCCCCCCCC
Confidence 7889999999999999999999999 8999988 999999999999888899998887543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=419.39 Aligned_cols=302 Identities=19% Similarity=0.239 Sum_probs=238.4
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+..++|++++.||+|+||.||+|++..+++ .||||++++.... ........+..++....+||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l 89 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGD------LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCC------EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeE
Confidence 3456788999999999999999999999887664 8999999754221 1112222333344445589999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+.+.+||||||++| +|.+.+.. .+.+++..+..|+.||+.||.|||++||+||||||+|||++.++++||+|
T Consensus 90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999995 77666653 35799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++..... .......+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+++..+...
T Consensus 168 FG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-- 239 (353)
T 3txo_A 168 FGMCKEGICN---GVTTATFCGTPDYIAPEILQEM---LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-- 239 (353)
T ss_dssp CTTCBCSCC------------CCGGGCCHHHHHHH---HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred ccceeecccC---CccccccCCCcCeEChhhcCCC---CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--
Confidence 9999864321 2334567899999999999743 5889999999999999999999999999999999988765
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLM------TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKE 344 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~------~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~ 344 (627)
...+|..+++++.+||.+||+.||.+||++ .++++ |+||...+|..+..+.+.+|+.|..... .+
T Consensus 240 ~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~------hp~f~~~~w~~l~~~~~~~p~~p~~~~~---~~ 310 (353)
T 3txo_A 240 EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR------HPFFKEIDWAQLNHRQIEPPFRPRIKSR---ED 310 (353)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCCST---TC
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh------CCcccCCCHHHHhcCcCCCCccCCCCCc---cc
Confidence 456788899999999999999999999998 77777 9999999999999999999998865332 33
Q ss_pred ccCCCccccCCCCCCC
Q 006887 345 DLKVDDVVRSRKPPNS 360 (627)
Q Consensus 345 ~~~~~~~~~~~~p~~~ 360 (627)
..+++...+...|..+
T Consensus 311 ~~~f~~~~~~~~~~~~ 326 (353)
T 3txo_A 311 VSNFDPDFIKEEPVLT 326 (353)
T ss_dssp CTTSCHHHHTSCCCCC
T ss_pred ccccCcccccCCCcCC
Confidence 3344444444444443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=415.99 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=201.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|+++... ..++.||||++.+..... . ..++.+++....+||||+++++++.+++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~~~~vAiK~i~~~~~~~--~-~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQV---GPEEKIALKHLIPTSHPI--R-IAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTT---SCEEEEEEEEECTTSCHH--H-HHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccC---CCCCEEEEEEEccccCHH--H-HHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 57999999999999999999875321 234689999987654321 1 23334455556689999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccCCcccccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDVGIPHLLL 198 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DFGla~~~~ 198 (627)
+||||||++ |+|.+.+ +.+++.++..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999998 5777766 258999999999999999999999999999999999999877 799999999998654
Q ss_pred CCCC-------------------------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC
Q 006887 199 GIPL-------------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR 253 (627)
Q Consensus 199 ~~~~-------------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf 253 (627)
.... ......+.+||+.|||||++.+. ..|+.++||||+||++|||++|+.||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHHHHHHHHCCCCC
Confidence 3211 01123456899999999999743 24889999999999999999999999
Q ss_pred CC-CCHHHHHHHHHhcc----------------------------------------------------CCCCCCCCCCH
Q 006887 254 CG-RSVDEIYDAVVRRQ----------------------------------------------------EIPPIPSGLPP 280 (627)
Q Consensus 254 ~~-~~~~e~~~~i~~~~----------------------------------------------------~~~~~p~~~s~ 280 (627)
.. .+..+.+..+.... ........+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 64 34444433332100 00112346889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
++.+||.+||+.||++|||+.|+|+ |+||.+.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~------Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL------HPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT------SGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc------CcccCCC
Confidence 9999999999999999999999998 9999865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=419.54 Aligned_cols=326 Identities=18% Similarity=0.242 Sum_probs=248.9
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+..++|++++.||+|+||.||+|++..+++ .||||++++..... .......+..++....+||||+++
T Consensus 45 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l 118 (396)
T 4dc2_A 45 ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR------IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118 (396)
T ss_dssp ----CCGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred cccCCChhHcEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCee
Confidence 3456788999999999999999999999887664 89999998643221 112223334445556699999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+.+.+||||||++| +|.+.+.. .+.+++..+..|+.||+.||.|||++||+||||||+|||++.+|++||+|
T Consensus 119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 119 HSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEee
Confidence 9999999999999999985 67666653 35799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---------CHHHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---------SVDEI 261 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---------~~~e~ 261 (627)
||+++.... ........+||+.|||||++.+ ..|+.++|||||||++|||++|++||... ....+
T Consensus 197 FGla~~~~~---~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 197 YGMCKEGLR---PGDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp CTTCBCCCC---TTCCBCCCCBCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred cceeeeccc---CCCccccccCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 999986332 1233456799999999999984 46899999999999999999999999642 23345
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCC
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM------TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSG 335 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~------~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 335 (627)
++.+... ...+|..+++++++||.+||+.||.+||++ .++++ |+||...+|+.+..+.+.||+.|.
T Consensus 271 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~------Hpff~~i~w~~l~~~~~~pp~~p~ 342 (396)
T 4dc2_A 271 FQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDMMEQKQVVPPFKPN 342 (396)
T ss_dssp HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH------STTTTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc------CccccCCCHHHHHcCCCCCCCcCC
Confidence 5555543 466788999999999999999999999985 56666 999999999999999999999987
Q ss_pred CcccccCccccCCCccccCCCCCCCCCCCCCCCCCCceeeeecCCCCcceEEEEec
Q 006887 336 YTEWFLSKEDLKVDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVH 391 (627)
Q Consensus 336 ~~~~~~s~~~~~~~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~~~~~~~~v~~~ 391 (627)
.... .+..+++...+...+..++.+. ..........|.+|+++...
T Consensus 343 ~~~~---~d~~~fd~~~~~~~~~~~~~~~-------~~~~~~~~~~f~~f~~~~~~ 388 (396)
T 4dc2_A 343 ISGE---FGLDNFDSQFTNEPVQLTPDDD-------DIVRKIDQSEFEGFEYINPL 388 (396)
T ss_dssp CCSS---TTGGGSCHHHHTSCCCCCCCCH-------HHHTTSCGGGGTTCCEECC-
T ss_pred CCCc---cchhhcChhhccCCCccCCCcc-------hhhccccccccCCcEeECcc
Confidence 5443 2233444444443333222211 11111122347788887644
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=438.64 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=223.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++++.||+|+||.||+|+++.+++ .||||++..........+. ++. .+++.++||||+++++++.+++.
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~------~~AiK~i~~~~~~~~~~~~-~Ei-~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPHESDKETVR-KEI-QTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSHHHHHHHH-HHH-HHHHHTCCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCC------EEEEEEEeccchhhHHHHH-HHH-HHHHhCCCCCCCeEEEEEEECCE
Confidence 689999999999999999999988775 8999999876544433332 333 25667899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC--CCeeeccCCccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA--DRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~--g~vkL~DFGla~~~ 197 (627)
+|||||||+| +|.+.+.. ..+.+++.++..|+.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999995 77777643 44679999999999999999999999999999999999999854 89999999999887
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--PIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--~~p 275 (627)
.. .......+||+.|||||++.+. +|+.++|||||||++|||++|.+||.+.+..+++..+....... ..+
T Consensus 308 ~~----~~~~~~~~GT~~y~APEv~~~~---~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 308 DP----KQSVKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp CT----TSEEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred cC----CCceeeeEECccccCHHHhCCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 43 2334567899999999999853 68999999999999999999999999999999999887654332 234
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGH 323 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~ 323 (627)
..+|+++++||.+||+.||.+||++.|+|+ |+||....|...
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~------Hpw~~~~~~~~~ 422 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTPGNAPGR 422 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTSCCCCTTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcCcCCCCCCCc
Confidence 679999999999999999999999999998 999998877654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=406.62 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=197.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHH-HHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~-ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+|.+.++||+|+||.||+|++. ++.||||+++...... +.. +.++ .+..++||||+++++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~~~~~---~~~-e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSREERS---WFR-EAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGGGHHH---HHH-HHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccchhh---HHH-HHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 46899999999999999999873 2479999997543322 221 1222 334679999999999998754
Q ss_pred ----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCcEEEecCCCe
Q 006887 120 ----KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK--------GILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 120 ----~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------gIvHrDLKP~NILld~~g~v 186 (627)
.+|||||||+ |+|.+.+.. .+++++.+.+++.|++.||+|||++ +||||||||+||||+.++.+
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 6899999999 677777743 4689999999999999999999987 99999999999999999999
Q ss_pred eeccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCCC---CCCCCccCcchhHHHHHHHHHhCCCCCCC-------
Q 006887 187 VLGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEV---RGPISFETDSWGFACSIIEMLTGVQPRCG------- 255 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~---~~~~s~~sDiwSlGviLyelltG~~Pf~~------- 255 (627)
||+|||+|+......... ......+||+.|||||++.+.. .+.|+.++|||||||+||||+||.+||..
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 999999998775432211 1233568999999999997532 12467899999999999999999776532
Q ss_pred --------CCHHHHHHHHHhccCCCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 256 --------RSVDEIYDAVVRRQEIPPIPSG-----LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 256 --------~~~~e~~~~i~~~~~~~~~p~~-----~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
....++...+.....++.+|.. +++.+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1234555555555555555543 3357899999999999999999999999988754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=414.50 Aligned_cols=285 Identities=24% Similarity=0.314 Sum_probs=236.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
.+.+..++|++++.||+|+||.||+|++..++. .||||++++........ ....+...+++..+||||++++
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~ 105 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCC------EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEE
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCC------EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEE
Confidence 445777899999999999999999999877664 89999997654322111 1122222235668999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+.+.+||||||++| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+||
T Consensus 106 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 106 FSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999985 77666653 457899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+... .
T Consensus 184 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~ 255 (373)
T 2r5t_A 184 GLCKENIEH---NSTTSTFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--P 255 (373)
T ss_dssp CBCGGGBCC---CCCCCSBSCCCCCCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--C
T ss_pred ccccccccC---CCccccccCCccccCHHHhCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--c
Confidence 999864332 233456799999999999974 46899999999999999999999999999999999888765 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
..++..+++++++||.+||+.||.+||++.+.++.++. |+||...+|+.+..+.+.+|+.|...
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~--h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS--HVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT--SGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC--CccccCCCHHHHHhCCCCCCCCCCCC
Confidence 55778899999999999999999999998644444443 99999999999999999999888653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=409.97 Aligned_cols=281 Identities=20% Similarity=0.259 Sum_probs=232.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++++.||+|+||.||+|++..++ +.||||++++.... ........+..++....+||+|+.++
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~------~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 87 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEE------EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCC------CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence 44577899999999999999999999987665 48999999754321 11111222222333344899999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..||||||++| +|.+.+.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus 88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeC
Confidence 999999999999999985 77777653 357999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......+||+.|||||++.+ ..++.++|+|||||++|||++|++||.+.+..++++.+... .
T Consensus 166 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~ 237 (353)
T 2i0e_A 166 GMCKENIWD---GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--N 237 (353)
T ss_dssp TTCBCCCCT---TCCBCCCCSCGGGCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C
T ss_pred CcccccccC---CcccccccCCccccChhhhcC---CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--C
Confidence 999864321 223456789999999999974 46899999999999999999999999999999999888765 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
..+|..+++++.+||.+||+.||.+||+ +.++++ |+||...+|+.+..+.+.+|+.|...
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~------h~~f~~~~w~~l~~~~~~~p~~p~~~ 302 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRYIDWEKLERKEIQPPYKPKAC 302 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc------CccccCCCHHHHHhCCCCCCcCCCCC
Confidence 5678899999999999999999999995 467766 99999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=409.30 Aligned_cols=281 Identities=21% Similarity=0.288 Sum_probs=229.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..+++ .||||++++... .........+..++....+||||++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 345678899999999999999999999877664 899999975421 111112223333444556999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+.+..||||||++| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEC
Confidence 999999999999999984 77777653 357999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.+..+++..+... .
T Consensus 163 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~ 234 (345)
T 1xjd_A 163 GMCKENMLG---DAKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N 234 (345)
T ss_dssp TTCBCCCCT---TCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C
T ss_pred hhhhhcccC---CCcccCCCCCcccCChhhhcC---CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C
Confidence 999864321 223456789999999999974 36899999999999999999999999999999999888764 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
+.+|..+++++.+||.+||+.||++||++. ++++ |+||...+|+.+..+.+.+|+.|...
T Consensus 235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~------hp~f~~~~w~~l~~~~~~~p~~p~~~ 295 (345)
T 1xjd_A 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ------HPLFREINWEELERKEIDPPFRPKVK 295 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG------SGGGTTCCHHHHHTTCSCC-------
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc------CccccCCCHHHHhhCCCCCCcCCCCC
Confidence 567888999999999999999999999997 7766 99999999999988888998887643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=401.32 Aligned_cols=280 Identities=20% Similarity=0.278 Sum_probs=230.9
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+..++|++++.||+|+||.||+|++..+++ .||||++++... .........+..++....+||||++++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR------IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 4567899999999999999999999877664 899999976432 22222333344445555699999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+..||||||++| +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999985 77666653 35799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC---------CCHHHHHHH
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG---------RSVDEIYDA 264 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~---------~~~~e~~~~ 264 (627)
++..... .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.. .....+++.
T Consensus 157 a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 157 CKEGLRP---GDTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CBCSCCT---TCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred cccccCC---CCcccccCCCccccCccccCC---CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 9864321 223456789999999999974 3688999999999999999999999975 233445555
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM------TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 265 i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~------~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
+... ...+|..+++++.+||.+||+.||.+||++ .++++ |+||...+|+.+..+...+|+.|....
T Consensus 231 i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~------hp~f~~~~w~~~~~~~~~~p~~p~~~~ 302 (345)
T 3a8x_A 231 ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG------HPFFRNVDWDMMEQKQVVPPFKPNISG 302 (345)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCCT
T ss_pred HHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc------CCccCCCCHHHHHhCCCCCCcCCCCCC
Confidence 5543 456788999999999999999999999985 56666 999999999999888888888876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=415.67 Aligned_cols=285 Identities=19% Similarity=0.259 Sum_probs=235.7
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+..++|++++.||+|+||.||+|++..++. .||+|++++...... .....++ ..++..++||||+++++
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~~AiK~~~k~~~~~~~~~~~~~~E-~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK------VYAMKLLSKFEMIKRSDSAFFWEE-RDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTCCCSTHHHH-HHHHHHCCCTTBCCEEE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCc------EEEEEEEehhhhhhhHHHHHHHHH-HHHHHhCCCCCCCeEEE
Confidence 34567899999999999999999999887664 899999965221110 0111122 23566789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++.+.+.+||||||++| +|.+.+.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|++||+|||
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999975 77666643 469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCC-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... .....+.+||+.|||||++.+.. .+.|+.++|||||||++|||++|++||.+.+..+++..+......
T Consensus 214 ~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 214 TCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp TCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred eeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 998764321 11234678999999999997532 112788999999999999999999999999999999888765433
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 272 PPIP--SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 272 ~~~p--~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
..+| ..+++++++||.+||..+|.+ ||++.++++ |+||...+|+....+...+|+.|....
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~------Hp~f~~~~w~~~~~~~~~~p~~p~~~~ 356 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR------HLFFKNDQWAWETLRDTVAPVVPDLSS 356 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT------SGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc------CccccCCCHHHHhhcccCCCCCCcCCC
Confidence 3334 579999999999999999988 999999998 999999999999999999999987544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=395.08 Aligned_cols=275 Identities=23% Similarity=0.279 Sum_probs=234.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.++.++|++.+.||+|+||.||+|++..++. .||+|++++..... .......+ ..++..++||||++++++
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E-~~~l~~l~hp~Iv~~~~~ 74 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTHPFIIRMWGT 74 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHH-HHHHHSCCBTTBCCEEEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHH-HHHHhhCCCCCCceEeEE
Confidence 3567899999999999999999999877664 89999997543211 11111222 235677899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+..|+||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+
T Consensus 75 ~~~~~~~~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 75 FQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCc
Confidence 9999999999999985 7777765 346799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
++.... .....+||+.|||||++.+ ..++.++|+|||||++|||++|+.||.+.+..+.+..+... ...
T Consensus 153 a~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~ 221 (318)
T 1fot_A 153 AKYVPD------VTYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELR 221 (318)
T ss_dssp CEECSS------CBCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCC
T ss_pred ceecCC------ccccccCCccccCHhHhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 987532 2345689999999999974 46889999999999999999999999999999998888765 356
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
+|..+++++.++|.+||+.||.+|| ++.++++ |+||...+|..+..+.+.+|..|...
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~------hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc------CccccCCCHHHHHhCCCCCCCCCCcC
Confidence 7889999999999999999999999 8888887 99999999999998888888887653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=414.52 Aligned_cols=284 Identities=19% Similarity=0.255 Sum_probs=231.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+..++|++++.||+|+||.||+|++..+++ .||||++++...... ......+. .++...+||||++++++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~------~vAvK~~~~~~~~~~~~~~~~~~E~-~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADK------VFAMKILNKWEMLKRAETACFREER-DVLVNGDSKWITTLHYA 142 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEEHHHHHHTTTTCCHHHHH-HHHHHSCTTTBCCEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCc------EEEEEEEEHHHhhhHHHHHHHHHHH-HHHHhCCCCCEEEEEEE
Confidence 4556899999999999999999999887654 899999975322111 01112222 24566799999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+.+||||||++ |+|.+.+.. ..+.+++..+..|+.||+.||.|||++||+||||||+|||++.++++||+|||+
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence 999999999999997 577776653 356899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
++...... .......+||+.|||||++... ..+.|+.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 222 a~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 222 CLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp CEECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 98764321 1123456899999999998621 1345889999999999999999999999999999999888754433
Q ss_pred CCCC---CCCCHHHHHHHHHhhhcCCCC--CCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcc
Q 006887 272 PPIP---SGLPPAVENVLLGCFEYDLRS--RPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTE 338 (627)
Q Consensus 272 ~~~p---~~~s~~l~~li~~cL~~dP~~--RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~ 338 (627)
..+| ..+++++++||.+||..+|++ ||++.++++ |+||...+|+.+ +...+|+.|....
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~------Hpff~~i~w~~l--~~~~~p~~P~~~~ 363 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK------HPFFSGIDWDNI--RNCEAPYIPEVSS 363 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT------SGGGTTCCTTTG--GGSCCSCCCCCSS
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC------CCccCCCCHHHH--hhCCCCCCCcCCC
Confidence 3333 569999999999999888888 999999988 999999999988 4567777776543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=396.60 Aligned_cols=276 Identities=21% Similarity=0.284 Sum_probs=236.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+..++|++++.||+|+||.||+|++..+++ .||||++++.... ...... ++. .++..++||||+++
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~-~E~-~~l~~l~hp~iv~~ 106 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN------HYAMKILDKQKVVKLKQIEHTL-NEK-RILQAVNFPFLVKL 106 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHH-HHH-HHHTTCCCTTBCCE
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCC------EEEEEEEEhHHhccHHHHHHHH-HHH-HHHHhCCCCCCCeE
Confidence 345667899999999999999999999877664 8999999754321 112222 222 35677899999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+.+..||||||++ |+|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|
T Consensus 107 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 999999999999999998 577777754 35699999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... .....+||+.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+++..+...
T Consensus 185 Fg~a~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-- 253 (350)
T 1rdq_E 185 FGFAKRVKG------RTWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-- 253 (350)
T ss_dssp CTTCEECSS------CBCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--
T ss_pred cccceeccC------CcccccCCccccCHHHhcC---CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--
Confidence 999987643 2245689999999999974 36889999999999999999999999999999999888765
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
...+|..+++++.++|.+||+.||.+||+ +.++++ |+||...+|..+..+...+|+.|...
T Consensus 254 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~------h~~f~~~~w~~~~~~~~~~p~~p~~~ 319 (350)
T 1rdq_E 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh------CcCcCCCCHHHHhhccCCCCCCCCCC
Confidence 45678899999999999999999999998 888887 99999999999988899999888654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=408.86 Aligned_cols=282 Identities=20% Similarity=0.265 Sum_probs=226.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+..++|++++.||+|+||.||+|++..+++ .||||++++...... ......+. .++...+||||++++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~------~vAiK~l~k~~~~~~~~~~~~~~E~-~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ------VYAMKIMNKWDMLKRGEVSCFREER-DVLVNGDRRWITQLHFA 129 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHHGGGCCHHHHH-HHHHHSCTTTBCCEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhHHHHHHHHHHH-HHHHhcCCCCeeeEEEE
Confidence 4667899999999999999999999877664 899999975322111 11112222 24566799999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+.+||||||++ |+|.+.+.. .+..+++..+..|+.||+.||+|||++||+||||||+|||++.++++||+|||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH-HSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999997 577777754 345799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCC----CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE----VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~----~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
++...... .......+||+.|||||++... ..+.|+.++|||||||++|||++|+.||.+.+..+++..+....
T Consensus 209 a~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 209 CLKLRADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp CEECCTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred heeccCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 98764321 1122356899999999998631 02358899999999999999999999999999999888887543
Q ss_pred C---CCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 270 E---IPPIPSGLPPAVENVLLGCFEYDLRSR---PLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 270 ~---~~~~p~~~s~~l~~li~~cL~~dP~~R---Ps~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
. .+..+..+|+++++||.+||. +|.+| |++.++++ |+||...+|+.+. ...+|+.|...
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~------Hpff~~i~w~~l~--~~~~p~~p~~~ 351 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT------HPFFFGLDWDGLR--DSVPPFTPDFE 351 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT------SGGGTTCCSTTST--TSCCSCCCC--
T ss_pred cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc------CCCcCCCCHHHHh--hcCCCCCCcCC
Confidence 2 233346899999999999998 99998 58999887 9999999999885 35677777643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=391.20 Aligned_cols=283 Identities=20% Similarity=0.262 Sum_probs=227.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+..++|++.+.||+|+||.||+|++.... ..++.||+|++++..... ......++. .+++.++||||+++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGA---NTGKIFAMKVLKKAMIVRNAKDTAHTKAER-NILEEVKHPFIVDL 86 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSST---TTTCEEEEEEECCC--------------HH-HHHHHCCCTTBCCE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccC---CCCcEEEEEEEEHHHhhhhhhHHHHHHHHH-HHHHhCCCCCccce
Confidence 45677899999999999999999999985321 234689999997653211 111122222 35667899999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++...+..||||||++| +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECC
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEe
Confidence 9999999999999999985 77776653 35789999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++..... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+...
T Consensus 165 fg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-- 236 (327)
T 3a62_A 165 FGLCKESIHD---GTVTHTFCGTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-- 236 (327)
T ss_dssp CSCC-------------CTTSSCCTTSCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--
T ss_pred CCcccccccC---CccccccCCCcCccCHhhCcC---CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--
Confidence 9998764321 122345689999999999974 46889999999999999999999999999998888888654
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
...+|..+++++.++|.+||+.||.+|| ++.++++ |+||...+|.....+...+|+.|...
T Consensus 237 ~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~------hp~f~~~~~~~~~~~~~~~p~~p~~~ 302 (327)
T 3a62_A 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA------HPFFRHINWEELLARKVEPPFKPLLQ 302 (327)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH------SGGGSSCCHHHHHTTCSCCSCCCC--
T ss_pred CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc------CCcccCCCHHHHhhccCCCCCCCCcC
Confidence 4567888999999999999999999999 7888888 99999999998888888888877643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=434.09 Aligned_cols=325 Identities=20% Similarity=0.255 Sum_probs=252.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++++.||+|+||.||+|++..+++ .||||++++... .........+..++....+||+|+.++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~------~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE------LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCC------EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCc------EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 344677899999999999999999999887764 899999975321 111111222233344455899999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+.+.+||||||++| +|.+.+.. .+.+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+||
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeec
Confidence 999999999999999985 77666653 357999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......+||+.|||||++.+ ..|+.++|||||||+||||++|++||.+.+..+++..+... .
T Consensus 487 Gla~~~~~~---~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~ 558 (674)
T 3pfq_A 487 GMCKENIWD---GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--N 558 (674)
T ss_dssp TTCEECCCT---TCCBCCCCSCSSSCCHHHHTC---CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--C
T ss_pred ceeeccccC---CcccccccCCCcccCHhhhcC---CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--C
Confidence 999864322 223456789999999999974 47899999999999999999999999999999999998754 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCcccccCcccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYTEWFLSKEDL 346 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~s~~~~ 346 (627)
..+|..+++++.+||.+||+.||.+||++ .+|++ |+||..++|+.+..+.+.||+.|.... .+..
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~------h~ff~~i~w~~l~~~~~~pp~~p~~~~----~~~~ 628 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE------HAFFRYIDWEKLERKEIQPPYKPKASG----RNAE 628 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS------SGGGSSCCHHHHTTTCSCCSCCCBCCG----GGHH
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc------CccccCCCHHHHHhCCCCCCCCCcCCC----Cchh
Confidence 66788999999999999999999999987 66666 999999999999999999999987543 2333
Q ss_pred CCCccccCCCCCCCCCCCCCCCCCCceeeeecCCCCcceEEEEecc
Q 006887 347 KVDDVVRSRKPPNSFKPENMDVPEGRVVGVEHNTEGESFVLVRVHG 392 (627)
Q Consensus 347 ~~~~~~~~~~p~~~~~p~~~~~~~~~~v~~~~~~~~~~~~~v~~~~ 392 (627)
+++...+...+..++.+ ...........|.+|+++...-
T Consensus 629 ~f~~~~~~~~~~~~~~~-------~~~~~~~~~~~f~~f~~~~~~~ 667 (674)
T 3pfq_A 629 NFDRFFTRHPPVLTPPD-------QEVIRNIDQSEFEGFSFVNSEF 667 (674)
T ss_dssp HHTTTTTSSCSSCCCCC-------HHHHTTCCGGGGTTCCEECSSC
T ss_pred hcCchhccCCCccCCCc-------hhhhhcccccccCCCcccChhh
Confidence 34444444433333211 1111111223477888876443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=398.40 Aligned_cols=280 Identities=19% Similarity=0.256 Sum_probs=233.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...++.++|++++.||+|+||.||+|++..++. .||+|++.+... .....+.. +. .++..++||||+++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~------~~AiK~~~~~~~~~~~~~~~~~~-E~-~il~~l~hp~Iv~l 80 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKK------MYAMKYMNKQKCVERNEVRNVFK-EL-QIMQGLEHPFLVNL 80 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHH-HH-HHHHTCCCTTBCCE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEehhhcccHHHHHHHHH-HH-HHHHhCCCCCCCcE
Confidence 556778899999999999999999999887664 899999975332 11122222 22 25667899999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+.+..|+||||+.| +|.+.+. ....+++..+..|+.||+.||.|||++||+||||||+|||++.+|+++|+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999999985 6666654 456799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDAVVR 267 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~i~~ 267 (627)
||+++.+.. .......+||+.|||||++.+.....|+.++|||||||++|||++|+.||... ...+++..+..
T Consensus 159 FG~a~~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~ 234 (384)
T 4fr4_A 159 FNIAAMLPR----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET 234 (384)
T ss_dssp CTTCEECCT----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred cceeeeccC----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence 999987643 23345678999999999997543446899999999999999999999999853 34555555543
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPL-MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs-~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
....+|..+++++.+||.+||+.||.+||+ +.++++ |+||...+|+.+..+.+.||+.|..
T Consensus 235 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~------hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 235 --TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN------FPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT------SGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred --cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc------ChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 346678899999999999999999999998 777776 9999999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=407.61 Aligned_cols=281 Identities=19% Similarity=0.290 Sum_probs=231.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHH-HHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL-NDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~-~~~ll~~~~hpnIv~l~~ 113 (627)
...+..++|++.+.||+|+||.||+|++..++. .||||++++............. +..+++.++||||+.+++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGR------YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCC------EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 344667899999999999999999999877664 8999999753221111111111 112456778999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
++...+.+||||||++| +|.+.+.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 216 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 216 SFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp EEEETTEEEEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCC
T ss_pred EEeeCCEEEEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccC
Confidence 99999999999999985 66666643 4579999999999999999999998 99999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... .......+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+... .
T Consensus 294 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~ 365 (446)
T 4ejn_A 294 GLCKEGIKD---GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E 365 (446)
T ss_dssp CCCCTTCC--------CCSSSCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C
T ss_pred CCceeccCC---CcccccccCCccccCHhhcCC---CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--C
Confidence 999864321 223456789999999999974 46899999999999999999999999999999988888654 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
..+|..+++++.+||.+||+.||.+|| ++.++++ |+||...+|.....+.+++|+.|...
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~------hp~f~~~~~~~~~~~~~~pp~~p~~~ 430 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ------HRFFAGIVWQHVYEKKLSPPFKPQVT 430 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCSCS
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh------CccccCCCHHHHhhCcCCCCccCCCC
Confidence 567888999999999999999999999 9999988 99999999999988889988887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=381.67 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=217.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
...++|++.+.||+|+||.||+|++..+++ .||||++...... ...... ++. .+++.++||||+++++++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~-~E~-~~l~~l~hpnIv~l~~~~ 83 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGR------EVAIKIIDKTQLNPTSLQKLF-REV-RIMKILNHPNIVKLFEVI 83 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHH-HHH-HHHHHCCCTTBCCEEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEhhcCCHHHHHHHH-HHH-HHHHhCCCCCEeeEEEEE
Confidence 345689999999999999999999877764 8999999764322 222222 222 256778999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
...+..|+||||++ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EECCEEEEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999997 577777753 357999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
+.... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+..++...+... ...+
T Consensus 162 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~ 233 (328)
T 3fe3_A 162 NEFTV----GGKLDAFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRI 233 (328)
T ss_dssp GGGSS----SCGGGTTSSSGGGCCHHHHHTC--CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC
T ss_pred eecCC----CCccccccCCcceeCcccccCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCC
Confidence 87643 2233456899999999999753 12357899999999999999999999999999998888765 4567
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|..+++++.+|+.+||+.||.+||++.++++ |+|+...
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~------h~~~~~~ 271 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK------DRWINAG 271 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT------CTTTTTT
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc------CHhhcCC
Confidence 7889999999999999999999999999998 9998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=366.92 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=212.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++...... ......++ ..+++.++||||+++++++..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALRE-ICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEESSCSSTTHHHHHHHH-HHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCc------eEEEEeeeccCCcCCcchHHHHH-HHHHhcCCCCCEeeEEeEEEeCC
Confidence 689999999999999999999887664 89999997654322 11222222 23567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..||||||++|++.+.+.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~lv~e~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 75 KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9999999999998888764 457899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccCCC------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVDEIYDAVVRRQEIP------ 272 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P-f~~~~~~e~~~~i~~~~~~~------ 272 (627)
.........||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+......+
T Consensus 154 ---~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 154 ---PVRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ---CCSCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ---ccccccCCccccCCcChHHHcCC--CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 12333456899999999998743 2478999999999999999987777 66667777666665422111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 ---------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ---------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.....+++++++||.+||+.||++||++.++++ |+||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~ 289 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFSDF 289 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTTC
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc------CcccccC
Confidence 122458899999999999999999999999998 9998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=371.47 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=208.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++++.||+|+||.||+|++.. ++.||+|++....... ......++. .+++.++||||+++++++..+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREI-SLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHH-HHHHHCCCTTBCCEEEEECCS
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHH-HHHHHcCCCCEeeeeeEEccC
Confidence 4789999999999999999999743 2489999997543322 111222222 255667999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..|+||||++|++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99999999999998888764 44669999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~----- 273 (627)
.. ........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 171 ~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IP---VRSYTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp SC---CC---CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred CC---cccccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 21 2233456899999999998642 3588999999999999999999999998776666555543221111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 274 -----------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 274 -----------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
+.+.+++++.+||.+||+.||++||++.++++ |+||...++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~~ 309 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN------HPYFKDLDP 309 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTTSCT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc------CcccccCCc
Confidence 12357889999999999999999999999998 999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=369.33 Aligned_cols=255 Identities=19% Similarity=0.296 Sum_probs=213.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|.+..++. .||||++..........+.++. .+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~E~--~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEI--LVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCC------EEEEEEEEGGGCSCHHHHHHHH--HHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCc------EEEEEEeecccccHHHHHHHHH--HHHhcCCCCCCCeEeEEEEECC
Confidence 4689999999999999999999876654 8999999765443333332222 3566789999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++ |+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999997 577666643 468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~ 277 (627)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.... .....+..
T Consensus 168 ~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T 3fxz_A 168 PE---QSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (297)
T ss_dssp ST---TCCBCCCCSCGGGCCHHHHHC---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred Cc---ccccCCccCCcCccChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 32 223345689999999999974 468899999999999999999999999988777665554433 33445678
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+++.+.+||.+||+.||++||++.++++ |+|+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~------h~~~~~ 275 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ------HQFLKI 275 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGGG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh------Chhhcc
Confidence 9999999999999999999999999998 888764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=375.76 Aligned_cols=270 Identities=20% Similarity=0.288 Sum_probs=221.6
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
....+..++|++.+.||+|+||.||+|++..+++ .+..||||+++............++. .++..++||||+++++
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEA-SIMGQFDHPNIIRLEG 117 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEE
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEEE
Confidence 3556788999999999999999999999876653 34579999998654433333333332 3566779999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++...+..||||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence 99988899999999985 76666643 45689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++................+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+... ..
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~ 272 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF---RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YR 272 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CC
Confidence 99877543322222334567889999999974 468899999999999999999 99999999999888877654 45
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+.+..+++++.+||.+||+.||.+||++.++++.|+.+..
T Consensus 273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 56788999999999999999999999999999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=405.53 Aligned_cols=278 Identities=18% Similarity=0.279 Sum_probs=231.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+..++|++.+.||+|+||.||+|++..+++ .||||++.+..... .......+. .++..++||||++++++
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~------~vAvK~l~k~~~~~~~~~~~~~~E~-~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNEK-QILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHH-HHHHHCCCTTBCCEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEhHhhhhhHHHHHHHHHH-HHHHHcCCCCEeeEEEE
Confidence 3677899999999999999999999877664 89999997532211 111112222 25567899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+.+||||||++ |+|.+.+.......+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999998 5777776644445699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcc
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDEIYDAVVRRQ 269 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e~~~~i~~~~ 269 (627)
++.+... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+ ..++...+...
T Consensus 333 a~~~~~~----~~~~~~~GT~~Y~APEvl~~---~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~- 404 (576)
T 2acx_A 333 AVHVPEG----QTIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV- 404 (576)
T ss_dssp CEECCTT----CCEECCCSCGGGCCHHHHTT---CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-
T ss_pred ceecccC----ccccccCCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-
Confidence 9876432 22345689999999999974 368899999999999999999999998753 45566555433
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
...++..+++++++||.+||+.||.+|| ++.++++ |+||...+|..+..+.+.+|+.|..
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~------HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE------HPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh------ChhhccCCHHHHhcCCCCCCCCCCc
Confidence 4567788999999999999999999999 6788887 9999999999998888888888764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=366.23 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=208.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-----HHHHHHHHHHHH--HHHhcCCCCcee
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-----RMRVLLERLNDL--FLKCQGVEGICW 110 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-----~~~~~~~~~~~~--ll~~~~hpnIv~ 110 (627)
+-.++|++.+.||+|+||.||+|++..+++ .||||+++..... ...... ++..+ .+....||||++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~-~e~~~l~~l~~~~h~niv~ 78 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGH------FVALKSVRVPNGGGGGGGLPISTV-REVALLRRLEAFEHPNVVR 78 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCC------EEEEEEEEEECCCTTSSCCCHHHH-HHHHHHHHHHHHCCTTBCC
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEecccccccccccchhHH-HHHHHHHHHhhcCCCCeEE
Confidence 335799999999999999999999876654 8999998743210 001111 11112 233457999999
Q ss_pred eEEEEEECC-----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 111 LQGISVING-----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 111 l~~~~~~~~-----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
+++++.... ..++||||++|+|.+.+.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 79 LMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC
T ss_pred eeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC
Confidence 999998765 689999999999999887655566999999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 159 ~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 159 VKLADFGLARIYSY----QMALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp EEECSCSCTTTSTT----CCCSGGGGCCCSSCCHHHHHT---SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred EEEeeCccccccCC----CcccCCccccccccCchHHcC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999986542 223356689999999999974 46899999999999999999999999999988877777
Q ss_pred HhccCCCC-------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 266 VRRQEIPP-------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 266 ~~~~~~~~-------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
......++ ..+.+++++.+||.+||+.||++||++.++++ |+|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------h~~~~~~ 303 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ------HSYLHKD 303 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT------STTC---
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc------CccccCC
Confidence 65322111 12367899999999999999999999999998 9988753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=366.21 Aligned_cols=257 Identities=20% Similarity=0.262 Sum_probs=206.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|++ .++ +.||+|++....... ..... ++. .+++.++||||+++++++...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~------~~~aiK~~~~~~~~~~~~~~~~-~E~-~~l~~l~h~~iv~~~~~~~~~ 72 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYG------ETFALKKIRLEKEDEGIPSTTI-REI-SILKELKHSNIVKLYDVIHTK 72 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTS------CEEEEEEECCSSGGGCCCHHHH-HHH-HGGGGCCCTTBCCEEEEEECS
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCC------CEEEEEEEeccccccccchhHH-HHH-HHHHhcCCCCEeeeeeEEccC
Confidence 6899999999999999999997 333 479999997654322 12222 222 256678999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..|+||||++|+|.+.+.. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 73 KRLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp SCEEEEEECCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred CeEEEEEEecCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 99999999999988887764 44679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP------ 272 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~------ 272 (627)
.. ........||+.|+|||++.+. ..++.++|+|||||++|||++|+.||.+.+..+.+..+......+
T Consensus 152 ~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 152 IP---VRKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp C------------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cc---ccccccccccccccCchheeCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence 21 2223455799999999998642 358899999999999999999999999988877766665421110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 ---------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ---------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.+...+++++.+||.+||+.||++||++.++++ |+||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~f~~~ 287 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE------HAYFKEN 287 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGGC-
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc------Ccchhhc
Confidence 122458999999999999999999999999998 9988653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=401.50 Aligned_cols=279 Identities=19% Similarity=0.272 Sum_probs=232.0
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+..++|++.+.||+|+||.||+|++..+++ .||||++.+..... ..... .+. .++..++||||++++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~------~vAiK~l~k~~~~~~~~~~~~~-~E~-~iL~~l~hp~Iv~l~ 251 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGK------LYACKKLNKKRLKKRKGYQGAM-VEK-KILAKVHSRFIVSLA 251 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHH-HHH-HHHHHCCCTTBCCEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEEEhHHhhhhHHHHHHH-HHH-HHHHhcCCCCEeeEE
Confidence 34677899999999999999999999877664 89999997543221 11122 222 255677999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
+++...+.+||||||++| +|.+.+.... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+
T Consensus 252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEe
Confidence 999999999999999994 7766665432 3579999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC----CHHHHHHHH
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR----SVDEIYDAV 265 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~----~~~e~~~~i 265 (627)
|||+++.+.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+. ...++...+
T Consensus 332 DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i 405 (543)
T 3c4z_A 332 DLGLAVELKAGQ---TKTKGYAGTPGFMAPELLLG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405 (543)
T ss_dssp CCTTCEECCTTC---CCBCCCCSCTTTSCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred ecceeeeccCCC---cccccccCCccccChhhhcC---CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence 999998764321 22335689999999999974 36899999999999999999999999875 346677766
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLM-----TDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~-----~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
... ...+|..+++++.+||.+||+.||.+||++ .++++ |+||...+|..+..+...+|+.|..
T Consensus 406 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~------Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 406 LEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT------HPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred hhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc------CccccCCCHHHHHcCCCCCCCCCCc
Confidence 543 456788999999999999999999999965 66766 9999999999998888889988864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=377.70 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=217.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||.||+|++..++. .||+|++++..... ......++. .++..++||||+++++++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~------~~avK~i~~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGL------EYAAKFIKKRQSRASRRGVCREEIEREV-SILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHH-HHHTTCCCTTBCCEEEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCC------EEEEEEEEccccccccchhHHHHHHHHH-HHHHhCCCcCCCcEEEEE
Confidence 579999999999999999999887664 89999997643321 111222222 256677899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----Ceeecc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLGD 190 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~D 190 (627)
...+..||||||++ |+|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999997 57777764 456799999999999999999999999999999999999998877 799999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.+.. .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+++..+.....
T Consensus 163 FG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 163 FGLAHEIED----GVEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CSSCEECCT----TCCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCCceEcCC----CCccccCCCCccEECchHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 999987643 223345689999999999974 4689999999999999999999999999999999888875433
Q ss_pred CCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 271 IPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 271 ~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
..+ .+..+++++++||.+||..||.+||++.++++ |+|+...+|..
T Consensus 236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~~~~~~~ 283 (361)
T 2yab_A 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITPVDTQQ 283 (361)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------STTTSCSSHHH
T ss_pred CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc------CcCcCCCchhh
Confidence 221 23678999999999999999999999999998 99998777643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.40 Aligned_cols=264 Identities=20% Similarity=0.291 Sum_probs=205.0
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.+.||+|+||.||+|++..+++ .||||+++..................++..+||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQ------IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCe------EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 4667899999999999999999999876654 8999999765433333323333334577889999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCc
Q 006887 117 INGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
.++..|+||||++|++.+.+... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||+
T Consensus 77 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 77 REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp CSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred ccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 99999999999999888877543 457899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCC-CCCCCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE-VRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEI 271 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~ 271 (627)
++..... .......||+.|+|||++... ....++.++|+|||||++|+|++|+.||.. ................
T Consensus 157 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 157 SGYLVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred ccccccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence 9876432 222345799999999997432 234688999999999999999999999986 3444445455444433
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
...+..+++++.+++.+||+.||++||++.++++ |+||.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~------hp~f~ 271 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ------HPFFT 271 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT------SHHHH
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh------Ccccc
Confidence 3344678999999999999999999999999988 77765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=373.73 Aligned_cols=267 Identities=21% Similarity=0.237 Sum_probs=208.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
......++|++.+.||+|+||.||+|++..+++ .||||+++........ ....++ ..+++.++||||+++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~~~~ 100 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNE------TVAIKRIRLEHEEEGVPGTAIRE-VSLLKELQHRNIIELKS 100 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTE------EEEEEECCCCC--------CHHH-HHHGGGCCCTTBCCEEE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCc------eEEEEEEcccccccccchhHHHH-HHHHHHcCCCCcceEEE
Confidence 344556799999999999999999999877664 8999999765432211 111122 23567789999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-----cCCCeee
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-----EADRAVL 188 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-----~~g~vkL 188 (627)
++..++..||||||++|+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 101 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 101 VIHHNHRLHLIFEYAENDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EEecCCEEEEEEecCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999999999998888863 45699999999999999999999999999999999999995 4455999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+++..... ........||+.|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 179 ~Dfg~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 179 GDFGLARAFGIP---IRQFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp CCTTHHHHHC--------------CCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcCCCccccCCc---ccccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 999999876431 2233456789999999998742 35899999999999999999999999998888777766543
Q ss_pred cCCCCC----------------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 269 QEIPPI----------------------------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 269 ~~~~~~----------------------------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
...+.. +..+++++.+||.+||+.||.+||++.++++ |+||...+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~~ 327 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE------HPYFSHNDF 327 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSSCS
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC------CcccCCCCC
Confidence 222110 0127899999999999999999999999998 999999888
Q ss_pred C
Q 006887 321 T 321 (627)
Q Consensus 321 ~ 321 (627)
+
T Consensus 328 ~ 328 (329)
T 3gbz_A 328 D 328 (329)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=377.90 Aligned_cols=272 Identities=18% Similarity=0.264 Sum_probs=222.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc-CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTE-DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e-d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...+..++|++.+.||+|+||.||+|++..... ....+..||||+++............++..++....+||||+++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345667899999999999999999999864332 1234568999999876443333333344434444448999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
++...+.+|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 99999999999999985 8888776532 24589999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.+||+|||+++.+..... ........||+.|||||++.+ ..++.++|||||||++|||++ |..||.+.+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEEccccCCcccCcccc-eecccCCCcccceECHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999987654221 122344578899999999974 468999999999999999999 999999998
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+++..+... ..+..|..+++++.++|.+||+.||.+||++.++++.|+.+.
T Consensus 311 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 311 VEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp GGGHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 88888766544 356678899999999999999999999999999999988754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=380.84 Aligned_cols=275 Identities=13% Similarity=0.136 Sum_probs=214.2
Q ss_pred CCCCcCCCCeEEEeEEeee--CCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCcee
Q 006887 34 TNAWIKPSALKLRHRIGRG--PFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICW 110 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G--~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~ 110 (627)
.+...+.++|++.+.||+| +||.||+|++..+++ .||||+++...... ......++. .+++.++||||++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~ 90 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGE------YVTVRRINLEACSNEMVTFLQGEL-HVSKLFNHPNIVP 90 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHH-HHHHHCCCTTBCC
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCC------EEEEEEecccccChHHHHHHHHHH-HHHHhCCCCCCCc
Confidence 3455677899999999999 999999999887664 89999997654322 222223232 3567789999999
Q ss_pred eEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 111 LQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
+++++..++..|+||||++ |+|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999998 588787776555779999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCC----CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 190 DVGIPHLLLGIPL----PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 190 DFGla~~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
|||++........ .........||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9998865533211 11222345899999999999753 246889999999999999999999999886655444332
Q ss_pred HhccC--------------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 006887 266 VRRQE--------------------------------------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMT 301 (627)
Q Consensus 266 ~~~~~--------------------------------------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~ 301 (627)
..... ..+.+..+++++.+||.+||+.||++||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 21110 1124566899999999999999999999999
Q ss_pred HHHHHHHhcccccCCCCCCCC
Q 006887 302 DILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 302 eil~~L~~~~~~~~~~~~w~~ 322 (627)
++++ |+||....+..
T Consensus 330 ell~------hp~f~~~~~~~ 344 (389)
T 3gni_B 330 TLLN------HSFFKQIKRRA 344 (389)
T ss_dssp HHTT------SGGGGGC---C
T ss_pred HHhc------CHHHHHHhhcc
Confidence 9998 99998776543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=380.57 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=201.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|.+..+++ .||||++....... ......++..++....+||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGE------VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCC------EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCC------EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 3689999999999999999999887764 89999986543221 1222223333444445699999999999865
Q ss_pred C--EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 G--KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 ~--~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+ .+||||||++|+|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 82 NDRDVYLVFDYMETDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp TSSCEEEEEECCSEEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCEEEEEecccCcCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 4 6999999999988877753 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC------------------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH
Q 006887 197 LLGIPL------------------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV 258 (627)
Q Consensus 197 ~~~~~~------------------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~ 258 (627)
+..... ........+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 643111 11123456899999999998742 4689999999999999999999999999988
Q ss_pred HHHHHHHHhccCCCC---------------------------------------------CCCCCCHHHHHHHHHhhhcC
Q 006887 259 DEIYDAVVRRQEIPP---------------------------------------------IPSGLPPAVENVLLGCFEYD 293 (627)
Q Consensus 259 ~e~~~~i~~~~~~~~---------------------------------------------~p~~~s~~l~~li~~cL~~d 293 (627)
.+.+..+......+. .+..+++++.+||.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 877776654322211 12267899999999999999
Q ss_pred CCCCCCHHHHHHHHHhcccccCCCC
Q 006887 294 LRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 294 P~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|++|||+.++++ |+|+...
T Consensus 317 P~~R~t~~e~l~------Hp~~~~~ 335 (388)
T 3oz6_A 317 PNKRISANDALK------HPFVSIF 335 (388)
T ss_dssp GGGSCCHHHHTT------STTTTTT
T ss_pred cccCCCHHHHhC------CHHHHHh
Confidence 999999999998 9997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.23 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=204.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.++||+|+||.||+|++..++. .||||++......... .....+...+.....||||+++++++..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGR------LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSC------EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCe------EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 679999999999999999999876654 8999998764332221 112222223455669999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..||||||+.|+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 131 ~~~lv~e~~~~~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECCCCBHHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEeccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999999999999888765 456799999999999999999999999999999999999999999999999999887643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+.. ....+......+.++..++
T Consensus 210 ~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 210 A----GAGEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLS 278 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSC
T ss_pred C----CCCcccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCC
Confidence 1 22345579999999999863 58999999999999999999977765432 2333333333334567889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+++.++|.+||+.||++||++.++++ |+|+.
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~------hp~~~ 309 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLA------LPVLR 309 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh------Ccccc
Confidence 99999999999999999999999998 88875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=367.52 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=210.7
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
....+..++|++.+.||+|+||.||+|++. +..||||++........ .....++. .+++.++||||++++
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~ 100 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREV-AIMKRLRHPNIVLFM 100 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHH-HHHHHCCCTTBCCEE
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHH-HHHHhCCCCCEeeEE
Confidence 456677899999999999999999999863 24799999976543222 11222222 255667899999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCCCeee
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g~vkL 188 (627)
+++...+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp EEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred EEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEE
Confidence 999999999999999985 7777765321 124899999999999999999999999 999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 181 ~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 181 CDFGLSRLKAST---FLSSKSAAGTPEWMAPEVLRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp CCCC--------------------CCTTSCHHHHTT---CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred CCCCCCcccccc---ccccccCCCCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 999999765331 122345689999999999974 36889999999999999999999999999999888888767
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.....++..+++++.+||.+||+.||.+||++.++++.|+....
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 77778899999999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.75 Aligned_cols=263 Identities=19% Similarity=0.239 Sum_probs=208.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-------------------------H
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-------------------------R 89 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-------------------------~ 89 (627)
...+..++|++.+.||+|+||.||+|++..++. .||||++........ .
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNT------YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTE------EEEEEEEECC-------------------------------
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCc------EEEEEEeehhhhhhhcccccccccccccccccccccccchH
Confidence 344566899999999999999999999877654 899999976432111 0
Q ss_pred HHHHHHHHHHHHhcCCCCceeeEEEEEE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 006887 90 VLLERLNDLFLKCQGVEGICWLQGISVI--NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166 (627)
Q Consensus 90 ~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~ 166 (627)
....++. .+++.++||||+++++++.. .+..||||||++| +|.+. ....++++..+..++.||+.||.|||++
T Consensus 81 ~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 81 EQVYQEI-AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp CHHHHHH-HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCS---SCSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHH-HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 1112222 25677899999999999986 6789999999986 44332 2456799999999999999999999999
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHH
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyel 246 (627)
||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.....++.++|+|||||++|+|
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 99999999999999999999999999998764321 122356899999999999754222246789999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 247 LTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 247 ltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
++|+.||.+.+...+...+.......+....+++++.+||.+||+.||++||++.++++ |+|+.
T Consensus 234 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~------hp~~~ 297 (298)
T 2zv2_A 234 VFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL------HPWVT 297 (298)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT------CHHHH
T ss_pred HHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc------Ccccc
Confidence 99999999988888877776655444445689999999999999999999999999987 77753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=380.09 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=211.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++.+...... .....++. .+++.++||||+++++++..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQ------KVALKFISRQLLKKSDMHMRVEREI-SYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCSHHHHHHH-HHHTTCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEehHHccchhHHHHHHHHH-HHHHhCCCCCCCeEEEEEEe
Confidence 4689999999999999999999877664 899999975322111 11122222 25677899999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
.+..|+||||++|+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred CCEEEEEEECCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 999999999999999988864 357999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
.. .......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+....++...+. .....+|..
T Consensus 159 ~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~ 230 (336)
T 3h4j_B 159 TD----GNFLKTSCGSPNYAAPEVINGKL--YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF 230 (336)
T ss_dssp TT----SBTTCCCTTSTTTSCGGGSCCSG--GGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--SSCCCCCTT
T ss_pred cC----CcccccccCCcCcCCHHHHcCCC--CCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--cCCCCCccc
Confidence 43 22334568999999999997531 23679999999999999999999998876655544332 223456788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+++++.+||.+||+.||.+||++.++++ |+||..
T Consensus 231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~------hp~~~~ 264 (336)
T 3h4j_B 231 LSPGAQSLIRRMIVADPMQRITIQEIRR------DPWFNV 264 (336)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHTT------CHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHh------Chhhcc
Confidence 9999999999999999999999999988 888764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=372.43 Aligned_cols=255 Identities=19% Similarity=0.252 Sum_probs=214.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+.|++.+.||+|+||.||+|++..++ +.||||++......... ....++. .+++.++||||+++++++..+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS------EVVAIKKMSYSGKQSNEKWQDIIKEV-RFLQKLRHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEESCSSCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEET
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC------eEEEEEEEccccccchHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEEC
Confidence 45999999999999999999987665 48999999764332221 1122222 255677999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+..||||||+.|++.+.+.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CeEEEEEecCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99999999999999888764 45679999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~ 278 (627)
. .....||+.|+|||++.+...+.++.++|||||||++|||++|+.||.+.+..+....+.........+..+
T Consensus 206 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 206 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 278 (348)
T ss_dssp S-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred C-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC
Confidence 2 234589999999999864334578999999999999999999999999988877776676655444456788
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
++.+.+||.+||+.||++||++.++++ |+|+.
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~------h~~~~ 310 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLK------HRFVL 310 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTT------CHHHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhh------Chhhh
Confidence 999999999999999999999999988 77654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=369.25 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=201.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++++.||+|+||.||+|.+..++ +.||+|+++............++. .+++.++||||+++++++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTG------VYVALKEVKLDSEEGTPSTAIREI-SLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSC------CEEEEEEEECCSTTCSCHHHHHHH-HHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCC------cEEEEEEeecccccccHHHHHHHH-HHHHhcCCCCcceEEEEEEECC
Confidence 468999999999999999999987665 489999997654322111222222 3567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLK----GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~----~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..||||||++|+|.+.+.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999999999999988886543 2468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--- 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--- 272 (627)
..... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+.+..+......+
T Consensus 157 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 157 AFGIP---VNTFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp ETTSC---CCCCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred ecCCC---cccCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 76431 2233456899999999998742 358899999999999999999999999998888777665421111
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 273 -----------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 273 -----------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
..+..+++++.+||.+||+.||++||++.++++ |+||....+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~------hp~f~~~~~ 302 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH------HPWFAEYYH 302 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGGGGCC
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC------Chhhhcccc
Confidence 112357899999999999999999999999998 999876544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=382.69 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=213.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|.+..++. .||+|++........ .....++. .+++.++||||+++++++..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~------~~a~K~i~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQ------EYAAMIINTKKLSARDHQKLEREA-RICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTE------EEEEEEEESCSCHHHHHHHHHHHH-HHHHHCCBTTBCCEEEEEECSS
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCc------EEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCcCCCeEEEEEEECC
Confidence 579999999999999999999877664 899999986543222 22223332 3566779999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe---cCCCeeeccCCccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN---EADRAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld---~~g~vkL~DFGla~ 195 (627)
..|+||||+.| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999985 77777763 46799999999999999999999999999999999999998 46789999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC-
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI- 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~- 274 (627)
..... ........||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+++..+.......+.
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 162 EVEGE---QQAWFGFAGTPGYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 235 (444)
T ss_dssp CCCTT---CCBCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EecCC---CceeecccCCcccCCHHHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc
Confidence 76432 222345689999999999974 36899999999999999999999999999999999888776544332
Q ss_pred -CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 275 -PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 275 -p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
...+++++.+||.+||+.||.+||++.++++ |+|+.
T Consensus 236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~------hp~~~ 272 (444)
T 3soa_A 236 EWDTVTPEAKDLINKMLTINPSKRITAAEALK------HPWIS 272 (444)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SCTTH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc------Ccccc
Confidence 2578999999999999999999999999998 88875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.08 Aligned_cols=267 Identities=18% Similarity=0.220 Sum_probs=206.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++..++. .||||++........ .....++. .+++.++||||+++++++...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQ------IVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECCCCC-HHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCc------EEEEEEeeccccchHHHHHHHHHH-HHHHhCCCCCccchhheeecCC
Confidence 689999999999999999999877654 899999876543322 22222222 3566778999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..++||||++|+++..+.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999866665543 456799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI-------- 271 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~-------- 271 (627)
. ........||+.|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+....+......
T Consensus 155 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 155 P---SDYYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp --------------GGGCCHHHHHTC--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c---ccccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 2 1223456899999999998742 36889999999999999999999999998877665554332110
Q ss_pred -----------CCC----------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcc
Q 006887 272 -----------PPI----------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSR 326 (627)
Q Consensus 272 -----------~~~----------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~ 326 (627)
.+. .+.+++++.+||.+||+.||.+||++.++++ |+||....+......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~~~~~~~~ 299 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH------HPYFENIREIEDLAK 299 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT------SGGGTTCC-------
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc------ChHHHhccCHHHHHH
Confidence 000 1468899999999999999999999999998 999988766544333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=376.38 Aligned_cols=287 Identities=18% Similarity=0.270 Sum_probs=227.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+..++|++.+.||+|+||.||+|++.... ..++.||||+++.... .........+..++....+||||+.+
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGH---DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCCCCGGGEEEEEEEEETTTEEEEEEEECSST---TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred cccccccceEEEEEeccCCCEEEEEEEEcccC---CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence 44566789999999999999999999985421 2346899999875321 00011111222334444489999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++...+..||||||++| +|.+.+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 125 HYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred EEEEeeCceEEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEee
Confidence 9999999999999999985 77777753 35799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC----CHHHHHHHHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR----SVDEIYDAVV 266 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~----~~~e~~~~i~ 266 (627)
||+++.+.... .......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||... ...++...+.
T Consensus 203 fG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 203 FGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp SSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred CCCCeecccCC--CCcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 99998654211 1122356899999999999753 235788999999999999999999999753 3344555444
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
. ..+.++..+++.+.+||.+||+.||.+|| ++.++++ |+||...+|..+.....++|+.|...
T Consensus 280 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~------h~~f~~~~~~~l~~~~~~~p~~p~~~ 347 (355)
T 1vzo_A 280 K--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQKINWDDLAAKKVPAPFKPVIR 347 (355)
T ss_dssp H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred c--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc------CcchhcCChhHhhhccCCCCCCCccc
Confidence 3 34667889999999999999999999999 8999988 99999999999888888888877643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=373.17 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=211.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|.+..++. .||+|+++...... ......++. .+++.++||||+++++++.+.+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGL------EFAAKIINTKKLSARDFQKLEREA-RICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCC------EEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEEeCC
Confidence 479999999999999999999877664 89999997654321 112222232 2556679999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---CeeeccCCccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vkL~DFGla~ 195 (627)
..|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 102 ~~~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEEECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999995 7777664 346799999999999999999999999999999999999997654 59999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+++..+.......+.+
T Consensus 180 ~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 180 EVND----SEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CCTT----CCSCCCSCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EecC----CcccccCCCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 7643 223345689999999999974 468999999999999999999999999999988888887654433322
Q ss_pred --CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 276 --SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 276 --~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..+++++.+||.+||+.||++||++.++++ |+|+.
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~ 289 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK------VPWIC 289 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT------SHHHH
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc------CcccC
Confidence 468999999999999999999999999987 66654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=373.26 Aligned_cols=272 Identities=20% Similarity=0.299 Sum_probs=220.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..... ...++.||||+++............++..++....+||||++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccc-cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 344677899999999999999999999765331 3455799999998755444333344444455555689999999999
Q ss_pred EEECC-EEEEEEecCCC-CHHHHHHHhcC---------------------------------------------------
Q 006887 115 SVING-KICIIMKFYEG-SVGDRMAQLKG--------------------------------------------------- 141 (627)
Q Consensus 115 ~~~~~-~~~LVmEy~~G-sL~d~l~~~~~--------------------------------------------------- 141 (627)
+...+ ..++||||++| +|.+.+.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 88754 49999999995 77777754321
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCC
Q 006887 142 -------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208 (627)
Q Consensus 142 -------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~ 208 (627)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.+..... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhcc
Confidence 1289999999999999999999999999999999999999999999999999987643221 12234
Q ss_pred ccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Q 006887 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLL 287 (627)
Q Consensus 209 ~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~ 287 (627)
...||+.|||||++.+ ..++.++|||||||++|||++ |..||.+....+.+............+..+++++.+++.
T Consensus 254 ~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp -CEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred ccCCCceeEChhhhcC---CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 5678999999999874 468999999999999999998 999999887666555555566667788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 288 GCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 288 ~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+||+.||.+||++.++++.|+.+.
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=369.77 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=207.7
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++.............++. .+++.++||||+++++++..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECC-------CHHHHH-HHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCc------EEEEEEEEcccccchHHHHHHHH-HHHHhCCCCCCCeEEEEEecCC
Confidence 3689999999999999999999887664 89999997654433222223332 3556689999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred eEEEEEEcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999986 6666553 34579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~p~~ 277 (627)
... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.. ..+...............
T Consensus 157 ~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (323)
T 3tki_A 157 YNN-RERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233 (323)
T ss_dssp ETT-EECCBCSCCSCGGGSCHHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred cCC-cccccCCCccCcCccCcHHhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcccc
Confidence 321 12223456899999999999743 22477899999999999999999999876543 333333333333333467
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+++++.+||.+||+.||.+||++.++++ |+|+...
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~------h~~~~~~ 268 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKK------DRWYNKP 268 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTTCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhh------Chhhccc
Confidence 8999999999999999999999999988 9998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=382.96 Aligned_cols=273 Identities=19% Similarity=0.233 Sum_probs=198.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.-.++|++++.||+|+||.||+|++..+++ .||||++......... ....++. .++..++||||+++++++
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~i~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~ 121 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKR------VVAIKKILRVFEDLIDCKRILREI-AILNRLNHDHVVKVLDIV 121 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--C------EEEEEEECSTTSSHHHHHHHHHHH-HHHHHCCCTTBCCEEEEC
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCc------EEEEEEechhhcCHHHHHHHHHHH-HHHHhCCCCCCCceEEEE
Confidence 3345889999999999999999999887664 8999999764332221 1122222 256677999999999998
Q ss_pred EEC-----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 116 VIN-----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 116 ~~~-----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
... +.+||||||++|+|.+.+. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 122 ~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 122 IPKDVEKFDELYVVLEIADSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CCSCTTTCCCEEEEECCCSEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred ecCCcccCceEEEEEeccccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 543 5699999999999888875 456799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCC------------------------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHH
Q 006887 191 VGIPHLLLGIPLPS------------------------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246 (627)
Q Consensus 191 FGla~~~~~~~~~~------------------------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyel 246 (627)
||+++......... ......+||+.|||||++.. ...|+.++|||||||++|||
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL--QENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT--CCCCCTHHHHHHHHHHHHHH
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC--CCCCCcHhHHHHHHHHHHHH
Confidence 99998764321110 12345689999999998743 34689999999999999999
Q ss_pred Hh-----------CCCCCCCCCH--------------------HHHHHHHHhccCC------------------------
Q 006887 247 LT-----------GVQPRCGRSV--------------------DEIYDAVVRRQEI------------------------ 271 (627)
Q Consensus 247 lt-----------G~~Pf~~~~~--------------------~e~~~~i~~~~~~------------------------ 271 (627)
++ |+++|.+.+. .+.+..+......
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 7777876542 1222222111000
Q ss_pred -----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcc
Q 006887 272 -----PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSR 326 (627)
Q Consensus 272 -----~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~ 326 (627)
....+.+++++.+||.+||..||.+||++.|+++ |+||....|......
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~------Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA------HPFFKEVRIAEVETN 411 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTTCCGGGCCC
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc------CHhhhhcCCCccCCC
Confidence 0112456899999999999999999999999999 999999888765543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=371.46 Aligned_cols=275 Identities=20% Similarity=0.275 Sum_probs=227.3
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc-CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTE-DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e-d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+.+..++|++.+.||+|+||.||+|++..++. ....+..||||+++............++..++....+||||+++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 34556788999999999999999999999876543 12345689999998765444333334444445554599999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCC
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPF 176 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~ 176 (627)
++++..++..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||+++|+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 9999999999999999985 8888876543 246999999999999999999999999999999999
Q ss_pred cEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCC
Q 006887 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCG 255 (627)
Q Consensus 177 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~ 255 (627)
|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999987643221 123345578899999999974 468999999999999999999 9999999
Q ss_pred CCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 256 RSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 256 ~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+..++...+... .....+..+++++.+||.+||+.||++||++.++++.|+.+..
T Consensus 297 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 297 VPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp CCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 9988888777644 3566788999999999999999999999999999999988654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=373.72 Aligned_cols=267 Identities=18% Similarity=0.253 Sum_probs=217.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||||++++...... ++.+++....+||||+++++++.+.+.
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~-----~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNM------EFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEETTTCCCH-----HHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEcccCChH-----HHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 579999999999999999999887664 899999976543321 223345566689999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-C---CeeeccCCccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-D---RAVLGDVGIPH 195 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g---~vkL~DFGla~ 195 (627)
.|+||||++ |+|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||+..+ + .+||+|||+++
T Consensus 91 ~~lv~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEEECCCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999998 47777775 45679999999999999999999999999999999999998433 3 59999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhccCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG---RSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~---~~~~e~~~~i~~~~~~~ 272 (627)
..... .......+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+ .+..+++..+.......
T Consensus 169 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 169 QLRAE---NGLLMTPCYTANFVAPEVLERQ---GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp ECBCT---TCCBCCSSCCSSCCCHHHHHHH---HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred cCcCC---CCceeccCCCccccCHHHhcCC---CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 76432 2233466899999999998743 588899999999999999999999986 45677777776554332
Q ss_pred C--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCC
Q 006887 273 P--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSS 334 (627)
Q Consensus 273 ~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~ 334 (627)
. .+..+++++.+||.+||+.||++||++.++++ |+|+. +|..+....+.++..|
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~------hp~~~--~~~~~~~~~~~~~~~p 298 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR------HPWIV--HWDQLPQYQLNRQDAP 298 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT------SHHHH--TGGGSCCSCCCCCCCH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc------CCeec--CccccccccCCCccch
Confidence 2 34679999999999999999999999999988 89884 4666666555555443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=367.49 Aligned_cols=272 Identities=20% Similarity=0.257 Sum_probs=215.4
Q ss_pred CCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+.|.+. +.||+|+||.||+|++..++. .||+|++....... ......++..++....+||||+++++++...
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQ------EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCC------EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 457887 899999999999999877664 89999997643221 1222333334555666889999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~DFGla 194 (627)
+..|+||||+.| +|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999996 6666664434578999999999999999999999999999999999999987 789999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--C
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--P 272 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--~ 272 (627)
+..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+...... .
T Consensus 182 ~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 182 RKIGHA----CELREIMGTPEYLAPEILNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp EEC-------------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred cccCCc----cccccccCCcCccCCeeecC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 876432 22345689999999999973 46889999999999999999999999999988887777654332 2
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcccCCCC
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDK 331 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~ 331 (627)
..+..+++.+.+||.+||+.||.+||++.++++ |+|+...+|.........++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~------h~~~~~~~~~~~~~~~~~~~ 307 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS------HSWLQQWDFENLFHPEETSS 307 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------CGGGCCCCTTCC--------
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC------CHhhcccccccccCccCCCC
Confidence 334678999999999999999999999999988 99999999887655443333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=356.66 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=206.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..++. .||+|++......... ....++. ..+..++||||+++++++..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNI------KVAIKAIFIPPREKEETLKRFEREV-HNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCS------EEEEEEEECCSSCCHHHHHHHHHHH-HHHTTCCBTTBCCEEEEEEC
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCC------eEEEEEeccCccccHHHHHHHHHHH-HHHhcCCCCCCceEEEeeee
Confidence 4789999999999999999999877654 8999998654322211 1222222 25667899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..|+||||++| +|.+.+.. .+++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred CCeEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 9999999999985 77777653 35799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---C
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP---P 273 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~---~ 273 (627)
..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+............ .
T Consensus 161 ~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 161 LSETS--LTQTNHVLGTVQYFSPEQAKG---EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp C---------------CCSSCCHHHHHT---CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHH
T ss_pred ccccc--ccccCccccCccccCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchh
Confidence 64321 122335679999999999974 368889999999999999999999999988877665554433221 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhccc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-LMTDILRVFKSSQN 312 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-s~~eil~~L~~~~~ 312 (627)
.+..+|+.+.++|.+||+.||.+|| ++.++++.|....+
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 4567899999999999999999999 88899998887543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=366.98 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=213.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..++. .||+|++....... . ...++. .+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~-~-~~~~E~-~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKK------TYMAKFVKVKGTDQ-V-LVKKEI-SILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCCTHHH-H-HHHHHH-HHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCc------EEEEEEEecCcccH-H-HHHHHH-HHHHhCCCCCCCeEeEEEecCC
Confidence 3689999999999999999999877664 89999997554322 2 222332 2456789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec--CCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE--ADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~--~g~vkL~DFGla~~ 196 (627)
..|+||||++| +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999985 77776643 3457999999999999999999999999999999999999987 78999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--C
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--I 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~--~ 274 (627)
+.. ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+++..+.......+ .
T Consensus 154 ~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 154 LKP----GDNFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CCT----TCEEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCC----CCccccccCChhhcCcHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence 643 122345679999999999974 3578899999999999999999999999999998888876543322 1
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+++++.+||.+||..||.+||++.++++ |+|+..
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~------hp~~~~ 263 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ------HPWLKQ 263 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------SHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc------Chhhcc
Confidence 2578999999999999999999999999998 888764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.14 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=217.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...++.++|++.+.||+|+||.||+|++. +..||||+++....... .....++. .++..++||||+++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~ 74 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEEC-PRLRIFSHPNVLPVLG 74 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHG-GGGCCCSCTTEECEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHH-HHHHhcCCCchhheEE
Confidence 45678899999999999999999999974 24799999986542221 11222222 2456679999999999
Q ss_pred EEEEC--CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCCCeee
Q 006887 114 ISVIN--GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 114 ~~~~~--~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g~vkL 188 (627)
++... +..++||||++ |+|.+.+.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeE
Confidence 99876 77899999998 48888876544456999999999999999999999999 999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||++.... .....||+.|+|||++.+.....++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 155 ~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 226 (271)
T 3kmu_A 155 SMADVKFSFQ--------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226 (271)
T ss_dssp EGGGSCCTTS--------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred Eeccceeeec--------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence 9888765421 23457899999999998653344555899999999999999999999999998888888877
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
...+.++..+++++.+++.+||+.||++||++.++++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 7778889999999999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=355.60 Aligned_cols=263 Identities=17% Similarity=0.237 Sum_probs=212.4
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+-.++|++.+.||+|+||.||+|++..++ +.||||++....... ...++...+....+|+|++.+++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNN------QQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTT------EEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCC------cEEEEEEeccCCccH---HHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 345678999999999999999999987665 489999987543321 12223334445558999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC-----eeeccC
Q 006887 117 INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR-----AVLGDV 191 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~-----vkL~DF 191 (627)
.....|+||||+.|+|.+.+.. ...++++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 77 ~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEecCCCHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9999999999998888888764 4557999999999999999999999999999999999999987776 999999
Q ss_pred CccccccCCCCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHH
Q 006887 192 GIPHLLLGIPLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDA 264 (627)
Q Consensus 192 Gla~~~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~ 264 (627)
|+++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+. ...+.+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 9998775432211 12345689999999999974 46899999999999999999999999874 34455544
Q ss_pred HHhccCCC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 265 VVRRQEIP---PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 265 i~~~~~~~---~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+....... .....+++++.+++.+||+.||++||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 44332222 2345789999999999999999999999999998887654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=365.26 Aligned_cols=263 Identities=20% Similarity=0.341 Sum_probs=211.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+.+++|++.+.||+|+||.||+|++..+++ .||+|++..........+..+. .++..++||||++++++
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~------~va~K~~~~~~~~~~~~~~~E~--~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGE------VMVMKELIRFDEETQRTFLKEV--KVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEESCCCHHHHHHHHHHH--HHHTTCCCTTBCCEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCc------EEEEEEeccCCHHHHHHHHHHH--HHHHhCCCcCcccEEEE
Confidence 345778899999999999999999999877664 8999998765554444443332 25677799999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+..++..|+||||++| +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 76 LYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred EecCCeeEEEEEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 9999999999999985 77666654 457799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-----------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH--
Q 006887 194 PHLLLGIPLPS-----------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE-- 260 (627)
Q Consensus 194 a~~~~~~~~~~-----------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e-- 260 (627)
++......... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 98765432111 11125689999999999974 468899999999999999999999987532211
Q ss_pred ---HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 261 ---IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 261 ---~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
....... ...+..+++++.+++.+||+.||++||++.++++.|+.+...
T Consensus 232 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 232 FGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp SSBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 224678899999999999999999999999999988876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.99 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=214.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||.||+|++..++. .||+|+++...... ......++. .+++.++||||+++++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGL------QYAAKFIKKRRTKSSRRGVSREDIEREV-SILKEIQHPNVITLHEVY 83 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEEEBCCSTTCSSSBCHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCc------EEEEEEEEccccccccchhhHHHHHHHH-HHHHhCCCCCCCcEEEEE
Confidence 579999999999999999999877664 89999997643221 112222222 245667899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----Ceeecc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLGD 190 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~D 190 (627)
...+..|+||||++ |+|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999998 57777764 346799999999999999999999999999999999999999887 799999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.....
T Consensus 162 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 162 FGLAHKIDFG----NEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CTTCEECCTT----SCCCCCCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CCCCeECCCC----CccccccCCcCcCCceeecC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 9999876432 23345689999999999973 4689999999999999999999999999998888877765432
Q ss_pred CCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 271 IPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 271 ~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
..+ .+..+++.+.+||.+||+.||.+||++.++++ |+|+...++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~~~ 280 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIKPKDT 280 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH------STTTSCCSH
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc------CCCccCCcc
Confidence 221 23578999999999999999999999999998 999887654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=367.12 Aligned_cols=258 Identities=20% Similarity=0.263 Sum_probs=208.7
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc----CCCCceee
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ----GVEGICWL 111 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~----~hpnIv~l 111 (627)
..+-.++|++.++||+|+||.||+|++..++. .||||+++....... ....+..++.... .||||+++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~--~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK------YYAVKVVRNIKKYTR--SAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECSCHHHHH--HHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCe------EEEEEEeccchhhhh--hhHHHHHHHHHhcccCCCCCCeecc
Confidence 33445799999999999999999999876654 899999975432221 1222222333322 49999999
Q ss_pred EEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---------
Q 006887 112 QGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE--------- 182 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~--------- 182 (627)
++++...+..||||||+.|+|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 99999999999999999889999988766667999999999999999999999999999999999999975
Q ss_pred ----------------CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHH
Q 006887 183 ----------------ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEM 246 (627)
Q Consensus 183 ----------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyel 246 (627)
++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVILN---LGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHH
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHcC---CCCCCccchHHHHHHHHHH
Confidence 78999999999986432 2345689999999999974 4689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCC------------------------CC--------------------CCCCHHH
Q 006887 247 LTGVQPRCGRSVDEIYDAVVRRQEIPP------------------------IP--------------------SGLPPAV 282 (627)
Q Consensus 247 ltG~~Pf~~~~~~e~~~~i~~~~~~~~------------------------~p--------------------~~~s~~l 282 (627)
++|+.||.+.+..+.+..+.......+ +| ...++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999999888777666544321111 11 1224778
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 283 ENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 283 ~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.+||.+||+.||++||++.++++ |+||.
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~------hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK------HKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT------SGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhc------CcccC
Confidence 89999999999999999999998 88863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=368.20 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=207.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||||++.............++ ..+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDN------LVALKEIRLEHEEGAPCTAIRE-VSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECC------CCCCCCC-HHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCc------EEEEEEEecccccccchhHHHH-HHHHHhcCCCCCCeeeeEEeeCCE
Confidence 689999999999999999999877664 8999999754332211111111 125677899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
.|+||||++|+|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 75 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred EEEEecccccCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 999999999998888765 4567999999999999999999999999999999999999999999999999999765321
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------- 273 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~------- 273 (627)
........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 154 ---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 154 ---TKTYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ------------CGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ---ccccccccCcccccChhhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhh
Confidence 2233456889999999998742 3588999999999999999999999999998887776654322111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 274 ---------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 274 ---------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
.+..+++++.+||.+||+.||.+||++.++++ |+||....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~ 289 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK------HPFFLSLG 289 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGGGGC
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc------Chhhhhcc
Confidence 12357899999999999999999999999998 99988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=372.31 Aligned_cols=284 Identities=15% Similarity=0.134 Sum_probs=208.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHH-------HHHHHHhcCCCCc
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERL-------NDLFLKCQGVEGI 108 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~-------~~~ll~~~~hpnI 108 (627)
+..++|++.+.||+|+||.||+|.+..+.. ...++.||||++.......... .+.+. +...+..++||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSC-CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccc-cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 445799999999999999999999876542 2345689999997654321111 11110 0113456789999
Q ss_pred eeeEEEEEEC----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--c
Q 006887 109 CWLQGISVIN----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--E 182 (627)
Q Consensus 109 v~l~~~~~~~----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~ 182 (627)
+++++++... ...||||||+.|+|.+.+.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998764 56899999996677777754 457899999999999999999999999999999999999999 8
Q ss_pred CCCeeeccCCccccccCCCCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV 258 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~ 258 (627)
++.+||+|||+++.+....... .......||+.|||||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG---VAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8999999999998765432111 11234569999999999974 3689999999999999999999999986432
Q ss_pred HHHHHHHHhccCCC--------C-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc----ccCCCCCCCCCCc
Q 006887 259 DEIYDAVVRRQEIP--------P-IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN----SVHSDGGWTGHGS 325 (627)
Q Consensus 259 ~e~~~~i~~~~~~~--------~-~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~----~~~~~~~w~~~~~ 325 (627)
...+.......... . .+..+++++.+++..||+.||.+||++.++++.|+.... ......+|.....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 22111111100000 0 125789999999999999999999999999998776543 3344556655444
Q ss_pred c
Q 006887 326 R 326 (627)
Q Consensus 326 ~ 326 (627)
.
T Consensus 347 ~ 347 (364)
T 3op5_A 347 G 347 (364)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=359.59 Aligned_cols=273 Identities=21% Similarity=0.288 Sum_probs=221.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..... ...++.||||+++............++...+....+||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccc-cchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 455777899999999999999999999754321 2345789999998765433333344444444444499999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKG----------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~----------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+...+..++||||++| +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999985 88888765432 258999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
||++.++.++|+|||+++....... ........||+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999987644221 112234567889999999873 468999999999999999999 99999987
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...+..............+..+++++.+++.+||+.||.+||++.++++.|++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 76655555555555566678899999999999999999999999999999887543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.45 Aligned_cols=270 Identities=18% Similarity=0.249 Sum_probs=213.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+-.++|++.+.||+|+||.||+|++..++ +.||||++....... ....+..++..+.+||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~---~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTN------EYVAIKLEPMKSRAP---QLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTT------EEEEEEEEETTCSSC---CHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCC------cEEEEEEeccccchH---HHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 34578999999999999999999987665 489999987543321 122233344444499999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC-----eeeccCC
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR-----AVLGDVG 192 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~-----vkL~DFG 192 (627)
.+..||||||+.|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDL-CDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred CCccEEEEEeCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999999999998888888865 3568999999999999999999999999999999999999998887 9999999
Q ss_pred ccccccCCCCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC---CHHHHHHHH
Q 006887 193 IPHLLLGIPLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR---SVDEIYDAV 265 (627)
Q Consensus 193 la~~~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~---~~~e~~~~i 265 (627)
+++.+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+. +..+.+..+
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG---KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcC---CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 998765432211 12346789999999999974 46899999999999999999999999974 344555555
Q ss_pred HhccCCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc----ccCCCCCCC
Q 006887 266 VRRQEIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN----SVHSDGGWT 321 (627)
Q Consensus 266 ~~~~~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~----~~~~~~~w~ 321 (627)
.......+ ....+| ++.+++.+||+.||.+||++.++++.|+.... ......+|.
T Consensus 233 ~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 233 GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 43221111 123455 99999999999999999999999998876543 234456776
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.08 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=207.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..++. .+..||+|+++............++. ..++.++||||++++++
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEE
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCccceEEEE
Confidence 556778899999999999999999999876442 34579999987654433333333332 24567799999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+. ++..|+||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 74 5678999999996 77776653 455799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........+|+.|+|||++.+ ..++.++|+|||||++|||++ |..||.+.+..++...+... ...
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~ 236 (281)
T 1mp8_A 163 SRYMEDST--YYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERL 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCC
T ss_pred ccccCccc--ccccccCCCcccccChhhccc---CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCC
Confidence 98764321 112234467889999999873 468899999999999999997 99999998888887777644 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.+..+++++.+++.+||+.||++||++.++++.|+.+.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 678899999999999999999999999999999888753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.38 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=216.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+++++|++.+.||+|+||.||+|++... ..||+|++........ .+. ++. .++..++||||++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~~~-~~~-~E~-~~l~~l~h~~i~~~~~~ 73 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMSEE-DFI-EEA-EVMMKLSHPKLVQLYGV 73 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEEECTTSBCHH-HHH-HHH-HHHHTCCCTTBCCEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCC-------CeEEEEEecccccCHH-HHH-HHH-HHHHhCCCCCEeeEEEE
Confidence 4568889999999999999999999997643 3699999986544332 222 222 35667789999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+++..|+||||++| +|.+.+.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 74 CLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred EecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccc
Confidence 9998999999999985 66666543 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........||+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+..+....+... ...
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~ 226 (269)
T 4hcu_A 153 TRFVLDDQ--YTSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 226 (269)
T ss_dssp GGGBCCHH--HHSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred cccccccc--cccccCcccccccCCHHHhcC---CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccC
Confidence 98654321 112234567889999999973 468999999999999999999 99999999998888877654 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+..+++++.+++.+||+.||++||++.++++.|+.+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 567888999999999999999999999999999988754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=376.08 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=205.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|++..+++ .||||+++........ ....++. .+++.++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vAiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEK------NVAIKKVNRMFEDLIDCKRILREI-TILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECSTTTSHHHHHHHHHHH-HHHHHCCCTTBCCEEEECCCS
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCc------EEEEEEeCchhcChHHHHHHHHHH-HHHHHcCCCCcceEEEEEecC
Confidence 5799999999999999999999887664 8999999764332221 1122222 356677999999999998766
Q ss_pred -----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 119 -----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 119 -----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+..||||||++|+|.+.+. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCcCCeEEEEEecCCcCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 5799999999999888875 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-------------------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-----
Q 006887 194 PHLLLGIPLPS-------------------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG----- 249 (627)
Q Consensus 194 a~~~~~~~~~~-------------------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG----- 249 (627)
++......... ......+||+.|+|||++.. ...|+.++|||||||++|||++|
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL--QENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTT--CSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc--CCCCCcccccchHHHHHHHHHhcccccc
Confidence 98765322110 12356789999999998753 34689999999999999999984
Q ss_pred ------CCCCCCCCH-----------------HHHHHHHHhc------------------------cCCCCC-----CCC
Q 006887 250 ------VQPRCGRSV-----------------DEIYDAVVRR------------------------QEIPPI-----PSG 277 (627)
Q Consensus 250 ------~~Pf~~~~~-----------------~e~~~~i~~~------------------------~~~~~~-----p~~ 277 (627)
.++|.+.+. .+.+..+... ....+. .+.
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 444544331 1111112111 111111 146
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
+++++.+||.+||+.||.+||++.++++ |+||....|.....
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~------Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALD------HPYLKDVRKKKLEN 375 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT------CGGGTTTCCTTTC-
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc------ChhhhhccCcccCc
Confidence 8999999999999999999999999998 99999988876554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=350.59 Aligned_cols=257 Identities=19% Similarity=0.251 Sum_probs=213.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|.+..++. .||+|++....... ......++. .++..++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGL------EFAAKIINTKKLSARDFQKLEREA-RICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCc------eEEEEEeecccCCHHHHHHHHHHH-HHHHHcCCCCcCeEEEEEEcC
Confidence 4689999999999999999999877664 89999997644222 112222222 355667999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL~DFGla 194 (627)
+..|+||||++| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 999999999985 77676653 356999999999999999999999999999999999999986655 999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 156 ~~~~~----~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 156 IEVND----SEAWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp EECCS----SCBCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EEccc----CccccCCCCCcCCcCchhhcC---CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc
Confidence 76643 222345689999999999974 46889999999999999999999999999998888887765443332
Q ss_pred --CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 275 --PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 275 --p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
...+++++.+++.+||+.||++||++.++++ |+|+...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~------h~~~~~~ 268 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK------VPWICNR 268 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT------SHHHHSC
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc------CccccCC
Confidence 2578999999999999999999999999998 8887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=374.32 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=209.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH--HH---hcCCCCceeeEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF--LK---CQGVEGICWLQGI 114 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l--l~---~~~hpnIv~l~~~ 114 (627)
..+|++.+.||+|+||.||+|++..+++ .||||+++....... .. ..+..++ +. ..+|+||++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~------~vAvK~~~~~~~~~~-~~-~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQ------HVALKMVRNEKRFHR-QA-AEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTE------EEEEEEECSCHHHHH-HH-HHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCc------EEEEEEECCccchHH-HH-HHHHHHHHHHhhccccCCcCEEEEEee
Confidence 4679999999999999999999877664 899999976433221 11 1122222 11 2378899999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC--eeeccCC
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR--AVLGDVG 192 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~--vkL~DFG 192 (627)
+...+..||||||+.|+|.+.+.......+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus 168 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 168 FTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred cccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999999999999988766667999999999999999999999999999999999999999987 9999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++... ......+||+.|||||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+......+
T Consensus 248 ~a~~~~------~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 248 SSCYEH------QRVYTYIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TCEETT------CCCCSSCSCGGGCCHHHHHTB---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cceecC------CcccccCCCCCccChHHHhCC---CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 997643 233456899999999999743 68999999999999999999999999998877766655321111
Q ss_pred C---------------------------------------------------------CCCCCCHHHHHHHHHhhhcCCC
Q 006887 273 P---------------------------------------------------------IPSGLPPAVENVLLGCFEYDLR 295 (627)
Q Consensus 273 ~---------------------------------------------------------~p~~~s~~l~~li~~cL~~dP~ 295 (627)
+ ++...++++.+||.+||+.||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0 1123478899999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCCCC
Q 006887 296 SRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 296 ~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+|||+.++++ |+|+...
T Consensus 399 ~Rpta~e~L~------Hpw~~~~ 415 (429)
T 3kvw_A 399 VRMTPGQALR------HPWLRRR 415 (429)
T ss_dssp TSCCHHHHHT------STTTC--
T ss_pred hCCCHHHHhC------ChhhccC
Confidence 9999999998 9998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=367.10 Aligned_cols=273 Identities=20% Similarity=0.303 Sum_probs=218.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..... ...+..||||+++............++..++....+||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeecccc-CCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 456788999999999999999999999854322 2345689999997654333223333344444444499999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKG---------------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLN 172 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~---------------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrD 172 (627)
+...+..|+||||++ |+|.+.+..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999998 588887765322 2479999999999999999999999999999
Q ss_pred cCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCC
Q 006887 173 LKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQ 251 (627)
Q Consensus 173 LKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~ 251 (627)
|||+|||++.++.++|+|||+++....... ........||+.|+|||++.+ +.++.++|||||||++|+|+| |..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhcc---CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999987643211 112234567899999999873 468999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 252 PRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 252 Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
||.+.+..+.+..+......+..+..+++++.+|+.+||+.||.+||++.++++.|+....
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 9998876666666666666677788899999999999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=366.05 Aligned_cols=268 Identities=19% Similarity=0.303 Sum_probs=209.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..+++. -...||+|.+.............++. .++..++||||++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGI 85 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHH-HHHHHCCBTTBCCEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHH-HHHHhCCCCCEeEEEEE
Confidence 3446678999999999999999999998766541 12357899886543322222222222 25567799999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+..++ .++||||+. |+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~-~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 86 CLTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EecCC-eEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 98655 778889988 577777654 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..++...+.. ....
T Consensus 164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~ 238 (327)
T 3poz_A 164 AKLLGAEEK-EYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERL 238 (327)
T ss_dssp HHHHTTTCC--------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCC
T ss_pred eeEccCCcc-cccccCCCccccccChHHhcc---CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCC
Confidence 987654221 222234567899999999974 468999999999999999999 9999999888877766554 3455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+.+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 6788899999999999999999999999999999887654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.83 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=200.7
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH---HHHHHHHHHHHHhcCCCCceeeEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR---VLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~---~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.++.++|++.+.||+|+||.||+|.+. + ..||||+++........ ....++. .+++.++||||+++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~------~~vavK~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~ 73 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--G------DEVAVKAARHDPDEDISQTIENVRQEA-KLFAMLKHPNIIALRG 73 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--T------EEEEEEEC----------CHHHHHHHH-HHHHHCCCTTBCCEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--C------CeEEEEEEecCCcccHHHHHHHHHHHH-HHHHhcCCCCEeeEEE
Confidence 356789999999999999999999874 2 37999998764332211 1122222 3566789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccCCCcEEEec-------
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG---ILVLNLKPFNFILNE------- 182 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g---IvHrDLKP~NILld~------- 182 (627)
++..++..|+||||++| +|.+.+ ....+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~ 150 (271)
T 3dtc_A 74 VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150 (271)
T ss_dssp EECCC--CEEEEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred EEecCCceEEEEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccc
Confidence 99999999999999986 554444 4568999999999999999999999999 999999999999986
Q ss_pred -CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHH
Q 006887 183 -ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEI 261 (627)
Q Consensus 183 -~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~ 261 (627)
++.++|+|||+++.... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....
T Consensus 151 ~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 151 SNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp SSCCEEECCCCC------------------CCGGGSCHHHHHH---CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred cCcceEEccCCccccccc-----ccccCCCCccceeCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 77899999999976543 12234579999999999874 4689999999999999999999999999998888
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
...+.......+.+..+++++.+++.+||+.||.+||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 877777776777889999999999999999999999999999998875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=363.20 Aligned_cols=271 Identities=19% Similarity=0.288 Sum_probs=222.0
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++|++.+.||+|+||.||+|++..... ...++.||||+++............++. .+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREA-ALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCC-CCCceeEEEEEeccccCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEE
Confidence 35667899999999999999999999875431 2345689999998755443333333333 245667999999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLK----------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLN 172 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~----------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrD 172 (627)
...+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 999999999999985 8888776532 15799999999999999999999999999999
Q ss_pred cCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCC
Q 006887 173 LKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQ 251 (627)
Q Consensus 173 LKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~ 251 (627)
|||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|+|||||++|||++ |..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhcc---CCcCcccccHHHHHHHHHHHhcCCC
Confidence 999999999999999999999987643211 122234578999999999874 468999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 252 PRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 252 Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
||.+.+..++...+... .....+..+++++.+++.+||+.||++||++.++++.|+.+...
T Consensus 276 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 99999988888777654 34567889999999999999999999999999999999986543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.30 Aligned_cols=272 Identities=19% Similarity=0.278 Sum_probs=222.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|.+..++. ......||+|+++............++..++....+||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGK-EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSS-SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCc-ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 456788999999999999999999999877653 2344689999998765433333334444444444489999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLK------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
+...+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999985 8888776532 35689999999999999999999999999999999999999
Q ss_pred cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHH
Q 006887 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260 (627)
Q Consensus 182 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e 260 (627)
.++.++|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhcc---CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 999999999999987643221 112234567889999999873 468999999999999999998 999999877666
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
....+.........+..+++.+.+++.+||+.||.+||++.++++.|+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 655665555566678889999999999999999999999999999888653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.62 Aligned_cols=273 Identities=20% Similarity=0.279 Sum_probs=200.7
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..+++ ....||||+++.... .....+.. +. .+++.++||||++++
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG---SFVKVAVKMLKADIIASSDIEEFLR-EA-ACMKEFDHPHVAKLV 91 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHH-HH-HHHTTCCCTTBCCCC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCC---cceeEEEEEecccccCHHHHHHHHH-HH-HHHHHCCCCceehhh
Confidence 455777899999999999999999999766542 223799999976432 22222222 22 256677999999999
Q ss_pred EEEEECCEE------EEEEecCCC-CHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 113 GISVINGKI------CIIMKFYEG-SVGDRMAQLKG----GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 113 ~~~~~~~~~------~LVmEy~~G-sL~d~l~~~~~----~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
+++...+.. ++||||+.| +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 999876655 999999995 77777754332 2689999999999999999999999999999999999999
Q ss_pred cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHH
Q 006887 182 EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260 (627)
Q Consensus 182 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e 260 (627)
.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDY-YRQGCASKLPVKWLALESLAD---NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp TTSCEEECCCCC------------------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred CCCCEEEeecccccccccccc-ccccccccCcccccCchhhcC---CCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999987643221 122234567889999999874 468999999999999999999 999999998888
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc-cccCCC
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ-NSVHSD 317 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~-~~~~~~ 317 (627)
+...+... .....+..+++++.+|+.+||+.||.+||++.++++.|+.+. |+++..
T Consensus 248 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 248 IYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 88777654 345668889999999999999999999999999999888754 445443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.25 Aligned_cols=271 Identities=18% Similarity=0.293 Sum_probs=208.2
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
.....++.++|++.+.||+|+||.||+|++.... ..+..||||+++............++. .++..++||||++++
T Consensus 37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPS---KKEISVAIKTLKVGYTEKQRRDFLGEA-SIMGQFDHPNIIRLE 112 (373)
T ss_dssp TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTT---SCBCCEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEE
T ss_pred HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCC---CCceeEEEEEecCccCHHHHHHHHHHH-HHHHhCCCCCCCeEE
Confidence 3455678889999999999999999999876432 134579999997654333332223332 256677999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..||||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 113 GVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 99998899999999997 577766653 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++................+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..++...+....
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~- 267 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY---RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY- 267 (373)
T ss_dssp ----------------------CTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhcc---CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 999876543221222223456789999999973 468999999999999999998 999999999888887776543
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+.+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 345577899999999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=370.37 Aligned_cols=257 Identities=19% Similarity=0.251 Sum_probs=214.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|.+..++. .||+|++..........+. ++. .++..++||||+++++++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~-~E~-~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGR------VFVAKFINTPYPLDKYTVK-NEI-SIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSHHHHHHHH-HHH-HHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCC------EEEEEEecccchhhHHHHH-HHH-HHHHhCCCcCCCeEEEEEEeCC
Confidence 3689999999999999999999877664 8999999866543333332 222 2567789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec--CCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE--ADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~--~g~vkL~DFGla~~ 196 (627)
..||||||++| +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999985 66666542 3457999999999999999999999999999999999999974 57899999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI--PPI 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~--~~~ 274 (627)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+...... ...
T Consensus 201 ~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 201 LNPD----EIVKVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CCTT----SCEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred cCCC----cceeeeccCCCccCchhccC---CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 6431 22334579999999999974 46889999999999999999999999999988888877654322 223
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
...+++++.+||.+||+.||.+||++.++++ |+|+...
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~~~ 311 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE------HPWLKGD 311 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT------STTTSSC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh------CccccCC
Confidence 4678999999999999999999999999998 9998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.91 Aligned_cols=265 Identities=21% Similarity=0.227 Sum_probs=212.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
..++|++.+.||+|+||.||+|++..+++ .||||++....... ...... +. .+++.++||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALR-EI-KILQLLKHENVVNLIEICR 86 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCC------EEEEEECCCSSCSSSSCHHHHH-HH-HHHHHCCCTTBCCEEEEEE
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCC------EEEEEEEecccccccchHHHHH-HH-HHHHhccCCCcccHhheee
Confidence 35789999999999999999999877664 89999986543221 112222 22 2556678999999999998
Q ss_pred E--------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 117 I--------NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 117 ~--------~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
. .+..|+||||++|++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl 165 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165 (351)
T ss_dssp EC--------CEEEEEEECCSEEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred ccccccccCCceEEEEEeccCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEE
Confidence 7 457899999999998888764 4467999999999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCC-CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 189 GDVGIPHLLLGIPL-PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~-~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
+|||+++.+..... .........||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999987653221 12233456899999999998643 3588999999999999999999999999988877766654
Q ss_pred ccCCCC--CCCC----------------------------CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 268 RQEIPP--IPSG----------------------------LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 268 ~~~~~~--~p~~----------------------------~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.....+ ..+. .++++.+||.+||+.||++||++.++++ |+||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~ 317 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFWS 317 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGGS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC------CCCcCC
Confidence 322211 1111 2788999999999999999999999998 999876
Q ss_pred CCC
Q 006887 318 GGW 320 (627)
Q Consensus 318 ~~w 320 (627)
..+
T Consensus 318 ~~~ 320 (351)
T 3mi9_A 318 DPM 320 (351)
T ss_dssp SSC
T ss_pred CCC
Confidence 533
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.19 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=211.7
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+..++|++.+.||+|+||.||+|++..++. .||+|++........ .....++. .+++.++||||++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~ 77 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKF------ILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRLYGY 77 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHHTCHHHHHHHH-HHHTTCCCTTBCCEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCc------EEEEEEEeccccchhhHHHHHHHHH-HHHHcCCCCCCcchhhe
Confidence 3456799999999999999999999877664 899999865332211 11222222 35677889999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+.+..++||||++| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 78 FHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 9999999999999995 77776653 35699999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+..... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+... ...
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~ 225 (279)
T 3fdn_A 156 SVHAPS-----SRRTDLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT 225 (279)
T ss_dssp ESCC-------------CCCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCC
T ss_pred cccCCc-----ccccccCCCCCccCHhHhcc---CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCC
Confidence 865432 22345689999999999974 36788999999999999999999999999988888777543 455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+|..+++++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~------h~~~~~ 263 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE------HPWITA 263 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH------CHHHHH
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh------CccccC
Confidence 77889999999999999999999999999999 888754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=358.78 Aligned_cols=271 Identities=19% Similarity=0.277 Sum_probs=222.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
....+..++|++.+.||+|+||.||+|++..... ...+..||||+++............++. .+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKG-RAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGG-CSSEEEEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCc-ccCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCceeeEEE
Confidence 4666788999999999999999999999865431 2345689999997654333222223332 2566779999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKG----------------------GKLSLSNVFRYAIDLAQGILQLHSKGILV 170 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~----------------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvH 170 (627)
++...+..|+||||++ |+|.+.+..... ..+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 9999999999999998 688887765322 34899999999999999999999999999
Q ss_pred cccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-C
Q 006887 171 LNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-G 249 (627)
Q Consensus 171 rDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G 249 (627)
|||||+|||++.++.++|+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC---CCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999987643221 112234568899999999874 468899999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 250 VQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 250 ~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..||.+.+..++...+... .....+..+++++.+++.+||+.||.+||++.++++.|+.+.
T Consensus 250 ~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999998888887766543 355678899999999999999999999999999999888754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=360.13 Aligned_cols=272 Identities=21% Similarity=0.305 Sum_probs=214.4
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
.....+..++|++.+.||+|+||.||+|++..++. ..+..||||+++............++. .++..++||||++++
T Consensus 36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLE 112 (333)
T ss_dssp --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEE
T ss_pred hccccCChHHhhcccEEecCCCeEEEEEEEecCCC--CccccEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEE
Confidence 34567889999999999999999999999876542 234579999998654433332222332 256678999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..+|||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 113 GVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence 999988999999999996 77666653 5568999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++................+|+.|+|||++.+ ..++.++|+|||||++|||++ |+.||.+.+..++...+... .
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~ 267 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-F 267 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-C
T ss_pred CcchhhccccccccccCCCCccccccCchhccc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-C
Confidence 999876543222222234457889999999973 468899999999999999999 99999999988888777654 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+.+..+++++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 455678899999999999999999999999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.26 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=199.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
....+.++|++.+.||+|+||.||+|++..+++ .||||++......... . .++. ..++.++||||++++++
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~-~-~~E~-~~l~~l~hpniv~~~~~ 84 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKE------LVAVKYIERGAAIDEN-V-QREI-INHRSLRHPNIVRFKEV 84 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCC------EEEEEEEESSTTSCHH-H-HHHH-HHHHHCCCTTBCCEEEE
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCc------EEEEEEEecCccccHH-H-HHHH-HHHHhCCCCCCCcEEEE
Confidence 445567899999999999999999999887764 8999999765432221 2 2222 24567899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC--eeeccC
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR--AVLGDV 191 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~--vkL~DF 191 (627)
+...+..|+||||++ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 85 ILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence 999999999999997 577777653 357999999999999999999999999999999999999987765 999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCC-ccCcchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPIS-FETDSWGFACSIIEMLTGVQPRCGRSV----DEIYDAVV 266 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s-~~sDiwSlGviLyelltG~~Pf~~~~~----~e~~~~i~ 266 (627)
|+++.... ........||+.|+|||++.+. .++ .++|||||||++|+|++|+.||.+.+. ......+.
T Consensus 163 g~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 163 GYSKSSVL----HSQPKSTVGTPAYIAPEVLLRQ---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp CCC-------------------CTTSCHHHHHCS---SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred Cccccccc----cCCCCCCcCCCCcCChhhhcCC---CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 99875432 2223456799999999998743 444 458999999999999999999987543 44555555
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
......+....+++++.+||.+||+.||.+||++.++++ |+||.
T Consensus 236 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~ 279 (361)
T 3uc3_A 236 SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT------HSWFL 279 (361)
T ss_dssp TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT------SHHHH
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh------Ccchh
Confidence 444334444578999999999999999999999999998 88874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=380.00 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=201.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++++.||+|+||.||+|++..+++ .||||++......... ....++. .+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vAiK~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEESGGGSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCC------EEEEEEECccccChHHHHHHHHHH-HHHHhCCCCCCCcEEEEEccC
Confidence 5789999999999999999999887664 8999999765322211 1112222 356778999999999998654
Q ss_pred ------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 ------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
..+||||||++|++.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 134 ~~~~~~~~~~lv~E~~~~~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CccccCCeEEEEEeCCCCCHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 4689999999998877663 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......+
T Consensus 210 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 210 LARTAGT----SFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp CC---------CCCC----CCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eeeecCC----CcccCCCcccccccCHHHHcC---CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9987643 223456789999999999985 368999999999999999999999999998887777665432211
Q ss_pred C--------------------C---------CCC-----------CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 P--------------------I---------PSG-----------LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 ~--------------------~---------p~~-----------~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
. . +.. .++++.+||.+||..||++|||+.++++ |
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ------H 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT------S
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc------C
Confidence 0 0 000 1567999999999999999999999998 9
Q ss_pred ccCCC
Q 006887 313 SVHSD 317 (627)
Q Consensus 313 ~~~~~ 317 (627)
+||..
T Consensus 357 p~~~~ 361 (464)
T 3ttj_A 357 PYINV 361 (464)
T ss_dssp TTTGG
T ss_pred hhhhh
Confidence 99873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.38 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=211.7
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.|+..+.||+|+||.||+|++..++ +.||||++..........+..+. ..+..++||||+++++++...+..
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g------~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSG------RQVAVKMMDLRKQQRRELLFNEV--VIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTC------CEEEEEEEETTTCCSHHHHHHHH--HHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCC------cEEEEEEEeccchhHHHHHHHHH--HHHHhCCCCCcceEEEEEEECCEE
Confidence 4889999999999999999987655 48999999765544433333322 356778999999999999999999
Q ss_pred EEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 122 CIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 122 ~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
|+||||++| +|.+.+ ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~lv~e~~~~~~L~~~l---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 118 WVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp EEEECCCCSCBHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEecCCCCCHHHHH---HhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence 999999985 555554 3457999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCC
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI-PPIPSGLP 279 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~-~~~p~~~s 279 (627)
........||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....+...... ...+..++
T Consensus 195 ---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2c30_A 195 ---VPKRKSLVGTPYWMAPEVISR---SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268 (321)
T ss_dssp ---SCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred ---ccccccccCCccccCHhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCC
Confidence 122345689999999999973 46889999999999999999999999998888887777654321 12334689
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+++.++|.+||+.||++||++.++++ |+|+...
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~------hp~~~~~ 301 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLD------HPFLLQT 301 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc------ChhhccC
Confidence 99999999999999999999999998 8887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=366.11 Aligned_cols=261 Identities=19% Similarity=0.205 Sum_probs=212.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
.++|++.+.||+|+||.||+|++..++ ..||||++.............++. .++..++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNK------VRVAIKKISPFEHQTYCQRTLREI-KILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCTTCHHHHHHHHHHH-HHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCC------eEEEEEEeccccCcHHHHHHHHHH-HHHHhcCCCCCccceeEEecCC
Confidence 368999999999999999999987665 489999997654433322233333 245667899999999998754
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 119 ----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 119 ----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
...|+||||++|+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 99 ~~~~~~~~iv~e~~~~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 99 IEQMKDVYIVQDLMETDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccceEEEEEcccCcCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 36899999999998887753 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP- 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~- 273 (627)
+...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+......+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTB--CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCC--CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 8765433223334566899999999987632 3588999999999999999999999999887766665543211110
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 ----------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ----------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....+++++.+||.+||+.||++||++.++++ |+|+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~~~ 320 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA------HPYLEQY 320 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGTTT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc------Ccchhhc
Confidence 12567899999999999999999999999998 9998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.38 Aligned_cols=284 Identities=19% Similarity=0.289 Sum_probs=228.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..... ...+..||||+++............++. .+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEA-SVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHH-HHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccC-CCCceEEEEEecccccCHHHHHHHHHHH-HHHHhcCCCCEeeeEEE
Confidence 455777899999999999999999998764211 1234689999997654433222222222 25667899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK--------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
+...+..|+||||++ |+|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 998899999999998 48888776532 156799999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDA 264 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~ 264 (627)
++|+|||+++....... ........||+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..++...
T Consensus 177 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred EEECcCccccccccccc-cccccCCCCCCCccChhhhcc---CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 99999999986543211 111224467899999999873 468899999999999999999 8999999998888877
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCc
Q 006887 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGS 325 (627)
Q Consensus 265 i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~ 325 (627)
+... .....+..+++++.++|.+||+.||.+||++.++++.|+....+.+...+|.....
T Consensus 253 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~ 312 (322)
T 1p4o_A 253 VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312 (322)
T ss_dssp HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTT
T ss_pred HHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccccc
Confidence 7654 34556788999999999999999999999999999999988777766555544333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=372.72 Aligned_cols=253 Identities=18% Similarity=0.214 Sum_probs=198.2
Q ss_pred CCCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|.+. +.||+|+||.||+|++..+++ .||||+++.... ..++..++.+..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~------~vAiK~~~~~~~------~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDCPK------ARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCC------EEEEEEeCcchh------HHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 3678887 789999999999999887764 899999964321 12233345566799999999999876
Q ss_pred ---CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeecc
Q 006887 118 ---NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGD 190 (627)
Q Consensus 118 ---~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~D 190 (627)
.+.+||||||++| +|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 5679999999985 8888876544457999999999999999999999999999999999999987 78999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH----HHHHHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE----IYDAVV 266 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e----~~~~i~ 266 (627)
||+++.... .......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+... ....+.
T Consensus 208 FG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 208 FGFAKETTS----HNSLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CTTCEECC---------------CTTCCGGGSCC---CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred cccccccCC----CCccccCCCCCCccCHhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 999987543 223346789999999999973 468999999999999999999999998755322 344444
Q ss_pred hccCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 267 RRQEIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 267 ~~~~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
......+ ....+++++.+||.+||+.||++||++.++++ |+|+..
T Consensus 281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~------hp~~~~ 327 (400)
T 1nxk_A 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN------HPWIMQ 327 (400)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------SHHHHT
T ss_pred cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc------CccccC
Confidence 4332222 22578999999999999999999999999998 888754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=358.50 Aligned_cols=264 Identities=16% Similarity=0.220 Sum_probs=212.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHH--HHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDL--FLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~--ll~~~~hpnIv~l~~~~ 115 (627)
.++|++.+.||+|+||.||+|++.... ++.||+|+++...... ...... +..+ .+....||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~-e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNG-----GRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEEEEEBCTTSCBCTHHH-HHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCC-----CEEEEEEEeccCcccccCCchhhH-HHHHHHhhhccCCCCeEeeeeee
Confidence 368999999999999999999985322 2589999987532211 011111 1112 23345899999999998
Q ss_pred E-----ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 116 V-----INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 116 ~-----~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
. .....++||||++|+|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred eecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 7 45679999999999999988776666799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 164 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 164 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CCSCCCCCGG----GGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CcccccccCC----CCccccccccceeCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999765321 12335679999999999974 4688999999999999999999999999888877776654211
Q ss_pred C-------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 271 I-------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 271 ~-------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
. ..++..+++.+.+||.+||+.||.+||++.++++ |+|+....+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~~~~~ 307 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQDLERCK 307 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTCCCCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc------Cccccccchhh
Confidence 1 1133568999999999999999999999999998 99998776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=373.84 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=218.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.++.++|++.+.||+|+||.||+|++..++ +.||||+++............++. .+++.++||||+++++
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~ 179 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADN------TLVAVKSCRETLPPDLKAKFLQEA-RILKQYSHPNIVRLIG 179 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTC------CEEEEEECCTTSCHHHHTTTTHHH-HHHTTCCCTTBCCEEE
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCC------eEEEEEEccccCCHHHHHHHHHHH-HHHHhCCCCCEEEEEE
Confidence 355688899999999999999999999987655 389999997653322222222222 3567789999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++..++..||||||++ |+|.+.+.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 180 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 180 VCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEecCCCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence 9998889999999998 577777654 44569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++....... ........+|+.|+|||++.+ +.++.++|||||||++|||++ |..||.+.+..++...+.. ...
T Consensus 259 ~s~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~ 333 (377)
T 3cbl_A 259 MSREEADGVY-AASGGLRQVPVKWTAPEALNY---GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGR 333 (377)
T ss_dssp GCEECTTSEE-ECCSSCCEEEGGGSCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TCC
T ss_pred CceecCCCce-eecCCCCCCCcCcCCHhHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCC
Confidence 9986532111 111122345778999999873 468899999999999999998 9999999998888776654 345
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.|..+++++.+||.+||+.||++||++.++++.|+.+.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 6678889999999999999999999999999999988754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=362.67 Aligned_cols=262 Identities=21% Similarity=0.222 Sum_probs=208.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH----HHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR----VLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~----~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.++|++.+.||+|+||.||+|++..+++ .||||+++........ ....++. .++..++||||+++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~ 81 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAF 81 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCS------EEEEEEC------------CTHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCc------EEEEEEEecCCcchhhhhhhHHHHHHH-HHHhhCCCCCCCeEEEEE
Confidence 4789999999999999999999876654 8999999754322111 1112222 245667999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...+..++||||++|++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eeCCceEEEEEcCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999999999988777653 44678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP-- 273 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~-- 273 (627)
.+... ........||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+..+.+..+......+.
T Consensus 161 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSP---NRAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSC---CCCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eccCC---cccCCcccccccccCchHhhCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 76432 2233456899999999998642 3588899999999999999999999999988887777765322111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 274 ------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 274 ------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
+...+++++.+||.+||+.||++||++.++++ |+||....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------h~~f~~~~~ 300 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFSNRPG 300 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGTSSSC
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc------ChhhhcCCC
Confidence 01456799999999999999999999999998 999886544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.20 Aligned_cols=269 Identities=19% Similarity=0.336 Sum_probs=207.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++.... ...++.||||++..........+..+. .++..++||||++++++
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREI--EILKSLQHDNIVKYKGV 79 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTC--SSCCEEEEEEEESCCCHHHHHHHHHHH--HHHHTCCCTTBCCEEEE
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEeccc--CCCCcEEEEEEcccCCHHHHHHHHHHH--HHHHhCCCCCEeeEEEE
Confidence 34567789999999999999999999864322 124568999999876554444333322 25667799999999999
Q ss_pred EEE--CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 115 SVI--NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 115 ~~~--~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+.. ....++||||++ |+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHH-CGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHh-cccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence 854 345899999997 587777754 3456999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH------------
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD------------ 259 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~------------ 259 (627)
|+++................||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcC---CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 999876543222223334568888999999974 46899999999999999999999998643221
Q ss_pred ----HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 260 ----EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 260 ----e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+...+ ......+.+..+++++.+++.+||+.||++||++.++++.|+.+..
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 236 MIVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHH-hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222222 3344566788999999999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=351.27 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=217.8
Q ss_pred CCCcCCCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...+..++|.+.+ .||+|+||.||+|.+.... .+..||||+++............++.. ++..++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHH-HHHhCCCCCEeEEEE
Confidence 3457778999988 9999999999999875432 235899999987544333333333332 455679999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++ ..+..++||||++| +|.+.+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 78 ~~-~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VC-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHT-TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Ee-cCCCcEEEEEeCCCCCHHHHHH-hCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 99 56679999999996 6666654 345679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++................||+.|+|||++.+ ..++.++|+|||||++|||++ |+.||.+.+..++...+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~ 231 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KR 231 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-Cc
Confidence 99876543222223344568999999999873 368889999999999999998 99999998888887766543 35
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
+..+..+++++.++|.+||+.||.+||++.++++.|+.....
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 667889999999999999999999999999999998886554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.20 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=211.6
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH------HHHHHHHHHHHHhcCCCC
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR------VLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~------~~~~~~~~~ll~~~~hpn 107 (627)
..+.+..++|++.+.||+|+||.||+|++..++. .||+|++......... ....++. .++..++|||
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~ 84 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKS------VVAIKSLILGDSEGETEMIEKFQEFQREV-FIMSNLNHPN 84 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCC------EEEEEECCCCTTTCCHHHHCCSHHHHHHH-HHHTTCCCTT
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCce------EEEEEEeeccccccchhHHHHHHHHHHHH-HHHHhCCCCC
Confidence 4566778999999999999999999999877664 8999999754332111 1122222 2566779999
Q ss_pred ceeeEEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCC
Q 006887 108 ICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEAD 184 (627)
Q Consensus 108 Iv~l~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g 184 (627)
|+++++++.... ++||||++ |+|.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 85 i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 85 IVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp BCCEEEEETTTT--EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC
T ss_pred chhhheeecCCC--eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC
Confidence 999999986554 79999999 577777654 4567999999999999999999999999 99999999999998877
Q ss_pred C-----eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH
Q 006887 185 R-----AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD 259 (627)
Q Consensus 185 ~-----vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~ 259 (627)
. ++|+|||+++.... ......||+.|+|||++.+. ...++.++|+|||||++|+|++|+.||...+..
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred CCCceeEEeCCCCccccccc------cccccCCCccccCchhhccC-CCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 6 99999999875432 23456899999999998533 345788999999999999999999999876544
Q ss_pred H--HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 260 E--IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 260 e--~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+ ....+......+.++..+++++.++|.+||+.||.+||++.++++.|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 3 3555555666677889999999999999999999999999999998875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=347.85 Aligned_cols=260 Identities=17% Similarity=0.222 Sum_probs=215.2
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++|++.+.||+|+||.||+|.+... ..||+|+++....... .+.. +. ..+..++||||+++++++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~~~-~~~~-E~-~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQ-------YDVAVKMIKEGSMSED-EFFQ-EA-QTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECBTTBCHH-HHHH-HH-HHHHHCCCTTBCCEEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCc-------eeEEEEEeccCCCcHH-HHHH-HH-HHHHhCCCCCEeeEEEEE
Confidence 456778999999999999999999987543 3699999976544332 2222 22 245667899999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..++..|+||||++| +|.+.+.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred ccCCceEEEEEccCCCcHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence 988999999999985 67777654 4456999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+....... .......+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||...+..+....+... ....
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 225 (268)
T 3sxs_A 152 RYVLDDQY--VSSVGTKFPVKWSAPEVFHY---FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225 (268)
T ss_dssp EECCTTCE--EECCSCCCCGGGCCHHHHHH---SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCC
T ss_pred eecchhhh--hcccCCCcCcccCCHHHHhc---cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-CCCC
Confidence 87643221 12234467888999999974 358899999999999999999 99999999888887777644 3455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+..+++++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 677889999999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.86 Aligned_cols=267 Identities=20% Similarity=0.345 Sum_probs=213.2
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
...+..++|++.+.||+|+||.||+|++..+++. -...||+|.+....... ...+..+. ..+..++||||+++++
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHM--LAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCHHH--HHHHTCCCTTBCCEEE
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHHHH--HHHhcCCCCCcCeEEE
Confidence 4557788999999999999999999998776541 12348888875433211 11111111 2456679999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++. ++..++||||+. |+|.+.+.. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHS-SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHH-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 986 456899999999 577777653 34578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.+.... .........||+.|+|||++.+ +.++.++|||||||++|+|++ |..||.+.+..++...+.. ...
T Consensus 161 ~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~ 235 (325)
T 3kex_A 161 VADLLPPDD-KQLLYSEAKTPIKWMALESIHF---GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GER 235 (325)
T ss_dssp GGGGSCCCT-TCCC-----CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCB
T ss_pred cccccCccc-ccccccCCCCcccccChHHhcc---CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCC
Confidence 998764422 1222345678899999999973 468999999999999999999 9999999888887776654 335
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 56678899999999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=362.72 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=206.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-----HHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-----RMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-----~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++..... .... ..++. .+++.++||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~-~~~E~-~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQ------QFAVKIVDVAKFTSSPGLSTED-LKREA-SICHMLKHPHIVELLETY 95 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHTSSSCCHHH-HHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCC------EEEEEEEEhhhccccccchHHH-HHHHH-HHHHhCCCCCCCcEEEEE
Confidence 579999999999999999999877664 8999998643211 1222 22222 245667999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eeec
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVLG 189 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL~ 189 (627)
..++..||||||++ |+|.+.+... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 99999999999999 5777766543 2356899999999999999999999999999999999999987655 9999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|||+++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. ..+++..+....
T Consensus 176 Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~ 248 (351)
T 3c0i_A 176 GFGVAIQLGES---GLVAGGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGK 248 (351)
T ss_dssp CCTTCEECCTT---SCBCCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTC
T ss_pred cCcceeEecCC---CeeecCCcCCcCccCHHHHcC---CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCC
Confidence 99999876432 122345689999999999974 46889999999999999999999999875 455666665443
Q ss_pred CCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 270 EIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 270 ~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.... ....+++++.+||.+||+.||++||++.++++ |+|+..
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~------hp~~~~ 292 (351)
T 3c0i_A 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN------HPWLKE 292 (351)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc------ChhhcC
Confidence 2221 12578999999999999999999999999988 777654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=350.84 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=207.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..++. .||+|++.............++. .+++.++||||+++++++...+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGL------ERVIKTINKDRSQVPMEQIEAEI-EVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEGGGCCSCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEccCCc------eEEEEEeeccccchhHHHHHHHH-HHHHhCCCchHHhHHHheecCCe
Confidence 679999999999999999999877654 89999997654322222222222 25667899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCcc
Q 006887 121 ICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIP 194 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla 194 (627)
.|+||||++| +|.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999985 888877543 34789999999999999999999999999999999999999 45678999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP- 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~- 273 (627)
+..... .......||+.|+|||++. +.++.++|+|||||++|+|++|+.||.+.+..+....+........
T Consensus 175 ~~~~~~----~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSD----EHSTNAAGTALYMAPEVFK----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp CC--------------CTTGGGCCHHHHT----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred eecCCc----ccCcCcccccCcCChHHhc----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence 765432 2234567999999999985 3588999999999999999999999999998888777655433222
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
....+++++.+||.+||+.||++||++.++++ |+||..
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~f~~ 284 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH------HEWFKQ 284 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT------SGGGGC
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc------CHHhhc
Confidence 22457999999999999999999999999998 888763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=355.83 Aligned_cols=261 Identities=19% Similarity=0.313 Sum_probs=213.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEE-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISV- 116 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~- 116 (627)
++|++.+.||+|+||.||+|.+..++ +.||+|+++..... .......++. .+++.++||||+++++++.
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETL------CRRAVKILKKKKLRRIPNGEANVKKEI-QLLRRLRHKNVIQLVDVLYN 77 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTC------CEEEEEEECHHHHHHSTTHHHHHHHHH-HHHTTCCCTTBCCEEEEEEC
T ss_pred cceeEeeEEecCCCeEEEEEEECCCC------cEEEEEEeccccccccchhHHHHHHHH-HHHHhcCCCCeeEEEEEEEc
Confidence 68999999999999999999987665 48999999754321 1112222222 2566779999999999984
Q ss_pred -ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 -INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 -~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..|+||||+++++.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 4567899999999888888877667889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
....... ........||+.|+|||++.+. ...++.++|+|||||++|+|++|+.||.+.+..+....+... ...++
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~ 233 (305)
T 2wtk_C 158 ALHPFAA-DDTCRTSQGSPAFQPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIP 233 (305)
T ss_dssp ECCTTCS-SCEECCCCSCGGGCCHHHHTCC-SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCC
T ss_pred ccCcccc-ccccccCCCCCCCcChhhccCc-ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCC
Confidence 7643211 1222355799999999998743 223477999999999999999999999999988888877654 45577
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+++++.++|.+||+.||.+||++.++++ |+|+...
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------~~~~~~~ 270 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ------HSWFRKK 270 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH------SHHHHSC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhc------CcccccC
Confidence 889999999999999999999999999998 8877654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=361.58 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=204.5
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcC-CCCceeeEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQG-VEGICWLQGIS 115 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~-hpnIv~l~~~~ 115 (627)
+..++|++.+.||+|+||.||+|.+.. ++.||||++........ .....++..++....+ |+||+++++++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTT-------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCC-------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 556789999999999999999998632 24799999976543221 2222333333333332 39999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++..|||||+..|+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 79 ITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp ECSSEEEEEECCCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eeCCEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99999999999888899888864 46799999999999999999999999999999999999997 6789999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCC--------CCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--------VRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVV 266 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~ 266 (627)
.+.... ........+||+.|+|||++.+. ....++.++|||||||++|||++|+.||.... ....+..+.
T Consensus 156 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 156 QMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 764321 11123456899999999998631 12468899999999999999999999998743 334455555
Q ss_pred hccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 267 ~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.......++...++++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~------hp~~~~ 279 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA------HPYVQI 279 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHS
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh------Cccccc
Confidence 555566778888999999999999999999999999998 877653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.11 Aligned_cols=274 Identities=18% Similarity=0.267 Sum_probs=221.7
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCc-CcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTE-DCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~e-d~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+.+..++|++.+.||+|+||.||+|++..... ....+..||||+++............++..++....+||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3556778999999999999999999999864332 123456899999986544333333334444444445999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+++...+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999985 8877776432 1348999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC---CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999999987643221 112234567899999999874 368899999999999999999 99999999
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+..++...+... .....+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 264 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 264 PVEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 988888777654 3456778899999999999999999999999999999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=356.86 Aligned_cols=263 Identities=18% Similarity=0.268 Sum_probs=202.4
Q ss_pred CCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
+.|++. +.||+|+||.||+|++..+++ .||||++..........+ .++...+.++.+||||+++++++..++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~-~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQ------EYAVKIIEKQPGHIRSRV-FREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCC------EEEEEEEECCSSCCHHHH-HHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCc------EEEEEEEeeCcchhHHHH-HHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 579985 789999999999999876654 899999976544333333 333344556678999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eeeccCCccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVLGDVGIPH 195 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL~DFGla~ 195 (627)
..|+||||++ |+|.+.+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999998 588777764 357999999999999999999999999999999999999988776 9999999987
Q ss_pred cccCCCC----CCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCC------------
Q 006887 196 LLLGIPL----PSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRS------------ 257 (627)
Q Consensus 196 ~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~------------ 257 (627)
....... ........+||+.|+|||++.+.. ...++.++|||||||++|||++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 111223457999999999986310 1247889999999999999999999998754
Q ss_pred ---HHHHHHHHHhccCCCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 258 ---VDEIYDAVVRRQEIPPIP----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 258 ---~~e~~~~i~~~~~~~~~p----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
...++..+.... ..++ ..+++++.+||.+||+.||.+||++.++++ |+|+....+
T Consensus 243 ~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~~~ 304 (316)
T 2ac3_A 243 PACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ------HPWVQGCAP 304 (316)
T ss_dssp HHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------STTCC----
T ss_pred hhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc------ChhhcCCCC
Confidence 234555554433 2233 468999999999999999999999999998 999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.05 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=218.3
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++|++.+.||+|+||.||+|++..... ...++.||||+++............++. .++..++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEA-LIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCC-CCcceeEEEEecccccChhhHHHHHHHH-HHHHhCCCCCCCeEEEEE
Confidence 45667899999999999999999999754321 2345689999997654333332223332 355667999999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---Ce
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKG-----GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RA 186 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~v 186 (627)
...+..|+||||++| +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 988899999999975 88888766432 4589999999999999999999999999999999999999555 59
Q ss_pred eeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006887 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i 265 (627)
||+|||+++.+..... ........||+.|||||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus 224 kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp EECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EECCCccccccccccc-cccCCCcCCcccEECHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999986543211 223345678999999999873 468999999999999999998 99999999999888877
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.... ....+..+++++.+|+.+||+.||.+||++.++++.|+...
T Consensus 300 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 300 TSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 6543 45567889999999999999999999999999999888754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.17 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=197.3
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceee
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
.....|..++|++.++||+|+||.||+|++.. .||+|+++....... .....++. .+++.++||||+.+
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLF 85 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---------EEEEEEESCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---------ceEEEEEeccCCCHHHHHHHHHHH-HHHHhCCCCcEEEE
Confidence 34667889999999999999999999997532 599999976543222 12222222 35677899999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++ ..+..++||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp EEEE-CSSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred Eeec-cCCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcc
Confidence 9965 45668999999995 66666543 456799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE-IYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e-~~~~i~~~~ 269 (627)
||+++...... .........||+.|+|||++......+++.++|||||||++|+|++|+.||.+....+ +...+....
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 242 (289)
T 3og7_A 164 FGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242 (289)
T ss_dssp CC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred ceecccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence 99997654311 1223345679999999999874434578899999999999999999999998865444 444444333
Q ss_pred CCCC---CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 270 EIPP---IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 270 ~~~~---~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+. .+..+++++.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2222 34578999999999999999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=348.47 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=210.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..++. .||+|++..........+..+. .+++.++||||+++++++...+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~E~--~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRI------RRAAKKIPKYFVEDVDRFKQEI--EIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCSCHHHHHHHH--HHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCc------EEEEEeehhhccchHHHHHHHH--HHHHhCCCCCEeeEEEEEecCCe
Confidence 479999999999999999999877664 8999999765444333333322 25567799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCcccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIPHL 196 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla~~ 196 (627)
.|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999985 77776653 3569999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC--
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI-- 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~-- 274 (627)
.... .......||+.|+|||++.+ .++.++|+|||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 159 ~~~~----~~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T 3f3z_A 159 FKPG----KMMRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD 230 (277)
T ss_dssp CCTT----SCBCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred ccCc----cchhccCCCCCccChHHhcc----cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 6432 23345679999999999863 4889999999999999999999999999988888877665332221
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
...+++++.++|.+||+.||.+||++.++++ |+||.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~------h~~~~ 266 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE------HEWFE 266 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT------SHHHH
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc------CHHHh
Confidence 1378999999999999999999999999987 77764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.43 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=214.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||.||+|++..++. .||+|+++...... ......++. .++..+.||||+++++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGL------EYAAKFIKKRQSRASRRGVSREEIEREV-SILRQVLHHNVITLHDVY 84 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSSSCSSSBCHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCe------EEEEEEEecccccccccchhHHHHHHHH-HHHHhCCCCCcceEEEEE
Confidence 579999999999999999999877654 89999997643211 111222222 245667899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----Ceeecc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLGD 190 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~D 190 (627)
...+..|+||||++ |+|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred ecCCEEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999997 57777765 356789999999999999999999999999999999999999888 799999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 163 fg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 163 FGLAHEIEDG----VEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235 (321)
T ss_dssp CTTCEECCTT----CCCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CccceecCcc----ccccccCCCCCccCcccccC---CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 9999876432 22345679999999999974 4688999999999999999999999999998888877765432
Q ss_pred CCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCC
Q 006887 271 IPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWT 321 (627)
Q Consensus 271 ~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~ 321 (627)
..+ .+..+++.+.+||.+||+.||++||++.++++ |+|+...+|.
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~------hp~~~~~~~~ 282 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR------HPWITPVDNQ 282 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH------STTTSCSSHH
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc------CccccCCCcc
Confidence 211 23678999999999999999999999999998 9998876554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=358.58 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=196.1
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
-.++|++.+.||+|+||.||+|++..++ +.||||+++......... ...++. ..+..++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDH------RDVAVKVLRADLARDPSFYLRFRREA-QNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECTTTTTSHHHHHHHHHHH-TTCCCCCCTTBCCEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCC------ceEEEEEeCccccCCHHHHHHHHHHH-HHHHcCCCCCcceEEEeee
Confidence 3578999999999999999999987665 489999997654322221 111211 2456679999999999987
Q ss_pred ECC----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 117 ING----KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 117 ~~~----~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
..+ ..|+||||++ |+|.+.+.. .+++++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeec
Confidence 643 3599999998 577777653 357999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++.+..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp SCC------------------CCTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 999876543322233345679999999999974 36889999999999999999999999999888777666554332
Q ss_pred CC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 272 PP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 272 ~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
++ .+..+++++.++|.+||+.||.+||+..+++.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 22 23568999999999999999999997666554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=350.85 Aligned_cols=257 Identities=19% Similarity=0.259 Sum_probs=186.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..++. .||||++........ .....++. .++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGL------EVAIKMIDKKAMYKAGMVQRVQNEV-KIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHH-HHHTTBCCTTBCCEEEEEEC
T ss_pred cccceeeeeecCCCceEEEEEEEccCCc------eEEEEEeehhhhhhhhHHHHHHHHH-HHHHhCCCCCeEeEEEEEcc
Confidence 3589999999999999999999876654 899999965332111 11122222 25667899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||++| +|.+.+. ....++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHH-TCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEecCCCCcHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 9999999999986 6665554 3446799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
.... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+.. .....|.
T Consensus 162 ~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 233 (278)
T 3cok_A 162 LKMP---HEKHYTLCGTPNYISPEIATR---SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPS 233 (278)
T ss_dssp CC----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCT
T ss_pred ccCC---CCcceeccCCCCcCCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCcc
Confidence 6421 122234679999999999874 3678899999999999999999999988776655544422 2345677
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.++.++.++|.+||+.||++||++.++++ |+|+...
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~------h~~~~~~ 269 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD------HPFMSRN 269 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT------STTTC--
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc------CccccCC
Confidence 89999999999999999999999999998 8887643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=381.02 Aligned_cols=260 Identities=25% Similarity=0.311 Sum_probs=217.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..+++ .||||++++..... ......++. ..++.++||||++++
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~~Ei-~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGH------KVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRHPHIIKLY 82 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCC------EEEEEEEEHHHHHHTTTHHHHHHHH-HHHTTCCCTTBCCEE
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhhhccCHHHHHHHHHHH-HHHHhCCCCCCCcEE
Confidence 445667899999999999999999999877664 89999997543221 111222222 256778999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..||||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEec
Confidence 999999999999999975 7766664 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+... .
T Consensus 161 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~ 232 (476)
T 2y94_A 161 GLSNMMSDG----EFLRTSCGSPNYAAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--I 232 (476)
T ss_dssp SSCEECCTT----CCBCCCCSCSTTCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--C
T ss_pred cchhhcccc----ccccccCCCcCeEChhhccCC--CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--C
Confidence 999876432 233456899999999999753 12468999999999999999999999999888888888654 3
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...|..+++++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~------hp~~~~ 272 (476)
T 2y94_A 233 FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE------HEWFKQ 272 (476)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT------CHHHHT
T ss_pred cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh------CHHhhh
Confidence 4567889999999999999999999999999998 888764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=350.19 Aligned_cols=262 Identities=18% Similarity=0.231 Sum_probs=214.9
Q ss_pred CCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 33 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+.++.++|++.+.||+|+||.||+|.+... ..||+|+++....... .+.. +. .++..++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vavK~~~~~~~~~~-~~~~-E~-~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-------YDVAIKMIKEGSMSED-EFIE-EA-KVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTT-------EEEEEEEECTTSBCHH-HHHH-HH-HHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCC-------CeEEEEEecCCCCCHH-HHHH-HH-HHHhcCCCCCEeeEE
Confidence 456678999999999999999999999987643 3699999986544332 2222 22 356677899999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Df 164 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECST
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccc
Confidence 99999899999999997 577776653 3457999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++...... ........||+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||...+..+....+... .
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~ 238 (283)
T 3gen_A 165 GLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-L 238 (283)
T ss_dssp TGGGGBCCHH--HHSTTSTTSCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-C
T ss_pred cccccccccc--cccccCCccCcccCCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-c
Confidence 9998654321 112234467889999999974 468999999999999999998 99999999988888777654 3
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
....+..+++.+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 45567888999999999999999999999999999887653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.06 Aligned_cols=256 Identities=19% Similarity=0.242 Sum_probs=209.2
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
..++|++.+.||+|+||.||+|++..+++ .||||++........ ++. .+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~------~vAiK~~~~~~~~~~-----~E~-~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGK------RFALKKVLQDPRYKN-----REL-DIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCC------EEEEEEEECCTTSCC-----HHH-HHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCC------EEEEEEEecCcchHH-----HHH-HHHHHcCCCCccchhheeeec
Confidence 45689999999999999999999887764 899999875433221 122 25677899999999999844
Q ss_pred -------------------------------------CCEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHH
Q 006887 118 -------------------------------------NGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQ 158 (627)
Q Consensus 118 -------------------------------------~~~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~ 158 (627)
....++||||++|+|.+.+... ....+++..+..++.||+.
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 3458999999999888777642 4578999999999999999
Q ss_pred HHHHHHHCCCeecccCCCcEEEe-cCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcch
Q 006887 159 GILQLHSKGILVLNLKPFNFILN-EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSW 237 (627)
Q Consensus 159 aL~yLHs~gIvHrDLKP~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiw 237 (627)
||.|||++||+||||||+|||++ .++.+||+|||+++.+... .......||+.|+|||++.+. ..++.++|||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Diw 226 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----EPSVAYICSRFYRAPELMLGA--TEYTPSIDLW 226 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----SCCCCCCCCSSCCCHHHHTTC--SSCCTHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----CCCcCcccCCCccCHHHhcCC--CCCCcchhhh
Confidence 99999999999999999999998 6889999999999876432 233456889999999998743 3588999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------------------------CCCCCCCHHHHHHHHHhh
Q 006887 238 GFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP---------------------------PIPSGLPPAVENVLLGCF 290 (627)
Q Consensus 238 SlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~---------------------------~~p~~~s~~l~~li~~cL 290 (627)
||||++|||++|++||.+.+..+.+..+......+ .++..+++++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999999988877776665421111 135568999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 291 EYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 291 ~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+.||.+||++.++++ |+||...
T Consensus 307 ~~dP~~R~t~~e~l~------hp~f~~~ 328 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA------HPFFDHL 328 (383)
T ss_dssp CSSGGGSCCHHHHHT------SGGGHHH
T ss_pred cCChhhCCCHHHHhc------CHHHHHH
Confidence 999999999999998 8887643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=354.28 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=206.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE---
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV--- 116 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~--- 116 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++..........+..+. .+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDK------RVAIKKIVLTDPQSVKHALREI--KIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTE------EEEEEEEECCSHHHHHHHHHHH--HHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCe------EEEEEEEecCChHHHHHHHHHH--HHHHhcCCCCeeEEEEeccccc
Confidence 4789999999999999999999877654 8999999866544444333322 2567789999999999873
Q ss_pred -----------ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-cCC
Q 006887 117 -----------INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-EAD 184 (627)
Q Consensus 117 -----------~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-~~g 184 (627)
..+..|+||||++|+|.+.+. .+++++..+..++.||+.||.|||++||+||||||+|||++ .++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYMETDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred cccccccccccccCceeEEeeccCCCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 347899999999998877763 46799999999999999999999999999999999999998 567
Q ss_pred CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006887 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDA 264 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~ 264 (627)
.+||+|||+++................||+.|+|||++.+ ...++.++|+|||||++|||++|+.||.+.+..+.+..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC--TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcC--cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999876432222233445678999999998864 24688999999999999999999999999888777666
Q ss_pred HHhccCC-----------------------C-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 265 VVRRQEI-----------------------P-----PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 265 i~~~~~~-----------------------~-----~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+...... + ..+..+++++.+||.+||+.||++||++.++++ |+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~ 310 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS------HPYMS 310 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT------SHHHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC------Ccccc
Confidence 6543211 0 123568999999999999999999999999998 99988
Q ss_pred CCCCC
Q 006887 317 DGGWT 321 (627)
Q Consensus 317 ~~~w~ 321 (627)
...|+
T Consensus 311 ~~~~p 315 (320)
T 2i6l_A 311 IYSFP 315 (320)
T ss_dssp TTCC-
T ss_pred cccCc
Confidence 76554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.08 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=204.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|.+..+++ .||||++........ .....++. .+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAYREL-RLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC------EEEEEECSSTTSSHHHHHHHHHHH-HHHHHCCBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCC------EEEEEEeCccccCHHHHHHHHHHH-HHHHhCCCcCCCCceeeEecC
Confidence 4789999999999999999999877664 899999965432221 11222222 256677899999999998765
Q ss_pred C------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 G------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+ .+|+||||+.++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CccccCceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 3 4699999998788777653 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.... ......||+.|+|||++.+. ..++.++|+|||||++|||++|++||.+.+..+.+..+......+
T Consensus 174 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 174 LARQADS------EMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp TCEECCS------SCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccc------ccCcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9987532 23456899999999998742 368999999999999999999999999988877666655422111
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 273 -----------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 273 -----------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
.+...+++++.+||.+||+.||.+||++.++++ |+||.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~------hp~f~~~~~ 316 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA------HPYFESLHD 316 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTTC-
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc------ChHHHhhcC
Confidence 123567999999999999999999999999998 999886543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.62 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=197.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|++..++. .||||++....... ......++. .+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILER------NVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEECTTSSHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCc------eEEEEEeccccCChHHHHHHHHHH-HHHHhcCCCCccceEEeeccc
Confidence 4689999999999999999999877654 89999997643222 111122222 356678999999999999765
Q ss_pred C------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 G------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+ ..|+||||++|++.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 4 789999999998887774 358999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 173 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 173 LARTAGT----SFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp C--------------------CTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred ccccccc----ccccCCceecCCccCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9986542 122345689999999999974 468999999999999999999999999988877777665432111
Q ss_pred --------------------CC--------------CC------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 --------------------PI--------------PS------GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 --------------------~~--------------p~------~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+ |. ..++++++||.+||+.||.+|||+.++++ |
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~------h 319 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ------H 319 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH------S
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC------C
Confidence 00 00 11578999999999999999999999998 8
Q ss_pred ccCCC
Q 006887 313 SVHSD 317 (627)
Q Consensus 313 ~~~~~ 317 (627)
+|+..
T Consensus 320 p~~~~ 324 (371)
T 2xrw_A 320 PYINV 324 (371)
T ss_dssp HHHHT
T ss_pred cchhh
Confidence 88763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.64 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=200.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||||++........ ...+..++....+|+++..+..++...+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~---~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEC---CCC---HHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCc------eEEEEeecccccchH---HHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 689999999999999999999876654 899998765433211 12222333344445556666666688899
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCccccc
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla~~~ 197 (627)
.++||||+.|+|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 80 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECCCCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEccCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999999998888888764 45679999999999999999999999999999999999999 78999999999999876
Q ss_pred cCCCCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccC
Q 006887 198 LGIPLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD---EIYDAVVRRQE 270 (627)
Q Consensus 198 ~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~---e~~~~i~~~~~ 270 (627)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. +.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcC---CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 5432211 22345689999999999974 36899999999999999999999999874322 22333222211
Q ss_pred CC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 271 IP---PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 271 ~~---~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.. .....+|+++.+++.+||+.||++||++.++++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 11 1336789999999999999999999999999998887654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=350.64 Aligned_cols=258 Identities=16% Similarity=0.231 Sum_probs=214.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..++ ..||+|++....... ......++. .++..++||||++++
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNK------FIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRHPNILRMY 80 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEE
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCC------cEEEEEEEcccccchHHHHHHHHHHH-HHHhcCCCCCEeeEE
Confidence 44566789999999999999999999987665 389999996532211 111222222 256677999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..|+||||++| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecc
Confidence 999999999999999985 87777754 356999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|++..... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+... .
T Consensus 159 g~~~~~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~ 228 (284)
T 2vgo_A 159 GWSVHAPS-----LRRRTMCGTLDYLPPEMIEG---KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--D 228 (284)
T ss_dssp TTCEECSS-----SCBCCCCSCGGGCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--C
T ss_pred cccccCcc-----cccccccCCCCcCCHHHhcc---CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--c
Confidence 99876532 12235679999999999974 36888999999999999999999999998888887777543 4
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..++..+++++.++|.+||+.||.+||++.++++ |+|+..
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~------h~~~~~ 268 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME------HPWVKA 268 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------CHHHHH
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh------CHHHHh
Confidence 5677889999999999999999999999999998 887753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.75 Aligned_cols=253 Identities=15% Similarity=0.183 Sum_probs=202.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++..++. .||||+++...... ......++...+....+||||+++++++...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGC------IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCc------eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 579999999999999999999876654 89999998643322 12222223333444459999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-------------
Q 006887 120 KICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA------------- 183 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~------------- 183 (627)
..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999985 8888876543 2679999999999999999999999999999999999999844
Q ss_pred ------CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 006887 184 ------DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS 257 (627)
Q Consensus 184 ------g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~ 257 (627)
..++|+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS-------PQVEEGDSRFLANEVLQEN--YTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTC-------SCCCCCCGGGCCHHHHTTC--CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred cccCCceEEEEcccccccccCC-------ccccCCCccccChhHhcCC--CCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 4799999999987643 1234699999999999742 256789999999999999999998876543
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. ...+. ....+.++..+++++.++|.+||+.||++||++.++++ |+|+...
T Consensus 236 ~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~ 286 (289)
T 1x8b_A 236 Q---WHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK------HSVLLSA 286 (289)
T ss_dssp H---HHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------CTTC---
T ss_pred H---HHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh------ChHhhhh
Confidence 2 33333 33456678899999999999999999999999999998 8887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=345.44 Aligned_cols=260 Identities=19% Similarity=0.259 Sum_probs=203.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..++ +.||||++........ ...+..++....+|+++..+..+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~---~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG------EEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT------EEEEEEEEESCSSCCH---HHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC------cEEEEEEecCCcchhH---HHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 468999999999999999999987665 4899999876543221 2223333333334444666666667889
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla~~ 196 (627)
..++||||+.|+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEecCCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999999998888888864 45679999999999999999999999999999999999999 4889999999999987
Q ss_pred ccCCCCCC----CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Q 006887 197 LLGIPLPS----SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---VDEIYDAVVRRQ 269 (627)
Q Consensus 197 ~~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---~~e~~~~i~~~~ 269 (627)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+ ..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 65432211 12345689999999999974 468899999999999999999999998743 223333333221
Q ss_pred CC---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 270 EI---PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 270 ~~---~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.. ...+..+|+++.+++.+||+.||++||++.++++.|+.+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 11 12346789999999999999999999999999998887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=350.61 Aligned_cols=263 Identities=19% Similarity=0.333 Sum_probs=208.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
..++|++.+.||+|+||.||+|++..++. .||||++........ ...++...+....+||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~--~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTGDEEE--EIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSSTTH--HHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCC------eEEEEEEecCcccHH--HHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 35789999999999999999999876654 899999976543322 222333344455589999999999987
Q ss_pred -----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 118 -----NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 118 -----~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
.+..|+||||++| +|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 5689999999986 8888887655578999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCC--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~--~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|++...... ........||+.|+|||++.+.. ...++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 174 g~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCcC---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 998765431 12234557999999999986321 3468899999999999999999999999988877776665554
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.....+..+++.+.+||.+||..||.+||++.++++ |+|+...
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------hp~~~~~ 293 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK------HPFIRDQ 293 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT------SHHHHCC
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh------ChHHhhC
Confidence 444446778999999999999999999999999998 8887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.12 Aligned_cols=253 Identities=18% Similarity=0.257 Sum_probs=197.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..++. .||||+++..... . ...++. .++..++||||+++++++...+.
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~--~-~~~~E~-~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQK------PYALKVLKKTVDK--K-IVRTEI-GVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEC-------------C-HHHHHCCCTTBCCEEEEEECSSE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCc------EEEEEEeccchhH--H-HHHHHH-HHHHhCCCCCCcceeeeEecCCe
Confidence 569999999999999999999877654 8999999764321 1 122222 24566789999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeeccCCcccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGDVGIPHL 196 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~DFGla~~ 196 (627)
.|+||||++ |+|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 123 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp EEEEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEEEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999998 57777764 3467999999999999999999999999999999999999975 88999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCC--C
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE-IYDAVVRRQEIP--P 273 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e-~~~~i~~~~~~~--~ 273 (627)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+ ++..+....... +
T Consensus 201 ~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 201 VEHQ----VLMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP 273 (349)
T ss_dssp ----------------CGGGSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred cCcc----cccccccCCCCccCHHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence 5431 22345689999999999974 368999999999999999999999998766544 566665443222 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....++.++.+||.+||+.||++||++.++++ |+|+...
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~~ 312 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ------HPWVTGK 312 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTTST
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc------CcccCCC
Confidence 34678999999999999999999999999998 9998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=361.00 Aligned_cols=264 Identities=19% Similarity=0.259 Sum_probs=208.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-----hHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-----DRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-----~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||.||+|++..++. .||+|++..... .....+ .++. .+++.++||||+++++++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~-~~E~-~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRA------IRAIKIMNKNKIRQINPKDVERI-KTEV-RLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHC---CHHHHH-HHHH-HHHHHCCCTTBCCEEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCc------eEEEeehhhhhhcccCHHHHHHH-HHHH-HHHHhCCCCCcceeehhh
Confidence 679999999999999999999877664 899999875321 122222 2222 245667899999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhc--------------------------------------CCCCCHHHHHHHHHHH
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLK--------------------------------------GGKLSLSNVFRYAIDL 156 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~--------------------------------------~~~ls~~~~~~i~~qI 156 (627)
.+.+..|+||||++ |+|.+.+.... ...+++..+..++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999998 57766653100 1124677888999999
Q ss_pred HHHHHHHHHCCCeecccCCCcEEEecCC--CeeeccCCccccccCCCCC-CCCCCccCCCCCcCCcccccCCCCCCCCcc
Q 006887 157 AQGILQLHSKGILVLNLKPFNFILNEAD--RAVLGDVGIPHLLLGIPLP-SSDLPRRLGTPNYMAPEQWQPEVRGPISFE 233 (627)
Q Consensus 157 a~aL~yLHs~gIvHrDLKP~NILld~~g--~vkL~DFGla~~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~ 233 (627)
+.||.|||+++|+||||||+|||++.++ .+||+|||+++.+...... ........||+.|+|||++.+. ...++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT-NESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS-SSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC-CCCCCcH
Confidence 9999999999999999999999998776 8999999999876432211 1123456899999999998743 3468899
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 234 TDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 234 sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+|||||||++|||++|+.||.+.+..+....+.........+ ..+++++.+||.+||+.||.+||++.++++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~------ 330 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ------ 330 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH------
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc------
Confidence 999999999999999999999999988888887665443333 348999999999999999999999999998
Q ss_pred cccCCCCC
Q 006887 312 NSVHSDGG 319 (627)
Q Consensus 312 ~~~~~~~~ 319 (627)
|+|+....
T Consensus 331 hp~~~~~~ 338 (345)
T 3hko_A 331 HPWISQFS 338 (345)
T ss_dssp SHHHHTTS
T ss_pred ChhhccCh
Confidence 88877553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=354.41 Aligned_cols=273 Identities=20% Similarity=0.299 Sum_probs=218.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..... ...++.||||+++............++..++....+||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCc-cccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 344667899999999999999999999764331 2355789999998765444333344444455555589999999999
Q ss_pred EEECC-EEEEEEecCCC-CHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcE
Q 006887 115 SVING-KICIIMKFYEG-SVGDRMAQLKG--------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNF 178 (627)
Q Consensus 115 ~~~~~-~~~LVmEy~~G-sL~d~l~~~~~--------------~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NI 178 (627)
+...+ ..|+||||++| +|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 59999999995 87777764321 1289999999999999999999999999999999999
Q ss_pred EEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 006887 179 ILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRS 257 (627)
Q Consensus 179 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~ 257 (627)
|++.++.++|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc---ccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999986643211 112234568999999999873 468999999999999999998 999998876
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+.+............+..+++++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5544444444445566788899999999999999999999999999998887643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.30 Aligned_cols=260 Identities=20% Similarity=0.191 Sum_probs=208.4
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.....+|++.+.||+|+||.||+|++..+++ .||||++....... .++. .+++.++||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~------~vaiK~~~~~~~~~-----~~E~-~il~~l~hpniv~l~~~~~ 117 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKRFK-----NREL-QIMRKLDHCNIVRLRYFFY 117 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECCTTSC-----CHHH-HHHHTCCCTTBCCEEEEEE
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCc------EEEEEEecccchhH-----HHHH-HHHHHcCCCCccceeeEEe
Confidence 3444579999999999999999999877664 89999987543221 1122 2566789999999999885
Q ss_pred EC------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCee
Q 006887 117 IN------GKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAV 187 (627)
Q Consensus 117 ~~------~~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vk 187 (627)
.. ..+++||||+++++.+.+... ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 118 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp EEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEE
T ss_pred ccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEE
Confidence 42 247899999999888776542 35789999999999999999999999999999999999999965 5689
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||+++.+... .......||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 198 l~DFG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 198 LCDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp ECCCTTCEECCTT----CCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eccchhhhhcccC----CCceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999876432 223456899999999998642 3588999999999999999999999999887766655543
Q ss_pred ccCCC---------------C------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 268 RQEIP---------------P------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 268 ~~~~~---------------~------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
....+ . ++..+++++.+||.+||+.||.+||++.++++ |+||....+
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~------hp~f~~~~~ 345 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA------HSFFDELRD 345 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGGGGGC
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC------CHhhccccc
Confidence 21110 1 23467899999999999999999999999998 999876544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=355.98 Aligned_cols=265 Identities=19% Similarity=0.232 Sum_probs=210.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN- 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~- 118 (627)
.++|++.+.||+|+||.||+|++..++ +.||||++.............++. .+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTG------EIVAIKKIEPFDKPLFALRTLREI-KILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECCCSSHHHHHHHHHHH-HHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCC------cEEEEEeecccccchHHHHHHHHH-HHHHhCcCCCcCCeeeeecccc
Confidence 468999999999999999999987665 489999997654333222222332 245667999999999987654
Q ss_pred ----CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 119 ----GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 119 ----~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
+..|+||||+.|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 83 ~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 83 FENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp STTCCCEEEEECCCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCccceEEEEEeccCccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 67999999999988887754 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCC-------CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 195 HLLLGIPLPSS-------DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 195 ~~~~~~~~~~~-------~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
+.......... ......||+.|+|||++.+ ...++.++|+|||||++|+|++|++||.+.+..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT--SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHS--CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeecc--CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 87653221111 1234579999999998763 24688999999999999999999999999887665554432
Q ss_pred ccCCCC------------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 268 RQEIPP------------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 268 ~~~~~~------------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
....+. .+..+++++.+||.+||+.||++||++.++++ |+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE------HPYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc------Cccccc
Confidence 111110 12468999999999999999999999999998 999987
Q ss_pred CCCCC
Q 006887 318 GGWTG 322 (627)
Q Consensus 318 ~~w~~ 322 (627)
..+..
T Consensus 312 ~~~~~ 316 (353)
T 2b9h_A 312 YHDPN 316 (353)
T ss_dssp TCCTT
T ss_pred cCCcc
Confidence 65543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.54 Aligned_cols=265 Identities=20% Similarity=0.221 Sum_probs=215.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-----h---HHHHHHHHHHHHHHHhcCCCCceee
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-----D---RMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-----~---~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
.++|++.+.||+|+||.||+|++..+++ .||||+++.... . .......++..++.+..+||||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCK------EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCc------eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 4799999999999999999999877654 899999976431 1 1112222333344444469999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++..++..|+||||++ |+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999998 577777753 35799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCC---CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
||++...... .......||+.|+|||++.+. ....++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 168 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 168 FGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccchhhcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 9999876432 223456799999999998521 134578899999999999999999999999988888877776
Q ss_pred ccCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 268 RQEIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 268 ~~~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
.......+ ..+++++.++|.+||+.||.+||++.++++ |+||....++.
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~~~ 294 (298)
T 1phk_A 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA------HPFFQQYVVEE 294 (298)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT------SGGGCTTC---
T ss_pred CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh------ChHhhhccchh
Confidence 54433322 468999999999999999999999999988 99988765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=360.17 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=206.8
Q ss_pred CCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 32 NDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 32 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+..++.++|++.+.||+|+||.||+|++.. +.||||++.......... +. +...+..++||||+++
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~--~~-E~~~l~~l~hpniv~~ 83 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPIQDKQSWQN--EY-EVYSLPGMKHENILQF 83 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETT--------EEEEEEEECGGGHHHHHH--HH-HHHTSTTCCCTTBCCE
T ss_pred CccccccchhhchhhheecccCceEEEEEEECC--------CEEEEEEeecCchHHHHH--HH-HHHHHhcCCCCCchhh
Confidence 345777899999999999999999999998652 479999997544332221 11 2224567799999999
Q ss_pred EEEEEECC----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecccCCC
Q 006887 112 QGISVING----KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK----------GILVLNLKPF 176 (627)
Q Consensus 112 ~~~~~~~~----~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~----------gIvHrDLKP~ 176 (627)
++++.... .+|+||||++| +|.+.+.. ..+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGG
T ss_pred cceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChH
Confidence 99998743 47999999985 77777743 4599999999999999999999999 9999999999
Q ss_pred cEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCC--CCCCccCcchhHHHHHHHHHhCCCCCC
Q 006887 177 NFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVR--GPISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 177 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~--~~~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
|||++.++.+||+|||+++.+..... ........||+.|+|||++.+... ..++.++|||||||++|||++|+.||.
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred hEEECCCCeEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999987654322 223345689999999999875211 245678899999999999999999997
Q ss_pred CCC----------------HHHHHHHHHhccCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 255 GRS----------------VDEIYDAVVRRQEIPPIPS-----GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 255 ~~~----------------~~e~~~~i~~~~~~~~~p~-----~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.. ..++...+......+..+. ..++++.+||.+||+.||++||++.++++.|+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 532 2333333433333333332 23456999999999999999999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.25 Aligned_cols=264 Identities=19% Similarity=0.238 Sum_probs=207.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcC-CCCceeeEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQG-VEGICWLQGI 114 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~-hpnIv~l~~~ 114 (627)
.+...+|++.+.||+|+||.||+|.+.. + +.||||++...... .......++..++..+.+ ||||++++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~------~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-K------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-C------CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-C------CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 3555679999999999999999998643 2 48999999764332 222223333334444443 7999999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
+..++.+|||||+..|+|.+.+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++ ++.+||+|||++
T Consensus 125 ~~~~~~~~lv~E~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 125 EITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EECSSEEEEEEECCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EecCCEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 999999999999777888888764 45789999999999999999999999999999999999995 689999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCC--------CCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--------VRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAV 265 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i 265 (627)
+.+.... ........+||+.|||||++.+. ....++.++|||||||++|||++|+.||.+.. ....+..+
T Consensus 202 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 202 NQMQPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp CCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred ccccCCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 8764321 11123456899999999998642 12368899999999999999999999998753 44555566
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
........++...+.++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~------hp~~~~ 326 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA------HPYVQI 326 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHS
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh------CcCccc
Confidence 6555556677888999999999999999999999999998 777653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=346.30 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=207.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+...|++.+.||+|+||.||+|.+..++. .||+|++........ .....++ ..+++.++||||+++++++.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~va~k~~~~~~~~~~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEE-AEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHH-HHHHTTCCCTTBCCEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCce------EEEEEEecchhhCHHHHHHHHHH-HHHHHhCCCCCeeeeeeeec
Confidence 445679999999999999999999877664 899999976432221 1222222 23567789999999999987
Q ss_pred E----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEe-cCCCeee
Q 006887 117 I----NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILN-EADRAVL 188 (627)
Q Consensus 117 ~----~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld-~~g~vkL 188 (627)
. ....|+||||++| +|.+.+.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.++|
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 6 4568999999985 77777753 356899999999999999999999999 99999999999997 7899999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i~~ 267 (627)
+|||++..... .......||+.|+|||++. +.++.++|+|||||++|+|++|+.||... +..+.+..+..
T Consensus 174 ~Dfg~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 174 GDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp CCTTGGGGCCT-----TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred eeCCCcccccc-----cccccccCCcCcCCHHHHh----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 99999975432 2233567999999999885 35889999999999999999999999874 44555555544
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
......++...++++.++|.+||+.||.+||++.++++ |+||..
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~------h~~f~~ 288 (290)
T 1t4h_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQE 288 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC-
T ss_pred cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh------Cccccc
Confidence 44444566778899999999999999999999999998 998865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=350.07 Aligned_cols=269 Identities=20% Similarity=0.297 Sum_probs=208.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+....|++.+.||+|+||.||+|++.... ...++.||+|+++............++. .++..++||||++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEG--DNTGEQVAVKSLKPESGGNHIADLKKEI-EILRNLYHENIVKYKGI 91 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTS--SSCSEEEEEEEEC-----CCHHHHHHHH-HHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEcccc--CccCeEEEEEEecccccchhHHHHHHHH-HHHHhCCCCCeeeeeeE
Confidence 33455677999999999999999999854322 2345699999997654322222222222 25667799999999999
Q ss_pred EEEC--CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 115 SVIN--GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 115 ~~~~--~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+... +..++||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence 9876 668999999985 77777654 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC--------------C
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR--------------S 257 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~--------------~ 257 (627)
|+++................||+.|+|||++.+ ..++.++|+|||||++|+|++|..|+... .
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ---SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecC---CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc
Confidence 999876543322233345678999999999874 36788999999999999999999875421 1
Q ss_pred HHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 258 VDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 258 ~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
...............+.+..+++++.+||.+||+.||.+||++.++++.|+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 22222233334455667889999999999999999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.83 Aligned_cols=270 Identities=18% Similarity=0.237 Sum_probs=215.8
Q ss_pred cCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc-CCCCc
Q 006887 30 TSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ-GVEGI 108 (627)
Q Consensus 30 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~-~hpnI 108 (627)
+.....+.++.++|++.+.||+|+||.||+|++..++. ...+|+|.+.............++..+ +..+ +||||
T Consensus 14 ~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~E~~~-l~~l~~hp~i 88 (327)
T 1fvr_A 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNI 88 (327)
T ss_dssp --CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHH-HTTCCCCTTB
T ss_pred CCCcccccccHHHccceeeeecCCCceEEEEEEccCCc----ccceeeeeeccccchHHHHHHHHHHHH-HHhccCCCch
Confidence 34445777888999999999999999999999876653 113599998764333222223333333 4445 99999
Q ss_pred eeeEEEEEECCEEEEEEecCCC-CHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeccc
Q 006887 109 CWLQGISVINGKICIIMKFYEG-SVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNL 173 (627)
Q Consensus 109 v~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDL 173 (627)
+++++++...+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 168 (327)
T 1fvr_A 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 168 (327)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 9999999999999999999984 8888775422 257999999999999999999999999999999
Q ss_pred CCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCC
Q 006887 174 KPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQP 252 (627)
Q Consensus 174 KP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~P 252 (627)
||+|||++.++.++|+|||+++.... ........+|+.|+|||++.+ ..++.++|+|||||++|||++ |..|
T Consensus 169 kp~NIl~~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 169 AARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp SGGGEEECGGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccceEEEcCCCeEEEcccCcCccccc----cccccCCCCCccccChhhhcc---ccCCchhcchHHHHHHHHHHcCCCCC
Confidence 99999999999999999999875322 112234567899999999874 357899999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 253 RCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 253 f~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
|.+.+..++...+... .....+..+++++.+||.+||+.||.+||++.++++.|+.+..
T Consensus 242 f~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 242 YCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp TTTCCHHHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHHhhcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999988888776543 3455678899999999999999999999999999998887654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=350.61 Aligned_cols=263 Identities=20% Similarity=0.352 Sum_probs=221.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+..++|++.+.||+|+||.||+|.+..++ ..||+|++....... ..+..+ . .+++.++||||+++++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~-~~~~~E-~-~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTMEV-EEFLKE-A-AVMKEIKHPNLVQLLG 76 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGT------EEEEEEEECSCSTHH-HHHHHH-H-HHHHHCCCTTBCCEEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCC------EEEEEEecCcCHHHH-HHHHHH-H-HHHHhCCCCCEeeEEE
Confidence 456688899999999999999999999987665 489999997654332 222222 2 3566778999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++...+..|+||||++ |+|.+.+.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999 588888876556779999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... ........+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..++...+.. ...
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-~~~ 230 (288)
T 3kfa_A 157 LSRLMTGDT--YTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYR 230 (288)
T ss_dssp GGGTSCSSS--SEEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCC
T ss_pred cceeccCCc--cccccCCccccCcCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-cCC
Confidence 998764321 112234467889999999974 468999999999999999999 9999999888887776654 345
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
...+..+++++.+++.+||+.||.+||++.++++.|+...
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 5678889999999999999999999999999999888754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=364.51 Aligned_cols=258 Identities=20% Similarity=0.236 Sum_probs=210.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
..+|++.+.||+|+||.||+|++..++ .||+|++........ ++. .+++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~-------~~aikk~~~~~~~~~-----~E~-~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESD-------EVAIKKVLQDKRFKN-----REL-QIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEEECCTTSCC-----HHH-HHHHTCCCTTBCCEEEEEEEES
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCC-------eEEEEEEecCcchHH-----HHH-HHHHhCCCCCcceEEEEEEecC
Confidence 467999999999999999999987654 488988865432211 122 3566789999999999986543
Q ss_pred ------EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-cCCCeeecc
Q 006887 120 ------KICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-EADRAVLGD 190 (627)
Q Consensus 120 ------~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-~~g~vkL~D 190 (627)
..|+||||+++++.+.+... ....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 38999999999887766532 357899999999999999999999999999999999999999 799999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.+... .......||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 186 FG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 186 FGSAKILIAG----EPNVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp CTTCEECCTT----CCCCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCCcccccCC----CCCcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999876432 223456899999999998643 3589999999999999999999999999887776665554211
Q ss_pred CC---------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 271 IP---------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 271 ~~---------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
.+ .++..+++++.+||.+||+.||.+||++.++++ |+||....+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~~~~~~ 332 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC------HPFFDELRTGE 332 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT------SGGGSTTTSSC
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc------Chhhhhhcccc
Confidence 11 123458899999999999999999999999998 99998876644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=364.97 Aligned_cols=255 Identities=19% Similarity=0.265 Sum_probs=206.5
Q ss_pred CeEE--EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKL--RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i--~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.|++ .+.||+|+||.||+|++..++. .||+|+++.........+.. +. .++..++||||+++++++...+
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~------~vavK~~~~~~~~~~~~~~~-E~-~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGL------KLAAKIIKTRGMKDKEEVKN-EI-SVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCC------EEEEEEEECCSHHHHHHHHH-HH-HHHTTCCCTTBCCEEEEEECSS
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCc------EEEEEEEcccccccHHHHHH-HH-HHHHhCCCCCCCeEEEEEEECC
Confidence 4555 6789999999999999877664 89999998765444333332 22 2567789999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE--ecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL--NEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl--d~~g~vkL~DFGla~~ 196 (627)
..||||||++| +|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999999985 77777654 34568999999999999999999999999999999999999 4567899999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--C
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--I 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~--~ 274 (627)
+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+........ .
T Consensus 239 ~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 239 YKPR----EKLKVNFGTPEFLAPEVVNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp CCTT----CBCCCCCSSCTTCCHHHHTT---CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred cCCc----cccccccCCCcEeChhhccC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 6432 22334579999999999873 4688999999999999999999999999998888888876543222 2
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
...+++++.+||.+||+.||.+||++.++++ |+||...
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~------hp~~~~~ 349 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK------HPWLSDH 349 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------SHHHHCH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc------CcCcCCC
Confidence 3578999999999999999999999999998 8887654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.40 Aligned_cols=265 Identities=18% Similarity=0.244 Sum_probs=192.4
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+...+|++.+.||+|+||.||+|++..+++ .||||++..........+.. +..++....+||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~-e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGR------EYALKRLLSNEEEKNRAIIQ-EVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEEEESSHHHHHHHHH-HHHHHHHHTTSTTBCCEEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCc------EEEEEEecCCchHHHHHHHH-HHHHHHHhccCCChhhcccccc
Confidence 4556689999999999999999999877664 89999986655444333333 3334444446999999999985
Q ss_pred E--------CCEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEecCCC
Q 006887 117 I--------NGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILNEADR 185 (627)
Q Consensus 117 ~--------~~~~~LVmEy~~GsL~d~l~~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld~~g~ 185 (627)
. ....++||||++|+|.+.+... ..+++++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3 4458999999999999988654 3467999999999999999999999999 999999999999999999
Q ss_pred eeeccCCccccccCCCCCC---------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 006887 186 AVLGDVGIPHLLLGIPLPS---------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR 256 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~---------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~ 256 (627)
+||+|||+++......... .......||+.|+|||++.......++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765422111 1112456999999999985333457889999999999999999999999876
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...++.. .....+.+..++..+.+||.+||+.||.+||++.++++.|+....
T Consensus 257 ~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 257 AKLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5544333 222334456778899999999999999999999999998887643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=352.28 Aligned_cols=267 Identities=24% Similarity=0.367 Sum_probs=209.4
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...+..++|++.+.||+|+||.||+|++..... ....||||+++.... .....+. ++. ..+..++||||+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~-~e~-~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFI-REV-NAMHSLDHRNLIRL 86 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHH-HHH-HHHHHCCCTTBCCE
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHH-HHH-HHHHhCCCCCcccE
Confidence 455777899999999999999999998754322 234699999976432 1222222 222 24566799999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++...+ .++||||++ |+|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 87 YGVVLTPP-MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEECSSS-CEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEccCC-ceeeEecccCCCHHHHHHh-ccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 99988655 899999998 577777764 345799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~ 269 (627)
||+++................+|+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+..++...+....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 9999876543222222334578889999999874 357889999999999999999 999999999999888887766
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
...+.+..+++++.+++.+||+.||.+||++.++++.|+..+
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 667778899999999999999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=349.21 Aligned_cols=264 Identities=18% Similarity=0.280 Sum_probs=205.9
Q ss_pred CCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCcee
Q 006887 31 SNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICW 110 (627)
Q Consensus 31 ~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~ 110 (627)
......+.+.++|++.+.||+|+||.||+|++..+++ .||||+++...... ..++..++....+||||++
T Consensus 26 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~----~~~E~~~l~~l~~~~~i~~ 95 (330)
T 3nsz_A 26 ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPVKKKK----IKREIKILENLRGGPNIIT 95 (330)
T ss_dssp GGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECSCCHHH----HHHHHHHHHHHTTSTTBCC
T ss_pred hhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCc------EEEEEEecccchHH----HHHHHHHHHHcCCCCCEEE
Confidence 3344566677899999999999999999999877664 89999997654432 2233334444456999999
Q ss_pred eEEEEEE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-Ce
Q 006887 111 LQGISVI--NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RA 186 (627)
Q Consensus 111 l~~~~~~--~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~v 186 (627)
+++++.. ....++||||++| ++.+.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp EEEEEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred eeeeeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEE
Confidence 9999987 6779999999996 5444432 489999999999999999999999999999999999999777 89
Q ss_pred eeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHH
Q 006887 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAV 265 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i 265 (627)
+|+|||+++..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||... +..+.+..+
T Consensus 171 kl~Dfg~a~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~ 244 (330)
T 3nsz_A 171 RLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244 (330)
T ss_dssp EECCCTTCEECCTT----CCCCSCCSCGGGCCHHHHTT--CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred EEEeCCCceEcCCC----CccccccccccccChhhhcC--CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence 99999999876432 23345689999999999874 246889999999999999999999999543 333222222
Q ss_pred Hh-------------cc----------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 266 VR-------------RQ----------------------EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 266 ~~-------------~~----------------------~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.. .. .....+..+++++.+||.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~----- 319 (330)
T 3nsz_A 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----- 319 (330)
T ss_dssp HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT-----
T ss_pred HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc-----
Confidence 11 00 001112237999999999999999999999999998
Q ss_pred ccccCCCCCCC
Q 006887 311 QNSVHSDGGWT 321 (627)
Q Consensus 311 ~~~~~~~~~w~ 321 (627)
|+||....++
T Consensus 320 -hp~f~~~~~~ 329 (330)
T 3nsz_A 320 -HPYFYTVVKD 329 (330)
T ss_dssp -SGGGTTCC--
T ss_pred -CccHhhhccC
Confidence 9999877553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.91 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=212.0
Q ss_pred CCCcCCCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...++.++|++.+ .||+|+||.||+|.+.... .+..||||+++....... .....++. .+++.++||||++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEA-NVMQQLDNPYIVRMI 84 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHH-HHHHTCCCTTBCCEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCC----ceeeEEEEeecccccCHHHHHHHHHHH-HHHHhCCCCCEEEEE
Confidence 4457778999999 9999999999999764322 235899999976543221 22222222 256677999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++ ..+..|+||||++| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 998 56779999999984 77776653 456999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++................||+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||.+.+..++...+... .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~ 237 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-E 237 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-C
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhcc---CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence 999876443221222234467899999999974 358889999999999999999 99999999988887776543 4
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+..+..+++++.++|.+||+.||.+||++.++++.|+....
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 566788999999999999999999999999999999987644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=343.14 Aligned_cols=260 Identities=20% Similarity=0.316 Sum_probs=216.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+++++|++.+.||+|+||.||+|.+... ..||+|++....... ..+.. +. ..+..++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~vaiK~~~~~~~~~-~~~~~-e~-~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMSE-EDFIE-EA-EVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTTBCH-HHHHH-HH-HHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCC-------CeEEEEEccccCCCH-HHHHH-HH-HHHHhCCCCCEeeEEEE
Confidence 3567889999999999999999999997532 379999998654432 22222 22 24566799999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+..++..|+||||++| +|.+.+.. ....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 72 CLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred EccCCCeEEEEeCCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccc
Confidence 9988999999999985 77766653 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........||+.|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+... ...
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~ 224 (267)
T 3t9t_A 151 TRFVLDDQ--YTSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRL 224 (267)
T ss_dssp GGGBCCHH--HHSTTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred cccccccc--ccccccccccccccChhhhcC---CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcC
Confidence 98653211 112234567889999999873 468899999999999999999 99999999988888777654 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+..+++.+.+++.+||+.||++||++.++++.|+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 567788999999999999999999999999999988754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.35 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=210.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..++. .||||++.+... .....+. ++. .+++.++||||+++++++...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~-~E~-~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTIL-REV-ELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCC------EEEEEEEEHHHHBCSCHHHHH-HHH-HHHHHCCCTTBCCEEEEEECS
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCC------EEEEEEEecccccchHHHHHH-HHH-HHHHhCCCCCcCeEEEEEEcC
Confidence 679999999999999999999877664 899999864321 1122222 222 245667999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe---cCCCeeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN---EADRAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld---~~g~vkL~DFGla 194 (627)
+..|+||||+.| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 999999999984 77777754 35799999999999999999999999999999999999995 4567999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
+.... .......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+.........
T Consensus 172 ~~~~~----~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 172 TCFQQ----NTKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp TTBCC----C----CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred eECCC----CCccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 87643 223345689999999999863 5899999999999999999999999999999999888776544433
Q ss_pred C--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 275 P--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 275 p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+ ..+++++++||.+||+.||.+||++.++++ |+|+...
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~------hp~~~~~ 283 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE------HPWIQKY 283 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH------CHHHHHT
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc------CHhhccC
Confidence 3 568999999999999999999999999998 8877543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.06 Aligned_cols=271 Identities=20% Similarity=0.272 Sum_probs=215.3
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
....++.++|++.+.||+|+||.||+|++...+ ...+..||||++..........+..+. .+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLG--DNTGALVAVKQLQHSGPDQQRDFQREI--QILKALHSDFIVKYRG 91 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTS--SSCSEEEEEEEESSCCHHHHHHHHHHH--HHHHTCCCTTBCCEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCC--CCcceEEEEEEeccCCHHHHHHHHHHH--HHHHhcCCCceeEEEE
Confidence 356688899999999999999999999864322 234568999999876554444333332 2566779999999999
Q ss_pred EEE--ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 114 ISV--INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 114 ~~~--~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++. ..+..|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 887 4567999999997 577777654 335699999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-----------
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD----------- 259 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~----------- 259 (627)
||+++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD---NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred cccceecccCCccceeeccCCccccccCHHHhcc---CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 9999876543222223345578999999999874 35789999999999999999999998654322
Q ss_pred ---HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 260 ---EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 260 ---e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.............+.+..+++++.+||.+||+.||.+||++.++++.|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 12222333444566788999999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=358.49 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=212.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch----hHH---HHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE----DRM---RVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~----~~~---~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++.... ... .....++..++....+||||+.+++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGH------EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCc------EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 469999999999999999999876654 899999976431 111 1222233333444448999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++...+..|+||||++| +|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999996 77777653 3579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCC---CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
++..+... ......+||+.|+|||++.+. ....++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 246 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 246 FSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TCEECCTT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccccCCC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 99876432 233456899999999998642 12358889999999999999999999999988888887776654
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 270 EIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 270 ~~~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.....+ ..+++.+.++|.+||+.||++||++.++++ |+||.
T Consensus 322 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~------hp~f~ 364 (365)
T 2y7j_A 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ------HPFFE 364 (365)
T ss_dssp CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGC
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CcccC
Confidence 333222 578899999999999999999999999998 88875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.39 Aligned_cols=254 Identities=18% Similarity=0.221 Sum_probs=200.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc-------CCCCceeeE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ-------GVEGICWLQ 112 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~-------~hpnIv~l~ 112 (627)
.++|++.+.||+|+||.||+|++..++ +.||||+++..... .... .++..++.... +|+||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~-~~~~-~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGK------KFVAMKVVKSAEHY-TETA-LDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSCHHH-HHHH-HHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCC------eEEEEEEEecCCcc-hHHH-HHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 478999999999999999999987765 48999999754322 1222 22222222221 388899999
Q ss_pred EEEE----ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCC---
Q 006887 113 GISV----INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEAD--- 184 (627)
Q Consensus 113 ~~~~----~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g--- 184 (627)
+++. .....||||||+.|++++.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 9987 34579999999999999998875557899999999999999999999999 999999999999998775
Q ss_pred ----------------------------------------------CeeeccCCccccccCCCCCCCCCCccCCCCCcCC
Q 006887 185 ----------------------------------------------RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218 (627)
Q Consensus 185 ----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmA 218 (627)
.++|+|||+++.... ......||+.|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~~~~gt~~y~a 261 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSCSCCSCGGGCC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCccCCCCCcccC
Confidence 799999999987642 2345589999999
Q ss_pred cccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCC---------------------
Q 006887 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV------DEIYDAVVRRQEI--------------------- 271 (627)
Q Consensus 219 PE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~------~e~~~~i~~~~~~--------------------- 271 (627)
||++.+ ..++.++|||||||++|||++|+.||.+.+. .+.+..+......
T Consensus 262 PE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 262 LEVLIG---SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp HHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ChhhcC---CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999984 3689999999999999999999999986542 2222222211100
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 -------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 -------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..++...++++.+||.+||+.||++||++.++++ |+||.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~ 396 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR------HPWLN 396 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT------SGGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh------Ccccc
Confidence 0122334577899999999999999999999998 88875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.57 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=205.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++........ .....++ ..+++.++||||+++++++...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E-~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGE------KVAIKKLSRPFQSEIFAKRAYRE-LLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSTTSSHHHHHHHHHH-HHHHHHCCCTTBCCCSEEECSC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCC------EEEEEEecccccchhHHHHHHHH-HHHHHhcCCCCchhhhhheecc
Confidence 4799999999999999999999877664 899999976433222 1122222 2356678899999999999876
Q ss_pred CEE------EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 GKI------CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~~~------~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+.. |+||||+.|+|.+.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEccccccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 654 999999999876665 3459999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus 190 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 190 LARHADA------EMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp CC--------------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccc------CcCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9986532 23456899999999998742 468899999999999999999999999988777766654422111
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 273 -----------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 273 -----------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
..+..+++++.+||.+||+.||++||++.++++ |+||....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~ 331 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT------HPFFEPFR 331 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTTTC
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc------CcccccCC
Confidence 112467999999999999999999999999998 99988653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=352.95 Aligned_cols=260 Identities=17% Similarity=0.174 Sum_probs=207.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhc------CCCCceeeEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ------GVEGICWLQG 113 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~------~hpnIv~l~~ 113 (627)
.++|++.+.||+|+||.||+|++..++. +.||+|+++...... . ....+..+ ++.+ .+.+++.+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~-~-~~~~E~~~-l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGK-----SQVALKIIRNVGKYR-E-AARLEINV-LKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEECSCHHHH-H-HHHHHHHH-HHHHHHHCTTSCSCBCCEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCc-----eEEEEEEEcccccch-h-HHHHHHHH-HHHHhhcCCCCceeEEEeee
Confidence 4799999999999999999999876542 489999997543221 1 12222222 2222 2334899999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE-------------
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL------------- 180 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl------------- 180 (627)
++...+..||||||++|++++.+.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 90 WFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 9999999999999999999998877555789999999999999999999999999999999999999
Q ss_pred ------ecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCC
Q 006887 181 ------NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 181 ------d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
+.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeeec---CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 6788999999999986432 2345689999999999974 468999999999999999999999999
Q ss_pred CCCHHHHHHHHHhccCCCC------------------------------------------CCCCCCHHHHHHHHHhhhc
Q 006887 255 GRSVDEIYDAVVRRQEIPP------------------------------------------IPSGLPPAVENVLLGCFEY 292 (627)
Q Consensus 255 ~~~~~e~~~~i~~~~~~~~------------------------------------------~p~~~s~~l~~li~~cL~~ 292 (627)
+.+..+....+.......+ .....++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 8887765544433211100 0112246889999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccccCCCCCCCC
Q 006887 293 DLRSRPLMTDILRVFKSSQNSVHSDGGWTG 322 (627)
Q Consensus 293 dP~~RPs~~eil~~L~~~~~~~~~~~~w~~ 322 (627)
||++||++.++++ |+||...++..
T Consensus 321 dP~~Rpt~~e~l~------hp~f~~~~~~~ 344 (355)
T 2eu9_A 321 DPAQRITLAEALL------HPFFAGLTPEE 344 (355)
T ss_dssp STTTSCCHHHHTT------SGGGGGCCHHH
T ss_pred ChhhCcCHHHHhc------ChhhcCCChhh
Confidence 9999999999988 99998776543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=343.67 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=212.8
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..... .+..||+|+++............++.. .++.++||||++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLDHPHIVKLIGI 81 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTC---CEEEEEEEECCTTSCHHHHHHHHHHHH-HHHHHCCTTBCCEEEE
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCC---CcceEEEEecccccCchHHHHHHHHHH-HHHhCCCCCcceEEEE
Confidence 456778899999999999999999999765432 345799999987543332222333332 4556689999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.. +..|+||||++ |+|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 764 45799999999 477776654 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........+|+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||...+..+....+... ...
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~ 233 (281)
T 3cc6_A 160 SRYIEDED--YYKASVTRLPIKWMSPESINF---RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRL 233 (281)
T ss_dssp GGCC-----------CCCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCC
T ss_pred Cccccccc--ccccccCCCCcceeCchhhcc---CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCC
Confidence 98764322 112234567899999999873 468899999999999999998 99999988877777666543 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.+..+++.+.+++.+||+.||++||++.++++.|+.+.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 667889999999999999999999999999999888653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.99 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=206.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|++..+++ .||||+++...... ......++. ..++.++||||++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~ 77 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGH------KVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRHPHIIKLY 77 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEE
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCc------eEEEEEeccccccchhHHHHHHHHH-HHHhcCCCCCEeEEE
Confidence 345567899999999999999999999876654 89999997543211 111122222 245678999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++...+..|+||||++ ++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 78 QVISTPTDFFMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999998 477777754 356899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|++...... .......||+.|+|||++.+. ...+.++|+||||+++|+|++|+.||...+..++...+... .
T Consensus 156 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~ 227 (276)
T 2h6d_A 156 GLSNMMSDG----EFLRTSCGSPNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--V 227 (276)
T ss_dssp CGGGCCCC-----------------CCTGGGTTS--CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C
T ss_pred ccccccCCC----cceecccCCccccCHHHHcCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--c
Confidence 999876432 223355799999999998743 12368999999999999999999999998888888777544 3
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
..+|..++.++.++|.+||+.||.+||++.++++ |+||..
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~------h~~~~~ 267 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE------HEWFKQ 267 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH------SHHHHT
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh------Chhhcc
Confidence 4567889999999999999999999999999998 777653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.63 Aligned_cols=261 Identities=24% Similarity=0.396 Sum_probs=217.8
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+..++|++.+.||+|+||.||+|.+... ..||||+++..... ...+..+. .+++.++||||+++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~vavK~~~~~~~~-~~~~~~E~--~~l~~l~h~~iv~l~~ 250 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKH-------TKVAVKTMKPGSMS-VEAFLAEA--NVMKTLQHDKLVKLHA 250 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTT-------EEEEEEEECTTSBC-HHHHHHHH--HHHTTCCCTTBCCEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCc-------cEEEEEEecCCCcc-HHHHHHHH--HHHhhCCCCCEeeEEE
Confidence 34568889999999999999999999987542 37999999865432 22333322 3567789999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++. .+..||||||++ |+|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp EEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred EEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 986 667999999998 588888765444578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... ........+|+.|+|||++. .+.++.++|||||||++|||+| |+.||.+.+..++...+... ..
T Consensus 330 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 403 (454)
T 1qcf_A 330 LARVIEDNE--YTAREGAKFPIKWTAPEAIN---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YR 403 (454)
T ss_dssp GGGGBCCHH--HHTTCSSSSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CC
T ss_pred CceEcCCCc--eeccCCCcccccccCHHHhc---cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 998764311 11123345788999999997 3468999999999999999999 99999999999988877654 34
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.|..+++++.+||.+||+.||++||++.++++.|+...
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 5568899999999999999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.57 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=213.7
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
..++|++.+.||+|+||.||+|++..+++ .||+|++..... ........++. .+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKE------VFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCc------eEEEEEechhhccCHHHHHHHHHHH-HHHHhCCCCCEeeeeeeec
Confidence 34689999999999999999999877664 899999876432 11222222222 3566789999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..|+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 9999999999999 466666543 3579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
..... ........||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||......+.+..+... ...++
T Consensus 164 ~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~ 235 (294)
T 2rku_A 164 KVEYD---GERKKVLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIP 235 (294)
T ss_dssp ECCST---TCCBCCCCSCCSSCCHHHHTT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCC
T ss_pred ecccC---ccccccccCCCCcCCcchhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCc
Confidence 76432 122344679999999999874 35788999999999999999999999998888877766543 45677
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+++.+.+++.+||+.||++||++.++++ |+|+...
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~------~~~~~~~ 272 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLN------DEFFTSG 272 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG------SHHHHTS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhh------ChheecC
Confidence 889999999999999999999999999988 7777643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=375.70 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=206.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|++..++. .||+|++.+.... ....+.+ +. .+++.++||||+++++++...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~-E~-~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHV------ERAIKIIRKTSVSTSSNSKLLE-EV-AVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCC------EEEEEEEEC-----CTTHHHHH-HH-HHHTTCCCTTBCCEEEEEECS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCc------EEEEEEEeccccCchHHHHHHH-HH-HHHHhCCCCCCCeEEEEEEeC
Confidence 469999999999999999999877664 8999999764321 1122222 22 356778999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC---CCeeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA---DRAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~---g~vkL~DFGla 194 (627)
+..|+||||++| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 999999999985 77777754 3569999999999999999999999999999999999999764 45999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
+..... ......+||+.|+|||++. +.|+.++|||||||++|+|++|.+||.+.+..+++..+.........
T Consensus 187 ~~~~~~----~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 187 AVFENQ----KKMKERLGTAYYIAPEVLR----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp EECBTT----BCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred eECCCC----ccccccCCCcCeeCHHHHc----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 876532 2334568999999999985 35899999999999999999999999999999999888776544332
Q ss_pred C--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 275 P--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 275 p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+ ..+++++++||.+||+.||.+||++.++++ |+|+.
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~------hp~~~ 296 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE------HPWIK 296 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------CHHHH
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc------Ccccc
Confidence 2 578999999999999999999999999988 77654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.54 Aligned_cols=262 Identities=17% Similarity=0.272 Sum_probs=210.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.+..++|++.+.||+|+||.||+|++..+++. ......||+|++..........+.++. .++..++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~--~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA--SMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHH--HHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHH--HHHHhCCCCCEeEEEEEE
Confidence 46678999999999999999999998766531 112357999999765544444333332 356778999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC--------e
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR--------A 186 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~--------v 186 (627)
..++..|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999998 577777754 3445999999999999999999999999999999999999999887 9
Q ss_pred eeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 006887 187 VLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i 265 (627)
+|+|||++..... .....||+.|+|||++.+. ..++.++|||||||++|||++ +.+||...+........
T Consensus 161 kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 161 KLSDPGISITVLP-------KDILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeccCcccccccC-------ccccCCcCcccCHHHhCCC--CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 9999999865421 1345689999999999742 358899999999999999999 55666666665554443
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 266 VRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 266 ~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
. .....+...++++.+++.+||+.||.+||++.++++.|+++..+
T Consensus 232 ~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 E---DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp H---TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred h---ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 3 24556777889999999999999999999999999999986544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=370.41 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=213.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.++.++|++.+.||+|+||.||+|.+.. +.||||+++.... ...+..+ . .+++.++||||++++++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~vavK~~~~~~~--~~~~~~E-~-~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDAT--AQAFLAE-A-SVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETT--------EEEEEEEESSCTT--SHHHHHH-H-HHHHTCCCTTBCCEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecC--------CeEEEEEeCCchH--HHHHHHH-H-HHHHhccCCCEEEEEEE
Confidence 456888999999999999999999998742 4799999976542 2222222 2 35677899999999999
Q ss_pred EEECC-EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 115 SVING-KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 115 ~~~~~-~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+...+ ..||||||++ |+|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 87665 7999999998 588888876544568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..++...+... ..
T Consensus 335 ~a~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 404 (450)
T 1k9a_A 335 LTKEASS------TQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YK 404 (450)
T ss_dssp TCEECC------------CCCTTTSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CC
T ss_pred Ccccccc------cccCCCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 9985432 1223467899999999974 468999999999999999998 99999998888888777544 45
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.|..+++++.+||.+||+.||.+||++.++++.|+.+.
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 6678899999999999999999999999999999888754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=348.07 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=210.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||+|+++.........+ .++. ..+..++||||+++++++...+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~-~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGK------LFALKCIKKSPAFRDSSL-ENEI-AVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECC------HH-HHHH-HHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCC------EEEEEEEecccccchHHH-HHHH-HHHHhCCCCCeeehhhhcccCCE
Confidence 579999999999999999999876654 899999986543332222 2222 24566799999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCcccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIPHL 196 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla~~ 196 (627)
.|+||||++ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999998 577777753 3579999999999999999999999999999999999999 7889999999999875
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--PI 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--~~ 274 (627)
... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..++...+....... +.
T Consensus 159 ~~~-----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 159 EQN-----GIMSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230 (304)
T ss_dssp CCC-----BTTHHHHSCCCBCCTTTBSS---CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred cCC-----CccccccCCCCccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 432 22344579999999999974 468899999999999999999999999999888888877654332 34
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+..+++++.++|.+||+.||++||++.++++ |+|+..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~------h~~~~~ 267 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS------HPWIDG 267 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT------SHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CccccC
Confidence 4678999999999999999999999999998 887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.93 Aligned_cols=263 Identities=20% Similarity=0.256 Sum_probs=207.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
.-..++|++.+.||+|+||.||+|++..+++ .||||++......... ....++. .+++.++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGR------IVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCC------EEEEEEEESCSSCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCc------eEEEEEEecCCCchHHHHHHHHHH-HHHhhCCCCCEeeEEEEe
Confidence 3456899999999999999999999877664 8999998765433322 2222222 356677899999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...+..|+||||++|++++.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred ecCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCce
Confidence 99999999999999877766643 45679999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI---- 271 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~---- 271 (627)
..... ........||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus 173 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 173 TLAAP---GEVYDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eecCC---ccccCCCcCCccccCcccccCC--CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 65432 1223456799999999998742 35889999999999999999999999998877665554422110
Q ss_pred ----------------CC---------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 ----------------PP---------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ----------------~~---------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+. ..+.+++++.+||.+||+.||++||++.++++ |+||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~ 313 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH------HDFFQMD 313 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG------SHHHHGG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc------CchhccC
Confidence 00 11367899999999999999999999999988 8887644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=353.20 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=214.4
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
..++|++.+.||+|+||.||+|++..+++ .||+|++..... ........++. .+++.++||||+++++++.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKE------VFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEechhhhcCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEe
Confidence 34689999999999999999999877664 899999875432 11222222222 3567789999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 99999999999995 66666543 3579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+.+..+... ...++
T Consensus 190 ~~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~ 261 (335)
T 2owb_A 190 KVEYD---GERKKVLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIP 261 (335)
T ss_dssp ECCST---TCCBCCCCSCCSSCCHHHHHT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCC
T ss_pred ecccC---cccccccCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCC
Confidence 76432 122345679999999999974 35788999999999999999999999998888877776544 45567
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+++++.+||.+||+.||++||++.++++ |+||...
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~------~~~~~~~ 298 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN------DEFFTSG 298 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG------SHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc------CccccCC
Confidence 889999999999999999999999999988 7777643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=358.63 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=205.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCC-----CceeeEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVE-----GICWLQGI 114 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hp-----nIv~l~~~ 114 (627)
.++|++.+.||+|+||.||+|++..+++ .||||+++...... .....+..++.....|+ +|+.++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQE------WVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECSSHHHH--HHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCc------EEEEEEEeccHHHH--HHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4789999999999999999999876654 89999997543211 11222222333333344 59999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecccCCCcEEEe--cCCCeeecc
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH--SKGILVLNLKPFNFILN--EADRAVLGD 190 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLH--s~gIvHrDLKP~NILld--~~g~vkL~D 190 (627)
+...+..||||||++|+|.+.+.......+++..+..++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 125 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred eccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999999999999988755577999999999999999999999 57999999999999995 478899999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ......||+.|+|||++.+ .+++.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 205 FG~a~~~~~------~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 205 FGSSCQLGQ------RIYQYIQSRFYRSPEVLLG---MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CTTCEETTC------CCCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccCceeccc------ccccccCCccccChHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999987632 2345689999999999974 3689999999999999999999999999988887776654322
Q ss_pred CCC----------------CCC------------------C----------------------------CCHHHHHHHHH
Q 006887 271 IPP----------------IPS------------------G----------------------------LPPAVENVLLG 288 (627)
Q Consensus 271 ~~~----------------~p~------------------~----------------------------~s~~l~~li~~ 288 (627)
.++ ++. . .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 110 000 0 01478999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 289 CFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 289 cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
||+.||++|||+.++|+ |+||...
T Consensus 356 mL~~dP~~Rpta~e~L~------hp~f~~~ 379 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQ------HSFFKKT 379 (382)
T ss_dssp HTCSCTTTSCCHHHHTT------SGGGCC-
T ss_pred hcCCChhhCCCHHHHhc------CcccccC
Confidence 99999999999999998 9998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.28 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=210.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..++. .||+|+++............++. .++..++||||++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~va~K~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIREL-QVLHECNSPYIVGFYGA 99 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEECCCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCc------EEEEEEeccccCHHHHHHHHHHH-HHHHHCCCCCEEEEeEE
Confidence 345667899999999999999999999876664 89999998764433333333332 24566799999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCC
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+..++..|+||||++| +|.+.+.. .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||
T Consensus 100 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 100 FYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEECCEEEEEEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECC
Confidence 9999999999999985 77777753 35699999999999999999999996 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH----------
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY---------- 262 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~---------- 262 (627)
+++.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..++.
T Consensus 178 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 178 VSGQLID-----SMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp CCHHHHH-----HC----CCCCTTCCHHHHTT---CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred CCccccc-----ccccCCCCCCCeECHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 9976543 12234589999999999974 46899999999999999999999999876654432
Q ss_pred --------------------------------HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 263 --------------------------------DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 263 --------------------------------~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..+.........+..++.++.+||.+||+.||++||++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~----- 324 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV----- 324 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT-----
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh-----
Confidence 2222222222223458999999999999999999999999998
Q ss_pred ccccCCCCCC
Q 006887 311 QNSVHSDGGW 320 (627)
Q Consensus 311 ~~~~~~~~~w 320 (627)
|+|+....+
T Consensus 325 -hp~~~~~~~ 333 (360)
T 3eqc_A 325 -HAFIKRSDA 333 (360)
T ss_dssp -SHHHHHHHH
T ss_pred -ChHhhcchH
Confidence 888765544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.65 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=208.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..++. .||+|++..........+..+. .++..++||||+++++++..++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~e~--~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGA------LAAAKVIETKSEEELEDYIVEI--EILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCC------EEEEEEEC----CCHHHHHHHH--HHHHHCCCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCc------EEEEEEecCCCHHHHHHHHHHH--HHHhcCCCCCEeeeeeeeeeCC
Confidence 3689999999999999999999877654 8999999765544444333332 2456679999999999999999
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIML-ELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CEEEEEECCTTEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999996 5544443 345679999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCCC
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI-PPIP 275 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~-~~~p 275 (627)
.. ........||+.|+|||++... ....++.++|+|||||++|+|++|..||...+..+....+...... ...+
T Consensus 169 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 169 KT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 11 1112345799999999998421 1346889999999999999999999999998888777666554322 2245
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
..++.++.++|.+||+.||.+||++.++++ |+|+....+
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~ 284 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE------HPFVSSITS 284 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT------STTTTTCCC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhc------ChHHhhhcc
Confidence 678999999999999999999999999988 999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=353.42 Aligned_cols=268 Identities=19% Similarity=0.298 Sum_probs=209.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..+++. -...||+|.+.............++. .++..++||||++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~iK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGI 85 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCS--CCEEEEEEEECCCSSCCCHHHHHHHH-HHHTTCCBTTBCCCCEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCce--EEEEEEEEeeccccCHHHHHHHHHHH-HHHHhCCCCCeeEEEEE
Confidence 3446778999999999999999999998776642 12346888886543322222222222 35677899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+..++ .++||+|+. |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EecCC-ceEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 98655 788889888 577777764 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+.. ....
T Consensus 164 a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-~~~~ 238 (327)
T 3lzb_A 164 AKLLGAEEK-EYHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERL 238 (327)
T ss_dssp -----------------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCC
T ss_pred eeEccCccc-cccccCCCccccccCHHHHcC---CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 987643221 222234567889999999974 468999999999999999999 9999999888887766654 4456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+.+..++.++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 6788899999999999999999999999999999988653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=353.03 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=197.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC-
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING- 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~- 119 (627)
++|++.+.||+|+||.||+|++..++. .||||+++............++. .+++.++||||+++++++...+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDC------NYAIKRIRLPNRELAREKVMREV-KALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCC------EEEEEEEECCSTTTHHHHHHHHH-HHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCc------EEEEEEeecCCchhHHHHHHHHH-HHHHhCCCCCEeeEEEEEEEecc
Confidence 479999999999999999999876664 89999997654433333333333 2566779999999999986543
Q ss_pred --------------------------------------------------------EEEEEEecCCC-CHHHHHHHhcC-
Q 006887 120 --------------------------------------------------------KICIIMKFYEG-SVGDRMAQLKG- 141 (627)
Q Consensus 120 --------------------------------------------------------~~~LVmEy~~G-sL~d~l~~~~~- 141 (627)
..|+||||++| +|.+.+.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 38999999995 77777754322
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCC---------CCCCCccCC
Q 006887 142 GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLP---------SSDLPRRLG 212 (627)
Q Consensus 142 ~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~---------~~~~~~~~G 212 (627)
...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ........|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 34566778999999999999999999999999999999999999999999999877543211 112345679
Q ss_pred CCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhc
Q 006887 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEY 292 (627)
Q Consensus 213 T~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~ 292 (627)
|+.|+|||++.+ ..++.++|+|||||++|||++|..|+.. ..+....+.. ...+..+...++++.+||.+||+.
T Consensus 239 t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 239 TKLYMSPEQIHG---NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp CGGGSCHHHHHC---CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCS
T ss_pred CcCccChHHhcC---CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc-cCCCcccccCChhHHHHHHHHccC
Confidence 999999999974 4689999999999999999998776421 1222222222 122222345678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccccCCC
Q 006887 293 DLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 293 dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
||.+||++.++++ |+||..
T Consensus 313 ~p~~Rps~~~~l~------~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIE------NAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHH------STTCCC
T ss_pred CCCcCCCHHHHhh------chhhhc
Confidence 9999999999998 888764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=377.95 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=214.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++.+... .....+.. +. .+++.++||||+++++++.
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~-E~-~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQ------ECAVKVISKRQVKQKTDKESLLR-EV-QLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCBSSCHHHHHH-HH-HHHTTCCCTTBCCEEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCC------EEEEEEEEhhhcccchHHHHHHH-HH-HHHHhCCCCCCCcEEEEEE
Confidence 4689999999999999999999887664 899999965432 22222222 22 2567779999999999999
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCC
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVG 192 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFG 192 (627)
..+..|+||||+. |+|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999998 57777765 45679999999999999999999999999999999999999 567899999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+++.+.. .......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+.......
T Consensus 175 ~a~~~~~----~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 175 LSTHFEA----SKKMKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp HHHHBCC----CCSHHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eeEEccc----ccccccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9987643 122345689999999999863 58899999999999999999999999999999998887765444
Q ss_pred CCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 PIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+ ..+++++++||.+||+.||.+||++.++++ |+|+...
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~------h~~~~~~ 288 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD------HEWIQTY 288 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh------Chhhccc
Confidence 433 568999999999999999999999999998 8887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.77 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=185.2
Q ss_pred CeEEE---eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLR---HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~---~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+|++. +.||+|+||.||+|++..+++ .||||++.+..... ..++...+..+.+||||+++++++.+.
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~----~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQ------AFAVKIISKRMEAN----TQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCC------EEEEEEEEGGGHHH----HHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCC------EEEEEEEChhhhhh----HHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 46665 779999999999999887664 89999997543222 223333444555699999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---CeeeccCCcc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vkL~DFGla 194 (627)
+..||||||++| +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred CEEEEEEEccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 999999999985 7777775 346799999999999999999999999999999999999998766 7999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-------VDEIYDAVVR 267 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-------~~e~~~~i~~ 267 (627)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+ ..+++..+..
T Consensus 157 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~ 230 (325)
T 3kn6_A 157 RLKPPD---NQPLKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230 (325)
T ss_dssp EECCC----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred eecCCC---CCcccccCCCcCccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence 865432 223345689999999999974 468999999999999999999999998643 3455655543
Q ss_pred ccCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 268 RQEIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 268 ~~~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
...... ....+++++.+||.+||+.||.+||++.++++ |+|+...
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~------h~w~~~~ 277 (325)
T 3kn6_A 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY------NEWLQDG 277 (325)
T ss_dssp TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT------CGGGCTT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc------ChhhccC
Confidence 322111 11368999999999999999999999999987 9988653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.96 Aligned_cols=261 Identities=18% Similarity=0.165 Sum_probs=199.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
...++|++.+.||+|+||.||+|++..++. .||||++........ .+.... ..+..++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~-~~~~~~--~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGM------SVAIKKVIQDPRFRN-RELQIM--QDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCC------EEEEEEEECCTTCCC-HHHHHH--HHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEecCccccH-HHHHHH--HHHHhcCCCCcccHHHhhhc
Confidence 445799999999999999999999877664 899999865433221 111211 12345689999999999876
Q ss_pred CC-------EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecccCCCcEEEec-CCC
Q 006887 118 NG-------KICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLH--SKGILVLNLKPFNFILNE-ADR 185 (627)
Q Consensus 118 ~~-------~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLH--s~gIvHrDLKP~NILld~-~g~ 185 (627)
.+ ..|+||||++|++.+.+... ....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 33 38999999999887766542 4567899999999999999999999 999999999999999997 899
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
+||+|||+++..... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 171 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS----EPNVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp EEECCCTTCBCCCTT----SCCCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEeeCCCceecCCC----CCcccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 999999999876432 223456799999999998642 34889999999999999999999999999888777666
Q ss_pred HhccCC------------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 266 VRRQEI------------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 266 ~~~~~~------------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
...... ...+..+++++.+||.+||+.||.+||++.++++ |+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~f 318 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC------HPYF 318 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT------SGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc------Cccc
Confidence 542111 1122346789999999999999999999999998 9998
Q ss_pred CCCC
Q 006887 316 SDGG 319 (627)
Q Consensus 316 ~~~~ 319 (627)
....
T Consensus 319 ~~~~ 322 (360)
T 3e3p_A 319 DELH 322 (360)
T ss_dssp GGGG
T ss_pred cccC
Confidence 8653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.37 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=192.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
....+..++|++.+.||+|+||.||+|.+..+++ .||||+++.............+...+++..+||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQ------IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTE------EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCC------EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 3556788999999999999999999999876654 8999999865443333333333334667789999999999
Q ss_pred EEEECCEEEEEEecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeec
Q 006887 114 ISVINGKICIIMKFYEGSVGDRMAQL---KGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~GsL~d~l~~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~ 189 (627)
++...+..|+||||++|++.+.+... ....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence 99999999999999999888777642 257899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCC-CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE-VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVR 267 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~ 267 (627)
|||+++..... .......||+.|+|||++... ....++.++|+|||||++|+|++|+.||.+.+.. +.+..+..
T Consensus 169 Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 169 DFGISGQLVDS----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp CCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred cCCCceecccc----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 99999876432 122344799999999998432 1346889999999999999999999999875422 22222211
Q ss_pred ccCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 268 RQEIPPI----PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 268 ~~~~~~~----p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
...+.+ ...+++++.+||.+||+.||++||++.++++ |+|+.
T Consensus 245 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~------hp~~~ 290 (327)
T 3aln_A 245 -GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK------HPFIL 290 (327)
T ss_dssp -SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT------SHHHH
T ss_pred -CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh------ChHHH
Confidence 111222 2468999999999999999999999999987 66654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.67 Aligned_cols=264 Identities=15% Similarity=0.165 Sum_probs=198.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHH-------HHHHHHHhcCCCCc
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLER-------LNDLFLKCQGVEGI 108 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~-------~~~~ll~~~~hpnI 108 (627)
+..++|++.+.||+|+||.||+|++..++. .+..||||++......... ....+ .+...+..+.||||
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPE---KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCG---GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCC---ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 456799999999999999999999876322 3458999999765432111 11111 01124567799999
Q ss_pred eeeEEEEEE----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC
Q 006887 109 CWLQGISVI----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 109 v~l~~~~~~----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g 184 (627)
+++++++.. .+..||||||+.|+|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred ceeecccccccCCCcEEEEEEeccCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 999999988 788999999996687777653 23799999999999999999999999999999999999999887
Q ss_pred --CeeeccCCccccccCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC--
Q 006887 185 --RAVLGDVGIPHLLLGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-- 256 (627)
Q Consensus 185 --~vkL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-- 256 (627)
.+||+|||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG---VALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 9999999999876432211 111245689999999999974 36899999999999999999999999652
Q ss_pred CHHHHHHHHHhccCCCCCC---------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 257 SVDEIYDAVVRRQEIPPIP---------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p---------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+........... ...++ ..+++++.++|.+||+.||++||++.++++.|+...
T Consensus 266 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 266 DPVAVQTAKTNL--LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp CHHHHHHHHHHH--HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred ccHHHHHHHHhh--cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 332222211111 11122 278999999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=377.51 Aligned_cols=262 Identities=21% Similarity=0.359 Sum_probs=220.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.+..++|++.+.||+|+||.||+|++..++ ..||||+++..... ...+..+ . .+++.++||||++++++
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~vavK~~~~~~~~-~~~~~~E-~-~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTME-VEEFLKE-A-AVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGT------EEEEEEECCSSSSC-HHHHHHH-H-HHHHHCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCC------eEEEEEEecCcccc-hHHHHHH-H-HHHHhcCCCCEeeEEEE
Confidence 45677889999999999999999999987655 48999999765433 2223332 2 25566799999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+...+..||||||++ |+|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 998899999999998 6888888765557799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........+|+.|+|||++.+ +.++.++|||||||++|||++ |..||.+.+..++...+.. ....
T Consensus 365 a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~ 438 (495)
T 1opk_A 365 SRLMTGDT--YTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRM 438 (495)
T ss_dssp EECCTTCC--EECCTTCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCC
T ss_pred ceeccCCc--eeecCCCcCCcceeCHhHHhc---CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 98764321 112234467889999999973 468899999999999999999 9999999988888776654 3455
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..|..+++++.+||.+||+.||.+||++.++++.|+.+.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 678899999999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=341.94 Aligned_cols=260 Identities=21% Similarity=0.256 Sum_probs=207.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||||+++............++. .+++.++||||+++++++...+.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEGGGCTTHHHHHHHHH-HHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCc------EEEEEEeeeccchhhhHHHHHHH-HHHHhcCCCCceeeeeEEEcCCE
Confidence 579999999999999999999876654 89999997544333222233332 24567799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp EEEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EEEEEEecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999986 6666553 345799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~p~~~ 278 (627)
... ........||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+.. ..+..+............+
T Consensus 158 ~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (276)
T 2yex_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (276)
T ss_dssp TTE-ECCBCCCCSCGGGCCGGGGTCS--SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred Ccc-hhcccCCccccCccChHHHhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhc
Confidence 211 1223456899999999998743 12477899999999999999999999876543 3333343333233334578
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
++.+.++|.+||+.||.+||++.++++ |+||...
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~~ 268 (276)
T 2yex_A 235 DSAPLALLHKILVENPSARITIPDIKK------DRWYNKP 268 (276)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTTCC
T ss_pred CHHHHHHHHHHCCCCchhCCCHHHHhc------CccccCh
Confidence 999999999999999999999999988 8887643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=351.71 Aligned_cols=264 Identities=19% Similarity=0.204 Sum_probs=204.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++.+.||+|+||.||+|++..+++ .||||+++............++. .+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREF-EVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHH-HHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHH-HHHHhcCCCCcceEEEEeec
Confidence 345789999999999999999999887664 89999997644322222222222 25566789999999999887
Q ss_pred CC--EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE----ecCCCeeec
Q 006887 118 NG--KICIIMKFYE-GSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL----NEADRAVLG 189 (627)
Q Consensus 118 ~~--~~~LVmEy~~-GsL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl----d~~g~vkL~ 189 (627)
.+ ..||||||++ |+|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 55 7899999998 577777764332 349999999999999999999999999999999999999 777789999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCC-----CCCCCCccCcchhHHHHHHHHHhCCCCCCCCC----HHH
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE-----VRGPISFETDSWGFACSIIEMLTGVQPRCGRS----VDE 260 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-----~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~----~~e 260 (627)
|||+++..... .......||+.|+|||++... ....++.++|||||||++|||++|+.||.... ..+
T Consensus 159 Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 159 DFGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred cCCCceecCCC----CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999876442 223456799999999997521 12468899999999999999999999997432 244
Q ss_pred HHHHHHhccCCC-----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 261 IYDAVVRRQEIP-----------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 261 ~~~~i~~~~~~~-----------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
++..+....... .++..+++.+.++|.+||+.||++||++.++++......|
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 555554433211 1223456788999999999999999999999996665444
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=348.49 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=195.5
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++|++.+.||+|+||.||+|++..++. .||||++..................+++..+||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGH------VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCC------EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCe------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 34566899999999999999999999876654 899999986544332222222333456778999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..++..|+||||+++.+ +.+.......+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 94 ITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp ECSSEEEEEECCCSEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCcEEEEEeccCCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999999995544 444444567899999999999999999999995 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGR-SVDEIYDAVVRRQEI 271 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-~~~e~~~~i~~~~~~ 271 (627)
+..... .......||+.|+|||++.+. ....++.++|||||||++|+|++|+.||... ...+.+..+.... .
T Consensus 173 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 247 (318)
T 2dyl_A 173 GRLVDD----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-P 247 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-C
T ss_pred hhccCC----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-C
Confidence 765432 222345799999999998532 1346888999999999999999999999874 4555665555433 2
Q ss_pred CCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 PPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ~~~p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+..+ ..+++++.++|.+||+.||.+||++.++++ |+|+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~------h~~~~ 288 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE------HSFIK 288 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT------SHHHH
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh------CHHHH
Confidence 2233 468999999999999999999999999987 66654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=368.97 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=197.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-------HHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-------RMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-------~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
.++|++.+.||+|+||.||+|.+..+++ .||||++.+.... .......++. .+++.++||||++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIRIISKRKFAIGSAREADPALNVETEI-EILKKLNHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEGGGGTTC--------CCHHHHH-HHHHHCCCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCc------EEEEEEEEechhcccccccchhHHHHHHHH-HHHHhCCCCCEeeEE
Confidence 3689999999999999999999887764 8999999754311 0011112222 255667999999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC---Ceee
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD---RAVL 188 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g---~vkL 188 (627)
+++. .+..|+||||++| +|.+.+. ..+.+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||
T Consensus 207 ~~~~-~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 207 NFFD-AEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EEEE-SSEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence 9975 5678999999985 6666553 456799999999999999999999999999999999999997544 5999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVR 267 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~ 267 (627)
+|||+++.... .......+||+.|||||++.+.....++.++|+|||||++|+|++|.+||.+.... .+...+..
T Consensus 284 ~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp CCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred eecccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 99999987643 22334568999999999986433457889999999999999999999999875443 33333333
Q ss_pred ccCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 268 RQEI--PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 268 ~~~~--~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
.... +..+..+++.+.+||.+||+.||++||++.++++ |+|+...+|
T Consensus 360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~~~~~ 408 (419)
T 3i6u_A 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQDEDM 408 (419)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGCCHHH
T ss_pred CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC------CcccCChhH
Confidence 2211 1122578999999999999999999999999998 999876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=345.28 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=200.5
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.....++|++.+.||+|+||.||+|++..++ +.||+|++........ .....++. ..+..++||||+++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRE------RIVALKLMSETLSSDPVFRTRMQREA-RTAGRLQEPHVVPIHD 101 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTT------EEEEEEECGGGGGGSHHHHHHHHHHH-HHHTTCCCTTBCCEEE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCC------eEEEEEecCcccccCHHHHHHHHHHH-HHHhhcCCCCeeEEEE
Confidence 3345689999999999999999999987665 4899999976533221 12222222 2566789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++..++..|+||||++| +|.+.+.. .+++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 99999999999999996 77777653 3579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI- 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~- 271 (627)
++....... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+...+...+......
T Consensus 180 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (309)
T 2h34_A 180 IASATTDEK--LTQLGNTVGTLYYMAPERFSE---SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRP 254 (309)
T ss_dssp C------------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCG
T ss_pred cCccccccc--cccccccCCCcCccCHHHHcC---CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCc
Confidence 987654321 122335679999999999974 46888999999999999999999999987766554444332221
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRP-LMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RP-s~~eil~~L~~~~ 311 (627)
...+..+|+++.++|.+||+.||++|| ++.++++.|+...
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 235678999999999999999999999 9999999888753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=373.41 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=209.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH------------HHHHHHHHHHHHHHhcCCCC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR------------MRVLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~------------~~~~~~~~~~~ll~~~~hpn 107 (627)
.++|++++.||+|+||.||+|++..++. .||||++.+..... ......++. .+++.++|||
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpn 107 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHS------EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI-SLLKSLDHPN 107 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCC------EEEEEEEEC----------------CTHHHHHHHH-HHHHTCCCTT
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCc------EEEEEEEEhhhcccccccccchhhHHHHHHHHHHH-HHHHhCCCCC
Confidence 3689999999999999999999887664 89999997643211 111222222 2566779999
Q ss_pred ceeeEEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC--
Q 006887 108 ICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-- 184 (627)
Q Consensus 108 Iv~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-- 184 (627)
|+++++++...+..||||||++| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence 99999999999999999999985 77777754 35799999999999999999999999999999999999998776
Q ss_pred -CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 006887 185 -RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263 (627)
Q Consensus 185 -~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~ 263 (627)
.+||+|||+++..... ......+||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.+..+++.
T Consensus 186 ~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257 (504)
T ss_dssp SSEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6999999999876432 2334568999999999985 358899999999999999999999999999999998
Q ss_pred HHHhccCCCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 264 AVVRRQEIPPI--PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 264 ~i~~~~~~~~~--p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.+.......+. ...+++++++||.+||+.||.+||++.++++ |+|+..
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~------h~~~~~ 307 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN------SRWIKK 307 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHH
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc------CHhhhh
Confidence 88765433322 2678999999999999999999999999998 887653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.66 Aligned_cols=257 Identities=18% Similarity=0.173 Sum_probs=203.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHH-----hcCCCCceeeEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-----CQGVEGICWLQGI 114 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~-----~~~hpnIv~l~~~ 114 (627)
.++|++.+.||+|+||.||+|.+.... ++.||||+++...... .. ...+..++.. ...|+++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~vavK~~~~~~~~~-~~-~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAG-----GRHVAVKIVKNVDRYC-EA-ARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT-----TEEEEEEEECSSHHHH-HH-HHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCC-----CcEEEEEEEecCCchh-HH-HHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 468999999999999999999984322 2589999997543221 11 1222222211 2345569999999
Q ss_pred EEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec------------
Q 006887 115 SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE------------ 182 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~------------ 182 (627)
+...+..|+||||+.++|.+.+......++++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 86 FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999999999999999987655567999999999999999999999999999999999999987
Q ss_pred -------CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 006887 183 -------ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255 (627)
Q Consensus 183 -------~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~ 255 (627)
++.++|+|||+++.... ......||+.|+|||++.+ ..++.++|+|||||++|||++|..||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVILA---LGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCcc------ccccccCCccccChHHhhC---CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 66899999999986432 2345689999999999974 3689999999999999999999999998
Q ss_pred CCHHHHHHHHHhccCCC------------------------------------------CCCCCCCHHHHHHHHHhhhcC
Q 006887 256 RSVDEIYDAVVRRQEIP------------------------------------------PIPSGLPPAVENVLLGCFEYD 293 (627)
Q Consensus 256 ~~~~e~~~~i~~~~~~~------------------------------------------~~p~~~s~~l~~li~~cL~~d 293 (627)
.+..+....+....... ..+...++++.+||.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 88776555443221110 011234578999999999999
Q ss_pred CCCCCCHHHHHHHHHhcccccCCCC
Q 006887 294 LRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 294 P~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|.+||++.++++ |+||...
T Consensus 317 P~~Rpt~~ell~------hp~f~~~ 335 (339)
T 1z57_A 317 PAKRITLREALK------HPFFDLL 335 (339)
T ss_dssp TTTSCCHHHHTT------SGGGGGG
T ss_pred cccccCHHHHhc------CHHHHHH
Confidence 999999999998 8887643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=342.92 Aligned_cols=261 Identities=20% Similarity=0.352 Sum_probs=198.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
..++|++.+.||+|+||.||+|.+..++ ..||||+++.... ........++. ..++.++||||+++++++.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDG------VPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTC------CEEEEEEECTTSSCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCC------ceEEEEeeehhhccCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEE
Confidence 4568999999999999999999987665 4899999975332 11122222222 3566789999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
.++..++||||++| +|.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 99999999999995 777777543 346799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR--SVDEIYDAVVRRQEI 271 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~--~~~e~~~~i~~~~~~ 271 (627)
++..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+. +..++...+......
T Consensus 183 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 183 GRFFSSK---TTAAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256 (310)
T ss_dssp -------------------CCSSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred eeeecCC---CccccccCCCeeEeChHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence 8765432 122234579999999999874 46889999999999999999999999764 344555555444333
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+..+..+++++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 33346789999999999999999999999999999988654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.58 Aligned_cols=268 Identities=18% Similarity=0.267 Sum_probs=207.6
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
...++.++|++.+.||+|+||.||+|++..... .+..||+|+++...... ...+.. +. ..+..++||||++++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLS-EA-ACMKDFSHPNVIRLL 102 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS---CEEEEEEEEC---CCCHHHHHHHHH-HH-HHHHTCCCTTBCCCC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCC---ceeEEEEEEEeccccchhHHHHHHH-HH-HHHhcCCCCCeeeee
Confidence 556788999999999999999999998765432 34689999997653322 222222 22 356778999999999
Q ss_pred EEEEECC-----EEEEEEecCCC-CHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 113 GISVING-----KICIIMKFYEG-SVGDRMAQL----KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 113 ~~~~~~~-----~~~LVmEy~~G-sL~d~l~~~----~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
+++...+ ..++||||++| +|.+.+... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 9987654 35999999995 777776432 3367999999999999999999999999999999999999999
Q ss_pred CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHH
Q 006887 183 ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEI 261 (627)
Q Consensus 183 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~ 261 (627)
++.++|+|||+++....... ........+|+.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..++
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp TSCEEECSCSCC-----------------CCGGGSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCcEEEeecCcceecccccc-cCcccccCCCccccCchhhcC---CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 99999999999987643221 122234568899999999974 468899999999999999999 9999999888888
Q ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 262 ~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...+... ..+..+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 259 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 8777654 3556788899999999999999999999999999999887653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=341.46 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=214.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
++.+..++|++.+.||+|+||.||+|.+... ..||+|+++...... ..+.. +. .+++.++||||++++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~vavK~~~~~~~~~-~~~~~-E~-~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSMSP-DAFLA-EA-NLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSSCH-HHHHH-HH-HHHHHCCCTTBCCEEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCC-------cEEEEEEecCCcccH-HHHHH-HH-HHHHhCCCcCcceEEEE
Confidence 5567778999999999999999999986532 379999997654332 22222 22 24566799999999998
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+. ++..++||||++ |+|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 86 456899999997 5777776543334799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........+|+.|+|||++.+ +.++.++|+|||||++|||++ |+.||.+.+..++...+... ...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~ 229 (279)
T 1qpc_A 156 ARLIEDNE--YTAREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRM 229 (279)
T ss_dssp CEECSSSC--EECCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCC
T ss_pred cccccCcc--cccccCCCCccCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCC
Confidence 98764322 112234567889999999873 468889999999999999999 99999999988888777644 345
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+..+++++.+++.+||+.||++||++.++++.|+....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 5678899999999999999999999999999998887543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.45 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=208.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|++.+.||+|+||.||+|++..++. .||||+++............++. .++..++||||+++++++..++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEETTTCSTTHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCc------EEEEEEecccccHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCCe
Confidence 569999999999999999999876654 89999997654322222223332 24566799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.|+||||++| +|.+.+ ..+++++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 95 ~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEEECCTTEEHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEEEEeCCCCcHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999996 666655 346799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
.. .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+... ..+.++..++
T Consensus 172 ~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 244 (303)
T 3a7i_A 172 TQ---IKRNTFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYS 244 (303)
T ss_dssp TB---CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSSCC
T ss_pred cc---cccCccCCCcCccCHHHHhc---CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccccC
Confidence 22 12245679999999999974 46888999999999999999999999998888777666543 3556778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
..+.+||.+||+.||.+||++.++++
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999999988
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=368.60 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=212.5
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+..++|++.+.||+|+||.||+|.+..+ ..||||+++...... ..+.. +. .+++.++||||+++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~~~-~~~~~-E~-~~l~~l~hp~iv~~~~ 246 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMSP-EAFLQ-EA-QVMKKLRHEKLVQLYA 246 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-------EEEEEEECCTTSSCH-HHHHH-HH-HHHHHCCCTTBCCEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCC-------ceEEEEEeccCCCCH-HHHHH-HH-HHHHhCCCCCEeeEEE
Confidence 34568889999999999999999999998653 369999998654322 22222 22 2566779999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++.. +..||||||++ |+|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 247 ~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 9865 67899999998 588888865455679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... ........+|+.|+|||++. .+.++.++|||||||++|||++ |+.||.+.+..++...+... ..
T Consensus 326 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 399 (452)
T 1fmk_A 326 LARLIEDNE--YTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR 399 (452)
T ss_dssp TTC----------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred cceecCCCc--eecccCCcccccccCHhHHh---cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 998764321 11223446788999999987 3468999999999999999999 99999999998888877644 35
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.|..+++.+.+||.+||+.||++||++.++++.|+...
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 5678899999999999999999999999999999988753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=342.02 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=206.9
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|++.+.||+|+||.||+|++..+++ .||+|++....... .......+. ..++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGK------ILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEECTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCc------EEEEEEEEcccCCHHHHHHHHHHH-HHHHhcCCCCCCeEEEEEecC
Confidence 4689999999999999999999876654 89999997654322 222222222 24566799999999998865
Q ss_pred -CCEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccCCCcEEEecCCCeee
Q 006887 118 -NGKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKG-----ILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 118 -~~~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~g-----IvHrDLKP~NILld~~g~vkL 188 (627)
++..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 5789999999985 8888776532 356999999999999999999999999 999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+++..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..++...+...
T Consensus 158 ~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~ 231 (279)
T 2w5a_A 158 GDFGLARILNHD---TSFAKTFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231 (279)
T ss_dssp CCCCHHHHC------CHHHHHHHSCCTTCCHHHHHC---C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ecCchheeeccc---cccccccCCCccccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc
Confidence 999999875321 111124579999999999974 36889999999999999999999999999888888777654
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
. .+.++..+++++.++|.+||+.||.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 232 K-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 3 45677889999999999999999999999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.03 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=204.2
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++........ .....++. .+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE------KVAIKKLSRPFQSEIFAKRAYREL-LLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEESSTTSSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCC------EEEEEEecccccchHHHHHHHHHH-HHHHhcCCCCcccHhheEecc
Confidence 4789999999999999999999877664 899999976433221 11222222 356677899999999999765
Q ss_pred CE------EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 GK------ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~~------~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+. .|+||||++|+|.+.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred cccccceeEEEEeccccCCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 43 4999999999776554 2459999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-- 270 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-- 270 (627)
+++.... ......||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 172 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 172 LARHADA------EMTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp CTTC--------------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred cccCCCC------CccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9976532 23456899999999998742 3688999999999999999999999999887766655543210
Q ss_pred ---------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 271 ---------------------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 271 ---------------------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
....+..+++++.+||.+||+.||++||++.++++ |+||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~------hp~f~~~~ 313 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT------HPFFEPFR 313 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTTTC
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc------Ccchhhcc
Confidence 11234578999999999999999999999999998 99987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.95 Aligned_cols=264 Identities=17% Similarity=0.262 Sum_probs=211.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.|++.+.||+|+||.||+|++..+.. .+..||+|++.............++. .+++.++||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREG-LLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEecCCCC
Confidence 57778999999999999999765543 34579999997654433322222322 356677999999999999765554
Q ss_pred -EEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 122 -CIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 122 -~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
++||||+. |+|.+.+.. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999997 577776643 457789999999999999999999999999999999999999999999999999986543
Q ss_pred CCC-CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 006887 200 IPL-PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277 (627)
Q Consensus 200 ~~~-~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~~ 277 (627)
... .........||+.|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..++...+... .....+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 252 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT---YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQPEY 252 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-CCCCCCTT
T ss_pred CcccccccCcCCCCCccccChhhhcc---CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-CCCCCCcc
Confidence 221 1223345678999999999974 468899999999999999999 56667677777766666543 45566888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 278 ~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
+++++.+++.+||+.||.+||++.++++.|+++...+
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=344.51 Aligned_cols=265 Identities=18% Similarity=0.266 Sum_probs=209.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE-ECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV-ING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~-~~~ 119 (627)
.+|++.+.||+|+||.||+|++..++. ....||+|.+.............++. .+++.++||||+++++++. .++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHH-HHHHhCCCCCEeeeeeEEEcCCC
Confidence 469999999999999999999765432 23469999998654433322223322 3567789999999999864 456
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 78999999996 77777643 45678999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC-CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 199 GIPLP-SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 199 ~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
..... ........||+.|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+... .....+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 255 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPE 255 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-CCCCCCT
T ss_pred ccchhccccccCCCCCccccChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-CCCCCCc
Confidence 32211 122335578899999999974 468899999999999999999 77788887777776666543 3455678
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
.+++++.+++.+||+.||.+||++.++++.|+.+...+
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999999876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.83 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=192.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++++.||+|+||.||+|.+..+++ .||||++...... ...... ++. .+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~-~E~-~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTY-REL-RLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTE------EEEEEECSSTTSSHHHHHHHH-HHH-HHHHHCCCTTBCCCSEEECS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCC------EEEEEEeCccccCHHHHHHHH-HHH-HHHHhCCCCCCCcEEEEEec
Confidence 4789999999999999999999877664 8999999764322 222222 222 25667789999999999865
Q ss_pred C------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 118 N------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 118 ~------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
. +..|+||||+.++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CSSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CCccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 3 56899999998888777643 57999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++.... ......||+.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 177 G~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 177 GLARHTAD------EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp --------------------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred cccccccc------cCCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99986532 23456899999999998742 46889999999999999999999999998887766665542111
Q ss_pred C---------------------C--------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 272 P---------------------P--------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 272 ~---------------------~--------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
+ . ....+++++.+||.+||+.||.+||++.++++ |+||....
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~------hp~~~~~~ 319 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFAQYH 319 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTTTC
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc------Chhhhhcc
Confidence 1 0 11357899999999999999999999999998 99987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.92 Aligned_cols=271 Identities=21% Similarity=0.260 Sum_probs=196.1
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
+..+..++|++.+.||+|+||.||+|++..+++ .||||++.............++. ..+..++||||++++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~ 81 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKE------KVAIKRINLEKCQTSMDELLKEI-QAMSQCHHPNIVSYYTS 81 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----C------EEEEECCC-----------------CCCCCCCTTBCCEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCc------EEEEEEEEhhhcchhHHHHHHHH-HHHhhcCCCCEeeEEEE
Confidence 566888999999999999999999999766553 89999987543322211112221 23556789999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCee
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQL------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vk 187 (627)
+...+..|+||||++ |+|.+.+... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEE
Confidence 999999999999997 5777777542 245699999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCC--CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 006887 188 LGDVGIPHLLLGIPL--PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAV 265 (627)
Q Consensus 188 L~DFGla~~~~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i 265 (627)
|+|||++........ .........||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||...+..+.....
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHH--HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccc--cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 999999977643211 11122356799999999998631 25788999999999999999999999987776665544
Q ss_pred HhccCC--------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 266 VRRQEI--------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 266 ~~~~~~--------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
...... ......+++++.++|.+||+.||.+||++.++++ |+||....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~~~ 296 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR------HKFFQKAKN 296 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT------STTC-----
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh------ChhhhcCCC
Confidence 432211 1234578899999999999999999999999998 998876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=344.90 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=197.0
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH-HHhcCCCCceeeEEEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF-LKCQGVEGICWLQGISVI 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l-l~~~~hpnIv~l~~~~~~ 117 (627)
-.++|++.+.||+|+||.||+|++. + +.||||++....... ...+ .+++ ...++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~------~~vavK~~~~~~~~~---~~~e-~~~~~~~~l~h~niv~~~~~~~~ 73 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ--G------ENVAVKIFSSRDEKS---WFRE-TELYNTVMLRHENILGFIASDMT 73 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET--T------EEEEEEEECGGGHHH---HHHH-HHHHHHTCCCCTTBCCEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC--C------EEEEEEEeccccchh---hHHH-HHHHHHhhccCcCeeeEEEeecc
Confidence 3578999999999999999999863 2 479999997543322 2222 2222 233799999999998765
Q ss_pred ----CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecccCCCcEEEecCC
Q 006887 118 ----NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH--------SKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 118 ----~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLH--------s~gIvHrDLKP~NILld~~g 184 (627)
.+..|+||||++| +|.+.+ ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccCCCceeEEehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 2468999999985 777766 3467999999999999999999999 99999999999999999999
Q ss_pred CeeeccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCCCCC---CCCccCcchhHHHHHHHHHhC----------C
Q 006887 185 RAVLGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEVRG---PISFETDSWGFACSIIEMLTG----------V 250 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~---~~s~~sDiwSlGviLyelltG----------~ 250 (627)
.+||+|||+++......... .......||+.|+|||++.+.... .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999998765432111 112345899999999999753211 345789999999999999999 8
Q ss_pred CCCCCCC-----HHHHHHHHHhccCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 251 QPRCGRS-----VDEIYDAVVRRQEIPPIPS-----GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 251 ~Pf~~~~-----~~e~~~~i~~~~~~~~~p~-----~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.||.... .......+......+..+. .+++++.+|+.+||+.||.+||++.++++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8986532 2233333333333333332 2567899999999999999999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.38 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=206.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh------HHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED------RMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~------~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
++|++.+.||+|+||.||+|++..+++ .||+|+++..... ....+ .++. .+++.++||||++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~-~~E~-~~l~~l~h~~i~~~~~~ 76 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGK------EYAAKFIKKRRLSSSRRGVSREEI-EREV-NILREIRHPNIITLHDI 76 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHH-HHHH-HHHHHCCCTTBCCEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCC------eeehHHhhhccccccccchHHHHH-HHHH-HHHHhCCCCCeeehhhe
Confidence 479999999999999999999877654 8999998764321 12222 2222 24566789999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----Ceeec
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLG 189 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~ 189 (627)
+...+..++||||++ ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 77 FENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred ecCCCeEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999997 577777653 35799999999999999999999999999999999999998877 89999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|||++...... .......||+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+....+....
T Consensus 155 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (283)
T 3bhy_A 155 DFGIAHKIEAG----NEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227 (283)
T ss_dssp CCTTCEECC------------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred ecccceeccCC----CcccccCCCcCccCcceecC---CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence 99999876432 22345579999999999874 468899999999999999999999999998888877775443
Q ss_pred CCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 270 EIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 270 ~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.... .+..+++.+.+++.+||+.||++||++.++++ |+|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~------h~~~~~ 271 (283)
T 3bhy_A 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE------HSWIKA 271 (283)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH------CHHHHH
T ss_pred cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh------CHHHHH
Confidence 2221 23578999999999999999999999999998 666553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.49 Aligned_cols=258 Identities=17% Similarity=0.205 Sum_probs=200.5
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh----------HHHHHHHHHHHHHHHhcCCCCce
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED----------RMRVLLERLNDLFLKCQGVEGIC 109 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~----------~~~~~~~~~~~~ll~~~~hpnIv 109 (627)
.++|++.+.||+|+||.||+|.+.. +..||||++...... .......++. .++..++||||+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv 92 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI-RLLNHFHHPNIL 92 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHH-HHHHHCCCTTBC
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHH-HHHHhCCCcCcc
Confidence 4689999999999999999998643 348999998653211 1111222222 245667899999
Q ss_pred eeEEEEEE-----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC
Q 006887 110 WLQGISVI-----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD 184 (627)
Q Consensus 110 ~l~~~~~~-----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g 184 (627)
++++++.. ....|+||||++|++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN 171 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence 99999865 337899999999999888864 445799999999999999999999999999999999999999999
Q ss_pred CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 006887 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDA 264 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~ 264 (627)
.++|+|||+++.... ........||+.|+|||++.+. ..++.++|+|||||++|+|++|+.||.+.+..+.+..
T Consensus 172 ~~kl~Dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 172 DITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CEEECCTTC-------------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CEEEEecCccccccc----ccccceecccceecCcHHhcCC--CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999975433 2223456899999999998742 3588999999999999999999999999888777766
Q ss_pred HHhccCCCC------------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 265 VVRRQEIPP------------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 265 i~~~~~~~~------------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
+......+. .+..+++.+.+||.+||+.||.+||++.++++ |+|
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~ 319 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR------HPY 319 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGG
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc------Cch
Confidence 654221111 12467899999999999999999999999998 999
Q ss_pred CCCC
Q 006887 315 HSDG 318 (627)
Q Consensus 315 ~~~~ 318 (627)
|...
T Consensus 320 f~~~ 323 (362)
T 3pg1_A 320 FESL 323 (362)
T ss_dssp GTTT
T ss_pred hhhc
Confidence 8765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.64 Aligned_cols=276 Identities=21% Similarity=0.278 Sum_probs=217.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..+++ .||||++........ ...+..++..+.++++|..+..++...+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~~~---~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE------EVAIKLENVKTKHPQ---LLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCC------EEEEEEEETTCSSCC---HHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCc------EEEEEEeccccccHH---HHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 4689999999999999999999877664 899999875443221 1223334445556678888888888999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE---ecCCCeeeccCCcccc
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL---NEADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl---d~~g~vkL~DFGla~~ 196 (627)
..||||||+.|+|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+++.
T Consensus 77 ~~~lvme~~g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEEECCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999999998898888864 45679999999999999999999999999999999999999 6889999999999988
Q ss_pred ccCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Q 006887 197 LLGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---VDEIYDAVVRRQ 269 (627)
Q Consensus 197 ~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---~~e~~~~i~~~~ 269 (627)
+...... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.. ..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 7543221 112236789999999999974 468999999999999999999999998754 334444443322
Q ss_pred CC---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc----ccccCCCCCCCCCCcccC
Q 006887 270 EI---PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS----QNSVHSDGGWTGHGSRIL 328 (627)
Q Consensus 270 ~~---~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~----~~~~~~~~~w~~~~~~~~ 328 (627)
.. ..++..+++++.+||.+||+.||++||++.++++.|+.+ .+.++...+|........
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~ 298 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC---
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccc
Confidence 11 123367899999999999999999999999999877764 345677778876554443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=377.11 Aligned_cols=266 Identities=19% Similarity=0.269 Sum_probs=211.3
Q ss_pred CCcCCCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 36 AWIKPSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 36 ~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
..+..+++.+.+ .||+|+||.||+|.+...+ .+..||||+++............++. .+++.++||||++++++
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~-~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREA-QIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHH-HHHTTCCCTTBCCEEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEE
Confidence 446677888887 8999999999999886433 23579999998654332222222332 25667899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.. +..||||||++| +|.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 405 ~~~-~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 405 CQA-EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp EES-SSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 875 569999999995 66666543 456799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++.+..............+|+.|||||++. .+.++.++|||||||++|||++ |+.||.+.+..++...+... ...
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~ 558 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECIN---FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRM 558 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhc---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 987643222122223345678999999997 3478999999999999999998 99999999988888877654 356
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..|..+++++.+||.+||+.||++||++.++++.|+....
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 6788999999999999999999999999999998887543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.53 Aligned_cols=247 Identities=17% Similarity=0.166 Sum_probs=202.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--------HHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------RMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--------~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
++|++.+.||+|+||.||+|++..++. .||||+++..... ....+. .+. .+++.++||||++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~-~E~-~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNK------EVVVKFIKKEKVLEDCWIEDPKLGKVT-LEI-AILSRVEHANIIKVL 95 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTE------EEEEEEEESTTSCTTSEEEETTTEEEE-HHH-HHHTTCCCTTBCCEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCc------EEEEEEEehhhcccccccchHHHHHHH-HHH-HHHHhCCCCCEeeEE
Confidence 579999999999999999999877664 8999999764321 111111 122 255667999999999
Q ss_pred EEEEECCEEEEEEecCC-C-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 113 GISVINGKICIIMKFYE-G-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
+++...+..++||||+. | +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999999996 4 6666664 456799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... . ...
T Consensus 174 fg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~--~~~ 239 (335)
T 3dls_A 174 FGSAAYLER----GKLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPFCELEE------T--VEA 239 (335)
T ss_dssp CTTCEECCT----TCCBCEECSCGGGCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G--TTT
T ss_pred cccceECCC----CCceeccCCCccccChhhhcCC--CCCCCcccchhHHHHHHHHHhCCCchhhHHH------H--Hhh
Confidence 999987643 2233456899999999999743 1237889999999999999999999976321 1 112
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
....+..+++++.+||.+||+.||++||++.++++ |+|+..
T Consensus 240 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~------hp~~~~ 280 (335)
T 3dls_A 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT------DPWVTQ 280 (335)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH------CTTTTC
T ss_pred ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc------CccccC
Confidence 33456778999999999999999999999999999 998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.42 Aligned_cols=269 Identities=20% Similarity=0.250 Sum_probs=207.1
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..++.++|++.+.||+|+||.||+|++..++. .||||++..........+..+ . .+++.++||||+++++++
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~E-~-~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGH------FYALKRILCHEQQDREEAQRE-A-DMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCC------EEEEEEEEESSHHHHHHHHHH-H-HHHHTCCCTTBCCCCEEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCc------EEEEEEEecCCHHHHHHHHHH-H-HHHhhcCCCCeeeEEEEE
Confidence 44677899999999999999999999876654 899999876554443333332 2 356778999999999998
Q ss_pred EE----CCEEEEEEecCCC-CHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeee
Q 006887 116 VI----NGKICIIMKFYEG-SVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 116 ~~----~~~~~LVmEy~~G-sL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL 188 (627)
.. .+..|+||||++| +|.+.+... ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 73 3478999999995 888777654 3477999999999999999999999999999999999999999999999
Q ss_pred ccCCccccccCCCCCC------CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--HHH
Q 006887 189 GDVGIPHLLLGIPLPS------SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS--VDE 260 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~------~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~--~~e 260 (627)
+|||+++......... .......||+.|+|||++.+.....++.++|||||||++|+|++|+.||.... ...
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999887643210000 00113457999999999875433347889999999999999999999996421 111
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
....+ ......+.+..+++++.++|.+||+.||.+||++.++++.|+.+..+
T Consensus 256 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 256 VALAV-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHH-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhHHh-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 22222 22333445578899999999999999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.51 Aligned_cols=270 Identities=19% Similarity=0.261 Sum_probs=211.4
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...++...|++++.||+|+||.||++.+.... ...++.||||+++............++. .+++.++||||++++++
T Consensus 25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN--DGTGEMVAVKALKADAGPQHRSGWKQEI-DILRTLYHEHIIKYKGC 101 (318)
T ss_dssp CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC----CCEEEEEEEECTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEE
T ss_pred CceecHHHHhhhheecCCCCeEEEEEEEccCC--CCCCcEEEEEEeccccChHHHHHHHHHH-HHHHhCCCcchhhEEEE
Confidence 34465566699999999999999999765432 2356789999998764433333333333 24566789999999999
Q ss_pred EEE--CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 115 SVI--NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 115 ~~~--~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+.. ...+++||||++| +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCceEEEEEecccCCcHHHHHh---hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 988 4689999999985 7766654 345999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH------------
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD------------ 259 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~------------ 259 (627)
|+++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE---YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 999876543221222345578999999999974 36888999999999999999999998753221
Q ss_pred --HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 260 --EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 260 --e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
.............+.+..+++++.+||.+||+.||.+||++.++++.|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 112223334455667889999999999999999999999999999999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.03 Aligned_cols=261 Identities=24% Similarity=0.293 Sum_probs=205.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|.....||+|+||.||+|++..++. .||||+++.........+.++. .+++.++||||+++++++...+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~--~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQV------RIAIKEIPERDSRYSQPLHEEI--ALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCC------EEEEEEEECCCC---HHHHHHH--HHHHTCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCe------EEEEEEccCCchHHHHHHHHHH--HHHHhCCCCCEeeEeeEEEeCC
Confidence 3444555689999999999999877654 8999999765543333333222 3567789999999999999999
Q ss_pred EEEEEEecCC-CCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-CCCeeeccCCcccc
Q 006887 120 KICIIMKFYE-GSVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-ADRAVLGDVGIPHL 196 (627)
Q Consensus 120 ~~~LVmEy~~-GsL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-~g~vkL~DFGla~~ 196 (627)
..++||||++ |+|.+.+..... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||+++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 9999999998 577777654322 35678999999999999999999999999999999999997 89999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~~~~~~~p 275 (627)
..... .......||+.|+|||++.+. ...++.++|+|||||++|+|++|+.||..... .............+.++
T Consensus 173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 2clq_A 173 LAGIN---PCTETFTGTLQYMAPEIIDKG-PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP 248 (295)
T ss_dssp SCC--------CCCCCCGGGCCHHHHHHG-GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC
T ss_pred cCCCC---CcccccCCCccccChhhhcCC-CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc
Confidence 64321 223356799999999998643 12378899999999999999999999976433 22233333334456778
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+++++.++|.+||+.||++||++.++++ |+|+...
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~~~~~~~ 285 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV------DEFLKVS 285 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT------SGGGCC-
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc------Chhhhhc
Confidence 899999999999999999999999999998 8887644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.84 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=206.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.++.++|++.+.||+|+||.||+|++. +..||||+++.... ...+..+. ..+..++||||++++++
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~--~~~~~~E~--~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDAT--AQAFLAEA--SVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC----HHHHHTH--HHHTTCCCTTBCCEEEE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchhH--HHHHHHHH--HHHHhCCCCCEeeEEEE
Confidence 45577899999999999999999999864 24799999976442 22222222 25667899999999998
Q ss_pred EEEC-CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 115 SVIN-GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 115 ~~~~-~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+... +..|+||||++| +|.+.+.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 7544 468999999986 88888765444458999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.... ......+|+.|+|||++.+ ..++.++|+|||||++|+|++ |+.||...+..++...+... ..
T Consensus 163 ~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~ 232 (278)
T 1byg_A 163 LTKEASS------TQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YK 232 (278)
T ss_dssp C------------------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CC
T ss_pred ccccccc------cccCCCccccccCHHHhCC---CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CC
Confidence 9876532 1233468899999999873 468899999999999999998 99999998887777666433 34
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...+..+++++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 56778899999999999999999999999999999887643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.94 Aligned_cols=272 Identities=20% Similarity=0.280 Sum_probs=213.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.-..+..++|++.+.||+|+||.||+|++.... +...++.||||++.............++. .++..++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMP-NDPSPLQVAVKTLPEVCSEQDELDFLMEA-LIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHH-HHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCC-CCCccceEEEEEeccccchhhHHHHHHHH-HHHhhCCCCCCCeEEE
Confidence 345577889999999999999999999854322 12345689999997554333222223332 2456679999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKG-----GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---AD 184 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g 184 (627)
++...+..|+||||++ |+|.+.+..... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 9998889999999997 588887765432 45899999999999999999999999999999999999984 44
Q ss_pred CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 006887 185 RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYD 263 (627)
Q Consensus 185 ~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~ 263 (627)
.++|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..++..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp CEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred eEEECccccccccccccc-cccCCCcCCCcceeCHhHhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 699999999986543221 122345578999999999873 468999999999999999998 999999998888887
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 264 ~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+... .....+..+++.+.++|.+||+.||.+||++.++++.|.....
T Consensus 257 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 77654 3455678899999999999999999999999999998886543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.63 Aligned_cols=259 Identities=19% Similarity=0.261 Sum_probs=206.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
...++|++.+.||+|+||.||+|.+..++. .||||++...... ..+..+. .++..++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~--~~~~~e~--~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ------IVAIKQVPVESDL--QEIIKEI--SIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCC------EEEEEEEETTSCC--HHHHHHH--HHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCC------EEEEEecCchHHH--HHHHHHH--HHHHhCCCCCCccEEEEEEe
Confidence 345789999999999999999999876654 8999999764422 2222222 25567799999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.+..|+||||++| +|.+.+. .....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEeecCCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999996 7766664 3567899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p 275 (627)
..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..... ....+
T Consensus 175 ~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 175 LTDTM---AKRNTVIGTPFWMAPEVIQE---IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp CBTTB---SCBCCCCSCGGGCCHHHHSS---SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred hhhhc---cccCccCCCCCccChhhcCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 64321 22335579999999999974 3688999999999999999999999998877666555443321 22345
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
..+++++.++|.+||+.||.+||++.++++ |+|+....
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~------~~~~~~~~ 286 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ------HPFVRSAK 286 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT------SHHHHTCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh------CHHHhcCC
Confidence 668999999999999999999999999988 88876553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.87 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=209.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||+|++..... .....+..+ . ..++.++||||+++++++...
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e-~-~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILRE-V-ELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGBSSSCHHHHHHH-H-HHHHTCCCTTBCCEEEEEECS
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCc------EEEEEEecccccchHHHHHHHHH-H-HHHHhccCCCccEEEEEEeCC
Confidence 579999999999999999999876654 899999865432 122222222 2 245667999999999999999
Q ss_pred CEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC---CCeeeccCCcc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA---DRAVLGDVGIP 194 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~---g~vkL~DFGla 194 (627)
+..|+||||++ ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999998 577777653 3469999999999999999999999999999999999999754 46999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
+..... .......||+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..++...+.......+.
T Consensus 172 ~~~~~~----~~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 172 TCFQQN----TKMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243 (287)
T ss_dssp GTBCCC----SSCSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred eeecCC----CccccccCcccccChHHhcC----CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 866431 22334568999999999863 4889999999999999999999999999988888887765544333
Q ss_pred C--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 275 P--SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 275 p--~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+ ..+++++.++|.+||+.||++||++.++++ |+|+..
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~------hp~~~~ 282 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE------HPWIQK 282 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH------SHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc------CHHHhc
Confidence 3 578999999999999999999999999998 777654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.64 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=201.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHH----------hcC
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK----------CQG 104 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~----------~~~ 104 (627)
...+..++|++.+.||+|+||.||+|++..++ +.||||++....... ... ..+..++.. ...
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~-~~~-~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNN------THVAMKIVRGDKVYT-EAA-EDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEECSCHHHH-HHH-HHHHHHHHHHHHTCCSHHHHHH
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCC------cEEEEEEecCCccch-hhh-hHHHHHHHHhhcccccchhccc
Confidence 34456789999999999999999999987665 489999997543222 111 222222221 224
Q ss_pred CCCceeeEEEEEECC----EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccCCCcEE
Q 006887 105 VEGICWLQGISVING----KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK-GILVLNLKPFNFI 179 (627)
Q Consensus 105 hpnIv~l~~~~~~~~----~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-gIvHrDLKP~NIL 179 (627)
|+||+++++++...+ ..++||||+.++|.+.+.......+++..+..++.||+.||.|||++ ||+||||||+|||
T Consensus 85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred cchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 899999999988654 79999999988999998876667799999999999999999999998 9999999999999
Q ss_pred EecC------CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC
Q 006887 180 LNEA------DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR 253 (627)
Q Consensus 180 ld~~------g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf 253 (627)
++.+ +.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred EeccCCCcCcceEEEcccccccccCC------CCCCCCCCccccCcHHHhC---CCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9543 3799999999987643 2344589999999999974 46899999999999999999999999
Q ss_pred CCCCH------HHHHHHHHhcc----------------------------------------CCCCCCCCCCHHHHHHHH
Q 006887 254 CGRSV------DEIYDAVVRRQ----------------------------------------EIPPIPSGLPPAVENVLL 287 (627)
Q Consensus 254 ~~~~~------~e~~~~i~~~~----------------------------------------~~~~~p~~~s~~l~~li~ 287 (627)
.+.+. .+.+..+.... ....++..+++++.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 86542 22222222110 011234456788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 288 GCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 288 ~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
+||+.||++||++.++++ |+||...
T Consensus 316 ~~L~~dP~~Rpt~~ell~------hp~f~~~ 340 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVN------HPWLKDT 340 (373)
T ss_dssp GGGCSSTTTCBCHHHHHT------CGGGTTC
T ss_pred HHhccCccccCCHHHHhh------Chhhhcc
Confidence 999999999999999998 9998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.94 Aligned_cols=264 Identities=13% Similarity=0.086 Sum_probs=202.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCc--ccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCcee-------
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDC--DEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICW------- 110 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~--~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~------- 110 (627)
.++|++.+.||+|+||.||+|++..+.... ..++.||||++..... + .++. .++..+.||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~-----~-~~E~-~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGR-----L-FNEQ-NFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTST-----H-HHHH-HHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccch-----H-HHHH-HHHHHhcccchhhhhhhhcc
Confidence 489999999999999999999987642100 0245899999975421 1 1111 1334446766665
Q ss_pred --------eEEEEEE-CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe
Q 006887 111 --------LQGISVI-NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN 181 (627)
Q Consensus 111 --------l~~~~~~-~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld 181 (627)
+++++.. ++..||||||+.|+|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 7788877 7889999999977998888765457899999999999999999999999999999999999999
Q ss_pred cCC--CeeeccCCccccccCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 006887 182 EAD--RAVLGDVGIPHLLLGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255 (627)
Q Consensus 182 ~~g--~vkL~DFGla~~~~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~ 255 (627)
.++ .++|+|||+++.+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG---CGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 8999999999876532211 112234589999999999974 3689999999999999999999999987
Q ss_pred CC--HHHHHHHHHhc-cCCCCCC------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 256 RS--VDEIYDAVVRR-QEIPPIP------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 256 ~~--~~e~~~~i~~~-~~~~~~p------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
.. ...+....... .....++ ..+++++.+||.+||+.||++||++.++++.|+.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 53 33333332211 1112222 25799999999999999999999999999988876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.22 Aligned_cols=247 Identities=13% Similarity=0.122 Sum_probs=189.5
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc---hhHHHHHHHHHHHH--HHHhcCCCCceeeE-
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---EDRMRVLLERLNDL--FLKCQGVEGICWLQ- 112 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~---~~~~~~~~~~~~~~--ll~~~~hpnIv~l~- 112 (627)
..++|++.+.||+|+||.||+|++..++ +.||||++.... ......+ .++..+ .+..++||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~-~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETG------ESFEVHVPYFTERPPSNAIKQM-KEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCC------CEEEEEEEEECC-CCTTHHHHH-HHHHHGGGGSTTCCSHHHHHHHH
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCC------cEEEEEEEeeccccchHHHHHH-HHHHHHHHhccccCCHHHHHHHh
Confidence 3578999999999999999999986655 489999997432 2222222 222221 34456899999988
Q ss_pred ------EEEEECC-----------------EEEEEEecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH
Q 006887 113 ------GISVING-----------------KICIIMKFYEGSVGDRMAQLKG-----GKLSLSNVFRYAIDLAQGILQLH 164 (627)
Q Consensus 113 ------~~~~~~~-----------------~~~LVmEy~~GsL~d~l~~~~~-----~~ls~~~~~~i~~qIa~aL~yLH 164 (627)
+++...+ ..||||||++|+|.+.+..... ..+++..++.++.||+.||+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 6666543 2899999999999998875321 12334788889999999999999
Q ss_pred HCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCC--------CCCCCCccCcc
Q 006887 165 SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--------VRGPISFETDS 236 (627)
Q Consensus 165 s~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~~~~s~~sDi 236 (627)
++||+||||||+|||++.++.+||+|||+++... ......+| +.|+|||++.+. ....++.++||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETT------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecC------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999999999999999999999999998632 22345578 999999998743 00158899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 237 WGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 237 wSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
|||||++|||++|+.||.+.+..+....+. ..+..+++++.+||.+||+.||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999999998766544333332 224678999999999999999999999999988
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.09 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=198.7
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..++.++|++.+.||+|+||.||+|++.. ..||||++..... ...+..+ . ..++.++||||+++++++
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~~--~~~~~~E-~-~~l~~l~hp~iv~~~~~~ 70 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA--------KDVAIKQIESESE--RKAFIVE-L-RQLSRVNHPNIVKLYGAC 70 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETT--------EEEEEEECSSTTH--HHHHHHH-H-HHHHHCCCTTBCCEEEBC
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECC--------eeEEEEEecChhH--HHHHHHH-H-HHHhcCCCCCcCeEEEEE
Confidence 35778899999999999999999998742 4799999965432 2222222 2 245667999999999987
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccCCCcEEEecCCC-eeec
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKG-GKLSLSNVFRYAIDLAQGILQLHS---KGILVLNLKPFNFILNEADR-AVLG 189 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~-~~ls~~~~~~i~~qIa~aL~yLHs---~gIvHrDLKP~NILld~~g~-vkL~ 189 (627)
. +..|+||||++| +|.+.+..... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+
T Consensus 71 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp T--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred c--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 6 448999999985 77777754222 357899999999999999999999 89999999999999998887 7999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS--VDEIYDAVVR 267 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~--~~e~~~~i~~ 267 (627)
|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+...+.
T Consensus 149 Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~- 218 (307)
T 2eva_A 149 DFGTACDIQT------HMTNNKGSAAWMAPEVFEG---SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH- 218 (307)
T ss_dssp CCCC------------------CCTTSSCHHHHTC---CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-
T ss_pred cccccccccc------ccccCCCCCceEChhhhCC---CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-
Confidence 9999876532 2234579999999999974 468899999999999999999999998643 333333333
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
....+..+..+++.+.+++.+||+.||.+||++.++++.|+.+...+
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 34456677889999999999999999999999999999998875433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.42 Aligned_cols=264 Identities=19% Similarity=0.229 Sum_probs=189.9
Q ss_pred CeEE-EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--C
Q 006887 42 ALKL-RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--N 118 (627)
Q Consensus 42 ~y~i-~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--~ 118 (627)
.|++ .++||+|+||.||+|++..+. .++.||||++....... ... ++. .+++.++||||+++++++.. +
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~~~~--~~~-~E~-~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGK----DDKDYALKQIEGTGISM--SAC-REI-ALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSS----CCCCEEEEECSSSSCCH--HHH-HHH-HHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCC----CCeEEEEEEECCCCCCH--HHH-HHH-HHHHhcCCCCeeeEeeEEecCCC
Confidence 4666 357999999999999976432 23589999997654322 122 222 25666789999999999965 6
Q ss_pred CEEEEEEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE----ecCCCee
Q 006887 119 GKICIIMKFYEGSVGDRMAQLK-------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL----NEADRAV 187 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~-------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl----d~~g~vk 187 (627)
...||||||++|+|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 7899999999999988876432 1359999999999999999999999999999999999999 6778999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH--------
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-------- 259 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-------- 259 (627)
|+|||+++.+.............+||+.|+|||++.+. ..++.++|||||||++|||++|++||.+....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC--CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999998765432222334567899999999998742 35899999999999999999999999865542
Q ss_pred -HHHHHHHhccCCCCC------------------------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 006887 260 -EIYDAVVRRQEIPPI------------------------------------PSGLPPAVENVLLGCFEYDLRSRPLMTD 302 (627)
Q Consensus 260 -e~~~~i~~~~~~~~~------------------------------------p~~~s~~l~~li~~cL~~dP~~RPs~~e 302 (627)
+.+..+......+.. ....++.+.+||.+||+.||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 333333322111110 1123778999999999999999999999
Q ss_pred HHHHHHhcccccCCCCCCC
Q 006887 303 ILRVFKSSQNSVHSDGGWT 321 (627)
Q Consensus 303 il~~L~~~~~~~~~~~~w~ 321 (627)
+++ |+||....+.
T Consensus 331 ~L~------hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQ------DPYFLEDPLP 343 (405)
T ss_dssp HHT------SGGGTSSSCC
T ss_pred Hhc------ChhhccCCCC
Confidence 998 9999876554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.18 Aligned_cols=269 Identities=19% Similarity=0.268 Sum_probs=200.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.++.++|++.+.||+|+||.||+|++. ++.||||++........ ..+.+...+..++||||+++++.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~---~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFANRQNF---INEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEET--------TEEEEEEEEEGGGHHHH---HHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEEC--------CeEEEEEEeeccchhhH---HHHHHHHHHHhccCcchhhheec
Confidence 56688899999999999999999999762 24899999975443222 22221122345799999999986
Q ss_pred EEE-----CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecccCCCcEE
Q 006887 115 SVI-----NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK---------GILVLNLKPFNFI 179 (627)
Q Consensus 115 ~~~-----~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~---------gIvHrDLKP~NIL 179 (627)
+.. ...+||||||++ |+|.+.+.. ..+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 653 236799999997 577777743 3458999999999999999999999 9999999999999
Q ss_pred EecCCCeeeccCCccccccCCCC-----CCCCCCccCCCCCcCCcccccCCCC----CCCCccCcchhHHHHHHHHHhCC
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPL-----PSSDLPRRLGTPNYMAPEQWQPEVR----GPISFETDSWGFACSIIEMLTGV 250 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~-----~~~~~~~~~GT~~YmAPE~~~~~~~----~~~s~~sDiwSlGviLyelltG~ 250 (627)
++.++.+||+|||+++.+..... .........||+.|+|||++.+... ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999987654221 1122235579999999999875211 24667899999999999999997
Q ss_pred CCCCC-CC-----------------HHHHHHHHHhccCCCCCCCC------CCHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 006887 251 QPRCG-RS-----------------VDEIYDAVVRRQEIPPIPSG------LPPAVENVLLGCFEYDLRSRPLMTDILRV 306 (627)
Q Consensus 251 ~Pf~~-~~-----------------~~e~~~~i~~~~~~~~~p~~------~s~~l~~li~~cL~~dP~~RPs~~eil~~ 306 (627)
.||.. .+ ..+....+......+.++.. +++++.+||.+||+.||++||++.++++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 76542 11 11222222233334444544 34589999999999999999999999999
Q ss_pred HHhcccccCCC
Q 006887 307 FKSSQNSVHSD 317 (627)
Q Consensus 307 L~~~~~~~~~~ 317 (627)
|+.+.+.|..+
T Consensus 313 L~~ll~~~~~~ 323 (336)
T 3g2f_A 313 MAELMMIWERN 323 (336)
T ss_dssp HHHHHHCCCC-
T ss_pred HHHHHHHHHhc
Confidence 99988877543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=356.52 Aligned_cols=265 Identities=18% Similarity=0.273 Sum_probs=202.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-CC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-NG 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-~~ 119 (627)
..|++.+.||+|+||.||+|++..++. ....||+|.++............++. .+++.++||||+++++++.. ++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT---EEEEEEEEECCSCSCSHHHHHHHHHH-TTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC---cEEEEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCC
Confidence 347889999999999999999764331 23579999997644333222222222 25667799999999998754 56
Q ss_pred EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 120 KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 120 ~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
..|+||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 78999999995 77776643 45678999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCC-CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 199 GIPLPS-SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 199 ~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
...... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..++...+... .....|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~p~ 319 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPE 319 (373)
T ss_dssp --------------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CCCCCCT
T ss_pred ccccccccccCCCCCcccccChHHhcC---CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CCCCCCC
Confidence 322111 12234568899999999973 468999999999999999999 78899887777666666543 3455678
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
.+++++.+++.+||+.||++||++.++++.|+.+...+
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999999876554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=360.61 Aligned_cols=258 Identities=16% Similarity=0.100 Sum_probs=187.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHH--HHHhcCCCCceeeE---
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDL--FLKCQGVEGICWLQ--- 112 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~--ll~~~~hpnIv~l~--- 112 (627)
..+|++.+.||+|+||.||+|++..++ +.||||++...... .......++..+ .+.. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~ 133 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERL------EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRL 133 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CB
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCC------ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeE
Confidence 456999999999999999999987665 48999999875532 122222222211 3344 799977754
Q ss_pred ----EEEEEC-----------------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHH
Q 006887 113 ----GISVIN-----------------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNV------FRYAIDLAQGILQLHS 165 (627)
Q Consensus 113 ----~~~~~~-----------------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~------~~i~~qIa~aL~yLHs 165 (627)
+++... ...||||||++|+|.+.+... +..+++..+ ..++.||+.||.|||+
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 555443 348999999999999988763 223444455 6777999999999999
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHH
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIE 245 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLye 245 (627)
+||+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+. ...++.++|||||||++||
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------RGPASSVPVTYAPREFLNAS-TATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC------EEEGGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCC------CccCccCCcCCcChhhccCC-CCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999999986532 11245678999999999742 2468999999999999999
Q ss_pred HHhCCCCCCCCCHHHH--HHH---HHh--ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 246 MLTGVQPRCGRSVDEI--YDA---VVR--RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 246 lltG~~Pf~~~~~~e~--~~~---i~~--~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
|++|+.||.+...... +.. ... .....+.+..+++.+.+||.+||+.||++||++.++++ |+||...
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~f~~~ 359 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME------TPEFLQL 359 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT------SHHHHHH
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc------CHHHHHH
Confidence 9999999987643211 100 000 01112223588999999999999999999999999987 7777644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.15 Aligned_cols=266 Identities=19% Similarity=0.234 Sum_probs=205.3
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcC-CCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQG-VEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~-hpnIv~l~ 112 (627)
...+..++|++.+.||+|+||.||+|.+.. ++.||||++...... .......++..++....+ |+||++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCC-------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 445667789999999999999999998643 247999999764322 222222333334444433 79999999
Q ss_pred EEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 113 GISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+++...+..|+|||+..|+|.+.+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++ ++.+||+|||
T Consensus 95 ~~~~~~~~~~lv~e~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 95 DYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEEECSSEEEEEECCCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEeecCCEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 99999999999999877899888864 45789999999999999999999999999999999999996 4899999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCC--------CCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHH
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE--------VRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYD 263 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--------~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~ 263 (627)
+++....... ........||+.|+|||++.+. ....++.++|||||||++|+|++|+.||.... ....+.
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 172 IANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 9987643211 1122355799999999998642 12368889999999999999999999998753 344455
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 264 ~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.+........++...++++.++|.+||+.||.+||++.++++ |+|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~------h~~~~~ 298 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA------HPYVQI 298 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHC
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc------CccccC
Confidence 555555556677888999999999999999999999999998 777653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.94 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=217.2
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.|..++|++.+.||+|+||.||+|++..+ ..||||+++...... ..+.. +. .+++.++|+||+++++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-------~~vavK~~~~~~~~~-~~~~~-E~-~~l~~l~hpniv~~~~ 329 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTMSP-EAFLQ-EA-QVMKKLRHEKLVQLYA 329 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-------EEEEEEEECTTSSCH-HHHHH-HH-HHHHHCCCTTBCCEEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCC-------ceEEEEEeCCCCCCH-HHHHH-HH-HHHHhCCCCCEeeEEE
Confidence 35568889999999999999999999998653 369999998654322 22322 22 2566779999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++.. +..||||||+.| +|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp EECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred EEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 9865 678999999985 88888865455679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++...... ........+|+.|||||++. .+.++.++|||||||+||||++ |+.||.+....+++..+... ..
T Consensus 409 ~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~ 482 (535)
T 2h8h_A 409 LARLIEDNE--YTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR 482 (535)
T ss_dssp STTTCCCHH--HHTTCSTTSCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred cceecCCCc--eecccCCcCcccccCHHHhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 998654211 01122345788999999987 3468999999999999999999 99999999998888877644 34
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.+..+++++.+||.+||+.||++||++.++++.|+...
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 5667899999999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=348.04 Aligned_cols=252 Identities=20% Similarity=0.226 Sum_probs=179.4
Q ss_pred CCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|++.+ .||+|+||.||+|++..+++ .||||++....... .+....+....||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~------~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQ------KCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEESSHHHH------HHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCC------EEEEEEecCcHHHH------HHHHHHHHhcCCCChHHHHHHHhhc
Confidence 47899965 59999999999999887664 89999997532211 112234566799999999999876
Q ss_pred ---CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeecc
Q 006887 118 ---NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGD 190 (627)
Q Consensus 118 ---~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~D 190 (627)
+...|+||||++| +|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 4568999999986 8888887644567999999999999999999999999999999999999976 45599999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD----AVV 266 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~----~i~ 266 (627)
||+++.... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.+........ .+.
T Consensus 175 fg~~~~~~~-----~~~~~~~~t~~y~aPE~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (336)
T 3fhr_A 175 FGFAKETTQ-----NALQTPCYTPYYVAPEVLG---PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246 (336)
T ss_dssp CTTCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred cccceeccc-----cccccCCCCcCccChhhhC---CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh
Confidence 999986542 2234568899999999986 3468889999999999999999999998766544321 121
Q ss_pred hccC--CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 267 RRQE--IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 267 ~~~~--~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.... ..+....+++++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~~ 293 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN------HPWINQ 293 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH------SHHHHT
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc------Cccccc
Confidence 1111 12223578999999999999999999999999998 888764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=376.16 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=207.7
Q ss_pred CcCCCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 37 WIKPSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 37 ~i~~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.++...+.+.. .||+|+||.||+|.+.... .++.||||+++...... ...+. ++. .++..++||||+++++
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~-~E~-~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELL-AEA-NVMQQLDNPYIVRMIG 437 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSS----CEEEEEEEEECGGGGCGGGHHHHH-HHH-HHHHHCCCTTBCCEEE
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCC----cceEEEEEEeccccCCHHHHHHHH-HHH-HHHHhCCCCCEeeEEE
Confidence 34555666654 8999999999999764322 23589999997643322 22222 222 2556678999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++. .+..+|||||++| +|.+.+. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 438 ~~~-~~~~~lv~E~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICE-AESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEE-SSSEEEEEECCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEe-cCCEEEEEEccCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 986 4568999999985 7777764 45679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+++.+..............||+.|+|||++. ...++.++|||||||++|||++ |+.||.+.+..++...+... ..
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~---~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~ 590 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ER 590 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC
T ss_pred CccccccCccccccccCCCCceeeeChhhhc---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 9987754332223334456789999999997 3468999999999999999998 99999999998888777654 45
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
...|..+++++.+||.+||+.||++||++.++++.|+...
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 6678899999999999999999999999999999988653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.57 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=201.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-------HHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-------RMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-------~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
++|++.+.||+|+||.||+|++..++. .||||++...... .......++. .+++.++||||+++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPALNVETEI-EILKKLNHPCIIKIKN 82 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECC---------------CHHHHH-HHHHHCCCTTBCCEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCc------EEEEEEeehhhhhhcccccchhhhhHHHHH-HHHHhCCCCCCceEee
Confidence 579999999999999999999877654 8999999754321 0111112222 2456679999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eeec
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVLG 189 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL~ 189 (627)
++..++ .|+||||++| +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 83 ~~~~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 83 FFDAED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEESSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred EEcCCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 987655 8999999985 7777664 4567999999999999999999999999999999999999987664 9999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~ 268 (627)
|||+++..... .......||+.|+|||++.+.....++.++|+|||||++|+|++|..||...... .+...+...
T Consensus 160 Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 160 DFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp CCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred cCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 99999875321 1123457999999999975322456889999999999999999999999875433 333334332
Q ss_pred cCC--CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 269 QEI--PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 269 ~~~--~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
... +..+..+++++.+||.+||+.||++||++.++++ |+|+...++
T Consensus 236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~------h~~~~~~~~ 283 (322)
T 2ycf_A 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQDEDM 283 (322)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGCCHHH
T ss_pred ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh------CcCcCCHHH
Confidence 211 1123578999999999999999999999999998 888876544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.87 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=203.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE---
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--- 117 (627)
++|++.+.||+|+||.||+|++..+++ .||+|+++...... .++. ..+..++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~-----~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGK------TYVIKRVKYNNEKA-----EREV-KALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCC------EEEEEEEECCSGGG-----HHHH-HHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCe------EEEEEEeccccHHH-----HHHH-HHHHhCCCCCEEEEeeeEecccc
Confidence 579999999999999999999876654 89999997654321 1122 24566799999999998864
Q ss_pred -------------CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC
Q 006887 118 -------------NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA 183 (627)
Q Consensus 118 -------------~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~ 183 (627)
....|+||||++| +|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4458999999995 88888876556789999999999999999999999999999999999999999
Q ss_pred CCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 006887 184 DRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD 263 (627)
Q Consensus 184 g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~ 263 (627)
+.++|+|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.. ..+...
T Consensus 159 ~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~ 229 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKND----GKRTRSKGTLRYMSPEQISS---QDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFT 229 (284)
T ss_dssp TEEEECCCTTCEESSCC----SCCCCCCSCCTTSCHHHHHC---SCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHH
T ss_pred CCEEECcchhheecccc----ccccccCCcccccChhhhcc---CCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHH
Confidence 99999999999876542 22344579999999999974 4688999999999999999999988753 222333
Q ss_pred HHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 264 AVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 264 ~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+. ...++..+++.+.++|.+||+.||.+||++.++++.|.....
T Consensus 230 ~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLR----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHH----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhh----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 332 234567889999999999999999999999999998887653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.04 Aligned_cols=269 Identities=19% Similarity=0.329 Sum_probs=209.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++.... ...++.||||++..........+..+. ..++.++||||++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREI--EILKSLQHDNIVKYKGV 110 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTS--SSCCEEEEEEEESSCCSHHHHHHHHHH--HHHHTCCCTTBCCEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEecccc--CCCceEEEEEEeccCCHHHHHHHHHHH--HHHHhCCCCCeeeEEEE
Confidence 45567789999999999999999999864321 124568999999876544443333322 25567799999999998
Q ss_pred EEECC--EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 115 SVING--KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 115 ~~~~~--~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+...+ ..++||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 86543 68999999985 77777754 4457999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-------------
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV------------- 258 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~------------- 258 (627)
|+++................+|+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcC---CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence 999876543211112234568889999999874 3588899999999999999999999864211
Q ss_pred ---HHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 259 ---DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 259 ---~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+.. ........+.+..+++++.++|.+||+.||++||++.++++.|+.+..
T Consensus 267 ~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 267 MIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHH-HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01122 222334456788899999999999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.65 Aligned_cols=255 Identities=18% Similarity=0.302 Sum_probs=195.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
++|++.+.||+|+||.||+|++. ++.||||++....... ...+.+.......+||||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~---~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEeccccch---hhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 68999999999999999999874 2479999996543322 1122211122335899999999999987
Q ss_pred --CEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecccCCCcEEEecCCCee
Q 006887 119 --GKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK--------GILVLNLKPFNFILNEADRAV 187 (627)
Q Consensus 119 --~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------gIvHrDLKP~NILld~~g~vk 187 (627)
+..|+||||++| +|.+.+.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 789999999985 88777743 4699999999999999999999999 999999999999999999999
Q ss_pred eccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCCCCCCCCc------cCcchhHHHHHHHHHhC----------C
Q 006887 188 LGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEVRGPISF------ETDSWGFACSIIEMLTG----------V 250 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~------~sDiwSlGviLyelltG----------~ 250 (627)
|+|||+++.+....... .......||+.|+|||++.+. .++. ++|||||||++|||++| .
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES---LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC---CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccc---cCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999997764422111 112356899999999999743 2333 38999999999999999 7
Q ss_pred CCCCCCC-----HHHHHHHHHhccCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 251 QPRCGRS-----VDEIYDAVVRRQEIPPIPS-----GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 251 ~Pf~~~~-----~~e~~~~i~~~~~~~~~p~-----~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.||.... .......+......+.++. .+++++.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 7776532 2333333333333344443 567789999999999999999999999999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.74 Aligned_cols=260 Identities=18% Similarity=0.251 Sum_probs=202.7
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..++|++.+.||+|+||.||+|++.. ++.||||++..........+..+. ..++.++||||+++++++...
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRD-------GAKVALKRRTPESSQGIEEFETEI--ETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTT-------CCEEEEEECCSCCSSHHHHHHHHH--HGGGSCCCTTBCCEEEECCCT
T ss_pred HHhccCccceeecCCCeeEEEEEECC-------CCEEEEEEecccChHHHHHHHHHH--HHHHhCCCCCEeeEEEEEcCC
Confidence 44789999999999999999998542 248999998876554444333322 245678999999999999999
Q ss_pred CEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 119 GKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 119 ~~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
+..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999984 7766654322 2358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH---H---HHHhcc
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY---D---AVVRRQ 269 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~---~---~i~~~~ 269 (627)
....... ........||+.|+|||++.+ +.++.++|||||||++|||++|+.||.+....+.. . ......
T Consensus 188 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 188 KGTELDQ-THLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp ECSSSSC-CCCBCCCEEETTTCCHHHHHH---CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccc-cccccccCCCccccCHHHhcC---CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 6543221 122234569999999999873 46889999999999999999999999865432211 1 111110
Q ss_pred ---------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 270 ---------EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 270 ---------~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
....++..++..+.+++.+||+.||++||++.++++.|+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 011123345678999999999999999999999999888754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.92 Aligned_cols=261 Identities=16% Similarity=0.183 Sum_probs=211.9
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-----------------HHHHHHHHHH
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-----------------RVLLERLNDL 98 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-----------------~~~~~~~~~~ 98 (627)
..+..++|++.+.||+|+||.||+|++ ++ +.||||++........ ..+. ++. .
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~E~-~ 95 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DN------KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK-NEL-Q 95 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TT------EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHH-HHH-H
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CC------ceEEEEEeecccccchhhhccccchhhhHHhHHHHHH-HHH-H
Confidence 334567999999999999999999997 33 4899999975322110 2222 222 2
Q ss_pred HHHhcCCCCceeeEEEEEECCEEEEEEecCCC-CHHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCee
Q 006887 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEG-SVGDR------MAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILV 170 (627)
Q Consensus 99 ll~~~~hpnIv~l~~~~~~~~~~~LVmEy~~G-sL~d~------l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvH 170 (627)
++..++||||+++++++...+..|+||||++| +|.+. +.......+++..++.++.||+.||.|||+ +||+|
T Consensus 96 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H 175 (348)
T 2pml_X 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175 (348)
T ss_dssp HHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence 56677899999999999999999999999996 77665 433235789999999999999999999999 99999
Q ss_pred cccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCc-cCcchhHHHHHHHHHhC
Q 006887 171 LNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISF-ETDSWGFACSIIEMLTG 249 (627)
Q Consensus 171 rDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~-~sDiwSlGviLyelltG 249 (627)
|||||+|||++.++.++|+|||++...... ......||+.|+|||++.+. ..++. ++|+|||||++|||++|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE--SSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC--CCEEHHHHHHHHHHHHHHHHHHS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC--CCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999876432 23456799999999999743 14555 99999999999999999
Q ss_pred CCCCCCCCH-HHHHHHHHhccCCCCCC-------------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 250 VQPRCGRSV-DEIYDAVVRRQEIPPIP-------------------SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 250 ~~Pf~~~~~-~e~~~~i~~~~~~~~~p-------------------~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..||...+. .++...+.... ..++ ..+++++.+||.+||+.||.+||++.++++
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~---- 322 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK---- 322 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT----
T ss_pred CCCCCCCCcHHHHHHHHhccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc----
Confidence 999998776 66776664432 3333 678999999999999999999999999998
Q ss_pred cccccCCCCCCC
Q 006887 310 SQNSVHSDGGWT 321 (627)
Q Consensus 310 ~~~~~~~~~~w~ 321 (627)
|+||...+|.
T Consensus 323 --hp~f~~~~~~ 332 (348)
T 2pml_X 323 --HEWLADTNIE 332 (348)
T ss_dssp --SGGGTTCCHH
T ss_pred --CccccCCCHH
Confidence 9998877654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=348.23 Aligned_cols=266 Identities=18% Similarity=0.275 Sum_probs=208.5
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceee
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
....+..++|++.+.||+|+||.||+|++.. .||+|+++...... ...+.. +. ..++.++||||+++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~-e~-~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAFKR-EV-MAYRQTRHENVVLF 94 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCCCT-TG-GGGTTCCCTTBCCC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHHHH-HH-HHHhcCCCCCEeEE
Confidence 3566888999999999999999999998742 49999997543211 111111 11 24566799999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++...+..++||||++| +|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECC
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEee
Confidence 9999999999999999985 66555532 445799999999999999999999999999999999999998 68999999
Q ss_pred CCccccccCCCC--CCCCCCccCCCCCcCCcccccCCC------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH
Q 006887 191 VGIPHLLLGIPL--PSSDLPRRLGTPNYMAPEQWQPEV------RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY 262 (627)
Q Consensus 191 FGla~~~~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~------~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~ 262 (627)
||+++....... .........||+.|+|||++.+.. ...++.++|||||||++|||++|+.||.+.+..+..
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999876532111 112233457999999999987421 235788999999999999999999999999988888
Q ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 263 DAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 263 ~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
..+.........+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 253 WQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 77765544444445789999999999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.44 Aligned_cols=263 Identities=19% Similarity=0.201 Sum_probs=203.8
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
..++|++.+.||+|+||.||+|++..+++ .||||+++............++. .+++.++||||+++++++...
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREF-EVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHH-HHHHHCCCTTBCCEEEEEECT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHH-HHHHhcCCCCCCeEEEeeccC
Confidence 35689999999999999999999877664 89999997644322222222222 255667899999999999875
Q ss_pred C--EEEEEEecCCC-CHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE----ecCCCeeecc
Q 006887 119 G--KICIIMKFYEG-SVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL----NEADRAVLGD 190 (627)
Q Consensus 119 ~--~~~LVmEy~~G-sL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl----d~~g~vkL~D 190 (627)
+ ..|+||||++| +|.+.+.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 78999999985 7777665432 2349999999999999999999999999999999999999 6777899999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCC-----CCCCCccCcchhHHHHHHHHHhCCCCCCCC----CHHHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV-----RGPISFETDSWGFACSIIEMLTGVQPRCGR----SVDEI 261 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-----~~~~s~~sDiwSlGviLyelltG~~Pf~~~----~~~e~ 261 (627)
||+++..... .......||+.|+|||++.+.. ...++.++|||||||++|||++|+.||... ...++
T Consensus 160 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 160 FGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp GGGCEECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred CCCceEccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 9999876432 2234567999999999986310 135778999999999999999999999742 33455
Q ss_pred HHHHHhccCCC-----------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 262 YDAVVRRQEIP-----------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 262 ~~~i~~~~~~~-----------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
+..+....... .++..+++.+.++|.+||+.||++||++.++++.++.+.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 55555433211 1113356788899999999999999999999998877654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=370.49 Aligned_cols=265 Identities=22% Similarity=0.357 Sum_probs=214.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...+..++|++.+.||+|+||.||+|++..++. .+..||||+++............++. .++..++||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PAMAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSS---CCEEEEEEECSSTTCHHHHHHHHHHH-HHHHHCCCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCC---ccEEEEEEEecccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEE
Confidence 345667899999999999999999999876542 34679999987654433333223332 35567799999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+. ++..|+||||++ |+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC
Confidence 85 566899999999 577776653 455799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++...... ........||+.|||||++.+ ..++.++|||||||++|||++ |..||.+.+..++...+... ...
T Consensus 538 a~~~~~~~--~~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~ 611 (656)
T 2j0j_A 538 SRYMEDST--YYKASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERL 611 (656)
T ss_dssp CCSCCC------------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCC
T ss_pred CeecCCCc--ceeccCCCCCcceeCHHHhcC---CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 98764321 112234567899999999973 468999999999999999997 99999999998888877654 355
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.+..+++.+.++|.+||+.||.+||++.++++.|+.+.
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 678899999999999999999999999999999888753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=329.53 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=195.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE---
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI--- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--- 117 (627)
++|++.+.||+|+||.||+|++..++. .||||++.... .....+.. +. .+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~-~~~~~~~~-E~-~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSR------YYAIKKIRHTE-EKLSTILS-EV-MLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEEEH-HHHHHHHH-HH-HHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCe------EEEEEEEeccH-HHHHHHHH-HH-HHHHhcCchHHHHHHHHHHhhcc
Confidence 479999999999999999999876654 89999996432 22222222 22 35677899999999998865
Q ss_pred ----------CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCe
Q 006887 118 ----------NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 118 ----------~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~v 186 (627)
.+..|+||||++| +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCE
Confidence 3578999999985 87777754 44568899999999999999999999999999999999999999999
Q ss_pred eeccCCccccccCCCC-----------CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 006887 187 VLGDVGIPHLLLGIPL-----------PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG 255 (627)
Q Consensus 187 kL~DFGla~~~~~~~~-----------~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~ 255 (627)
+|+|||+++....... .........||+.|+|||++.+. +.++.++|+|||||++|+|++ ||..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 9999999987542110 01123456799999999998742 368899999999999999998 5543
Q ss_pred -CCHHHHHHHHHhcc--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 256 -RSVDEIYDAVVRRQ--EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 256 -~~~~e~~~~i~~~~--~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.+..+....+.... ..+.++...++.+.++|.+||+.||.+||++.++++ |+|+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~~~ 290 (303)
T 1zy4_A 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN------SGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH------SSCSCCC
T ss_pred chhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC------CCCcCCC
Confidence 23344444443322 123355677889999999999999999999999998 9988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.28 Aligned_cols=263 Identities=16% Similarity=0.164 Sum_probs=198.7
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..+..++|++.+.||+|+||.||+|++..+. +...++.||||+++............... .+....|+||+.+++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~e~~~~~--~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLN-DAKNKQKFVLKVQKPANPWEFYIGTQLME--RLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCCHHHHHHHHHHHH--HSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCc-ccccCcEEEEEEeCCCChhHHHHHHHHHH--Hhhhhhhhhhhhhheee
Confidence 3456688999999999999999999643322 12345689999998765443322222111 12233489999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---------
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQL---KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE--------- 182 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~--------- 182 (627)
...+..||||||++ |+|.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 99999999999998 6888887653 3467999999999999999999999999999999999999998
Q ss_pred --CCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH
Q 006887 183 --ADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE 260 (627)
Q Consensus 183 --~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e 260 (627)
++.+||+|||+++.+.... ........+||+.|||||++.+ ..++.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcC---CCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 8999999999997654221 1223345689999999999974 368999999999999999999999986533211
Q ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcc
Q 006887 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRP-LMTDILRVFKSSQ 311 (627)
Q Consensus 261 ~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RP-s~~eil~~L~~~~ 311 (627)
.. + ..... ....++.+.+++..||+.+|.+|+ ++.++.+.|+...
T Consensus 293 ~~--~--~~~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 CK--P--EGLFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EE--E--CSCCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ee--e--chhcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00 0 00011 123478899999999999999985 7777777776643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.78 Aligned_cols=260 Identities=21% Similarity=0.259 Sum_probs=197.6
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+..++|++.+.||+|+||.||+|++.. ++.||||++.............++. .++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERTQGGELQFQTEV-EMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSS-------SCCEEEEECCC-----CCCHHHHHH-HGGGTCCCTTBCCCCEEEC
T ss_pred HHHhhccccceeEecCCCcEEEEEEecC-------CCEEEEEEeccccCchHHHHHHHHH-HHHHhccCCCccceEEEEe
Confidence 3556789999999999999999997432 3479999997654322111122222 2456788999999999999
Q ss_pred ECCEEEEEEecCCC-CHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccCCCcEEEecCCCeeecc
Q 006887 117 INGKICIIMKFYEG-SVGDRMAQLK--GGKLSLSNVFRYAIDLAQGILQLHSK---GILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 117 ~~~~~~LVmEy~~G-sL~d~l~~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~---gIvHrDLKP~NILld~~g~vkL~D 190 (627)
..+..++||||++| +|.+.+.... ..++++..+..++.|++.||.|||++ ||+||||||+|||++.++.++|+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999985 7777776432 24599999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC-----CHHHHHHHH
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR-----SVDEIYDAV 265 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~-----~~~e~~~~i 265 (627)
||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+
T Consensus 178 fg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 178 FGLAKLMDYKD--THVTTAVRGTIGHIAPEYLST---GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp CSSCEECCSSS--SCEECCCCSCGGGCCHHHHHH---SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred CccccccCccc--ccccccccCCcCccCHHHhcc---CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 99998764321 122234569999999999874 35889999999999999999999999621 111111111
Q ss_pred HhccC------------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 266 VRRQE------------IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 266 ~~~~~------------~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..... ....+...++.+.+++.+||+.||.+||++.++++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11000 011222344789999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.45 Aligned_cols=265 Identities=15% Similarity=0.158 Sum_probs=195.3
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.+...+|++.+.||+|+||.|+.... .+ ++.||||++.+...... .++..++....+||||+++++++.
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~-~~------~~~vAvK~~~~~~~~~~----~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGM-FD------NRDVAVKRILPECFSFA----DREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEE-SS------SSEEEEEEECTTTEEEC----HHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEE-eC------CeEEEEEEECHHHHHHH----HHHHHHHHhccCCCCcCeEEEEEe
Confidence 35556799999999999998654332 22 34899999976543322 123334444458999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CC--CeeeccC
Q 006887 117 INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---AD--RAVLGDV 191 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g--~vkL~DF 191 (627)
+.+..||||||++|+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++ .++|+||
T Consensus 89 ~~~~~~lv~E~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCAATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCSEEHHHHHHS-SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCCCCHHHHHHh-cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 9999999999999998888864 3344566677899999999999999999999999999999953 33 5779999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++................||+.|||||++.+.....++.++|||||||++|||++ |..||.......... +.....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~ 246 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACS 246 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCC
Confidence 999877543222233455689999999999975434567889999999999999999 999997655444332 221111
Q ss_pred CCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 271 IPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 271 ~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
... .+...+..+.+||.+||+.||.+||++.++++ |+||....|
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~------hp~f~~~~~ 292 (432)
T 3p23_A 247 LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK------HPFFWSLEK 292 (432)
T ss_dssp CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT------STTTCCHHH
T ss_pred ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh------CccccChHH
Confidence 111 12334567899999999999999999999998 999876654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.34 Aligned_cols=252 Identities=18% Similarity=0.205 Sum_probs=202.3
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhc-CCCCceeeE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQ-GVEGICWLQ 112 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~-~hpnIv~l~ 112 (627)
-.++|++.+.||+|+||.||+|++..++ +.||||++....... .......+..++.... .|+||++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDN------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTT------EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3578999999999999999999987665 489999997543211 0001111222333333 479999999
Q ss_pred EEEEECCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-cCCCeeec
Q 006887 113 GISVINGKICIIMKFYE--GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-EADRAVLG 189 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~--GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-~~g~vkL~ 189 (627)
+++...+..++|||++. ++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999999997 678877764 45799999999999999999999999999999999999999 78999999
Q ss_pred cCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 006887 190 DVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 190 DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~ 269 (627)
|||+++.... .......||+.|+|||++.+. ..++.++|+|||||++|||++|+.||.... + +..
T Consensus 193 Dfg~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~-- 257 (320)
T 3a99_A 193 DFGSGALLKD-----TVYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIR-- 257 (320)
T ss_dssp CCTTCEECCS-----SCBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH--
T ss_pred eCcccccccc-----ccccCCCCCccCCChHHhccC--CCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhc--
Confidence 9999987643 223345799999999998743 224688999999999999999999997532 1 222
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
....++..+++++.+||.+||+.||++||++.++++ |+|+....
T Consensus 258 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------hp~~~~~~ 301 (320)
T 3a99_A 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN------HPWMQDVL 301 (320)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSCC
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc------CHhhcCcc
Confidence 234467789999999999999999999999999998 88887653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.22 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=198.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.|...+.||+|+||.||+|.+. +..||||++..... ........++. .+++.++||||+++++++...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~ 102 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDG 102 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESS--------SCEEEEEEECCCTTSCTTTHHHHHHHHH-HHHHHCCCTTBCCEEEEECSS
T ss_pred ccccCCccccCCCeEEEEEEEC--------CceEEEEEEecccCcchHHHHHHHHHHH-HHHHhcCCCCeEEEEEEEecC
Confidence 3445689999999999999852 24799999875321 22222223332 245667999999999999988
Q ss_pred CEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 119 GKICIIMKFYE-GSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 119 ~~~~LVmEy~~-GsL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+..|+||||++ |+|.+.+.... ..++++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence 99999999997 58877776443 46799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhc----
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDE----IYDAVVRR---- 268 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e----~~~~i~~~---- 268 (627)
...... ........||+.|+|||++.+ .++.++|+|||||++|+|++|.+||.+....+ +...+...
T Consensus 183 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (307)
T 2nru_A 183 SEKFAQ-TVMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI 257 (307)
T ss_dssp CCSCSS-CEECSSCCSCGGGCCHHHHTT----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH
T ss_pred cccccc-cccccccCCCcCcCChHHhcC----CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh
Confidence 543211 112234579999999999863 47889999999999999999999998754332 22222111
Q ss_pred -----cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 269 -----QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 269 -----~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
......+..+++.+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1112233445678999999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.73 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=201.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHH-hcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLK-CQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~-~~~hpnIv~l~~~~~~~~ 119 (627)
++|++.+.||+|+||.||+|++. ++.||||+++..... ... .+.+++.. .++||||+++++++...+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~---~~~-~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSREER---SWF-REAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECGGGHH---HHH-HHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCchhHH---HHH-HHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 68999999999999999999873 248999999754322 222 22223333 379999999999998775
Q ss_pred ----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecccCCCcEEEecCCCe
Q 006887 120 ----KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH--------SKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 120 ----~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLH--------s~gIvHrDLKP~NILld~~g~v 186 (627)
..|+||||++| +|.+.+.. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 79999999995 88777753 46899999999999999999999 8999999999999999999999
Q ss_pred eeccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCCCCC---CCCccCcchhHHHHHHHHHhC----------CCC
Q 006887 187 VLGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEVRG---PISFETDSWGFACSIIEMLTG----------VQP 252 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~~---~~s~~sDiwSlGviLyelltG----------~~P 252 (627)
||+|||+++......... .......||+.|+|||++.+.... .++.++|||||||++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765422110 023456899999999998753211 233689999999999999999 789
Q ss_pred CCCC-----CHHHHHHHHHhccCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 253 RCGR-----SVDEIYDAVVRRQEIPPIPS-----GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 253 f~~~-----~~~e~~~~i~~~~~~~~~p~-----~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
|... ...++...+......+.++. .+++.+.+|+.+||+.||++||++.++++.|+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 8764 33455555544444444443 345689999999999999999999999999987643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.96 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=193.1
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-----HHHHHHHHHHHHh---cCCCCcee
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-----VLLERLNDLFLKC---QGVEGICW 110 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-----~~~~~~~~~ll~~---~~hpnIv~ 110 (627)
-.++|++.+.||+|+||.||+|++..++ +.||||+++........ .....+...+... .+|+||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDR------LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTC------CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCC------eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 3478999999999999999999977665 48999999765432111 0111122222222 28999999
Q ss_pred eEEEEEECCEEEEEEec-CC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe-cCCCee
Q 006887 111 LQGISVINGKICIIMKF-YE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN-EADRAV 187 (627)
Q Consensus 111 l~~~~~~~~~~~LVmEy-~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld-~~g~vk 187 (627)
+++++...+..++|||| +. ++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.++
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999999 55 588777764 35699999999999999999999999999999999999999 889999
Q ss_pred eccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 006887 188 LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR 267 (627)
Q Consensus 188 L~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~ 267 (627)
|+|||+++.... .......||+.|+|||++.+. ...+.++|+|||||++|+|++|+.||.... + +..
T Consensus 181 l~dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~ 247 (312)
T 2iwi_A 181 LIDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILE 247 (312)
T ss_dssp ECCCSSCEECCS-----SCBCCCCSCTTTSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHH
T ss_pred EEEcchhhhccc-----CcccccCCcccccCceeeecC--CCCCccchHHHHHHHHHHHHHCCCCCCChH--H----Hhh
Confidence 999999987643 223456799999999998743 123568999999999999999999997532 1 221
Q ss_pred ccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 268 ~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....++..+++++.++|.+||+.||++||++.++++ |+|+...
T Consensus 248 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~------~~~~~~~ 290 (312)
T 2iwi_A 248 --AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL------DPWMQTP 290 (312)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH------STTTCC-
T ss_pred --hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc------ChhhcCc
Confidence 234567889999999999999999999999999998 8887654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.05 Aligned_cols=258 Identities=18% Similarity=0.216 Sum_probs=188.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|.+.+.||+|+||+||.+.. .+ ++.||||++.....+ ...++..++....+||||+++++++..++.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~------g~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQ------GRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SS------SSEEEEEEEEGGGHH----HHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred heeeccCeEeeCCCeEEEEEEE-EC------CeEEEEEEEcHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 4567789999999999987543 22 358999998754322 122333344455699999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC------------
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGK-----LSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA------------ 183 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~-----ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~------------ 183 (627)
.||||||++|+|.+.+....... .++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999999999988886432111 1233467899999999999999999999999999999754
Q ss_pred -CCeeeccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCC----CCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 184 -DRAVLGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPE----VRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 184 -g~vkL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~----~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
+.+||+|||+++......... .......||+.|||||++.+. ....++.++|||||||++|||++ |..||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998765422111 123356899999999999752 12568899999999999999999 99999876
Q ss_pred CHHHHHHHHHhccCCCC-C----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 257 SVDEIYDAVVRRQEIPP-I----PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~-~----p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+ ..+.......+ . +..+++++.+||.+||+.||.+||++.++++ |+||..
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------hp~f~~ 301 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR------HPLFWP 301 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSC
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh------CCccCC
Confidence 5443 22322222211 1 1234688999999999999999999999998 888753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.73 Aligned_cols=232 Identities=17% Similarity=0.215 Sum_probs=184.5
Q ss_pred CCCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|.+. +.||+|+||.||+|.+..+++ .||+|+++.... ..++...+.+..+||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~------~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDCPK------ARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCc------EEEEEEecccHH------HHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 3578888 789999999999999877664 899999964321 12233345577799999999999987
Q ss_pred ---CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeecc
Q 006887 118 ---NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGD 190 (627)
Q Consensus 118 ---~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~D 190 (627)
.+..||||||++| +|.+.+.......+++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 6789999999985 8888887655568999999999999999999999999999999999999998 78899999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||++..... ..++.++|+|||||++|||++|+.||.+.+..+..........
T Consensus 164 fg~a~~~~~----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 215 (299)
T 3m2w_A 164 FGFAKETTG----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 215 (299)
T ss_dssp CTTCEECTT----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSC
T ss_pred ccccccccc----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHh
Confidence 998865421 2477899999999999999999999987655443221111111
Q ss_pred --CCCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 271 --IPPIP----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 271 --~~~~p----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...++ ..+++++.+||.+||+.||.+||++.++++ |+|+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~------hp~~~~ 262 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN------HPWIMQ 262 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT------SHHHHT
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc------Chhhcc
Confidence 11222 568999999999999999999999999998 887754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.59 Aligned_cols=247 Identities=14% Similarity=0.124 Sum_probs=182.6
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH--HHHHHHHHHHHHHhcCC-CC--------
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM--RVLLERLNDLFLKCQGV-EG-------- 107 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~--~~~~~~~~~~ll~~~~h-pn-------- 107 (627)
...+|++.+.||+|+||.||+|++..+++ .||||+++....... ...+.++. ..+..+.| +|
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~~~~~~~~~~~~~~~~~~E~-~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEV-LRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEECCSCC----CCHHHHHHH-HGGGGSTTCCSHHHHHHHT
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCC------ceEEEEEecCCCccHHHHHHHHHHH-HHHHhhccCCCHHHHHHhc
Confidence 34569999999999999999999887664 899999974333221 11112222 12334443 21
Q ss_pred -------------ceeeEEEEEE-----CCEEEEEEecCCCCHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHH
Q 006887 108 -------------ICWLQGISVI-----NGKICIIMKFYEGSVGDRMAQL-----KGGKLSLSNVFRYAIDLAQGILQLH 164 (627)
Q Consensus 108 -------------Iv~l~~~~~~-----~~~~~LVmEy~~GsL~d~l~~~-----~~~~ls~~~~~~i~~qIa~aL~yLH 164 (627)
...+..++.. ....+++|+++.|+|.+++... ....+++..++.++.||+.||.|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 1111111111 2247899999999999888533 2455778899999999999999999
Q ss_pred HCCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCC-------CCCCCCccCcch
Q 006887 165 SKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE-------VRGPISFETDSW 237 (627)
Q Consensus 165 s~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-------~~~~~s~~sDiw 237 (627)
++||+||||||+|||++.++.+||+|||+++.... .....+| +.|||||++.+. ....++.++|||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCC------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 99999999999999999999999999999886532 1345678 999999998321 133578899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 238 GFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 238 SlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
||||++|||++|+.||.+.+..+....+.. ....+|+++.+||.+||+.||++||++.++++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999999988766554443322 23468899999999999999999999988865
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.54 Aligned_cols=228 Identities=17% Similarity=0.149 Sum_probs=180.0
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH---HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR---MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~---~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
-.++|++.+.||+|+||.||+|++..++ +.||||+++...... ...+..+. ..+..++||||+++++++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~e~--~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALD------RQVALTFVDPQGVLPDDVLQETLSRT--LRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTT------EEEEEEESCTTCCSCHHHHHHHHHHH--HHHHTCCCTTBCCEEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCC------ceEEEEEECcccccCHHHHHHHHHHH--HHHhcCCCCCcceeeEEE
Confidence 3467999999999999999999987665 489999998654322 22222222 245778999999999999
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
..++..||||||++| +|.+.+. .+ ....++..++.||+.||.|||++||+||||||+|||++.+|.++|+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~---~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-- 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVAD---TS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-- 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHT---TC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred EECCcEEEEEEecCCCCHHHHHh---cC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--
Confidence 999999999999985 6666653 23 3666789999999999999999999999999999999999999998543
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYD---AVVRRQEI 271 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~---~i~~~~~~ 271 (627)
|++ +++.++|||||||++|||+||+.||.+.+..+.+. ........
T Consensus 175 ---------------------~~~----------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 ---------------------TMP----------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI 223 (286)
T ss_dssp ---------------------CCT----------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC
T ss_pred ---------------------ccC----------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC
Confidence 333 36779999999999999999999998865433110 00011100
Q ss_pred C--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 272 P--PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 272 ~--~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
. ..+..+++++.++|.+||+.||++| ++.++++.|+....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0 1346789999999999999999999 99999999987643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=317.20 Aligned_cols=244 Identities=15% Similarity=0.156 Sum_probs=183.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--------HHHHHHHHHHHHHHHhc------
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------RMRVLLERLNDLFLKCQ------ 103 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--------~~~~~~~~~~~~ll~~~------ 103 (627)
+..++|++.+.||+|+||.||+|++. + +.||||+++..... ....+ .++..++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~------~~vAvK~~~~~~~~~~~~~~~~~~~~~-~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIAD--H------TPVAIKIIAIEGPDLVNGSHQKTFEEI-LPEIIISKELSLLSGEV 87 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEET--T------EEEEEEEEEESCSSCBTTBCCBCHHHH-HHHHHHHHHHHHGGGCS
T ss_pred cccccchheeeecccCceEEEEEEeC--C------ceEEEEEEecCCccccccccchhHHHH-HHHHHHHHHHHHhhccc
Confidence 45678999999999999999999872 2 48999999865321 11222 22222222222
Q ss_pred --CCCCceeeEEEEEE------------------------------CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHH
Q 006887 104 --GVEGICWLQGISVI------------------------------NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVF 150 (627)
Q Consensus 104 --~hpnIv~l~~~~~~------------------------------~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~ 150 (627)
.||||+.+.+++.. .+..||||||++| ++++.+. .+.+++..++
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~ 164 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAK 164 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHH
Confidence 58888888887542 6789999999985 4666553 3678999999
Q ss_pred HHHHHHHHHHHHHH-HCCCeecccCCCcEEEecCC--------------------CeeeccCCccccccCCCCCCCCCCc
Q 006887 151 RYAIDLAQGILQLH-SKGILVLNLKPFNFILNEAD--------------------RAVLGDVGIPHLLLGIPLPSSDLPR 209 (627)
Q Consensus 151 ~i~~qIa~aL~yLH-s~gIvHrDLKP~NILld~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~ 209 (627)
.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 165 ~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~ 236 (336)
T 2vuw_A 165 SILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GI 236 (336)
T ss_dssp HHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TE
T ss_pred HHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------Cc
Confidence 99999999999999 99999999999999999887 899999999987643 24
Q ss_pred cCCCCCcCCcccccCCCCCCCCccCcchhHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC-----CCCCCCHHH
Q 006887 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACS-IIEMLTGVQPRCGRSV-DEIYDAVVRRQEIPP-----IPSGLPPAV 282 (627)
Q Consensus 210 ~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGvi-LyelltG~~Pf~~~~~-~e~~~~i~~~~~~~~-----~p~~~s~~l 282 (627)
.+||+.|||||++.+. .+.++|||||+++ .+++++|..||.+... ..+...+........ .+..+++++
T Consensus 237 ~~gt~~y~aPE~~~g~----~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGD----GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp EECCCCTTCSGGGCCC----SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred EEEeecccChhhhcCC----CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHH
Confidence 5899999999999753 3789999998777 7778999999854221 223333332211111 123578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHH-HHHHhcccccCC
Q 006887 283 ENVLLGCFEYDLRSRPLMTDIL-RVFKSSQNSVHS 316 (627)
Q Consensus 283 ~~li~~cL~~dP~~RPs~~eil-~~L~~~~~~~~~ 316 (627)
.+||.+||++| |+.+++ + |+||.
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~------Hp~f~ 336 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQ------HSLFK 336 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHH------CGGGC
T ss_pred HHHHHHHhccC-----CHHHHHhc------CCCcC
Confidence 99999999976 999998 7 88863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=339.39 Aligned_cols=240 Identities=20% Similarity=0.244 Sum_probs=184.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++.... ++.||||++..............+. .++..++||||+++++++...+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVN-----GRPVVLKGLVHSGDAEAQAMAMAER-QFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGT-----TEEEEEEESCSSCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCC-----CcEEEEEEeCccCCHHHHHHHHHHH-HHHHhcCCCCcCeEeeeEeecC
Confidence 479999999999999999999986521 2589999987654333222222222 3567789999999999998765
Q ss_pred E-----EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 120 K-----ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 120 ~-----~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
. .||||||++| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 4 7999999996 5544332 379999999999999999999999999999999999999875 999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
++.... .....||+.|||||++.+ .++.++|||||||++|+|++|.+||.+.....+ ....
T Consensus 228 a~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~ 288 (681)
T 2pzi_A 228 VSRINS-------FGYLYGTPGFQAPEIVRT----GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDD 288 (681)
T ss_dssp CEETTC-------CSCCCCCTTTSCTTHHHH----CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTC
T ss_pred chhccc-------CCccCCCccccCHHHHcC----CCCCceehhhhHHHHHHHHhCCCCCcccccccc--------cccc
Confidence 987642 145679999999999863 348899999999999999999999875321100 0000
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHh
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPL-MTDILRVFKS 309 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs-~~eil~~L~~ 309 (627)
.....++.+.+||.+||+.||.+||+ +.++.+.|..
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00123578999999999999999995 5555555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.42 Aligned_cols=252 Identities=19% Similarity=0.216 Sum_probs=188.6
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
.++|++.+.||+|+||.||+|.+..++ +.||||+++............++. .++..++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg------~~VAVKvi~~~~~~~~~~~~~~Ei-~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTG------EQVAIKQCRQELSPKNRERWCLEI-QIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTT------CCEEECCCCSCCCHHHHHHHHHHH-HHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCC------cEEEEEEecccCCHHHHHHHHHHH-HHHHhCCCCCCCceeeeecccc
Confidence 478999999999999999999977655 489999997654333332233333 24566799999999998755
Q ss_pred ----CCEEEEEEecCC-CCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC---eee
Q 006887 118 ----NGKICIIMKFYE-GSVGDRMAQLK-GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR---AVL 188 (627)
Q Consensus 118 ----~~~~~LVmEy~~-GsL~d~l~~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~---vkL 188 (627)
++..|+||||++ |+|.+.+.... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 667899999997 57777765432 236899999999999999999999999999999999999997765 899
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHH----
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDA---- 264 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~---- 264 (627)
+|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+......+..
T Consensus 166 ~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 166 IDLGYAKELDQG----ELCTEFVGTLQYLAPELLEQ---KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp CSCCCCCBTTSC----CCCCCCCSCCTTCSSCSSCC---SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred cccccccccccc----cccccccCCcccCChHHhcc---CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 999999876432 23345689999999999973 4789999999999999999999999976533221100
Q ss_pred -----HHh-----c----cCC----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 006887 265 -----VVR-----R----QEI----PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305 (627)
Q Consensus 265 -----i~~-----~----~~~----~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~ 305 (627)
+.. . ... ..++..+++.+.++|.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~ 297 (676)
T 3qa8_A 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297 (676)
T ss_dssp -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence 000 0 000 0122346789999999999999999999988654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=286.00 Aligned_cols=191 Identities=12% Similarity=0.030 Sum_probs=126.8
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCc---------hhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK---------EDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~---------~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.....++.|++|.+..++....++ .||+|++.+.. .+.....+.++.+++.+...|+||++++++
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~------~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~ 310 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGE------DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH 310 (569)
T ss_dssp EEECC-C--------CCEEEEECS------SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE
T ss_pred hhhhccccCCcccccccccccccc------eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 334456778888777777666654 69999997532 111122334444445555589999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+++++..||||||++| +|.+.+. ..+++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus 311 ~ed~~~~yLVMEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 311 GENAQSGWLVMEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EECSSEEEEEEECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCEEEEEEecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeeccc
Confidence 9999999999999997 7777775 45677764 4789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP 252 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P 252 (627)
|+..... .....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 386 Ar~~~~~---~~~~~t~vGTp~YmAPE~l~g----~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQD---CSWPTNLVQSFFVFVNELFAE----NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC------CCSHHHHHHHHHHHHHHC---------------------CCCCTTHHH
T ss_pred CeeCCCC---CccccCceechhhccHHHhCC----CCCCcccccccccchhhhccccch
Confidence 9876432 233456789999999999964 467789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-24 Score=241.97 Aligned_cols=189 Identities=16% Similarity=0.113 Sum_probs=133.2
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHH-----HHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMR-----VLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~-----~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
...+.||+|+||.||+|.... ..+|+|+...... .... ....++. .+++.++||||+.+..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD--------FDVIIKERVKKGYRDERLDENIRKSRTAREA-RYLALVKDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEEECSS--------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHH-HHHHHGGGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECC--------CeEEEEEEecccccchhhhhHHHHHHHHHHH-HHHHhcCCCCcCceEEEEE
Confidence 446789999999999995322 3689998754321 1111 1112222 2556679999996666666
Q ss_pred ECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 117 INGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 117 ~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..+..||||||++ |+|.+.+.. +..++.||+.||.|||+++|+||||||+|||++. .+||+|||+++
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred eCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence 7778899999998 566665532 6689999999999999999999999999999998 99999999998
Q ss_pred cccCCCCCCC----CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCC
Q 006887 196 LLLGIPLPSS----DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 196 ~~~~~~~~~~----~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
.......... .....+||+.|||||++.... ..|+..+|+||...-.++...++.+|.
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~-~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL-EGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH-HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH-HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 7643110000 113568999999999997532 247888999999988888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=199.73 Aligned_cols=142 Identities=11% Similarity=0.021 Sum_probs=101.8
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----------------HHHHHHHHHHHHHHhcCCC
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----------------MRVLLERLNDLFLKCQGVE 106 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----------------~~~~~~~~~~~ll~~~~hp 106 (627)
++.+.||+|+||.||+|++ .++ +.||||+++...... ......++..++.. ++|.
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g------~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~-l~~~ 164 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK-LQGL 164 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH-TTTS
T ss_pred EecCEeccCCCceEEEEEe-CCC------CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh-ccCC
Confidence 3449999999999999998 444 489999997532210 11222233333333 3334
Q ss_pred CceeeEEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 107 GICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 107 nIv~l~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
.+.+++.. +..|+||||++| +|.+ + .......++.|++.||.|||++||+||||||+|||++ ++.
T Consensus 165 ---~v~~~~~~-~~~~lvmE~~~g~~L~~-l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 ---AVPKVYAW-EGNAVLMELIDAKELYR-V--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp ---SSCCEEEE-ETTEEEEECCCCEEGGG-C--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred ---CcCeEEec-cceEEEEEecCCCcHHH-c--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 44444433 456999999986 6554 2 1234557999999999999999999999999999999 999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCccccc
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 223 (627)
++|+|||+|+. +..|+|||++.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999998864 34478999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=174.48 Aligned_cols=138 Identities=17% Similarity=0.172 Sum_probs=96.6
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccE--EEEEEecCCchh-----------------------HHHHHHHHHH
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHE--VAVKILHPVKED-----------------------RMRVLLERLN 96 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~--VAVK~l~~~~~~-----------------------~~~~~~~~~~ 96 (627)
-|++.+.||+|+||.||+|.+..++ +. ||||+++..... .......++.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 121 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDG------KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF 121 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETT------EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCC------cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence 3789999999999999999975444 37 999997653211 0011122222
Q ss_pred HHHHHhcCCCCc--eeeEEEEEECCEEEEEEecCC--C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCC
Q 006887 97 DLFLKCQGVEGI--CWLQGISVINGKICIIMKFYE--G----SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLH-SKG 167 (627)
Q Consensus 97 ~~ll~~~~hpnI--v~l~~~~~~~~~~~LVmEy~~--G----sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~g 167 (627)
. .+..+.|+++ +.++.. +..+|||||++ | +|.+.... .++..+..++.||+.+|.||| +.|
T Consensus 122 ~-~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 122 R-NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp H-HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred H-HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 2 3344455543 333332 24689999995 3 44433221 235578899999999999999 999
Q ss_pred CeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 168 ILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 168 IvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=167.03 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=91.0
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch-----------------hH---HHHHHHHHHHHHHHh
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE-----------------DR---MRVLLERLNDLFLKC 102 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~-----------------~~---~~~~~~~~~~~ll~~ 102 (627)
|++..+||+|+||.||+|.+.. ++.||||+++.... .. ........+...+..
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECCC-------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 8999999999999999998632 45899999764210 00 001111111112233
Q ss_pred cCCCCceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec
Q 006887 103 QGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE 182 (627)
Q Consensus 103 ~~hpnIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~ 182 (627)
+.+.++....-+.... .+|||||++|..+..+ .....+..++.||+.+|.|||+.|||||||||.|||+++
T Consensus 170 L~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp HHHTTCSCCCEEEEET--TEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred HHhcCCCCCeeeeccC--ceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 3333332222222223 3799999998433221 122345678899999999999999999999999999988
Q ss_pred CCC----------eeeccCCcccc
Q 006887 183 ADR----------AVLGDVGIPHL 196 (627)
Q Consensus 183 ~g~----------vkL~DFGla~~ 196 (627)
++. +.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 773 88999996643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=116.99 Aligned_cols=140 Identities=13% Similarity=0.029 Sum_probs=99.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
..|++...++.|+.+.||++... +..+++|+.......... ...++...+.....+..++++++++...+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~~~~~-~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTY-DVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTT-CHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccCCCHH-HHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 36899999999999999999732 237999998752111111 122222233333346778899999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS----------------------------------- 165 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs----------------------------------- 165 (627)
.|+||||++|..+.... .+......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred eEEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999994433321 1223345778899999999998
Q ss_pred ------------------------CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 ------------------------KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ------------------------~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876556799999653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=108.52 Aligned_cols=134 Identities=9% Similarity=-0.057 Sum_probs=86.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCC-CceeeEEEEEECCE
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVE-GICWLQGISVINGK 120 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hp-nIv~l~~~~~~~~~ 120 (627)
.|.+....+.|..+.||++... + +..+++|+........... +...+.....+. .+++++++...++.
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~------g~~~vlK~~~~~~~~~~~~----E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-G------RPVLFVKTDLSGALNELQD----EAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-T------SCCEEEEEECSCTTSCHHH----HHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred CCceEecccCCCCceEEEEecC-C------CCeEEEEeCCcccchhhhH----HHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 4555443345566999999642 2 2369999986542222221 222222222332 26678888887788
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--------------------------------- 167 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--------------------------------- 167 (627)
.++||||++|..++ . . ... ...++.+++..|..||+..
T Consensus 90 ~~~v~e~i~G~~l~-~---~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL-S---S--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEEECCSSEETT-T---S--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CEEEEEecCCcccC-c---C--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 99999999984433 1 1 112 2356677777777777643
Q ss_pred -------------------------CeecccCCCcEEEecCCCeeeccCCccc
Q 006887 168 -------------------------ILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 168 -------------------------IvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=6.6e-09 Score=109.71 Aligned_cols=141 Identities=12% Similarity=0.043 Sum_probs=94.9
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEec--CCchhHHHHHHHHHHHHHHHhc-CCCCceeeEEEEEEC---
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH--PVKEDRMRVLLERLNDLFLKCQ-GVEGICWLQGISVIN--- 118 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~--~~~~~~~~~~~~~~~~~ll~~~-~hpnIv~l~~~~~~~--- 118 (627)
-.+.|+.|.++.||++.... ..+++|+.. +...........++...+.... .+..+++++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~--------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG--------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS--------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred eEEEcCCcccceEEEEEECC--------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 46779999999999987432 368999876 4321111112222322322222 234578888887765
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS--------------------------------- 165 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs--------------------------------- 165 (627)
+..|+||||++|..+.. ..-..++......++.+++..|..||+
T Consensus 114 g~~~~vme~v~G~~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp SSCEEEEECCCCBCCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred CCeEEEEEecCCeecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 45899999999843211 011346788888999999999999997
Q ss_pred -------------------------CCCeecccCCCcEEEecCCC--eeeccCCcccc
Q 006887 166 -------------------------KGILVLNLKPFNFILNEADR--AVLGDVGIPHL 196 (627)
Q Consensus 166 -------------------------~gIvHrDLKP~NILld~~g~--vkL~DFGla~~ 196 (627)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997764 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=3.4e-09 Score=109.37 Aligned_cols=184 Identities=13% Similarity=0.032 Sum_probs=110.7
Q ss_pred eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCC--ceeeEEEEEECC---EE
Q 006887 47 HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG--ICWLQGISVING---KI 121 (627)
Q Consensus 47 ~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpn--Iv~l~~~~~~~~---~~ 121 (627)
+.++.|....||++. ..+++|+.... ........+.+.+.....+.. ++.++......+ ..
T Consensus 26 ~~~~~G~~n~v~~v~-----------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp CEEEECSSEEEEEST-----------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred EecCCCCcceEEEEC-----------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 458999999999873 15899986533 112223333333323223332 445555443332 35
Q ss_pred EEEEecCCCCHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 006887 122 CIIMKFYEGSVGD-RMAQLKGGKLSLSNVFRYAIDLAQGILQLHS----------------------------------- 165 (627)
Q Consensus 122 ~LVmEy~~GsL~d-~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs----------------------------------- 165 (627)
|+||++++|..+. ... ..++.++...++.|++..|..||+
T Consensus 92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 8999999984332 221 246778888888999999999886
Q ss_pred -----------------------CCCeecccCCCcEEEec--CCCeeeccCCccccccCCCCCCCCCCcc---CC-----
Q 006887 166 -----------------------KGILVLNLKPFNFILNE--ADRAVLGDVGIPHLLLGIPLPSSDLPRR---LG----- 212 (627)
Q Consensus 166 -----------------------~gIvHrDLKP~NILld~--~g~vkL~DFGla~~~~~~~~~~~~~~~~---~G----- 212 (627)
..++|+|++|.||+++. ...+.|+||+.+..-.... ........ .+
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHH
Confidence 13699999999999998 4567899999876532100 00000000 00
Q ss_pred ----CCCcCC-cccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCC
Q 006887 213 ----TPNYMA-PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC 254 (627)
Q Consensus 213 ----T~~YmA-PE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~ 254 (627)
..++.. |+... ......+.|+++.++|.+.+|..+|.
T Consensus 247 ~~l~~Y~~~~~~~~~~-----r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLE-----KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHH-----HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHH-----HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 001112 22221 11223589999999999999987763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=2.6e-05 Score=78.15 Aligned_cols=137 Identities=12% Similarity=-0.035 Sum_probs=84.7
Q ss_pred eEEEeEEeeeCC-eEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEE
Q 006887 43 LKLRHRIGRGPF-GEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 43 y~i~~~LG~G~f-G~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~ 121 (627)
|+.. .+..|.. +.||+......+ ..+++|+-....... +..+...+.....+-.+++++.++.+.+..
T Consensus 27 ~~~~-~~~~G~S~~~v~rl~~~~~~------~~~~lk~~~~~~~~~----~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 27 YRWA-RDNVGQSGATIYRLYGKPNA------PELFLKHGKGSVAND----VTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp CEEE-EEECSSSSCEEEEEECCTTC------CCEEEEEEETHHHHH----HHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred CeEE-EccCCCcCCeEEEEEecCCC------eEEEEEECCCCCHhH----HHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 4433 3444544 479988754332 468999876443222 222222332222333478888999999999
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q 006887 122 CIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK----------------------------------- 166 (627)
Q Consensus 122 ~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~----------------------------------- 166 (627)
|+|||+++|..+...... .......+..+++..|..||+.
T Consensus 96 ~lvme~l~G~~~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp EEEEECCCSEEHHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred EEEEEeeCCccccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 999999998433222110 1122334455566666666631
Q ss_pred -----------------------CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 -----------------------GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 -----------------------gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987767799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.1e-05 Score=78.99 Aligned_cols=134 Identities=16% Similarity=0.111 Sum_probs=81.7
Q ss_pred EeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCC-C-CceeeEEEEE-ECCEEE
Q 006887 46 RHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV-E-GICWLQGISV-INGKIC 122 (627)
Q Consensus 46 ~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~h-p-nIv~l~~~~~-~~~~~~ 122 (627)
.+.++.|....||+. . ..+++|+-.. .. .......+.+.+.....+ + .++..+.++. ..+..|
T Consensus 24 v~~l~~G~~n~v~~v----g-------~~~VlR~~~~--~~-~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~ 89 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----N-------GDWVFRFPKS--QQ-GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF 89 (306)
T ss_dssp EEEEEECSSEEEEEE----T-------TTEEEEEESS--HH-HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred eeecCCCcceeEEEE----C-------CEEEEEecCC--ch-HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence 345788888899988 1 2589998532 11 122233333333332222 1 3566666664 345678
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------
Q 006887 123 IIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK------------------------------------ 166 (627)
Q Consensus 123 LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~------------------------------------ 166 (627)
+||||++|..+..... ..++......++.++...|..||+.
T Consensus 90 ~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 9999999944332111 1234555555555666666555542
Q ss_pred ------------------------CCeecccCCCcEEEec---CCCe-eeccCCcccc
Q 006887 167 ------------------------GILVLNLKPFNFILNE---ADRA-VLGDVGIPHL 196 (627)
Q Consensus 167 ------------------------gIvHrDLKP~NILld~---~g~v-kL~DFGla~~ 196 (627)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4564 7999997653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00013 Score=75.24 Aligned_cols=30 Identities=13% Similarity=0.088 Sum_probs=27.0
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00021 Score=76.11 Aligned_cols=29 Identities=10% Similarity=0.075 Sum_probs=24.9
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++|+|+.|.|||++.+ .++|+||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 569999999999999865 48999998664
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0003 Score=73.51 Aligned_cols=30 Identities=10% Similarity=-0.011 Sum_probs=25.1
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 468999999999999964457899999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00094 Score=71.78 Aligned_cols=32 Identities=6% Similarity=0.128 Sum_probs=27.5
Q ss_pred HHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 164 Hs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+...++|+|++|.|||++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 346799999999999998776 99999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0016 Score=66.50 Aligned_cols=29 Identities=14% Similarity=0.091 Sum_probs=24.7
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.++|+|+.|.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 6677889999997653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0045 Score=64.15 Aligned_cols=76 Identities=20% Similarity=0.298 Sum_probs=50.2
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH--HHhcCCCCceeeEEEEEECCEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF--LKCQGVEGICWLQGISVINGKI 121 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l--l~~~~hpnIv~l~~~~~~~~~~ 121 (627)
.-.+.|+.|....+|+.... +..+++|+....... ....+.+.+ +.......+++++..+...+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~~~~----~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--------VQTVFVKINERSYRS----MFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--------SCEEEEEEEEGGGHH----HHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeeEEeCCccceeeeEEEEC--------CCeEEEEeCCcccHH----HHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 34677999999999998731 237899987643221 122222222 2222235678888888878899
Q ss_pred EEEEecCCCC
Q 006887 122 CIIMKFYEGS 131 (627)
Q Consensus 122 ~LVmEy~~Gs 131 (627)
|+||||++|.
T Consensus 107 ~lvme~l~G~ 116 (312)
T 3jr1_A 107 FLLLEALNKS 116 (312)
T ss_dssp EEEEECCCCC
T ss_pred EEEEEeccCC
Confidence 9999999974
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.005 Score=60.41 Aligned_cols=138 Identities=9% Similarity=0.005 Sum_probs=92.1
Q ss_pred CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCc
Q 006887 131 SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPR 209 (627)
Q Consensus 131 sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~ 209 (627)
+|.+.+. ..+.+|++++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 4555554 478899999999999999999877622 1112344567999999999988764 2110
Q ss_pred cCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHh
Q 006887 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGC 289 (627)
Q Consensus 210 ~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~c 289 (627)
.....+.+||... ...+.+.=|||||+++|.-+--.. .+..+..+|++|.+||..|
T Consensus 98 -~~~~~~~~pe~~~----~~~te~~~IysLG~tLY~ALDygL-------------------~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 -AGEPPPVAGKLGY----SQCMETEVIESLGIIIYKALDYGL-------------------KENEERELSPPLEQLIDHM 153 (229)
T ss_dssp ----------CCSS----SSSCHHHHHHHHHHHHHHHHTTTC-------------------CTTEEECCCHHHHHHHHHH
T ss_pred -ccccCCCChhhcc----ccchHHHHHHHHHHHHHHHhhcCC-------------------CcccchhhCHHHHHHHHHH
Confidence 1122456888753 134567789999999998775322 2334677999999999999
Q ss_pred hhc-------------------------CCCCCCCHHHHHHHHH
Q 006887 290 FEY-------------------------DLRSRPLMTDILRVFK 308 (627)
Q Consensus 290 L~~-------------------------dP~~RPs~~eil~~L~ 308 (627)
... .+..|++++++++.=.
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 865 2357788888887443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.023 Score=57.98 Aligned_cols=146 Identities=14% Similarity=0.126 Sum_probs=75.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCC-chhHHHHHHHHHHHHHHH-hcCCCCceeeE-E--EE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPV-KEDRMRVLLERLNDLFLK-CQGVEGICWLQ-G--IS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~-~~~~~~~~~~~~~~~ll~-~~~hpnIv~l~-~--~~ 115 (627)
....-.+.|+.|....+|+..... + .+++|+..+. .......+..... .+.. ....|.++... + +.
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~~-g-------~~vlk~~~~~~~~~~l~~e~~~l~-~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTTK-D-------PLILTLYEKRVEKNDLPFFLGLMQ-HLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEESS-C-------CEEEEEECC---CCHHHHHHHHHH-HHHHTTCCCCCBCCBTTCCSCE
T ss_pred CcceEeeccCCCcccceEEEEeCC-c-------cEEEEEeCCCCCHHHHHHHHHHHH-HHHHCCCCCCcccCCCCCCEEE
Confidence 344556778888889999987432 1 5899998763 2222222222211 1111 12233333210 1 12
Q ss_pred EECCEEEEEEecCCCCHH------------HHH---HHh-cC--CC----CCHHHHHH---------------HHHHHHH
Q 006887 116 VINGKICIIMKFYEGSVG------------DRM---AQL-KG--GK----LSLSNVFR---------------YAIDLAQ 158 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~------------d~l---~~~-~~--~~----ls~~~~~~---------------i~~qIa~ 158 (627)
...+..+++|+|++|... ..+ ... .. .+ ........ +...+..
T Consensus 93 ~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~ 172 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 172 (322)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHH
Confidence 345788999999998321 111 111 11 01 11110000 0112444
Q ss_pred HHHHHHH-------CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 159 GILQLHS-------KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 159 aL~yLHs-------~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.+..++. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 173 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5566653 369999999999999977556799999654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.012 Score=59.46 Aligned_cols=78 Identities=9% Similarity=-0.066 Sum_probs=45.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCC--CCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGV--EGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~h--pnIv~l~~~~~~~ 118 (627)
....-.+.+|.|..+.||+.+.. +|+.|.+|+-....... ....+.+.+.+...... -.+++.+.. ..
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-------DG~~~~vK~~~~~~~~~-~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~ 84 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-------DGTPLFVKALPDDAPAL-DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD 84 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-------TSCEEEEEECCTTCCCC-TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-------CCCEEEEEEeCCCCcch-hhHHHHHHHHHHHHHhhCCCCcceEEec--cC
Confidence 45677889999999999999753 34589999875433211 11122222222222222 124455544 23
Q ss_pred CEEEEEEecCCC
Q 006887 119 GKICIIMKFYEG 130 (627)
Q Consensus 119 ~~~~LVmEy~~G 130 (627)
.++||||+.+
T Consensus 85 --~~lv~e~l~~ 94 (288)
T 3f7w_A 85 --RTLAMEWVDE 94 (288)
T ss_dssp --TEEEEECCCC
T ss_pred --ceEEEEeecc
Confidence 4789999985
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.23 E-value=0.043 Score=56.14 Aligned_cols=29 Identities=10% Similarity=-0.081 Sum_probs=24.6
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3589999999999998 4 889999997643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.60 E-value=0.081 Score=56.99 Aligned_cols=78 Identities=14% Similarity=0.060 Sum_probs=41.6
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCch-hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKE-DRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKIC 122 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~-~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~ 122 (627)
-.+.|+.|....||++.......+ ...+..+++|+...... .... . +...+.....+.-.+++++.+. + .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li---~-E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLV---A-ESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHH---H-HHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHH---H-HHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 356788888899999976431100 01235799999854221 2221 1 1112211112222356666543 3 3
Q ss_pred EEEecCCC
Q 006887 123 IIMKFYEG 130 (627)
Q Consensus 123 LVmEy~~G 130 (627)
+||||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 89999987
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.19 Score=54.75 Aligned_cols=78 Identities=12% Similarity=0.058 Sum_probs=40.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+... ++.|+.|-...+|++..... +..+++|+..+....-... ..+...+..+..+.-.+++++.+ .+
T Consensus 108 ~~~~~-i~~lsgG~tN~~y~v~~~~~------~~~~vLRi~g~~~~~~idR--~~E~~vl~~L~~~gl~P~ll~~~--~~ 176 (458)
T 2qg7_A 108 VDSLE-FQIINGGITNILIKVKDMSK------QAKYLIRLYGPKTDEIINR--EREKKISCILYNKNIAKKIYVFF--TN 176 (458)
T ss_dssp STTEE-EEEECC--CEEEEEEEETTT------TEEEEEEEECC-CCSCSCH--HHHHHHHHHHTTSSSBCCEEEEE--TT
T ss_pred ccCeE-EEEcCCCeEeEEEEEEECCC------CceEEEEECCCChhhhcCH--HHHHHHHHHHHhcCCCCCEEEEe--CC
Confidence 34444 45688888899999975431 2368999875432111110 11222222222232345677766 33
Q ss_pred EEEEEEecCCC
Q 006887 120 KICIIMKFYEG 130 (627)
Q Consensus 120 ~~~LVmEy~~G 130 (627)
.+||||++|
T Consensus 177 --G~v~e~I~G 185 (458)
T 2qg7_A 177 --GRIEEFMDG 185 (458)
T ss_dssp --EEEEECCCS
T ss_pred --eEEEEeeCC
Confidence 359999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.046 Score=57.21 Aligned_cols=28 Identities=18% Similarity=-0.027 Sum_probs=23.5
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.+.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998654 8999998664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.46 E-value=0.045 Score=58.15 Aligned_cols=151 Identities=15% Similarity=0.125 Sum_probs=75.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCC-cCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLST-EDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~-ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
++.+.+++ +.|..|-...+|++...... .....+..|++|+..+..... ... .++.+++.....+.-.+++++.+.
T Consensus 48 ~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~-~~~-~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 48 VQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGV-DSL-VLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp CCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCH-HHH-HHHHHHHHHHHHTTSSCCEEEEET
T ss_pred CCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchH-HHH-HHHHHHHHHHHhcCCCCeEEEEcC
Confidence 33455554 45766777889998753210 001123579999864321111 111 122222222112222356666553
Q ss_pred ECCEEEEEEecCCCCHH---------------HHHHHhcC------CCCC--HHHHHHHHHHHHH---------------
Q 006887 117 INGKICIIMKFYEGSVG---------------DRMAQLKG------GKLS--LSNVFRYAIDLAQ--------------- 158 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~---------------d~l~~~~~------~~ls--~~~~~~i~~qIa~--------------- 158 (627)
+ .+||||++|..+ +.+..... +... +..+.+|..++..
T Consensus 125 --~--g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 --E--GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp --T--EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred --C--ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 3 399999997221 11221111 1122 3455556554422
Q ss_pred ----HHHHHH----H----CCCeecccCCCcEEEecC----CCeeeccCCccc
Q 006887 159 ----GILQLH----S----KGILVLNLKPFNFILNEA----DRAVLGDVGIPH 195 (627)
Q Consensus 159 ----aL~yLH----s----~gIvHrDLKP~NILld~~----g~vkL~DFGla~ 195 (627)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233333 2 248999999999999876 789999999765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.11 Score=53.94 Aligned_cols=31 Identities=13% Similarity=0.120 Sum_probs=27.3
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.026 Score=58.15 Aligned_cols=31 Identities=13% Similarity=0.048 Sum_probs=26.7
Q ss_pred CCCeecccCCCcEEEecC----CCeeeccCCcccc
Q 006887 166 KGILVLNLKPFNFILNEA----DRAVLGDVGIPHL 196 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~----g~vkL~DFGla~~ 196 (627)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6789999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=91.09 E-value=0.52 Score=50.70 Aligned_cols=29 Identities=10% Similarity=0.084 Sum_probs=25.5
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
.++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 8888999999997753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 627 | ||||
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-41 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-34 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-07 |
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 5e-41
Identities = 50/259 (19%), Positives = 95/259 (36%), Gaps = 15/259 (5%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVE 106
IG G FG V+ A ++E VA+K + + + + ++ FL+
Sbjct: 22 EIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+G + ++M++ GS D + ++ L + QG+ LHS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
++ ++K N +L+E LGD G ++ + +GTP +MAPE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMAPEVILAMD 187
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286
G + D W + IE+ P + + + + N +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 287 LGCFEYDLRSRPLMTDILR 305
C + + RP +L+
Sbjct: 248 DSCLQKIPQDRPTSEVLLK 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 16/283 (5%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W I + + RIG G FG V+ + +VAVK+L+ ++ +
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKN 53
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
L+ I G S ++ I+ ++ EGS + K + + A
Sbjct: 54 EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
AQG+ LH+K I+ +LK N L+E +GD G+ + S + G+
Sbjct: 113 TAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK-SRWSGSHQFEQLSGSIL 171
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP-- 273
+MAPE + + + P SF++D + F + E++TG P + + +V R + P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 274 --IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314
+ S P A++ ++ C + RPL IL + S+
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 9/276 (3%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I L+L ++G G FG V + + VAVK L P + + + + +
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS---GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 98 L-FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+ + + L G+ V+ + ++ + + G L + RYA+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
A+G+ L SK + +L N +L D +GD G+ L R +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
APE + S +D+W F ++ EM T G +P G + +I + + E P P
Sbjct: 181 CAPESLK---TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311
P + NV++ C+ + RP + +Q
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-40
Identities = 54/263 (20%), Positives = 101/263 (38%), Gaps = 18/263 (6%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKC 102
++ +G+G FG V+LA S +A+K+L + ++ V + ++
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKF------ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 103 QGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
I L G ++ +I+++ R Q K K Y +LA +
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSY 121
Query: 163 LHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQW 222
HSK ++ ++KP N +L A + D G + PSS GT +Y+ PE
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFG-----WSVHAPSSRRTTLCGTLDYLPPEMI 176
Query: 223 QPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAV 282
+ + D W E L G P + E Y + R + P +
Sbjct: 177 E---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGA 231
Query: 283 ENVLLGCFEYDLRSRPLMTDILR 305
+++ +++ RP++ ++L
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 48/269 (17%), Positives = 86/269 (31%), Gaps = 17/269 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I P L +G G FG V + VA+K++ + E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-------VAIKMIKEGSMSEDEFIEEAKVM 53
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ L E + L G+ I II ++ + + + D+
Sbjct: 54 MNLSH---EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+ + L SK L +L N ++N+ + D G+ +L SS +
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWS 168
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
PE S ++D W F + E+ + G P + E + + + P
Sbjct: 169 PPEVLM---YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-LYRPH 224
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305
V ++ C+ RP +L
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 54/272 (19%), Positives = 102/272 (37%), Gaps = 6/272 (2%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I PS + + IG G FGEV+ T + VA+K L ++ RV
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ + I L+G+ + II ++ E D+ + K G+ S+ + +A
Sbjct: 62 IMGQFSH-HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
G+ L + + +L N ++N + D G+ +L P + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSG 277
APE + +D W F + E++T + + + P P
Sbjct: 181 APEAIS---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 278 LPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
P A+ +++ C++ + RP DI+ +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 49/265 (18%), Positives = 95/265 (35%), Gaps = 14/265 (5%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
++ +G G FG+V+ A + ++ A K++ E+ + + ++ L
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSV------LAAAKVIDTKSEEELEDYMVEID--ILASC 66
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
I L + I+++F G D + L+ S + + L
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
H I+ +LK N + L D G+ +GTP +MAPE
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR---TIQRRDSFIGTPYWMAPEVVM 183
Query: 224 PEV--RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGLPP 280
E P ++ D W ++IEM P + + + + + PS
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 281 AVENVLLGCFEYDLRSRPLMTDILR 305
++ L C E ++ +R + +L+
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 58/318 (18%), Positives = 113/318 (35%), Gaps = 12/318 (3%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+K + K +G G FG V+ E VA+K L + +
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI--PVAIKELREATSPKANKEILDEAY 63
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ +C L GI + + +I + + + + + + +A
Sbjct: 64 VMASVDN-PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+G+ L + ++ +L N ++ + D G+ LL +M
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWM 180
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
A E + ++D W + ++ E++T G +P G EI ++ + E P P
Sbjct: 181 ALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPP 236
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336
V +++ C+ D SRP +++ F G LP + S +
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 296
Query: 337 TEWFLSKEDLKVDDVVRS 354
+ +ED+ DDVV +
Sbjct: 297 YRALMDEEDM--DDVVDA 312
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 56/315 (17%), Positives = 112/315 (35%), Gaps = 29/315 (9%)
Query: 19 DDSDHLRTAVATSNDTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAV 77
D+++ W L+ +G G FG+V AT Y ++ +VAV
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI-QVAV 72
Query: 78 KILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRM 136
K+L + R L + + E I L G ++G I +I ++ G + + +
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 137 AQLKG---------------------GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKP 175
+ L+ ++ +A +A+G+ L K + +L
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192
Query: 176 FNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETD 235
N ++ + D G+ ++ +MAPE G + ++D
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLF---EGIYTIKSD 248
Query: 236 SWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDL 294
W + + E+ + GV P G VD + +++ P + ++ C+ +D
Sbjct: 249 VWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 308
Query: 295 RSRPLMTDILRVFKS 309
R RP ++
Sbjct: 309 RKRPSFPNLTSFLGC 323
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 50/269 (18%), Positives = 97/269 (36%), Gaps = 11/269 (4%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGI 108
+G G FG V + + +VA+K+L E + R + + I
Sbjct: 17 LGCGNFGSVRQGVY----RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYI 71
Query: 109 CWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGI 168
L G+ + ++M+ G + K ++ +SNV ++ G+ L K
Sbjct: 72 VRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 169 LVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRG 228
+ +L N +L A + D G+ L + + APE
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN---FR 187
Query: 229 PISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLL 287
S +D W + ++ E L+ G +P E+ + + + P PP + ++
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMS 246
Query: 288 GCFEYDLRSRPLMTDILRVFKSSQNSVHS 316
C+ Y RP + + ++ S+ S
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-36
Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 19/273 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ LKL R+G G FGEVW+ + T+ VAVK L L E +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTK-------VAVKSLKQGSMSPDAFLAEA--N 60
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDL 156
L + Q + + L + V I II ++ E GS+ D + G KL+++ + A +
Sbjct: 61 LMKQLQH-QRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
A+G+ + + + +L+ N ++++ + D G+ L+ + + + +
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKW 176
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
APE G + ++D W F + E++T G P G + E+ + R P
Sbjct: 177 TAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-MVRP 232
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
P + ++ C++ RP + V +
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-36
Identities = 50/272 (18%), Positives = 98/272 (36%), Gaps = 17/272 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I PS L IG G FG V L L+ + +VA+K + + E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYW-LNKD------KVAIKTIREGAMSEEDFIEEAE-- 52
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ + L G+ + IC++ +F E + + G + + +D+
Sbjct: 53 -VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+G+ L ++ +L N ++ E + D G+ + + + +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWA 169
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
+PE + S ++D W F + E+ + G P RS E+ + + P
Sbjct: 170 SPEVFS---FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-LYKPR 225
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
V ++ C++ RP + +LR
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 8e-36
Identities = 54/292 (18%), Positives = 107/292 (36%), Gaps = 28/292 (9%)
Query: 37 WIKPSALKLRHR-IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV----- 90
++ L L + +G G FG V + + VAVKIL D
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYY----QMKKVVKTVAVKILKNEANDPALKDELLA 57
Query: 91 ---LLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLS 147
++++L++ ++ + GIC ++M+ E ++ Q + +
Sbjct: 58 EANVMQQLDNPYIVR--MIGICE-------AESWMLVMEMAELGPLNKYLQ-QNRHVKDK 107
Query: 148 NVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDL 207
N+ ++ G+ L + +L N +L A + D G+ L
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 208 PRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVV 266
+ APE S ++D W F + E + G +P G E+ +
Sbjct: 168 THGKWPVKWYAPECIN---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-L 223
Query: 267 RRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318
+ E P+G P + +++ C+ YD+ +RP + ++ V ++G
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 56/290 (19%), Positives = 101/290 (34%), Gaps = 23/290 (7%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ L +G G FG+V AT Y + D VAVK+L P R L
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKS-DAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEG-----------------SVGDRMAQLK 140
+ I L G I G +I ++ + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 141 GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200
L L ++ ++ +A+G+ L SK + +L N +L + D G+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRC-GRSVD 259
R +MAPE +FE+D W + + E+ + G VD
Sbjct: 199 SNYVVKGNAR-LPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ +++ P P + +++ C++ D RP I+++ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 133 bits (335), Expect = 1e-35
Identities = 59/278 (21%), Positives = 96/278 (34%), Gaps = 30/278 (10%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----------VKEDRMRVLLE 93
+ + +GRG V H + + E AVKI+ V+E R L E
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCK------EYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 94 RLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRY 152
D+ K G I L+ N ++ + G + D + + LS +
Sbjct: 60 V--DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKI 115
Query: 153 AIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
L + I LH I+ +LKP N +L++ L D G L P L G
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCG 171
Query: 213 TPNYMAPEQWQPEV---RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269
TP+Y+APE + + E D W + +L G P R + ++
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231
Query: 270 EIPPIP--SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P V++++ + R + L
Sbjct: 232 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 1e-35
Identities = 47/263 (17%), Positives = 95/263 (36%), Gaps = 17/263 (6%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+IG+G G V+ A + + EVA++ ++ ++ + +++ + ++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEIL--VMREN 74
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
I ++ ++ ++M++ G G + + + + Q + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS ++ ++K N +L L D G I S +GTP +MAPE
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ---ITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP-PIPSGLPPAV 282
R + D W IEM+ G P + + P L
Sbjct: 190 ---RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 283 ENVLLGCFEYDLRSRPLMTDILR 305
+ L C + D+ R ++L+
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 1e-35
Identities = 58/283 (20%), Positives = 115/283 (40%), Gaps = 18/283 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
++ + + ++H++G G +GEV+ + VAVK L + L E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDTMEVEEFLKEAA-- 65
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDL 156
+K + L G+ II +F G++ D + + ++S + A +
Sbjct: 66 -VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 157 AQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
+ + L K + +L N ++ E + D G+ L+ G + +
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKW 182
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275
APE S ++D W F + E+ T G+ P G + ++Y+ ++ + P
Sbjct: 183 TAPESLA---YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERP 238
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS-SQNSVHSD 317
G P V ++ C++++ RP +I + F++ Q S SD
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 1e-35
Identities = 54/274 (19%), Positives = 104/274 (37%), Gaps = 11/274 (4%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I S +K+ IG G FGEV L + VA+K L ++ R
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKR---EIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ + + L+G+ + + II +F E D + G+ ++ + +A
Sbjct: 80 IMGQFDH-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL--GIPLPSSDLPRRLGTPN 215
G+ L + +L N ++N + D G+ L +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPI 274
+ APE Q + +D W + + E+++ G +P + ++ +A+ + +PP
Sbjct: 199 WTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP- 254
Query: 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
P P A+ ++L C++ D RP I+
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 20/277 (7%)
Query: 36 AW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER 94
AW I +L+L ++G+G FGEVW+ T + VA+K L P L E
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTW-------NGTTRVAIKTLKPGTMSPEAFLQEA 63
Query: 95 LNDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYA 153
+K E + L + V I I+ ++ GS+ D + G L L + A
Sbjct: 64 Q---VMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119
Query: 154 IDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGT 213
+A G+ + + +L+ N ++ E + D G+ L+ +
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFP 177
Query: 214 PNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272
+ APE G + ++D W F + E+ T G P G E+ D V R
Sbjct: 178 IKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M 233
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
P P P ++ +++ C+ + RP + +
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 12/263 (4%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
L +G G +GEV LA + ++ E VAVKI+ + +++ +
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
E + G + +++ G + + + R+ L G++ L
Sbjct: 62 H-ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
H GI ++KP N +L+E D + D G+ + L + GT Y+APE +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEIPPIPSGLPPAV 282
R + D W + ML G P S + Y ++ + A
Sbjct: 179 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 283 ENVLLGCFEYDLRSRPLMTDILR 305
+L + +R + DI +
Sbjct: 237 LALLHKILVENPSARITIPDIKK 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 6e-35
Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 24/279 (8%)
Query: 37 W-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
W + LKL IG+G FG+V L + ++VAVK + L E
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDY--------RGNKVAVKCIKN-DATAQAFLAEAS 52
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAI 154
L+ + + L I G + I+ ++ GS+ D + L + ++++
Sbjct: 53 VMTQLRHSNL--VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 110
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
D+ + + L + +L N +++E + A + D G+ SS
Sbjct: 111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPV 164
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273
+ APE + S ++D W F + E+ + G P + ++ V +
Sbjct: 165 KWTAPEALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMD 220
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312
P G PPAV V+ C+ D RP + + +
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-35
Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 12/273 (4%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
I+ ++L IG G FG+V + + VA+K D +R +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ I L G+ + + IIM+ Q++ L L+++ YA L+
Sbjct: 61 TMRQFDH-PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 158 QGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYM 217
+ L SK + ++ N +++ D LGD G+ + + + +M
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWM 176
Query: 218 APEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
APE + +D W F + E+L GV+P G +++ + E P+P
Sbjct: 177 APESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPP 232
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
PP + +++ C+ YD RP T++ +
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 53/282 (18%), Positives = 110/282 (39%), Gaps = 17/282 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + + +G+G FG V+ +D E VA+K ++ R R+
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPE-TRVAIKTVNEAASMRERIEFLNEAS 75
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKG--------GKLSLSN 148
+ + + L G+ +IM+ G + + L+ SLS
Sbjct: 76 VMKEFNCHHVVRLL-GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 149 VFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP 208
+ + A ++A G+ L++ + +L N ++ E +GD G+ +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGG 193
Query: 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ-PRCGRSVDEIYDAVVR 267
+ L +M+PE + G + +D W F + E+ T + P G S +++ V+
Sbjct: 194 KGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249
Query: 268 RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ P P + ++ C++Y+ + RP +I+ K
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 130 bits (328), Expect = 9e-35
Identities = 57/275 (20%), Positives = 102/275 (37%), Gaps = 22/275 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--VKEDRMRVLLERLNDLFLK 101
+L +G G EV LA +VAVK+L ++ + R
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHR------DVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 102 CQG---VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQ 158
V + + I+M++ +G + G ++ D Q
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQ 122
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
+ H GI+ ++KP N +++ + + D GI + + +GT Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IPS 276
PEQ + + +D + C + E+LTG P G S + VR IPP
Sbjct: 183 PEQAR---GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 277 GLPPAVENVLLGCFEYDLRSRP-----LMTDILRV 306
GL ++ V+L + +R + D++RV
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 54/271 (19%), Positives = 97/271 (35%), Gaps = 24/271 (8%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLF 99
LK IGRG F V+ +T EVA L K +R R E
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 100 LKC-QGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQ 158
L+ V + I ++ + + + + + + + + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILK 123
Query: 159 GILQLHSKGILVL--NLKPFNFILNEAD-RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
G+ LH++ ++ +LK N + +GD+G+ L +S +GTP
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPE 178
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPI 274
+MAPE + D + F ++EM T P ++ +IY V +
Sbjct: 179 FMAPEMY----EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234
Query: 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P V+ ++ GC + R + D+L
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 48/287 (16%), Positives = 93/287 (32%), Gaps = 28/287 (9%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+ + +K + IG G FG+V A + + A+K + +
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARI----KKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEG---------------SVGDRMAQLKGG 142
+ K I L G G + + +++ +A
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 143 KLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202
LS + +A D+A+G+ L K + +L N ++ E A + D G+
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QE 178
Query: 203 PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ-PRCGRSVDEI 261
+MA E + +D W + + E+++ P CG + E+
Sbjct: 179 VYVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 262 YDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
Y+ + + P V +++ C+ RP IL
Sbjct: 236 YEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (324), Expect = 6e-34
Identities = 55/290 (18%), Positives = 103/290 (35%), Gaps = 31/290 (10%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
++ IG G FG V+ A + + VAVK+L M+ +R L +
Sbjct: 15 IEYVRDIGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 103 QGVEGICWLQGISVINGKICIIMKFYEG-----------------------SVGDRMAQL 139
+ L G+ + +C++ ++ S R++
Sbjct: 74 DNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 140 KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199
LS + A +A G+ L + + +L N ++ E + D G+ +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSV 258
+D +M PE + E+D W + + E+ + G+QP G +
Sbjct: 193 ADYYKAD-GNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
+E+ V R I P P + N++ C+ RP I R+ +
Sbjct: 249 EEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-34
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 23/295 (7%)
Query: 33 DTNAW-IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL 91
D + W LKL +GRG FG+V A + + VAVK+L
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATC-RTVAVKMLKEGATHSEHRA 62
Query: 92 LERLNDLFLKCQGVEGICWLQGISVI-NGKICIIMKFYEG---------------SVGDR 135
L + + + L G G + +I++F +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 136 MAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195
L L+L ++ Y+ +A+G+ L S+ + +L N +L+E + + D G+
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQ-PRC 254
+ P R +MAPE + ++D W F + E+ + P
Sbjct: 183 DIYKDPDYVRKGDAR-LPLKWMAPETIF---DRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 255 GRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
G +DE + ++ P P + +L C+ + RP ++++ +
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 129 bits (326), Expect = 1e-33
Identities = 49/266 (18%), Positives = 90/266 (33%), Gaps = 19/266 (7%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +G G FG V T + A K + E + + + +
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPHESDKETVRKEIQ--TMSVL 80
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+ L + ++ +I +F G + K+S Y + +G+ +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 164 HSKGILVLNLKPFNFILN--EADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
H + L+LKP N + ++ L D G+ L P + GT + APE
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEFAAPEV 196
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IPSGLP 279
+ P+ + TD W +L+G+ P G + DE V SG+
Sbjct: 197 AE---GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 280 PAVENVLLGCFEYDLRSRPLMTDILR 305
++ + D +R + L
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (325), Expect = 1e-33
Identities = 58/281 (20%), Positives = 103/281 (36%), Gaps = 25/281 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILH-PVKEDRMRVLLERLNDLFLKC 102
+ +G G FG V + K ++ P D+ V E + +
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGR------VFVAKFINTPYPLDKYTVKNEI--SIMNQL 83
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
+ L ++ +I++F G + DR+A + K+S + V Y +G+
Sbjct: 84 HH-PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLK 141
Query: 162 QLHSKGILVLNLKPFNFIL--NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+H I+ L++KP N + +A + D G+ L P + T + AP
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEFAAP 197
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IPSG 277
E R P+ F TD W +L+G+ P G E V R S
Sbjct: 198 EIVD---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 278 LPPAVENVLLGCFEYDLRSRPLMTDILR--VFKSSQNSVHS 316
+ P ++ + + + R R + D L K +++ S
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-33
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 22/288 (7%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEY-HEVAVKILHPVKEDRMRVLLERLN 96
+ L L +G G FG+V LA +D +VAVK+L ++ L
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 97 DLFLKCQGVEGICWLQGISVINGKICIIMKFYEG---------------SVGDRMAQLKG 141
++ + I L G +G + +I+++ +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 142 GKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIP 201
+LS ++ A +A+G+ L SK + +L N ++ E + + D G+ + I
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 202 LPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDE 260
+MAPE + ++D W F + E+ T G P G V+E
Sbjct: 190 YYKK-TTNGRLPVKWMAPEALF---DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 261 IYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308
++ +++ PS + ++ C+ RP ++
Sbjct: 246 LFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 9e-33
Identities = 52/270 (19%), Positives = 100/270 (37%), Gaps = 18/270 (6%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--VKEDRMRVLLERL 95
+P K +G G F V LA ++ E A+KIL + ++ + R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSR------EYAIKILEKRHIIKENKVPYVTRE 58
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAI 154
D+ + L + K+ + + + G+ + + K G + Y
Sbjct: 59 RDVMSRLDH-PFFVKLYFTFQDDEKLYFGLSYAKN--GELLKYIRKIGSFDETCTRFYTA 115
Query: 155 DLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTP 214
++ + LH KGI+ +LKP N +LNE + D G +L + +GT
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTA 174
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPI 274
Y++PE +D W C I +++ G+ P + I+ +++ +
Sbjct: 175 QYVSPELLT---EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDF 229
Query: 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P P +++ D R ++
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 49/276 (17%), Positives = 105/276 (38%), Gaps = 11/276 (3%)
Query: 38 IKPSALKLR--HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERL 95
I PS+L + IGRG FG V+ T ++ + AVK L+ + +
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
+ + L G +++ + + + + ++ ++ + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS-SDLPRRLGTP 214
+A+G+ L SK + +L N +L+E + D G+ + S +
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273
+MA E Q + ++D W F + E++T G P + +I +++ +
Sbjct: 199 KWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL 254
Query: 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
P P + V+L C+ RP ++++ +
Sbjct: 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 55/273 (20%), Positives = 100/273 (36%), Gaps = 25/273 (9%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLFL 100
++ + IG G +G + + K L + ++ ++ E L
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGK------ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLA 157
K + I N + I+M++ E G + + + + L V R L
Sbjct: 61 KHPNIVRYYDR-IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 158 QGILQLHSKG-----ILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLG 212
+ + H + +L +LKP N L+ LGD G+ +L +S +G
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKAFVG 176
Query: 213 TPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272
TP YM+PEQ R + ++D W C + E+ + P S E+ + R +
Sbjct: 177 TPYYMSPEQMN---RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFR 232
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
IP + ++ RP + +IL
Sbjct: 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 7e-32
Identities = 57/268 (21%), Positives = 103/268 (38%), Gaps = 22/268 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
R +G G F EV LA + + VA+K + + +E + K +
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQK------LVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 104 GVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
I L I G + +IM+ G + DR+ ++ G + + R + +
Sbjct: 66 H-PNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKY 122
Query: 163 LHSKGILVLNLKPFNFILNEAD---RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
LH GI+ +LKP N + D + ++ D G+ + P S L GTP Y+AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED----PGSVLSTACGTPGYVAP 178
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP--SG 277
E + P S D W +L G P + ++++ +++ + P
Sbjct: 179 EVLA---QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 278 LPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ + ++ + E D R L+
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-32
Identities = 62/267 (23%), Positives = 112/267 (41%), Gaps = 23/267 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLF 99
L +G+G FG+V+LA + + A+K L + +D ++E+ +
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTMVEK--RVL 56
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLK-GGKLSLSNVFRYAIDLAQ 158
+ + + +M++ G GD M ++ K LS YA ++
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNG--GDLMYHIQSCHKFDLSRATFYAAEIIL 114
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
G+ LHSKGI+ +LK N +L++ + D G+ L + GTP+Y+A
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKTNTFCGTPDYIA 171
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGL 278
PE + D W F + EML G P G+ +E++ ++ R + P P L
Sbjct: 172 PEILL---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWL 226
Query: 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305
+++L+ F + R + +R
Sbjct: 227 EKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 8e-31
Identities = 47/267 (17%), Positives = 92/267 (34%), Gaps = 22/267 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +GRG FG V S + K + D++ V E L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKK------TYMAKFVKVKGTDQVLVKKEIS---ILNIA 58
Query: 104 GVEGICWLQGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQ 162
I L ++ +I +F G + +R+ +L+ + Y + + +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQF 117
Query: 163 LHSKGILVLNLKPFNFILNEADRAV--LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPE 220
LHS I +++P N I + + + G L P + P Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEYYAPE 173
Query: 221 QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IPSGL 278
Q +S TD W + +L+G+ P + +I + ++ + +
Sbjct: 174 VHQ---HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
Query: 279 PPAVENVLLGCFEYDLRSRPLMTDILR 305
+ + + +SR ++ L+
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-30
Identities = 46/273 (16%), Positives = 87/273 (31%), Gaps = 29/273 (10%)
Query: 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKC 102
+G G G+V + + E + A+K+L + R + + +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDCPKARREVELHWRASQCPHI-- 67
Query: 103 QGVEGICWLQGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
V + + + + I+M+ + G + R+ + + + I
Sbjct: 68 --VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 162 QLHSKGILVLNLKPFNFILNEAD---RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
LHS I ++KP N + L D G + L TP Y+A
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET----TSHNSLTTPCYTPYYVA 181
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP------ 272
PE PE D W + +L G P I + R +
Sbjct: 182 PEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
P S + V+ ++ + + R +T+ +
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 19/265 (7%)
Query: 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND 97
+K + +G G G V+ +H S +A K++H + +R + R
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIRELQ 56
Query: 98 LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLA 157
+ +C I G +G+I I M+ +G D++ + K G++ + + +I +
Sbjct: 57 VLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVI 114
Query: 158 QGILQLHSK-GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNY 216
+G+ L K I+ ++KP N ++N L D G + L S +GT +Y
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSMANSFVGTRSY 169
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276
M+PE+ Q S ++D W S++EM G P E+ ++ ++ +
Sbjct: 170 MSPERLQ---GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAA 224
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMT 301
PP Y + SRP M
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMA 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (302), Expect = 2e-30
Identities = 57/261 (21%), Positives = 101/261 (38%), Gaps = 21/261 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLF 99
+ IGRG FGEV+ + + A+K L +K+ L ER+
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQL-KGGKLSLSNVFRYAIDLAQ 158
+ I + K+ I+ G GD L + G S +++ YA ++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIIL 118
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
G+ +H++ ++ +LKP N +L+E + D+G L +GT YMA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG-----LACDFSKKKPHASVGTHGYMA 173
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP-IPSG 277
PE Q V D + C + ++L G P + ++ + +P
Sbjct: 174 PEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 278 LPPAVENVLLGCFEYDLRSRP 298
P + ++L G + D+ R
Sbjct: 232 FSPELRSLLEGLLQRDVNRRL 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-29
Identities = 43/270 (15%), Positives = 85/270 (31%), Gaps = 30/270 (11%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVK-------EDRMRVLLERLN 96
++ +G G FG V+ VA+K + + + RV +E
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEV-- 58
Query: 97 DLFLKCQ-GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
L K G G+ L +I++ E + G L +
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+ + + H+ G+L ++K N +++ G++ + G L + GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR----GELKLIDFGSGALLKDTVYTDFDGTRV 174
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIP 275
Y PE + W + +M+ G P + ++R Q
Sbjct: 175 YSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEIIRGQ--VFFR 224
Query: 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ ++++ C RP +I
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (291), Expect = 2e-29
Identities = 55/279 (19%), Positives = 96/279 (34%), Gaps = 26/279 (9%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+L +IG G FG+++L T + E EVA+K+ VK ++ +E ++ Q
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLEC-VKTKHPQLHIES--KIYKMMQ 60
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
G GI + G +++ G + + K SL V A + I +
Sbjct: 61 GGVGIPTI-RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 164 HSKGILVLNLKPFNFILNEAD---RAVLGDVGIPHLL----LGIPLPSSDLPRRLGTPNY 216
HSK + ++KP NF++ + D G+ +P + GT Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 217 MAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE------ 270
+ S D ++ G P G R E
Sbjct: 180 ASINTHL---GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
I + G P L C +P + + ++F++
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (290), Expect = 2e-29
Identities = 46/281 (16%), Positives = 87/281 (30%), Gaps = 28/281 (9%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
K+ RIG G FG ++ T+ L+ + +VA+K + L +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKFEPRRSDAPQ---LRDEYRTYKLLA 58
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
G GI + +++ G + + L G K S+ V A + + +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVI-DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL---------GIPLPSSDLPRRLGTP 214
H K ++ ++KP NF++ + + + + +P + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE---- 270
YM+ S D + L G P G R E
Sbjct: 178 RYMSINTHL---GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 271 --IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
+ + +G P + + P + +F
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 48/269 (17%), Positives = 84/269 (31%), Gaps = 18/269 (6%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP--VKEDRMRVLLERLN---DL 98
+G G F V + + A K + K R V E + +
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGL------QYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 99 FLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQ 158
+ Q + L + + +I++ G + L+ + +
Sbjct: 67 LKEIQH-PNVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEATEFLKQILN 124
Query: 159 GILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMA 218
G+ LHS I +LKP N +L + + I L ++ GTP ++A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 219 PEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IPS 276
PE P+ E D W +L+G P G + E V S
Sbjct: 185 PEIVN---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 277 GLPPAVENVLLGCFEYDLRSRPLMTDILR 305
++ + D + R + D L+
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 54/300 (18%), Positives = 99/300 (33%), Gaps = 43/300 (14%)
Query: 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKC 102
+ L+ IG+G FGEVW EVAVKI +E E + L+
Sbjct: 5 IVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREERSWFREAEIYQTVMLRH 56
Query: 103 QG-VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
+ + I + ++ ++ ++E G L +++ + + A+ A G+
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEH--GSLFDYLNRYTVTVEGMIKLALSTASGLA 114
Query: 162 QLHS--------KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLP-RRLG 212
LH I +LK N ++ + + D+G+ P R+G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 213 TPNYMAPEQWQPEV---RGPISFETDSWGFACSIIEMLTGVQPRCGR------------- 256
T YMAPE + D + E+
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 257 --SVDEIYDAVVRRQEIPPIPSGL-----PPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309
SV+E+ V ++ P IP+ + ++ C+ + +R I +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 7e-28
Identities = 47/259 (18%), Positives = 99/259 (38%), Gaps = 22/259 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP----VKEDRMRVLLERLNDLF 99
+G+G FG+V L + A+KIL K++ + E
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVTESR---V 58
Query: 100 LKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQG 159
L+ + L+ + ++C +M++ G + + Y ++
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSA 117
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ LHS+ ++ ++K N +L++ + D G+ + + + GTP Y+AP
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKTFCGTPEYLAP 174
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279
E + D WG + EM+ G P + + +++ ++ + P L
Sbjct: 175 EVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLS 229
Query: 280 PAVENVLLGCFEYDLRSRP 298
P +++L G + D + R
Sbjct: 230 PEAKSLLAGLLKKDPKQRL 248
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-27
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 14/261 (5%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLFL 100
+L +G G +G+V+L D A+K+L V++ + +
Sbjct: 27 ELLKVLGTGAYGKVFLVRK---ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 101 KCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGG-KLSLSNVFRYAIDLAQG 159
+ + L K+ +I+ + G G+ L + + V Y ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYING--GELFTHLSQRERFTEHEVQIYVGEIVLA 141
Query: 160 ILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAP 219
+ LH GI+ ++K N +L+ VL D G+ + + GT YMAP
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYDFCGTIEYMAP 199
Query: 220 EQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR--QEIPPIPSG 277
+ + G D W + E+LTG P + RR + PP P
Sbjct: 200 DIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 278 LPPAVENVLLGCFEYDLRSRP 298
+ ++++ D + R
Sbjct: 259 MSALAKDLIQRLLMKDPKKRL 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 6e-27
Identities = 45/295 (15%), Positives = 95/295 (32%), Gaps = 45/295 (15%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHP---VKEDRMRVLLERLNDLFL 100
+ IG G +G+V+ A + VA+K + + + + E L
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 101 KCQGVEGICWLQGISVI-----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
+ + L + + K+ ++ + + + + ++ + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
L +G+ LHS ++ +LKP N ++ + + L D G+ + +S + T
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS----VVVTLW 180
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-------- 267
Y APE + + D W C EM G S + ++
Sbjct: 181 YRAPEVLL---QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 268 -----------------RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
Q I + + +++LL C ++ R L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-27
Identities = 48/294 (16%), Positives = 93/294 (31%), Gaps = 42/294 (14%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
IG G +G V A ++ VA+K + P + R + L+ +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKV------RVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 104 G---VEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGI 160
+ ++ ++ K ++ G D LK LS ++ + + +G+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMG--ADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 161 LQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPE 220
+HS +L +LKP N +LN + D G+ + + L + T Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 221 QWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------- 273
+ D W C + EML+ G+ + + ++ P
Sbjct: 183 IMLNSK--GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 274 ----------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ ++L ++ R + L
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-27
Identities = 56/286 (19%), Positives = 95/286 (33%), Gaps = 41/286 (14%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLER--LNDL-FLKCQGV 105
+G G F V+ A + + VA+K + + + R L ++ L+
Sbjct: 6 LGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 106 EGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS 165
I L I ++ F E + + L+ S++ Y + QG+ LH
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 166 KGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE 225
IL +LKP N +L+E L D G+ P+ ++ T Y APE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPELLFG- 174
Query: 226 VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------------ 273
D W C + E+L V G S + + P
Sbjct: 175 -ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 274 --------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
I S + +++ G F ++ +R T L+
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 2e-26
Identities = 61/257 (23%), Positives = 99/257 (38%), Gaps = 21/257 (8%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLND--LFLK 101
++ +G G FG V L + A+K+L R++ +E ND L L
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLK-QVEHTNDERLMLS 59
Query: 102 CQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGIL 161
I + G +I +IM + EG + + K + YA ++ +
Sbjct: 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALE 118
Query: 162 QLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQ 221
LHSK I+ +LKP N +L++ + D G + GTP+Y+APE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV------PDVTYTLCGTPDYIAPEV 172
Query: 222 WQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPA 281
P + D W F I EML G P + + Y+ ++ + P
Sbjct: 173 VS---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNED 227
Query: 282 VENVLLGCFEYDLRSRP 298
V+++L DL R
Sbjct: 228 VKDLLSRLITRDLSQRL 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 5e-26
Identities = 59/289 (20%), Positives = 90/289 (31%), Gaps = 38/289 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +IG G +G V+ A + L+ E VA+K + E LK
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
I L + K+ ++ +F + M + L + Y L QG+
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS +L +LKP N ++N L D G+ +P + T Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILL 175
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR---------------- 267
S D W C EM+T G S + + R
Sbjct: 176 G--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 268 -----------RQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
RQ+ + L ++L YD R L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 3e-25
Identities = 55/252 (21%), Positives = 94/252 (37%), Gaps = 19/252 (7%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVE 106
+G G FG V L H S A+KIL K +++ + LN+ L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGN------HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSK 166
+ L+ N + ++M++ G + + G+ S + YA + LHS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 167 GILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEV 226
++ +LKP N ++++ + D G GTP +APE
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGF------AKRVKGRTWTLCGTPEALAPEIIL--- 211
Query: 227 RGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVL 286
+ D W I EM G P +IY+ +V + PS ++++L
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLL 269
Query: 287 LGCFEYDLRSRP 298
+ DL R
Sbjct: 270 RNLLQVDLTKRF 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (257), Expect = 4e-25
Identities = 52/289 (17%), Positives = 88/289 (30%), Gaps = 40/289 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+IG G +G V+ A + + A+K + KED LK
Sbjct: 5 HGLEKIGEGTYGVVYKAQN-------NYGETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
I L + ++ ++ + + + + +GG L + + L GI
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
H + +L +LKP N ++N + D G+ +P + T Y AP+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP---------- 273
S D W C EM+ G G S + + R P
Sbjct: 174 GS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 274 -----------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
GL + ++L + D R L
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 8e-23
Identities = 54/301 (17%), Positives = 90/301 (29%), Gaps = 48/301 (15%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------RMRVLLERL 95
+ +IG+G FGEV+ A H + + +VA+K + E R +L+ L
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
+ + G I ++ F E + ++ K +LS + R
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQM 125
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL-LGIPLPSSDLPRRLGTP 214
L G+ +H IL ++K N ++ L D G+ L + R+ T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 215 NYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP- 273
Y PE E D WG C + EM T G + + +
Sbjct: 186 WYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 274 -----------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDIL 304
P +++ D R D L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 305 R 305
Sbjct: 304 N 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 56/308 (18%), Positives = 98/308 (31%), Gaps = 56/308 (18%)
Query: 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV---- 90
AW + + +G G +G V A + +VA+K L+ + +
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAY 65
Query: 91 ----LLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSL 146
LL+ + + G+ + ++M F +G M K KL
Sbjct: 66 RELRLLKHMRHENV--IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---KHEKLGE 120
Query: 147 SNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSD 206
+ + +G+ +H+ GI+ +LKP N +NE + D G+ S+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSE 174
Query: 207 LPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV 266
+ + T Y APE + D W C + EM+TG G + ++
Sbjct: 175 MTGYVVTRWYRAPEVILN--WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 267 RRQEIPP-----------------------------IPSGLPPAVENVLLGCFEYDLRSR 297
+ PP I + P N+L D R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 298 PLMTDILR 305
+ L
Sbjct: 293 VTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 53/313 (16%), Positives = 107/313 (34%), Gaps = 59/313 (18%)
Query: 32 NDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVL 91
+ W +L ++GRG + EV+ A + + E +V VKIL PVK+ +
Sbjct: 26 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPVKKKK---- 75
Query: 92 LERLNDLFLKCQGVEGICWLQGI--SVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNV 149
++R + +G I L I ++ ++ + + ++ Q L+ ++
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 131
Query: 150 FRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLP 208
Y ++ + + HS GI+ ++KP N +++ R + L D G+ P +
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY----HPGQEYN 187
Query: 209 RRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVDEIYDAVVR 267
R+ + + PE + D W C + M+ +P G + + +
Sbjct: 188 VRVASRYFKGPELLVD--YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 268 -----------------------------------RQEIPPIPSGLPPAVENVLLGCFEY 292
R + P + L Y
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 293 DLRSRPLMTDILR 305
D +SR + +
Sbjct: 306 DHQSRLTAREAME 318
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 5e-22
Identities = 51/289 (17%), Positives = 90/289 (31%), Gaps = 46/289 (15%)
Query: 49 IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVE 106
IG G FG V+ A S E VA+K + K + R ++ +L+ + +
Sbjct: 28 IGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKRFKNRELQIMRKLDHCNIVR--LR 79
Query: 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLH 164
+ G + +++ + +V L + V Y L + + +H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 165 SKGILVLNLKPFNFILNEADRAV-LGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
S GI ++KP N +L+ + L D G L + + + Y APE
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVSYICSRYYRAPELIF 195
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP---------- 273
+ D W C + E+L G G S + +++ P
Sbjct: 196 GAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 274 -----------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
PP + EY +R +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.4 bits (223), Expect = 1e-20
Identities = 50/290 (17%), Positives = 92/290 (31%), Gaps = 40/290 (13%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQ 103
+ +IG G +G V+ A + + E VA+K + +D LK
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 104 GVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+ I L + + K+ ++ +F + + G V + L +G+
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFC 117
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQ 223
HS+ +L +LKP N ++N L + G+ +P + T Y P+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 224 PEVRGPISFETDSWGFACSIIEMLTGVQPRC-GRSVDEIYDAVVRRQEIPP--------- 273
S D W C E+ +P G VD+ + R P
Sbjct: 175 G--AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 274 ------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILR 305
+ L ++L + + R + L+
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 6e-20
Identities = 47/238 (19%), Positives = 83/238 (34%), Gaps = 27/238 (11%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--------RMRVLLERL 95
+ IG G G V A + VA+K L ++ R VL++ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 96 NDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAID 155
N + + + Q + ++M+ + + + Q+ +L +
Sbjct: 74 NHKNIIS--LLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQ 127
Query: 156 LAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPN 215
+ GI LHS GI+ +LKP N ++ + D G L S + + T
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRY 183
Query: 216 YMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273
Y APE D W C + EM+ GR + ++ V+ + P
Sbjct: 184 YRAPEVIL---GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.9 bits (214), Expect = 5e-19
Identities = 52/310 (16%), Positives = 93/310 (30%), Gaps = 56/310 (18%)
Query: 33 DTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-- 90
+ W P + +G G +G V A + VAVK L + +
Sbjct: 10 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKR 63
Query: 91 ------LLERLNDLFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKL 144
LL+ + + G+ + + ++ + + + K KL
Sbjct: 64 TYRELRLLKHMKHENV--IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKL 118
Query: 145 SLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPLPS 204
+ +V + +G+ +HS I+ +LKP N +NE + D G+
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH------TD 172
Query: 205 SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDA 264
++ + T Y APE + D W C + E+LTG G +
Sbjct: 173 DEMTGYVATRWYRAPEIMLN--WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230
Query: 265 VVRRQEIPP-----------------------------IPSGLPPAVENVLLGCFEYDLR 295
++R P + G P ++L D
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290
Query: 296 SRPLMTDILR 305
R L
Sbjct: 291 KRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.5 bits (197), Expect = 6e-17
Identities = 51/251 (20%), Positives = 85/251 (33%), Gaps = 24/251 (9%)
Query: 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV-----LLERLND- 97
L ++G G F VWLA ++ VA+KI+ K LL+R+ND
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNT------HVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 98 -----LFLKCQGVEGICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKL-SLSNVFR 151
+ + + NG +++ G + + + L V +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 152 YAIDLAQGILQLHSK-GILVLNLKPFNFILNEADR-AVLGDVGIPHLLLGIPLPSSDLPR 209
+ L G+ +H + GI+ ++KP N ++ D L + I L
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TN 188
Query: 210 RLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ 269
+ T Y +PE P D W AC I E++TG
Sbjct: 189 SIQTREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 270 EIPPIPSGLPP 280
+I + LP
Sbjct: 246 QIIELLGELPS 256
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 47.5 bits (112), Expect = 9e-07
Identities = 17/150 (11%), Positives = 54/150 (36%), Gaps = 12/150 (8%)
Query: 48 RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGV 105
+G G V+ +++ E VK +++ + + F
Sbjct: 7 LMGEGKESAVFNCYS-------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 106 EGICWLQGISVINGKICIIMKFYEGS--VGDRMAQLKGGKLSLSNVFRYAIDLAQGILQL 163
+ + + G + +EG+ + + + + ++ + N + + + +
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 164 HSKGILVLNLKPFNFILNEADRAVLGDVGI 193
+ +GI+ +L +N +++E + + D
Sbjct: 120 YHRGIVHGDLSQYNVLVSE-EGIWIIDFPQ 148
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 627 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.62 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.67 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.31 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=458.55 Aligned_cols=276 Identities=18% Similarity=0.300 Sum_probs=236.9
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
|+.++|++++.||+|+||.||+|++..+++ .||||++++... ........ +. .+++.++||||++++++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~------~~AiK~i~k~~~~~~~~~~~~~~-E~-~il~~l~hp~Iv~l~~~ 73 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR------YYAMKILRKEVIIAKDEVAHTVT-ES-RVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHH-HH-HHHHSCCCTTBCCEEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEchhhccCHHHHHHHHH-HH-HHHHhCCCCCEEEEEee
Confidence 667899999999999999999999887764 899999975422 12222222 22 35677899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.+++.+||||||++| +|.+.+. +.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+
T Consensus 74 ~~~~~~~~iv~ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 74 FQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eccccccccceeccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccc
Confidence 9999999999999995 6666654 446799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
|+..... .......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+... ...
T Consensus 152 a~~~~~~---~~~~~~~~GT~~Y~aPE~~~~---~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~ 223 (337)
T d1o6la_ 152 CKEGISD---GATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIR 223 (337)
T ss_dssp CBCSCCT---TCCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred ccccccC---CcccccceeCHHHhhhhhccC---CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCC
Confidence 9876432 233456789999999999985 46899999999999999999999999999999999888765 467
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
+|..+|+++++||.+||++||.+||+ +.++++ |+||...+|..+..+.+.+|..|...
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~------Hp~f~~i~~~~l~~~~~~~p~~P~~~ 286 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME------HRFFLSINWQDVVQKKLLPPFKPQVT 286 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCS
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc------CcccccCCHHHHHhCCCCCCCCCCCC
Confidence 88999999999999999999999995 788877 99999999999988888888877543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=446.36 Aligned_cols=276 Identities=19% Similarity=0.263 Sum_probs=227.8
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
..+.+++|++.+.||+|+||.||+|++..+++ .||||++++... ........++.. +++.++||||+++++
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~ 75 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSR------EYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYF 75 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCSTTBCCEEE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEehHHccCHHHHHHHHHHHH-HHHHcCCCCeeEEEE
Confidence 34566899999999999999999999987764 899999975332 111122223322 466789999999999
Q ss_pred EEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++.+++.+||||||++| +|.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||
T Consensus 76 ~~~~~~~~~ivmEy~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 76 TFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEECCEEEEEEEccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccc
Confidence 99999999999999995 7767665 34679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
+|+.+.... ........+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+++..+... ..
T Consensus 154 ~a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~ 227 (288)
T d1uu3a_ 154 TAKVLSPES-KQARANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EY 227 (288)
T ss_dssp TCEECC-----------CCCCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CC
T ss_pred cceecccCC-cccccccccCCccccCceeecc---CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CC
Confidence 998764322 1223345689999999999974 46899999999999999999999999999999999888754 45
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSR 326 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~ 326 (627)
.+|..+++++++||.+||+.||++|||+.|+++...-..|+||...+|+.+..+
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC
Confidence 678899999999999999999999999998765433345999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-53 Score=441.55 Aligned_cols=271 Identities=23% Similarity=0.286 Sum_probs=232.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.++|++++.||+|+||.||+|+++.++. .||||++++.... ....+ .++ ..+++.++||||+++++++.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~-~~E-~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGR------YYAMKVLKKEIVVRLKQVEHT-NDE-RLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHH-HHH-HHHHHSCCBTTBCCEEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCC------EEEEEEEchHHccCHHHHHHH-HHH-HHHHHhccCcChhheeeeEe
Confidence 4689999999999999999999887764 8999999753321 11222 222 23667889999999999999
Q ss_pred ECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 117 INGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 117 ~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
+++.+|+||||+.|+.+..+.. ....+++..+..|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eCCeeeeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceE
Confidence 9999999999999644444433 456789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
... ...+.+||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+++..+... ...+|.
T Consensus 154 ~~~------~~~~~~Gt~~Y~APE~l~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~ 222 (316)
T d1fota_ 154 VPD------VTYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPP 222 (316)
T ss_dssp CSS------CBCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCT
T ss_pred ecc------ccccccCcccccCHHHHcC---CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCC
Confidence 643 2345789999999999974 36899999999999999999999999999999999988765 456788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
.+++++.+++.+||++||.+|+ ++.++++ |+||..++|+.+..+...+|..|..
T Consensus 223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~------Hp~f~~i~~~~l~~~~~~~p~~p~~ 281 (316)
T d1fota_ 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN------HPWFKEVVWEKLLSRNIETPYEPPI 281 (316)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT------SGGGSSCCHHHHHTTCSCCSCCCCC
T ss_pred CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc------CcccccCCHHHHHhCCCCcCCCCCc
Confidence 9999999999999999999996 8889887 9999999999988888888877653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=430.49 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=216.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++.+.||+|+||.||+|++..++. .||+|++++..... ......++. .+++.++||||+++++++.+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKF------ILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHH-HHHHTCCCTTBCCEEEEEEC
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCc------EEEEEEEchHHccChHHHHHHHHHH-HHHHhcCCCCCCeEEEEEEE
Confidence 4689999999999999999999887664 89999997543211 112222222 35677899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++.+|||||||+ |+|.+.+.. .+++++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred CCEEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999999 577776653 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
... ......+||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+++..+... ...+|.
T Consensus 156 ~~~-----~~~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~ 225 (263)
T d2j4za1 156 APS-----SRRTTLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPD 225 (263)
T ss_dssp CCC-----CCCEETTEEGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCT
T ss_pred cCC-----CcccccCCCCcccCHHHHcC---CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCc
Confidence 543 23346689999999999985 36899999999999999999999999999999998888654 456788
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
.+|+++++||.+||+.||++|||+.|+++ |+|+.
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~------hp~~~ 259 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLE------HPWIT 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT------CHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHc------CcCcC
Confidence 99999999999999999999999999998 88764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=442.48 Aligned_cols=273 Identities=21% Similarity=0.315 Sum_probs=229.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
++|++++.||+|+||+||+|++..+++ .||||++++... ....... .+..++...++||||+++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~------~vAvK~i~k~~~~~~~~~~~~~-~e~~~l~~~~~hp~Iv~~~~~~~~ 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ------FFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTHMFCTFQT 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEEHHHHHHTTCHHHHH-HHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCC------EEEEEEEchhhccChHHHHHHH-HHHHHHHHhCCCCcEEEEEEEEcc
Confidence 689999999999999999999987764 899999975321 1222222 223345567899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++.+||||||++| +|.+.+. ....+++.++..++.||+.||+|||+++|+||||||+|||+++++++||+|||+++.
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCceeEEEeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 9999999999995 7777665 345799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPS 276 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~ 276 (627)
.... ........||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+++..+... .+.+|.
T Consensus 153 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~ 224 (320)
T d1xjda_ 153 NMLG---DAKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPR 224 (320)
T ss_dssp CCCT---TCCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT
T ss_pred cccc---cccccccCCCCCcCCHHHHcC---CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCc
Confidence 5432 233345689999999999984 47899999999999999999999999999999999888654 567888
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHH-HHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMT-DILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~-eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
.+|+++++||.+||+.||.+||++. ++++ |+||...+|+.+..+.+.||..|..
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~------hpff~~~~~~~l~~~~~~pp~~p~~ 279 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ------HPLFREINWEELERKEIDPPFRPKV 279 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG------SGGGTTCCHHHHHTTCSCC------
T ss_pred cCCHHHHHHHHHhcccCCCCCcCHHHHHHh------CchhccCCHHHHHhcCCCCCCCCCC
Confidence 9999999999999999999999985 7766 9999999999888888888877654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-52 Score=440.75 Aligned_cols=273 Identities=22% Similarity=0.293 Sum_probs=234.1
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
...++|++++.||+|+||.||+|+++.+++ .||||++++.... ....+.. +. .+++.++||||++++++
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~------~~AvK~i~~~~~~~~~~~~~~~~-E~-~il~~l~hpnIv~~~~~ 109 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGN------HYAMKILDKQKVVKLKQIEHTLN-EK-RILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHH-HH-HHHTTCCCTTBCCEEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCC------EEEEEEEchHHccCHHHHHHHHH-HH-HHHHHcCCCcEeecccc
Confidence 445799999999999999999999987765 8999999753321 1122222 22 25677899999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+...+..++||||+.| ++.+.+. ..+.+++..+..|+.||+.||.|||+++||||||||+|||++.+|++||+|||+
T Consensus 110 ~~~~~~~~~v~e~~~~g~l~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 110 FKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccccchhhhHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence 9999999999999995 6666654 345799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
|+.+.. ...+.+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+++..+... .+.
T Consensus 188 a~~~~~------~~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~ 256 (350)
T d1rdqe_ 188 AKRVKG------RTWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVR 256 (350)
T ss_dssp CEECSS------CBCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred eeeccc------ccccccCccccCCHHHHcC---CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCC
Confidence 987643 2345689999999999984 36889999999999999999999999999999999888765 456
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRP-----LMTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RP-----s~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
+|..+++++.+||.+||+.||.+|+ ++.++++ |+||...+|..+..+.+.+|+.|...
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~------Hp~f~~~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc------CccccCCCHHHHHhcCCCcCccCCCC
Confidence 7889999999999999999999994 8899887 99999999999988888888887644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-52 Score=431.61 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=217.5
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHH--HHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRV--LLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~--~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.|++++.||+|+||.||+|++..+++ .||||+++......... ...++. .+++.++||||+++++++.+++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEV-RFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEECCSSCHHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEETT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCc------EEEEEEEchhhccCHHHHHHHHHHH-HHHHHCCCCCEeeEEEEEEECC
Confidence 59999999999999999999887764 89999998654322222 122222 2567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..|||||||.|++++.+.. ..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999999877765543 457899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPPIPSGLP 279 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~~p~~~s 279 (627)
....+||+.|||||++.+...++|+.++|||||||++|||++|..||.+.+..+.+..+.........+..+|
T Consensus 168 -------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 168 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp -------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred -------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 2346899999999999765456799999999999999999999999999998888888877665555567799
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 280 PAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 280 ~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+++++||.+||+.||.+|||+.++++ |+|+.
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~------Hp~~~ 271 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK------HRFVL 271 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT------CHHHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHh------CHHhc
Confidence 99999999999999999999999987 88764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=429.33 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=217.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|++++.||+|+||.||+|++..++. .||||+++.........+..+. .+++.++||||+++++++.+++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~E~--~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSV------LAAAKVIDTKSEEELEDYMVEI--DILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECSSSGGGGGTHHHH--HHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCe------EEEEEEECcCCHHHHHHHHHHH--HHHHhCCCCCCCeEEEEEeeCCe
Confidence 469999999999999999999887764 8999999876554444333332 25567899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|||||||+| +|.+.+.. ..+++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999996 55555443 557899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCC--CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPE--VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE-IPPIPS 276 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~--~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~-~~~~p~ 276 (627)
. .....+.+||+.|||||++.+. ...+|+.++|||||||++|||+||++||.+.+..+++..+..... ....+.
T Consensus 163 ~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (288)
T d2jfla1 163 T---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239 (288)
T ss_dssp H---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGG
T ss_pred C---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 1 1122356899999999998542 234689999999999999999999999999998888887776542 234567
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 277 GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 277 ~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
.+|+++.+||.+||+.||++|||+.|+++ |+|+..
T Consensus 240 ~~s~~~~~li~~~L~~dp~~R~t~~ell~------hp~~~~ 274 (288)
T d2jfla1 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ------HPFVTV 274 (288)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGCC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCC
Confidence 89999999999999999999999999988 998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=429.09 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=214.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++++.||+|+||.||+|++..+++ .||||+++.......+.+.+ +. .+++.++||||+++++++.+++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~------~vAvK~~~~~~~~~~~~~~~-E~-~il~~l~HpnIv~~~~~~~~~~~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIIN-EI-LVMRENKNPNIVNYLDSYLVGDE 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCC------EEEEEEEEGGGCSCHHHHHH-HH-HHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCC------EEEEEEEecccChHHHHHHH-HH-HHHHhCCCCCEeeEeEEEEECCE
Confidence 479999999999999999999877664 89999997654433333333 32 25677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
+|||||||+| +|.+.+. .+.+++..+..|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+..
T Consensus 92 ~~ivmEy~~gg~L~~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEEECCTTCBHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEEecCCCcHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999995 5555443 35799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQ-EIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~-~~~~~p~~~ 278 (627)
. .......+||+.|||||++.+ .+|+.++|||||||++|+|++|++||.+.+..+.+..+.... .....+..+
T Consensus 169 ~---~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 169 E---QSKRSTMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHSS---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred c---cccccccccCCCccChhhhcC---CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence 2 223346689999999999984 468999999999999999999999999988877666665443 334567789
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
|+++++||.+||+.||++||++.|+++ |+|+.
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~------Hp~~~ 274 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ------HQFLK 274 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT------CGGGG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc------CHhhC
Confidence 999999999999999999999999987 99875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=424.67 Aligned_cols=259 Identities=21% Similarity=0.261 Sum_probs=209.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++++.||+|+||.||+|++..+++ .||||+++............++. .+++.++||||+++++++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~Ei-~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECC-------CHHHHH-HHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEehhhcchHHHHHHHHH-HHHHhCCCCCEeeEeeeeccCce
Confidence 589999999999999999999987764 89999997654333222223332 35677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
.||||||++| +|.+.+. ..+.+++.+++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+|+.+..
T Consensus 78 ~~ivmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EEEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eEEEEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999995 7766653 456899999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCCCCCC
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVD-EIYDAVVRRQEIPPIPSGL 278 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~-e~~~~i~~~~~~~~~p~~~ 278 (627)
.. ........+||+.|||||++.+. ..++.++|||||||++|||++|++||...+.. ..+..+.........+..+
T Consensus 156 ~~-~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T d1nvra_ 156 NN-RERLLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232 (271)
T ss_dssp TT-EECCBCCCCSCGGGSCTHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGS
T ss_pred CC-ccccccceeeCcCccCHhHhcCC--CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence 22 12233567899999999999743 12467899999999999999999999875543 3444444333333444678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 279 PPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 279 s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
|+++.+||.+||+.||++|||+.++++ |+||..
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~------hpwf~~ 265 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKK------DRWYNK 265 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhCc
Confidence 999999999999999999999999988 999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=422.10 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=204.3
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|++++.||+|+||.||+|+++.+++ .||||+++....... .....++. .+++.++||||+++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGK------ILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECCTTSCHHHHHHHHHHH-HHTTSCCCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEChhhCCHHHHHHHHHHH-HHHHHCCCCCEeeEEEEEEeC
Confidence 4689999999999999999999987765 899999976543222 22222222 35677899999999999864
Q ss_pred -CCEEEEEEecCC-CCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecccCCCcEEEecCCCeee
Q 006887 118 -NGKICIIMKFYE-GSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKG-----ILVLNLKPFNFILNEADRAVL 188 (627)
Q Consensus 118 -~~~~~LVmEy~~-GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~g-----IvHrDLKP~NILld~~g~vkL 188 (627)
++.+|||||||+ |+|.+.+... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 456899999999 5888777543 3578999999999999999999999976 999999999999999999999
Q ss_pred ccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 189 GDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 189 ~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
+|||+|+.+... .......+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+++..+...
T Consensus 156 ~DFG~a~~~~~~---~~~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~ 229 (269)
T d2java1 156 GDFGLARILNHD---TSFAKAFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229 (269)
T ss_dssp CCHHHHHHC--------------CCCSCCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred eeccceeecccC---CCccccCCCCcccCCHHHHcC---CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 999999886532 223346789999999999974 46899999999999999999999999999999998888765
Q ss_pred cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccccc
Q 006887 269 QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSV 314 (627)
Q Consensus 269 ~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~ 314 (627)
. .+.+|..+|+++.+||.+||+.||.+||++.|+++ |||
T Consensus 230 ~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~------hp~ 268 (269)
T d2java1 230 K-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE------NPL 268 (269)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT------STT
T ss_pred C-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh------CCc
Confidence 4 45678899999999999999999999999999988 776
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=422.76 Aligned_cols=264 Identities=24% Similarity=0.349 Sum_probs=209.9
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch--hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE--DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~--~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
.+.|+.++|++.+.||+|+||+||+|++.. .||||+++.... .....+.+ +. .++..++||||++++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~-E~-~~l~~l~HpnIv~~~ 70 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKN-EV-GVLRKTRHVNILLFM 70 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS---------EEEEEECCCSSCCTTHHHHHHH-HH-HHHTTCCCTTBCCEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC---------EEEEEEEEcccCCHHHHHHHHH-HH-HHHHhCCCCCEeeee
Confidence 356889999999999999999999997431 599999975432 23333322 22 356778999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++. ++.+||||||++ |+|.+.+.. ...++++..++.++.||+.||+|||+++||||||||+|||++.++.+||+||
T Consensus 71 ~~~~-~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 71 GYST-APQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EEEC-SSSCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred EEEe-ccEEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccc
Confidence 9875 456899999999 577776653 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIY-DAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~-~~i~~~~~ 270 (627)
|+|+...... .........||+.|||||++.+...++|+.++|||||||++|||+||+.||.+.+..+.+ ..+.....
T Consensus 149 Gla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 227 (276)
T d1uwha_ 149 GLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227 (276)
T ss_dssp CCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC
T ss_pred cceeeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 9998764322 122345678999999999998655567999999999999999999999999987655444 44433332
Q ss_pred CC---CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 271 IP---PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 271 ~~---~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+ ..+..+|+++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 32 3567899999999999999999999999999999887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-51 Score=436.44 Aligned_cols=278 Identities=19% Similarity=0.270 Sum_probs=228.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh---HHHHHHHHHH-HHHHHhcCCCCceeeEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED---RMRVLLERLN-DLFLKCQGVEGICWLQG 113 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~---~~~~~~~~~~-~~ll~~~~hpnIv~l~~ 113 (627)
|+.++|++++.||+|+||.||+|++..+++ .||||++.+.... .......+.. ..+++..+||||+++++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~------~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCC------EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 467899999999999999999999887764 8999999753321 1111222211 12456678999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++.+++.+|||||||+ |+|.+.+.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence 9999999999999999 577777653 4678999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR-RQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~-~~~~ 271 (627)
+|+.+.. ......+||+.|||||++... ..|+.++|||||||++|||+||+.||.+.+..+....... ....
T Consensus 153 la~~~~~-----~~~~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~ 225 (364)
T d1omwa3 153 LACDFSK-----KKPHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225 (364)
T ss_dssp TCEECSS-----SCCCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC
T ss_pred eeeecCC-----CcccccccccccchhHHhhcC--CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 9987643 233456899999999998632 3588999999999999999999999987654433322221 2334
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGY 336 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 336 (627)
..+|..+|+++++||.+||+.||.+||+ +.++++ |+||...+|..+..+..++|..|..
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~------Hp~f~~i~~~~~~~~~~~~p~~p~~ 289 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE------SPFFRSLDWQMVFLQKYPPPLIPPR 289 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc------CccccCCCHHHHhcCCCCcCcCCCC
Confidence 5677899999999999999999999998 688887 9999999999988888888887654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-51 Score=425.23 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=209.1
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..++.++|++.+.||+|+||.||+|++..+++ ....||||.+.............++. .+++.++||||+++++++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEA-SIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHH-HHHHhCCCCCCccEEEEE
Confidence 45778899999999999999999999876653 23469999987655443333233333 256778999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
..++.+|||||||+|+.++.+.....+.+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999999644444434455679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCC--CCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 196 LLLGIPLPSS--DLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 196 ~~~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
.+........ ......||+.|||||++. .+.|+.++|||||||++|||+| |++||.+.+..+++..+... ..+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~ 252 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRL 252 (299)
T ss_dssp -------------------CGGGSCHHHHH---SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHh---cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC
Confidence 7754322111 122346899999999987 4579999999999999999998 89999999999988887654 456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+.|..+++++.+|+.+||+.||++||++.++++.|+.+
T Consensus 253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 67889999999999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=429.95 Aligned_cols=269 Identities=20% Similarity=0.306 Sum_probs=220.5
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.|+.++|++.+.||+|+||+||+|++..+++ ......||+|++.............++..++.+..+||||++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISK-TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSS-SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCc-ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 455888999999999999999999999876653 2234579999997654433333334444455566699999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK---------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLN 172 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~---------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrD 172 (627)
+.+.+.+|||||||+ |+|.+.+.... ...+++..++.|+.||+.||.|||+++|+|||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999 58877775432 13589999999999999999999999999999
Q ss_pred cCCCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCC
Q 006887 173 LKPFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQ 251 (627)
Q Consensus 173 LKP~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~ 251 (627)
|||+|||++.++.+||+|||+|+....... .....+..||+.|||||++. .+.|+.++|||||||++|||+| |++
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLF---EGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CchhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHc---CCCCCcceeccchhHHHHHHHhCCCC
Confidence 999999999999999999999987654221 11223567899999999997 4479999999999999999998 899
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 006887 252 PRCGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFK 308 (627)
Q Consensus 252 Pf~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~ 308 (627)
||.+.+..+.+..+......++.|..+|+++.+||.+||+.||++|||+.+|++.|.
T Consensus 266 Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999987777666777777778889999999999999999999999999999999885
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-50 Score=427.76 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=220.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..++. .||||++..........+ .++.. +++.++||||+++++++.+++.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~------~vAvK~i~~~~~~~~~~~-~~E~~-il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGN------NFAAKFVMTPHESDKETV-RKEIQ-TMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTE------EEEEEEECCCSHHHHHHH-HHHHH-HHHHTCCTTBCCEEEEEEETTE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEcccchhhHHHH-HHHHH-HHHhCCCCCCCcEEEEEEECCE
Confidence 589999999999999999999887764 899999977655443333 33332 4566799999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--cCCCeeeccCCccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--EADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~~g~vkL~DFGla~~~ 197 (627)
+|||||||+| +|.+.+.. ..+++++..+..|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999994 77676643 456799999999999999999999999999999999999995 4678999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~--~p 275 (627)
.. ........||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+++..+.......+ .+
T Consensus 177 ~~----~~~~~~~~gT~~Y~aPEv~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 177 DP----KQSVKVTTGTAEFAAPEVAEG---KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp CT----TSCEEEECSCTTTCCHHHHHT---CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred cc----ccccceecCcccccCHHHHcC---CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 43 223346789999999999984 3688999999999999999999999999999999988876543322 23
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGH 323 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~ 323 (627)
..+|+++++||.+||+.||++|||+.|+++ |+|+....+...
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~~~~~~~~~~ 291 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTPGNAPGR 291 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH------STTTSCTTCCSC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCCCCCc
Confidence 578999999999999999999999999998 999987766543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-51 Score=423.32 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=202.6
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|++.+.||+|+||+||+|+++.+++ .||||++.+...........++. .+++.++||||+++++++.+++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQK------LVAIKCIAKKALEGKEGSMENEI-AVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCC------EEEEEEEEC----------CHHH-HHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCC------EEEEEEEchHHhhhHHHHHHHHH-HHHHhCCCCCCCcEEEEEEECCE
Confidence 569999999999999999999887764 89999998655433332233333 25677899999999999999999
Q ss_pred EEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe---cCCCeeeccCCcccc
Q 006887 121 ICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN---EADRAVLGDVGIPHL 196 (627)
Q Consensus 121 ~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld---~~g~vkL~DFGla~~ 196 (627)
+|||||||+ |+|.+.+. ..+.+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+.
T Consensus 82 ~~lvmE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp EEEEECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EEEEEeccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999 57877775 456899999999999999999999999999999999999994 578999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--PI 274 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--~~ 274 (627)
... .....+.+||+.|||||++.+ .+|+.++|||||||++|||++|++||.+.+..++...+....... +.
T Consensus 160 ~~~----~~~~~~~~GT~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 160 EDP----GSVLSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232 (307)
T ss_dssp -----------------CTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT
T ss_pred ccC----CCeeeeeeeCccccCcHHHcC---CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc
Confidence 643 223346789999999999974 468999999999999999999999999999999988887655433 34
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
+..+|+++.+||.+||+.||++|||+.|+++ |+|+..
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~~ 269 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ------HPWIAG 269 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH------STTTTS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc------CHhhCC
Confidence 4689999999999999999999999999998 999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=416.71 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=215.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++|++.+.||+|+||+||+|+++.+++ .||||++++..... ......++.. +++.++||||+++++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~------~~AvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGL------QYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVY 82 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCC------EEEEEEEEhhhcchhhhhHHHHHHHHHHH-HHHhCCCCCCCcEEEEE
Confidence 579999999999999999999887764 89999997543211 1122223322 45667999999999999
Q ss_pred EECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC----Ceeecc
Q 006887 116 VINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD----RAVLGD 190 (627)
Q Consensus 116 ~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g----~vkL~D 190 (627)
.+++.+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EECCEEEEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999 577777653 35799999999999999999999999999999999999998776 499999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+++.... ........||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+++..+.....
T Consensus 161 fG~a~~~~~----~~~~~~~~~t~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 161 FGLAHKIDF----GNEFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp CTTCEECTT----SCBCSCCCCCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred hhhhhhcCC----CccccccCCCCcccCHHHHcC---CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 999987643 223445689999999999974 4689999999999999999999999999999999888876543
Q ss_pred CCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCCCCCCccc
Q 006887 271 IPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGWTGHGSRI 327 (627)
Q Consensus 271 ~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w~~~~~~~ 327 (627)
..+ .+..+|+++++||.+||+.||++||++.++++ |+|+...+|....+..
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~~~~~~~~l~~~ 286 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIKPKDTQQALSSA 286 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTCC----------
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCChhHhhccC
Confidence 322 34679999999999999999999999999998 9999988876654433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-51 Score=421.03 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=220.2
Q ss_pred CCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 32 NDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 32 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
+-..+.|+.++|++.+.||+|+||+||+|++..++ +.||||+++...... +.+.+ +. .+++.++||||+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~-~~~~~-E~-~il~~l~HpnIv~~ 78 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS------LTVAVKTLKEDTMEV-EEFLK-EA-AVMKEIKHPNLVQL 78 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGT------EEEEEEECCTTCSCH-HHHHH-HH-HHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCC------eEEEEEEECCccchH-HHHHH-HH-HHHHhCCCCCEecC
Confidence 33456788999999999999999999999987765 489999997654432 23333 22 25667899999999
Q ss_pred EEEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++.+++..||||||++ |++.+.+.......+++..++.++.||+.||+|||++||+||||||+||||++++.+||+|
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcc
Confidence 999999999999999999 6888887765667899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQP-RCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~P-f~~~~~~e~~~~i~~~~ 269 (627)
||+|+...... ........||+.|||||++.+ +.|+.++|||||||++|||++|..| |.+.+..++++.+. ..
T Consensus 159 FG~a~~~~~~~--~~~~~~~~g~~~y~aPE~~~~---~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-~~ 232 (287)
T d1opja_ 159 FGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KD 232 (287)
T ss_dssp CCCTTTCCSSS--SEEETTEEECGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred ccceeecCCCC--ceeeccccccccccChHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-cC
Confidence 99998764321 112234468999999999874 4799999999999999999996555 55667777666554 44
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
..++.|..+|+++.+||.+||+.||++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 56778899999999999999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=411.81 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=206.1
Q ss_pred CeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE---
Q 006887 42 ALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVI--- 117 (627)
Q Consensus 42 ~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~--- 117 (627)
-|++.++||+|+||+||+|++..++. .||+|++...... .......++. .+++.++||||+++++++..
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~------~va~K~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEEESS
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCe------EEEEEEEchhhCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEeeccc
Confidence 35888899999999999999987764 8999998764322 2222222332 25677899999999999875
Q ss_pred -CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecccCCCcEEEe-cCCCeeeccCC
Q 006887 118 -NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKG--ILVLNLKPFNFILN-EADRAVLGDVG 192 (627)
Q Consensus 118 -~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--IvHrDLKP~NILld-~~g~vkL~DFG 192 (627)
++.+||||||++| +|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 4568999999995 77676653 457999999999999999999999998 99999999999996 57899999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS-VDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~-~~e~~~~i~~~~~~ 271 (627)
+|+.... ......+||+.|||||++. +.|+.++|||||||++|||++|+.||.+.. ..+++..+......
T Consensus 161 la~~~~~-----~~~~~~~GT~~Y~aPE~~~----~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 161 LATLKRA-----SFAKAVIGTPEFMAPEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231 (270)
T ss_dssp GGGGCCT-----TSBEESCSSCCCCCGGGGG----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred cceeccC-----CccCCcccCccccCHHHhC----CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC
Confidence 9986432 2334678999999999985 358999999999999999999999998654 55666666555444
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+.++..+++++++||.+||+.||++|||+.|+++ |+||.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~------Hp~fk 270 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQ 270 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC
T ss_pred cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC------CcccC
Confidence 5566788999999999999999999999999998 88863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=412.14 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=211.7
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
..|++++|++.+.||+|+||.||+|.+..++. .....||||+++............++. .++..++||||+++++++
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~-~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEE
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHH-HHHHhcCCCCEeeeeEEE
Confidence 46888999999999999999999999876542 233579999997655443333333333 356778999999999999
Q ss_pred EECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 116 VINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 116 ~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...+..++||||+.++++..+.......+++..++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999754444444466789999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCC
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPRCGRSVDEIYDAVVRRQEIPPI 274 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~~~e~~~~i~~~~~~~~~ 274 (627)
.+..............||+.|||||++.+ +.++.++|||||||++|||++| .+||.+.+..+++..+.. ...++.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~ 234 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPT 234 (283)
T ss_dssp ---------------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHcc---CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-cCCCCC
Confidence 87543332333345679999999999974 4799999999999999999995 556667778788776654 456677
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 275 PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 275 p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
|..+++++.+||.+||+.||++||++.++++.|+++.
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 8899999999999999999999999999999888654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=408.68 Aligned_cols=257 Identities=20% Similarity=0.347 Sum_probs=207.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|++++|++.+.||+|+||.||+|++..+ ..||||+++...... ..+.++ . .++..++||||+++++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~i~~~~~~~-~~~~~E-~-~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIREGAMSE-EDFIEE-A-EVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTT-------EEEEEEECCSSSSCH-HHHHHH-H-HHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCC-------CEEEEEEECCCcCcH-HHHHHH-H-HHHHhcCCCCcccccceecc
Confidence 7889999999999999999999997543 369999997654433 233332 2 24567899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++..||||||++ |+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CCceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence 999999999999 566665543 556789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
...... .......||+.|||||++.+ ..|+.++|||||||++|||+| |.+||...+..+++..+... ..+..|
T Consensus 151 ~~~~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p 224 (263)
T d1sm2a_ 151 VLDDQY--TSSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKP 224 (263)
T ss_dssp ----------------CTTSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCC
T ss_pred ccCCCc--eeecceecCcccCChHHhcC---CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCc
Confidence 654221 22234679999999999974 469999999999999999999 67888888888888877654 456678
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+++++.+||.+||+.||++||++.++++.|+++.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 899999999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=413.06 Aligned_cols=265 Identities=19% Similarity=0.264 Sum_probs=217.7
Q ss_pred CCcCCCCeEEEeE-EeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 36 AWIKPSALKLRHR-IGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 36 ~~i~~~~y~i~~~-LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
..|..++|.+.+. ||+|+||.||+|.+..++. +..||||+++............++.. ++..++||||++++++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~----~~~vAvK~l~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK----QIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---C----CEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCC----cEEEEEEEEChhcCHHHHHHHHHHHH-HHHhCCCCCEeeEeee
Confidence 3466788999985 9999999999998765432 35799999987554433333333333 4566799999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+.. +.+||||||++| +|.+.+. .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~-~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHT-TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhh-ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 864 568999999996 6655543 3456899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++.+..............||+.|||||++.+ +.++.++|||||||++|||+| |+.||.+.+..++...+.. ...+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-~~~~ 231 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRM 231 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCC
T ss_pred hhcccccccccccccccccCccccChHHHhC---CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 9987654333334456679999999999973 468999999999999999998 9999999988888877764 4456
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+.|..+|+++.+||.+||+.||++||++.++++.|+...
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 788999999999999999999999999999999887543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=426.92 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=207.6
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|..++|++++.||+|+||+||+|++..+++ .||+|+++............++.. +++.++||||+++++++.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGL------VMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTE------EEEEEEEECCCCTTHHHHHHHHGG-GGGGCCCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEChhhCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEE
Confidence 456789999999999999999999887764 899999986544333333333322 5677899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
++.+||||||++| +|.+.+.. .+.+++..+..++.||+.||.|||+ +||+||||||+||||+.++++||+|||+|+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred CCEEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 9999999999995 77666653 4579999999999999999999997 599999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHH--------------
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEI-------------- 261 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~-------------- 261 (627)
.+.. ....+.+||+.|||||++.+ .+|+.++|||||||++|||++|+.||.+.+..+.
T Consensus 154 ~~~~-----~~~~~~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 154 QLID-----SMANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp HHHH-----HTC---CCSSCCCCHHHHHC---SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred ccCC-----CccccccCCccccCchHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 7643 22345699999999999985 4799999999999999999999999987553321
Q ss_pred ----------------------------HHHHHhccCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 262 ----------------------------YDAVVRRQEIPPIP-SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 262 ----------------------------~~~i~~~~~~~~~p-~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
...+. ....+..+ ..+|.++.+||.+||+.||++|||+.|+++ |
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~------H 298 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV------H 298 (322)
T ss_dssp --------------------CCCCHHHHHHHHH-TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT------S
T ss_pred CCcccccccccccccccccccchhHHHHHhhhh-ccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh------C
Confidence 11111 11112222 246899999999999999999999999998 8
Q ss_pred ccCCCCCC
Q 006887 313 SVHSDGGW 320 (627)
Q Consensus 313 ~~~~~~~w 320 (627)
+|+...+|
T Consensus 299 pf~~~~~~ 306 (322)
T d1s9ja_ 299 AFIKRSDA 306 (322)
T ss_dssp HHHHHHHH
T ss_pred HhhCcCCc
Confidence 88765433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-49 Score=422.64 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=218.0
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++++.||+|+||.||+|++..+++ .||||+++.........+. ++. .+++.++||||+++++++.+++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~~~~~~~~~-~Ei-~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGR------VFVAKFINTPYPLDKYTVK-NEI-SIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSHHHHHHHH-HHH-HHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEECCcchhHHHHHH-HHH-HHHHhCCCCCCCcEEEEEEECCE
Confidence 579999999999999999999887764 8999999876544433332 222 35677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe--cCCCeeeccCCccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN--EADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld--~~g~vkL~DFGla~~~ 197 (627)
+|||||||+| +|.+.+.. ...++++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999995 66565532 446799999999999999999999999999999999999997 6789999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--CCC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--PIP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--~~p 275 (627)
.. ........||+.|||||++.+ .+|+.++|||||||++|||+||++||.+.+..+++..+....... ..+
T Consensus 180 ~~----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 252 (352)
T d1koba_ 180 NP----DEIVKVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252 (352)
T ss_dssp CT----TSCEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred CC----CCceeeccCcccccCHHHHcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 43 223346789999999999974 468999999999999999999999999999999998887654332 244
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..+|+++.+||.+||+.||.+|||+.|+++ |+|+...
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~------Hp~~~~~ 289 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE------HPWLKGD 289 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT------STTTSSC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CHhhCCC
Confidence 689999999999999999999999999988 9998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=408.81 Aligned_cols=259 Identities=22% Similarity=0.353 Sum_probs=214.1
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQG 113 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~ 113 (627)
.++.|+.++|++.++||+|+||.||+|++... ..||||+++...... ..+.+ +.. ++..++||||+++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~vAvK~~~~~~~~~-~~~~~-E~~-~l~~l~HpnIv~~~g 75 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQGSMSP-DAFLA-EAN-LMKQLQHQRLVRLYA 75 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEECTTSSCH-HHHHH-HHH-HHHHCCCTTBCCEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCC-------CEEEEEEEccCcCCH-HHHHH-HHH-HHHhCCCCCEeEEEe
Confidence 35668889999999999999999999997532 379999997654332 22333 222 456679999999999
Q ss_pred EEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 114 ISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 114 ~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
++. ++..||||||++ |+|.+.+......++++..++.++.||+.||.|||+++|+||||||+||||++++.+||+|||
T Consensus 76 ~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence 875 456799999999 566666554444579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
+|+.+.... ........||+.|||||++. .+.++.++|||||||++|||+| |.+||...+..+++..+.. ...
T Consensus 155 la~~~~~~~--~~~~~~~~gt~~y~APE~~~---~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~ 228 (272)
T d1qpca_ 155 LARLIEDNE--YTAREGAKFPIKWTAPEAIN---YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYR 228 (272)
T ss_dssp TCEECSSSC--EECCTTCCCCTTTSCHHHHH---HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCC
T ss_pred ceEEccCCc--cccccccCCcccccChHHHh---CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCC
Confidence 999875422 12234567999999999997 3468999999999999999999 5666777788888877764 345
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
+..|..+++++.+|+.+||+.||++|||+.++++.|+.
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 66788999999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=412.58 Aligned_cols=269 Identities=20% Similarity=0.313 Sum_probs=212.8
Q ss_pred CcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 37 WIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 37 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
.|+.++|++.+.||+|+||.||+|++...+. ...++.||||+++.............+...+.+..+|+||+.+++++.
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTS-SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCc-ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3777899999999999999999999876653 345678999999765444333333344445667778999999999876
Q ss_pred E-CCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEE
Q 006887 117 I-NGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFIL 180 (627)
Q Consensus 117 ~-~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILl 180 (627)
. ++.+++|||||+ |+|.+.+.... ...+++..++.++.||+.||.|||+++|+||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 456899999999 67777775432 2458999999999999999999999999999999999999
Q ss_pred ecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCHH
Q 006887 181 NEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPRCGRSVD 259 (627)
Q Consensus 181 d~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~~~ 259 (627)
+.++.+||+|||+|+...... .........||+.|||||++.+ +.++.++|||||||++|||+|| .+||.+.+..
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp CGGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999998764422 2223346689999999999974 4789999999999999999986 6789887766
Q ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 260 EIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 260 e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+.+..+......++.|..+++++.++|.+||+.||++|||+.++++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 655555556667788999999999999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=407.45 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=207.3
Q ss_pred cCCCCeEEE-eEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-HHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 38 IKPSALKLR-HRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-MRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 38 i~~~~y~i~-~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
++.+.+.+. ++||+|+||.||+|.+...+ .++.||||+++....+. ......++. .+++.++||||+++++++
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~g~~ 77 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEA-NVMQQLDNPYIVRMIGIC 77 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHH-HHHHTCCCTTBCCEEEEE
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCC----cCeEEEEEEEChhhCCHHHHHHHHHHH-HHHHhCCCCCCceEEEEe
Confidence 344455655 46999999999999875432 24689999997543322 222222332 255778999999999998
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
.. +..||||||++| +|.+.+. ...++++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 78 ~~-~~~~lvmE~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 78 EA-ESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp ES-SSEEEEEECCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cc-CCEEEEEEcCCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhh
Confidence 64 557899999995 6666654 4567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+.+..............||+.|||||++.+ +.++.++|||||||++|||+| |++||.+.+..++...+.. ...++
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~ 230 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMG 230 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCC
T ss_pred hhccccccccccccccCCCceecCchhhcC---CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCC
Confidence 877543332233345679999999999973 468999999999999999998 8999999999888877764 44677
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
.|..+|+++.+||.+||+.||++||++.++++.|+.
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 889999999999999999999999999999887764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=406.33 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=208.9
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.|+.++|++.+.||+|+||.||+|++..+++ .+..||||+++....+.......++. .+++.++||||+++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCc---eeEEEEEEEeccccCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEE
Confidence 45778899999999999999999999876543 34579999997655444333333333 246678999999999998
Q ss_pred EECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcc
Q 006887 116 VINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIP 194 (627)
Q Consensus 116 ~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla 194 (627)
. ++.+||||||++| ++.+.+ ......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~-~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHH-HHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred e-cCeEEEEEEeccCCcHHhhh-hccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhh
Confidence 5 5678999999995 554444 345678999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 195 HLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 195 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
+.+.... ........||+.|||||++. .+.|+.++|||||||++|||+| |.+||.+.+..+++..+... ..++
T Consensus 156 ~~~~~~~--~~~~~~~~gt~~y~apE~l~---~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-~~~~ 229 (273)
T d1mp8a_ 156 RYMEDST--YYKASKGKLPIKWMAPESIN---FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 229 (273)
T ss_dssp -----------------CCGGGCCHHHHH---HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCC
T ss_pred eeccCCc--ceeccceecCcccchhhHhc---cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 8764321 22234567899999999997 4479999999999999999998 89999999999998887754 4567
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 274 IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 274 ~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+|..+|+++.+||.+||+.||++|||+.++++.|+++.
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 88999999999999999999999999999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-49 Score=404.64 Aligned_cols=259 Identities=20% Similarity=0.222 Sum_probs=216.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-----H---HHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-----R---MRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-----~---~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
++|++.+.||+|+||+||+|++..++ +.||||++++.... . ......++..++.++..||||++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~------~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTC------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT------EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCC------CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 68999999999999999999987766 48999999764321 1 1112223333444555699999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+++.+||||||++ |+|.+.+.. .+++++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eecccCcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccc
Confidence 99999999999999998 588887753 457999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCC---CCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPE---VRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
|+++.+... .......||+.|+|||++.+. ....++.++||||+||++|||++|+.||.+.+..+....+...
T Consensus 155 G~a~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 155 GFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp TTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred hheeEccCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999876432 233456899999999998642 2345788999999999999999999999999999988888876
Q ss_pred cCCCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 269 QEIPP--IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 269 ~~~~~--~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
....+ .+..+|+++++|+.+||+.||++||++.++++ |+||..
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~------h~~~~~ 275 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA------HPFFQQ 275 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT------SGGGCT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc------CHHHHH
Confidence 54333 33579999999999999999999999999988 998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-49 Score=404.46 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=205.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH--HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR--VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~--~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++.+.||+|+||.||+|++..+++ .||||++++....... ....++. .+++.++||||+++++++...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~~E~-~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHR------DVAVKVLRADLARDPSFYLRFRREA-QNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSTTTTCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCC------EEEEEEEchhhccCHHHHHHHHHHH-HHHHhcCCCCCCcccceeeec
Confidence 579999999999999999999887764 8999999865432222 2222222 256789999999999998764
Q ss_pred C----EEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 119 G----KICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 119 ~----~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
+ .+||||||++| +|.+.+. ..+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+|+|||+
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred cCCCceEEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhh
Confidence 3 48999999995 5555543 346799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP 273 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~ 273 (627)
++...............+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+..+++..+......++
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp CEECC----------------TTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred hhhhccccccccccccccCcccccCHHHHcC---CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 8876544333344556789999999999974 4689999999999999999999999999998888877776544332
Q ss_pred --CCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhcc
Q 006887 274 --IPSGLPPAVENVLLGCFEYDLRSRP-LMTDILRVFKSSQ 311 (627)
Q Consensus 274 --~p~~~s~~l~~li~~cL~~dP~~RP-s~~eil~~L~~~~ 311 (627)
.+..+|+++.+||.+||++||.+|| ++.++++.|.++.
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 3467999999999999999999999 8999988887653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=411.15 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=212.4
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..|+.++|++.+.||+|+||.||+|++..... ....||||++++... .....+.. +. .+++.++||||++++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~-Ei-~~l~~l~H~nIv~~~ 77 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIR-EV-NAMHSLDHRNLIRLY 77 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHH-HH-HHHHHCCCTTBCCEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHH-HH-HHHHhCCCCCEEEEE
Confidence 45788999999999999999999998765432 335799999976432 22223322 22 256677999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+ +..++||||++ |++.+.+.. ..+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 78 g~~~~-~~~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 78 GVVLT-PPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEee-cchheeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 99964 56789999999 566666554 4567999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
|+++.+..............||+.|||||++.+ ..++.++|||||||++|||+| |++||.+.+..+++..+.....
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC---CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 999987543332333345578899999999984 468999999999999999998 8999999999999999988877
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 271 IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 271 ~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.++.+..+|+++.+||.+||+.||++|||+.++++.|++++
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 78888999999999999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=401.65 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=216.8
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
|++++|++.++||+|+||+||+|+++. + +.||||++++..... ..+.++. .++..++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~-~------~~vAvK~l~~~~~~~-~~~~~Ev--~~~~~l~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-Q------YDVAIKMIKEGSMSE-DEFIEEA--KVMMNLSHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETT-T------EEEEEEEEESSSSCH-HHHHHHH--HHHHTCCCTTBCCEEEEECC
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECC-C------CEEEEEEECcCcCCH-HHHHHHH--HHHHhcCCCceeeEEEEEee
Confidence 578999999999999999999999753 2 479999998755433 2333322 25677899999999999999
Q ss_pred CCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++.+++||||+.+ ++.+.+. .....+++..+++++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~-~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHH-SGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CCceEEEEEccCCCcHHHhhh-ccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 9999999999985 5555543 3556789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
+.... ........||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..++...+... ..+..|
T Consensus 150 ~~~~~--~~~~~~~~~t~~y~aPE~~~~---~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p 223 (258)
T d1k2pa_ 150 VLDDE--YTSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRP 223 (258)
T ss_dssp CSSSS--CCCCCCSCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCC
T ss_pred ccCCC--ceeecccCCCCCcCCcHHhcC---CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCc
Confidence 65422 223345679999999999984 468999999999999999998 89999999999998888654 466788
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..+++++.+||.+||+.||++|||+.++++.|..
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9999999999999999999999999999997753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=407.06 Aligned_cols=273 Identities=20% Similarity=0.286 Sum_probs=224.3
Q ss_pred CCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcC-cccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 34 TNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTED-CDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 34 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed-~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+.|+.++|++.+.||+|+||.||+|++..+++. ...+..||||++++............+...+.+..+||||++++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 35668999999999999999999999998766532 23456899999987665444444444444566666999999999
Q ss_pred EEEEECCEEEEEEecCC-CCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 113 GISVINGKICIIMKFYE-GSVGDRMAQLK--------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~-GsL~d~l~~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+++.+++..++||||+. |++.+.+.... ...+++.+++.++.||+.||.|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999 57777775432 2468999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
||++.++.+||+|||+++....... ........||+.|||||++.+ +.|+.++|||||||++|||++ |.+||.+.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~---~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcC---CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 9999999999999999988765332 223455689999999999973 579999999999999999998 79999999
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
+..+++..+.. ...++.|..+++++.+||.+||+.||++|||+.++++.|+++.
T Consensus 242 ~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 242 PVEELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CHHHHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 99988877764 4567789999999999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=402.95 Aligned_cols=259 Identities=23% Similarity=0.260 Sum_probs=213.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
++|++++.||+|+||.||+|++..+++ .||||+++...... ...+. ++. .+++.++||||+++++++.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~-~Ei-~il~~l~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAI-REI-SLLKELNHPNIVKLLDVIHTE 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEC-------CCHHHH-HHH-HHHTTCCCTTBCCEEEEEEET
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCC------EEEEEEEehhhcChHHHHHHH-HHH-HHHHhCCCCcEEEeccccccc
Confidence 689999999999999999999987764 89999997543221 12222 222 256778999999999999999
Q ss_pred CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccccc
Q 006887 119 GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLL 198 (627)
Q Consensus 119 ~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~ 198 (627)
+.+||||||+.|++.+.+.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc
Confidence 99999999999988888876667889999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Q 006887 199 GIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP----- 273 (627)
Q Consensus 199 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~----- 273 (627)
.. ........||+.|+|||++... ..++.++|+|||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 154 ~~---~~~~~~~~gt~~y~apE~~~~~--~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 154 VP---VRTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp CC---SBCTTCCBCCCTTCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CC---cccceeecccceeeehhhhccc--cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 32 2334456899999999998743 2467899999999999999999999999888776666543211110
Q ss_pred ----------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 ----------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 ----------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....+++++.+||.+||..||++|||+.|+++ |+||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~------H~ff~~~ 289 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA------HPFFQDV 289 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGTTC
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC------CHhhccC
Confidence 01357899999999999999999999999998 9998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=409.27 Aligned_cols=264 Identities=19% Similarity=0.313 Sum_probs=209.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++++.||+|+||+||+|++..+++. ....||+|.++............++.. +++.++||||+++++++.+
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHH-HHHHCCCTTBCCEEEEEES
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEec
Confidence 4557899999999999999999998876641 234699999876443322222233332 4566799999999999986
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCcccc
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHL 196 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~ 196 (627)
++ .+++|||+. |+|.+.+.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+++.
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred CC-eeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 55 566677776 677777654 567899999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCCC
Q 006887 197 LLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIPPIP 275 (627)
Q Consensus 197 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~~~p 275 (627)
+..... ........||+.|||||++. .+.|+.++|||||||++|||+| |.+||.+.+..++...+.. ...++.|
T Consensus 161 ~~~~~~-~~~~~~~~gt~~y~APE~l~---~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p 235 (317)
T d1xkka_ 161 LGAEEK-EYHAEGGKVPIKWMALESIL---HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQP 235 (317)
T ss_dssp TTTTCC---------CCTTTSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCC
T ss_pred cccccc-cccccccccCccccChHHHh---cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence 654221 22233457999999999997 4479999999999999999998 8999999988888776654 4456778
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
..+++++.+|+.+||+.||.+||++.++++.|..+.
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999999887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=404.09 Aligned_cols=261 Identities=16% Similarity=0.239 Sum_probs=213.3
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHH--HHHhcCCCCceeeEEEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDL--FLKCQGVEGICWLQGISV 116 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~--ll~~~~hpnIv~l~~~~~ 116 (627)
++|++++.||+|+||+||+|++..++. +.||||+++...... .....+ +..+ .++..+||||+++++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~-E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEEEEEBCTTSCBCTHHH-HHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCC-----EEEEEEEEehhhccchHHHHHHH-HHHHHHHHhhcCCCCcceeeeeec
Confidence 689999999999999999999876532 479999986532211 111111 1222 234568999999999986
Q ss_pred E-----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 117 I-----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 117 ~-----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
. ....|++|||+.|+++..........+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 4 34689999999998877776667788999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+++.... ........||+.|||||++.+ .+|+.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 161 g~~~~~~~----~~~~~~~~gT~~Y~APE~~~~---~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSF----QMALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCG----GGGGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhhcc----cccCCCcccChhhcCcchhcC---CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 99876533 223346789999999999974 47999999999999999999999999999988887776542111
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCCC
Q 006887 272 -------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGGW 320 (627)
Q Consensus 272 -------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~w 320 (627)
..++..+++.+.+||.+||++||++|||+.|+++ |+||.+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~------Hpff~~i~~ 301 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQDLER 301 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTCCC
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhcCchh
Confidence 1234568999999999999999999999999998 999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=401.55 Aligned_cols=255 Identities=22% Similarity=0.234 Sum_probs=205.7
Q ss_pred EEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH----HHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 45 LRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR----VLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 45 i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~----~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
.++.||+|+||+||+|++..+++ .||||+++........ ....++. .+++.++||||+++++++..++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCS------EEEEEEC------------CTHHHHHH-HHHHHCCCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEECCCCc------EEEEEEEehhhhhhhhHHHHHHHHHHH-HHHHhCCCCCEeEEEeeeccCCc
Confidence 46889999999999999877664 8999999754332211 1122222 25677899999999999999999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCC
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGI 200 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~ 200 (627)
+||||||+.|++...+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CEEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred eeehhhhhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 999999999876665543 5577999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------
Q 006887 201 PLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP------- 273 (627)
Q Consensus 201 ~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~------- 273 (627)
.......+||+.|||||++.+. ..|+.++|||||||++|||+||.+||.+.+..+.+..+......+.
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ---cccccceecChhhccHHHHccC--CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 2233456899999999998642 3589999999999999999999999999998888777764321110
Q ss_pred -------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 274 -------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 274 -------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
....+++++.+||.+||+.||++|||+.|+|+ |+||.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~------Hp~f~~~ 286 (299)
T d1ua2a_ 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFSNR 286 (299)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGTSS
T ss_pred hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC------CHhhCCC
Confidence 11357899999999999999999999999998 9998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=400.03 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=210.9
Q ss_pred CCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceee
Q 006887 32 NDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWL 111 (627)
Q Consensus 32 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l 111 (627)
...++.|+.++|++.+.||+|+||.||+|++..+. .||||+++...... ..+.++ . .+++.++||||+++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-------~vAiK~l~~~~~~~-~~~~~E-~-~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTMSP-EAFLQE-A-QVMKKLRHEKLVQL 77 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEECCTTSSCH-HHHHHH-H-HHHHHCCCTTBCCE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCC-------EEEEEEECcccCCH-HHHHHH-H-HHHHhcccCCEeEE
Confidence 34567789999999999999999999999986543 69999997654432 233332 2 25677899999999
Q ss_pred EEEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeecc
Q 006887 112 QGISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGD 190 (627)
Q Consensus 112 ~~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~D 190 (627)
++++. ++..++||||+++ ++.+.+.......+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|
T Consensus 78 ~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 78 YAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp EEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcc
Confidence 99985 4568999999995 666666554557799999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQ 269 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~ 269 (627)
||+++.+.... ........||+.|||||++. .+.++.++|||||||++|||++ |.+|+.+....+++..+...
T Consensus 157 fGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~- 230 (285)
T d1fmka3 157 FGLARLIEDNE--YTARQGAKFPIKWTAPEAAL---YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG- 230 (285)
T ss_dssp CCTTC----------------CCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-
T ss_pred cchhhhccCCC--ceeeccccccccccChHHHh---CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-
Confidence 99998764322 22234567999999999997 4578999999999999999999 56667777888888777654
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKS 309 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~ 309 (627)
..++.+..+++++++||.+||+.||++||++.++++.|+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 4566889999999999999999999999999999988775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=408.95 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=202.5
Q ss_pred CCCeEEEe-EEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 40 PSALKLRH-RIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 40 ~~~y~i~~-~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
.++|+++. .||+|+||.||+|++..+++ .||||+++.... ..++..++++..+||||+++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~------~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDCPK------ARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEECSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCC------EEEEEEECCcHH------HHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 35899886 59999999999999887764 899999975322 22333455667799999999999876
Q ss_pred ---CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec---CCCeeecc
Q 006887 118 ---NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE---ADRAVLGD 190 (627)
Q Consensus 118 ---~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~---~g~vkL~D 190 (627)
++.+|||||||+ |+|.+.+......++++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467899999998 48888876544567999999999999999999999999999999999999975 56799999
Q ss_pred CCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 006887 191 VGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQE 270 (627)
Q Consensus 191 FGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~ 270 (627)
||+|+..... ......+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+....+.....
T Consensus 158 FG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~ 230 (335)
T d2ozaa1 158 FGFAKETTSH----NSLTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230 (335)
T ss_dssp CTTCEECCCC----CCCCCCSCCCSSCCCCCCCGG---GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC
T ss_pred cceeeeccCC----CccccccCCcccCCcHHHcCC---CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh
Confidence 9999876542 234567899999999999753 689999999999999999999999988776555544433222
Q ss_pred C--CCCC----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 271 I--PPIP----SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 271 ~--~~~p----~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
. ..+| ..+|+++.+||.+||+.||++||++.++++ |+|+.
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~ 276 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN------HPWIM 276 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SHHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc------CHHhh
Confidence 1 1222 358999999999999999999999999998 88764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=402.81 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=225.4
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.|+.++|++.+.||+|+||.||+|++..... ...++.||||++++...........++..++..+.+||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 455888999999999999999999999865432 2456799999998765544443444444455555689999999999
Q ss_pred EEECCEEEEEEecCCC-CHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCc
Q 006887 115 SVINGKICIIMKFYEG-SVGDRMAQLK----------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFN 177 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G-sL~d~l~~~~----------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~N 177 (627)
+.+.+..|||||||+| ++.+.+.... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 9999999999999995 6666665432 2368999999999999999999999999999999999
Q ss_pred EEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 006887 178 FILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGR 256 (627)
Q Consensus 178 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~ 256 (627)
||++.++.++|+|||+++....... ........||+.|||||++. .+.++.++|||||||++|||+| |.+||.+.
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIF---NCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhc---CCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999987654322 22334568999999999997 4578999999999999999998 77778787
Q ss_pred CHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 257 SVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 257 ~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
+..+.+..+......+..|..+++++.+||.+||+.||++||++.+++++|++.
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 777777677767777788889999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=405.81 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=214.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++++.||+|+||.||+|++..+++ .||||+++....+.. ...++. .+++.++||||+++++++.+++.
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~------~~AiK~i~~~~~~~~--~~~~Ei-~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKK------TYMAKFVKVKGTDQV--LVKKEI-SILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECCCTHHHH--HHHHHH-HHHHHSCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEcCCcccHH--HHHHHH-HHHHhCCCCCCCeEEEEEEECCE
Confidence 679999999999999999999987764 899999987654432 222333 25677899999999999999999
Q ss_pred EEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC--CCeeeccCCccccc
Q 006887 121 ICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA--DRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~--g~vkL~DFGla~~~ 197 (627)
+|||||||+| +|.+.+.. ...++++.++..|+.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++..
T Consensus 76 ~~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999995 77766643 34579999999999999999999999999999999999999854 47999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--CC
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIPP--IP 275 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~~--~p 275 (627)
.. ........||+.|||||.+.+ ..|+.++|||||||++|+|++|..||.+.+..+++..+.......+ .+
T Consensus 155 ~~----~~~~~~~~~t~~y~ape~~~~---~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 155 KP----GDNFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp CT----TCEEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred cc----CCcccccccccccccchhccC---CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc
Confidence 43 222345689999999999874 4688999999999999999999999999999999998876543322 22
Q ss_pred CCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 276 SGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 276 ~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
..+|+++++||.+||..||.+||++.|+++ |+|+.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~------hp~~~ 262 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ------HPWLK 262 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH------SHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc------CHhhc
Confidence 478999999999999999999999999998 88775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=402.51 Aligned_cols=266 Identities=18% Similarity=0.242 Sum_probs=218.0
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
-++|+.++|++.+.||+|+||.||+|++..++. ...||||+++............++..++..+.+||||++++++
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTE----EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCe----EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 567899999999999999999999999877653 1358899987554433332333344344444489999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQL--------------KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~--------------~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
+.+++..||||||++ |+|.+.+... ....+++..+.+++.||+.||.|||+++|+||||||+|||
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 999999999999999 6887776532 2467999999999999999999999999999999999999
Q ss_pred EecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCH
Q 006887 180 LNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPRCGRSV 258 (627)
Q Consensus 180 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~~ 258 (627)
++.++.+||+|||+++.... ........||+.|+|||.+. .+.|+.++|||||||++|||++| .+||.+.+.
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~----~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp ECGGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHH---HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EcCCCceEEccccccccccc----cccccceecCCcccchHHhc---cCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999986543 12223557999999999997 45789999999999999999996 568999999
Q ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhccc
Q 006887 259 DEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQN 312 (627)
Q Consensus 259 ~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~ 312 (627)
.+++..+... ..++.|..+++++.+||.+||+.||++||++.++++.|+++..
T Consensus 233 ~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 233 AELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHGGGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9998887653 4677889999999999999999999999999999998887653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-48 Score=398.75 Aligned_cols=266 Identities=19% Similarity=0.305 Sum_probs=220.0
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
+..++|++++.||+|+||+||+|++.... +...+..||||+++............++.. .++.++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSS-TTSSEEEEEEEECCTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCc-cCCCCeEEEEEEEChhcChHHHHHHHHHHH-HHHhcCCCCcccceeeecc
Confidence 34568999999999999999999986533 234556899999987554443333333333 4677899999999999999
Q ss_pred CCEEEEEEecCC-CCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Q 006887 118 NGKICIIMKFYE-GSVGDRMAQLK----------------------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLK 174 (627)
Q Consensus 118 ~~~~~LVmEy~~-GsL~d~l~~~~----------------------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLK 174 (627)
.+..++||||++ |+|.+.+.... ...+++..++.++.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999998 67777775321 2358899999999999999999999999999999
Q ss_pred CCcEEEecCCCeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCC
Q 006887 175 PFNFILNEADRAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPR 253 (627)
Q Consensus 175 P~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf 253 (627)
|+|||++.++.+||+|||+|+....... .....+..||+.|||||++. ...|+.++|||||||++|||++| .+||
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIF---YNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHc---cCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999987643221 22334568999999999998 44799999999999999999998 4789
Q ss_pred CCCCHHHHHHHHHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 254 CGRSVDEIYDAVVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 254 ~~~~~~e~~~~i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
.+.+..++...+.... .+++|..+++++.+||.+||+.||++|||+.++++.|+++
T Consensus 244 ~~~~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999998877544 6678899999999999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=392.92 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=207.9
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGIS 115 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~ 115 (627)
+.|+.++|++.+.||+|+||.||+|+++. ..||||+++..... +.+.+ +. .+++.++||||+++++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~vAvK~i~~~~~~--~~~~~-E~-~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDATA--QAFLA-EA-SVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC----HHHHH-TH-HHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC--------eEEEEEEECcHHHH--HHHHH-HH-HHHHhCCCCCEeeEEEEE
Confidence 46888999999999999999999999742 37999999765432 22322 22 256778999999999998
Q ss_pred EE-CCEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 116 VI-NGKICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 116 ~~-~~~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
.+ ++.+||||||++ |+|.+.+.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 64 456899999998 5788777654445689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCC
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLT-GVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyellt-G~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++.... ......+|+.|||||++.+ +.++.++|||||||++|||+| |++||...+..+++..+.. ...+
T Consensus 150 s~~~~~------~~~~~~~~~~y~aPE~l~~---~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~ 219 (262)
T d1byga_ 150 TKEASS------TQDTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKM 219 (262)
T ss_dssp ------------------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCC
T ss_pred ceecCC------CCccccccccCCChHHHhC---CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 986532 2344578999999999973 479999999999999999998 7999999998888888754 4567
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 273 PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 273 ~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
++|..+++++.+||.+||+.||.+||++.++++.|+.+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 789999999999999999999999999999999988753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=405.50 Aligned_cols=288 Identities=17% Similarity=0.253 Sum_probs=229.2
Q ss_pred CCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCch---hHHHHHHHHHHHHHHHhcCCCCceeeE
Q 006887 36 AWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKE---DRMRVLLERLNDLFLKCQGVEGICWLQ 112 (627)
Q Consensus 36 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~---~~~~~~~~~~~~~ll~~~~hpnIv~l~ 112 (627)
..+..++|++++.||+|+||.||+|++..... .++.||||++++... ........++..++.++.+||||++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHD---TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTT---TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCC---CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence 34567899999999999999999999865432 456899999875321 111111223333455555669999999
Q ss_pred EEEEECCEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccC
Q 006887 113 GISVINGKICIIMKFYEG-SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDV 191 (627)
Q Consensus 113 ~~~~~~~~~~LVmEy~~G-sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DF 191 (627)
+++.+.+..++||||+.| +|.+.+. ..+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.++|+||
T Consensus 96 ~~~~~~~~~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 96 YAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeeccCCceeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeec
Confidence 999999999999999995 6666665 3456889999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cc
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVR--RQ 269 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~--~~ 269 (627)
|+++.+.... ........||+.|+|||.+.+. ...++.++|||||||+||||++|+.||.+.+..+....+.. ..
T Consensus 174 G~a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~-~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 174 GLSKEFVADE--TERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred cchhhhcccc--cccccccccccccchhHHhhcC-CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 9998764321 2223456899999999999754 33578899999999999999999999987654433333322 12
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHHhcccccCCCCCCCCCCcccCCCCCCCCCc
Q 006887 270 EIPPIPSGLPPAVENVLLGCFEYDLRSRPL-----MTDILRVFKSSQNSVHSDGGWTGHGSRILPDKSSSGYT 337 (627)
Q Consensus 270 ~~~~~p~~~s~~l~~li~~cL~~dP~~RPs-----~~eil~~L~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 337 (627)
..+++|..+++++.+||.+||++||.+||+ +.|+++ |+||..++|..+..+.+++|+.|...
T Consensus 251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~------Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc------CHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 356678899999999999999999999994 788887 99999999999999999999988653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-47 Score=389.75 Aligned_cols=256 Identities=19% Similarity=0.242 Sum_probs=208.4
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH--HHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR--MRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~--~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|+++++||+|+||+||+|++. ++ +.||||+++...... ...+.+ +. .+++.++||||+++++++..
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~------~~vAvK~i~~~~~~~~~~~~~~~-E~-~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YG------ETFALKKIRLEKEDEGIPSTTIR-EI-SILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TS------CEEEEEEECCSSGGGCCCHHHHH-HH-HGGGGCCCTTBCCEEEEEEC
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CC------CEEEEEEEehhhcChHHHHHHHH-HH-HHHHhCCCCcEEeeeeeccc
Confidence 368999999999999999999975 33 389999997654322 222222 22 25677899999999999999
Q ss_pred CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccc
Q 006887 118 NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLL 197 (627)
Q Consensus 118 ~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~ 197 (627)
++..|++|||+.|++++.+.. ..+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred CCceeEEEEeehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 999999999999988777754 5678999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------
Q 006887 198 LGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI------ 271 (627)
Q Consensus 198 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~------ 271 (627)
... ........||+.|+|||.+.+. ..++.++|+|||||++|||++|++||.+.+..+.+..+......
T Consensus 151 ~~~---~~~~~~~~~~~~y~~pE~~~~~--~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 151 GIP---VRKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp CC------------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccC---ccccceecccchhhhHHHHhCC--CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 432 2223455799999999998743 36789999999999999999999999998887777665432111
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 272 ---------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 272 ---------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
...+..+++++.+||.+||+.||++|||+.|+++ |+||.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~------Hp~f~ 285 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE------HAYFK 285 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGG
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccC
Confidence 1124567899999999999999999999999988 99875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=394.33 Aligned_cols=249 Identities=18% Similarity=0.205 Sum_probs=200.1
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhH-----HHHHHHHHHHHHHHhc-CCCCceeeEEE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDR-----MRVLLERLNDLFLKCQ-GVEGICWLQGI 114 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~-----~~~~~~~~~~~ll~~~-~hpnIv~l~~~ 114 (627)
++|++.+.||+|+||.||+|++..++. .||||++++..... ......++..++.+.. .||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCC------EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 579999999999999999999887764 89999987532110 0000112222333332 49999999999
Q ss_pred EEECCEEEEEEecCCC--CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecC-CCeeeccC
Q 006887 115 SVINGKICIIMKFYEG--SVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEA-DRAVLGDV 191 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~G--sL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~-g~vkL~DF 191 (627)
+.+.+..|+||||+.| ++.+.+. ....+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeeCCeEEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcc
Confidence 9999999999999975 4555554 34679999999999999999999999999999999999999854 78999999
Q ss_pred CccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 006887 192 GIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI 271 (627)
Q Consensus 192 Gla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~ 271 (627)
|+|+.... ....+..||+.|||||++.+. ..++.++|||||||++|||++|+.||.+.+ .+... .
T Consensus 156 G~a~~~~~-----~~~~~~~GT~~y~aPE~~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~ 220 (273)
T d1xwsa_ 156 GSGALLKD-----TVYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q 220 (273)
T ss_dssp TTCEECCS-----SCBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C
T ss_pred ccceeccc-----ccccccccCCCcCCHHHHcCC--CCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c
Confidence 99987532 233467899999999998743 234678999999999999999999997632 22222 3
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 272 PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 272 ~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..++..+|+++++||.+||+.||++|||+.|+++ |+|+...
T Consensus 221 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~------hp~~~~~ 261 (273)
T d1xwsa_ 221 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN------HPWMQDV 261 (273)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGSSC
T ss_pred cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc------CHhhCCC
Confidence 4577889999999999999999999999999988 9998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=395.70 Aligned_cols=275 Identities=19% Similarity=0.297 Sum_probs=226.4
Q ss_pred CCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEE
Q 006887 35 NAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGI 114 (627)
Q Consensus 35 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~ 114 (627)
.+.|+.++|++.++||+|+||.||+|.++.... ...++.||||+++............++. .+++.++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~VAvK~~~~~~~~~~~~~~~~E~-~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEA-SVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHH-HHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCccc-CCCCcEEEEEEECcccChHHHHHHHHHH-HHHHHcCCCCEeeeeeE
Confidence 355899999999999999999999999865432 1234689999998654433332223333 25667899999999999
Q ss_pred EEECCEEEEEEecCC-CCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCC
Q 006887 115 SVINGKICIIMKFYE-GSVGDRMAQLK--------GGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADR 185 (627)
Q Consensus 115 ~~~~~~~~LVmEy~~-GsL~d~l~~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~ 185 (627)
+..++..++||||++ |+|.+.+.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 998999999999998 67777665432 145789999999999999999999999999999999999999999
Q ss_pred eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 006887 186 AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTG-VQPRCGRSVDEIYDA 264 (627)
Q Consensus 186 vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG-~~Pf~~~~~~e~~~~ 264 (627)
+||+|||+++.+..... ........||+.|||||.+. .+.++.++|+|||||++|||+|| .+||.+.+..+++..
T Consensus 172 ~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~---~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~ 247 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLK---DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247 (308)
T ss_dssp EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHH---HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred EEEeecccceeccCCcc-eeeccceecccccCCHHHHc---cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999987654221 12223457999999999997 44788999999999999999998 688999999999988
Q ss_pred HHhccCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCC
Q 006887 265 VVRRQEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHS 316 (627)
Q Consensus 265 i~~~~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~ 316 (627)
+... ..++.|..+++.+.++|.+||+.||++||++.++++.|++..++.|.
T Consensus 248 i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 248 VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 7754 45677889999999999999999999999999999999987766543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=384.58 Aligned_cols=264 Identities=18% Similarity=0.239 Sum_probs=206.5
Q ss_pred EEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-CCEEE
Q 006887 44 KLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI-NGKIC 122 (627)
Q Consensus 44 ~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~-~~~~~ 122 (627)
.+.++||+|+||+||+|++..++. ....||||+++............++.. ++..++||||+++++++.. ++..+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHH-HHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHH-HHHhCCCCCEeEEeEEEEecCCceE
Confidence 346889999999999999876542 234699999976443333222333332 4567799999999999876 56899
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccCCCC
Q 006887 123 IIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLGIPL 202 (627)
Q Consensus 123 LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~~~~ 202 (627)
+|||||+|+.+..+.......+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.+.....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999996444444444566788999999999999999999999999999999999999999999999999988754332
Q ss_pred CC-CCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCCCCCCCH
Q 006887 203 PS-SDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCG-RSVDEIYDAVVRRQEIPPIPSGLPP 280 (627)
Q Consensus 203 ~~-~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~-~~~~e~~~~i~~~~~~~~~p~~~s~ 280 (627)
.. .......||+.|+|||.+. .+.++.++||||||+++|||+||..||.. .+..++...+... ..+..|..+++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~ 261 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPD 261 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHH---HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCH
T ss_pred ccceecccccccccccChHHHh---cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcH
Confidence 22 2233467999999999987 45799999999999999999997666654 4555666666544 45667889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccC
Q 006887 281 AVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVH 315 (627)
Q Consensus 281 ~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~ 315 (627)
++.+||.+||+.||++||++.|+++.|+++...+.
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999998876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=392.72 Aligned_cols=267 Identities=21% Similarity=0.202 Sum_probs=212.6
Q ss_pred cccCCCCCCCcCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCC
Q 006887 28 VATSNDTNAWIKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEG 107 (627)
Q Consensus 28 ~~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpn 107 (627)
.+++...+.....-+|+.++.||+|+||+||+|++..+++ .||||++........ ++.. +++.++|||
T Consensus 7 ~~~~~~~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~-----~Ei~-il~~l~h~n 74 (350)
T d1q5ka_ 7 VATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKRFKN-----RELQ-IMRKLDHCN 74 (350)
T ss_dssp EEEESSSSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCSSSCC-----HHHH-HHHHCCCTT
T ss_pred ccCCCCCCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCC------EEEEEEECccchHHH-----HHHH-HHHhcCCCC
Confidence 3334333344434479999999999999999999987764 899999976543221 2222 456679999
Q ss_pred ceeeEEEEEEC------CEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEE
Q 006887 108 ICWLQGISVIN------GKICIIMKFYEGSVGDRMAQL--KGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFI 179 (627)
Q Consensus 108 Iv~l~~~~~~~------~~~~LVmEy~~GsL~d~l~~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NIL 179 (627)
|+++++++... ..+||||||++|++.+.+... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 75 iv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NIL 154 (350)
T d1q5ka_ 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154 (350)
T ss_dssp BCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEE
Confidence 99999998653 358999999998877666442 4567999999999999999999999999999999999999
Q ss_pred EecCC-CeeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH
Q 006887 180 LNEAD-RAVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV 258 (627)
Q Consensus 180 ld~~g-~vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~ 258 (627)
++.++ .+||+|||+++.+... ....+.+||+.|+|||.+.+. ..|+.++|||||||++|||++|++||.+.+.
T Consensus 155 l~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 155 LDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp ECTTTCCEEECCCTTCEECCTT----SCCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred EecCCCceeEecccchhhccCC----cccccccccccccChHHhhcc--cCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 99775 8999999999876432 233456899999999998643 3689999999999999999999999999888
Q ss_pred HHHHHHHHhccCC------------------C---------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 259 DEIYDAVVRRQEI------------------P---------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 259 ~e~~~~i~~~~~~------------------~---------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+.+..+...... + .....+++++.+||.+||+.||++|||+.|+++
T Consensus 229 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------ 302 (350)
T d1q5ka_ 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA------ 302 (350)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------
T ss_pred HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc------
Confidence 7776665431110 0 112457899999999999999999999999998
Q ss_pred cccCCCC
Q 006887 312 NSVHSDG 318 (627)
Q Consensus 312 ~~~~~~~ 318 (627)
|+||...
T Consensus 303 Hp~f~~~ 309 (350)
T d1q5ka_ 303 HSFFDEL 309 (350)
T ss_dssp SGGGGGG
T ss_pred CHhhccc
Confidence 9998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=389.71 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=203.0
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHH-HHHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRM-RVLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~-~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
.++|++++.||+|+||+||+|++..+++ .||||++++...... .....++. .+++.++||||+++++++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~Ei-~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAYREL-RLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC------EEEEEECSSTTSSHHHHHHHHHHH-HHHHHCCBTTBCCCSEEECSC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEchhhcChHHHHHHHHHH-HHHHhcCCCCeeEEEEEeccC
Confidence 4789999999999999999999887764 899999976433222 11222222 255678999999999999765
Q ss_pred C------EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 G------KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ~------~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+ .+||||||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~~~~~lv~e~~~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccccceEEEEEecccccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccccccc
Confidence 4 479999999766665543 3579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEI- 271 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~- 271 (627)
+|+.... ..+...||+.|||||++.+. ..++.++|||||||++|||++|++||.+.+..+.+..+......
T Consensus 167 ~a~~~~~------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 167 LARQADS------EMTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238 (346)
T ss_dssp TCEECCS------SCCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeccCC------ccccccccccccCHHHHcCC--CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence 9987642 33566899999999998743 35789999999999999999999999998876665544332111
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 272 ----------------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 272 ----------------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
......+++++.+||.+||..||++|||+.|+|+ |+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~------Hp~f~~~~ 308 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA------HPYFESLH 308 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGTTTC
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhCcCC
Confidence 1133568999999999999999999999999998 99988654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=383.72 Aligned_cols=261 Identities=21% Similarity=0.224 Sum_probs=204.8
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh--HHHHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED--RMRVLLERLNDLFLKCQGVEGICWLQGISVI 117 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~--~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~ 117 (627)
.++|++++.||+|+||+||+|++..+++ .||||++...... ......+ +. .+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~-E~-~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALR-EI-KILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEC----CTTSSCHHHHH-HH-HHHHHCCCTTBCCEEEEEEC
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCC------EEEEEEEehhhcchHHHHHHHH-HH-HHHHHhcCCCccceEeeeec
Confidence 4799999999999999999999887664 8999998654322 1122222 22 25677899999999998754
Q ss_pred --------CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeec
Q 006887 118 --------NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLG 189 (627)
Q Consensus 118 --------~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~ 189 (627)
++..|+||||+.++++..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred ccccccccCceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEee
Confidence 345899999999877765543 45679999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCC-CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 006887 190 DVGIPHLLLGIPLP-SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRR 268 (627)
Q Consensus 190 DFGla~~~~~~~~~-~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~ 268 (627)
|||+++.+...... .......+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCC--CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999876532211 2223456899999999998753 36889999999999999999999999998887776665543
Q ss_pred cCCCC--CCC----------------------------CCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 269 QEIPP--IPS----------------------------GLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 269 ~~~~~--~p~----------------------------~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+. ... ..++++.+||.+||+.||++|||+.|+++ |+||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~------Hpff~~ 310 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFWS 310 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGSS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc------Chhhcc
Confidence 22111 000 13678889999999999999999999998 999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-45 Score=378.52 Aligned_cols=257 Identities=20% Similarity=0.253 Sum_probs=201.4
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
++|++.+.||+|+||.||+|++..+++ .||||++........ ...+.+++....+|++|+.+..++..++.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~~~---~~~E~~i~~~l~~~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGE------EVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWCGAEGDY 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE------EEEEEEEESCTTSCC---HHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCC------EEEEEEEchhccCHH---HHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence 579999999999999999999877664 899999876443221 22333344444456667777888889999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEe---cCCCeeeccCCccccc
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILN---EADRAVLGDVGIPHLL 197 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld---~~g~vkL~DFGla~~~ 197 (627)
.++||||++|++.+.+.. ..+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..++|+|||+|+.+
T Consensus 78 ~~ivme~~~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEcCCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999999988777654 567899999999999999999999999999999999999985 4557999999999987
Q ss_pred cCCCCC----CCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc--
Q 006887 198 LGIPLP----SSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVV---RR-- 268 (627)
Q Consensus 198 ~~~~~~----~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~---~~-- 268 (627)
...... ........||+.|||||++.+ .+++.++|||||||++|||+||+.||......+....+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT---BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC---CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 643321 122346689999999999984 368999999999999999999999998766544332221 11
Q ss_pred -cCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhc
Q 006887 269 -QEIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSS 310 (627)
Q Consensus 269 -~~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~ 310 (627)
...+..+..+|+++.+++.+||+.||++||++.++.+.|+..
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111224568999999999999999999999999988877754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.2e-45 Score=375.77 Aligned_cols=259 Identities=19% Similarity=0.255 Sum_probs=208.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.++|++.+.||+|+||.||+|++..+++ .||||+++....... ..++.+.+....+|+|++.+++++..+.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~~~~---~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKFEPRRSDAPQ---LRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEECCTTSCC---HHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEccccCcHH---HHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 4689999999999999999999887664 899999865433211 1222234445556799999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEec-----CCCeeeccCCcc
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNE-----ADRAVLGDVGIP 194 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~-----~g~vkL~DFGla 194 (627)
..|+||||+.|+|.+.+.. ....+++.++..++.|++.||+|||++||+||||||+|||++. ++.++|+|||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEEEECCCCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ccEEEEEecCCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999999999998887754 5568999999999999999999999999999999999999974 578999999999
Q ss_pred ccccCCCC----CCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Q 006887 195 HLLLGIPL----PSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRS---VDEIYDAVVR 267 (627)
Q Consensus 195 ~~~~~~~~----~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~---~~e~~~~i~~ 267 (627)
+.+..... ........+||+.|||||++.+ .+++.++|||||||++|||+||+.||.+.+ ..+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC---CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 98754321 1223446789999999999984 469999999999999999999999998643 3334443332
Q ss_pred ccC---CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 268 RQE---IPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 268 ~~~---~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
... ...++..+|+++.+++..|+..+|++||+++.+.+.|+.+.
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 221 12244678999999999999999999999998887776643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=385.97 Aligned_cols=260 Identities=18% Similarity=0.199 Sum_probs=206.5
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEEC--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVIN-- 118 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~-- 118 (627)
++|++++.||+|+||+||+|++..+++ .||||++++...........++. .+++.++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~Ei-~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKV------RVAIKKISPFEHQTYCQRTLREI-KILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCS------EEEEEEECCTTCHHHHHHHHHHH-HHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCc------EEEEEEEehhcChHHHHHHHHHH-HHHHHcCCCCCCcEEEEEeeccc
Confidence 469999999999999999999887764 89999997655433322222333 356678999999999998754
Q ss_pred ---CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 119 ---GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 119 ---~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
...||+|+++.|+|.+.+.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34778887777888888753 479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP--- 272 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~--- 272 (627)
...............+||+.|+|||++... ..++.++||||+||++|||++|+.||.+.+..+...........+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTB--CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCCCccceeeccccccceechHHHhhcC--CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 765543333444567899999999998642 357889999999999999999999999887766554443211110
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 --------------------------PIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 --------------------------~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
.....+++++.+|+.+||+.||.+||++.++|+ |+|+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~------hpf~~~~ 301 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA------HPYLEQY 301 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGTTT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc------CHhhccC
Confidence 113467899999999999999999999999998 9987643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=371.47 Aligned_cols=258 Identities=20% Similarity=0.263 Sum_probs=209.7
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh-HHHHHHHHHHHHHHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED-RMRVLLERLNDLFLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~-~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~ 119 (627)
++|+++++||+|+||+||+|++..++. .||||+++..... .......++. .+++.++||||+++++++...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~E~-~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEESSCSSTTHHHHHHHHH-HHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCc------EEEEEEEehhhCChHHHHHHHHHH-HHHHhcCcCCEEeecccccccc
Confidence 689999999999999999999987764 8999999754432 2222222222 3567789999999999999999
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCccccccC
Q 006887 120 KICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGIPHLLLG 199 (627)
Q Consensus 120 ~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGla~~~~~ 199 (627)
..++||+++.|.++..+.. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~iv~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EEEEEEECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceeEEeeeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999999866666544 567899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccCC-------
Q 006887 200 IPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPR-CGRSVDEIYDAVVRRQEI------- 271 (627)
Q Consensus 200 ~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf-~~~~~~e~~~~i~~~~~~------- 271 (627)
. ........+++.|+|||++.+. ..++.++|||||||++|||++|+.|| .+.+..+.+..+......
T Consensus 154 ~---~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 154 P---VRCYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp C---CSCCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred C---CccceeeccccchhhhhHhccC--CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 2 2233445688999999998743 24788999999999999999999885 455666666655432111
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCC
Q 006887 272 --------------------PPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSD 317 (627)
Q Consensus 272 --------------------~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~ 317 (627)
...+..+++++.+||.+||+.||.+|||+.|+|+ |+||..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~------Hp~f~~ 288 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFSD 288 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGSS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc------ChhhcC
Confidence 1233567899999999999999999999999988 999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.1e-45 Score=380.46 Aligned_cols=257 Identities=18% Similarity=0.264 Sum_probs=202.9
Q ss_pred CCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q 006887 39 KPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVI- 117 (627)
Q Consensus 39 ~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~- 117 (627)
+.++|+++++||+|+||+||+|++..+++ .||||++++..... ..++..++..+..||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~------~vAiK~i~~~~~~~----~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNE------KVVVKILKPVKKKK----IKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSSCHHH----HHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCC------EEEEEEECHHHHHH----HHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 34689999999999999999999887764 89999997655332 22333445555579999999999874
Q ss_pred -CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCC-CeeeccCCccc
Q 006887 118 -NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEAD-RAVLGDVGIPH 195 (627)
Q Consensus 118 -~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g-~vkL~DFGla~ 195 (627)
...+|+||||+.++.+..+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||+|+
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred CCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 3569999999996443222 35799999999999999999999999999999999999999765 58999999998
Q ss_pred cccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc------
Q 006887 196 LLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSV-DEIYDAVVRR------ 268 (627)
Q Consensus 196 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~-~e~~~~i~~~------ 268 (627)
..... ......+||+.|+|||.+.+. ..++.++|+|||||++|||++|+.||..... .+....+...
T Consensus 179 ~~~~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 179 FYHPG----QEYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp ECCTT----CCCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eccCC----CcccccccCccccCcccccCC--CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 76532 234566899999999998753 3578999999999999999999999976542 2222211110
Q ss_pred ------c-----------------------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCCC
Q 006887 269 ------Q-----------------------EIPPIPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDGG 319 (627)
Q Consensus 269 ------~-----------------------~~~~~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 319 (627)
. ........+++++.+||.+||..||++|||+.|+|+ |+||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~------Hp~F~~v~ 326 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME------HPYFYTVV 326 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTTSC
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCCCC
Confidence 0 001112347899999999999999999999999998 99999887
Q ss_pred CC
Q 006887 320 WT 321 (627)
Q Consensus 320 w~ 321 (627)
|+
T Consensus 327 ~~ 328 (328)
T d3bqca1 327 KD 328 (328)
T ss_dssp CC
T ss_pred CC
Confidence 74
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=380.58 Aligned_cols=253 Identities=20% Similarity=0.213 Sum_probs=195.8
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEE--
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVI-- 117 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~-- 117 (627)
++|++++.||+|+||+||+|++..+++ .||||++++....... ....++. .+++.++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~------~vAvK~i~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTE------EEEEEEEESTTSSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCC------EEEEEEEChhhcCHHHHHHHHHHH-HHHHhcCCCCeeEEEEEEeccc
Confidence 579999999999999999999987764 8999999765432222 2222332 25667899999999999863
Q ss_pred ----CCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCCc
Q 006887 118 ----NGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVGI 193 (627)
Q Consensus 118 ----~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFGl 193 (627)
.+.+|+||||+.|++++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+
T Consensus 90 ~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp STTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhh
Confidence 36899999999998877653 4689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-
Q 006887 194 PHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP- 272 (627)
Q Consensus 194 a~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~- 272 (627)
++.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+.......+......+
T Consensus 166 ~~~~~~----~~~~~~~~~t~~y~aPE~l~~---~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 166 ARTAGT----SFMMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp -------------------CCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred hhcccc----ccccccccccccccChhhhcC---CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCC
Confidence 876543 233455689999999999975 368999999999999999999999999888776665554321110
Q ss_pred -------------------CC--------------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccc
Q 006887 273 -------------------PI--------------------PSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNS 313 (627)
Q Consensus 273 -------------------~~--------------------p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~ 313 (627)
.. +...++++.+||.+||..||++|||+.|+|+ |+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~------Hp 312 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ------HP 312 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT------ST
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------Cc
Confidence 00 0123678899999999999999999999998 99
Q ss_pred cCCC
Q 006887 314 VHSD 317 (627)
Q Consensus 314 ~~~~ 317 (627)
|+..
T Consensus 313 w~~~ 316 (355)
T d2b1pa1 313 YINV 316 (355)
T ss_dssp TTGG
T ss_pred ccCC
Confidence 9875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=379.82 Aligned_cols=255 Identities=21% Similarity=0.229 Sum_probs=201.1
Q ss_pred CCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHH-HHHHHHHHHHHHhcCCCCceeeEEEEEEC
Q 006887 40 PSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMR-VLLERLNDLFLKCQGVEGICWLQGISVIN 118 (627)
Q Consensus 40 ~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~-~~~~~~~~~ll~~~~hpnIv~l~~~~~~~ 118 (627)
+++|++++.||+|+||+||+|++..+++ .||||++++....... ....++. .+++.++||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~------~vAiK~i~~~~~~~~~~~~~~~Ei-~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTE------EEEEEECSCTTSSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCC------EEEEEEECchhcChHHHHHHHHHH-HHHHhcCCCCeeeEEEEEeec
Confidence 5789999999999999999999887764 8999999865432222 1222222 256778999999999998632
Q ss_pred ------CEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCeeeccCC
Q 006887 119 ------GKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRAVLGDVG 192 (627)
Q Consensus 119 ------~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~vkL~DFG 192 (627)
+..|++|++..|+|.+.+ ..+++++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~---~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred cccccCceEEEEEeecCCchhhhc---ccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence 235555555556777665 34679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Q 006887 193 IPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGRSVDEIYDAVVRRQEIP 272 (627)
Q Consensus 193 la~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~~~~e~~~~i~~~~~~~ 272 (627)
++.... ....+..||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+......+
T Consensus 167 ~a~~~~------~~~~~~~g~~~y~apE~~~~~--~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 167 LARHTD------DEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp ---CCT------GGGSSSCHHHHTSCHHHHTTC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccC------cccccccccccccCchhhcCC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 987643 233456899999999997643 356889999999999999999999999988877776665432221
Q ss_pred C-----------------------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 273 P-----------------------------IPSGLPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 273 ~-----------------------------~p~~~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
. ....+++++++||.+||+.||.+|||+.|+|+ |+||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~------Hp~f~~~ 307 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFAQY 307 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTTT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc------CHhhCCC
Confidence 1 12467899999999999999999999999998 9998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-44 Score=369.95 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=195.9
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHH-HHHhcCCCCceeeEEEEEECC
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDL-FLKCQGVEGICWLQGISVING 119 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~-ll~~~~hpnIv~l~~~~~~~~ 119 (627)
.+|.+.++||+|+||.||+|++. ++.||||+++..... ....+ .++ .+..++||||+++++++..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~~~~---~~~~e-~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSREER---SWFRE-AEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGGGHH---HHHHH-HHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccchh---HHHHH-HHHHHHhhCCCCcCcceEEEEEeCC
Confidence 47999999999999999999863 248999999654322 12122 222 334578999999999998754
Q ss_pred ----EEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecccCCCcEEEecCCCe
Q 006887 120 ----KICIIMKFYE-GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS--------KGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 120 ----~~~LVmEy~~-GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs--------~gIvHrDLKP~NILld~~g~v 186 (627)
.+||||||++ |+|.+.+.. .++++..++.++.|++.||.|||+ +||+||||||+||||+.++.+
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 6899999998 577777653 468999999999999999999996 599999999999999999999
Q ss_pred eeccCCccccccCCCCCC-CCCCccCCCCCcCCcccccCCCC---CCCCccCcchhHHHHHHHHHhCCCCCCC-------
Q 006887 187 VLGDVGIPHLLLGIPLPS-SDLPRRLGTPNYMAPEQWQPEVR---GPISFETDSWGFACSIIEMLTGVQPRCG------- 255 (627)
Q Consensus 187 kL~DFGla~~~~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~~---~~~s~~sDiwSlGviLyelltG~~Pf~~------- 255 (627)
||+|||+++......... .......||+.|||||++.+... ..++.++|||||||+||||+||.+||..
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999999876533221 23345789999999999875321 1367789999999999999999887642
Q ss_pred --------CCHHHHHHHHHhccCCCCCCCC-----CCHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhcc
Q 006887 256 --------RSVDEIYDAVVRRQEIPPIPSG-----LPPAVENVLLGCFEYDLRSRPLMTDILRVFKSSQ 311 (627)
Q Consensus 256 --------~~~~e~~~~i~~~~~~~~~p~~-----~s~~l~~li~~cL~~dP~~RPs~~eil~~L~~~~ 311 (627)
.+..++...+......+.++.. .+..+.+|+.+||+.||++|||+.|+++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1233444444444444444433 2356899999999999999999999999887653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-38 Score=336.86 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=190.3
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHH----------HHhcCCCC
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLF----------LKCQGVEG 107 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~l----------l~~~~hpn 107 (627)
+..++|+++++||+|+||+||+|++..+++ .||||++++...... .. .++..++ .....|+|
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~------~vAvKvi~~~~~~~~-~~-~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNT------HVAMKIVRGDKVYTE-AA-EDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEECSCHHHHH-HH-HHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEeccccchH-HH-HHHHHHHHHhcchhhhhhhhcCcCc
Confidence 344579999999999999999999887764 899999976543211 11 1111111 12346789
Q ss_pred ceeeEEEEEE--CCEEEEEEecCC--CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccCCCcEEEec
Q 006887 108 ICWLQGISVI--NGKICIIMKFYE--GSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS-KGILVLNLKPFNFILNE 182 (627)
Q Consensus 108 Iv~l~~~~~~--~~~~~LVmEy~~--GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~gIvHrDLKP~NILld~ 182 (627)
|+++++++.. ....+++|+++. ++............+++..+..++.||+.||.|||+ .||+||||||+||||+.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999988754 456677777665 344444444456789999999999999999999998 89999999999999987
Q ss_pred CCC------eeeccCCccccccCCCCCCCCCCccCCCCCcCCcccccCCCCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 006887 183 ADR------AVLGDVGIPHLLLGIPLPSSDLPRRLGTPNYMAPEQWQPEVRGPISFETDSWGFACSIIEMLTGVQPRCGR 256 (627)
Q Consensus 183 ~g~------vkL~DFGla~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~~~~~s~~sDiwSlGviLyelltG~~Pf~~~ 256 (627)
++. ++++|||.+..... .....+||+.|+|||++.+ ..|+.++|+||+||++++|++|+.||...
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cCcccccceeeEeeccccccccc------ccccccccccccChhhccc---cCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 654 89999999876532 2345689999999999984 46899999999999999999999999754
Q ss_pred CHH------HHHHHHHhc-c---------------------------------------CCCCCCCCCCHHHHHHHHHhh
Q 006887 257 SVD------EIYDAVVRR-Q---------------------------------------EIPPIPSGLPPAVENVLLGCF 290 (627)
Q Consensus 257 ~~~------e~~~~i~~~-~---------------------------------------~~~~~p~~~s~~l~~li~~cL 290 (627)
+.. +........ . .....+...++++.+||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 321 111111100 0 001112335678999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhcccccCCCC
Q 006887 291 EYDLRSRPLMTDILRVFKSSQNSVHSDG 318 (627)
Q Consensus 291 ~~dP~~RPs~~eil~~L~~~~~~~~~~~ 318 (627)
..||.+|||+.|+|+ |+||.+.
T Consensus 313 ~~dP~~Rpta~e~L~------Hp~f~~~ 334 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVN------HPWLKDT 334 (362)
T ss_dssp CSSTTTCBCHHHHHT------CGGGTTC
T ss_pred CCChhHCcCHHHHhc------CcccCCC
Confidence 999999999999987 9999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.6e-22 Score=194.04 Aligned_cols=135 Identities=12% Similarity=0.052 Sum_probs=98.2
Q ss_pred eEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchh----------------HHHHHHHHHHHHHHHhcCCC
Q 006887 43 LKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKED----------------RMRVLLERLNDLFLKCQGVE 106 (627)
Q Consensus 43 y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~----------------~~~~~~~~~~~~ll~~~~hp 106 (627)
+.+.++||+|+||+||+|++.. + +.||||+++..... .........+...+..+.|.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g------~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-F------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-T------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred chhCCEeeeCcceEEEEEECCC-C------CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence 4578999999999999998742 2 48999997642110 00001111112245567888
Q ss_pred CceeeEEEEEECCEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccCCCcEEEecCCCe
Q 006887 107 GICWLQGISVINGKICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHSKGILVLNLKPFNFILNEADRA 186 (627)
Q Consensus 107 nIv~l~~~~~~~~~~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gIvHrDLKP~NILld~~g~v 186 (627)
+++..+++. . .+++|||+++... ..++...+..++.|++.+|.|||++||+||||||+|||++++ .+
T Consensus 75 ~v~~~~~~~--~--~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 75 AVPKVYAWE--G--NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp SSCCEEEEE--T--TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EE
T ss_pred CcceEEEec--C--CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CE
Confidence 988877653 2 3799999998432 124556677899999999999999999999999999999965 58
Q ss_pred eeccCCccccc
Q 006887 187 VLGDVGIPHLL 197 (627)
Q Consensus 187 kL~DFGla~~~ 197 (627)
+|+|||+|+..
T Consensus 142 ~liDFG~a~~~ 152 (191)
T d1zara2 142 WIIDFPQSVEV 152 (191)
T ss_dssp EECCCTTCEET
T ss_pred EEEECCCcccC
Confidence 99999998764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=4.2e-06 Score=81.18 Aligned_cols=140 Identities=13% Similarity=0.050 Sum_probs=83.2
Q ss_pred CCeEEEeEEeeeCCeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCE
Q 006887 41 SALKLRHRIGRGPFGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGK 120 (627)
Q Consensus 41 ~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~ 120 (627)
+.|++.+..+.++.+.||+.... +..+.+|+........... ..++...+.....+--+++++.++..++.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~--------~~~~vlk~~~~~~~~~~~~-~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTYD-VEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTTC-HHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hceEEEEcCCCCCCCcEEEEEeC--------CCeEEEEEcCCCcccchhh-HHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 46777776655666799998621 1357889876543221111 11222222222234346778888888999
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 006887 121 ICIIMKFYEGSVGDRMAQLKGGKLSLSNVFRYAIDLAQGILQLHS----------------------------------- 165 (627)
Q Consensus 121 ~~LVmEy~~GsL~d~l~~~~~~~ls~~~~~~i~~qIa~aL~yLHs----------------------------------- 165 (627)
.++||++++|........ +......++.+++..|..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred eEEEEEeccccccccccc------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999844322110 001112223333333444442
Q ss_pred ------------------C------CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 ------------------K------GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ------------------~------gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
. .++|+|+.|.|||+++++...|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27999999999999977666799999664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.62 E-value=9.2e-05 Score=70.97 Aligned_cols=74 Identities=14% Similarity=0.048 Sum_probs=45.7
Q ss_pred EEeeeC-CeEEEEEEEcCCCcCcccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEEECCEEEEEEe
Q 006887 48 RIGRGP-FGEVWLATHYLSTEDCDEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISVINGKICIIMK 126 (627)
Q Consensus 48 ~LG~G~-fG~Vy~a~~~~s~ed~~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~~~~~~~LVmE 126 (627)
.+..|. -+.||+..... +..+++|............+..... .+.... -.+++++.+....+..++||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-------~~~~vlK~~~~~~~~~l~~E~~~l~--~L~~~g-vpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGALNELQDEAARLS--WLATTG-VPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-------SCCEEEEEECSCTTSCHHHHHHHHH--HHHTTT-CCBCCEEEEEECSSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeCC-------CCEEEEEeCCccCHhHHHHHHHHHH--HHHhcC-CCCCceeeecccccceEEEEE
Confidence 344554 36899987422 2358899877655444333322221 222222 237778888888889999999
Q ss_pred cCCCC
Q 006887 127 FYEGS 131 (627)
Q Consensus 127 y~~Gs 131 (627)
+++|.
T Consensus 87 ~i~G~ 91 (255)
T d1nd4a_ 87 EVPGQ 91 (255)
T ss_dssp CCSSE
T ss_pred eeecc
Confidence 99873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.92 E-value=0.00073 Score=69.68 Aligned_cols=28 Identities=11% Similarity=0.090 Sum_probs=24.3
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.++|+|+.|.|||++.++ ++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998664 8999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.89 E-value=0.021 Score=56.54 Aligned_cols=27 Identities=11% Similarity=0.021 Sum_probs=22.3
Q ss_pred CCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 167 GILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 167 gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
++||+|+.|.|||++. + ..++||+-|.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 5899999999999974 3 4588999664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.67 E-value=0.039 Score=53.81 Aligned_cols=30 Identities=17% Similarity=0.097 Sum_probs=26.1
Q ss_pred CCCeecccCCCcEEEecCCCeeeccCCccc
Q 006887 166 KGILVLNLKPFNFILNEADRAVLGDVGIPH 195 (627)
Q Consensus 166 ~gIvHrDLKP~NILld~~g~vkL~DFGla~ 195 (627)
.|+||+|+.++||+++.+...-|.||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.31 E-value=0.042 Score=55.76 Aligned_cols=85 Identities=14% Similarity=0.116 Sum_probs=47.7
Q ss_pred cCCCCeEEEeEEeeeCCeEEEEEEEcCCCcCc-ccccEEEEEEecCCchhHHHHHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006887 38 IKPSALKLRHRIGRGPFGEVWLATHYLSTEDC-DEYHEVAVKILHPVKEDRMRVLLERLNDLFLKCQGVEGICWLQGISV 116 (627)
Q Consensus 38 i~~~~y~i~~~LG~G~fG~Vy~a~~~~s~ed~-~~~~~VAVK~l~~~~~~~~~~~~~~~~~~ll~~~~hpnIv~l~~~~~ 116 (627)
++.+++++. .|+.|--=.+|++......... .....|.+++.-... ...... ++..++.....+.-.+++++++.
T Consensus 40 ~~~~~l~v~-~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~--~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 40 VPLEHLRIS-RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLV--AESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp CCGGGEEEE-EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHH--HHHHHHHHHHHTTSSSCEEEEET
T ss_pred CCccceEEE-EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHH--HHHHHHHHHHhCCCCCeEEEEcC
Confidence 556677764 6887888899999865432111 223467777765322 222221 22222222223333467777763
Q ss_pred ECCEEEEEEecCCC
Q 006887 117 INGKICIIMKFYEG 130 (627)
Q Consensus 117 ~~~~~~LVmEy~~G 130 (627)
+ .+||||++|
T Consensus 116 --~--g~I~efi~g 125 (395)
T d1nw1a_ 116 --G--GRLEEYIPS 125 (395)
T ss_dssp --T--EEEECCCCE
T ss_pred --C--ceEEEEecc
Confidence 3 689999997
|